Citrus Sinensis ID: 044374
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 804 | 2.2.26 [Sep-21-2011] | |||||||
| Q39203 | 797 | G-type lectin S-receptor- | yes | no | 0.920 | 0.928 | 0.622 | 0.0 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.905 | 0.879 | 0.447 | 1e-177 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.898 | 0.827 | 0.336 | 1e-116 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.893 | 0.851 | 0.337 | 1e-112 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.893 | 0.844 | 0.327 | 1e-109 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.891 | 0.851 | 0.335 | 1e-108 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.891 | 0.846 | 0.332 | 1e-108 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.884 | 0.867 | 0.321 | 1e-104 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.855 | 0.829 | 0.338 | 1e-104 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.853 | 0.876 | 0.330 | 1e-103 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/771 (62%), Positives = 571/771 (74%), Gaps = 31/771 (4%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFAT-NGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
+VIIKGN TI+S FRLGFF+T NG S+WYLGI YAS+PTPT+VWVANR + V+D
Sbjct: 24 KVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 83
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
STL +T G L + + ++ ++WQ+ N + TD ETGNL+L++ GS VWQSFD+PTD
Sbjct: 84 STLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTD 143
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ ++TSW+SLFDPSPGFYSLRLSP+ +N+ +LVY GT YWSTGNWTG A
Sbjct: 144 TWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPS-FNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQ 240
FV VPEMTIPYIY+FHF+NPYT ASF Y PLD+ +P L+RF V +GQLKQYTW
Sbjct: 203 FVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 241 QTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCS 300
QT WNMFW QPED CRV+ LCG GFC S LL+PC C GFRP + W S DYS GC
Sbjct: 263 QTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAWRSDDYSDGCR 322
Query: 301 RESKVLCDQSDWFEEVGVVEFIGAVTES-FSAGRSICERSCLANCSCIGLYHDVRTNLCK 359
RE+ ++SD FE VG + + G V S +S C ++CL N SC+G YH ++NLCK
Sbjct: 323 RENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCK 382
Query: 360 NLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAAL--VLAAV 417
L NL+N + NIS ++++ +VGSI+ L L
Sbjct: 383 ILLESPNNLKN--------------------SKGNISKSIIILCSVVGSISVLGFTLLVP 422
Query: 418 MLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS- 476
++++ R +++K+ +ED F VLNLKVFS+KEL + T GFS+K+GHGGFGAVF+G L
Sbjct: 423 LILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPG 482
Query: 477 DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536
ST VAVKRLERPGSGE EFRAEVCTIGNIQHVNLVRLRGFCSEN HRLLVYDYM G+L
Sbjct: 483 SSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSL 542
Query: 537 SLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595
S YL + L+W+ RFRIA+GTA+GIAYLHE CRDCIIHCDIKPENILLDSDY AKVS
Sbjct: 543 SSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVS 602
Query: 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVE 655
DFGLAKL+GRDFSRVLATMRGTWGYVAPEWISGL ITTKADVYS+GMTLLELIGGRRNV
Sbjct: 603 DFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVI 662
Query: 656 APASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAI 715
+ +G +KWFFPPWAAR+II+GNV +VVD RL G Y EE R+A VAI
Sbjct: 663 V----NSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAI 718
Query: 716 WCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDS 766
WCIQDNEE+RP MGTVVKMLEGV+EVT PPPP+LIQALVSG+SY GV S
Sbjct: 719 WCIQDNEEIRPAMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGVSGTS 769
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1609), Expect = e-177, Method: Compositional matrix adjust.
Identities = 351/784 (44%), Positives = 484/784 (61%), Gaps = 56/784 (7%)
Query: 1 GRVIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
G + G+ TI+S + T+ +GFF S++Y+G+WY + + T +WVANR+K+V+D
Sbjct: 28 GDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQL-SQTILWVANRDKAVSDKNS 86
Query: 61 STLLITEKGKLAIKDSQNSIIW----QSTNTEKATDMYLLETGNLVLLSSAGSL----VW 112
S I+ + + + + +W ST++ A + L + GNLVL + SL +W
Sbjct: 87 SVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLW 146
Query: 113 QSFDHPTDTWLPGMNISV------GGSITSWKSLFDPSPGFYSLRL-SPTGYNQIELVYN 165
QSFDHP DTWLPG+ I + +TSWKSL DPSPG +SL L T Y ++++N
Sbjct: 147 QSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAY---KILWN 203
Query: 166 GTIVYWSTGNWTGNA--FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLS 223
G+ YWS+G W + F +VPEM + YIY F F + T+ + F Y+ N +S
Sbjct: 204 GSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSN-TTDSYFTYSIYNQLN-----VS 257
Query: 224 RFHVDPSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFR 283
RF +D SGQ+KQ+TW + WN+FWSQP C+V+ CG+FG C C C GFR
Sbjct: 258 RFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFR 317
Query: 284 PVDCYGWNSGDYSGGCSRESKVLCDQSD--WFEEVGVVEFIGAVTESFSAGRSICERSCL 341
P+ W+ DYS GC R++++ C + D F + ++ SIC +C
Sbjct: 318 PMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQ 377
Query: 342 ANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVR-----APRGGTERKNIS 396
+CSC +D ++ C ++LNL+ L +++ +I Y+R P G K+ +
Sbjct: 378 GDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNN 437
Query: 397 TLMVLVAGIVGSIAALVLAAVMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTR 456
++ A ++GS+ +VL ++++++ + R++++ E+ L FSY+EL T+
Sbjct: 438 KGLIFGA-VLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDG---TLSAFSYRELQNATK 493
Query: 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
FS+KLG GGFG+VF+G L DS+ +AVKRLE GE++FR EV TIG IQHVNLVRLRG
Sbjct: 494 NFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRG 553
Query: 517 FCSENSHRLLVYDYMRNGALSLYL----RKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
FCSE S +LLVYDYM NG+L +L ++ + L W +RF+IA+GTARG+AYLH+ECRD
Sbjct: 554 FCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRD 613
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
CIIHCDIKPENILLDS + KV+DFGLAKL+GRDFSRVL TMRGT GY+APEWISG+AIT
Sbjct: 614 CIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAIT 673
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-EGNVA 691
KADVYSYGM L EL+ GRRN E E+ FFP WAA + +G++
Sbjct: 674 AKADVYSYGMMLFELVSGRRNTEQ------------SENEKVRFFPSWAATILTKDGDIR 721
Query: 692 AVVDDRL-GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLI 750
++VD RL G A +EE R VA WCIQD E RP M VV++LEGVLEV PP PR I
Sbjct: 722 SLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSI 781
Query: 751 QALV 754
QALV
Sbjct: 782 QALV 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 284/844 (33%), Positives = 428/844 (50%), Gaps = 122/844 (14%)
Query: 8 NSTIISQNQTFRLGFFATNGESSWYLGIWYASIP-TPTYVWVANREKSVADVTQSTLLIT 66
N +S N TF +GF + L IW+A +P PT VW NR V ++ L +
Sbjct: 42 NRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNSPVTK--EAVLELE 99
Query: 67 EKGKLAIKDSQNSIIWQSTNTEKATDMYLL-ETGNLVLLSS---AGSLVWQSFDHPTDTW 122
G L + D QN+++W S + + ++ E+GN +LL + AG +WQSF P+DT
Sbjct: 100 ATGNLVLSD-QNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTL 158
Query: 123 LPGMNISVGGSITSWKSLFDPSP---GFYSLRLSPTGYN-QIELVYN------GTIVYWS 172
LP ++V +TS +PSP G YSL++ + + L YN YWS
Sbjct: 159 LPNQPLTVSLELTS-----NPSPSRHGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWS 213
Query: 173 -------TGNWT------GNAFVNVPEMTIPYIYKFHFLNP------YTSKASFGYTEKP 213
TG+ T G+ + E +I +Y + NP Y + ++ G T+ P
Sbjct: 214 GPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYK--NPVDDNRNYNNSSNLGLTKNP 271
Query: 214 LDNGQKPPLSRFHVDPSGQLKQYTWSQQ---TDYWNMFWSQPEDICRVHGLCGNFGFCKS 270
+ L R ++ +G L+ Y W + W W+ + C + G+CGN G C
Sbjct: 272 V-------LRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICGN-GVCNL 323
Query: 271 SLLRP---CMCFDGFRPVDCYGWNSGDYSGGCSRESKVL--CDQSD-------------- 311
+ C+C G + + + CS S ++ C+ +
Sbjct: 324 DRTKKNADCLCLPGSVKLP-----DQENAKLCSDNSSLVQECESNINRNGSFKISTVQET 378
Query: 312 --WFEEVGVVEFIGAVTESFSAGRSICERSCLANCSCIGLYHDVRTNLCKNLYGELLNLR 369
+F E V+E I ++ C CL++C C+ + + + Y +L
Sbjct: 379 NYYFSERSVIENISDISNVRK-----CGEMCLSDCKCVASVYGLDD---EKPYCWILKSL 430
Query: 370 NLTSDSTNEDILYVRA-----------PRGGTERKN--ISTLMVLVAGIVGSIAALVLAA 416
N L+V+ RK+ + ++++ +VG + + L
Sbjct: 431 NFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLG 490
Query: 417 VMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS 476
++L +++ K + + + F+Y++L T FS+ LG GGFG V++G ++
Sbjct: 491 MLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVA 550
Query: 477 DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535
TLVAVKRL+R S GEREF EV TIG++ H+NLVRL G+CSE+SHRLLVY+YM NG+
Sbjct: 551 GETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGS 610
Query: 536 LSLYL---RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTA 592
L ++ + L+W RF IAV TA+GIAY HE+CR+ IIHCDIKPENILLD ++
Sbjct: 611 LDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCP 670
Query: 593 KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652
KVSDFGLAK++GR+ S V+ +RGT GY+APEW+S IT KADVYSYGM LLE++GGRR
Sbjct: 671 KVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRR 730
Query: 653 NVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVAL 712
N++ + +F+P WA +++ G VD RL G + EE +
Sbjct: 731 NLDM------------SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALK 778
Query: 713 VAIWCIQDNEEMRPTMGTVVKMLEGVL-EVTAPPPPRLIQALVS---GESYHGVRKDSSN 768
VA WCIQD MRP+MG VVK+LEG E+ PP P+ I L+ + Y +R++ +N
Sbjct: 779 VAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILELIEEGLEDVYRAMRREFNN 838
Query: 769 GVGT 772
+ +
Sbjct: 839 QLSS 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-112, Method: Compositional matrix adjust.
Identities = 269/798 (33%), Positives = 401/798 (50%), Gaps = 80/798 (10%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQST 62
+ I N TIIS +Q F LGFF S WYLGIWY IP TYVWVANR+ ++ + T
Sbjct: 36 LTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS-SNGT 94
Query: 63 LLITEKGKLAIKDSQNSIIWQST----NTEKATDMYLLETGNLVLLSSAGSLVWQSFDHP 118
L I+ L I D + +W + + LL+ GN +L S L+WQSFD P
Sbjct: 95 LKIS-GNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNNRLLWQSFDFP 153
Query: 119 TDTWLPGMNIS------VGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWS 172
TDT L M + + SWK+ DPS G +S +L + + + + +I+Y S
Sbjct: 154 TDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRS 213
Query: 173 TGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQ 232
G W G F +VP TI Y + + ++ Y + SR +++ +G
Sbjct: 214 -GPWNGMRFSSVPG-TIQVDYMVYNFTASKEEVTYSYRINKTN-----LYSRLYLNSAGL 266
Query: 233 LKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNS 292
L++ TW + T W W P+D+C + +CGNFG+C S+ L C C GF+PV+ W+
Sbjct: 267 LQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDL 326
Query: 293 GDYSGGCSRESKVLCDQSDWFEEVGVVEF--IGAVTESFSAGRSICERSCLANCSCIGLY 350
D S GC R++++ CD D F + ++ A G +C+ CL +C+C
Sbjct: 327 RDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFA 386
Query: 351 H-DVRT--NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVG 407
+ D+R + C E+L++RN + LYVR E K I ++ + I
Sbjct: 387 NADIRNGGSGCVIWTREILDMRNYAKGGQD---LYVRLAAAELEDKRIKNEKIIGSSIGV 443
Query: 408 SIAALVLAAVMLMILRKKRKKRKDVDEEDVFP-----------VLNLKVFSYKELH---- 452
SI L+L+ V+ ++K+K+ + +V V++ + ++ KE
Sbjct: 444 SI-LLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYL 502
Query: 453 -----------TVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-GEREFRA 498
T T FS KLG GGFG V++G L D +AVKRL + S G EF
Sbjct: 503 ELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMN 562
Query: 499 EVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS--LYLRKDGLNLNWDVRFRIA 556
EV I +QH+NLVRL G C + ++L+Y+Y+ N +L L+ + NLNW RF I
Sbjct: 563 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 622
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR- 615
G ARG+ YLH++ R IIH D+K N+LLD + T K+SDFG+A++ GR+ + T R
Sbjct: 623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA-NTRRV 681
Query: 616 -GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDK 674
GT+GY++PE+ + K+DV+S+G+ LLE+I G+RN S R+ N+ G
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG------- 734
Query: 675 WFFPPWAARQIIEGNVAAVVD----DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730
+ R EGN +VD D L + E R + + C+Q+ E RP M +
Sbjct: 735 -----FVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSS 789
Query: 731 VVKMLEGVLEVTAPPPPR 748
V+ ML E TA P P+
Sbjct: 790 VMVMLGS--ETTAIPQPK 805
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 262/799 (32%), Positives = 395/799 (49%), Gaps = 81/799 (10%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQST 62
+ I N+TI+S F LGFF +S WYLGIWY +I TYVWVANR+ ++ + T
Sbjct: 38 LTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSS-SIGT 96
Query: 63 LLITEKGKLAIKDSQNSIIWQST----NTEKATDMYLLETGNLVLLSSAGS----LVWQS 114
L I++ L + D ++ +W + + LL+ GN VL S S ++WQS
Sbjct: 97 LKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQS 155
Query: 115 FDHPTDTWLPGMNISVGGS------ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTI 168
FD PTDT LP M + I SWKS DPS G +S +L G+ +I ++N
Sbjct: 156 FDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEI-FLWNRES 214
Query: 169 VYWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVD 228
+ +G W G F VPEM +++ N TSK Y+ + + SR +
Sbjct: 215 RMYRSGPWNGIRFSGVPEMQP---FEYMVFNFTTSKEEVTYSFRIT---KSDVYSRLSIS 268
Query: 229 PSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCY 288
SG L+++TW + WN FW P+D C + CG +G+C S+ C C GF+P +
Sbjct: 269 SSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQ 328
Query: 289 GWNSGDYSGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCSC 346
W D S GC R++ + C D F + ++ T S G + CE+ CL +C+C
Sbjct: 329 VWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNC 388
Query: 347 IGLYH-DVR--TNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVA 403
+ D+R + C GEL ++RN + LYVR E K + ++ +
Sbjct: 389 TAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQD---LYVRLAATDLEDKRNRSAKIIGS 445
Query: 404 GIVGSIAALVLAAVMLMILRKKRKK---------------------------RKDVDEED 436
I G L+L+ ++ + ++K+K+ R+ + E+
Sbjct: 446 SI-GVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISREN 504
Query: 437 VFPVLNLKVFSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPG-SGE 493
L L + ++E+ T FS KLG GGFG V++G+L D +AVKRL + G
Sbjct: 505 NTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGT 564
Query: 494 REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN--LNWDV 551
EF+ EV I +QH+NLVRL C + ++L+Y+Y+ N +L +L N LNW +
Sbjct: 565 DEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQM 624
Query: 552 RFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV- 610
RF I G ARG+ YLH++ R IIH D+K NILLD T K+SDFG+A++ GRD +
Sbjct: 625 RFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEAN 684
Query: 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE 670
+ GT+GY++PE+ + K+DV+S+G+ LLE+I +RN S R+ N+ G
Sbjct: 685 TRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGC-- 742
Query: 671 HGDKWFFPPWAARQIIEGNVAAVVDDRL---GGAYKVEEAERVALVAIWCIQDNEEMRPT 727
R EG ++D + ++ E R + + C+Q+ E RPT
Sbjct: 743 ----------VWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPT 792
Query: 728 MGTVVKMLEGVLEVTAPPP 746
M V+ ML G T P P
Sbjct: 793 MSLVILML-GSESTTIPQP 810
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1014), Expect = e-108, Method: Compositional matrix adjust.
Identities = 267/796 (33%), Positives = 403/796 (50%), Gaps = 79/796 (9%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I+ ++IS++++F LGFF + Y+GIWY +I T VWVANREK + D + L
Sbjct: 38 IREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLD-HKGALK 96
Query: 65 ITEKGKLAIKDSQNSIIWQSTNTEKATD---MYLLETGNLVLLSSAG--SLVWQSFDHPT 119
I + G L I + QN IW STN E ++ L +TG+LVL S + W+SF++PT
Sbjct: 97 IADDGNLVIVNGQNETIW-STNVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWESFNNPT 155
Query: 120 DTWLPGMNISVGGSI------TSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWST 173
DT+LPGM + V S+ WKS DPSPG YS+ + P G +I +++ G W +
Sbjct: 156 DTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEI-VIWEGEKRKWRS 214
Query: 174 GNWTGNAFVNVPEMT--IPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSG 231
G W F +P+M YIY F +P S +T D+ RF + P G
Sbjct: 215 GPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSD---FLRFWIRPDG 271
Query: 232 QLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSL---LRPCMCFDGFRPVDCY 288
+Q+ W++ WN+ +P C + CGN+ C S C C DGF PV
Sbjct: 272 VEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQD 331
Query: 289 GWNSGDYSGGCSRESKVLCDQSDWF-EEVGVVEFIGAVTESFSA-----GRSICERSCLA 342
WN+ D+SGGC R + C+QS +E G G F + C+ C
Sbjct: 332 QWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCAR 391
Query: 343 NCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLV 402
+CSC Y V C +L+++ + + +I + GG K STL ++V
Sbjct: 392 DCSCKA-YALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGG--KENSTLWIIV 448
Query: 403 AGIVGSIAALVLAAVMLMILRKKRK----KRKDVDEEDVF--------PVL--------- 441
++G+ L L +L +K K K+KD+ D+ P+
Sbjct: 449 FSVIGAFL-LGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVDT 507
Query: 442 -NLKVFSYKELHTVTRGFSE--KLGHGGFGAVFQGELSDSTLVAVKRLE-RPGSGEREFR 497
+L +FS+ + + T F+E KLG GGFG V++G S+ +AVKRL + G EF+
Sbjct: 508 PDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFK 567
Query: 498 AEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFR 554
E+ I +QH NLVRL G C E++ ++L+Y+YM N +L +L K G +L+W R+
Sbjct: 568 NEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQG-SLDWRKRWE 626
Query: 555 IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG--RDFSRVLA 612
+ G ARG+ YLH + R IIH D+K NILLD++ K+SDFG+A++ +D + +
Sbjct: 627 VIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIR 686
Query: 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHG 672
+ GT+GY+APE+ + K+DVYS+G+ +LE++ GR+NV + + IG
Sbjct: 687 VV-GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIG------ 739
Query: 673 DKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV 732
+A +G ++D + V EA R V + C QD+ RP MG+V+
Sbjct: 740 -------YAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVL 792
Query: 733 KMLEGVLEVTAPPPPR 748
MLE + + PPPR
Sbjct: 793 LMLES--QTSQLPPPR 806
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 267/803 (33%), Positives = 393/803 (48%), Gaps = 86/803 (10%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQST 62
+ I N TIIS +Q F LGFF + S WYLGIWY IP TYVWVANR+ ++ + T
Sbjct: 36 LTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS-SNGT 94
Query: 63 LLITEKGKLAIKDSQNSIIWQST----NTEKATDMYLLETGNLVLLSSAGS----LVWQS 114
L I++ L I D + +W + + LL+ GN VL S + +WQS
Sbjct: 95 LKISDNN-LVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153
Query: 115 FDHPTDTWLPGMNI----SVGG---SITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGT 167
FD PTDT L M + GG + SWK+ DPS G +S +L +G+ + +YN
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEF-YIYNKE 212
Query: 168 IVYWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHV 227
+ + +G W GN F +VP M P Y + + + Y + S +
Sbjct: 213 SITYRSGPWLGNRFSSVPGMK-PVDYIDNSFTENNQQVVYSYRVNKTN-----IYSILSL 266
Query: 228 DPSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDC 287
+G L++ TW + W W P+D+C + CGN+G+C ++ C C GF P++
Sbjct: 267 SSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNE 326
Query: 288 YGWNSGDYSGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCS 345
D S GC R++K+ CD D F + + S G + CE CL C+
Sbjct: 327 QAALRDD-SVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCN 385
Query: 346 CIGLYH-DVRT--NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLV 402
C + D+R + C G L ++RN + LYVR G E K I + ++
Sbjct: 386 CTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQD---LYVRVAAGDLEDKRIKSKKIIG 442
Query: 403 AGIVGSIAALVLAAVMLMILRKKRKK--------------------------RKDVDEED 436
+ I SI L+L+ ++ ++K+K+ R +E+
Sbjct: 443 SSIGVSIL-LLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKEN 501
Query: 437 VFPVLNLKVFSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-GE 493
L L + +K L T FS KLG GGFG V++G L D +AVKRL + S G
Sbjct: 502 KTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGT 561
Query: 494 REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS--LYLRKDGLNLNWDV 551
EF EV I +QH+NLVRL G C + ++L+Y+Y+ N +L L+ + NLNW
Sbjct: 562 DEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQK 621
Query: 552 RFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611
RF I G ARG+ YLH++ R IIH D+K N+LLD + T K+SDFG+A++ GR+ +
Sbjct: 622 RFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA- 680
Query: 612 ATMR--GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG 669
T R GT+GY++PE+ + K+DV+S+G+ LLE+I G+RN S R+ N+ G
Sbjct: 681 NTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG-- 738
Query: 670 EHGDKWFFPPWAARQIIEGNVAAVVD----DRLGGAYKVEEAERVALVAIWCIQDNEEMR 725
+ R EG +VD D L + E R + + C+Q+ E R
Sbjct: 739 ----------FVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDR 788
Query: 726 PTMGTVVKMLEGVLEVTAPPPPR 748
P M +V+ ML E TA P P+
Sbjct: 789 PVMSSVMVMLGS--ETTAIPQPK 809
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (978), Expect = e-104, Method: Compositional matrix adjust.
Identities = 254/789 (32%), Positives = 393/789 (49%), Gaps = 78/789 (9%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
+ + TI+S +TFR GFF+ +S Y GIWY S+ T +WVAN++K + D + +
Sbjct: 36 LNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWVANKDKPIND-SSGVIS 94
Query: 65 ITEKGKLAIKDSQNSIIWQSTNTEKA----TDMYLLETGNLVLL-SSAGSLVWQSFDHPT 119
+++ G L + D Q ++W + + +A T LL++GNLVL +S+ + +W+SF +PT
Sbjct: 95 VSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAELLDSGNLVLKEASSDAYLWESFKYPT 154
Query: 120 DTWLPGM----NISVGG---SITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTI--VY 170
D+WLP M N +GG +ITSWKS DPSPG Y+ L Y ++ ++ N
Sbjct: 155 DSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTV 214
Query: 171 WSTGNWTGNAFVNVPEMTI-PYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDP 229
W +G W G F +P++ ++Y+F + + Y L F++D
Sbjct: 215 WRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSY-------ANDSTLRYFYMDY 267
Query: 230 SGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYG 289
G + + WS+ W + P C + CG F C C C GFRP +
Sbjct: 268 RGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIE 327
Query: 290 WNSGDYSGGCSRESKVLCDQ------SDWFEEVGVVEFIGAVTESFSAGRSICERSCLAN 343
WN+G++SGGC+R + C++ +D F + ++ S A C R+CL
Sbjct: 328 WNNGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKLPDFARRS-EASEPECLRTCLQT 386
Query: 344 CSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMV--L 401
CSCI H + C G L++ + L++ + LY+R + K+ +++ +
Sbjct: 387 CSCIAAAHGLGYG-CMIWNGSLVDSQELSASGLD---LYIRLAHSEIKTKDKRPILIGTI 442
Query: 402 VAGIVGSIAALVLAAVMLMILRKKRKKRKDVDEEDVF------------PVLNLKVFSYK 449
+AG + +AA VL A I+ KKR K+K D E +F + L +F ++
Sbjct: 443 LAGGIFVVAACVLLA--RRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKELPLFEFQ 500
Query: 450 ELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERP-GSGEREFRAEVCTIGNI 506
L T FS KLG GGFG V++G+L + +AVKRL R G G E EV I +
Sbjct: 501 VLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKL 560
Query: 507 QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGTARGI 563
QH NLV+L G C R+LVY++M +L YL R+ L L+W RF I G RG+
Sbjct: 561 QHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKL-LDWKTRFNIINGICRGL 619
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVA 622
YLH + R IIH D+K NILLD + K+SDFGLA++ G + + GT+GY+A
Sbjct: 620 LYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMA 679
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PE+ G + K+DV+S G+ LLE+I GRRN + + + W
Sbjct: 680 PEYAMGGLFSEKSDVFSLGVILLEIISGRRNSNSTLLA--------------YVWSIWN- 724
Query: 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG-VLEV 741
EG + ++VD + +E + + + C+Q+ RP++ TV ML + ++
Sbjct: 725 ----EGEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADI 780
Query: 742 TAPPPPRLI 750
P P I
Sbjct: 781 PEPKQPAFI 789
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 265/784 (33%), Positives = 390/784 (49%), Gaps = 96/784 (12%)
Query: 13 SQNQTFRLGFFATNGESSWYLGIWYA-SIPTPTYVWVANREKSVADVTQSTLLITEKGKL 71
S N TF + F + +S+ + +A S+P +W A S + +L + G L
Sbjct: 44 SPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSAGTVDS-----RGSLRLHTSGSL 94
Query: 72 AIKDSQNSIIWQS-TNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISV 130
+ + + +W S T+ T + +TG +LL++ VW SFD+PTDT + N +
Sbjct: 95 RLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTA 154
Query: 131 GGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNAFVNV-PEMTI 189
G + S G YS +L +G + L +N + +YW+ G + + P +++
Sbjct: 155 GKILRS---------GLYSFQLERSG--NLTLRWNTSAIYWNHGLNSSFSSNLSSPRLSL 203
Query: 190 PY-----IYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYT-WSQQTD 243
I++ + L A Y+ D G +D G L+ Y+ S+ +
Sbjct: 204 QTNGVVSIFESNLLG----GAEIVYSG---DYGDSNTFRFLKLDDDGNLRIYSSASRNSG 256
Query: 244 YWNMFWSQPEDICRVHGLCGNFGFCKSSLLRP-CMCFD-GFRPVDCYGWNSGDYSGGCSR 301
N WS D C V+G CGNFG C + P C C F VD D GC R
Sbjct: 257 PVNAHWSA-VDQCLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDV-----NDRRKGCKR 310
Query: 302 ESKVLCDQSDWFEEVGVVEFIGAV---------TESFSAGRSICERSCLANCSCIGL--Y 350
+ ++ SD +++ + +ESF AG S C +CL++ C+
Sbjct: 311 KVEL----SDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSM 366
Query: 351 HDVRTNLCKNLYGELLNLRNLTSDSTNEDILYV---------RAPRGGTERKNISTLMVL 401
D N + G S + + RA +G + +V
Sbjct: 367 SDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVA 426
Query: 402 VAGIVGSIAALVLAAVMLMILRKKRKKRKDVDEEDVF-------PVLNLKVFSYKELHTV 454
VA I G + + + + +K + + PV F+YKEL
Sbjct: 427 VAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQ----FTYKELQRC 482
Query: 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRL 514
T+ F EKLG GGFG V++G L++ T+VAVK+LE GE++FR EV TI + H+NLVRL
Sbjct: 483 TKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 542
Query: 515 RGFCSENSHRLLVYDYMRNGALS--LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
GFCS+ HRLLVY++MRNG+L L+ L W+ RF IA+GTA+GI YLHEECRD
Sbjct: 543 IGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRD 602
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIG-RDFSRVLATMRGTWGYVAPEWISGLAI 631
CI+HCDIKPENIL+D ++ AKVSDFGLAKL+ +D ++++RGT GY+APEW++ L I
Sbjct: 603 CIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPI 662
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691
T+K+DVYSYGM LLEL+ G+RN + E + F WA + +GN
Sbjct: 663 TSKSDVYSYGMVLLELVSGKRNFDV------------SEKTNHKKFSIWAYEEFEKGNTK 710
Query: 692 AVVDDRLGGAYKV--EEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRL 749
A++D RL V E+ R+ + WCIQ+ RPTMG VV+MLEG+ E+ P P+
Sbjct: 711 AILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKT 770
Query: 750 IQAL 753
I +
Sbjct: 771 ISEV 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 256/774 (33%), Positives = 399/774 (51%), Gaps = 88/774 (11%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
+K TI+SQ +F +GFF+ G + YLGIWY I T VWVANR+ + D++ TL
Sbjct: 33 LKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLYDLS-GTLK 91
Query: 65 ITEKGKLAIKDSQNSIIWQSTNT---EKAT----DMYLLETGNLVLLSSAGS--LVWQSF 115
++E G L + + +N IIW S+++ +KA+ + +L+TGNLV+ +S +WQS
Sbjct: 92 VSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSGDDQDYIWQSL 151
Query: 116 DHPTDTWLPGM----NISVGGS--ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIV 169
D+P D +LPGM N G + +TSW+++ DPS G Y+ ++ P G Q L N +V
Sbjct: 152 DYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVV 211
Query: 170 YWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDP 229
+ TG W G F +P + IY++ ++ +T + + YT K L+N L+R ++P
Sbjct: 212 F-RTGPWNGLRFTGMPNLKPNPIYRYEYV--FTEEEVY-YTYK-LEN--PSVLTRMQLNP 264
Query: 230 SGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYG 289
+G L++YTW WN + S D C + LCG++G C + C C GF
Sbjct: 265 NGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQA 324
Query: 290 WNSGDYSGGCSRESKVLCDQ-SDWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCSC 346
W +GD+S GC R K+ C + D F ++ ++ T + + C++ CL NC+C
Sbjct: 325 WVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTC 384
Query: 347 IGLY-HDVRT--NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVA 403
D+R C +G+L+++R + + LYVR
Sbjct: 385 SAYSPFDIRDGGKGCILWFGDLIDIREYNENGQD---LYVR------------------- 422
Query: 404 GIVGSIAALVLAAVMLMILRKKRKK---RKDVDEEDVFPVLNLKVFSYKELHTVTRGFS- 459
LA+ + L+++ + RK +E+ P L+L S T GFS
Sbjct: 423 ----------LASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVS-----EATSGFSA 467
Query: 460 -EKLGHGGFGAVFQGELSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGF 517
KLG GGFG V++G L+ VAVKRL R G EF+ E+ I +QH NLV++ G+
Sbjct: 468 GNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGY 527
Query: 518 CSENSHRLLVYDYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
C + R+L+Y+Y N +L ++ ++ L+W R I G ARG+ YLHE+ R II
Sbjct: 528 CVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRII 587
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT-MRGTWGYVAPEWISGLAITTK 634
H D+K N+LLDSD AK+SDFGLA+ +G D + T + GT+GY++PE+ + K
Sbjct: 588 HRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLK 647
Query: 635 ADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694
+DV+S+G+ +LE++ GRRN N+ G A RQ +E ++
Sbjct: 648 SDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGH------------AWRQFLEDKAYEII 695
Query: 695 DDRLG-GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPP 747
D+ + + E RV + + C+Q + + RP M VV ML + + P P
Sbjct: 696 DEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQP 749
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 804 | ||||||
| 224130324 | 821 | predicted protein [Populus trichocarpa] | 0.929 | 0.909 | 0.694 | 0.0 | |
| 359489821 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.957 | 0.957 | 0.660 | 0.0 | |
| 240255701 | 818 | receptor-like protein kinase 4 [Arabidop | 0.940 | 0.924 | 0.634 | 0.0 | |
| 356522602 | 837 | PREDICTED: G-type lectin S-receptor-like | 0.956 | 0.918 | 0.602 | 0.0 | |
| 357514545 | 835 | S-locus-specific glycoprotein [Medicago | 0.956 | 0.920 | 0.601 | 0.0 | |
| 75319455 | 797 | RecName: Full=G-type lectin S-receptor-l | 0.920 | 0.928 | 0.622 | 0.0 | |
| 297814301 | 811 | hypothetical protein ARALYDRAFT_327738 [ | 0.925 | 0.917 | 0.625 | 0.0 | |
| 6049881 | 790 | Similar to receptor-like protein kinase | 0.910 | 0.926 | 0.613 | 0.0 | |
| 351726734 | 690 | receptor-like protein kinase precusor-li | 0.818 | 0.953 | 0.616 | 0.0 | |
| 357504427 | 711 | S-locus-specific glycoprotein [Medicago | 0.812 | 0.918 | 0.595 | 0.0 |
| >gi|224130324|ref|XP_002320809.1| predicted protein [Populus trichocarpa] gi|222861582|gb|EEE99124.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1116 bits (2886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/777 (69%), Positives = 620/777 (79%), Gaps = 30/777 (3%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQST 62
V+I GNSTI S N+TF LGF G+ +WYL I YASIPTP VWVANREK + ++T +
Sbjct: 54 VLITGNSTISSLNKTFNLGFVNPGGKPNWYLAISYASIPTPPIVWVANREKPITNLTSTR 113
Query: 63 LLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTW 122
L IT +GKLAI S IWQSTNTE+A + L E GNLVLLS+ G ++WQSFD PTDTW
Sbjct: 114 LEITAEGKLAIIALPGSTIWQSTNTEEARGLLLQENGNLVLLSAEGLIIWQSFDFPTDTW 173
Query: 123 LPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNAFV 182
LPGMNI+ S+ SW+S+ DPSPG +SLR++P G+N+ ELVYN + YWSTGNWTG+AF
Sbjct: 174 LPGMNITSERSLISWRSINDPSPGLFSLRINPLGFNEFELVYNKSAKYWSTGNWTGDAFN 233
Query: 183 NVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQQT 242
VPEMTIPYIYKFHF +P+T ASF YTE+ LD G +PPL+RF VD GQLKQYTW+QQ
Sbjct: 234 GVPEMTIPYIYKFHFSDPFTPSASFWYTERELDGGLRPPLTRFQVDVIGQLKQYTWTQQN 293
Query: 243 DYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCSRE 302
+YWNMFWSQP++ CRV+GLCGN G C S+LL+PC+C GF PV Y W S DY+GGC RE
Sbjct: 294 EYWNMFWSQPDNKCRVYGLCGNLGVCNSTLLKPCVCVSGFIPVSDYDWESEDYTGGCVRE 353
Query: 303 SKVLCDQSDWFEEVGVVEFIGAVTESFSAGRSICERSCLANCSCIGLYHDVRTNLCKNLY 362
S+ LC++SD F E GVV F GA SF R++CER+CL+NCSCIGL+HD +T+LCKNLY
Sbjct: 354 SRDLCEESDGFMEFGVVRFEGAAMVSFGGTRNVCERTCLSNCSCIGLFHDGKTHLCKNLY 413
Query: 363 GELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAALVLAAVMLMIL 422
G LLNLRN +SDST +D+LYVR P+ G RK +S ++L+ I GS+ L L A ML+IL
Sbjct: 414 GSLLNLRNSSSDSTFQDVLYVRVPKEGIVRKGVSKSVLLIGSIGGSVVLLGLVAGMLLIL 473
Query: 423 RKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVA 482
RK+RK K V+ + VFP LNLKVF+YKEL TRGFS+KLGHGGFGAVFQGEL DSTLVA
Sbjct: 474 RKRRKNGKGVEGDGVFPGLNLKVFTYKELCAATRGFSDKLGHGGFGAVFQGELLDSTLVA 533
Query: 483 VKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK 542
VKRLERPGSGE+EFRAEVCTIGNIQH+NLVRLRGFCSE+SHRLL+YDYM NG LS YLR+
Sbjct: 534 VKRLERPGSGEKEFRAEVCTIGNIQHINLVRLRGFCSESSHRLLIYDYMPNGPLSAYLRR 593
Query: 543 DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602
DGLNL WDVRFR+AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL
Sbjct: 594 DGLNLIWDVRFRVAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 653
Query: 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRN 662
IGRDFSRVLATMRGTWGYVAPEWISG+AITTKADVYSYGMTLLEL+GGRRN
Sbjct: 654 IGRDFSRVLATMRGTWGYVAPEWISGVAITTKADVYSYGMTLLELLGGRRN--------- 704
Query: 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNE 722
+IIEGNVAAVVDDRLG AY +EEA+RVA VA+WCIQDNE
Sbjct: 705 ---------------------KIIEGNVAAVVDDRLGSAYDIEEAQRVASVAVWCIQDNE 743
Query: 723 EMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSSNGVGTGGDGSGD 779
EMRPTMG VVKMLEGV+EVT PPPP+L+QALVSGESYHGV+ DS GV GGD GD
Sbjct: 744 EMRPTMGMVVKMLEGVVEVTTPPPPKLLQALVSGESYHGVQIDSGKGVSIGGDCCGD 800
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489821|ref|XP_002276095.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1058 bits (2736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/783 (66%), Positives = 607/783 (77%), Gaps = 13/783 (1%)
Query: 1 GRVIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
G V+I GN TI+S+N TF++GFF+ NG +WYLGIWYAS+PTPTYVWVANRE V V
Sbjct: 22 GEVLITGNKTILSENGTFKMGFFSANGGPNWYLGIWYASLPTPTYVWVANRETPVKSVES 81
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
+T+ + G+L I + S++WQ+TN EK+T + LLE+GNLVLLS +VWQSFD P D
Sbjct: 82 ATVELGGDGRLKIMEVGGSVVWQTTNVEKSTAVKLLESGNLVLLSRKEKVVWQSFDFPAD 141
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ SIT WKS DPSPG YSLRL P Y + ELV+NGT++YWSTGNWTG+
Sbjct: 142 TWLPGMNMTAHRSITCWKSSVDPSPGSYSLRLKPPDYGEFELVFNGTMMYWSTGNWTGDR 201
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDN---GQKPPLSRFHVDPSGQLKQYT 237
F VPEMTIPYIYKF FL+P+T A+F YT L+N G +PPL+RFHVD SG L+QYT
Sbjct: 202 FAGVPEMTIPYIYKFRFLHPFTPAAAFWYTATALENSGGGGRPPLNRFHVDSSGLLRQYT 261
Query: 238 WSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSG 297
W QTD WNMFWSQPE+ CRV+GLCGN G C + L+PC C GF+P D W+SGD+SG
Sbjct: 262 WFPQTDTWNMFWSQPENRCRVYGLCGNLGLCNTVTLKPCECLAGFQPSDELSWSSGDFSG 321
Query: 298 GCSRESKVLCDQSDW-FEEVGVVEFIGAVTESFSAGRSICERSCLANCSCIGLYHDVRTN 356
GC RE +C ++D FE +G V F GA CE SCL NCSCIGLY + R+N
Sbjct: 322 GCLREDNNVCSETDGGFEGIGSVSFNGAALVPIPGNSKSCEASCLMNCSCIGLYRNARSN 381
Query: 357 LCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAALVLAA 416
LC N+YG +LNL+NL+SDST E L+VR R G +KN VL+A + G L L+
Sbjct: 382 LCYNVYGPVLNLKNLSSDSTEEGELHVRVHRRGNGKKNKWKWPVLIACVAGFSIILGLSM 441
Query: 417 VMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS 476
+L++ RK+R+++K V+EEDVF V NL+VFSYKEL+ T+GFSEKLGHGGFG VF+GELS
Sbjct: 442 AVLLVFRKRRQRKKKVEEEDVFSVTNLRVFSYKELNAATQGFSEKLGHGGFGTVFKGELS 501
Query: 477 DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536
DS+ VAVKRLERPG GE+EFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD M+NG L
Sbjct: 502 DSSQVAVKRLERPGGGEKEFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDCMQNGPL 561
Query: 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSD 596
S+YLR+DG NL+WDVRFR+A+GTARGIAYLHEECRDCIIHCDIKPENILLDSD+ KVSD
Sbjct: 562 SVYLRRDGENLSWDVRFRVAIGTARGIAYLHEECRDCIIHCDIKPENILLDSDFIPKVSD 621
Query: 597 FGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656
FGLAKL+GRDFSRVLATMRGTWGYVAPEWISG+AIT KADVYSYGMTLLELIGGRRNVE
Sbjct: 622 FGLAKLMGRDFSRVLATMRGTWGYVAPEWISGVAITAKADVYSYGMTLLELIGGRRNVET 681
Query: 657 PASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIW 716
P S GD+WFFPPWAARQIIEGNVAAVVD+RL +Y EAERV LVA+W
Sbjct: 682 PPSAGGGGA---AATGDEWFFPPWAARQIIEGNVAAVVDERLRDSYNTAEAERVGLVAVW 738
Query: 717 CIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSSNGVGTGGDG 776
CIQD E RPTMG VVKMLEG++EV PPPP+L+QALVSGES+HGV +S GG
Sbjct: 739 CIQDEEAARPTMGMVVKMLEGIVEVAVPPPPKLLQALVSGESFHGVLAES------GGTS 792
Query: 777 SGD 779
+GD
Sbjct: 793 TGD 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240255701|ref|NP_567172.4| receptor-like protein kinase 4 [Arabidopsis thaliana] gi|332656462|gb|AEE81862.1| receptor-like protein kinase 4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/768 (63%), Positives = 583/768 (75%), Gaps = 12/768 (1%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFAT-NGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
+VIIKGN TI+S FRLGFF+T NG S+WYLGI YAS+PTPT+VWVANR + V+D
Sbjct: 24 KVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 83
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
STL +T G L + + ++ ++WQ+ N + TD ETGNL+L++ GS VWQSFD+PTD
Sbjct: 84 STLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTD 143
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ ++TSW+SLFDPSPGFYSLRLSP+ +N+ +LVY GT YWSTGNWTG A
Sbjct: 144 TWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPS-FNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQ 240
FV VPEMTIPYIY+FHF+NPYT ASF Y PLD+ +P L+RF V +GQLKQYTW
Sbjct: 203 FVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 241 QTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCS 300
QT WNMFW QPED CRV+ LCG GFC S LL+PC C GFRP + W S DYS GC
Sbjct: 263 QTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAWRSDDYSDGCR 322
Query: 301 RESKVLCDQSDWFEEVGVVEFIGAVTES-FSAGRSICERSCLANCSCIGLYHDVRTNLCK 359
RE+ ++SD FE VG + + G V S +S C ++CL N SC+G YH ++NLCK
Sbjct: 323 RENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCK 382
Query: 360 NLYGELLNLRNLTS-DSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAAL--VLAA 416
L NL+N +S +ED+LY+R P+ G + NIS ++++ +VGSI+ L L
Sbjct: 383 ILLESPNNLKNSSSWTGVSEDVLYIREPKKGNSKGNISKSIIILCSVVGSISVLGFTLLV 442
Query: 417 VMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS 476
++++ R +++K+ +ED F VLNLKVFS+KEL + T GFS+K+GHGGFGAVF+G L
Sbjct: 443 PLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLP 502
Query: 477 -DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535
ST VAVKRLERPGSGE EFRAEVCTIGNIQHVNLVRLRGFCSEN HRLLVYDYM G+
Sbjct: 503 GSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGS 562
Query: 536 LSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594
LS YL + L+W+ RFRIA+GTA+GIAYLHE CRDCIIHCDIKPENILLDSDY AKV
Sbjct: 563 LSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKV 622
Query: 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654
SDFGLAKL+GRDFSRVLATMRGTWGYVAPEWISGL ITTKADVYS+GMTLLELIGGRRNV
Sbjct: 623 SDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNV 682
Query: 655 EAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVA 714
+ +G +KWFFPPWAAR+II+GNV +VVD RL G Y EE R+A VA
Sbjct: 683 IV----NSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVA 738
Query: 715 IWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGV 762
IWCIQDNEE+RP MGTVVKMLEGV+EVT PPPP+LIQALVSG+SY GV
Sbjct: 739 IWCIQDNEEIRPAMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGV 786
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522602|ref|XP_003529935.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/784 (60%), Positives = 580/784 (73%), Gaps = 15/784 (1%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQST 62
+I++GN+T+ S N TFRLG F+ + SS+YL I + S+P P +W+ANR T S+
Sbjct: 23 IILQGNATLQSPNNTFRLGLFSFSPNSSFYLAIRHTSLPFPNTIWLANRLHPSPSQTASS 82
Query: 63 LLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLET------GNLVLLSSAGSLVWQSFD 116
L +T+ G+L + S N+ +W +T + + + GNL+L + G ++WQSFD
Sbjct: 83 LQLTQTGQLLLTHS-NTTLWTTTISNIHPSNFSSLSLKLLDSGNLILTAPNGVVLWQSFD 141
Query: 117 HPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNW 176
PTDTWLPGMN++ S+ SW++ DPSPG YSLRL P Y + ELV+N T+ YWSTGNW
Sbjct: 142 SPTDTWLPGMNLTRLNSLLSWRTETDPSPGLYSLRLKPPFYGEFELVFNDTVPYWSTGNW 201
Query: 177 TGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQY 236
T +F+N+PEM+IPY+Y FHFL+P++ A+FG++E+ P + F V+P GQ++QY
Sbjct: 202 TNGSFLNIPEMSIPYLYNFHFLSPFSPAAAFGFSERAESEAGNRPPTMFRVEPFGQIQQY 261
Query: 237 TWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYS 296
TW+ Q WNMFWS+PE +C V GLCG FG C +PC C GF+PVD GW SGDYS
Sbjct: 262 TWNSQAGSWNMFWSKPEPLCLVRGLCGRFGVCIGETSKPCECISGFQPVDGDGWGSGDYS 321
Query: 297 GGCSRESKVLCDQSDWFEEVGVVEF-IGAVTESFSAGRSICERSCLANCSCIGLYHDVRT 355
GC R CD SD F ++G V F G V+ RS CER CL +C C+GL D +
Sbjct: 322 RGCYRGDSG-CDGSDGFRDLGNVRFGFGNVSLIKGKSRSFCERECLGDCGCVGLSFDEGS 380
Query: 356 NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTE-RKNISTLMVLVAGIVGSIAALVL 414
+CKN YG L + +NLT + YVR PRGG+ RK + ++ I + + V+
Sbjct: 381 GVCKNFYGSLSDFQNLTGGGESGG-FYVRVPRGGSGGRKGLDRKVLAGVVIGVVVVSGVV 439
Query: 415 AAVMLMILRKKRKK-RKDVDEEDVF-PVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQ 472
+LM+++KKR RK + EED F PVLNLKVFSYKEL TRGFSEK+GHGGFG VFQ
Sbjct: 440 VVTLLMMVKKKRDGGRKGLLEEDGFVPVLNLKVFSYKELQLATRGFSEKVGHGGFGTVFQ 499
Query: 473 GELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532
GELSD+++VAVKRLERPG GE+EFRAEV TIGNIQHVNLVRLRGFCSENSHRLLVY+YM+
Sbjct: 500 GELSDASVVAVKRLERPGGGEKEFRAEVSTIGNIQHVNLVRLRGFCSENSHRLLVYEYMQ 559
Query: 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTA 592
NGALS+YLRK+G L+WDVRFR+AVGTA+GIAYLHEECR CIIHCDIKPENILLD D+TA
Sbjct: 560 NGALSVYLRKEGPCLSWDVRFRVAVGTAKGIAYLHEECRCCIIHCDIKPENILLDGDFTA 619
Query: 593 KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652
KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG+AITTKADVYSYGMTLLEL+GGRR
Sbjct: 620 KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGVAITTKADVYSYGMTLLELVGGRR 679
Query: 653 NVEAPASGRNANIG--GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERV 710
NVEAP S G G E G KWFFPPWAA+QIIEGNV+ VVD RLG Y ++EA RV
Sbjct: 680 NVEAPPSAGGGGGGRESGSETGTKWFFPPWAAQQIIEGNVSDVVDKRLGNGYNIDEARRV 739
Query: 711 ALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSSNGV 770
ALVA+WCIQD+E MRPTMG VVKMLEG++EV+ PPPP+L+QALV+G+S+HGV+ DS NGV
Sbjct: 740 ALVAVWCIQDDEAMRPTMGMVVKMLEGLVEVSVPPPPKLLQALVTGDSFHGVKADSGNGV 799
Query: 771 GTGG 774
TGG
Sbjct: 800 STGG 803
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357514545|ref|XP_003627561.1| S-locus-specific glycoprotein [Medicago truncatula] gi|355521583|gb|AET02037.1| S-locus-specific glycoprotein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2437), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/793 (60%), Positives = 583/793 (73%), Gaps = 24/793 (3%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESS----WYLGIWYASIPTPTYVWVANREKSVADV 58
+I+ N T++SQNQTF+LG F ++ +YL I + S+P+P +WVANR K ++ +
Sbjct: 19 IILSQNKTLLSQNQTFQLGLFNLEQQNQLQPRYYLSIRFTSLPSPNIIWVANRNKPISSL 78
Query: 59 TQSTLLITEKGKLAIKDSQNSIIWQSTNTEKAT---DMYLLETGNLVLLSSAGSLVWQSF 115
T S L +T G+L + + ++++WQ+ NT + + LLE GNLVL + G ++WQSF
Sbjct: 79 TGSALQLTPTGQLLLTQN-DTVLWQTKNTLDESPLPQLNLLENGNLVLETKNGVVLWQSF 137
Query: 116 DHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175
D PTDTWLPGMN++ ++ SW++L +P GFYSLRL P Y + ELV+NGT+ YW TG
Sbjct: 138 DEPTDTWLPGMNLTRVHNLLSWRTLTNPDNGFYSLRLKPPNYGEFELVFNGTVSYWDTGK 197
Query: 176 WTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQ 235
WTG AF VPEMT+P IY+F F + Y+ ASFG++E+ L+NG +PP + F V+P GQ++Q
Sbjct: 198 WTGGAFTGVPEMTVP-IYRFDFEDAYSPMASFGFSERALENGVRPP-TMFRVEPFGQMRQ 255
Query: 236 YTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDY 295
YTWS Q WNMFWS+PE IC V G+CG FG C +LR C C GF VD GW+SGDY
Sbjct: 256 YTWSSQAGSWNMFWSRPESICSVKGVCGRFGVCVGDVLRVCECVKGFVAVDGGGWSSGDY 315
Query: 296 SGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSA-GRSICERSCLANCSCIGLYHDVR 354
SGGC R KV CD D FE+ GVV F SF A RS+CER CL +C C+GL D +
Sbjct: 316 SGGCWRGEKV-CDNGDGFEDFGVVRFGFENVSSFRAKSRSLCERGCLNSCDCVGLSFDEK 374
Query: 355 TNLCKNLYGELLNLRNLT---SDSTNEDILYVRAPRGGTERK----NISTLMVLVAGIVG 407
+ C+N G L + +NLT S N ++LYVR P +E K N L +V G V
Sbjct: 375 SGFCRNFLGSLFDFQNLTALESGGGNGNVLYVRVPGNVSEGKIKGWNGKVLSGVVIGCVL 434
Query: 408 SIAALVLAAVMLMILRKKRKKRKDVD--EEDVF-PVLNLKVFSYKELHTVTRGFSEKLGH 464
+ ++ + +++ KRK+ K + EED F PVLNLKVFSYKEL TRGFSEKLGH
Sbjct: 435 FLVLVLGVVAVTLVVLAKRKRLKKENGLEEDGFVPVLNLKVFSYKELQLATRGFSEKLGH 494
Query: 465 GGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524
GGFG VFQGELSDST+VAVKRLERPG GE+EFRAEV TIGNIQHVNLVRLRGFCSEN+HR
Sbjct: 495 GGFGTVFQGELSDSTVVAVKRLERPGGGEKEFRAEVSTIGNIQHVNLVRLRGFCSENAHR 554
Query: 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584
LLVY+YM NGALS YLRK+G L+WDVR R+A+GTA+GIAYLHEECR CIIHCDIKPENI
Sbjct: 555 LLVYEYMPNGALSAYLRKEGPCLSWDVRLRVAIGTAKGIAYLHEECRSCIIHCDIKPENI 614
Query: 585 LLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTL 644
LLDSD+TAKVSDFGLAKLIGRDFSRVLAT RGT GYVAPEWISG+ ITTKADVYSYGMTL
Sbjct: 615 LLDSDFTAKVSDFGLAKLIGRDFSRVLATRRGTLGYVAPEWISGVEITTKADVYSYGMTL 674
Query: 645 LELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKV 704
LEL+GGRRNVEAP S + + E GDKWFFPPWAA+ II+ NVAAVVD +LG Y +
Sbjct: 675 LELVGGRRNVEAPPS--SGDRKSDCETGDKWFFPPWAAQLIIDDNVAAVVDKKLGNVYNI 732
Query: 705 EEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRK 764
EEA+RVALVA+WCIQD+E MRPTM VVKMLEG++EV PPPP+L+QALV+GES+ GV+
Sbjct: 733 EEAKRVALVAVWCIQDDEAMRPTMSMVVKMLEGLVEVALPPPPKLLQALVTGESFRGVKV 792
Query: 765 DSSNGVGTGGDGS 777
DSSN V T G S
Sbjct: 793 DSSNAVSTAGSSS 805
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|75319455|sp|Q39203.1|SD22_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2; AltName: Full=Receptor-like kinase 4; AltName: Full=S-domain-2 (SD2) receptor kinase 2; Short=SD2-2; Flags: Precursor gi|166848|gb|AAA32858.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/771 (62%), Positives = 571/771 (74%), Gaps = 31/771 (4%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFAT-NGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
+VIIKGN TI+S FRLGFF+T NG S+WYLGI YAS+PTPT+VWVANR + V+D
Sbjct: 24 KVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 83
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
STL +T G L + + ++ ++WQ+ N + TD ETGNL+L++ GS VWQSFD+PTD
Sbjct: 84 STLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTD 143
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ ++TSW+SLFDPSPGFYSLRLSP+ +N+ +LVY GT YWSTGNWTG A
Sbjct: 144 TWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPS-FNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQ 240
FV VPEMTIPYIY+FHF+NPYT ASF Y PLD+ +P L+RF V +GQLKQYTW
Sbjct: 203 FVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 241 QTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCS 300
QT WNMFW QPED CRV+ LCG GFC S LL+PC C GFRP + W S DYS GC
Sbjct: 263 QTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAWRSDDYSDGCR 322
Query: 301 RESKVLCDQSDWFEEVGVVEFIGAVTES-FSAGRSICERSCLANCSCIGLYHDVRTNLCK 359
RE+ ++SD FE VG + + G V S +S C ++CL N SC+G YH ++NLCK
Sbjct: 323 RENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCK 382
Query: 360 NLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAAL--VLAAV 417
L NL+N + NIS ++++ +VGSI+ L L
Sbjct: 383 ILLESPNNLKN--------------------SKGNISKSIIILCSVVGSISVLGFTLLVP 422
Query: 418 MLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS- 476
++++ R +++K+ +ED F VLNLKVFS+KEL + T GFS+K+GHGGFGAVF+G L
Sbjct: 423 LILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPG 482
Query: 477 DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536
ST VAVKRLERPGSGE EFRAEVCTIGNIQHVNLVRLRGFCSEN HRLLVYDYM G+L
Sbjct: 483 SSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSL 542
Query: 537 SLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595
S YL + L+W+ RFRIA+GTA+GIAYLHE CRDCIIHCDIKPENILLDSDY AKVS
Sbjct: 543 SSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVS 602
Query: 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVE 655
DFGLAKL+GRDFSRVLATMRGTWGYVAPEWISGL ITTKADVYS+GMTLLELIGGRRNV
Sbjct: 603 DFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVI 662
Query: 656 APASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAI 715
+ +G +KWFFPPWAAR+II+GNV +VVD RL G Y EE R+A VAI
Sbjct: 663 V----NSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAI 718
Query: 716 WCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDS 766
WCIQDNEE+RP MGTVVKMLEGV+EVT PPPP+LIQALVSG+SY GV S
Sbjct: 719 WCIQDNEEIRPAMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGVSGTS 769
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814301|ref|XP_002875034.1| hypothetical protein ARALYDRAFT_327738 [Arabidopsis lyrata subsp. lyrata] gi|297320871|gb|EFH51293.1| hypothetical protein ARALYDRAFT_327738 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2420), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/767 (62%), Positives = 572/767 (74%), Gaps = 23/767 (2%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFAT-NGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
+VIIKGN TI+S FRLGFF+T NG S+WYLGI YAS+PTPT+VWVANR + V+D
Sbjct: 30 KVIIKGNHTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 89
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
STL +T G L +++S++ ++W++ N E TD ETGNL+L++ GS VWQSFD+PTD
Sbjct: 90 STLELTSTGHLIVRNSRDGVVWRTDNKEPGTDFRFSETGNLILINDDGSPVWQSFDNPTD 149
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ ++TSW++LFDPSPGFYSLRLSP G+N+ +LVY G YWSTGNWTG A
Sbjct: 150 TWLPGMNVTGLTAMTSWRTLFDPSPGFYSLRLSP-GFNEFQLVYKGATPYWSTGNWTGEA 208
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQ 240
FV VPEMTIPYIY+FHF+NPYT ASF Y PLD +P L+RF V +GQLKQYTW
Sbjct: 209 FVGVPEMTIPYIYRFHFVNPYTPAASFWYIVPPLDAVSEPRLTRFMVGANGQLKQYTWDP 268
Query: 241 QTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCS 300
QT WNMFW QPE CRV+ LCG GFC S LL+PC C GFRP + W S DYS GC
Sbjct: 269 QTQSWNMFWLQPEGPCRVYSLCGQLGFCSSELLKPCACIRGFRPKNDDAWRSDDYSDGCR 328
Query: 301 RESKVLCDQSDWFEEVGVVEFIGAVTES-FSAGRSICERSCLANCSCIGLYHDVRTNLCK 359
RE+ + SD FE VG + + G V S +S C ++CL N SC+G YH+ +NLCK
Sbjct: 329 RENGESGEMSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHNENSNLCK 388
Query: 360 NLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAAL--VLAAV 417
L +NL+N +S + G + NIS ++++ +VGSI+ L L
Sbjct: 389 ILLESPINLKNSSSWT------------GISNDGNISKSIIILCSVVGSISVLGITLLVP 436
Query: 418 MLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS- 476
++++ R +++K+ +ED F VLNLKVFS+KEL T GFS+K+GHGGFGAVF+G L
Sbjct: 437 LILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQAATNGFSDKVGHGGFGAVFKGTLPG 496
Query: 477 DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536
ST VAVKRLERPGSGE EFRAEVCTIGNIQHVNLVRLRGFCSEN HRLLVYDYM G+L
Sbjct: 497 SSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSL 556
Query: 537 SLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595
S YL + LNW+ RFRIA+GTA+GIAYLHE CRDCIIHCDIKPENILLDSDY AKVS
Sbjct: 557 SSYLSRTSPKLLNWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVS 616
Query: 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVE 655
DFGLAKL+GRDFSRVLATMRGTWGYVAPEWISGL ITTKADVYS+GMTLLELIGGRRNV
Sbjct: 617 DFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVI 676
Query: 656 APASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAI 715
+ +G +KWFFPPWAAR+II+GNV +VVD RL Y +EE R+A VAI
Sbjct: 677 V----NSDTLGEKDTEPEKWFFPPWAAREIIQGNVDSVVDSRLNREYNMEEVTRMATVAI 732
Query: 716 WCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGV 762
WCIQDNEE+RP MGTVVKMLEGV+EVT PPPP+LIQALVSG+SY GV
Sbjct: 733 WCIQDNEEIRPAMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGV 779
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6049881|gb|AAF02796.1|AF195115_16 Similar to receptor-like protein kinase precusor; F5I10.19 [Arabidopsis thaliana] gi|2252839|gb|AAB62838.1| Similar to receptor-like protein kinase precusor [Arabidopsis thaliana] gi|7267121|emb|CAB80792.1| AT4g00340 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 921 bits (2380), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/772 (61%), Positives = 567/772 (73%), Gaps = 40/772 (5%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFAT-NGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
+VIIKGN TI+S FRLGFF+T NG S+WYLGI YAS+PTPT+VWVANR + V+D
Sbjct: 24 KVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 83
Query: 61 STLLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120
STL +T G L + + ++ ++WQ+ N + TD ETGNL+L++ GS VWQSFD+PTD
Sbjct: 84 STLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTD 143
Query: 121 TWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNA 180
TWLPGMN++ ++TSW+SLFDPSPGFYSLRLSP+ +N+ +LVY GT YWSTGNWTG A
Sbjct: 144 TWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPS-FNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 181 FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQ 240
FV VPEMTIPYIY+FHF+NPYT ASF Y PLD+ +P L+RF V +GQLKQYTW
Sbjct: 203 FVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 241 QTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCS 300
QT WNMFW QPED CRV+ LCG GFC S LL+PC C GFRP + W S DYS GC
Sbjct: 263 QTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAWRSDDYSDGCR 322
Query: 301 RESKVLCDQSDWFEEVGVVEFIGAVTES-FSAGRSICERSCLANCSCIGLYHDVRTNLCK 359
RE+ ++SD FE VG + + G V S +S C ++CL N SC+G YH ++NLCK
Sbjct: 323 RENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKSNLCK 382
Query: 360 NLYGELLNLRNLTS-DSTNEDILYVRAPRGGTERKNISTLMVLVAGIVGSIAAL--VLAA 416
L NL+N +S +ED+LY+R P+ G + NIS ++++ +VGSI+ L L
Sbjct: 383 ILLESPNNLKNSSSWTGVSEDVLYIREPKKGNSKGNISKSIIILCSVVGSISVLGFTLLV 442
Query: 417 VMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS 476
++++ R +++K+ +ED F VLNLKVFS+KEL + T GFS+K+GHGGFGAVF+G L
Sbjct: 443 PLILLKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLP 502
Query: 477 -DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535
ST VAVKRLERPGSGE EFRAEVCTIGNIQHVNLVRLRGFCSEN HRLLVYDYM G+
Sbjct: 503 GSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGS 562
Query: 536 LSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594
LS YL + L+W+ RFRIA+GTA+GIAYLHE CRDCIIHCDIKPENILLDSDY AKV
Sbjct: 563 LSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKV 622
Query: 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654
SDFGLAKL+GRDFSRVLATMRGTWGYVAPEWISGL ITTKADVYS+GMTLLELIG
Sbjct: 623 SDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIG----- 677
Query: 655 EAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVA 714
AR+II+GNV +VVD RL G Y EE R+A VA
Sbjct: 678 ---------------------------AREIIQGNVDSVVDSRLNGEYNTEEVTRMATVA 710
Query: 715 IWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDS 766
IWCIQDNEE+RP MGTVVKMLEGV+EVT PPPP+LIQALVSG+SY GV S
Sbjct: 711 IWCIQDNEEIRPAMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGVSGTS 762
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726734|ref|NP_001235345.1| receptor-like protein kinase precusor-like protein [Glycine max] gi|223452468|gb|ACM89561.1| receptor-like protein kinase precusor-like protein [Glycine max] gi|223452568|gb|ACM89611.1| receptor-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2087), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/672 (61%), Positives = 500/672 (74%), Gaps = 14/672 (2%)
Query: 126 MNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNAFVNVP 185
MN++ S+TSW++ DP+PG YSLRL P + + ELV+N T+ YWSTGNWT F+N+P
Sbjct: 1 MNLTRFNSLTSWRTQTDPTPGLYSLRLKPPFFGEFELVFNDTVSYWSTGNWTDGKFLNIP 60
Query: 186 EMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQQTDYW 245
EM+IPY+Y FHFL+P++ A FG++E+ + G +PP + F V+P GQ++QYTW+ Q W
Sbjct: 61 EMSIPYLYSFHFLSPFSPAAEFGFSERASETGTQPP-TMFRVEPFGQIRQYTWNNQAGSW 119
Query: 246 NMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDYSGGCSRESKV 305
MFWS PE +C+V GLCG FG C + C C GF P+D GW SGDYS GC R
Sbjct: 120 KMFWSMPEPVCQVRGLCGRFGVCIGETSKLCECVSGFEPLDGDGWGSGDYSKGCYR-GDA 178
Query: 306 LCDQSDWFEEVGVVEF-IGAVTESFSAGRSICERSCLANCSCIGLYHDVRTNLCKNLYGE 364
CD SD F ++G V F G V+ RS CE CL +C C+GL D + +C+N YG
Sbjct: 179 GCDGSDGFRDLGDVRFGFGNVSLIKGKSRSFCEGECLRDCGCVGLSFDEGSGVCRNFYGL 238
Query: 365 LLNLRNLTSDSTNEDILYVRAPRGGTE-RKNI----STLMVLVAGIVGSIAALVLAAVML 419
L + +NLT + YVR P+GG+ RK + V++ +V ++ VM+
Sbjct: 239 LSDFQNLTGGGESGG-FYVRVPKGGSGGRKKVFDRKVLSGVVIGVVVVLGVVVMALLVMV 297
Query: 420 MILRKKRKKRKDVDEEDVF-PVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDS 478
R +K + +EED F PVLNLKVFSYKEL TRGFSEK+GHGGFG VFQGELSD+
Sbjct: 298 KKKRGGGRKGLEEEEEDGFVPVLNLKVFSYKELQLATRGFSEKVGHGGFGTVFQGELSDA 357
Query: 479 TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538
++VAVKRLERPG GE+EFRAEV TIGNIQHVNLVRLRGFCSENSHRLLVY+YM+NGAL++
Sbjct: 358 SVVAVKRLERPGGGEKEFRAEVSTIGNIQHVNLVRLRGFCSENSHRLLVYEYMQNGALNV 417
Query: 539 YLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598
YLRK+G L+WDVRFR+AVGTA+GIAYLHEECR CIIHCDIKPENILLD D+TAKVSDFG
Sbjct: 418 YLRKEGPCLSWDVRFRVAVGTAKGIAYLHEECRCCIIHCDIKPENILLDGDFTAKVSDFG 477
Query: 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPA 658
LAKLIGRDFSRVL TMRGTWGYVAPEWISG+AITTKADVYSYGMTLLELIGGRRNVEAP
Sbjct: 478 LAKLIGRDFSRVLVTMRGTWGYVAPEWISGVAITTKADVYSYGMTLLELIGGRRNVEAPL 537
Query: 659 SG--RNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIW 716
S G E G KWFFPPWAA++IIEGNV+ V+D RLG AY +EEA RVALVA+W
Sbjct: 538 SAGGGGGGGESGDEMGGKWFFPPWAAQRIIEGNVSDVMDKRLGNAYNIEEARRVALVAVW 597
Query: 717 CIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSSNGV-GTGGD 775
CIQD+E MRPTMG VVKMLEG++EV+ PPPP+L+QALV+G+S+HGV+ DS NG TGG
Sbjct: 598 CIQDDEAMRPTMGMVVKMLEGLVEVSVPPPPKLLQALVTGDSFHGVKADSGNGASSTGGS 657
Query: 776 GS-GDIGESRGD 786
S GD+ S D
Sbjct: 658 LSDGDLEVSTAD 669
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357504427|ref|XP_003622502.1| S-locus-specific glycoprotein [Medicago truncatula] gi|355497517|gb|AES78720.1| S-locus-specific glycoprotein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/675 (59%), Positives = 492/675 (72%), Gaps = 22/675 (3%)
Query: 3 VIIKGNSTIISQNQTFRLGFFATNGESS----WYLGIWYASIPTPTYVWVANREKSVADV 58
+I+ N T++SQNQTF+LG F ++ +YL I + S+P+P +WVANR K ++ +
Sbjct: 19 IILSQNKTLLSQNQTFQLGLFNLEQQNQLQPRYYLSIRFTSLPSPNIIWVANRNKPISSL 78
Query: 59 TQSTLLITEKGKLAIKDSQNSIIWQSTNTEKAT---DMYLLETGNLVLLSSAGSLVWQSF 115
T S L +T G+L + + ++++WQ+ NT + + LLE GNLVL + G ++WQSF
Sbjct: 79 TGSALQLTPTGQLLLTQN-DTVLWQTKNTLDESPLPQLNLLENGNLVLETKNGVVLWQSF 137
Query: 116 DHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175
D PTDTWLPGMN++ ++ SW++L +P GFYSLRL P Y + ELV+NGT+ YW TG
Sbjct: 138 DEPTDTWLPGMNLTRVHNLLSWRTLTNPDNGFYSLRLKPPNYGEFELVFNGTVSYWDTGK 197
Query: 176 WTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQ 235
WTG AF VPEMT+P IY+F F + Y+ ASFG++E+ L+NG +PP + F V+P GQ++Q
Sbjct: 198 WTGGAFTGVPEMTVP-IYRFDFEDAYSPMASFGFSERALENGVRPP-TMFRVEPFGQMRQ 255
Query: 236 YTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNSGDY 295
YTWS Q WNMFWS+PE IC V G+CG FG C +LR C C GF VD GW+SGDY
Sbjct: 256 YTWSSQAGSWNMFWSRPESICSVKGVCGRFGVCVGDVLRVCECVKGFVAVDGGGWSSGDY 315
Query: 296 SGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSA-GRSICERSCLANCSCIGLYHDVR 354
SGGC R KV CD D FE+ GVV F SF A RS+CER CL +C C+GL D +
Sbjct: 316 SGGCWRGEKV-CDNGDGFEDFGVVRFGFENVSSFRAKSRSLCERGCLNSCDCVGLSFDEK 374
Query: 355 TNLCKNLYGELLNLRNLT---SDSTNEDILYVRAPRGGTERK----NISTLMVLVAGIVG 407
+ C+N G L + +NLT S N ++LYVR P +E K N L +V G V
Sbjct: 375 SGFCRNFLGSLFDFQNLTALESGGGNGNVLYVRVPGNVSEGKIKGWNGKVLSGVVIGCVL 434
Query: 408 SIAALVLAAVMLMILRKKRKKRKDVD--EEDVF-PVLNLKVFSYKELHTVTRGFSEKLGH 464
+ ++ + +++ KRK+ K + EED F PVLNLKVFSYKEL TRGFSEKLGH
Sbjct: 435 FLVLVLGVVAVTLVVLAKRKRLKKENGLEEDGFVPVLNLKVFSYKELQLATRGFSEKLGH 494
Query: 465 GGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524
GGFG VFQGELSDST+VAVKRLERPG GE+EFRAEV TIGNIQHVNLVRLRGFCSEN+HR
Sbjct: 495 GGFGTVFQGELSDSTVVAVKRLERPGGGEKEFRAEVSTIGNIQHVNLVRLRGFCSENAHR 554
Query: 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584
LLVY+YM NGALS YLRK+G L+WDVR R+A+GTA+GIAYLHEECR CIIHCDIKPENI
Sbjct: 555 LLVYEYMPNGALSAYLRKEGPCLSWDVRLRVAIGTAKGIAYLHEECRSCIIHCDIKPENI 614
Query: 585 LLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTL 644
LLDSD+TAKVSDFGLAKLIGRDFSRVLAT RGT GYVAPEWISG+ ITTKADVYSYGMTL
Sbjct: 615 LLDSDFTAKVSDFGLAKLIGRDFSRVLATRRGTLGYVAPEWISGVEITTKADVYSYGMTL 674
Query: 645 LELIGGRRNVEAPAS 659
LEL+GGRRNVEAP S
Sbjct: 675 LELVGGRRNVEAPPS 689
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 804 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.905 | 0.879 | 0.447 | 1e-164 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.481 | 0.459 | 0.346 | 1.1e-108 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.458 | 0.471 | 0.336 | 2.4e-106 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.491 | 0.469 | 0.328 | 3e-105 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.482 | 0.456 | 0.342 | 8.6e-105 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.374 | 0.363 | 0.510 | 2.8e-103 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.358 | 0.350 | 0.523 | 3.1e-102 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.481 | 0.456 | 0.327 | 7.5e-100 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.482 | 0.467 | 0.291 | 6.1e-96 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.359 | 0.340 | 0.387 | 1.3e-92 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1603 (569.3 bits), Expect = 1.0e-164, P = 1.0e-164
Identities = 351/784 (44%), Positives = 472/784 (60%)
Query: 1 GRVIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQ 60
G + G+ TI+S + T+ +GFF S++Y+G+WY + + T +WVANR+K+V+D
Sbjct: 28 GDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQL-SQTILWVANRDKAVSDKNS 86
Query: 61 STLLITEKGKLAIKDSQNSIIWQ----STNTEKATDMYLLETGNLVLLSSAGSL----VW 112
S I+ + + + + +W ST++ A + L + GNLVL + SL +W
Sbjct: 87 SVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLW 146
Query: 113 QSFDHPTDTWLPGMNISV----GGS--ITSWKSLFDPSPGFYSLRLSP-TGYNQIELVYN 165
QSFDHP DTWLPG+ I + G S +TSWKSL DPSPG +SL L T Y ++++N
Sbjct: 147 QSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAY---KILWN 203
Query: 166 GTIVYWSTGNWTGNA--FVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLS 223
G+ YWS+G W + F +VPEM + YIY F F + T+ + F Y+ + N +S
Sbjct: 204 GSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFSFFSN-TTDSYFTYS---IYNQLN--VS 257
Query: 224 RFHVDPSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFR 283
RF +D SGQ+KQ+TW + WN+FWSQP C+V+ CG+FG C C C GFR
Sbjct: 258 RFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFR 317
Query: 284 PVDCYGWNSGDYSGGCSRESKVLCDQSD--WFEEVGVVEFIGAVTESFSAGRSICERSCL 341
P+ W+ DYS GC R++++ C + D F + ++ SIC +C
Sbjct: 318 PMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQ 377
Query: 342 ANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVR-----APRGGTERKNIS 396
+CSC +D ++ C ++LNL+ L +++ +I Y+R P G K+ +
Sbjct: 378 GDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNN 437
Query: 397 TLMVLVAGIVGSXXXXXXXXXXXXXXXXXXXXXXDVDEEDVFPVLNLKVFSYKELHTVTR 456
++ A ++GS E+ L FSY+EL T+
Sbjct: 438 KGLIFGA-VLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDG---TLSAFSYRELQNATK 493
Query: 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
FS+KLG GGFG+VF+G L DS+ +AVKRLE GE++FR EV TIG IQHVNLVRLRG
Sbjct: 494 NFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRG 553
Query: 517 FCSENSHRLLVYDYMRNGALS--LYLRK--DGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
FCSE S +LLVYDYM NG+L L+L + + + L W +RF+IA+GTARG+AYLH+ECRD
Sbjct: 554 FCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRD 613
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
CIIHCDIKPENILLDS + KV+DFGLAKL+GRDFSRVL TMRGT GY+APEWISG+AIT
Sbjct: 614 CIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAIT 673
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-EGNVA 691
KADVYSYGM L EL+ GRRN E N + FFP WAA + +G++
Sbjct: 674 AKADVYSYGMMLFELVSGRRNTE---QSENEKVR---------FFPSWAATILTKDGDIR 721
Query: 692 AVVDDRL-GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLI 750
++VD RL G A +EE R VA WCIQD E RP M VV++LEGVLEV PP PR I
Sbjct: 722 SLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSI 781
Query: 751 QALV 754
QALV
Sbjct: 782 QALV 785
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.1e-108, Sum P(2) = 1.1e-108
Identities = 145/418 (34%), Positives = 209/418 (50%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I N TIIS +Q F LGFF S WYLGIWY IP TYVWVANR+ ++ + TL
Sbjct: 38 ISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSS-SNGTLK 96
Query: 65 ITEKGKLAIKDSQNSIIWQSTN-----TEKATDMYLLETGNLVLLSSAGSLVWQSFDHPT 119
I+ L I D + +W STN LL+ GN +L S L+WQSFD PT
Sbjct: 97 ISGNN-LVIFDQSDRPVW-STNITGGDVRSPVAAELLDNGNFLLRDSNNRLLWQSFDFPT 154
Query: 120 DTWLPGMNIS----VGGS--ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWST 173
DT L M + G + + SWK+ DPS G +S +L + + + + +I+Y S
Sbjct: 155 DTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRS- 213
Query: 174 GNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPL-SRFHVDPSGQ 232
G W G F +VP TI Y + N SK Y+ + K L SR +++ +G
Sbjct: 214 GPWNGMRFSSVPG-TIQVDYMVY--NFTASKEEVTYSYRI----NKTNLYSRLYLNSAGL 266
Query: 233 LKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYGWNS 292
L++ TW + T W W P+D+C + +CGNFG+C S+ L C C GF+PV+ W+
Sbjct: 267 LQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDL 326
Query: 293 GDYSGGCSRESKVLCDQSDWFEEVGVVEF--IGAVTESFSAGRSICERSCLANCSCIGLY 350
D S GC R++++ CD D F + ++ A G +C+ CL +C+C
Sbjct: 327 RDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFA 386
Query: 351 H-DVRT--NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAGI 405
+ D+R + C E+L++RN +D LYVR E K I ++ + I
Sbjct: 387 NADIRNGGSGCVIWTREILDMRNYAKGG--QD-LYVRLAAAELEDKRIKNEKIIGSSI 441
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 2.4e-106, Sum P(2) = 2.4e-106
Identities = 135/401 (33%), Positives = 215/401 (53%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
+K TI+SQ +F +GFF+ G + YLGIWY I T VWVANR+ + D++ TL
Sbjct: 33 LKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSPLYDLS-GTLK 91
Query: 65 ITEKGKLAIKDSQNSIIWQSTNT---EKAT----DMYLLETGNLVLLSSAGS--LVWQSF 115
++E G L + + +N IIW S+++ +KA+ + +L+TGNLV+ +S +WQS
Sbjct: 92 VSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSGDDQDYIWQSL 151
Query: 116 DHPTDTWLPGM----NISVGGS--ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIV 169
D+P D +LPGM N G + +TSW+++ DPS G Y+ ++ P G Q L N +V
Sbjct: 152 DYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVV 211
Query: 170 YWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDP 229
+ TG W G F +P + IY++ ++ +T + + YT K L+N L+R ++P
Sbjct: 212 F-RTGPWNGLRFTGMPNLKPNPIYRYEYV--FTEEEVY-YTYK-LENPSV--LTRMQLNP 264
Query: 230 SGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYG 289
+G L++YTW WN + S D C + LCG++G C + C C GF
Sbjct: 265 NGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQA 324
Query: 290 WNSGDYSGGCSRESKVLCDQS-DWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCSC 346
W +GD+S GC R K+ C + D F ++ ++ T + + C++ CL NC+C
Sbjct: 325 WVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTC 384
Query: 347 IGLY-HDVRTNL--CKNLYGELLNLRNLTSDSTNEDILYVR 384
D+R C +G+L+++R + +D LYVR
Sbjct: 385 SAYSPFDIRDGGKGCILWFGDLIDIREYNENG--QD-LYVR 422
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 3.0e-105, Sum P(2) = 3.0e-105
Identities = 140/426 (32%), Positives = 207/426 (48%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I+ ++IS++++F LGFF + Y+GIWY +I T VWVANREK + D + L
Sbjct: 38 IREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLD-HKGALK 96
Query: 65 ITEKGKLAIKDSQNSIIWQSTNTEKATD---MYLLETGNLVLLSSAG--SLVWQSFDHPT 119
I + G L I + QN IW STN E ++ L +TG+LVL S + W+SF++PT
Sbjct: 97 IADDGNLVIVNGQNETIW-STNVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWESFNNPT 155
Query: 120 DTWLPGMNISVGGSITS------WKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWST 173
DT+LPGM + V S+ WKS DPSPG YS+ + P G +I +++ G W +
Sbjct: 156 DTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEI-VIWEGEKRKWRS 214
Query: 174 GNWTGNAFVNVPEMT--IPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSG 231
G W F +P+M YIY F +P S +T D+ RF + P G
Sbjct: 215 GPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSD---FLRFWIRPDG 271
Query: 232 QLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSL---LRPCMCFDGFRPVDCY 288
+Q+ W++ WN+ +P C + CGN+ C S C C DGF PV
Sbjct: 272 VEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQD 331
Query: 289 GWNSGDYSGGCSRESKVLCDQSDWF-EEVGVVEFIGAVTESFSA-----GRSICERSCLA 342
WN+ D+SGGC R + C+QS +E G G F + C+ C
Sbjct: 332 QWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCAR 391
Query: 343 NCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLV 402
+CSC Y V C +L+++ + + +I + GG K STL ++V
Sbjct: 392 DCSCKA-YALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGG--KENSTLWIIV 448
Query: 403 AGIVGS 408
++G+
Sbjct: 449 FSVIGA 454
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 8.6e-105, Sum P(2) = 8.6e-105
Identities = 144/421 (34%), Positives = 211/421 (50%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I N+TI+S F LGFF +S WYLGIWY +I TYVWVANR+ ++ + TL
Sbjct: 40 ISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSS-SIGTLK 98
Query: 65 ITEKGKLAIKDSQNSIIWQS--TNTEKATDMY--LLETGNLVLLSSAGS----LVWQSFD 116
I++ L + D ++ +W + T + + + LL+ GN VL S S ++WQSFD
Sbjct: 99 ISDSN-LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFD 157
Query: 117 HPTDTWLPGMNIS----VGGS--ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVY 170
PTDT LP M + G + I SWKS DPS G +S +L G+ +I L +N
Sbjct: 158 FPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFL-WNRESRM 216
Query: 171 WSTGNWTGNAFVNVPEMTIPYIYK-FHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDP 229
+ +G W G F VPEM P+ Y F+F TSK Y+ + + SR +
Sbjct: 217 YRSGPWNGIRFSGVPEMQ-PFEYMVFNFT---TSKEEVTYSFRIT---KSDVYSRLSISS 269
Query: 230 SGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCYG 289
SG L+++TW + WN FW P+D C + CG +G+C S+ C C GF+P +
Sbjct: 270 SGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQV 329
Query: 290 WNSGDYSGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCSCI 347
W D S GC R++ + C D F + ++ T S G + CE+ CL +C+C
Sbjct: 330 WGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCT 389
Query: 348 GLYH-DVRTNL--CKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVAG 404
+ D+R + C GEL ++RN +D LYVR E K + ++ +
Sbjct: 390 AFANTDIRGSGSGCVTWTGELFDIRNYAKGG--QD-LYVRLAATDLEDKRNRSAKIIGSS 446
Query: 405 I 405
I
Sbjct: 447 I 447
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 2.8e-103, Sum P(2) = 2.8e-103
Identities = 163/319 (51%), Positives = 214/319 (67%)
Query: 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGN 505
F+YKEL T+ F EKLG GGFG V++G L++ T+VAVK+LE GE++FR EV TI +
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISS 533
Query: 506 IQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL-RKDGLN-LNWDVRFRIAVGTARGI 563
H+NLVRL GFCS+ HRLLVY++MRNG+L +L D L W+ RF IA+GTA+GI
Sbjct: 534 THHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGI 593
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV-LATMRGTWGYVA 622
YLHEECRDCI+HCDIKPENIL+D ++ AKVSDFGLAKL+ +R ++++RGT GY+A
Sbjct: 594 TYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLA 653
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PEW++ L IT+K+DVYSYGM LLEL+ G+RN + N H F WA
Sbjct: 654 PEWLANLPITSKSDVYSYGMVLLELVSGKRNFDV---SEKTN------HKK---FSIWAY 701
Query: 683 RQIIEGNVAAVVDDRLGGAYKV--EEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
+ +GN A++D RL V E+ R+ + WCIQ+ RPTMG VV+MLEG+ E
Sbjct: 702 EEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITE 761
Query: 741 VTAPPPPRLIQAL-VSGES 758
+ P P+ I + SG S
Sbjct: 762 IKNPLCPKTISEVSFSGNS 780
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 3.1e-102, Sum P(3) = 3.1e-102
Identities = 159/304 (52%), Positives = 217/304 (71%)
Query: 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGN 505
F+YK+L + T FS KLG GGFG+V++G L D + +AVK+LE G G++EFRAEV IG+
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGS 542
Query: 506 IQHVNLVRLRGFCSENSHRLLVYDYMRNGALS--LYLRKDG-LNLNWDVRFRIAVGTARG 562
I H++LVRLRGFC+E +HRLL Y+++ G+L ++ +KDG + L+WD RF IA+GTA+G
Sbjct: 543 IHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKG 602
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
+AYLHE+C I+HCDIKPENILLD ++ AKVSDFGLAKL+ R+ S V TMRGT GY+A
Sbjct: 603 LAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLA 662
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PEWI+ AI+ K+DVYSYGM LLELIGGR+N + P+ E +K FP +A
Sbjct: 663 PEWITNYAISEKSDVYSYGMVLLELIGGRKNYD-PS-----------ETSEKCHFPSFAF 710
Query: 683 RQIIEGNVAAVVDDRLGGAYKVEE-AERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741
+++ EG + +VD ++ +E +R A+WCIQ++ + RP+M VV+MLEGV V
Sbjct: 711 KKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPV 770
Query: 742 TAPP 745
PP
Sbjct: 771 VQPP 774
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 7.5e-100, Sum P(2) = 7.5e-100
Identities = 138/422 (32%), Positives = 199/422 (47%)
Query: 5 IKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I N TIIS +Q F LGFF + S WYLGIWY IP TYVWVANR+ ++ + TL
Sbjct: 38 ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS-SNGTLK 96
Query: 65 ITEKGKLAIKDSQNSIIWQSTN-----TEKATDMYLLETGNLVLLSSAGS----LVWQSF 115
I++ L I D + +W STN LL+ GN VL S + +WQSF
Sbjct: 97 ISDNN-LVIFDQSDRPVW-STNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQSF 154
Query: 116 DHPTDTWLPGMNIS----VGGS---ITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTI 168
D PTDT L M + GG + SWK+ DPS G +S +L +G+ + +YN
Sbjct: 155 DFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEF-YIYNKES 213
Query: 169 VYWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVD 228
+ + +G W GN F +VP M P Y + + + Y + S +
Sbjct: 214 ITYRSGPWLGNRFSSVPGMK-PVDYIDNSFTENNQQVVYSYRVNKTNI-----YSILSLS 267
Query: 229 PSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVDCY 288
+G L++ TW + W W P+D+C + CGN+G+C ++ C C GF P++
Sbjct: 268 STGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQ 327
Query: 289 GWNSGDYSGGCSRESKVLCDQSDWFEEVGVVEFIGAVTESFSAGRSI--CERSCLANCSC 346
D S GC R++K+ CD D F + + S G + CE CL C+C
Sbjct: 328 AALRDD-SVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNC 386
Query: 347 IGLYH-DVRT--NLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLMVLVA 403
+ D+R + C G L ++RN +D LYVR G E K I + ++ +
Sbjct: 387 TAFANTDIRNGGSGCVIWSGGLFDIRNYAKGG--QD-LYVRVAAGDLEDKRIKSKKIIGS 443
Query: 404 GI 405
I
Sbjct: 444 SI 445
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 513 (185.6 bits), Expect = 6.1e-96, Sum P(2) = 6.1e-96
Identities = 125/429 (29%), Positives = 206/429 (48%)
Query: 6 KGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLI 65
+ + T++S + TFR GFF+ + Y GIW+ +IP T VWVAN + D + + I
Sbjct: 32 RDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPIND-SSGMVSI 90
Query: 66 TEKGKLAIKDSQNSIIWQSTNT---EKATDMY--LLETGNLVLLSSAGS---LVWQSFDH 117
+++G L + D + + W STN A Y LL TGNLVLL + + ++W+SF+H
Sbjct: 91 SKEGNLVVMDGRGQVHW-STNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEILWESFEH 149
Query: 118 PTDTWLPGMNISV----GGSIT--SWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYW 171
P + +LP M+++ G S+ SWKS FDPSPG YS L P + ++ +V+ ++ W
Sbjct: 150 PQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPEL-VVWKDDLLMW 208
Query: 172 STGNWTGNAFVNVPEMTIPY-IYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPS 230
+G W G F+ +P M +++ + S Y L L F +D
Sbjct: 209 RSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNTL-------LYHFLLDSE 261
Query: 231 GQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSS--LLRPCMCFDGFRPVDCY 288
G + Q W+ W + P C + CG F C+ + PCMC GF+P
Sbjct: 262 GSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQSYA 321
Query: 289 GWNSGDYSGGCSRESKVLCD---------QSDWFEEVGVVEFIGAVTESFSAGRSICERS 339
WN+G+++ GC R++ + C+ +SD F V ++ + + A C S
Sbjct: 322 EWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMK-VPHNPQRSGANEQDCPES 380
Query: 340 CLANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGGTERKNISTLM 399
CL NCSC D R C G L++++ + + Y+R +++ +++
Sbjct: 381 CLKNCSCTAYSFD-RGIGCLLWSGNLMDMQEFSGTGV---VFYIRLADSEFKKRTNRSIV 436
Query: 400 VLVAGIVGS 408
+ V +VG+
Sbjct: 437 ITVTLLVGA 445
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 1.3e-92, Sum P(2) = 1.3e-92
Identities = 122/315 (38%), Positives = 177/315 (56%)
Query: 443 LKVFSYKELHTVTRGFSEK--LGHGGFGAVFQGELSDSTLVAVKRLE-RPGSGEREFRAE 499
L VFS + T F ++ LG GGFG V++G L D +AVKRL + G G EF+ E
Sbjct: 514 LPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNE 573
Query: 500 VCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFRIA 556
+ I +QH NLVRL G C E ++LVY+YM N +L +L K L ++W +RF I
Sbjct: 574 IILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQAL-IDWKLRFSII 632
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR- 615
G ARG+ YLH + R IIH D+K N+LLD++ K+SDFG+A++ G + + T+R
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA-NTVRV 691
Query: 616 -GTWGYVAPEW-ISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673
GT+GY++PE+ + GL + K+DVYS+G+ LLE++ G+RN +S + IG
Sbjct: 692 VGTYGYMSPEYAMEGL-FSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYA----- 745
Query: 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
W+ G +VD ++ EA R VA+ C+QD+ RP M +V+
Sbjct: 746 -WYL-------YTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 734 MLEG-VLEVTAPPPP 747
MLE + AP P
Sbjct: 798 MLESDTATLAAPRQP 812
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39203 | SD22_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6225 | 0.9203 | 0.9284 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00026940001 | SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (820 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 804 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-48
Identities = 70/191 (36%), Positives = 104/191 (54%), Gaps = 9/191 (4%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVRLRGFC 518
LG GGFG V+ VA+K +++ S E E+ + + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+ +H LV +Y G+L L+++ L+ D RI + G+ YLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 579 IKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE-WISGLAITTKAD 636
+KPENILLDSD K++DFGL+KL+ D +L T+ GT Y+APE + + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 637 VYSYGMTLLEL 647
++S G+ L EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 75/197 (38%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
KLG G FG V++ +VAVK L++ + R E+ + + H N+VRL
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ H LV +Y G L YL + G L+ D +IA+ RG+ YLH II
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI-SGLAITTK 634
H D+KPENILLD + K++DFGLAK + + S L T GT Y+APE + G K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKS-SSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 635 ADVYSYGMTLLELIGGR 651
DV+S G+ L EL+ G+
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 63/298 (21%)
Query: 458 FSEKLGHGGFGAVFQGELSD-----STLVAVKRL--ERPGSGEREFRAEVCTIGNIQHVN 510
+KLG G FG V++G+L VAVK L + EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+L G C+E +V +YM G L YLRK+ L+ A+ ARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV---APEWIS 627
IH D+ N L+ + K+SDFGL++ + D RG + APE +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYRKRGGKLPIRWMAPESLK 176
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687
T+K+DV+S+G+ L E+ G++ +P + +++E
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIF---------------------TLGEQ-PYPGMSNEEVLE 214
Query: 688 GNVAAVVDDRLGGAYKVEEAER----------VALVAIWCIQDNEEMRPTMGTVVKML 735
++ R + + + C ++ E RPT +V++L
Sbjct: 215 ---------------YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
EKLG G FG V+ + LVA+K ++ + +RE E+ + ++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ LV +Y G L L+K G L+ + + RF + YLH + I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED-EARF-YLRQILSALEYLHSKG---IV 119
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+KPENILLD D K++DFGLA+ + L T GT Y+APE + G
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPG--EKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 636 DVYSYGMTLLELIGGR 651
D++S G+ L EL+ G+
Sbjct: 178 DIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHV 509
+KLG G FG V++G L T VAVK L + G+ E EF E + + H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHP 61
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
N+VRL G C++ +V +YM G L +LRK G L ++A+ A+G+ YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT---WGYVAPEWI 626
++ +H D+ N L+ + K+SDFGL++ I D W +APE +
Sbjct: 121 -KNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW--MAPESL 176
Query: 627 SGLAITTKADVYSYGMTLLELI 648
T+K+DV+S+G+ L E+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 68/301 (22%)
Query: 458 FSEKLGHGGFGAVFQGELSD-----STLVAVKRL--ERPGSGEREFRAEVCTIGNIQHVN 510
+KLG G FG V++G L VAVK L + EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEE 569
+V+L G C+E ++V +YM G L YLRK L+ A+ ARG+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV-----APE 624
IH D+ N L+ + K+SDFGL++ + D + G + APE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYKVKGGKLPIRWMAPE 174
Query: 625 WISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684
+ T+K+DV+S+G+ L E+ G++ +P + +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIF---------------------TLGEE-PYPGMSNAE 212
Query: 685 IIEGNVAAVVDDRLGGAYKVEEAER----------VALVAIWCIQDNEEMRPTMGTVVKM 734
++E +++ R + + + C ++ E RPT +V++
Sbjct: 213 VLE---------------YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEI 257
Query: 735 L 735
L
Sbjct: 258 L 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 76/209 (36%), Positives = 111/209 (53%), Gaps = 21/209 (10%)
Query: 455 TRGFSEKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRA---EVCTIGNIQHVN 510
TRG E LG G FG+V+ D+ L+AVK +E G E E A E+ + ++QH N
Sbjct: 3 TRG--ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 511 LVRLRGFC--SENSHRLLVYDYMRNGALSLYLRKDG-LNLNWDVR---FRIAVGTARGIA 564
+VR G E + + +Y+ G+LS L+K G L +R +I G+A
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIRKYTRQIL----EGLA 115
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLATMRGTWGYVAP 623
YLH I+H DIK NIL+DSD K++DFG AK +G + ++RGT ++AP
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 624 EWISGLAITTKADVYSYGMTLLELIGGRR 652
E I G AD++S G T++E+ G+
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 460 EKLGHGGFGAVFQGELSD----STLVAVKRL-ERPGSGER-EFRAEVCTIGNIQHVNLVR 513
+KLG G FG V++G+L +T VAVK L E ER +F E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRK--------DGLNLNWDVRFRIAVGTARGIAY 565
L G C+E LV +YM G L YLRK + L+ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT------WG 619
L + +H D+ N L+ D K+SDFGL++ + + + W
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV---YDDDYYRKKTGGKLPIRW- 173
Query: 620 YVAPEWISGLAITTKADVYSYGMTLLEL 647
+APE + T+K+DV+S+G+ L E+
Sbjct: 174 -MAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 75/209 (35%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQH-VNLVRL 514
KLG G FG V+ D LVA+K L E F E+ + ++ H N+V+L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRD 572
F + LV +Y+ G+L L+K G L+ I + YLH +
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 573 CIIHCDIKPENILLDSDYT-AKVSDFGLAKLIGRDFSRV-----LATMRGTWGYVAPEWI 626
IIH DIKPENILLD D K+ DFGLAKL+ S +T GT GY+APE +
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 627 SGL---AITTKADVYSYGMTLLELIGGRR 652
GL ++ +D++S G+TL EL+ G
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 48/108 (44%), Positives = 64/108 (59%), Gaps = 8/108 (7%)
Query: 44 TYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTNTEKATDMY--LLETGNL 101
T VWVANR + D + TL++ G L + D ++W S + K + L + GNL
Sbjct: 3 TVVWVANRLNPLTD-SSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNL 61
Query: 102 VLLSSAGSLVWQSFDHPTDTWLPGM---NISVGGSI--TSWKSLFDPS 144
VL ++G ++WQSFDHPTDT LPG N+ +GGS TSWKS DPS
Sbjct: 62 VLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
+ +G G FG V++G L VA+K++ + E+ + N++H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
G + ++ +Y NG+L ++K G + +G+AYLHE+
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQG--- 119
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
+IH DIK NIL D K++DFG+A D S+ A++ GT ++APE I +T
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 634 KADVYSYGMTLLELIGGR 651
+D++S G T++EL+ G
Sbjct: 179 ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/191 (31%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+G G FG V G+ VAVK L+ + + F AE + ++H NLV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + +V +YM G+L YLR G + + A+ G+ YL E+ +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+ N+L+ D AKVSDFGLAK + S+ + + + APE + +TK+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 637 VYSYGMTLLEL 647
V+S+G+ L E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 70/193 (36%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFC 518
KLG G FG V+ G + +T VAVK L +PG+ E F E + ++H LV+L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 519 SENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
SE +V +YM G+L +L+ G L +A A G+AYL E IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRN--YIHR 127
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+ NIL+ + K++DFGLA+LI D +R A W APE + T K+
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW--TAPEAANYGRFTIKS 185
Query: 636 DVYSYGMTLLELI 648
DV+S+G+ L E++
Sbjct: 186 DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREF-RAEVCTIGNIQHVNLVRLRGF 517
EK+G GGFG V++ VA+K ++ ++E E+ + +H N+V+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 518 CSENSHRLLVYDYMRNGALS--LYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRD 572
+ +V ++ G+L L L + IA +G+ YLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG-- 118
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
IIH DIK NILL SD K+ DFGL+ + +R TM GT ++APE I+G
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMVGTPYWMAPEVINGKPYD 175
Query: 633 TKADVYSYGMTLLELIGGR 651
KAD++S G+T +EL G+
Sbjct: 176 YKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 5/119 (4%)
Query: 2 RVIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQS 61
+ T++S F LGFF +S Y I Y + T VWVANR+ +
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNPSG--SSC 57
Query: 62 TLLITEKGKLAIKDSQNSIIWQSTNTEK--ATDMYLLETGNLVLLSSAGSLVWQSFDHP 118
TL + G L I D +++W S T + LL+ GNLVL S G+ +WQSFD+P
Sbjct: 58 TLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 458 FSEKLGHGGFGAVFQGE---LSDST--LVAVKRLERPGSGE--REFRAEVCTIGNIQHVN 510
F ++LG G FG V L D+T VAVK L G + +F E+ + + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 511 LVRLRGFC---SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
+V+ +G C S RL + +Y+ +G+L YL++ +N + +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRL-IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEW 625
+ I H D+ NIL++S+ K+SDFGLAK++ +D+ V + APE
Sbjct: 127 S--QRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 626 ISGLAITTKADVYSYGMTLLELIG-GRRNVEAPA 658
+ ++ +DV+S+G+TL EL G + PA
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRG 516
KLG G FG V++G +++T VAVK L +PG+ ++F AE + ++H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
C+ +V + M+ G+L YL+ G L +A A G+AYL + I
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDF--SRVLATMRGTWGYVAPEWISGLAITT 633
H D+ N+L+ + KV+DFGLA++I D +R A W APE +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW--TAPEAALYNRFSI 183
Query: 634 KADVYSYGMTLLELI 648
K+DV+S+G+ L E++
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 6/114 (5%)
Query: 171 WSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPS 230
W +G W G F +PEM Y ++F YT + +N SR +
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVY---YTYRMTNN---SIYSRLTLSSE 54
Query: 231 GQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRP 284
G L+++TW + WN+FWS P+D C V+G CG +G+C + C C GF P
Sbjct: 55 GSLERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVP 108
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG-EREFRAEVCTIGNIQHVNLVRLRGFC 518
KLG G FG V++G + VA+K L+ +++F+ EV + ++H +L+ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 519 SENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
S ++ + M G+L +LR +G L +A A G+AYL E+ IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHR 128
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D+ NIL+ D KV+DFGLA+LI D + + + APE S +TK+DV
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK-KIPYKWTAPEAASHGTFSTKSDV 187
Query: 638 YSYGMTLLEL 647
+S+G+ L E+
Sbjct: 188 WSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKR--LERPGSGEREF-RAEVCTIGNIQHVNLVRLR 515
+++G G FG V+ SD L +K L ERE EV + + H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLN---------LNWDVRFRIAVGTARGIAYL 566
E +V +Y G LS ++K L+W F V + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---F---VQLCLALKYL 119
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
H + I+H DIKP+NI L S+ K+ DFG++K++ + T+ GT Y++PE
Sbjct: 120 HSR-K--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELC 175
Query: 627 SGLAITTKADVYSYGMTLLELIGGRR 652
K+D++S G L EL +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 460 EKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLV 512
+ +G G FG V +G L VA+K L + GS + +F E +G H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
RL G +++ +++ +YM NG+L +LR++ + G A G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM--- 125
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWISG 628
+H D+ NIL++S+ KVSDFGL++ + D T G W APE I+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRW--TAPEAIAY 182
Query: 629 LAITTKADVYSYGMTLLELI 648
T+ +DV+S+G+ + E++
Sbjct: 183 RKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-24
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTL 63
+ T++S N F LGFF + Y I Y S + T VWVANR+ V+D TL
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSS-SRTVVWVANRDNPVSDS--CTL 58
Query: 64 LITEKGKLAIKDSQNSIIWQSTNTEK--ATDMYLLETGNLVLLSSAGSLVWQSFDH 117
+ G L + D ++W S T + LL+ GNLV+ S G+ +WQSFD+
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 460 EKLGHGGFGAVFQGEL----SDSTLVAVKRL--ERPGSGEREFRAEVCTIGNIQHVNLVR 513
++LGHG FG+V +G VAVK L E +G++EF E + + H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
L G C +LV + G L YL+K D++ +A A G+AYL E
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAMGMAYL-ESKH-- 115
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW--GYVAPEWISGLAI 631
+H D+ N+LL + + AK+SDFG+++ +G AT G W + APE I+
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 632 TTKADVYSYGMTLLE 646
++K+DV+SYG+TL E
Sbjct: 176 SSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 458 FSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHV 509
+LG G FG VF GE D LVAVK L+ S ++F E + N QH
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR-------------IA 556
N+V+ G C+E ++V++YM +G L+ +LR G + + IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMR 615
V A G+ YL + +H D+ N L+ D K+ DFG+++ + D+ RV
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++DV+S+G+ L E+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 3/190 (1%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+++G G FG V+ G + VA+K + E +F E + + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C+E S LV+++M +G LS YLR + + + + G+AYL +IH
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHR 124
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D+ N L+ + KVSDFG+ + + D + + +PE S ++K+DV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 638 YSYGMTLLEL 647
+S+G+ + E+
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERP--------GSGEREFRAEVCTIGNIQH 508
F + +G G F V E + A+K L++ + E EV T N H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE--KEVLTRLN-GH 61
Query: 509 VNLVRLRGFCS-ENSHRL-LVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAY 565
+++L + + ++ L V +Y NG L Y+RK G L+ RF A + Y
Sbjct: 62 PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAA-EILLALEY 117
Query: 566 LHEECRDC-IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD------------FSRVLA 612
LH IIH D+KPENILLD D K++DFG AK++ + +
Sbjct: 118 LH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 613 TMR-------GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
R GT YV+PE ++ +D+++ G + +++ G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 462 LGHGGFGAVFQG----ELSDSTL-VAVKRL--ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
LG G FG V++G E + VA+K L E +E E + ++ H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLR--KDGLN----LNWDVRFRIAVGTARGIAYLHE 568
G C + L+ M G L Y+R KD + LNW V A+G++YL E
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-E 126
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT---MRGTWGYVAPEW 625
E R ++H D+ N+L+ + K++DFGLAKL+ D A + W +A E
Sbjct: 127 EKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW--MALES 182
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I T K+DV+SYG+T+ EL+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 11/193 (5%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFC 518
+KLG G FG V+ G + T VA+K L + GS E F AE + +QH LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 519 SENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
++ ++ +YM NG+L +L+ G+ L + +A A G+A++ R IH
Sbjct: 71 TQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISGLAITTKA 635
D++ NIL+ K++DFGLA+LI + +R A W APE I+ T K+
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW--TAPEAINYGTFTIKS 184
Query: 636 DVYSYGMTLLELI 648
DV+S+G+ L E++
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 27/203 (13%)
Query: 462 LGHGGFGAVFQGELS----DSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRL 514
+G G FG VF+G L VA+K L +PG E++ F +E +G H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLR-KDGLNLNWDVRFRIAVGTARGIA----YLHEE 569
G ++ +++ +YM NGAL YLR DG + VG RGIA YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEW 625
+H D+ NIL++S+ KVSDFGL++++ D T G W APE
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW--TAPEA 181
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I+ T+ +DV+S+G+ + E++
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 53/150 (35%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 507 QHVNLVRLRG-FCSENSHRL-LVYDYMRNGAL-SLY--LRKDGLNLNWDVRFRIAVGTAR 561
+ +V+ G F E+S + + +Y G+L S+Y ++K G + V +IA +
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G++YLH IIH DIKP NILL K+ DFG++ G + + T GT Y+
Sbjct: 117 GLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYM 170
Query: 622 APEWISGLAITTKADVYSYGMTLLELIGGR 651
APE I G + +DV+S G+TLLE+ R
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 461 KLGHGGFGAVFQG-ELSDSTLVAVK--RLERP-GSGEREFRAEVCTIGNIQHVNLVRLRG 516
K+G G FG V+ L L+AVK R++ +E E+ + ++H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 517 FCSENSHRLLVYDYMR---NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
HR VY +M G L L G L+ V + G+AYLH
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHG--- 119
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV---LATMRGTWGYVAPEWISGLA 630
I+H DIKP NI LD + K+ DFG A + + + + + ++ GT Y+APE I+G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 631 ITTK---ADVYSYGMTLLELIGGRR 652
AD++S G +LE+ G+R
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
EK+G G FG V++G L +T VAVK R P +R+F E + H N+V+L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C + +V + + G+L +LRK L ++++ A G+ YL E ++C IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNC-IHR 117
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI-----T 632
D+ N L+ + K+SDFG++ R+ + T+ + +W + A+ T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 633 TKADVYSYGMTLLE 646
+++DV+SYG+ L E
Sbjct: 174 SESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 7/199 (3%)
Query: 451 LHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN 510
+ F ++LG G FG V G+ VA+K + E +F E + + H N
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
LV+L G C++ +V +YM NG L YLR+ L + + + YL
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE--- 117
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISG 628
+ IH D+ N L+ D KVSDFGLA+ + D S W PE
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA--PPEVFDY 175
Query: 629 LAITTKADVYSYGMTLLEL 647
++K+DV+S+G+ + E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 462 LGHGGFGAVFQ-GELSDSTLVAVKRLERPGSGEREFRAEVCTIG------NIQHVNLVRL 514
LG G FG V + L A+K L++ + + T+ I H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 515 RGFCS--ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECR 571
+ LV +Y G L +L K+G RF A + A + YLH
Sbjct: 59 --HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEYLHSLG- 113
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
II+ D+KPENILLD+D K++DFGLAK + + SR T GT Y+APE + G
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAPEVLLGKGY 170
Query: 632 TTKADVYSYGMTLLELIGGR 651
D +S G+ L E++ G+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
EKLG G +G+V++ +VA+K + + E E+ + +V+ G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-EIIKEISILKQCDSPYIVKYYGSY 67
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDCII 575
+N+ +V +Y G++S ++ L + IA T +G+ YLH + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE---EIAAILYQTLKGLEYLH---SNKKI 121
Query: 576 HCDIKPENILLDSDYTAKVSDFGLA-KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
H DIK NILL+ + AK++DFG++ +L R T+ GT ++APE I + K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNNK 179
Query: 635 ADVYSYGMTLLELIGGR 651
AD++S G+T +E+ G+
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 31/208 (14%)
Query: 460 EKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLV 512
E +G G FG V +G L VA+K L + G E R+F +E +G H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA--VGTARGIA----YL 566
L G +++ +++ ++M NGAL +LR++ D +F + VG RGIA YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYL 122
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWG------Y 620
E +H D+ NIL++S+ KVSDFGL++ + D S T + G +
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSSLGGKIPIRW 177
Query: 621 VAPEWISGLAITTKADVYSYGMTLLELI 648
APE I+ T+ +DV+SYG+ + E++
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPG-SGERE----------FRAEVCTIGNIQ 507
E +G G +G V+ ++ ++AVK++E P R R+E+ T+ ++
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
H+N+V+ GF + + + +Y+ G++ LR G VRF G+AYLH
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLH 125
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEWI 626
+ I+H D+K +N+L+D+D K+SDFG++K + +M+G+ ++APE I
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 627 --SGLAITTKADVYSYGMTLLELIGGRR 652
+ K D++S G +LE+ GRR
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 461 KLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFR----AEVCTIGNIQHVNLVRLR 515
LG G G V++ + A+K++ G+ EFR E+ T+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 516 G-FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G F E + V +YM G+L+ L+K G + V IA +G+ YLH + I
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITT 633
IH DIKP N+L++S K++DFG++K++ + T GT Y++PE I G + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 634 KADVYSYGMTLLELIGGR 651
AD++S G+TLLE G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 450 ELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV 509
L +T G E +G G FGAV QGE + VAVK ++ + + F E + + H
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYTGQK-VAVKNIKCDVTAQ-AFLEETAVMTKLHHK 59
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYL 566
NLVRL G N +V + M G L +LR G +++ ++F + V A G+ YL
Sbjct: 60 NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV--AEGMEYL 116
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+ ++H D+ NIL+ D AKVSDFGLA++ S + + + APE +
Sbjct: 117 ESKK---LVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEAL 169
Query: 627 SGLAITTKADVYSYGMTLLEL 647
++K+DV+SYG+ L E+
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 460 EKLGHGGFGAVFQGELSDSTL----VAVKRL--ERPGSGEREFRAEVCTIGNIQHVNLVR 513
+KLG G FG V +GE S S VAVK L ++ +F E + ++ H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 514 LRG--------FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
L G +E + + D +R AL +L ++ D AV A G+ Y
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFL----ISTLCD----YAVQIANGMRY 112
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL--AKLIGRDFSRVLATMRGTWGYVAP 623
L + R IH D+ NILL SD K+ DFGL A D + ++ + + AP
Sbjct: 113 LESK-R--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 624 EWISGLAITTKADVYSYGMTLLEL 647
E + + +DV+ +G+TL E+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 462 LGHGGFGAVFQGELS----DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRL 514
+G G FG V G L VA+K L + G E R+F +E +G H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA--VGTARGIAYLHEECRD 572
G +++ ++V +YM NG+L +LRK D +F + VG RGIA + D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 573 C-IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWIS 627
+H D+ NIL++S+ KVSDFGL++++ D T G W APE I+
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW--TAPEAIA 182
Query: 628 GLAITTKADVYSYGMTLLELI 648
T+ +DV+SYG+ + E++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 18/209 (8%)
Query: 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS----GEREFRA---EVCTIGNIQ 507
T+G E LG G +G V+ G + L+AVK++E S E+E+ EV + +++
Sbjct: 3 TKG--EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
HVN+V+ G C +++ + +++ G++S L + G L V + G+AYLH
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH 119
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-----DFSRVLATMRGTWGYVA 622
+C++H DIK N++L + K+ DFG A+ + S +L +M GT ++A
Sbjct: 120 N---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGR 651
PE I+ K+D++S G T+ E+ G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 6/191 (3%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFC 518
+KLG G FG V+ G ++ST VAVK L +PG+ + F E + +QH LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 519 SENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
++ ++ +YM G+L +L+ D G + + A G+AY+ R IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D++ N+L+ K++DFGLA++I + + + APE I+ + T K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 638 YSYGMTLLELI 648
+S+G+ L E++
Sbjct: 188 WSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 462 LGHGGFGAVFQGELSD------STLVAVKRL-ERPGSGER-EFRAEVCTIGNIQHVNLVR 513
LG G FG V++G T VA+K + E ER EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLR----KDGLNLNWDV-----RFRIAVGTARGIA 564
L G S L+V + M G L YLR + N ++A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVAP 623
YL + +H D+ N ++ D T K+ DFG+ + I D+ R ++AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 624 EWISGLAITTKADVYSYGMTLLEL 647
E + TTK+DV+S+G+ L E+
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
EKLG G +G V++ + +VA+K RL+ P + RE + + ++H N+
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNI 60
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRK--DGLNLNWDVRFRIAVGTARGIAYLHEE 569
V+L LV++Y L YL K L+ N ++ I RG+AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNL-IK-SIMYQLLRGLAYCH-- 115
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWI 626
I+H D+KP+NIL++ D K++DFGLA+ G R ++ + T+ W Y APE +
Sbjct: 116 -SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL---W-YRAPEIL 170
Query: 627 SG-LAITTKADVYSYGMTLLELIGGR 651
G +T D++S G E+I G+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKR--LERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
E +G G V+ L ++ VA+KR LE+ + E R EV + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDC 573
LV Y+ G+L L + K IA +G+ YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLI---GRDFSRVLATMRGTWGYVAPEWIS-GL 629
IH DIK NILL D + K++DFG++ + G +V T GT ++APE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 630 AITTKADVYSYGMTLLELIGGR 651
KAD++S+G+T +EL G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 5/189 (2%)
Query: 461 KLGHGGFGAVFQGELSDSTL-VAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCS 519
KLG G +G V++G +L VAVK L+ EF E + I+H NLV+L G C+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 520 ENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
++ ++M G L YLR+ + +N V +A + + YL + IH D
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
+ N L+ ++ KV+DFGL++L+ D A + + APE ++ + K+DV+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189
Query: 639 SYGMTLLEL 647
++G+ L E+
Sbjct: 190 AFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-20
Identities = 90/359 (25%), Positives = 156/359 (43%), Gaps = 51/359 (14%)
Query: 402 VAGIVGSIAALVLAAVMLMILRKKRK-KRKDVDEEDVFPVLNLKVFSYKELHTVT----- 455
+ +G+ L L A + +R + + K V+ ED L+ F K ++T
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED--GTWELQFFDSKVSKSITINDIL 689
Query: 456 RGFSEK--LGHGGFGAVFQGELSDSTL-VAVKRLERPGSGEREFRAEVCTIGNIQHVNLV 512
E+ + G GA ++G+ + + VK + S A+ +G +QH N+V
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIV 746
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+L G C L+++Y+ LS LR NL+W+ R +IA+G A+ + +LH C
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
++ ++ PE I++D + L L+ D +++ YVAPE IT
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDIT 856
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE------HGDKWFFPPWAARQII 686
K+D+Y +G+ L+EL+ G+ +A G + +I H D W P I
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDMWIDP------SI 909
Query: 687 EGNVAAVVDDRLGGAYKVEEAERVAL--VAIWCIQDNEEMRPTMGTVVKMLEGVLEVTA 743
G+V+ V + E V + +A+ C + RP V+K LE ++
Sbjct: 910 RGDVS------------VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 461 KLGHGGFGAVFQGE------LSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVR 513
+LG G FG VF E D LVAVK L+ P + ++F+ E + N+QH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN---------------LNWDVRFRIAVG 558
G C + ++V++YM++G L+ +LR G + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGT 617
A G+ YL + +H D+ N L+ ++ K+ DFG+++ + D+ RV
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 618 WGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++DV+S+G+ L E+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 461 KLGHGGFGAVFQGELS------DSTLVAVKRL-ERPGSGEREFRAEVCTIGNIQHVNLVR 513
+LG G FG VF E D LVAVK L E S ++F+ E + +QH ++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN--------------LNWDVRFRIAVGT 559
G C+E L+V++YMR+G L+ +LR G + L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 560 ARGIAY---LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMR 615
A G+ Y LH +H D+ N L+ K+ DFG+++ I D+ RV
Sbjct: 132 ASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++D++S+G+ L E+
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 59/192 (30%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
F ++LG G FG V G+ VA+K ++ E EF E + + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C++ +V +YM NG L YLR+ G + G+AYL + IH
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+ N L+D KVSDFGL++ + D S V + W PE + ++K+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLLYSKFSSKS 182
Query: 636 DVYSYGMTLLEL 647
DV+++G+ + E+
Sbjct: 183 DVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 5/192 (2%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
EK+G G G V++ + + VA+K++ + E+ + + +H N+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+V +YM G+L+ + ++ + +N + +G+ YLH +IH D
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRD 141
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
IK +NILL D + K++DFG A + ++ S+ ++ GT ++APE I K D++
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 639 SYGMTLLELIGG 650
S G+ +E+ G
Sbjct: 201 SLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 461 KLGHGGFGAVFQGELSDSTLV-AVKRLERPGSGEREFRA---EVCTIGNIQHVNLVRLRG 516
+LG G G V + + + AVK + R E + E+ + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
N + +YM G+L L++ + + +IAV +G+ YLHE+ + IIH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+KP NIL++S K+ DFG++ G+ + + T GT Y+APE I G + K+D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 637 VYSYGMTLLELIGGR 651
++S G++L+EL GR
Sbjct: 182 IWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 462 LGHGGFGAVF---QGELSDST--LVAVKRLERPGSGERE--FRAEVCTIGNIQHVNLVRL 514
LG G FG V +D T +VAVK L+R + ++ E+ + + H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 515 RGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+G CSE + L+ +Y+ G+L YL K LNL + F A G+AYLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHSQH-- 127
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEWISGLA 630
IH D+ N+LLD+D K+ DFGLAK + G ++ RV + A E +
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 631 ITTKADVYSYGMTLLELI 648
+ +DV+S+G+TL EL+
Sbjct: 187 FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 11/190 (5%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG-FC 518
+ +G G FG V G+ VAVK ++ + + F AE + ++H NLV+L G
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
E +V +YM G+L YLR G + L D + ++ + YL + +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D+ N+L+ D AKVSDFGL K + S T + + APE + +TK+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 638 YSYGMTLLEL 647
+S+G+ L E+
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFC 518
+KLG+G FG V+ G + +T VAVK L +PG+ E F E + ++H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 519 SENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
SE +V +YM G+L +L+ +G L +A A G+AY+ R IH
Sbjct: 71 SEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D++ NIL+ K++DFGLA+LI + + + APE T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 638 YSYGMTLLELIGGRRNVEAPASGRN 662
+S+G+ L EL+ R P G N
Sbjct: 187 WSFGILLTELVTKGR---VPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHV 509
F E+LG G FG V++GEL +T VA+K L+ ++EFR E + ++QH
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYL---------------RKDGLNLNWDVRFR 554
N+V L G C++ ++++Y+ +G L +L +L+
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 555 IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLAT 613
IA+ A G+ YL +H D+ N L+ T K+SDFGL++ I D+ RV +
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++D++S+G+ L E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 458 FSEKLGHGGFGAV-----------------FQGELSDSTLVAVKRLERPG---SGEREFR 497
F EKLG G FG V LVAVK L RP + +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFL 67
Query: 498 AEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK----------DGLNL 547
EV + + N+ RL G C+ + ++ +YM NG L+ +L+K + +L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 548 NWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRD 606
++ +A A G+ YL E + +H D+ N L+ +YT K++DFG+++ L D
Sbjct: 128 SFSTLLYMATQIASGMRYL--ESLN-FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 607 FSRV--LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLE 646
+ RV A + W +A E + TTK+DV+++G+TL E
Sbjct: 185 YYRVQGRAPLPIRW--MAWESVLLGKFTTKSDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSGER-EFRAEVCTIGNIQHVN 510
+LG G FG VF E D LVAVK L+ R +F E + N+QH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG------------LNLNWDVRFRIAVG 558
+V+ G C E ++V++YM++G L+ +LR G L IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRDFSRVLATMRGT 617
A G+ YL + +H D+ N L+ + K+ DFG+++ + D+ RV
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 618 WGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++DV+S G+ L E+
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 64/198 (32%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 462 LGHGGFGAVFQGEL----SDSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVR 513
LG GGFG V EL S + A+K +++ + +E + H +V+
Sbjct: 1 LGVGGFGRV---ELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
L + + ++ +Y G L LR GL + RF IA YLH
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNRG--- 113
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
II+ D+KPEN+LLDS+ K+ DFG AK + + T GT YVAPE I
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWTFCGTPEYVAPEIILNKGYDF 171
Query: 634 KADVYSYGMTLLELIGGR 651
D +S G+ L EL+ GR
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 458 FSEKLGHGGFGAVFQ---GELSDST--LVAVKRLERPGSGE-REFRAEVCTIGNIQHVNL 511
F ++LG G FG+V L D+T +VAVK+L+ + R+F E+ + ++QH N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 512 VRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
V+ +G C R LV +Y+ G+L YL+K L+ A +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS- 126
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEWIS 627
+ + H D+ NIL++S+ K+ DFGL K++ +++ +V + APE ++
Sbjct: 127 -KRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 628 GLAITTKADVYSYGMTLLEL 647
+ +DV+S+G+ L EL
Sbjct: 185 ESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
E LG G FG VF+G L D T VAVK + + P + +F +E + H N+V+L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C++ +V + + G +LRK L + A+ A G+AYL E ++C IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNC-IHR 117
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+ N L+ + K+SDFG+++ G S L + W APE ++ ++++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW--TAPEALNYGRYSSES 175
Query: 636 DVYSYGMTLLE 646
DV+SYG+ L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 462 LGHGGFGAVFQ----GELSDS--TLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVR 513
+G G FG VFQ G L T+VAVK L+ S + +F+ E + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRK---------------------DGLNLNWDVR 552
L G C+ L+++YM G L+ +LR + L L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 553 FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVL 611
IA A G+AYL E +H D+ N L+ + K++DFGL++ I D+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I TT++DV++YG+ L E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 462 LGHGGFGAVFQGELS--DSTL--VAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRL 514
LG G FG+V +G+LS D + VAVK ++ E F +E + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 515 RGFCSENSHR------LLVYDYMRNGALSLYL---RKDGLNLNWDVR--FRIAVGTARGI 563
G C E S +++ +M++G L +L R GL ++ + V A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSR--VLATMRGTWGY 620
YL IH D+ N +L D T V+DFGL+K I D+ R +A M W
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW-- 181
Query: 621 VAPEWISGLAITTKADVYSYGMTLLEL 647
+A E ++ T+K+DV+++G+T+ E+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 460 EKLGHGGFGAVFQGEL-SDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
E++G G FG VF G L +D+T VAVK R P + +F E + H N+VRL G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
C++ +V + ++ G +LR +G L ++ A G+ YL + C IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--C-IH 117
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWISGLAIT 632
D+ N L+ K+SDFG+++ + V A+ G + APE ++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 633 TKADVYSYGMTLLE 646
+++DV+S+G+ L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 460 EKLGHGGFGAVFQ-GELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRL- 514
E +G G FG V + SD ++ K ++ E+E +EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 515 -RGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGTARGIAYLH--E 568
R N +V +Y G L+ + +K+ + + +RI + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
+ + ++H D+KP NI LD++ K+ DFGLAK++G D S T GT Y++PE ++
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPYYMSPEQLNH 184
Query: 629 LAITTKADVYSYGMTLLEL 647
++ K+D++S G + EL
Sbjct: 185 MSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 71/223 (31%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 462 LGHGGFGAVFQGELS----DST--LVAVKRLERPGSGERE--FRAEVCTIGNIQHVNLVR 513
LGHG FG V++G D+ VAVK L S + E F E + H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR------IAVGTARGIAYLH 567
L G E R ++ + M G L +LR++ A A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 568 EECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGR-DFSRV--LATMRGTWGYV 621
EE IH DI N LL AK++DFG+A+ I R + R A + W +
Sbjct: 133 EENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW--M 188
Query: 622 APE-WISGLAITTKADVYSYGMTLLELIG-------GRRNVEA 656
PE ++ G+ T+K DV+S+G+ L E+ GR N E
Sbjct: 189 PPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 45/296 (15%)
Query: 462 LGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLVR 513
LG G FG V +G S VA+K ++ SG + F+ + +G++ H +VR
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
L G C S +L V G+L ++R+ +L+ V A+G+ YL E
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL-ATMRGTWGYVAPEWISGLAIT 632
++H ++ NILL SD +++DFG+A L+ D + + + ++A E I T
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692
++DV+SYG+T+ E++ E A R + E G++ P QI +V
Sbjct: 190 HQSDVWSYGVTVWEMMS--YGAEPYAGMRPHEVPDLLEKGERLAQP-----QICTIDVYM 242
Query: 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPR 748
V +V W I +N +RPT K L A PPR
Sbjct: 243 V------------------MVKCWMIDEN--VRPTF----KELANEFTRMARDPPR 274
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 462 LGHGGFGAVFQGEL------SDST--LVAVKRLERPGSGER---EFRAEVCTIGNIQHVN 510
LG G FG V EL D+T VAVK L +P SG + + E+ + N+ H N
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHEN 67
Query: 511 LVRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+V+ +G C+E+ L+ +++ +G+L YL ++ +N + + AV +G+ YL
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWI 626
+H D+ N+L++S++ K+ DFGL K I D + V + + APE +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 627 SGLAITTKADVYSYGMTLLELI 648
+DV+S+G+TL EL+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 34/210 (16%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE------REFRAEVCTIGNIQHVNLV 512
E LG G FG+V++G L D AVK + G+ ++ E+ + +QH N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR---IAVGTAR---GIAYL 566
+ G E + + + + G+L+ L+K G F I + T + G+ YL
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-------SFPEPVIRLYTRQILLGLEYL 118
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
H+ +H DIK NIL+D++ K++DFG+AK + + +G+ ++APE I
Sbjct: 119 HDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVI 173
Query: 627 S-----GLAITTKADVYSYGMTLLELIGGR 651
+ GLA AD++S G T+LE+ G+
Sbjct: 174 AQQGGYGLA----ADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 7/192 (3%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
F ++LG G FG V G+ VA+K + E +F E + + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C++ +V ++M NG L YLR+ L+ D+ + G+ YL R+ IH
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+ N L+ S KVSDFG+ + + D S A W PE + ++K+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS--PPEVFNFSKYSSKS 182
Query: 636 DVYSYGMTLLEL 647
DV+S+G+ + E+
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 47/135 (34%), Positives = 77/135 (57%), Gaps = 7/135 (5%)
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
F +EN + + ++M G+L +K G + ++ +IAV G+ YL+ R I+H
Sbjct: 72 FLNEN-NICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
DIKP NIL++S K+ DFG++ G + + T GT Y++PE I G T K+D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 637 VYSYGMTLLELIGGR 651
V+S G++++EL G+
Sbjct: 185 VWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 460 EKLGHGGFGAVFQ-GELSDSTLVAVKRL---ERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
++G G G VF+ + VA+K++ G + E+ + QH +V+L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLH 567
S +LV +YM + LS LR D + + G+AY+H
Sbjct: 66 DVFPHGSGFVLVMEYMPSD-LSEVLR--------DEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
I+H D+KP N+L+ +D K++DFGLA+L + R+ + T Y APE +
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 628 GL-AITTKADVYSYGMTLLELIGGR 651
G D+++ G EL+ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 462 LGHGGFGAVFQGELSDSTL-VAVKRLE-RPGSGE--REFRAEVCTI---GNIQHVNLVRL 514
LG G FG V+ D+ +AVK++ P S E +E A C I N+QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G ++ + +YM G++ L+ G L V + G+ YLH + I
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH---SNMI 125
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--LATMRGTWGYVAPEWISGLAIT 632
+H DIK NIL DS K+ DFG +K + S + ++ GT +++PE ISG
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 633 TKADVYSYGMTLLELI 648
KADV+S G T++E++
Sbjct: 186 RKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLE-RPGSG-EREFR 497
F L +T LG G FG VF + TLV VK L+ + EFR
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 498 AEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLR----KDGL----NLNW 549
E+ + H N+VRL G C E ++ +Y G L +LR KD L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 550 DVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609
+ + A G+ +L +H D+ N L+ S KVS L+K + ++
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDV---YNS 170
Query: 610 VLATMRGTWG---YVAPEWISGLAITTKADVYSYGMTLLEL 647
+R ++APE + +TK+DV+S+G+ + E+
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 462 LGHGGFGAVFQGELS----DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLR 515
LG G FG + +G L VA+ L S R F AE T+G H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
G + + ++V +YM NGAL +LRK L + G A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYV 129
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-VLATMRGT----WGYVAPEWISGLA 630
H + +L++SD K+S F + D S + TM G W APE I
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSPVLWA--APEAIQYHH 184
Query: 631 ITTKADVYSYGMTLLELI 648
++ +DV+S+G+ + E++
Sbjct: 185 FSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTL-VAVKRL-ERPGSGERE-FRAEVCTIGNI-QH 508
F + LG G FG V + SD+ + VAVK L S ERE +E+ + ++ H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK--DGLNLNWDVRFRIAVGTARGIAYL 566
N+V L G C+ L++ +Y G L +LR+ + D+ + A+G+A+L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFL 157
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL-ATMRGTWGYVAPEW 625
++CI H D+ N+LL K+ DFGLA+ I D + V+ R ++APE
Sbjct: 158 --ASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 626 ISGLAITTKADVYSYGMTLLEL 647
I T ++DV+SYG+ L E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 462 LGHGGFGAVFQGELSD-------STLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLV 512
LG G FG V++G +D VAVK L + + + +EF E + N H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRK------DGLNLNWDVRFRIAVGTARGIAYL 566
+L G C N + ++ + M G L YLR L I + A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 567 HEECRDCIIHCDIKPENILL-----DSDYTAKVSDFGLAKLIGR-DFSRVLATMRGTWGY 620
E+ IH D+ N L+ D+D K+ DFGLA+ I + D+ R +
Sbjct: 123 -EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 621 VAPEWISGLAITTKADVYSYGMTLLELI 648
+APE + TT++DV+S+G+ + E++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCS 519
KLG G FG V+ G + +T VA+K L +PG+ E F E + ++H LV L S
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 520 ENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
E +V ++M G+L +L++ DG L +A A G+AY+ R IH D
Sbjct: 72 EEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
++ NIL+ + K++DFGLA+LI + + + APE T K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 639 SYGMTLLELIGGRR 652
S+G+ L EL+ R
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 461 KLGHGGFGAVFQGE-LSDSTLVAVKR--LERPGSGEREFRA-EVCTIGNIQHVNLVRLR- 515
KLG G +G+V++ + LSD+ A+K L ERE E+ + ++ H N++ +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 516 GFCSENSHRL-LVYDYMRNGALSLYLRKDGLN---LNWDVRFRIAVGTARGIAYLHEECR 571
F N +L +V +Y G LS + K + +RI + RG+ LHE+
Sbjct: 67 AFLDGN--KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK- 123
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
I+H D+K NILL ++ K+ D G++K++ ++ ++ T GT Y+APE G
Sbjct: 124 --ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK---TQIGTPHYMAPEVWKGRPY 178
Query: 632 TTKADVYSYGMTLLELIGGRRNVEA 656
+ K+D++S G L E+ EA
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 64/189 (33%), Positives = 97/189 (51%), Gaps = 7/189 (3%)
Query: 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCS 519
KLG G FG V+ G + +T VA+K L +PG+ E F E + ++H LV+L S
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 520 ENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
E +V +YM G+L +L+ + G L +A A G+AY+ R +H D
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
++ NIL+ + KV+DFGLA+LI + + + APE T K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 639 SYGMTLLEL 647
S+G+ L EL
Sbjct: 188 SFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 460 EKLGHGGFGAVFQGE---LSDSTLVAVKRLERPGSGERE--FRAEVCTIGNIQHVNLVRL 514
+++G+G FG V GE V VK L + + + F EV + H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNW----DVRFRIAVGTARGIAYLHEEC 570
G C E+ LLV ++ G L YLR + + DV R+A A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR----VLATMRGTW---GYVAP 623
+ IH D+ N L +D + K+ D+GLA + T ++AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA------LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 624 EWISGLA-------ITTKADVYSYGMTLLEL 647
E + T K++++S G+T+ EL
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 37/279 (13%)
Query: 462 LGHGGFG-AVFQGELSDSTLVAVKRLERPGSGEREFR---AEVCTIGNIQHVNLVRLRGF 517
LG G FG A D +LV K + E+E R E+ + +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 518 CSENSHRLLVYDYMRNGAL-SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+++ L+ +Y G L +R+ G ++ ++Y+H+ I+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
DIK NI L K+ DFG++K++G ++S T+ GT Y++PE G+ K+D
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA-ETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696
+++ G L EL+ +R +A N P +I++GN VV
Sbjct: 184 IWALGCVLYELLTLKRTFDA------TN-------------PLNLVVKIVQGNYTPVVS- 223
Query: 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735
V +E ++LV +Q + E RPT V+
Sbjct: 224 -------VYSSELISLVHS-LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 64/195 (32%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRG 516
LG G FG V S A+K L + E + +I+H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
++S+ LV +Y+ G L +LRK G RF A + YLH I++
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL-ALEYLHSLD---IVY 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+KPEN+LLDSD K++DFG AK + GR + T+ GT Y+APE I
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAKRVKGRTY-----TLCGTPEYLAPEIILSKGYGKAV 179
Query: 636 DVYSYGMTLLELIGG 650
D ++ G+ + E++ G
Sbjct: 180 DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLE--RPGSGERE-----FRAEVCTIGNIQHVNL 511
++LG G F + +Q ++ TL+AVK++ R S E+E R E+ + + H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+R+ G E+SH L ++M G++S L K G V RG++YLHE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-AVIINYTEQLLRGLSYLHE--- 121
Query: 572 DCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRV---LATMRGTWGYVAPEWIS 627
+ IIH D+K N+L+DS +++DFG A + + + GT ++APE +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 628 GLAITTKADVYSYGMTLLELIGGR 651
G DV+S G ++E+ +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 460 EKLGHGGFGAVFQGELSDS----TLVAVKRLERPGSGER--EFRAEVCTIGNIQHVNLVR 513
+G G FG V+ G L DS AVK L R E +F E + + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 514 LRGFC--SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVG--TARGIAYLHEE 569
L G C SE S L+V YM++G L ++R + N V+ I G A+G+ YL +
Sbjct: 61 LLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHNPT--VKDLIGFGLQVAKGMEYLASK 117
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVL----ATMRGTWGYVAPE 624
+H D+ N +LD +T KV+DFGLA+ I +++ V A + W +A E
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW--MALE 172
Query: 625 WISGLAITTKADVYSYGMTLLELI 648
+ TTK+DV+S+G+ L EL+
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 463 GHGGFGAVFQGELSDSTLV-AVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLR-G 516
G G FG V + D+ + A+K + + E+ E + + H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 517 FC-SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
F EN + LV D + G L +L + V+F + YLH + II
Sbjct: 69 FQDEENMY--LVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLHSKG---II 122
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H DIKP+NILLD ++DF +A + D + + GT GY+APE + +
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 636 DVYSYGMTLLELIGGRR 652
D +S G+T E + G+R
Sbjct: 181 DWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRL 514
K+G G +G V++ + +VA+K+++ G + R E+ + + H N+++L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKL 63
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
LV+++M L ++ L + +G+A+ H I
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKL-IKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI-TT 633
+H D+KPEN+L++++ K++DFGLA+ G R T Y APE + G +T
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 634 KADVYSYGMTLLELIGGR 651
D++S G EL+ R
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
+KLG G FG V+ + T VAVK + +PGS E F AE + +QH LV+L
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
++ ++ ++M G+L +L+ D G + A G+A++ E R+ I
Sbjct: 69 VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN-YI 124
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D++ NIL+ + K++DFGLA++I + + + APE I+ + T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 636 DVYSYGMTLLELI 648
DV+S+G+ L+E++
Sbjct: 185 DVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTL---VAVKRLERPGSGE--REFRAEV---CTIGNIQHV 509
F + +G G FG V + + L A+KR++ S + R+F E+ C +G H
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHP 68
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTA--------- 560
N++ L G C + L +Y +G L +LRK + L D F IA TA
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSSQQLL 127
Query: 561 -------RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613
RG+ YL ++ IH D+ NIL+ +Y AK++DFGL++ + +
Sbjct: 128 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
+ W +A E ++ TT +DV+SYG+ L E++
Sbjct: 185 LPVRW--MAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCS 519
LG G +G V+ +LS +A+K + S + E+ ++H N+V+ G S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 520 ENSHRLLVYDYMRNGALSLYLR-KDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
EN + + + G+LS LR K G L N G+ YLH+ I+H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 578 DIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS-GL-AITT 633
DIK +N+L+++ Y+ K+SDFG +K + + T GT Y+APE I G
Sbjct: 133 DIKGDNVLVNT-YSGVVKISDFGTSKRLAG-INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 634 KADVYSYGMTLLELIGGR 651
AD++S G T++E+ G+
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 462 LGHGGFGAVFQGELS--DSTL-VAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G FG+V +G+L+ DS L VAVK ++ S +F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 516 GFCSENSHR------LLVYDYMRNGALSLYLRKDGLN-----LNWDVRFRIAVGTARGIA 564
G C + +++ +M++G L +L L L + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRV--LATMRGTWGYV 621
YL + IH D+ N +L+ + V+DFGL+K I D+ R +A M W +
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW--I 181
Query: 622 APEWISGLAITTKADVYSYGMTLLEL 647
A E ++ TTK+DV+S+G+T+ E+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 41/137 (29%), Positives = 78/137 (56%), Gaps = 6/137 (4%)
Query: 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588
++M G+L L+K G + ++ +I++ RG+ YL E+ + I+H D+KP NIL++S
Sbjct: 79 EHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNS 135
Query: 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
K+ DFG++ G+ + + GT Y++PE + G T ++D++S G++L+E+
Sbjct: 136 RGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192
Query: 649 GGRRNVEAPASGRNANI 665
GR + P + +
Sbjct: 193 IGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 33/206 (16%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE-------REFRAEVCTIGNIQHVNLVR 513
+G G +G V++ +L+ VA+K++ P S E RE A + + + +H N+VR
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFEHPNIVR 65
Query: 514 LRGFC--SENSHRL---LVYDYMRNGALSLYLRK---DGL--NLNWDVRFRIAVGTARGI 563
L C L LV++++ L+ YL K GL D+ ++ RG+
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLL----RGV 120
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--VLATMRGTWGYV 621
+LH I+H D+KP+NIL+ SD K++DFGLA++ + + V+ T+ W Y
Sbjct: 121 DFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL---W-YR 173
Query: 622 APEWISGLAITTKADVYSYGMTLLEL 647
APE + + T D++S G EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 447 SYKELHTVTRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLE---RPGSGEREFRAEVCT 502
++K+L EKLG G + V++G + +VA+K + G+ R E+
Sbjct: 1 NFKQL--------EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISL 51
Query: 503 IGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG----LNLNWDVRFRIAVG 558
+ ++H N+VRL + +LV++YM L Y+ G L+ N F +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQL- 109
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMR 615
+GIA+ HE + ++H D+KP+N+L++ K++DFGLA+ G FS + T+
Sbjct: 110 -LKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL- 164
Query: 616 GTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGR 651
W Y AP+ + G +T D++S G + E+I GR
Sbjct: 165 --W-YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 8/192 (4%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFR-AEVCTIGNIQHVNLVRLRGFC 518
K+G G G V + S VAVK+++ RE EV + + QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+V +++ GAL+ + +N + + + + +++LH + +IH D
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRD 140
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
IK ++ILL SD K+SDFG + ++ R ++ GT ++APE IS L T+ D++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 639 SYGMTLLELIGG 650
S G+ ++E++ G
Sbjct: 200 SLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 34/284 (11%)
Query: 462 LGHGGFGAVF---QGELSDS-TLVAVKRLERP---------GSGEREFRAEVCTIGNIQH 508
LG G FG VF + D+ L A+K L++ ER+ AEV H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+V+L L+ D++R G L L K+ + DV+F +A A + +LH
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH- 115
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
II+ D+KPENILLD + K++DFGL+K D + + GT Y+APE ++
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA---RQI 685
T AD +S+G+ + E++ G + + + G F P A R +
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRAL 232
Query: 686 IEGNVAAVVDDRLG-GAYKVEEAERVALVAI--WCIQDNEEMRP 726
+ N A +RLG G VEE +R + W E++P
Sbjct: 233 FKRNPA----NRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKR--LERPGSGERE---FRAEVCTIGNIQHVNLVR 513
E +G G FG V++ + + +VA+K LE E E + E+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE---EAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEEC 570
G + S ++ +Y G+ L+ L+ IA G+ YLHEE
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLD-----ETYIAFILREVLLGLEYLHEEG 118
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
+ IH DIK NILL + K++DFG++ + S+ T GT ++APE I
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQSG 174
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASG 660
KAD++S G+T +EL G E P S
Sbjct: 175 YDEKADIWSLGITAIELAKG----EPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 460 EKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGEREFRAEVC------TIGNIQ 507
+ LG G FG V + E ++ VAVK L+ + E++ V IG +
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIG--K 74
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKD---GLNLNWD-------------- 550
H N++ L G C++ +V +Y +G L +LR G + D
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 551 VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSR 609
V F V ARG+ +L + CI H D+ N+L+ D+ K++DFGLA+ I D+ R
Sbjct: 135 VSFAYQV--ARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
R ++APE + T ++DV+S+G+ L E+
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE----------FRAEVCTIGNIQHVN 510
+G G FG+V+ G S L+AVK++E P E+ + +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+ G + H + +Y+ G+++ L G VR + +G+ YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-QILKGLNYLHN-- 124
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-------GRDFSRVLATMRGTWGYVAP 623
R IIH DIK NIL+D+ K+SDFG++K + + +R +++G+ ++AP
Sbjct: 125 RG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR--PSLQGSVFWMAP 181
Query: 624 EWISGLAITTKADVYSYGMTLLELIGGR 651
E + + T KAD++S G ++E++ G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 35/208 (16%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE-------FRA--EVCTIGNIQHV 509
+KLG G + V++ +VA+K+++ GER+ F A E+ + ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHP 62
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVG--------TAR 561
N++ L S+ LV+++M L ++ D + T R
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIK--------DKSIVLTPADIKSYMLMTLR 113
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+ YLH + I+H D+KP N+L+ SD K++DFGLA+ G +R + T Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVVTRWYR 169
Query: 622 APEWISGLAI-TTKADVYSYGMTLLELI 648
APE + G D++S G EL+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRG 516
+G G +G V VA+K++ +R R E+ + +++H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 517 -FCSENSHRL----LVYDYMRNGALSLY-LRKDGLNLNWD-VRFRIAVGTARGIAYLHEE 569
+ +V + M L+ + K L D +++ RG+ YLH
Sbjct: 67 ILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLHSA 122
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-----TMRGTWGYVAPE 624
+IH D+KP NIL++S+ K+ DFGLA+ + D R W Y APE
Sbjct: 123 N---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR--W-YRAPE 176
Query: 625 WISGLAITTKA-DVYSYGMTLLELIGGR 651
+ + TKA D++S G EL+ +
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 458 FSEKLGHGGFGAV----------FQGELSDS-----TLVAVKRLERP---GSGEREFRAE 499
EKLG G FG V F GE + LVAVK L R + +F E
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLKE 67
Query: 500 VCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI---- 555
+ + +++ N++RL G C + ++ +YM NG L+ +L + + + I
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 556 -------AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRDF 607
AV A G+ YL +H D+ N L+ + YT K++DFG+++ L D+
Sbjct: 128 IANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
R+ ++A E I TT +DV+++G+TL E+
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 17/209 (8%)
Query: 448 YKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKR-LERPGSGE--REFRAEVCTI 503
Y+ L V G G +G V + + +VA+K+ E + + EV +
Sbjct: 3 YEVLGVV--------GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVL 54
Query: 504 GNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI 563
++H N+V L+ LV++Y+ L L G L D + I
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAI 113
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
AY H IIH DIKPENIL+ K+ DFG A+ + + L T Y AP
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 624 EWISGLAITTKA-DVYSYGMTLLELIGGR 651
E + G K DV++ G + EL+ G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 74/293 (25%), Positives = 118/293 (40%), Gaps = 48/293 (16%)
Query: 460 EKLGHGGFGAVFQGELSDS--TLVAVKR--LERP--GSGEREFRAEV------CTIGNIQ 507
E LG G FG V++ ++ L+A+K + P G +RE + TI Q
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 508 --HVNLVRLRGFCSENSHRLLVYDYMRNGALSLY---LRKDGLNLNWDVRFRIAVGTARG 562
H N+VR EN +V D + L + L++ + + I V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
+ YLH+E R I+H D+ P NI+L D ++DFGLAK + L ++ GT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSC 181
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PE + KADV+++G L ++ ++ P N A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYSTNMLS---------------LA 222
Query: 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735
+I+E + + +E V V C+ + E RP + V M+
Sbjct: 223 TKIVEAVYEPLPEGMY--------SEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 461 KLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV----NLVR 513
+LG G FG V +G VA+K L+ E+ R E+ I H +VR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ G C E +LV + G L+ +L +KD + ++ V V + G+ YL +
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV--SMGMKYLEGKN- 115
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW--GYVAPEWISGL 629
+H D+ N+LL + + AK+SDFGL+K +G D S A G W + APE I+
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 630 AITTKADVYSYGMTLLE 646
++++DV+SYG+T+ E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLVRLR 515
K+G G FG VF+ +D + A+K+++ RE E + + ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ +V +Y NG L L+ G L D +R + G+A+LH + I
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
+H DIK N+ LD+ K+ D G+AKL+ D + T+ GT Y++PE K
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 635 ADVYSYGMTLLELIGGRRNVEAPASG 660
+DV++ G+ L E G+ +A G
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 460 EKLGHGGFGAVFQGELS---DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRL 514
+++G+G FG V GE++ V VK L S + +F E ++QH NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLR--KDGLNLNWDVRF--RIAVGTARGIAYLHEEC 570
G C+E + LLV ++ G L YLR + + D R+A A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW---GYVAPEWI- 626
++ IH D+ N LL +D T K+ D+GL+ ++ V W ++APE +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL--WVPLRWIAPELVD 175
Query: 627 ---SGLAI---TTKADVYSYGMTLLEL 647
L + T +++V+S G+T+ EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 462 LGHGGFGAVFQGE------LSDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLV 512
LG G FG V + + T VAVK L+ + E R E + + H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRK----------DGLNLNW------DVR---- 552
+L G CS++ LL+ +Y + G+L +LR+ N N D R
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 553 ---FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609
A +RG+ YL E ++H D+ N+L+ K+SDFGL++ + + S
Sbjct: 127 GDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 610 VLATM-RGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
V + R ++A E + TT++DV+S+G+ L E++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 6e-15
Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQ-HVNLVRL 514
++LG G FG+V+ LVA+K++++ E R EV ++ + H N+V+L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKL 63
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ EN V++YM L + G + V I +G+A++H +
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGF 120
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAK 601
H D+KPEN+L+ K++DFGLA+
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+++G G +G V++ +++ LVA+K +LE PG + E+ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 517 FCSENSHRLLVYDYMRNGALS-LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+V +Y G+L +Y G L+ + T +G+AYLHE + I
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGK---I 123
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI---SGLAIT 632
H DIK NILL D K++DFG++ + ++ + GT ++APE
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVAAVERKGGYD 182
Query: 633 TKADVYSYGMTLLEL 647
K D+++ G+T +EL
Sbjct: 183 GKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 68/199 (34%), Positives = 96/199 (48%), Gaps = 25/199 (12%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLR 515
++GHG FGAV F ++ + +VA+K++ G E EV + ++H N + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 516 GFCSENSHRLLVYDYMRNGALS-LYLRKDGLNLNWDVRFR-IAVGTARGIAYLHEECRDC 573
G LV +Y A L + K L +V I G +G+AYLH R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKKPLQ---EVEIAAICHGALQGLAYLHSHER-- 136
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI-- 631
IH DIK NILL T K++DFG A L+ S V GT ++APE I LA+
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI--LAMDE 188
Query: 632 ---TTKADVYSYGMTLLEL 647
K DV+S G+T +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 50/142 (35%), Positives = 72/142 (50%), Gaps = 14/142 (9%)
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDV-RFRIAVGTARGIAYLHEECRDCII 575
F + + LV +Y+ G L+ L G +L+ DV R IA + YLH + II
Sbjct: 62 FQGKK-NLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIA-EIVLALEYLH---SNGII 115
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMR-----GTWGYVAPEWISG 628
H D+KP+NIL+DS+ K++DFGL+K L+ R + GT Y+APE I G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 629 LAITTKADVYSYGMTLLELIGG 650
+ D +S G L E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 72/221 (32%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 443 LKVFSYKELHTVTRGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRL-ERPG-SGERE 495
L++ EL V + LG G FG V++G + VA+K L E G E
Sbjct: 1 LRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 496 FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI 555
F E + ++ H +LVRL G C + +L V M +G L Y+ + N+ +
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 556 AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA--- 612
V A+G+ YL EE R ++H D+ N+L+ S K++DFGLA+L+ D A
Sbjct: 115 CVQIAKGMMYL-EERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171
Query: 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI--GGR 651
M W +A E I T ++DV+SYG+T+ EL+ GG+
Sbjct: 172 KMPIKW--MALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 72/238 (30%), Positives = 114/238 (47%), Gaps = 38/238 (15%)
Query: 462 LGHGGFGAVFQG----ELSDSTL-VAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRL 514
LG G FG V++G E + VA+K L S +E E + ++ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLN------LNWDVRFRIAVGTARGIAYLHE 568
G C ++ +L + M G L Y+R+ N LNW V+ A+G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
++H D+ N+L+ + K++DFGLAKL+G D A G V +W++
Sbjct: 128 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA----EGGKVPIKWMAL 180
Query: 629 LAI-----TTKADVYSYGMTLLELI--GGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679
+I T ++DV+SYG+T+ EL+ G + PAS I E G++ PP
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 45/149 (30%), Positives = 82/149 (55%), Gaps = 13/149 (8%)
Query: 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588
++M G+L L K+ + ++ ++++ RG+AYL E+ + I+H D+KP NIL++S
Sbjct: 83 EHMDGGSLDQVL-KEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNS 139
Query: 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
K+ DFG++ G+ + + GT Y++PE + G + ++D++S G++L+EL
Sbjct: 140 RGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196
Query: 649 GGRRNVEAPAS-------GRNANIGGGGE 670
GR + P + GR G GE
Sbjct: 197 IGRYPIPPPDAKELEAIFGRPVVDGEEGE 225
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCT-----IGNIQHVNLVRLR 515
+G G FG V + SD + AVK L++ +++ + + + N++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 516 GFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + + +L V DY+ G L +L+++ L RF A A I YLH I
Sbjct: 63 -YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN---I 117
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
I+ D+KPENILLDS ++DFGL K G + +T GT Y+APE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 635 ADVYSYGMTLLELIGG 650
D + G L E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 447 SYKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVC---- 501
S EL V R +G G G V++ L A+K + G+ E R ++C
Sbjct: 72 SLSELERVNR-----IGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIE 124
Query: 502 TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGT 559
+ ++ H N+V+ N ++ ++M G+L +G ++ D +F +A
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL------EGTHI-ADEQFLADVARQI 177
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMR--- 615
GIAYLH R I+H DIKP N+L++S K++DFG+ SR+LA TM
Sbjct: 178 LSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGV--------SRILAQTMDPCN 226
Query: 616 ---GTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGR 651
GT Y++PE I+ G D++S G+++LE GR
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCT-----IGNIQHVNLVRLR 515
+G G FG V + +D AVK L++ +++ + + + N++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 516 GFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + + +L V DY+ G L +L+++ RF A A + YLH I
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN---I 117
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
I+ D+KPENILLDS ++DFGL K G + S+ +T GT Y+APE +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 635 ADVYSYGMTLLELIGG 650
D + G L E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 8/192 (4%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFR-AEVCTIGNIQHVNLVRLRGFC 518
K+G G G V E VAVK ++ RE EV + + QH N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
++ ++++ GAL+ + + LN + + + + YLH + +IH D
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRD 142
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
IK ++ILL D K+SDFG I +D + ++ GT ++APE IS T+ D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 639 SYGMTLLELIGG 650
S G+ ++E++ G
Sbjct: 202 SLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLER-------PGSGEREFRAEVCTIGNIQHVNL 511
EK+G G +G VF+ + ++ +VA+KR+ P S RE +C + ++H N+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNI 61
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA----VGTARGIAYLH 567
VRL + LV++Y L+K + N D+ I +G+A+ H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPE 624
++H D+KP+N+L++ + K++DFGLA+ G R +S + T+ W Y P+
Sbjct: 117 SHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL---W-YRPPD 169
Query: 625 WISGLAI-TTKADVYSYGMTLLELIGGRR 652
+ G + +T D++S G EL R
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 460 EKLGHGGFGAVFQGEL---SDSTL--------VAVKRLERPGSGEREFRAEVCTIGNIQH 508
E LG G F +++G L SD + V +K L F + + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+LV+L G C + + ++V +Y++ G L ++L ++ N++ + +A A + YL +
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 569 ECRDCIIHCDIKPENILL-----DSDYT--AKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
+ ++H ++ +NIL+ + Y K+SD G+ + RV R W +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RIPW--I 171
Query: 622 APEWISGLA--ITTKADVYSYGMTLLEL 647
APE I +T AD +S+G TLLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 8/192 (4%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFR-AEVCTIGNIQHVNLVRLRGFC 518
K+G G G V E VAVK+++ RE EV + + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+V +++ GAL+ + +N + + + R ++YLH + +IH D
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG---VIHRD 143
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
IK ++ILL SD K+SDFG + ++ + ++ GT ++APE IS L T+ D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 639 SYGMTLLELIGG 650
S G+ ++E+I G
Sbjct: 203 SLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 54/192 (28%), Positives = 96/192 (50%), Gaps = 8/192 (4%)
Query: 461 KLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFR-AEVCTIGNIQHVNLVRLRGFC 518
K+G G G V + S LVAVK+++ RE EV + + QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+V +++ GAL+ + +N + + + + ++ LH + +IH D
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG---VIHRD 141
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVY 638
IK ++ILL D K+SDFG + ++ R ++ GT ++APE IS L + D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 639 SYGMTLLELIGG 650
S G+ ++E++ G
Sbjct: 201 SLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE-F-----RAEVCTIGNIQHVNLV 512
++G G +G V++ LVA+K++ E+E F R E+ + ++H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIR-EIKLLQKLRHPNIV 61
Query: 513 RLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRF------RIAVGTARGIA 564
RL+ + +V++YM + L+ GL + +V+F G+
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHD-LT------GLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
YLH + I+H DIK NIL+++D K++DFGLA+ + S T Y PE
Sbjct: 115 YLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 625 WISGLAI-TTKADVYSYGMTLLELIGGR 651
+ G + D++S G L EL G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRL 514
+ E LGHG G V++ L ++AVK L+ +++ +E+ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 515 RG-FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
G F EN + ++M G+L +Y + + V RIAV +G+ YL
Sbjct: 65 YGAFFVENRISICT-EFMDGGSLDVYRK-----IPEHVLGRIAVAVVKGLTYLWSLK--- 115
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
I+H D+KP N+L+++ K+ DFG++ + + + T GT Y+APE ISG
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 634 KADVYSYGMTLLELIGGR 651
+DV+S G++ +EL GR
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
E++G G FG VF+G + +VA+K LE + + E+ + + + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDC 573
+ + ++ +Y+ G+ LR + F+IA +G+ YLH E +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFD-----EFQIATMLKEILKGLDYLHSEKK-- 122
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLA-KLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
IH DIK N+LL K++DFG+A +L R T GT ++APE I A
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYD 179
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPAS 659
+KAD++S G+T +EL G E P S
Sbjct: 180 SKADIWSLGITAIELAKG----EPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 15/134 (11%)
Query: 526 LVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584
LV +Y+ G + ++ G L +W + IA G+ LH+ IIH DIKPEN+
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQ---RGIIHRDIKPENL 128
Query: 585 LLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGM 642
L+D K++DFGL++ L + F GT Y+APE I G+ +D +S G
Sbjct: 129 LIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 643 TLLELIGGRRNVEA 656
+ E + G A
Sbjct: 182 VIFEFLFGYPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGER--EFRAEVCTIGNIQHVN 510
F E+LG FG +++G L + LVA+K L+ + ++ EF+ E + + H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYL-------------RKDGL---NLNWDVRFR 554
+V L G ++ ++++Y+ G L +L +DG +L+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 555 IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLAT 613
IA+ A G+ YL +H D+ NIL+ K+SD GL++ I D+ RV
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
++ PE I ++ +D++S+G+ L E+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 460 EKLGHGGFG-AVFQGELSDSTLVAVKRL--ERPGSGER-EFRAEVCTIGNIQHVNLVRLR 515
+K+G G FG A+ D +K + + ER E R EV + N++H N+V+ +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLN---------LNWDVRFRIAVGTARGIAYL 566
EN + +V DY G LY + + L+W V+ +A + ++
Sbjct: 66 ESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEW 625
H+ I+H DIK +NI L D T K+ DFG+A+++ LA T GT Y++PE
Sbjct: 118 HDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEI 172
Query: 626 ISGLAITTKADVYSYGMTLLELIGGRRNVEA 656
K+D+++ G L E+ + EA
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 461 KLGHGGFGAVFQG---ELSDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHVNLVRL 514
+LG G FG V +G VAVK L+ + E E + + + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C E +LV + G L+ +L+K+ ++ + + G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW--GYVAPEWISGLAIT 632
+H D+ N+LL + + AK+SDFGL+K +G D + A G W + APE ++ +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 633 TKADVYSYGMTLLE 646
+K+DV+S+G+ + E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 461 KLGHGGFGAVFQGELSDSTLVAVKRLE----RPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+LG G G VF+ S L+ ++L +P + R E+ + +V G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYG 70
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + ++M G+L L+K G + + ++++ +G+ YL E+ + I+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMH 127
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+KP NIL++S K+ DFG++ G+ + + GT Y++PE + G + ++D
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673
++S G++L+E+ GR + P + + G GD
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 458 FSEKLGHGGFGAVFQGELSD-----------------STLVAVKRLERPGSGER---EFR 497
F EKLG G FG V E+ + LVAVK L RP + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFL 67
Query: 498 AEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKD-------------- 543
EV + ++ N++RL G C + ++ +YM NG L+ +L
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 544 ----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599
+++ +A+ A G+ YL +H D+ N L+ + T K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 600 AK-LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
++ L D+ R+ ++A E I TT +DV+++G+TL E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKR--LERPGSGEREF-RAEVCTIGNIQHVNLVRLR 515
+K+G G FG ++ + SDS +K L + E+E + EV + ++H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 516 GFCSENSHRLLVYDYMRNGALSLYL-RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
EN +V +Y G L + R+ G+ + D V + G+ ++H+ I
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---I 122
Query: 575 IHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
+H DIK +NI L + AK+ DFG+A+ + D + T GT Y++PE
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 634 KADVYSYGMTLLEL 647
K D++S G L EL
Sbjct: 182 KTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 461 KLGHGGFGAVFQGELSD------STLVAVKRLERPGS-GER-EFRAEVCTIGNIQHVNLV 512
+LG G FG V++G D T VAVK + S ER EF E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRK---DGLN------LNWDVRFRIAVGTARGI 563
RL G S+ L+V + M +G L YLR + N ++A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWG---- 619
AYL+ + +H D+ N ++ D+T K+ DFG+ RD +G G
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT----RDIYETDYYRKGGKGLLPV 185
Query: 620 -YVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678
++APE + TT +D++S+G+ L E+ E P G
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI---TSLAEQPYQG------------------ 224
Query: 679 PWAARQIIEGNVAAVVDDRLGGAYKVEE--AERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
+ Q+++ V+D GG + ERV + C Q N +MRPT +V +L+
Sbjct: 225 -LSNEQVLK----FVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 462 LGHGGFGAVFQGELSDSTL-VAVKRLE-RPGSGE--REFRAEVCTI---GNIQHVNLVRL 514
LG G FG V+ +D+ +AVK+++ P S E +E A C I N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 515 RGFCSENSHRLL--VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
G + R L ++M G++ L+ G L +V + G++YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHS---N 125
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAK------LIGRDFSRVLATMRGTWGYVAPEWI 626
I+H DIK NIL DS K+ DFG +K L G + ++ GT +++PE I
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG----MKSVTGTPYWMSPEVI 181
Query: 627 SGLAITTKADVYSYGMTLLELIGGR 651
SG KAD++S G T++E++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 460 EKLGHGGFGAVFQGE--LSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVN 510
EK+G G +G V++ +++ T +A+K RLE+ P + RE + + +QH N
Sbjct: 8 EKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIRE----ISLLKEMQHGN 62
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---DGLNLNWDVRF--RIAVGTARGIAY 565
+VRL+ LV++Y L L L+K + + R RGIAY
Sbjct: 63 IVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 566 LHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYV 621
H ++H D+KP+N+L+D K++DFGLA+ G R F+ + T+ W Y
Sbjct: 118 CHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL---W-YR 170
Query: 622 APEWISG-LAITTKADVYSYGMTLLELIGGR 651
APE + G +T D++S G E++ +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKR-LERPGSGEREFRA--EVCTIGNIQHVNLVRLR 515
+G G +G V + + ++ +VA+K+ LE + A E+ + ++H NLV L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 516 GFCSENSHRLLVYDYMRNGALS-LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
LV++++ + L L +GL+ + ++ + RGI + H I
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--LRGIEFCH---SHNI 121
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLI---GRDFSRVLATMRGTWGYVAPEWISGLAI 631
IH DIKPENIL+ K+ DFG A+ + G ++ +AT W Y APE + G
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT---RW-YRAPELLVGDTK 177
Query: 632 TTKA-DVYSYGMTLLELIGG 650
+A D+++ G + E++ G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 21/202 (10%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHV---NLVR 513
E +G G +GAV++G + +VA+K L+ P + + EV + ++ N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 514 LRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEE 569
G RL ++ +Y G++ ++ + ++ I+V + Y+H
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPI----AEKY-ISVIIREVLVALKYIH-- 118
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS-G 628
+ +IH DIK NIL+ + K+ DFG+A L+ ++ S+ +T GT ++APE I+ G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEG 176
Query: 629 LAITTKADVYSYGMTLLELIGG 650
TKAD++S G+T+ E+ G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLVRLRGF 517
+G G FG V +D LV +K++ + E A E + + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
E+ ++V +Y G L+ Y++K + L+ D V + ++H + I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILH 124
Query: 577 CDIKPENILLDSDYTA-KVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITTK 634
D+K +NILLD K+ DFG++K++ S+ A T+ GT Y++PE G K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 635 ADVYSYGMTLLELIGGRRNVEA 656
+D+++ G L EL +R EA
Sbjct: 182 SDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 66/198 (33%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLR 515
++GHG FGAV F ++ + +VA+K++ G E EV + I+H N + +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 516 GFCSENSHRL-LVYDYMRNGALSLY-LRKDGLNLNWDVRFR-IAVGTARGIAYLHEECRD 572
G C H LV +Y A L + K L +V I G +G+AYLH
Sbjct: 92 G-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLHSHN-- 145
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL--- 629
+IH DIK NILL K++DFG A + S V GT ++APE I +
Sbjct: 146 -MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEG 199
Query: 630 AITTKADVYSYGMTLLEL 647
K DV+S G+T +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTL---VAVKRLERPGS--GEREFRAEV---CTIGNIQHV 509
F + +G G FG V + + L A+K L+ S R+F E+ C +G H
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG--HHP 63
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF---------------- 553
N++ L G C + + +Y G L +LRK + L D F
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV-LETDPAFAKEHGTASTLTSQQLL 122
Query: 554 RIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613
+ A A G+ YL E+ IH D+ N+L+ + +K++DFGL++ + +
Sbjct: 123 QFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
+ W +A E ++ TTK+DV+S+G+ L E++
Sbjct: 180 LPVRW--MAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 37/211 (17%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
EK+G G +G V++ + +VA+K RLE P + R E+ + + H N+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNI 60
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRK-------DGLNLNWDVRFRIAVGTARGIA 564
VRL + LV+++ L L L+K GL+ + + +GIA
Sbjct: 61 VRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIA 113
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYV 621
Y H R ++H D+KP+N+L+D + K++DFGLA+ G R ++ + T+ W Y
Sbjct: 114 YCHSH-R--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL---W-YR 166
Query: 622 APEWISGLA-ITTKADVYSYGMTLLELIGGR 651
APE + G +T D++S G E++ R
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRG 516
LG GGFG V ++ + + A K+L++ GE+ E + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI-AVGTARGIAYLHEECRDCII 575
LV M G L ++ G + R A G+ +LH+ I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 576 HCDIKPENILLDSDYTAKVSDFGLA-KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
+ D+KPEN+LLD ++SD GLA +L G + A GT GY+APE + G
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFS 174
Query: 635 ADVYSYGMTLLELIGGR 651
D ++ G TL E+I GR
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520
LG GGFG V ++ + + A K+LE+ +R + E + Q + V R S
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMALNEKQILEKVNSRFVVS- 64
Query: 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI-AVGTA-----RGIAYLHEEC---- 570
L Y Y AL L L L D++F I +G A R + Y E C
Sbjct: 65 -----LAYAYETKDALCLVLT---LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 571 ---RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
++ I++ D+KPENILLD ++SD GLA + + + GT GY+APE +
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVK 174
Query: 628 GLAITTKADVYSYGMTLLELIGGR 651
T D ++ G L E+I G+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 462 LGHGGFGAVFQGELSDSTL-VAVKRLE-RPGSGE--REFRAEVCTI---GNIQHVNLVRL 514
LG G FG V+ +D+ +AVK++ P S E +E A C I N++H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 515 RGFCSENSHRLL--VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
G + + L +YM G++ L+ G L +V R +G++YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHS---N 125
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF--SRVLATMRGTWGYVAPEWISGLA 630
I+H DIK NIL DS K+ DFG +K I + ++ GT +++PE ISG
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185
Query: 631 ITTKADVYSYGMTLLELI 648
KADV+S T++E++
Sbjct: 186 YGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 55/222 (24%)
Query: 460 EKL---GHGGFGAVFQGELSDST-LVAVK--RLER-----PGSGEREFRAEVCTIGNIQH 508
EKL G G +G V++ + S +VA+K R++ P S RE + N++H
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLL----NLRH 65
Query: 509 VNLVRLR---------------GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF 553
N+V L+ +C ++ LL D M S K
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT-PFSESQVKC---------- 112
Query: 554 RIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRV 610
+ + RG+ YLHE IIH D+K N+LL K++DFGLA+ G + +
Sbjct: 113 -LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 611 LATMRGTWGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
+ T+ W Y APE + G T A D+++ G L EL+ +
Sbjct: 169 VVTL---W-YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/197 (32%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLR 515
++GHG FGAV F + +VAVK++ G E EV + ++H N + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 516 GFCSENSHRLLVYDYMRNGALSLY-LRKDGLNLNWDVRFR-IAVGTARGIAYLHEECRDC 573
G + LV +Y A L + K L +V I G +G+AYLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAITHGALQGLAYLHSHN--- 141
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL---A 630
+IH DIK NILL K++DFG A S V GT ++APE I +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 631 ITTKADVYSYGMTLLEL 647
K DV+S G+T +EL
Sbjct: 197 YDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLV 512
KLG G FG V++ ++ +VA+K++ E+ G R E+ + ++H N+V
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVV 70
Query: 513 RLRGFC---SENSHRLLVYDYMRNGALSLYLRKD--GLNLNWDVRFR------IAVGTAR 561
L + S R YM ++ Y+ D GL N V+ +
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYM----VTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--------------GRDF 607
GI YLHE + I+H DIK NIL+D+ K++DFGLA+ R +
Sbjct: 127 GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 608 SRVLATMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGR 651
+ ++ T W Y PE + G TT D++ G E+ R
Sbjct: 184 TNLVVT---RW-YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
K+G G +G VF+ ++ +VA+K+ + P + R E+ + ++H NLV L
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 65
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
LV++Y + L+ L K+ + + +I T + + + H+ +CI
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH--NCI 122
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLI---GRDFSRVLATMRGTWGYVAPEWISG-LA 630
H D+KPENIL+ K+ DFG A+++ G D++ +AT W Y APE + G
Sbjct: 123 -HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT---RW-YRAPELLVGDTQ 177
Query: 631 ITTKADVYSYGMTLLELIGG 650
DV++ G EL+ G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
E++G G FG V++G + +VA+K LE + + E+ + + R G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + ++ +Y+ G+ +L L K G L I +G+ YLH E + IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGS-ALDLLKPG-PLEETYIATILREILKGLDYLHSERK---IH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLA-KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
DIK N+LL K++DFG+A +L R T GT ++APE I A KA
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 636 DVYSYGMTLLELIGGRRNVEAPAS 659
D++S G+T +EL G E P S
Sbjct: 183 DIWSLGITAIELAKG----EPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 71/284 (25%), Positives = 117/284 (41%), Gaps = 47/284 (16%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLV-AVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRL 514
++LG G +G+V++ + + A+K RLE S + E+ + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 515 RGFCSENSHRLLVYDYMRNGAL-SLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRD 572
G + +YM G+L LY + DV RI +G+ +L EE
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI- 631
IIH D+KP N+L++ + K+ DFG++ G + + T G Y+APE I
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 632 -----TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686
T ++DV+S G+++LE+ GR + +PP I
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR-----------------------YPYPPETYANIF 216
Query: 687 EGNVAAVVDD---RLGGAYKVEEAERVALVAIWCIQDNEEMRPT 727
++A+VD L Y + + VA C+ RPT
Sbjct: 217 -AQLSAIVDGDPPTLPSGYSDDAQDFVAK----CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 22/191 (11%)
Query: 481 VAVK--RLERPGSGERE---FRAEVCTIGNIQHVNLVRL--RGFCSENSHRLLVYDYMRN 533
VA+K R + P E + FR E + H N+V L G V++Y+
Sbjct: 6 VAIKLLRTDAP-EEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPG 63
Query: 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDY 590
L L DG L R+ + +A H I+H D+KP+NI++
Sbjct: 64 RTLREVLAADGA-LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRP 119
Query: 591 TAKVSDFGLAKLIG--RDFSRVLAT----MRGTWGYVAPEWISGLAITTKADVYSYGMTL 644
AKV DFG+ L+ RD T + GT Y APE + G +T +D+Y++G+
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 645 LELIGGRRNVE 655
LE + G+R V+
Sbjct: 180 LECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 460 EKLGHGGFGAVFQG--ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
EKLG G + VF+G +L+++ LVA+K RLE EV + +++H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ LV++Y+ + L Y+ G ++ RG+AY H R ++
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVL 126
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAK---LIGRDFSRVLATMRGTWGYVAPEWISGLA-I 631
H D+KP+N+L++ K++DFGLA+ + + +S + T+ W Y P+ + G +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL---W-YRPPDVLLGSSEY 182
Query: 632 TTKADVYSYGMTLLELIGGR 651
+T+ D++ G E+ GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 50/148 (33%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 506 IQHVNLVRLRGFCSENSHRLL--VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI 563
+ H ++RL F +E+ R L + +Y+ G L YLR G N F A +
Sbjct: 58 VSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCAL 114
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRDFSRVLATMRGTWGYVA 622
YLH + I++ D+KPENILLD + K++DFG AK L R + T+ GT Y+A
Sbjct: 115 EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-----TLCGTPEYLA 166
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGG 650
PE I D ++ G+ + E++ G
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
EK+G G +G V++ +VA+K++ E G R E+ + + H N+V+L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKL 64
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ LV++++ + L ++ G+ L + + +G+A+ H R
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSH-R 120
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISG 628
++H D+KP+N+L++++ K++DFGLA+ G R ++ + T+ W Y APE + G
Sbjct: 121 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL---W-YRAPEILLG 174
Query: 629 LAI-TTKADVYSYGMTLLELIGGR 651
+T D++S G E++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 460 EKLGHGGFGAVFQG--ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
+KLG G + V++G +L+D+ LVA+K RLE EV + +++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
LV++Y+ + L YL G ++N RG+ Y H R ++
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVL 126
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAK---LIGRDFSRVLATMRGTWGYVAPEWISGLA-I 631
H D+KP+N+L++ K++DFGLA+ + + +S + T+ W Y P+ + G
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL---W-YRPPDILLGSTDY 182
Query: 632 TTKADVYSYGMTLLELIGGR 651
+T+ D++ G E+ GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 45/227 (19%)
Query: 458 FSEKLGHGGFGAVFQGEL-----------------SDSTLVAVKRLERPG--SGEREFRA 498
F EKLG G FG V E + LVAVK L + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 499 EVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK----------DGLNLN 548
E+ + ++ N++RL C + ++ +YM NG L+ +L + D + ++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 549 WDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRDF 607
+ +A A G+ YL +H D+ N L+ +YT K++DFG+++ L D+
Sbjct: 129 YSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 608 SRVLATMRGTWGYVAP-EWISGLAI-----TTKADVYSYGMTLLELI 648
R+ V P W+S +I TT +DV+++G+TL E++
Sbjct: 186 YRIQGRA------VLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 20/196 (10%)
Query: 462 LGHGGFGAVF--QGELSDSTLVAVK-RLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
+G G FG Q SD + RL + S + R E + ++H N+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 519 SENSHRLLVYDYMRNGALSLYLRK-------DGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ H +V +Y G L ++ + L W V+ + G+ ++HE+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKR- 120
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
++H DIK +NI L + K+ DFG A+L+ + T GT YV PE +
Sbjct: 121 --VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA-CTYVGTPYYVPPEIWENMPY 177
Query: 632 TTKADVYSYGMTLLEL 647
K+D++S G L EL
Sbjct: 178 NNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRG 516
LG GGFG V ++ ++ + A K+L++ SGE+ E + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 517 FCSENSHRLLVYDYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTAR---GIAYLHEEC 570
+H LV M G L ++ + GL + R+ +A+ GI +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHSMD 115
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
I++ D+KPEN+LLD ++SD GLA + + + GT GY+APE +
Sbjct: 116 ---IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 631 ITTKADVYSYGMTLLELIGGR 651
+ D ++ G ++ E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGE--REFRAEVCTI---GNIQHVNLVRL 514
LG G FG V+ ++ +A K+++ P S E +E A C I N+QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 515 RGFCSENSHRLLV--YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
G + + + L +YM G++ L+ G L V + G++YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHS---N 125
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR---GTWGYVAPEWISGL 629
I+H DIK NIL DS K+ DFG +K + + +R GT +++PE ISG
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 630 AITTKADVYSYGMTLLELI 648
KADV+S G T++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 461 KLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLR 515
++GHG FGAV F ++ +S +VA+K++ G E EV + ++H N ++ R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 516 GFCSENSHRLLVYDYMRNGALSLY-LRKDGLNLNWDVRFRIAV---GTARGIAYLHEECR 571
G LV +Y A L + K L IA G +G+AYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-----EVEIAAVTHGALQGLAYLHSHN- 135
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-- 629
+IH D+K NILL K+ DFG A ++ V GT ++APE I +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDE 188
Query: 630 -AITTKADVYSYGMTLLEL 647
K DV+S G+T +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTL--VAVKRLE-----RPGSGEREFRAEVCTIGNIQHVN 510
F LG G FG V + VA+KR E + + F +E + I H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPF 92
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGT--ARGIAYLHE 568
V L G + S+ LV +++ G +LR++ RF VG A I + E
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLIFE 145
Query: 569 ECRDC-IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
+ I++ D+KPEN+LLD D K++DFG AK++ +R T+ GT Y+APE +
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTY-TLCGTPEYIAPEILL 201
Query: 628 GLAITTKADVYSYGMTLLELIGG 650
+ AD ++ G+ + E++ G
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 459 SEKLGHGGFGAVFQG------ELSDSTLVAVKRLERPGS-GER-EFRAEVCTIGNIQHVN 510
S +LG G FG V++G + T VA+K + S ER EF E + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLR--------KDGLNL-NWDVRFRIAVGTAR 561
+VRL G S+ L++ + M G L YLR + ++A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+AYL+ + +H D+ N ++ D+T K+ DFG+ RD +G G +
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYRKGGKGLL 183
Query: 622 APEWISGLAI-----TTKADVYSYGMTLLEL 647
W+S ++ TT +DV+S+G+ L E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
EK+G G FG VF+G + +VA+K LE + + E+ + + + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+++ ++ +Y+ G+ +L L + G L+ I +G+ YLH E + IH
Sbjct: 70 SYLKDTKLWIIMEYLGGGS-ALDLLEPG-PLDETQIATILREILKGLDYLHSEKK---IH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLA-KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
DIK N+LL K++DFG+A +L R T GT ++APE I A +KA
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 636 DVYSYGMTLLELIGGRRNVEAPAS 659
D++S G+T +EL G E P S
Sbjct: 183 DIWSLGITAIELAKG----EPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 460 EKLGHGGFGAVFQG--ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
+KLG G + VF+G +L+++ LVA+K RLE EV + N++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV-GTARGIAYLHEECRDCI 574
LV++Y+ + L YL G NL +I + RG++Y H+ I
Sbjct: 70 DIIHTERCLTLVFEYLDSD-LKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---I 124
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAK---LIGRDFSRVLATMRGTWGYVAPEWISG-LA 630
+H D+KP+N+L++ K++DFGLA+ + + +S + T+ W Y P+ + G
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL---W-YRPPDVLLGSTE 180
Query: 631 ITTKADVYSYGMTLLELIGGR 651
+T D++ G L E+ GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCT-----IGNIQHVNLVRLR 515
+G G FG V ++ AVK L++ +++ + + + N++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 516 GFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
F + + +L V DY+ G L +L+++ L RF A A + YLH I
Sbjct: 63 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---I 117
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
++ D+KPENILLDS ++DFGL K + + +T GT Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 635 ADVYSYGMTLLELIGG 650
D + G L E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 32/205 (15%)
Query: 462 LGHGGFGAVFQG-ELSDS----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRL 514
LG G FG V++G + D VA+K L S +E E + + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLR--KDGLN----LNWDVRFRIAVGTARGIAYLHE 568
G C ++ +L V M G L Y+R KD + LNW V+ A+G++YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL-E 126
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
E R ++H D+ N+L+ S K++DFGLA+L+ D + A G V +W++
Sbjct: 127 EVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA----DGGKVPIKWMAL 180
Query: 629 LAI-----TTKADVYSYGMTLLELI 648
+I T ++DV+SYG+T+ EL+
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 42/114 (36%), Positives = 56/114 (49%), Gaps = 17/114 (14%)
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
GI +LH IIH D+KP NI++ SD T K+ DFGLA+ G F + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYR 184
Query: 622 APEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675
APE I G+ D++S G + E+I G V P G +H D+W
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT--VLFP----------GTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 462 LGHGGFGAVFQGEL--------SDSTLVAVKRLERPGSGE--REFRAEVCTIGNI-QHVN 510
LG G FG V E + VAVK L+ + + + +E+ + I +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---DGLNLNWD--------VRFR----I 555
++ L G C+++ ++ +Y G L YLR G++ ++D + F+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 556 AVGTARGIAYL-HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLAT 613
A ARG+ YL ++C IH D+ N+L+ D K++DFGLA+ + D+ +
Sbjct: 140 AYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
R ++APE + T ++DV+S+G+ L E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 462 LGHGGFGAVFQGELSDSTL---VAVKRLERPGS--GEREFRAEV---CTIGNIQHVNLVR 513
+G G FG V + + L A+KR++ S R+F E+ C +G+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIIN 60
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF----------------RIAV 557
L G C + L +Y +G L +LRK + L D F A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 558 GTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617
ARG+ YL ++ IH D+ NIL+ +Y AK++DFGL++ + + +
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 618 WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
W +A E ++ TT +DV+SYG+ L E++
Sbjct: 177 W--MAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 459 SEKLGHGGFGAVFQG----ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLV 512
+G G FG V+QG ++ VAVK + S +F E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+L G +EN +V + G L YL K L+L + + + TA +AYL E
Sbjct: 71 KLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYL--ES 125
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
+ + H DI N+L+ S K+ DFGL++ + + + + ++APE I+
Sbjct: 126 KRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 631 ITTKADVYSYGMTLLELI 648
T+ +DV+ +G+ + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE---FRAEVCTIGNIQH-VNLVRL 514
++G G FG V + S T++AVKR+ R E+E ++ + +V+
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 515 RG---------FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
G C E L Y +Y + ++ +IAV T + + Y
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKY-----VYEVLKS-VIPEEILGKIAVATVKALNY 122
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR-GTWGYVAPE 624
L EE + IIH D+KP NILLD + K+ DFG++ G+ + T G Y+APE
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPE 177
Query: 625 WI---SGLAITTKADVYSYGMTLLELIGGR 651
I + ++DV+S G+TL E+ G+
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 42/211 (19%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
EK+G G +G V++G +VA+K RLE P + RE + + +QH N+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQHPNI 61
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRK--DGL--------NLNWDVRFRIAVGTAR 561
V L+ + S L++++ LS+ L+K D L L ++I +
Sbjct: 62 VCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----Q 112
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTW 618
GI + H ++H D+KP+N+L+D+ K++DFGLA+ G R ++ + T+ W
Sbjct: 113 GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL---W 166
Query: 619 GYVAPEWISGLA-ITTKADVYSYGMTLLELI 648
Y APE + G +T D++S G E+
Sbjct: 167 -YRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPGSGERE------FRAEVCTIGNIQHVNLVRL 514
LG G FG V EL + A+K L++ E + V + +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61
Query: 515 RGFCS--ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
FC+ H V +Y+ G L +++ G RF A G+ +LH +
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH---KK 115
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKL-IGRDFSRVLATMRGTWGYVAPEWISGLAI 631
II+ D+K +N+LLD D K++DFG+ K + + +T GT Y+APE + G
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKY 173
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASG 660
D +S+G+ L E++ G ++P G
Sbjct: 174 NESVDWWSFGVLLYEMLIG----QSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 462 LGHGGFGAVFQGEL--------SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ----HV 509
LG G FG V E ++ VAVK L + + E++ V + ++ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKD---GLNLNWDVR--------FRIAVG 558
N++ L G C+++ ++ +Y G L YLR G+ ++D+ F+ V
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 559 ----TARGIAYL-HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLA 612
ARG+ YL ++C IH D+ N+L+ + K++DFGLA+ + D+ +
Sbjct: 142 CTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL--IGG 650
R ++APE + T ++DV+S+G+ + E+ +GG
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 462 LGHGGFGAVFQGEL--------SDSTLVAVKRLERPGSGE--REFRAEVCTIGNI-QHVN 510
LG G FG V + E + VAVK L+ + + + +E+ + I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---DGLNLNWDV--------RFRIAVG- 558
++ L G C++ ++ +Y G L +LR G + +D+ F+ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 559 ---TARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLATM 614
ARG+ YL E R CI H D+ N+L+ D K++DFGLA+ + D+ + +
Sbjct: 140 AYQVARGMEYL--ESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLEL--IGG 650
R ++APE + T ++DV+S+G+ + E+ +GG
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPGSGEREFRAEV-CTIGNIQHVNLVRLRGF-- 517
LG G FG V EL + L AVK L++ + + +V CT+ + + L F
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD---DVECTMTEKRVLALAGKHPFLT 59
Query: 518 ----CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
C + RL V +Y+ G L ++++ G RF A G+ +LHE R
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHE--RG 116
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGTWGYVAPEWISGLA 630
II+ D+K +N+LLDS+ K++DFG+ K ++G + T GT Y+APE +S
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS---TFCGTPDYIAPEILSYQP 172
Query: 631 ITTKADVYSYGMTLLELIGGR 651
D ++ G+ L E++ G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRLRG 516
+G G +G+V + VA+K+L RP E R +R E+ + ++QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 517 -FCSENSHR-----LLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEE 569
F S S LV YM+ L+K G L+ D + G+ Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI-SG 628
IIH D+KP N+ ++ D K+ DFGLA+ + + + T W Y APE I +
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT---RW-YRAPEVILNW 189
Query: 629 LAITTKADVYSYGMTLLELIGGR 651
+ D++S G + E++ G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY 620
RG+ YLH I+H DIKP N+L++S+ K+ DFGLA++ D S+ + T Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 621 VAPEWISGLA-ITTKADVYSYGMTLLELIGGR 651
APE + G T+ D++S G EL+G R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 37/208 (17%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-------- 510
E LG G FG V + + A+K L++ E+ + +QHV
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVAQEKSILME 74
Query: 511 ------LVRLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI 563
+ + F EN R+ + +++ G L +LRK G N DV
Sbjct: 75 LSHPFIVNMMCSFQDEN--RVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYHAELVLAF 131
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVA 622
YLH + II+ D+KPEN+LLD+ KV+DFG AK + R F T+ GT Y+A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLA 183
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGG 650
PE I D ++ G+ L E I G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 462 LGHGGFGAVFQGEL--SDSTL--VAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRL 514
LG G FG+V + +L D + VAVK L+ S EF E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 515 RGFC--SENSHRL----LVYDYMRNGALSLYLR-----KDGLNLNWDVRFRIAVGTARGI 563
G S RL ++ +M++G L +L ++ L R + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVA 622
YL + IH D+ N +L+ + T V+DFGL+K I D+ R + ++A
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 623 PEWISGLAITTKADVYSYGMTLLELI 648
E ++ TT +DV+++G+T+ E++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERP----------GSGEREFRAEVCTIGNIQHVN 510
+G G FG V+Q D+ + A+K L + GER V T+ + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNIL--VRTLLD-ESPF 57
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V L+ +S LV DYM G L +L+K+G +F IA + +LH+
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHK-- 114
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGTWGYVAPEWISG 628
I++ D+KPENILLD+ + DFGL+K L + T GT Y+APE +
Sbjct: 115 -YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN---TFCGTTEYLAPEVLLD 170
Query: 629 LAITTK-ADVYSYGMTLLELIGG 650
TK D +S G+ + E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 462 LGHGGFGAVFQGEL--------SDSTLVAVKRLERPGSGE--REFRAEVCTIGNI-QHVN 510
LG G FG V E + T VAVK L+ + + + +E+ + I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYL---RKDGL------------NLNWDVRFRI 555
++ L G C+++ ++ +Y G L YL R G+ L++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 556 AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLATM 614
A ARG+ YL + CI H D+ N+L+ D K++DFGLA+ I D+ +
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLEL--IGG 650
R ++APE + T ++DV+S+G+ L E+ +GG
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRL-RGFC 518
LG G FG V++ + A K ++ E E F E+ + +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWD-VRFRIAVGTARGIAYLHEECRDCIIHC 577
EN +L+ ++ GAL + + L +R+ + + +LH +IH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSHK---VIHR 127
Query: 578 DIKPENILLDSDYTAKVSDFGL-AKLIGRDFSRVLATMRGTWGYVAPEWI-----SGLAI 631
D+K NILL D K++DFG+ AK R T GT ++APE +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPY 185
Query: 632 TTKADVYSYGMTLLELIGGR 651
KAD++S G+TL+EL
Sbjct: 186 DYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA-EVCTIGNIQHVNLVRLRGF 517
EK+G G G VF +++ VA+K++ ++E E+ + +++ N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC---- 573
+V +Y+ G+L+ + T A + CR+C
Sbjct: 85 FLVGDELFVVMEYLAGGSLT----------------DVVTETCMDEAQIAAVCRECLQAL 128
Query: 574 -------IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+IH DIK +N+LL D + K++DFG I + S+ +TM GT ++APE +
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 187
Query: 627 SGLAITTKADVYSYGMTLLELIGG 650
+ A K D++S G+ +E++ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 461 KLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRA----EVCTIGNIQHVNLVRLR 515
K+G G F V++ L D +VA+K+++ + + R E+ + + H N+++
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 516 GFCSENSHRLLVYDYMRNGALSL---YLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
EN+ +V + G LS + +K + ++ V + ++H + R
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-R- 126
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR-----GTWGYVAPEWIS 627
I+H DIKP N+ + + K+ D GL GR FS T GT Y++PE I
Sbjct: 127 -IMHRDIKPANVFITATGVVKLGDLGL----GRFFSS--KTTAAHSLVGTPYYMSPERIH 179
Query: 628 GLAITTKADVYSYGMTLLEL 647
K+D++S G L E+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 61/234 (26%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN---------- 510
+G G FG V+ + + A+K L + +++ I HV
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRK---------SDMIKRNQIAHVRAERDILADAD 59
Query: 511 ---LVRLRGFCS--ENSHRLLVYDYMRNGAL-SLYLRKDGLNLNWDVRFRIAVGTARGIA 564
+V+L + S + H LV +YM G L +L +RKD RF IA +
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALD 115
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR--------- 615
+H + IH DIKP+NIL+D+D K++DFGL K + + R
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 616 -------------------GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
GT Y+APE + G + D +S G+ L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNI-----QHVNLVR 513
E +G G +G V++ + LVA+K ++ E E + E NI H N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY----NILRKYSNHPNIAT 67
Query: 514 LRGFCSENSHRL------LVYDYMRNGA---LSLYLRKDGLNLNWDVRFRIAVGTARGIA 564
G + + LV + G+ L LRK G L + I T RG+A
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
YLHE + +IH DIK +NILL + K+ DFG++ + R T GT ++APE
Sbjct: 128 YLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR-RNTFIGTPYWMAPE 183
Query: 625 WIS-----GLAITTKADVYSYGMTLLEL 647
I+ + ++DV+S G+T +EL
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 9e-11
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 42/216 (19%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVC---TIGNIQHVNL 511
+KLG G +G V++ + +VA+K++ +R FR E+ +G+ H N+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD--HPNI 69
Query: 512 VRLRG-FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLHE 568
V+L +EN + LV++YM L +R + L DV R I + + Y+H
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETD-LHAVIRANILE---DVHKRYIMYQLLKALKYIHS 125
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWG------YVA 622
+IH D+KP NILL+SD K++DFGLA R L+ + YVA
Sbjct: 126 GN---VIHRDLKPSNILLNSDCRVKLADFGLA--------RSLSELEENPENPVLTDYVA 174
Query: 623 PEW-------ISGLAITTKADVYSYGMTLLELIGGR 651
W + T D++S G L E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGER-EFRAEVC------TIGNIQHVNLVR 513
LG G FG V E L A+K L++ R E + +C T + +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
L H V +Y G L +++ D + V + V G+ YLHE +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV--VLGLQYLHE---NK 121
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
I++ D+K +N+LLD++ K++DFGL K G F +T GT ++APE ++ + T
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 634 KADVYSYGMTLLELIGGRRNVEAPASG 660
D + G+ + E++ G E+P G
Sbjct: 181 AVDWWGLGVLIYEMLVG----ESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 481 VAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRL------RGFCSENSHRLLVYDY 530
VAVK+L RP +R +R E+ + + H N++ L + E LV +
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 531 M-RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589
M N +++ D +++ + +++ G I +LH IIH D+KP NI++ SD
Sbjct: 108 MDANLCQVIHMELDHERMSY-LLYQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSD 159
Query: 590 YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649
T K+ DFGLA+ +F ++ T Y APE I G+ D++S G + EL+
Sbjct: 160 CTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 650 GRRNVEAPASGRNANIGGGGEHGDKW 675
G + I G +H D+W
Sbjct: 218 G------------SVIFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 460 EKLGHGGFGAVFQGELS-DSTLVAVK--RL-ERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
EKLG G + V++G+ + LVA+K RL E G+ R E + ++H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
LV++Y+ L Y+ K L+ + RG++Y+H+ I+
Sbjct: 70 DIIHTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAK---LIGRDFSRVLATMRGTWGYVAPEWISG-LAI 631
H D+KP+N+L+ K++DFGLA+ + +S + T+ W Y P+ + G
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL---W-YRPPDVLLGSTEY 181
Query: 632 TTKADVYSYGMTLLELIGG 650
+T D++ G +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/127 (33%), Positives = 66/127 (51%), Gaps = 10/127 (7%)
Query: 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENIL 585
+ D M G L +L + G+ ++RF A G+ ++H +++ D+KP NIL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANIL 129
Query: 586 LDSDYTAKVSDFGLAKLIGRDFSRVLATMR-GTWGYVAPEWIS-GLAITTKADVYSYGMT 643
LD ++SD GLA DFS+ GT GY+APE + G+A + AD +S G
Sbjct: 130 LDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 185
Query: 644 LLELIGG 650
L +L+ G
Sbjct: 186 LFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRA----EVCTIGNIQHVNLV 512
++G G G V++ ++AVK++ R G+ E R +V + +V
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIV 77
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+ G+ +S + + M L L++ + D+ ++ V + + YL E+
Sbjct: 78 KCYGYFITDSDVFICMELMSTCLDKL-LKRIQGPIPEDILGKMTVAIVKALHYLKEK--H 134
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR--DFSRVLATMRGTWGYVAPEWISGLA 630
+IH D+KP NILLD+ K+ DFG++ GR D S+ G Y+APE I
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVD-SKAKTRSAGCAAYMAPERIDPPD 190
Query: 631 ITTK----ADVYSYGMTLLELIGGR 651
K ADV+S G++L+EL G+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/195 (30%), Positives = 85/195 (43%), Gaps = 11/195 (5%)
Query: 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCT-----IGNIQHVNLVRLR 515
+G G FG V + D AVK L++ R+ + + + N++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
V D++ G L +L+++ RF A A + YLH I+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN---IV 118
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+KPENILLDS ++DFGL K G S T GT Y+APE I
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 636 DVYSYGMTLLELIGG 650
D + G L E++ G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 12/195 (6%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGER----EFRAEVCTIGNIQHVNLVRLRG 516
+G G FG V Q D+ + A+K + + R AE + + +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
F ++ +L LV ++ G L +L+++G RF A + LH+ +I
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFN---VI 115
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+KPENILLD + DFGL KL +D + T GT Y+APE + G T
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT-NTFCGTPEYLAPELLLGHGYTKAV 174
Query: 636 DVYSYGMTLLELIGG 650
D ++ G+ L E++ G
Sbjct: 175 DWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGER--EFRAEVCTIGNIQHVNLVRL-RGF 517
+LG G FG V++ + ++ ++A ++ S E ++ E+ + + H N+V+L F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
EN+ +L+ ++ GA+ + + L + T + YLHE + IIH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI-----SGLAIT 632
D+K NIL D K++DFG++ R R + GT ++APE +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 633 TKADVYSYGMTLLEL 647
KADV+S G+TL+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 50/220 (22%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
E+LG G +G V + + T++AVKR+ RA V + Q L+ L
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRI----------RATVNS--QEQKRLLMDL---- 50
Query: 519 SENSHRLLVYDYMRN--GAL---------------SLY-----LRKDGLNLNWDVRFRIA 556
+ S R + Y GAL SL + GL + D+ +IA
Sbjct: 51 -DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA 109
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR- 615
V + + YLH + +IH D+KP N+L++ + K+ DFG++ G V T+
Sbjct: 110 VSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDA 164
Query: 616 GTWGYVAPEWISG----LAITTKADVYSYGMTLLELIGGR 651
G Y+APE I+ K+DV+S G+T++EL GR
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 461 KLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE-------REFRAEVCTIGNIQHVNLV 512
++G G +G V++ S VA+K + + + RE A + + H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIV 65
Query: 513 RLRGFCS-----ENSHRLLVYDYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIA 564
RL C+ + LV++++ + L YL K GL + + RG+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLD 122
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
+LH +CI+H D+KPENIL+ S K++DFGLA++ L + T Y APE
Sbjct: 123 FLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPE 177
Query: 625 WISGLAITTKADVYSYGMTLLEL 647
+ T D++S G E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520
LG GGFG V ++ + + A KRLE+ +R + E + Q + V + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR--KGESMALNEKQILEKVNSQFVVN- 64
Query: 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI------AVGTARGIAYLHEEC---- 570
L Y Y AL L L + D++F I R + Y E
Sbjct: 65 -----LAYAYETKDALCLVLT---IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 571 ---RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R+ ++ D+KPENILLD ++SD GLA I + GT GY+APE ++
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRVGTVGYMAPEVLN 174
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI 665
T D + G + E+I G ++P GR +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEG----QSPFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRG- 516
E +G+G +G V++G + L A+K ++ G E E + E+ + H N+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 517 FCSENSHRL-----LVYDYMRNGALS-LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
F +N + LV ++ G+++ L G L + I RG+++LH+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS--- 627
+IH DIK +N+LL + K+ DFG++ + R R T GT ++APE I+
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 187
Query: 628 --GLAITTKADVYSYGMTLLELIGG 650
K+D++S G+T +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENIL 585
+ D M G L +L + G+ ++RF A G+ ++H +++ D+KP NIL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANIL 129
Query: 586 LDSDYTAKVSDFGLAKLIGRDFSRVLATMR-GTWGYVAPEWIS-GLAITTKADVYSYGMT 643
LD ++SD GLA DFS+ GT GY+APE + G A + AD +S G
Sbjct: 130 LDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCM 185
Query: 644 LLELIGG 650
L +L+ G
Sbjct: 186 LFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRLRG 516
+G G +G V + + VA+K+L RP R +R E+ + ++ H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 517 FCSENSHR------LLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+ S LV M GA L+ ++ L+ + ++F + RG+ Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDD-HIQF-LVYQILRGLKYIHSA 137
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE----W 625
IIH D+KP NI ++ D K+ DFGLA+ + + +AT W Y APE W
Sbjct: 138 G---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---W-YRAPEIMLNW 190
Query: 626 ISGLAITTKADVYSYGMTLLELIGGR 651
+ D++S G + EL+ G+
Sbjct: 191 MH---YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 30/204 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA-EVCTIGNIQHVNLVRLRGF 517
EK+G G G V+ +++ VA+K++ ++E E+ + +H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC---- 573
+V +Y+ G+L+ DV + + IA + CR+C
Sbjct: 85 YLVGDELWVVMEYLAGGSLT------------DVVTETCMDEGQ-IAAV---CRECLQAL 128
Query: 574 -------IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+IH DIK +NILL D + K++DFG I + S+ +TM GT ++APE +
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 187
Query: 627 SGLAITTKADVYSYGMTLLELIGG 650
+ A K D++S G+ +E++ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 43/225 (19%)
Query: 444 KVFSYKELHTVTRGFSEKLGHGGFGAVFQG--ELSDSTLVAVK--RLER----PGSGERE 495
K+ +YK+L +KLG G + V++G +L+ LVA+K RLE P + RE
Sbjct: 3 KLETYKKL--------DKLGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAPFTAIRE 53
Query: 496 FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK--DGLNLNWDVR- 552
+ +++H N+V L LV++Y+ L Y+ GL+++ +VR
Sbjct: 54 ----ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMH-NVRL 107
Query: 553 --FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK---LIGRDF 607
F++ RG+AY H + ++H D+KP+N+L+ K++DFGLA+ + + +
Sbjct: 108 FLFQLL----RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160
Query: 608 SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGR 651
S + T+ W Y P+ + G +T D++ G E+ GR
Sbjct: 161 SNEVVTL---W-YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 460 EKLGHGGFGAVFQG---ELSD-----STLVAVKRLERPGSGEREFRAEVCTI-GNIQHVN 510
E LG G F +F+G E+ D T V +K L++ E E ++ + H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
LV G C ++V +Y++ G+L YL+K+ +N + +A A + +L ++
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK- 119
Query: 571 RDCIIHCDIKPENILLDSDYTA--------KVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
+ H ++ +N+LL + K+SD G++ + + + R W V
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV---LPKEILLERIPW--VP 172
Query: 623 PEWISG-LAITTKADVYSYGMTLLELIGG 650
PE I ++ AD +S+G TL E+ G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 51/217 (23%)
Query: 462 LGHGGFGAVFQGELSD-STLVAVKR-LERPGSGEREFRAEVCTIGNIQHVNLVRLRG--- 516
+G+G FG V++ D S VA+K+ L+ P RE + + N+ H+N++ L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDYYY 129
Query: 517 ------------------FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVG 558
F + H+ + + N AL L+L K +
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK-----------LYSYQ 178
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAK-LIG--RDFSRVLATM 614
R +AY+H + I H D+KP+N+L+D + +T K+ DFG AK L+ R S + +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 615 RGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGG 650
Y APE + G TT D++S G + E+I G
Sbjct: 236 -----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 64/207 (30%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520
LG GGFG V ++ + + A K+LE+ +R + E + + + V R S
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKRILEKVNSRFVVS- 64
Query: 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI------AVGTARGIAYLHEEC---- 570
L Y Y AL L L + D++F I R I Y E C
Sbjct: 65 -----LAYAYETKDALCLVLT---IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 571 ---RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR---GTWGYVAPE 624
R+ I++ D+KPENILLD ++SD GLA I T+R GT GY+APE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-----ETVRGRVGTVGYMAPE 171
Query: 625 WISGLAITTKADVYSYGMTLLELIGGR 651
I+ T D + G + E+I G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 69/266 (25%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 462 LGHGGFGAVFQGELSDST----LVAVKRLE-----RPGSGEREFRAEVCTIGNIQHVNLV 512
LG GG+G VFQ + A+K L+ R +AE + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
L L+ +Y+ G L ++L ++G+ + F ++ + + +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLHQQG-- 120
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
II+ D+KPENILLD+ K++DFGL K + + V T GT Y+APE +
Sbjct: 121 -IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHG 178
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNA-----NIGGGGEHGDKWFFPPW---AARQ 684
D +S G + +++ G P + N I G K PP+ AR
Sbjct: 179 KAVDWWSLGALMYDMLTG----APPFTAENRKKTIDKILKG-----KLNLPPYLTPEARD 229
Query: 685 IIEGNVAAVVDDRLGGAYKVEEAERV 710
+++ + RLG +A V
Sbjct: 230 LLKKLLKRNPSSRLGAG--PGDAAEV 253
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 465 GGFGAVFQGELSDSTL-----VAVKRLERPGSGER--EFRAEVCTIGNIQHVNLVRLRGF 517
G FG +F G L D V VK ++ S + E C + + H N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 518 CSENSHRLLV-YDYMRNGALSLYLRK---DGLNLNWDVRFR----IAVGTARGIAYLHEE 569
C E+ V Y YM G L L+L++ N + + +A+ A G++YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAK--------LIGRDFSRVLATMRGTWGYV 621
+ +IH DI N ++D + K++D L++ +G + +R + M
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM------- 186
Query: 622 APEWISGLAITTKADVYSYGMTLLELI 648
A E + ++ +DV+S+G+ L EL+
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 47/214 (21%)
Query: 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV--RLRGFC 518
LG G FG V EL AVK L++ +V I + +V R+
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKK----------DVVLIDDDVECTMVEKRVLALA 52
Query: 519 SEN-------------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR---- 561
EN H V +++ G L +++ G RF + T
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-------RFDLYRATFYAAEI 105
Query: 562 --GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGT 617
G+ +LH + II+ D+K +N++LD D K++DFG+ K + G + + +T GT
Sbjct: 106 VCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGT 159
Query: 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
Y+APE + GL T D +S+G+ L E++ G+
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 45/214 (21%)
Query: 460 EKLGH---GGFGAVFQG-ELSDSTLVAVKRL--ERPGSGEREF-----RAEVCTIGNIQH 508
EKL G +G V++ + +VA+K+L E+ G F R E+ + +QH
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLR-EINILLKLQH 63
Query: 509 VNLVRLR----GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGT---- 559
N+V ++ G S +V +Y+ + SL F + V
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQ-------PFLQSEVKCLMLQ 114
Query: 560 -ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMR 615
G+A+LH+ + I+H D+K N+LL++ K+ DFGLA+ G + +++++ T+
Sbjct: 115 LLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL- 170
Query: 616 GTWGYVAPEWISGLAI-TTKADVYSYGMTLLELI 648
W Y APE + G +T D++S G EL+
Sbjct: 171 --W-YRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFRAEVCT----IGNIQHVNLVRLRG 516
LG G FG V E + A+K L++ ++ A T + N +H L L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + RL V +Y G L +L ++ + RF A + YLH D ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGYLHS--CD-VV 117
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+K EN++LD D K++DFGL K G + T GT Y+APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 636 DVYSYGMTLLELIGGR 651
D + G+ + E++ GR
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA-EVCTIGNIQHVNLVRLRGF 517
EK+G G G V+ +++ VA+K++ ++E E+ + ++ N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC---- 573
+V +Y+ G+L+ + T + CR+C
Sbjct: 85 YLVGDELWVVMEYLAGGSLT----------------DVVTETCMDEGQIAAVCRECLQAL 128
Query: 574 -------IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+IH DIK +NILL D + K++DFG I + S+ +TM GT ++APE +
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 187
Query: 627 SGLAITTKADVYSYGMTLLELIGG 650
+ A K D++S G+ +E++ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 8/92 (8%)
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWG 619
G+ +LH+ II+ D+KPEN+LLD+D ++SD GLA + G+ ++ A GT G
Sbjct: 109 GLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---GTPG 162
Query: 620 YVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
++APE + G D ++ G+TL E+I R
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 45/164 (27%), Positives = 84/164 (51%), Gaps = 19/164 (11%)
Query: 506 IQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
+ H++L + G C S ++V +++ +G L + LRK+ + + +A A ++Y
Sbjct: 73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSY 132
Query: 566 LHEECRDCIIHCDIKPENILLD----SDYTA---KVSDFGLAKLIGRDFSRVLATMRGTW 618
L ++ ++H ++ +NILL ++ T+ K+SD G++ SR R W
Sbjct: 133 LEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA---LSREERVERIPW 186
Query: 619 GYVAPEWI-SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGR 661
+APE + G +++T AD +S+G TLLE+ + E P R
Sbjct: 187 --IAPECVPGGNSLSTAADKWSFGTTLLEIC---FDGEVPLKER 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520
LG GGFG V ++ + + A K+LE+ +R + E + Q + V R S
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVS- 64
Query: 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRI------AVGTARGIAYLHEEC---- 570
L Y Y AL L L L D++F I R + Y E
Sbjct: 65 -----LAYAYETKDALCLVLT---LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 571 ---RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R+ I++ D+KPENILLD ++SD GLA I + + + GT GY+APE +
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYMAPEVVK 174
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI 665
T D + G + E+I G+ +P R +
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK----SPFRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLE----------RPGSGEREFRAEVCTIGNIQH 508
++G GG+G VF + D+ +VA+KR++ R ER+ + T
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD----ILTTTK--S 60
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
LV+L ++ + L +Y+ G L G+ RF +A + LHE
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-LIGRDFSRVLATMRGTWGYVAPEWIS 627
IH D+KPEN L+D+ K++DFGL+K ++ S V G+ Y+APE +
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLR 171
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN 664
G D +S G L E + G P SG N
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGF----PPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
GI +LH IIH D+KP NI++ SD T K+ DFGLA+ G F ++ T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYR 192
Query: 622 APEWISGLAITTKADVYSYGMTLLELIGGR 651
APE I G+ D++S G + E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG---T 617
G+ Y+H ++H D+KP N+L+++D K+ DFGLA+ + M T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 618 WGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
Y APE + TKA DV+S G L EL+G +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 450 ELHTVTRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSG--EREFRAEVC 501
E++ T F E+LG FG V++G L + VA+K L+ G EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 502 TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL---------------RKDGLN 546
+QH N+V L G ++ +++ Y + L +L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 547 LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GR 605
L I A G+ +L ++H D+ N+L+ K+SD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
D+ +++ +++PE I + +D++SYG+ L E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVA---VKRLERPGSG--EREFRAEVCTIGNIQHVNLVRL 514
+++G+G FG V E+ T VA VK L+ S + EF + +QH N+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRF--RIAVGTARGIAYLHEECR 571
G C E LLV++Y G L YL + N + R+A A G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-----------VLATMRGTWGY 620
+H D+ N L SD T KV D+G+ SR +R +
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIG------PSRYKEDYIETEDDKCVPLR----W 167
Query: 621 VAPEWISGL------AITTK-ADVYSYGMTLLEL 647
+APE + A TK ++V++ G+TL EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGF 517
E +G+G +G V++G + L A+K ++ E E + E+ + H N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 518 CSENS------HRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+ S LV ++ G+++ ++ G L D I RG+A+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS--- 627
+IH DIK +N+LL + K+ DFG++ + R R T GT ++APE I+
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 197
Query: 628 --GLAITTKADVYSYGMTLLELIGG 650
++D++S G+T +E+ G
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 12/147 (8%)
Query: 505 NIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIA 564
N+ H +++R++ + +V + + L YL K L D I G+
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHYSSD-LYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV--- 621
YLH + IIH D+K ENI ++ + D G A+ F V G G V
Sbjct: 172 YLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ-----FPVVAPAFLGLAGTVETN 223
Query: 622 APEWISGLAITTKADVYSYGMTLLELI 648
APE ++ +KAD++S G+ L E++
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 460 EKLGHGGFGAVFQ-GELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGF 517
E +G G +G V++ D +L AVK L+ + E AE + ++ H N+V+ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 518 CSENSHRL-----LVYDYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+ + LV + G+++ ++ G L+ + I G G+ +LH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN- 146
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGL-AKLIGRDFSRVLATMRGTWGYVAPEWIS- 627
+ IIH D+K NILL ++ K+ DFG+ A+L R T GT ++APE I+
Sbjct: 147 --NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIAC 202
Query: 628 ----GLAITTKADVYSYGMTLLELIGG 650
+ + DV+S G+T +EL G
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 481 VAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536
VA+K+L RP +R +R E+ + + H N++ L + D
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQD------- 96
Query: 537 SLYLRKDGLNLNWDVRFRIAVGTAR----------GIAYLHEECRDCIIHCDIKPENILL 586
+YL + ++ N ++ + R GI +LH IIH D+KP NI++
Sbjct: 97 -VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152
Query: 587 DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLE 646
SD T K+ DFGLA+ G F ++ T Y APE I G+ D++S G + E
Sbjct: 153 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 647 LI 648
++
Sbjct: 211 MV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 458 FSEKLGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLVR 513
F +G G +G V +D +K+L + RE +A E + ++H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 514 LR-GFCSENSHRLLVYDYMRNGALSLYLRKDGLNL-------NWDVRFRIAVGTARGIAY 565
R + E+ +V + G L L++ L W V+ +A + Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
LHE+ I+H D+K +N+ L KV D G+A+++ + +T+ GT Y++PE
Sbjct: 118 LHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPEL 173
Query: 626 ISGLAITTKADVYSYGMTLLEL 647
S K+DV++ G + E+
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 41/242 (16%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG---- 516
LG G FG VF EL + A+K L++ +V + + +V R
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK----------DVVLMDDDVECTMVEKRVLSLA 52
Query: 517 ---------FCS--ENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIA 564
+C+ + V +Y+ G L +++ +L + A G+
Sbjct: 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQ 110
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGTWGYVA 622
+LH + I++ D+K +NILLD+D K++DFG+ K ++G + T GT Y+A
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIA 164
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PE + G T D +S+G+ L E++ G ++P G + D +P W
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIG----QSPFHGHDEEELFQSIRMDNPCYPRWLT 220
Query: 683 RQ 684
R+
Sbjct: 221 RE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 30/206 (14%)
Query: 461 KLGHGGFGAVFQG-ELSDS-TLVAVKRLE-------RPGSGEREFRAEVCTIGNIQHVNL 511
++G G +G VF+ +L + VA+KR+ P S RE A + + +H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNV 66
Query: 512 VRLRGFCS-----ENSHRLLVYDYMRNGALSLYLRK---DGLNLNW--DVRFRIAVGTAR 561
VRL C+ + LV++++ + L+ YL K G+ D+ F++ R
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL----R 121
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+ +LH ++H D+KP+NIL+ S K++DFGLA++ F L ++ T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 622 APEWISGLAITTKADVYSYGMTLLEL 647
APE + + T D++S G E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR---DFSRVLATMRGT 617
RG+ Y+H +IH D+KP N+L++ D ++ DFG+A+ + + + T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 618 WGYVAPEWISGL-AITTKADVYSYGMTLLELIGGR 651
Y APE + L TT D++S G E++G R
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA-EVCTIGNIQHVNLVRLRGF 517
EK+G G G V+ +++ VA++++ ++E E+ + ++ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC---- 573
+V +Y+ G+L+ + T + CR+C
Sbjct: 86 YLVGDELWVVMEYLAGGSLT----------------DVVTETCMDEGQIAAVCRECLQAL 129
Query: 574 -------IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+IH DIK +NILL D + K++DFG I + S+ +TM GT ++APE +
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVV 188
Query: 627 SGLAITTKADVYSYGMTLLELIGG 650
+ A K D++S G+ +E+I G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 462 LGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEV-CTIGNIQHVNLVRLRGF-- 517
LG G FG V L L AVK L++ + + +V CT+ + ++L R F
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD---DVECTMTEKRILSLARNHPFLT 59
Query: 518 ----CSENSHRLL-VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
C + RL V +++ G L +++K RF A T+ + +LH++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
II+ D+K +N+LLD + K++DFG+ K + + +T GT Y+APE + +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 633 TKADVYSYGMTLLELIGGRRNVEA 656
D ++ G+ L E++ G EA
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA--EVCTIGNIQHVNLVRLRG 516
EKLG G + V++G + LVA+K + F A E + ++H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
V++YM ++ G ++VR RG+AY+H I+H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHILH 126
Query: 577 CDIKPENILLDSDYTAKVSDFGLAK---LIGRDFSRVLATMRGTWGYVAPEWISGLA-IT 632
D+KP+N+L+ K++DFGLA+ + + +S + T+ W Y P+ + G +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL---W-YRPPDVLLGATDYS 182
Query: 633 TKADVYSYGMTLLELIGGR 651
+ D++ G +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 541 RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600
+D L+ D R + A+G+ +L ++CI H D+ N+LL AK+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLA 259
Query: 601 KLIGRDFSRVL-ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
+ I D + V+ R ++APE I T ++DV+SYG+ L E+
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
C + + RL LV +Y+ G L ++++ RF A + +LHE II+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG---IIY 119
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+K +N+LLD+D K++D+G+ K G +T GT Y+APE + G D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 637 VYSYGMTLLELIGGR 651
++ G+ + E++ GR
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 462 LGHGGFGAVFQGELSDSTL-VAVKR--LERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
LG G G VF SD VAVK+ L P S + R E+ I + H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71
Query: 519 SENSHRL--------------LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIA 564
+ L +V +YM L+ L + L+ F RG+
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARLF--MYQLLRGLK 128
Query: 565 YLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSR---VLATMRGTWGY 620
Y+H ++H D+KP N+ +++ D K+ DFGLA+++ +S + + W Y
Sbjct: 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-Y 184
Query: 621 VAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
+P + TKA D+++ G E++ G+
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREF---RAEVCTIGNIQHVNLVRLRGF 517
LG G G V + +SD AVK ++ G E + +AEVC + N ++V+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK---- 95
Query: 518 CSENSHRLLVYDYMRNG------ALSLYLRKDGLNLNWDVRFRIAVGTA-----RGIAYL 566
C E+ RN AL L G +L +++ R G+ ++
Sbjct: 96 CHED----FAKKDPRNPENVLMIALVLDYANAG-DLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 567 ------HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWG 619
H +IH DIK NILL S+ K+ DFG +K+ S V T GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 620 YVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652
YVAPE + KAD++S G+ L EL+ +R
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 462 LGHGGFGAVF----QGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
LG G +G VF G L A+K L++ ++ AE T Q + VR F
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLEAVRRCPF 66
Query: 518 ------CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+ +L L+ DY+ G L +L + +VR IA + +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQLG 125
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI-SGL 629
II+ DIK ENILLDS+ ++DFGL+K + + GT Y+APE I G
Sbjct: 126 ---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 630 AITTKA-DVYSYGMTLLELIGG 650
KA D +S G+ EL+ G
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 520 ENSHRLLVYDYMRNGAL-SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+ + LV +Y G L SL R + +F +A I +H+ +H D
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL-AIHSVHQMG---YVHRD 127
Query: 579 IKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR-GTWGYVAPEWISGLAITTKA-- 635
IKPEN+L+D K++DFG A + + V + + GT Y+APE ++ + K
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 636 ----DVYSYGMTLLELIGGRRNVEAPASGRNAN 664
D +S G+ E+I GR S + N
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 462 LGHGGFGAVFQGELSDSTL-VAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRG 516
+G G +G+V + + L VAVK+L RP +R +R E+ + +++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 517 FCS-----ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ E + + + ++ L+ ++ L + V+F I RG+ Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLI-YQILRGLKYIHSAD- 140
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE-WISGLA 630
IIH D+KP N+ ++ D K+ DFGLA+ + + +AT W Y APE ++ +
Sbjct: 141 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT---RW-YRAPEIMLNWMH 194
Query: 631 ITTKADVYSYGMTLLELIGGR 651
D++S G + EL+ GR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTW 618
RG+ Y+H ++H D+KP N+LL+++ K+ DFGLA++ D + L T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 619 GYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
Y APE + TKA D++S G L E++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+G G +G V++ D+ LVA+K++ E+ G R E+ + + H N+V L+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73
Query: 517 FCSENSHRL----------LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
++ L LV++YM + + L L ++ + D G+ Y
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGL-LESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
H++ +H DIK NILL++ K++DFGLA+L + SR T Y PE +
Sbjct: 133 HKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL 189
Query: 627 SGLAITTKA-DVYSYGMTLLEL 647
G A DV+S G L EL
Sbjct: 190 LGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 39/119 (32%), Positives = 62/119 (52%), Gaps = 4/119 (3%)
Query: 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589
Y+ S L +D L L+ + + A+G+++L ++CI H D+ NILL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--ASKNCI-HRDLAARNILLTHG 250
Query: 590 YTAKVSDFGLAKLIGRDFSRVL-ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
K+ DFGLA+ I D + V+ R ++APE I T ++DV+SYG+ L E+
Sbjct: 251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 5/157 (3%)
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
H LV L S V +Y+ G L ++++ RF A + + YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 113
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
E II+ D+K +N+LLDS+ K++D+G+ K G +T GT Y+APE +
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILR 169
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN 664
G D ++ G+ + E++ GR + S N +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGEREFRAEV-CTIGNIQHVNLVRLRGF-- 517
LG G FG V EL + V A+K L++ + + +V CT+ + + L F
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD---DVDCTMTEKRILALAAKHPFLT 59
Query: 518 ----CSENSHRLL-VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
C + RL V +Y+ G L +++ RF A T + +LH R
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL-ALMFLH---RH 115
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
+I+ D+K +NILLD++ K++DFG+ K G T GT Y+APE + L
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 633 TKADVYSYGMTLLELIGGRRNVEA 656
D ++ G+ + E++ G+ EA
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 9/195 (4%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFRAEVCT----IGNIQHVNLVRLRG 516
LG G FG V E + A+K L++ ++ A T + N +H L L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ V +Y G L +L ++ + RF A + YLH E +++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VVY 119
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+K EN++LD D K++DFGL K +D + T GT Y+APE + D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 637 VYSYGMTLLELIGGR 651
+ G+ + E++ GR
Sbjct: 179 WWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 448 YKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE----REFRAEVCT 502
Y++L V G G +G V + VA+K+L RP E R +R E+
Sbjct: 17 YRDLKQV--------GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRL 67
Query: 503 IGNIQHVNLVRLRGFCS--ENSHRL----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA 556
+ +++H N++ L + + R LV +M L ++ + L+ + ++F +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD-LGKLMKHEKLSED-RIQF-LV 124
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616
+G+ Y+H IIH D+KP N+ ++ D K+ DFGLA+ + + + T
Sbjct: 125 YQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVT--- 178
Query: 617 TWGYVAPEWI-SGLAITTKADVYSYGMTLLELIGGR 651
W Y APE I + + T D++S G + E++ G+
Sbjct: 179 RW-YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPGSGEREFRA----EVCTIGNIQHVNLVRLRG 516
+G G +G V + ++ +VA+K+ + E + E+ + ++ N+V L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
LV++Y+ L L VR I + I + H ++ I+H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH---KNDIVH 123
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGR----DFSRVLATMRGTWGYVAPEWISGLAIT 632
DIKPEN+L+ + K+ DFG A+ + +++ +AT W Y +PE + G
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT---RW-YRSPELLLGAPYG 179
Query: 633 TKADVYSYGMTLLELIGGR 651
D++S G L EL G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 462 LGHGGFGAVF----QGELSDSTLVAVKRLERPGSGEREFRAEVCTIGN--IQHVN----L 511
LG G +G VF L A+K L++ ++ E ++HV L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 512 VRLRGFCSENSHRLLVYDYMRNGAL--SLYLRKDGLNLNWDVRFRIAVG-TARGIAYLHE 568
V L + L+ DY+ G + LY R N + D R G + +LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSED-EVRFYSGEIILALEHLH- 122
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
+ I++ DIK ENILLDS+ ++DFGL+K + + GT Y+APE I G
Sbjct: 123 --KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 629 LAITTKA-DVYSYGMTLLELIG--------GRRNVEAPASGR 661
KA D +S G+ + EL+ G RN ++ S R
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 54/223 (24%)
Query: 461 KLGHGGFGAVFQG---ELSDSTLVAVKRLERPG--------SGERE---FRAEVCTIGNI 506
+G G +G V++ D A+K+ + S RE R +
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE-------L 59
Query: 507 QHVNLVRLRGFCSENSHRL--LVYDYMRNGALSLYLRKDGLNLNW---DVRFRIAVGTAR 561
+H N+V L E++ + L++DY + + + + R I +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI--------IKFHRQAKRVSIPPSMVK 111
Query: 562 --------GIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLIGRDFSR 609
G+ YLH + ++H D+KP NIL+ + K+ D GLA+L +
Sbjct: 112 SLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLK 167
Query: 610 VLATMRG---TWGYVAPEWISGLAITTKA-DVYSYGMTLLELI 648
LA + T Y APE + G TKA D+++ G EL+
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL-ATMRGTW 618
ARG+ +L R CI H D+ NILL + K+ DFGLA+ I +D V R
Sbjct: 183 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLEL 647
++APE I TT++DV+S+G+ L E+
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 457 GFSEKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIGNIQHVNLVRL 514
F LG G FG V E + L A+K L++ + + +V CT+ + + L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD---DVECTMVEKRVLALQDK 59
Query: 515 RGF------CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
F C + RL V +Y+ G L ++++ G F A + G+ +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFFLH 118
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R II+ D+K +N++LDS+ K++DFG+ K D T GT Y+APE I+
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFCGTPDYIAPEIIA 174
Query: 628 GLAITTKADVYSYGMTLLELIGGR 651
D ++YG+ L E++ G+
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 70/292 (23%), Positives = 103/292 (35%), Gaps = 58/292 (19%)
Query: 460 EKLGHGGFGAVFQGELSDSTLV-AVKRLERPGSGEREFRAEVCT----IGNIQHVNLVRL 514
+ LG G G VF L + + A+K L++ +R V T + + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRK--DGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
++ LV DY G L L++ RF A + YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG-- 123
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAK-------LIGRDFSRVLATMR---------- 615
I++ D+KPENILL +SDF L+K + + +
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 616 -----------GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRN-- 662
GT Y+APE ISG + D ++ G+ L E++ G P G N
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT----TPFKGSNRD 238
Query: 663 ---ANIGGG-----GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEE 706
+NI G +AR +I + RLG E
Sbjct: 239 ETFSNILKKEVTFPGSPPV-----SSSARDLIRKLLVKDPSKRLGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL-ATMRGTW 618
ARG+ +L R CI H D+ NILL + K+ DFGLA+ I +D V + R
Sbjct: 184 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLEL 647
++APE I TT++DV+S+G+ L E+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/231 (23%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRA----EVCTIGNIQHVNLVRL 514
+K+G G F V++ L D VA+K+++ + + RA E+ + + H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
E++ +V + G LS ++ K + ++ V + ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR---VLATMRGTWGYVAPEWISG 628
++H DIKP N+ + + K+ D GL GR FS ++ GT Y++PE I
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGL----GRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679
K+D++S G L E+ +++P G N+ + ++ +PP
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 41/143 (28%), Positives = 74/143 (51%), Gaps = 22/143 (15%)
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFR------IAVGTARGIAYLHEEC 570
C + RL V +Y+ G L ++++ G +F+ A A G+ +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVG-------KFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAK--LIGRDFSRVLATMRGTWGYVAPEWISG 628
II+ D+K +N++LD++ K++DFG+ K + G +R T GT Y+APE I+
Sbjct: 122 ---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGTPDYIAPEIIAY 175
Query: 629 LAITTKADVYSYGMTLLELIGGR 651
D +++G+ L E++ G+
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFRAEVCT----IGNIQHVNLVRLRG 516
LG G FG V E + A+K L++ ++ A T + N +H L L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + RL V +Y+ G L +L ++ + RF + YLH I+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHS---GKIV 117
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+K EN++LD D K++DFGL K G + + T GT Y+APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 636 DVYSYGMTLLELIGGR 651
D + G+ + E++ GR
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V + D+ + A+K+L + E+E RAE + + +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66
Query: 517 FCS--ENSHRLLVYDYMRNGAL-SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
+ S + ++ L+ +Y+ G + +L ++KD + RF IA T I +H+
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETILAIDSIHKLG--- 121
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLA----KLIGRDFSRVLA 612
IH DIKP+N+LLD+ K+SDFGL K +F R+L+
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRLERPGSGEREFRAEVCT----IGNIQHVNLVRLRG 516
LG G FG V E + A+K L + ++ A T + N +H L L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + RL V +Y G L +L ++ + RF A + YLH RD ++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHS--RD-VV 117
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR---GTWGYVAPEWISGLAIT 632
+ DIK EN++LD D K++DFGL K D ATM+ GT Y+APE +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 633 TKADVYSYGMTLLELIGGR 651
D + G+ + E++ GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+++G G +G V++ L L AVK +LE PG + E+ + +H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ +Y G+L G + + + T +G+AYLH + + +H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK---MH 129
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK-- 634
DIK NILL + K++DFG+A I ++ + GT ++APE +A K
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPE----VAAVEKNG 184
Query: 635 -----ADVYSYGMTLLEL 647
D+++ G+T +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 429 RKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDS-TLVAVKRLE 487
R+D+D +V+ ++ +LG G FG V++ + ++ L A K +E
Sbjct: 5 RRDLDPNEVWEIIG------------------ELGDGAFGKVYKAKNKETGALAAAKVIE 46
Query: 488 RPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN 546
E E + E+ + H +V+L G + ++ ++ GA+ D +
Sbjct: 47 TKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV------DAIM 100
Query: 547 LNWDVRFR------IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600
L D I + YLH IIH D+K N+LL D K++DFG++
Sbjct: 101 LELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS 157
Query: 601 -----KLIGRDFSRVLATMRGTWGYVAPEWISGLAITT-----KADVYSYGMTLLEL 647
L RD + GT ++APE + + KAD++S G+TL+E+
Sbjct: 158 AKNVKTLQRRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 39/193 (20%)
Query: 461 KLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
K+G G FG VF+ +VA+K++ E+ G R E+ + ++H N+V L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 77
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKD-------GLNLNWDVRFRIAVGTA------RG 562
C R Y R S YL + GL N +V+F ++ G
Sbjct: 78 EIC-----RTKATPYNRYKG-SFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG------ 616
+ Y+H R+ I+H D+K NIL+ D K++DFGLA R FS +
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLA----RAFSLSKNSKPNRYTNRV 184
Query: 617 -TWGYVAPEWISG 628
T Y PE + G
Sbjct: 185 VTLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 6/135 (4%)
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
C + RL V +++ G L ++++ RF + + + +LHE II+
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLHERG---IIY 119
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+K +N+LLD++ K++D+G+ K R +T GT Y+APE + G D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 637 VYSYGMTLLELIGGR 651
++ G+ + E++ GR
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 506 IQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
+ H ++V L G C + ++V +++ G L L++ + L +F++A A ++Y
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 566 LHEECRDCIIHCDIKPENILL-----DSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTW 618
L E +D ++H ++ +NILL D + K+SD G+ + SR R W
Sbjct: 121 L--EDKD-LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV---LSRQECVERIPW 174
Query: 619 GYVAPEWISGLA-ITTKADVYSYGMTLLEL 647
+APE + ++ AD +S+G TL E+
Sbjct: 175 --IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 41/211 (19%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRG 516
+G G +G+V + VAVK+L RP R +R E+ + +++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 517 FCS-----ENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFR---------IAVGTAR 561
+ EN + + LV + M G +LN V+ + + R
Sbjct: 82 VFTPATSIENFNEVYLVTNLM------------GADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+ Y+H IIH D+KP N+ ++ D ++ DFGLA+ + + +AT W Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT---RW-YR 182
Query: 622 APE-WISGLAITTKADVYSYGMTLLELIGGR 651
APE ++ + D++S G + EL+ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 37/181 (20%)
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFR------IAVGTARGIAYLHEEC 570
C + RL V +Y+ G L +++ G RF+ A A G+ +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVG-------RFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
II+ D+K +N++LDS+ K++DFG+ K D T GT Y+APE I+
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEIIAYQP 177
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690
D +++G+ L E++ G+ E GE D+ F + I+E NV
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFE-------------GEDEDELF------QSIMEHNV 218
Query: 691 A 691
A
Sbjct: 219 A 219
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 18/199 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLE----RPGSGEREFRAEVCTIGNIQHVNLVRL 514
+K+G G F V++ L D VA+K+++ ++ E+ + + H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 515 RGFCSENSHRLLVYDYMRNGALS---LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
E++ +V + G LS Y +K + ++ V + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR- 126
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR---VLATMRGTWGYVAPEWISG 628
++H DIKP N+ + + K+ D GL GR FS ++ GT Y++PE I
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGL----GRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 629 LAITTKADVYSYGMTLLEL 647
K+D++S G L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL-ATMRGTW 618
A+G+ +L R CI H D+ NILL + K+ DFGLA+ I +D V R
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLEL 647
++APE I T ++DV+S+G+ L E+
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 47/196 (23%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLE-RPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+++G G +G V++ ++ L A+K ++ PG + E+ + + +H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
+ ++ G+L G + + ++ T +G+ YLH + + +H
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHR 130
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA-- 635
DIK NILL + K++DFG++ I ++ + GT ++APE A+ K
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVA---AVERKGGY 186
Query: 636 ----DVYSYGMTLLEL 647
D+++ G+T +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
EK+G G +G V++ + + LVA+K RLE P + RE +I V L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 512 VRLRGFCSENSHRLL--VYDYMRNGA---LSLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
+ + +N L V++Y+ + + R G L +G+A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 567 HEECRDCIIHCDIKPENILLDSDYTA-KVSDFGLAKLIGRDFSRVLATMRG---TWGYVA 622
H+ ++H D+KP+N+L+D K++D GL GR FS + + T Y A
Sbjct: 127 HKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL----GRAFSIPVKSYTHEIVTLWYRA 179
Query: 623 PEWISGLA-ITTKADVYSYGMTLLELI 648
PE + G +T D++S G E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRG 516
+G G FG V + VA+K++ +P S +R +R E+ + +++H N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 517 -FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
F S V + + L L L + F + RG+ Y+H ++
Sbjct: 77 IFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFIQYFLYQI--LRGLKYVHSAG---VV 130
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE-WISGLAITTK 634
H D+KP NIL++ + K+ DFGLA++ + ++T Y APE ++ +
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----YRAPEIMLTWQKYDVE 186
Query: 635 ADVYSYGMTLLELIGGR 651
D++S G E++ G+
Sbjct: 187 VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 63/255 (24%), Positives = 92/255 (36%), Gaps = 69/255 (27%)
Query: 462 LGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVN---------- 510
+G G FG V D + L A+K L + A+V HV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRK---------ADVLMRNQAAHVKAERDILAEAD 59
Query: 511 ---LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
+V+L + + V DY+ G + L + G+ RF IA T I +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-AIESVH 118
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLA--------------------------- 600
+ IH DIKP+NIL+D D K++DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 601 --------------KLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITTKADVYSYGMTLL 645
+ R R LA ++ GT Y+APE + T D +S G+ L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 646 ELIGGRRNVEAPASG 660
E++ G+ A
Sbjct: 236 EMLVGQPPFLADTPA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY 620
RG+ Y+H ++H D+KP N+LL+++ K+ DFGLA+ + + W Y
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-Y 174
Query: 621 VAPEWI-SGLAITTKADVYSYGMTLLELIGGR 651
APE + + TT DV+S G EL+G +
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-06
Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 3/49 (6%)
Query: 336 CERSCLANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVR 384
C +CL+NCSC ++ + C G L NLR S S+ LY+R
Sbjct: 37 CREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLR---SLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 462 LGHGGFGAVF---------QGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNL 511
LG G +G VF G+L ++ + + R E + +I Q L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR-----IAVG-TARGIAY 565
V L ++ L+ DY+ G L +L + RF+ I G + +
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEH 120
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
LH + II+ DIK ENILLDS+ ++DFGL+K D + GT Y+AP+
Sbjct: 121 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 626 ISG--LAITTKADVYSYGMTLLELIGG 650
+ G D +S G+ + EL+ G
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 20/149 (13%)
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYL 566
+ N ++L + +L+ DY+++G L L+K+G L+ +V+ I + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-EVKK-IIRQLVEALNDL 125
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAK-----VSDFGLAKLIGRDFSRVLATMRGTWGYV 621
H + IIH DIK EN+L Y + D+GL K+IG + GT Y
Sbjct: 126 H---KHNIIHNDIKLENVL----YDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYF 173
Query: 622 APEWISGLAITTKADVYSYGMTLLELIGG 650
+PE I G D ++ G+ EL+ G
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 461 KLGHGGFGAVFQG---ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG- 516
K+G G +G V++ + D A+K++E G R E+ + ++H N++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 517 FCSENSHRL-LVYDYMRNGALSLY-------LRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
F S + ++ L++DY + + K + L + + GI YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 569 ECRDCIIHCDIKPENILLDSDYT----AKVSDFGLAKLIGRDFSRV--LATMRGTWGYVA 622
+ ++H D+KP NIL+ + K++D G A+L + L + T+ Y A
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 623 PEWISGLAITTKA-DVYSYGMTLLELI 648
PE + G TKA D+++ G EL+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 46/214 (21%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRL------ERPGSG----EREFRAEVCTIGNIQHVN 510
+G G FG V S + A+K L +R S ER+ A H N
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---------HAN 101
Query: 511 ---LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNL--NWDV-----RFRIAVGTA 560
+V+L ++ + +V +YM G D +NL N+D+ RF A
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGG--------DLVNLMSNYDIPEKWARFYTA-EVV 152
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY 620
+ +H IH D+KP+N+LLD K++DFG + + T GT Y
Sbjct: 153 LALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 621 VAPEWISGLAITT----KADVYSYGMTLLELIGG 650
++PE + + D +S G+ L E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 43/165 (26%), Positives = 63/165 (38%), Gaps = 8/165 (4%)
Query: 490 GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN-LN 548
+G + E+ + I H ++ L S +V M L+ D L
Sbjct: 127 VTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLP 183
Query: 549 WDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA-KLIGRDF 607
+ I +AYLH IIH D+K ENI LD A + DFG A KL
Sbjct: 184 LEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652
+ GT +PE ++ K D++S G+ L E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 461 KLGHGGFGAVFQGELSD---STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG- 516
K+G G +G V++ + D A+K++E G R E+ + ++H N++ L+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 517 FCSENSHRL-LVYDYMRNGALSLY-------LRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
F S ++ L++DY + + K + L + + GI YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 569 ECRDCIIHCDIKPENILLDSDYT----AKVSDFGLAKLIGRDFSRV--LATMRGTWGYVA 622
+ ++H D+KP NIL+ + K++D G A+L + L + T+ Y A
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 623 PEWISGLAITTKA-DVYSYGMTLLELI 648
PE + G TKA D+++ G EL+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 48/212 (22%)
Query: 461 KLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFR--AEVCTIGNIQ-------HVN 510
K+G G F V + A+K +++ F+ +V + IQ H N
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKK------HFKSLEQVNNLREIQALRRLSPHPN 59
Query: 511 LVRLRGFCSENSHRLL----------VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTA 560
++RL + L +Y+ ++ RK L V+
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-------RKRPLPEK-RVK-SYMYQLL 110
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTW 618
+ + ++H R+ I H DIKPENIL+ D K++DFG + I ++ ++T W
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIST---RW 163
Query: 619 GYVAPEWI--SGLAITTKADVYSYGMTLLELI 648
Y APE + G K D+++ G E++
Sbjct: 164 -YRAPECLLTDGY-YGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGERE----FRAE--VCTIGNIQHVNLVRL 514
+G G FG V ++ + + A+K L + +R FR E V G+ Q + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDV-RFRIA--VGTARGIAYLHEECR 571
F EN + LV DY G L L K L D+ RF IA V I LH
Sbjct: 69 -AFQDEN-YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---- 122
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-- 629
+H DIKP+N+LLD + +++DFG + +D + + GT Y++PE + +
Sbjct: 123 --YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 630 ---AITTKADVYSYGMTLLELIGG 650
+ D +S G+ + E++ G
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 16/97 (16%)
Query: 458 FSEKLGHGGFGAVFQ------GELSDSTLVAVKRLERPGSGEREFRAEVCT------IGN 505
+ LG G FG V Q + + VAVK L + G+ E++A + IG+
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGH 69
Query: 506 IQHVNLVRLRGFCSENSHRLLV-YDYMRNGALSLYLR 541
H+N+V L G C++ L+V +Y + G LS YLR
Sbjct: 70 --HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 35/185 (18%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 477 DSTLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRLRGFCSENSHRL----LVY 528
++ V ++ ++ G E+ + I N++++ GF + L L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588
+Y G L L K+ +L++ + +A+ +G+ L++ + ++ + L+
Sbjct: 102 EYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTE 158
Query: 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL--AITTKADVYSYGMTLLE 646
+Y K+ GL K++ + + M Y + + ++ + T K D+YS G+ L E
Sbjct: 159 NYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214
Query: 647 LIGGR 651
+ G+
Sbjct: 215 IFTGK 219
|
Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+ Y+H+ I+H D+K +NI L ++ K+ DFG+++L+ + T GT Y+
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYM 172
Query: 622 APEWISGLAITTKADVYSYGMTLLEL 647
+PE + +K+D++S G L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 14/114 (12%)
Query: 543 DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602
+GL + F V ARG+ +L ++C+ H D+ N+LL K+ DFGLA+
Sbjct: 232 EGLTTLDLLSFTYQV--ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARD 286
Query: 603 IGRDFSRVLATMRGTW----GYVAPEWISGLAITTKADVYSYGMTLLEL--IGG 650
I D + V +G+ ++APE I TT +DV+SYG+ L E+ +GG
Sbjct: 287 IMHDSNYV---SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 454 VTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVR 513
+ E G + QG+ L+A KR++ + E+ +G + H N+++
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILK 227
Query: 514 LRGFCSENSHRLLV--------YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
+ ++ ++ Y +M + A KD L R I + Y
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDW---KDRPLL-KQTR-AIMKQLLCAVEY 282
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA-----KLIGRDFSRVLATMRGTWGY 620
+H++ +IH DIK ENI L+ D + DFG A + D+ V GT
Sbjct: 283 IHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-----GTVAT 334
Query: 621 VAPEWISGLAITTKADVYSYGMTLLELI 648
+PE ++G D++S G+ LL+++
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 460 EKLGHGGFGAVFQ-GELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGF 517
E +G G +G VF+ + + AVK L+ + E AE + + H N+V+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 518 C----SENSHRL-LVYDYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+N +L LV + G+++ ++ K G + + I G+ +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV- 142
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGL-AKLIGRDFSRVLATMRGTWGYVAPEWIS- 627
+ IH D+K NILL ++ K+ DFG+ A+L R T GT ++APE I+
Sbjct: 143 --NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIAC 198
Query: 628 ----GLAITTKADVYSYGMTLLELIGG 650
+ DV+S G+T +EL G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V +L ++ V A+K L + +R FR E + N + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDV-RFRIA--VGTARGIAYLHEECRDC 573
+ ++ LV DY G L L K L D+ RF +A V + LH
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH------ 122
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA--- 630
+H DIKP+NIL+D + +++DFG + D + + GT Y++PE + +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 631 --ITTKADVYSYGMTLLELIGGRRNVEAP--ASGRNANIGGGGEHGDKWFFP 678
+ D +S G+ + E++ G E P A G H +++ FP
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG----ETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 45/171 (26%), Positives = 69/171 (40%), Gaps = 10/171 (5%)
Query: 481 VAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL 540
V +K +R G+ E + I H ++++L+G + N L+ + L YL
Sbjct: 120 VVIKAGQRGGTA-----TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-LYCYL 173
Query: 541 RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600
N+ I R I YLHE + IIH DIK ENI ++ + DFG A
Sbjct: 174 -AAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 601 KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
+ GT APE ++ D++S G+ L E+
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD------FSRVLATM 614
R + Y+H + H D+KP+NIL ++D K+ DFGLA++ D ++ +AT
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 169
Query: 615 RGTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGGR 651
W Y APE T D++S G E++ G+
Sbjct: 170 --RW-YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 47/226 (20%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLE--RPGSGEREFRAEVCTIG-------------N 505
LG G +G V + +VA+K+++ + + R V G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 506 IQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR------IAVGT 559
I+H N++ L E LV D M + L+K ++ +R I +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-----LKK---VVDRKIRLTESQVKCILLQI 128
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK-----LIGRDFSRVLATM 614
G+ LH + +H D+ P NI ++S K++DFGLA+ S+
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 615 RG--------TWGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
R T Y APE + G A D++S G EL+ G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V + D+ V A+K L + E+E RAE + + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 517 FCSENSHRLLVYDYMRNG-ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + L+ +++ G ++L ++KD L + +F IA T I +H+ I
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT-EEETQFYIA-ETVLAIDSIHQLG---FI 123
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGR----------------DFS----------- 608
H DIKP+N+LLDS K+SDFGL + + DF+
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 609 ------RVLA-TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
R LA + GT Y+APE D +S G+ + E++ G
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAI 631
++H D+K NI L K+ DFG +K S V ++ GT Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPA 658
+ KAD++S G+ L EL+ R + P+
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 45/229 (19%)
Query: 462 LGHGGFGAVFQGELSDST-LVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V + D+ + A+K L + E+E RAE + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 517 FCSENSHRLLVYDYMRNG-ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + L+ +++ G ++L ++KD L+ +F IA T I +H+ I
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS-EEATQFYIA-ETVLAIDAIHQLG---FI 123
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGR----------------DFS----------- 608
H DIKP+N+LLD+ K+SDFGL + + DFS
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 609 ------RVLA-TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
R LA + GT Y+APE D +S G+ + E++ G
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 22/151 (14%)
Query: 517 FCSENSHRLL--VYDYMRNGALSLYLRKDGLNLNWD-VRFRIAVGTARGIAYLHEECRDC 573
FCS + R L V +Y+ G + L+ G L D R A T + YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKL-------------IGRDFSRVL-ATMRGTWG 619
I+H D+KP+N+L+ S K++DFGL+K+ I +D L + GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 620 YVAPEWISGLAITTKADVYSYGMTLLELIGG 650
Y+APE I D ++ G+ L E + G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 62/241 (25%), Positives = 92/241 (38%), Gaps = 55/241 (22%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGER----EFRAEVCTIGNIQHVNLVRLRG 516
LG G FG V D+ L A+K L + R +AE + + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + V DY+ G + L + G+ RF IA T + +H + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC-AVESVH---KMGFIH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLA------------------------------------ 600
DIKP+NIL+D D K++DFGL
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 601 ---------KLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
+ R R LA ++ GT Y+APE + T D +S G+ L E++ G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 651 R 651
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-05
Identities = 26/104 (25%), Positives = 47/104 (45%), Gaps = 20/104 (19%)
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI---------------GRD 606
I Y+H + ++H D+KP+NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 607 FSR--VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
+S + + GT Y+APE + G+ + D+Y+ G+ L +++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 10/103 (9%)
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD---FSRVLATMRG 616
A G+ +L ++C+ H D+ N+L+ K+ DFGLA+ I RD S+ +
Sbjct: 249 ANGMEFL--ASKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 617 TWGYVAPEWISGLAITTKADVYSYGMTLLEL--IGGRRNVEAP 657
W +APE I TT +DV+S+G+ L E+ +GG E P
Sbjct: 306 KW--MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYV 621
I Y+H + IIH DIK EN+L++ + DFG A G + + GT
Sbjct: 273 IDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 622 APEWISGLAITTKADVYSYGMTLLE 646
APE ++G T D++S G+ + E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 61/247 (24%), Positives = 93/247 (37%), Gaps = 55/247 (22%)
Query: 462 LGHGGFGAV-FQGELSDSTLVAVKRLERPGSGER----EFRAEVCTIGNIQHVNLVRLRG 516
LG G FG V ++ L A+K L + R +AE + + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + V DY+ G + L + + RF IA T I +H + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL-AIESVH---KMGFIH 124
Query: 577 CDIKPENILLDSDYTAKVSDFGLA------------------------------------ 600
DIKP+NIL+D D K++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 601 ---------KLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
+ + R LA ++ GT Y+APE + T D +S G+ L E++ G
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 651 RRNVEAP 657
+ AP
Sbjct: 245 QPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 18/38 (47%), Positives = 28/38 (73%), Gaps = 3/38 (7%)
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602
YLH R IIH D+KP+N+L+ ++ K++DFGL+K+
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 29/96 (30%), Positives = 39/96 (40%), Gaps = 18/96 (18%)
Query: 566 LHEE-----CRDCI-----IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615
L+EE C C+ +H K NILL D + G R
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWD--GLLKLDGSVAFKTP------EQSR 65
Query: 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
++APE I G + T KAD+YS G+TL E +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE 101
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 517 FCS--ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECRDC 573
FC+ ++ + +V +YM G L L N+DV + A TA + L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV------NLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA--- 630
+IH D+KP+N+LLD K++DFG + T GT Y++PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 631 -ITTKADVYSYGMTLLELIGG 650
+ D +S G+ L E++ G
Sbjct: 223 YYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 16/26 (61%), Positives = 20/26 (76%)
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLA 600
IH DIKP+NIL+D K+SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 4/80 (5%)
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA---- 630
IH D+KP+N+LLD K++DFG + ++ T GT Y++PE +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 631 ITTKADVYSYGMTLLELIGG 650
+ D +S G+ L E++ G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 458 FSEKLGHGGFGAVFQ------GELSDSTLVAVKRLE-RPGSGERE-FRAEVCTIGNI-QH 508
F + LG G FG V + G+ + VAVK L+ + ERE +E+ + ++ QH
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK 542
N+V L G C+ L++ +Y G L +LRK
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 16/93 (17%)
Query: 462 LGHGGFGAVFQGEL------SDSTLVAVKRLERPGSGEREFRAEVCT------IGNIQHV 509
LGHG FG V + S VAVK L + G+ E +A + IGN H+
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIGN--HL 71
Query: 510 NLVRLRGFCSE-NSHRLLVYDYMRNGALSLYLR 541
N+V L G C++ N +++ ++ + G LS +LR
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLR 104
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI---GR--DFSRVLATM-RG 616
+ Y+HE I H DIKPENI++D + + D+G+A G+ ++S+ + RG
Sbjct: 139 LEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649
T Y + +G +T + D+ S G +L+ G
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 804 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.4 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.28 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.28 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.89 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.34 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.8 | |
| PLN02236 | 344 | choline kinase | 96.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.4 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.14 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.08 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.72 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.52 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.93 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-55 Score=474.64 Aligned_cols=286 Identities=48% Similarity=0.809 Sum_probs=254.5
Q ss_pred cccccChHHHHHhhcccc--cccccccceeEEEEEeCCCcEEEEEEecCCCCC-HHHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 442 NLKVFSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG-EREFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 442 ~~~~~~~~el~~~t~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
..+.|++.+|.++|++|+ ..||+|+||.||+|.+.++..||||++...... .++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567899999999999998 599999999999999999999999999875554 77899999999999999999999999
Q ss_pred ecCC-eEEEEEEEcCCCChhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEee
Q 044374 519 SENS-HRLLVYDYMRNGALSLYLRKDGL-NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSD 596 (804)
Q Consensus 519 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 596 (804)
.+.+ +++||||||++|+|.++|+.... .++|.+|++||.++|+||+|||..+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 59999999999999999998766 899999999999999999999999988999999999999999999999999
Q ss_pred cCCccccCCCcccccccc-ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 597 FGLAKLIGRDFSRVLATM-RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 597 fGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
||+++..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+. ...
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~------------~~~ 287 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR------------GEL 287 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc------------ccc
Confidence 9999765441 1111222 7999999999999999999999999999999999999888753321 233
Q ss_pred CchHHHHHHhhcCccceecccccc-CCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLG-GAYKV-EEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+..|+...+.++.+.+++|+++. ..++. ++..++..++.+|++.+|++||+|.+|+++|+.+..
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 488999999999999999999987 55554 688999999999999999999999999999976543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=406.46 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=214.2
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCC-eEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENS-HRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~ 533 (804)
+.+.||+|+||+||+|.+.....||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999977777999999764332 558999999999999999999999999988 79999999999
Q ss_pred CChhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 611 (804)
|+|.++++. ....+++..+++++.+||+||.|||+++. ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999988 46789999999999999999999999774 99999999999999997 99999999998754322 223
Q ss_pred cccccccccccchhcc--CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 612 ATMRGTWGYVAPEWIS--GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~--~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
+...||+.|||||++. ...|+.|+|||||||+||||+||+.||...... .-+......
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------------------~~~~~v~~~-- 261 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------------------QVASAVVVG-- 261 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------------------HHHHHHHhc--
Confidence 4478999999999999 569999999999999999999999999864321 111111112
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
..+...+......+..++.+||+.||+.||++.+|+.+|+.+....
T Consensus 262 -------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 262 -------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2223334446788999999999999999999999999999876533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=407.67 Aligned_cols=261 Identities=31% Similarity=0.458 Sum_probs=228.4
Q ss_pred HHHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 450 ELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 450 el~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
++......+.++||+|-||.||.|.+.....||||.++......+.|.+|+.+|++|+|+|||+++|+|..+..++||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 34444455778999999999999999888899999999877778899999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 530 YMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.|+|.++|+. .+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++..
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999997 5668999999999999999999999988 99999999999999999999999999997777666
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......-+..|.|||.+....++.|||||||||+||||+| |+.|+..+...
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------------------- 411 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------------------- 411 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------------------
Confidence 66666677899999999999999999999999999999998 88887754321
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
++.+.++...+-..|..++..+.+|+..||+.+|++|||+..+...|+++...
T Consensus 412 -ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 412 -EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 12233333334455667888999999999999999999999999999886553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=406.29 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=221.0
Q ss_pred HHHhhcccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCC
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENS 522 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 522 (804)
+......+.++||+|+||+||+|+.. +...||||.++.... ...+|++|+++++.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33344457789999999999999753 356899999987544 4678999999999999999999999999999
Q ss_pred eEEEEEEEcCCCChhHHHhhCC---------C----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 523 HRLLVYDYMRNGALSLYLRKDG---------L----NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
..++|+|||..|+|.+||..+. . +|+..+.+.||.|||.||.||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999997432 2 3788899999999999999999887 9999999999999999
Q ss_pred CceEEeecCCcccc-CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
..|||+||||++.. +.++.+......-+++|||||.++.+.|+.+||||||||+|||+++ |+.|+......
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------- 712 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------- 712 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------
Confidence 99999999999864 5566666556677899999999999999999999999999999998 88888764432
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+...+.+|.+. ..+..++.++..|+..||+.+|++||+++||-..|+....
T Consensus 713 ------------EVIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 ------------EVIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------------HHHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 234445555442 4466778899999999999999999999999999987543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=397.40 Aligned_cols=265 Identities=26% Similarity=0.484 Sum_probs=227.2
Q ss_pred cChHHHHHhhccc-----------ccccccccceeEEEEEeC----CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCC
Q 044374 446 FSYKELHTVTRGF-----------SEKLGHGGFGAVFQGELS----DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQH 508 (804)
Q Consensus 446 ~~~~el~~~t~~~-----------~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H 508 (804)
++|++.-++...| .+.||.|.||.|++|+++ ....||||.++.- +...++|..|+.+|.+++|
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence 5666655554443 467999999999999775 2467999999864 3455789999999999999
Q ss_pred CCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 509 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
|||++|.|+.......+||+|||+||+|+.||+.+...+.+.+..-++.+||.||.||.+.+ +|||||.++||||+.
T Consensus 690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNS 766 (996)
T ss_pred CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeecc
Confidence 99999999999999999999999999999999998888999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCccccCCCcccccccc--ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcC
Q 044374 589 DYTAKVSDFGLAKLIGRDFSRVLATM--RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANI 665 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 665 (804)
+..+||+||||++.+.++.....++. ..+.+|.|||.+..+.++.+||||||||||||.++ |.+|+=.+..+
T Consensus 767 nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----- 841 (996)
T KOG0196|consen 767 NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----- 841 (996)
T ss_pred ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----
Confidence 99999999999998876654333333 24689999999999999999999999999999987 88887544322
Q ss_pred CCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
++.+.++...+-..+++++..|.+|++.|||+|-.+||.+.+|+.+|.++.+.
T Consensus 842 -----------------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 842 -----------------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----------------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 23344445555567889999999999999999999999999999999987653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=364.88 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=208.8
Q ss_pred cChHHHHHhhcccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC
Q 044374 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS 522 (804)
Q Consensus 446 ~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 522 (804)
.+..||+. .+.||+|..|+|||+.++ .++.+|+|++... ....+++.+|+++++..+||+||+++|.|..+.
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 45555553 468999999999999876 5788999999543 334578999999999999999999999999888
Q ss_pred -eEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 523 -HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 523 -~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
...|+||||.+|+|+.++...+ .+++...-+|+.++++||.|||+ .+ ||||||||+||||+..|++||||||.+
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence 5999999999999999998764 69999999999999999999996 45 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 601 KLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 601 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
..+-.. ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..+.+. ...|
T Consensus 227 ~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----------------~~~~ 287 (364)
T KOG0581|consen 227 GILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----------------YLDI 287 (364)
T ss_pred HHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----------------CCCH
Confidence 876543 456789999999999999999999999999999999999999999764111 0111
Q ss_pred H--HHHhhcCccceeccccccCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 A--ARQIIEGNVAAVVDDRLGGAYKV-EEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~--~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+ ...+..+.-. ..+. ...+++..++..||++||.+||++.|++++
T Consensus 288 ~~Ll~~Iv~~ppP---------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 288 FELLCAIVDEPPP---------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHhcCCCC---------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 1112222111 1122 356789999999999999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=358.69 Aligned_cols=249 Identities=29% Similarity=0.434 Sum_probs=205.3
Q ss_pred cccccccccccceeEEEE-EeCCCcEEEEEEecCCCC--------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGS--------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
+-+++.||+|+||.|-+| ....++.||||++++... .....++|+++|++++|||||++++++......||
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 345789999999999999 455789999999965321 22345799999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCcccc
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLI 603 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~ 603 (804)
||||+++|.|.+++-.++ .+.+..-..++.|++.|+.|||+.+ |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 254 VlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999998765 6777888899999999999999999 9999999999999766 78999999999987
Q ss_pred CCCccccccccccccccccchhccCCCC---CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAI---TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
+. ...+.+.+||+.|.|||++.+... ..|+|+||+|||||-+|+|..||....... -
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------------s 389 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------------S 389 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------------------c
Confidence 63 455788999999999999977643 347899999999999999999998643321 1
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+++..|...- ......+..++..+++.+||..||++|||+.|+++.
T Consensus 390 l~eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 233344443321 112233567789999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.80 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=208.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+...+.||+|||..||+++. ..++.||+|++.+ .....+...+||++.+.|+|||||+++++|++.++.|||.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 34457899999999999976 7899999999975 334456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
|++++|.++++. ...+++.++..+..||+.||.|||+.+ |+|||||..|+||++++++||+|||||..+..+..+
T Consensus 100 C~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er- 174 (592)
T KOG0575|consen 100 CHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER- 174 (592)
T ss_pred cCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc-
Confidence 999999999984 458999999999999999999999988 999999999999999999999999999987655333
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..+.+||+.|+|||++....++..+||||+|||||-||.|++||+...-. -..+.+...+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------------------ety~~Ik~~~- 234 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------------------ETYNKIKLNE- 234 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------------------HHHHHHHhcC-
Confidence 56789999999999999999999999999999999999999999843110 0111221111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...|.....+..+|+..+|++||.+|||+++|+..
T Consensus 235 ---------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ---------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12233556678899999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=352.48 Aligned_cols=196 Identities=31% Similarity=0.504 Sum_probs=176.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.++||+|+|++||+|++. .+..||||.+.... ...+.+..|+.+|+.++|||||+|++++...+..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 4567999999999999775 57899999997543 2345578999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC------CceEEeecCCccccCCCc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD------YTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DfGla~~~~~~~ 607 (804)
|+|.+||+.++ .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+.+...
T Consensus 94 GDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~- 168 (429)
T KOG0595|consen 94 GDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG- 168 (429)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-
Confidence 99999999876 7999999999999999999999998 9999999999999775 46999999999987643
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcC
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPAS 659 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~ 659 (804)
....+.+|++-|||||+++..+|+.|+|+||+|+|||++++|+.||+....
T Consensus 169 -~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 169 -SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred -hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 345678999999999999999999999999999999999999999986433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.05 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=208.3
Q ss_pred ccccccccccceeEEEE-EeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeee-EEecCCe-EEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRG-FCSENSH-RLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV~E~ 530 (804)
.+.++||+|.||+|||+ .+.++..||.|.++-. ....++...|+.+|++|+|||||++++ .+.++.+ ++|||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 35689999999999999 5668999999999732 334456889999999999999999998 4555555 8999999
Q ss_pred cCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 531 MRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECR-DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 531 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|..|+|...++. .+..++++.+++++.|+++||.++|..-+ ..|+||||||.||+|+.+|.+||+||||++++.+.
T Consensus 102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 999999998863 45679999999999999999999998432 24999999999999999999999999999998765
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.. .....+|||.||+||.+++..|+.||||||+||++|||+.-+.||.+.. ..-..+++.
T Consensus 182 ~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------------------~~~L~~KI~ 241 (375)
T KOG0591|consen 182 TT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------------------LLSLCKKIE 241 (375)
T ss_pred hH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------------------HHHHHHHHH
Confidence 33 3567899999999999999999999999999999999999999998531 112334555
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.++...+.+. --+..+.+|+..|+..||+.||+...++..+..
T Consensus 242 qgd~~~~p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 QGDYPPLPDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cCCCCCCcHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 5554433332 335678899999999999999986666555544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.01 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=206.5
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|.||+||+|+|.+ .||||+++... +..+.|++|+..+++-+|.||+-++|+|..... .||+.+|++
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 356799999999999999853 49999997543 344679999999999999999999999998877 999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~ 612 (804)
.+|..+|+.....++..+.++|+.|||+||.|||.++ |||||||..||||.+++.|||+||||+..-..- ......
T Consensus 472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 9999999988888999999999999999999999998 999999999999999999999999999754322 112234
Q ss_pred ccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 613 TMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...|...|||||+++. .+|++.+||||||+|+|||++|..||.....+....+.+ .|-
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-------------------rG~ 609 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-------------------RGY 609 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------------------ccc
Confidence 4568899999999865 479999999999999999999999998432221111111 010
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+ ..|.. ....++.+++.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 610 l--~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 L--MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c--Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 01110 1123566789999999999999999999999999988654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=356.03 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=207.7
Q ss_pred cChHHHHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 446 ~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
+.+++|... +=||+|+.|.||.|++.+ +.||||+++.-. ..+|+-|++|+||||+.+.|+|....-+|
T Consensus 121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~n-etVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISEL-----EWLGSGAQGAVFLGRLHN-ETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhh-----hhhccCcccceeeeeccC-ceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 445555443 359999999999999954 569999886422 35788899999999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
||||||..|-|...|+... .+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++....
T Consensus 189 IiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999998765 7888889999999999999999988 99999999999999999999999999997654
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
. .....+.||..|||||++.+.+.++|+|||||||||||||||..||..-+.. .
T Consensus 265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---A--------------------- 318 (904)
T KOG4721|consen 265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---A--------------------- 318 (904)
T ss_pred h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---e---------------------
Confidence 3 3345678999999999999999999999999999999999999999743221 0
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
-+-.+-...|.-..+..+++-+.-|++.||+..|.+||++++|+.+|+
T Consensus 319 ---IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 319 ---IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ---eEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 011222233344456677788999999999999999999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.90 Aligned_cols=276 Identities=25% Similarity=0.380 Sum_probs=206.9
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||||++.+ +.||||++.........-+++|.-+-.++|+||+++++.-.... +++||+||.+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 356789999999999999955 78999999754333333334455556779999999999876665 8899999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC------RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
.|+|.++|..+ .++|....+|+..+++||+|||+.. +++|+|||||++||||.+|+++.|+|||+|..+...
T Consensus 292 kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 292 KGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred CCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 99999999986 6999999999999999999999864 567999999999999999999999999999877543
Q ss_pred c-cccccccccccccccchhccCCC-CC-----ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 607 F-SRVLATMRGTWGYVAPEWISGLA-IT-----TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 607 ~-~~~~~~~~gt~~y~aPE~l~~~~-~~-----~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
. .......+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-+.. .+.....++...+.+....+..
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCCCCHHH
Confidence 2 22344588999999999998753 22 368999999999999997655542 1111112222222233333333
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+.++....+.+.-... .....+.+.+..||..||+.|-|+.=|-+.+.++..
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 333334444444444333322 345678899999999999999999999998877554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=391.84 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=214.5
Q ss_pred hhcccccccccccceeEEEEEeCC--C----cEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSD--S----TLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
....+.+.||+|+||.||+|...+ + ..||||.++.. .+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 334456789999999999997653 3 34999999764 456678999999999999999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCC
Q 044374 526 LVYDYMRNGALSLYLRKD------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 599 (804)
|++|||++|+|..||++. ...++....+.++.+||+|+.|||++. +|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999987 567999999999999999999999988 99999999999999999999999999
Q ss_pred cccc-CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLI-GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
|+.+ ..++.+......-+.+|||||.+..+.|+.|+|||||||+|||++| |..||......+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------------- 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------------- 912 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----------------
Confidence 9944 4444444444456789999999999999999999999999999998 788887543210
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
....+.+|. +| +.+..++..+.+|+..||+.+|++||++..|++.+..+...
T Consensus 913 ---v~~~~~~gg-------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 913 ---VLLDVLEGG-------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ---HHHHHHhCC-------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 111112221 22 34556788899999999999999999999999998876543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.41 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=212.3
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..-|.++||+|-||.|...+......||||+++... ...++|..|+++|.+++||||++|+|+|..++.+++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 344678999999999999999888999999998643 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc-CCCcccc
Q 044374 533 NGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~-~~~~~~~ 610 (804)
+|+|.+|+..+..+ +.-....+|+.|||.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+ ..++.+.
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999877433 356677889999999999999988 999999999999999999999999999954 4556666
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh--CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG--GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
....+-+.+|||||.+..++++.+||||+||++|||+++ ...||...... ++.+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----------------------~vve- 751 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----------------------QVVE- 751 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----------------------HHHH-
Confidence 666778899999999999999999999999999999875 66777643221 1111
Q ss_pred ccceeccccc---cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRL---GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...++++..- --..+.-++..+.+++++||..+-++||+++++...|++.
T Consensus 752 n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111110 1122445677889999999999999999999999999763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.89 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=211.5
Q ss_pred HHHhhcccccccccccceeEEEEEeCC--C--cE-EEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELSD--S--TL-VAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN 521 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 521 (804)
|......+.++||+|+||.||+|++.. + .. ||||..+.. .....+|.+|.++|++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 333344456899999999999997653 2 23 899999852 23456899999999999999999999999999
Q ss_pred CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 522 SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 522 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
..++||||+|.+|+|.++|++.+..++..++++++.++|+||+|||+++ +|||||.++|+|++.++.+||+||||++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999999998878999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
... .+........-+.+|+|||.+....|+.++|||||||++||+++ |..||...... .
T Consensus 311 ~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------------------~ 370 (474)
T KOG0194|consen 311 AGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------------------E 370 (474)
T ss_pred CCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------------------H
Confidence 643 11111112346789999999999999999999999999999998 78888754221 1
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
+...+.. ....-..+...+..+..++..|+..+|++||+|.+|.+.|+.+....
T Consensus 371 v~~kI~~--------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 371 VKAKIVK--------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHh--------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 2222211 11112223345677888899999999999999999999999866543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.13 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=202.6
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC--eEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS--HRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~~~ 532 (804)
...+.||+|+||+||.+...+ +...|||.+.... ...+.+.+|+.+|.+++|||||+++|...... .+++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 345789999999999997764 8899999997542 22566899999999999999999999855444 6899999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCC--Cccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGR--DFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~--~~~~ 609 (804)
+|+|.+++.+.+..+++..+.++..||++||+|||+++ |+||||||+||||+. ++.+||+|||+++.... ....
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99999999987657999999999999999999999988 999999999999999 79999999999987653 2333
Q ss_pred cccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......||+.|||||++..+ ....++|||||||++.||+||+.||... .....+......+.
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----------------~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----------------FEEAEALLLIGRED 239 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----------------cchHHHHHHHhccC
Confidence 34567899999999999863 3345999999999999999999998742 00111111111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.. ..++...+....+++..|++.+|+.|||+.++++..-
T Consensus 240 ~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 SL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11 1334445677889999999999999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.93 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=204.5
Q ss_pred ccccccccceeEEEEE-eCCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEEcC
Q 044374 459 SEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDYMR 532 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~~ 532 (804)
.++||+|.||.||+|+ ...++.||+|++.... .......+||.+|++|+||||++|.+...+. ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4689999999999994 5678999999997543 2345678999999999999999999998776 68999999998
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+ +|.-++...+..+++.++..++.|++.||.|+|..+ |+|||||.+|||||.+|.+||+|||||+++........+
T Consensus 202 h-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 202 H-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred c-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 8 788888887888999999999999999999999988 999999999999999999999999999988777666678
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCCCCCccCchHHHHHHhhc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
..+-|..|.|||++.+. .|+.++|+||.||||.||++|+..|.+...-+... +++... .+ .|...++.
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~-e~-----~W~~~kLP- 350 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT-ED-----YWPVSKLP- 350 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC-hh-----ccccccCC-
Confidence 88899999999998875 69999999999999999999999887654322111 111100 00 11110100
Q ss_pred Cccceecccc------ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDR------LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+.+. +.+. -.......+.|+..+|..||.+|.|+.++++.
T Consensus 351 --~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 --HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred --cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00111111 1111 11223456778889999999999999988753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.76 Aligned_cols=243 Identities=25% Similarity=0.372 Sum_probs=207.0
Q ss_pred cccccccceeEEEE-EeCCCcEEEEEEecCCCCCHH-HHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGER-EFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~-~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
++||+|+.|.||.| +...++.||||++....+..+ -+.+|+.+|+..+|+|||++++.+...+++++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 58999999999999 455788899999987766554 5789999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
+.+... .+++.++..|+.++++||+|||..+ |+|||||.+|||++.++.+||+|||++..+..... ...+.+||
T Consensus 359 DvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGT 432 (550)
T KOG0578|consen 359 DVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGT 432 (550)
T ss_pred hhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCC
Confidence 999875 5999999999999999999999988 99999999999999999999999999987765543 35678899
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
+.|||||++....|.+|.||||||++++||+-|++||-...+-+ +...+..... +.
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------------------AlyLIa~ng~-----P~ 488 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------------------ALYLIATNGT-----PK 488 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------------------HHHHHhhcCC-----CC
Confidence 99999999999999999999999999999999999997543321 1111111111 11
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+ ..+......+.+++.+||+.|+++||++.|++++
T Consensus 489 l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 L--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred c--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2 1233456779999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.82 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=200.3
Q ss_pred cccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecC-CeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSEN-SHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~~~ 525 (804)
..+.++||+|+||.||+|.. ..++.||||+++.... ....+.+|+.++.++ +||||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 34678999999999999964 2346799999975322 345688999999999 899999999988764 4678
Q ss_pred EEEEEcCCCChhHHHhhCC-------------------------------------------------------------
Q 044374 526 LVYDYMRNGALSLYLRKDG------------------------------------------------------------- 544 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 544 (804)
+||||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999987532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-ccccccccccccccc
Q 044374 545 LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAP 623 (804)
Q Consensus 545 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aP 623 (804)
..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 23677888999999999999999987 99999999999999999999999999986533211 112234567889999
Q ss_pred hhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCC
Q 044374 624 EWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY 702 (804)
Q Consensus 624 E~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 702 (804)
|++.+..++.++|||||||+||||++ |+.||...... ......+..+... ..
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------------------~~~~~~~~~~~~~---------~~ 298 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------------------EEFCQRLKDGTRM---------RA 298 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------------------HHHHHHHhcCCCC---------CC
Confidence 99999999999999999999999997 99998643211 1111222222111 11
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 703 KVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 703 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+......+.+++.+||+.||++||++.+|+++|+.++.
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22334568899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.41 Aligned_cols=243 Identities=27% Similarity=0.352 Sum_probs=200.6
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||.++. +.++.+|+|++++.. .+.+..++|..+|.+++||.||++.-.+.+.+.+|||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 3568999999999999955 467899999997642 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
.||.|.-+|++++ .+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.. ....
T Consensus 108 ~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t 182 (357)
T KOG0598|consen 108 NGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDAT 182 (357)
T ss_pred CCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CCcc
Confidence 9999999999876 7888888889999999999999998 999999999999999999999999999864332 2234
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
.+.+||+.|||||++.+..|+..+|-||+|+++|||++|.+||...... ...+.+..+.+
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------------------~~~~~I~~~k~- 242 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------------------KMYDKILKGKL- 242 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------------------HHHHHHhcCcC-
Confidence 5689999999999999999999999999999999999999999865322 11222222221
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCC----CHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP----TMGTVV 732 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~eVl 732 (804)
...+.-.......++...++.||++|- .+.+|-
T Consensus 243 --------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 243 --------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred --------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 111222345677888899999999994 455544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.10 Aligned_cols=266 Identities=19% Similarity=0.247 Sum_probs=201.7
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.++|+|+||.|||.+.+ .|+.||||++..++.. .+-..+||++|++++|+|+|.|+.+|......+||+||++..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 47999999999999876 5899999999765442 3557899999999999999999999999999999999999977
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|+++-+. ...++.+....++.|+++|+.|+|+.+ +|||||||+||||+.++.+||||||.|+.+... ....+..+
T Consensus 88 L~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTDYV 162 (396)
T KOG0593|consen 88 LHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTDYV 162 (396)
T ss_pred HHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhhhh
Confidence 7665443 447889999999999999999999988 999999999999999999999999999987643 33456678
Q ss_pred cccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc-cee
Q 044374 616 GTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV-AAV 693 (804)
Q Consensus 616 gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 693 (804)
.|..|.|||.+.+ .+|...+||||+||++.||++|...|.+.++-.....+. ..-..+.+-...-+..... ..+
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~----ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR----KTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH----HHHcccCHHHHHHhccCCceeee
Confidence 8999999999888 689999999999999999999998887644321110000 0000111111111111111 111
Q ss_pred ccccccC-----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGG-----AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.-+.... ..-+.....++.++..|++.||.+|++-++++..
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111110 0111234468899999999999999999998843
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.00 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=203.6
Q ss_pred cccccccccccceeEEEEE-eCCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+++.++||.|.-++||+|. .+.++.||||++... ....+.+++|+..|..++||||++++..|..++.+++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 4467899999999999995 456799999999743 3345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--
Q 044374 533 NGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-- 609 (804)
Q Consensus 533 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 609 (804)
+||+.++++.. ...+++..+..|+.++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+-....+
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 99999999764 346899999999999999999999988 999999999999999999999999988655332211
Q ss_pred -cccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 -VLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 -~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
...+.+||+.|||||+++. ..|+.|+||||||++..||.+|..||....+-+.. ..+ .
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------------------l~t-L 245 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------------------LLT-L 245 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------------------HHH-h
Confidence 1256789999999999654 36899999999999999999999999865432111 011 1
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+......-..+..+....-...+.+++..|+++||.+|||++++++.
T Consensus 246 qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111111111111223478889999999999999999999864
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.97 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=204.4
Q ss_pred hhcccccccccccceeEEEEEeC----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
....+.+.||+|+||.||+|.+. .+..||+|.++.... ....|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34457789999999999999753 356899999976432 235788999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876667899999999999999999999988 9999999999999999999999999876543221
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
........++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------------------~~~~~~~ 222 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------------------DVIKAVE 222 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------------HHHHHHH
Confidence 111122345678999999999999999999999999999875 99998643211 0111122
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
++.. ...+...+..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 223 ~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 DGFR---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 2111 112233456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.91 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=222.7
Q ss_pred HHHHHhhcccccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 449 KELHTVTRGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 449 ~el~~~t~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
.|+++....+..+||-|-||.||.|.|+. .-.||||.++......++|..|..+|+.++|||+|+|+|+|......|||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 34555455566899999999999999875 46799999999888899999999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 528 YDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
+|||.+|+|.+||+... ..++.-..+.++.||+.||.||..++ +|||||.++|+||.++..+||+||||++++..+
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999998754 45677788999999999999999988 999999999999999999999999999998877
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
..........++.|.|||-+....++.|+|||+|||+||||.| |..|+..-+. .
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------------------S------ 473 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------------S------ 473 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------------------H------
Confidence 6555555567889999999999999999999999999999998 7777764211 1
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
++.++++...+-+-+..+++.+.+|++.||+.+|.+||++.||-+.+|.+.
T Consensus 474 ---qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 474 ---QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 223333333433445667889999999999999999999999999887654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.40 Aligned_cols=258 Identities=17% Similarity=0.279 Sum_probs=204.9
Q ss_pred ccccChHHHHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 443 LKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 443 ~~~~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
.+.++..++.... ...||+|+++.||+|.+ +++.||||+++..... .+.|.+|+.++.+++||||++++|++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 3445555553221 14699999999999998 6788999999765333 35678999999999999999999998
Q ss_pred ec----CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceE
Q 044374 519 SE----NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAK 593 (804)
Q Consensus 519 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~k 593 (804)
.+ ....++||||+++|+|.+++.... .+++...++++.+++.||+|||+. + ++||||||+|||+++++.+|
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEE
Confidence 76 357799999999999999998754 688999999999999999999984 5 78999999999999999999
Q ss_pred EeecCCccccCCCccccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCC
Q 044374 594 VSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 594 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 671 (804)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 164 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------- 228 (283)
T PHA02988 164 IICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------- 228 (283)
T ss_pred EcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----------
Confidence 9999999865432 123457899999999976 67899999999999999999999999743211
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....+..+.. ....+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 229 -------~-~~~~i~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 229 -------E-IYDLIINKNN--------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -------H-HHHHHHhcCC--------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1111111110 11122234567899999999999999999999999998643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.16 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=205.3
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||++.+.++..+|+|.++.......++.+|+.++++++||||+++++++......++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 34567899999999999998888889999988666667889999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..+..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++..............
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 99999865557899999999999999999999988 999999999999999999999999999865433222222334
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
++..|+|||++.+..++.++||||||+++|||++ |+.||...... -....+..+...
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------------------~~~~~i~~~~~~--- 220 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------------------EVVEMISRGFRL--- 220 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------------------HHHHHHHCCCCC---
Confidence 5678999999998889999999999999999999 88888643211 111122222110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
..+......+..++.+||+.+|.+||++.+++++|.
T Consensus 221 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 ------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=336.05 Aligned_cols=247 Identities=32% Similarity=0.513 Sum_probs=196.2
Q ss_pred cccccccccceeEEEEEeC-----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.||.|.||.||+|.+. .+..|+||.++.... ..++|.+|+..+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999876 357899999965433 357899999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cc
Q 044374 531 MRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FS 608 (804)
Q Consensus 531 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~ 608 (804)
+++|+|.++|... ...+++..++.|+.||++||+|||+.+ |+|+||+++|||++.++.+||+|||++...... ..
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 568999999999999999999999987 999999999999999999999999999876322 22
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... ......+.+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------------------~~~~~~~~~ 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------------------EEIIEKLKQ 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------------------HHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-------------------ccccccccc
Confidence 22334557789999999999999999999999999999999 6788754211 111222222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
+... ..+......+..++..||+.+|++||+|.+|++.|
T Consensus 221 ~~~~---------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQRL---------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEET---------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc---------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2221 12223456788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.97 Aligned_cols=270 Identities=22% Similarity=0.301 Sum_probs=206.3
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHH--HHHHHHHHcCCC-CCCceeeeeEEecCC-eEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGERE--FRAEVCTIGNIQ-HVNLVRLRGFCSENS-HRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV~E~~ 531 (804)
...++||.|.||.||+|+. ..+..||||++++.-...++ -.+|+..|+++. |||||+|.+++.+.+ .+++|||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence 3457999999999999965 46888999999876544444 467999999998 999999999998888 999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+. +|.++++.++..+++..+..|+.||++||+|+|.+| ++|||+||+|||+..+..+||+|||+||..... ...
T Consensus 93 d~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--pPY 166 (538)
T KOG0661|consen 93 DC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK--PPY 166 (538)
T ss_pred hh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC--CCc
Confidence 76 899999988889999999999999999999999988 999999999999999999999999999976543 235
Q ss_pred cccccccccccchhc-cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCC-cCCCCCCCCCccCchH-H-HHHHhhc
Q 044374 612 ATMRGTWGYVAPEWI-SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNA-NIGGGGEHGDKWFFPP-W-AARQIIE 687 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l-~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~-~-~~~~~~~ 687 (804)
+..+.|..|.|||++ +...|+.+.|+|++|||++|+.+-+..|.+...-+.. .++..........++. . ....+ .
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m-n 245 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM-N 245 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh-c
Confidence 667889999999976 5567999999999999999999999888765432111 0110000011111110 0 00000 0
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
=.+....-..+..-.+ ....++++++..|++.||.+|||+.+.+++
T Consensus 246 f~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111111112 256788999999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=382.14 Aligned_cols=268 Identities=26% Similarity=0.468 Sum_probs=212.4
Q ss_pred cChHHHHHhhcccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE
Q 044374 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 446 ~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 524 (804)
++++++.... ...+.||+|+||.||+|+. .++..||||+++..... ...|++.+++++|||||+++|+|.+....
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 4445544332 2345899999999999976 57889999999754322 23468889999999999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||+++|+|.++++ .++|..+.+|+.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||......
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999996 38899999999999999999997655669999999999999999998886 66654332
Q ss_pred CCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||+.... .......|+...
T Consensus 834 ~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-------------~~~~~~~~~~~~ 895 (968)
T PLN00113 834 TD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-------------VHGSIVEWARYC 895 (968)
T ss_pred cC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-------------CCCcHHHHHHHh
Confidence 21 223578999999999999999999999999999999999999854221 122344555444
Q ss_pred hhcCccceeccccccC--CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 685 IIEGNVAAVVDDRLGG--AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.........+|+.+.. ..+.++..++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4444455556666543 2345667788999999999999999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.14 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=204.0
Q ss_pred ccccccccceeEEEEE-eCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 459 SEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.++||+|.||.||+|+ ...++.||||+++..... .....+||+.|+.++|+||+.|++++...+..-||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 4689999999999995 457899999999754332 45678999999999999999999999999999999999976
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|...++.+...++...+..++.++++||+|||.+. |+||||||.|+|++++|.+||+|||+++.++..... ....
T Consensus 86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-~~~~ 161 (318)
T KOG0659|consen 86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-QTHQ 161 (318)
T ss_pred cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc-cccc
Confidence 899999998889999999999999999999999988 999999999999999999999999999998765433 2334
Q ss_pred ccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC---CCCC----ccCchHHHHHHhh
Q 044374 615 RGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG---EHGD----KWFFPPWAARQII 686 (804)
Q Consensus 615 ~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~~ 686 (804)
+-|..|.|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+..+-+....+... ...+ -..++.+..-+
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-- 239 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-- 239 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh--
Confidence 78999999998877 47999999999999999999988766654332211111000 0001 11122222111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+.+..-+ ........+++..++..||.+|.+++|.+++
T Consensus 240 -----~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 -----QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred -----cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111111 2234456899999999999999999998876
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=329.80 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=208.1
Q ss_pred HhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.....+.+.||+|+||.||+|...+++.||||.++......+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34456778999999999999988777889999998766667889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999997643 46899999999999999999999988 99999999999999999999999999987653322111
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+..|+|||++.+..++.++||||||++++||++ |+.||...... .....+..+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------------~~~~~~~~~~- 221 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------------------EVLQQVDQGY- 221 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHcCC-
Confidence 22223468999999999899999999999999999999 98888642111 1111111110
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
....+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 222 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 --------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.39 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=206.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++++...+..+++|||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 34668999999999999998888889999987655566789999999999999999999999999999999999999999
Q ss_pred hhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 99999754 356889999999999999999999987 99999999999999999999999999987644322222334
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.++..|+|||++....++.++||||||+++|||++ |+.||...... .....+..+...
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------------------~~~~~~~~~~~~-- 223 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------------------DVMSALQRGYRM-- 223 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------------------HHHHHHHcCCCC--
Confidence 46778999999998889999999999999999998 99888642111 111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
......+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 224 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=327.75 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=205.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.+.||+|+||.||+|+..++..+|||.++.......++.+|+.++.+++||||+++++++......++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 34678999999999999988777789999998665567789999999999999999999999999889999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..............
T Consensus 86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 99999876557899999999999999999999987 999999999999999999999999999865433222222234
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
++..|+|||++.+..++.++||||||+++|||++ |+.||...... -.......+...
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~~~~--- 220 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------------------ETVEKVSQGLRL--- 220 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------------HHHHHHhcCCCC---
Confidence 5678999999998889999999999999999998 98888642110 011112211111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=347.50 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=199.5
Q ss_pred cccccccccccceeEEEEEe------CCCcEEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
..+.++||+|+||.||+|+. ..+..||||+++... ...+.+.+|+.++..+ +||||++++++|......++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34678999999999999963 235689999997543 2345688999999999 89999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC--------------------------------------------------------------
Q 044374 527 VYDYMRNGALSLYLRKDG-------------------------------------------------------------- 544 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 544 (804)
||||+++|+|.++++...
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999886432
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-cc
Q 044374 545 ------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-VL 611 (804)
Q Consensus 545 ------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 611 (804)
..+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 14678889999999999999999987 999999999999999999999999999865433211 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.+..+..
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------------------~~~~~~~~~~~~ 335 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------------------SKFYKMIKEGYR 335 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------------------HHHHHHHHhCcc
Confidence 22345678999999999999999999999999999998 88887642111 111122222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
. ..+.....++.+++.+|++.||++||+|.+|+++|+.
T Consensus 336 ~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 M---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0 1111224568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.04 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=217.7
Q ss_pred hhcccccccccccceeEEEEEeCC---C--cEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSD---S--TLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
......++||.|-||.||+|.+.+ + -.||||..+.. ....+.|.+|..+|++++||||++|+|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 333456789999999999997632 2 35899999864 3456789999999999999999999999986 46899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|||.++-|.|.+||+.+...++......++.||+.||+|||+.. +|||||..+|||+.....+||+|||+++.+..+
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999998888999999999999999999999988 999999999999999999999999999998777
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.....+...-+..|||||.+.-+.++.+||||.|||.+||++. |..||..-..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-------------------------- 598 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-------------------------- 598 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--------------------------
Confidence 5555556667889999999999999999999999999999986 9999975322
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.++...++..-+-..+..++..+..++.+||..+|.+||.+.+|...|++++.
T Consensus 599 --sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 599 --SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 12223333333445677889999999999999999999999999999887665
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.46 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=204.1
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.+.+.||+|+||.||++....+..+|+|.+........++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 46688999999999999887777899999976655667899999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..............+
T Consensus 87 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05059 87 LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163 (256)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCC
Confidence 9999876557899999999999999999999988 9999999999999999999999999998654332221222234
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
+..|+|||.+.+..++.++||||||+++|||++ |+.||...... -.......+.
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~~------ 218 (256)
T cd05059 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------------------EVVESVSAGY------ 218 (256)
T ss_pred CccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------------------HHHHHHHcCC------
Confidence 568999999999999999999999999999999 78888643211 0111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
....+...+..+.+++.+|++.+|++||++.+|+++|
T Consensus 219 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 ---RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111223456789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.04 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=205.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.++||+|+||.||+|... .++.||+|+++.......++.+|+.++.+++||||+++++++......++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 346678999999999999765 4788999999876656678999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++.............
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9999997643 46899999999999999999999987 9999999999999999999999999998754432222222
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||++.+..++.++||||||+++|||++ |..||...... -....+..+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------------------~~~~~~~~~---- 221 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKG---- 221 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------------------HHHHHHHCC----
Confidence 334678999999999999999999999999999998 88887642110 011111111
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
.....+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 222 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112223356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.66 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=203.2
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCC----C--CCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----G--SGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.+.||+|.||.|+.|.. ..++.||||.+... . ...+.+.+|+.++++++ ||||++++.++......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 44667999999999999955 46799999977543 1 23456778999999999 99999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCC
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~ 606 (804)
|||+.+|.|.+++.. ...+.+.....++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++.... .
T Consensus 99 mEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~ 173 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G 173 (370)
T ss_pred EEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence 999999999999998 558888999999999999999999988 9999999999999999 999999999999763 2
Q ss_pred ccccccccccccccccchhccCCC-CC-ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLA-IT-TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~-~~-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .-..+.
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------------------~~l~~k 234 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------------------PNLYRK 234 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------------------HHHHHH
Confidence 233467789999999999999977 75 789999999999999999999985221 111222
Q ss_pred hhcCccceeccccccCCCCHHH-HHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEE-AERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
+..+.. .++... ...+..++.+|++.||.+|+++.+|+
T Consensus 235 i~~~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 IRKGEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HhcCCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 222211 112222 67789999999999999999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.42 Aligned_cols=243 Identities=26% Similarity=0.375 Sum_probs=206.4
Q ss_pred ccccccccceeEEEEEe-CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 459 SEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.||+|.||.||+|.. ..++.||+|++... ....+++++|+.++.+++++||.+++|.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 37899999999999955 46789999999753 4456789999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
+.+.|.... .+++..+.-|+.++..||.|||.++ .+|||||+.||||.++|.+||+|||.+..+.....+. .+.+
T Consensus 98 v~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 98 VLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred hhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 999998754 4588888889999999999999988 9999999999999999999999999998877665544 7889
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
||+.|||||++....|+.|+||||||++.+||++|.+|+....+-+-..+ +.+-.-
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------------------Ipk~~P 228 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------------------IPKSAP 228 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------------------ccCCCC
Confidence 99999999999988999999999999999999999999976544221111 011111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+.+ ...+.+.+++..||.+||++||++.++++.
T Consensus 229 P~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222 445679999999999999999999999865
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.96 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=197.2
Q ss_pred ccccccccccceeEEEEEeCC-----------------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-----------------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGF 517 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~ 517 (804)
.+.++||+|+||.||++.+.+ +..||||.+..... ...+|.+|+.++.+++||||++++++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 456789999999999997532 23699999975432 34578999999999999999999999
Q ss_pred EecCCeEEEEEEEcCCCChhHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 044374 518 CSENSHRLLVYDYMRNGALSLYLRKDG------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI 579 (804)
Q Consensus 518 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 579 (804)
+...+..++||||+++++|.+++.... ..+++..+++++.||+.||+|||+.+ |+||||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dl 164 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCc
Confidence 999999999999999999999986432 24678889999999999999999988 999999
Q ss_pred CCCcEEecCCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhC--CCCCCC
Q 044374 580 KPENILLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG--RRNVEA 656 (804)
Q Consensus 580 kp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg--~~p~~~ 656 (804)
||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||+++ ..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 9999999999999999999997653321 1222334567899999999888999999999999999999974 455543
Q ss_pred CcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 657 PASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.... ............... .. ....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 245 ~~~~---------------~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 245 LTDE---------------QVIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCHH---------------HHHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 2111 001111111111100 00 00112234567899999999999999999999999986
Q ss_pred c
Q 044374 737 G 737 (804)
Q Consensus 737 ~ 737 (804)
+
T Consensus 304 ~ 304 (304)
T cd05096 304 E 304 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.88 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=204.2
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.|.+.||.|+|++|++|+- ..++.+|||++.+. ....+-...|-..|.+| .||.|++|+-.|.+...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 4789999999999999954 46889999999653 23344567788888888 899999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR- 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 609 (804)
+++|+|.++|++.+ .+++.....++.+|+.||+|||+.+ ||||||||+|||||.|+++||+|||.|+.+......
T Consensus 156 A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 156 APNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred cCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 99999999999876 7899999999999999999999988 999999999999999999999999999987533211
Q ss_pred ---------c--ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 610 ---------V--LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 610 ---------~--~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
. ....+||-.|.+||+|.....+..+|+|+||||||.|+.|++||....+-
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------------ 293 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------------ 293 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------------------
Confidence 1 14578999999999999999999999999999999999999999853211
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...++ +++ +.-+++..-++.+.+|+.+.|..||.+|++..+|-++
T Consensus 294 -liFqk--------I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 -LIFQK--------IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHH--------HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 01111 111 1223344444677888889999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.97 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=199.7
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC----CeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN----SHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~lV~E~~~ 532 (804)
.+.+.||+|.||.||+|+|. |+.||||++...++..+.-+.||.....|+|+||+.+++.=..+ .+++||++|.+
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 35678999999999999995 55699999987766666666777777888999999998765433 37899999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-----ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+|||.+||... .++.+..++++..+|.||+|||. ++++.|.|||||++||||..++.+.|+|+|||.....+.
T Consensus 293 ~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t 370 (513)
T KOG2052|consen 293 HGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT 370 (513)
T ss_pred CCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccC
Confidence 99999999875 78999999999999999999997 468889999999999999999999999999998765442
Q ss_pred ---cccccccccccccccchhccCCC------CCccceEEeehhhHHHhhhC----------CCCCCCCcCCCCCcCCCC
Q 044374 608 ---SRVLATMRGTWGYVAPEWISGLA------ITTKADVYSYGMTLLELIGG----------RRNVEAPASGRNANIGGG 668 (804)
Q Consensus 608 ---~~~~~~~~gt~~y~aPE~l~~~~------~~~ksDV~S~Gvvl~elltg----------~~p~~~~~~~~~~~~~~~ 668 (804)
.-.....+||.+|||||++.... --..+||||||+|+||+.-. +.||....+
T Consensus 371 ~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp--------- 441 (513)
T KOG2052|consen 371 DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP--------- 441 (513)
T ss_pred CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC---------
Confidence 22345678999999999996632 22468999999999999863 233332111
Q ss_pred CCCCCccCchHHHHHHhhcCccceeccccccCCC-CHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 669 GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY-KVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+..+ ..+.+-.-.+-+.+.+...+ +.+....+.+++..||..||..|-|+-.|-+.|.++.+
T Consensus 442 ----~DPs~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 ----SDPSF-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ----CCCCH-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11111 11111111111112111111 23567789999999999999999999999999887653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.27 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=199.5
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
..+.+.||+|+||.||++... +...||||+++.... ....+.+|+.+++++ +|+||++++++|......++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 446789999999999998642 235799999975432 235688999999999 89999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC--------------------------------------------------------------
Q 044374 527 VYDYMRNGALSLYLRKDG-------------------------------------------------------------- 544 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 544 (804)
||||+++|+|.++++...
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999886421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-cccccccc
Q 044374 545 -------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRG 616 (804)
Q Consensus 545 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~g 616 (804)
..+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 13677889999999999999999987 99999999999999999999999999976533221 11222345
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
+..|||||++.+..++.++|||||||++|||++ |+.||...... .-.......+
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------------------~~~~~~~~~~------- 331 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------------------SKFYKMVKRG------- 331 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------------------HHHHHHHHcc-------
Confidence 678999999999999999999999999999997 99998643211 0011111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.....+...+..+.+++..||+.+|++||++.+|+++|+++.
T Consensus 332 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 --YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011111122467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.64 Aligned_cols=242 Identities=28% Similarity=0.427 Sum_probs=205.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCCCH---HHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.||+|.||.||||+.+ +.+.||+|.+.+....+ +.+++|+++++.++|||||.+++.|+...+.++|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 4578999999999999665 56889999997665444 5578999999999999999999999999999999999988
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|..+|...+ .++++.+..|+.++..||.|||+.+ |+|||+||+|||++.++.+|++|||+|+.++.. ....+.
T Consensus 86 -~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vlts 159 (808)
T KOG0597|consen 86 -DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTS 159 (808)
T ss_pred -hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-ceeeee
Confidence 9999998765 7999999999999999999999988 999999999999999999999999999987653 345667
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+-|||||++.+.+|+..+|.||+|||+||+++|++||.... +.... +.+
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------i~~Lv-~~I-------- 212 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ITQLV-KSI-------- 212 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------HHHHH-HHH--------
Confidence 889999999999999999999999999999999999999997421 11111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+. ..++......+..++...+++||..|-+-.+++.+
T Consensus 213 ~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 213 LKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1111 12233556778899999999999999999998754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=326.13 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=202.7
Q ss_pred ccccccccccceeEEEEEeCC------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
.+.+.||+|+||.||+|.... ...||+|.++.... ...+|.+|+.++.+++||||+++++++......+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 466899999999999997643 25799999975432 2356899999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceE
Q 044374 529 DYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAK 593 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 593 (804)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEE
Confidence 9999999999997532 35788899999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCC
Q 044374 594 VSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 594 l~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 671 (804)
|+|||+++..... .........+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----------- 233 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----------- 233 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 9999999764322 1222334456789999999998899999999999999999998 99998643211
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
-....+..+... ..+...+.++.+++.+||+.+|.+||++.+|+++|+.
T Consensus 234 --------~~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 --------EVIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111222222111 1233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=323.55 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=203.9
Q ss_pred cccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|.+.. ...||||.++.... ...+|.+|+.++.+++||||+++++++......++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 3467899999999999997742 45799999875433 34578899999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|+++++|.+++......+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999876667899999999999999999999987 99999999999999999999999999987642211
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......++..|+|||.+.+..++.++||||||++++||++ |..||...... .....+..
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------------------~~~~~~~~ 223 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------------------DVIKAVED 223 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------------------HHHHHHHc
Confidence 11122345678999999999999999999999999999998 98888532110 11112211
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+.. ...+...+..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 224 ~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYR---------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 011223456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=326.03 Aligned_cols=248 Identities=25% Similarity=0.305 Sum_probs=198.1
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
...+.||+|+||.||++.. .+++.||||.+.... .....+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3457899999999999976 468899999986432 22345788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|+|..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 9999998886543 46899999999999999999999988 9999999999999999999999999998653321 1
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ............
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~-- 220 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---------------KREEVDRRVKED-- 220 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---------------hHHHHHHHhhcc--
Confidence 234568999999999999999999999999999999999999997532210 000011111100
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
...++......+.+|+..||+.||++||+ ++++++.
T Consensus 221 --------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 --------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01122233457889999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=332.73 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=200.5
Q ss_pred cccccccccccceeEEEEEeC-CCc----EEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
....+.||+|+||.||+|.+. +++ .||||+++... ...+++.+|+.+++.++||||++++|+|... ..++|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 345678999999999999764 333 48999997532 2346789999999999999999999999865 577999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|.+++......+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999887667899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cc-ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 RV-LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 ~~-~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.. ......+..|+|||++.+..++.++||||||+++|||++ |+.||...... . ......
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------------------~-~~~~~~ 225 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------E-ISSILE 225 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------------------H-HHHHHh
Confidence 11 122334678999999999999999999999999999998 99988642110 0 111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+.. ...+......+..++..||+.+|.+||++.+|+..|..+..
T Consensus 226 ~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 KGER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1110 01112234568899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.26 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=207.1
Q ss_pred HHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 452 HTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 452 ~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
......+.++||+|+||.||+|...+++.||+|.+.........+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 34556678899999999999999888899999999877667788999999999999999999999874 45689999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++++|.+++... +..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998754 346899999999999999999999887 9999999999999999999999999997654322222
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....++..|+|||++....++.++||||||++++||++ |+.||...... -....+..+.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~~~ 220 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------------------EVIQNLERGY 220 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------------------HHHHHHHcCC
Confidence 223345778999999998889999999999999999999 99998643211 0111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
....+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 ---------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.04 Aligned_cols=251 Identities=29% Similarity=0.394 Sum_probs=204.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||+|+..+...||+|+++......+++++|+.++.+++||||+++++++.+ ...++||||+++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~ 86 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 86 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCc
Confidence 45778999999999999988777789999998765666789999999999999999999998754 56799999999999
Q ss_pred hhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++... ...+++..+..++.++++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.............
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 99999764 345789999999999999999999987 99999999999999999999999999986543322222234
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------------------~~~~~~~~~~---- 220 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------------------EVLDQVERGY---- 220 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------------------HHHHHHhcCC----
Confidence 46778999999988899999999999999999999 78787642211 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
....+.+....+.+++.+|++.+|++||++.++++.|++.
T Consensus 221 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.75 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=203.6
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||++...++..+|+|.++......+.+.+|+.++++++|+|++++++++. ....+++|||+++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 3466899999999999998888888999999876666778999999999999999999999885 456899999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||++..............
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 999997643 45899999999999999999999988 99999999999999999999999999986543322222233
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.++..|+|||++.+..++.++||||||++++||++ |+.||...... .....+..+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~----- 219 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------------------EVLEQVERG----- 219 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHcC-----
Confidence 45678999999988889999999999999999999 88888642110 011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.....+......+.+++.+|++.+|++||++.++++.|++
T Consensus 220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.38 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=196.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||+++.. +++.||||+++.. ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 6889999999743 123356788999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 9999987654 6899999999999999999999988 999999999999999999999999998753221 1223345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------------------~~~~~~~~~~~---- 212 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------KLFELILMEEI---- 212 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------------------HHHHHHHcCCC----
Confidence 7999999999999999999999999999999999999999642110 01111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
.++......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11223346688999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.27 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=206.5
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.++||+|+||.||+|...++..+|+|.+..... ...++..|+.+++.++|+||+++++++......++||||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 345689999999999999988889999999976544 4667899999999999999999999999999999999999999
Q ss_pred ChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++... +..+++..+..++.+++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......... ...
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 999999764 346899999999999999999999988 999999999999999999999999999866433221 223
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~---- 220 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------------------EVYDQITAG---- 220 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------------------HHHHHHHhC----
Confidence 446778999999998899999999999999999998 88888643211 011111111
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 -----YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111223445678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.10 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=197.5
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999764 68889999886432 2346789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc-ccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV-LATMR 615 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~ 615 (804)
.+++......+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999876667899999999999999999999887 9999999999999999999999999987543221111 11122
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------------------~~~~~~~~~------ 212 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------------------QTREAIEQG------ 212 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------------------HHHHHHHcC------
Confidence 3567999999999899999999999999999998 88887532110 011111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.....+...+..+.+++.+|++.+|++||++.+|.++|+
T Consensus 213 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 ---VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111112233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.22 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=200.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|+.. .++.||||+++.. ......+.+|+.++.+++||||+++++++......++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 35679999999999999876 5789999999643 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..... ..
T Consensus 84 ~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 84 PGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 9999999997654 6889999999999999999999988 99999999999999999999999999986533 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+... .
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------------------~~~~i~~~--~ 214 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------------------TWENLKYW--K 214 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------------------HHHHHHhc--c
Confidence 44578999999999999999999999999999999999999997532210 01111110 0
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+...............+.+++..|++.+|.+||++.+|+++
T Consensus 215 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0010000000011235668889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.90 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=203.2
Q ss_pred hcccccccccccceeEEEEEeCC------CcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
...+.+.||+|+||.||+|...+ ++.||||.++..... .+.+.+|+.++.+++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 34567899999999999997633 478999999765433 4689999999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceE
Q 044374 527 VYDYMRNGALSLYLRKDG-------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAK 593 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 593 (804)
||||+++++|.+++...+ ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEE
Confidence 999999999999997542 34788899999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCC
Q 044374 594 VSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 594 l~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 671 (804)
|+|||+++..... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----------- 231 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----------- 231 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------
Confidence 9999999754322 1122233446788999999999999999999999999999998 99998643211
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
-....+..+... ..+......+.+++..||+.||++||++.||+++|++
T Consensus 232 --------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 --------EVIECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --------HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 011112222111 1122334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=332.22 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+-|.|-.|++ ..|+.+|||++... ......+.+||.+|+.+.|||++++++++....++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 4567899999999999976 47899999999654 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|-|.+++-.++ .+.+.+..+++.||+.|+.|.|..+ |+||||||+|+|||.++++||+|||||.+... ....
T Consensus 95 ~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gklL 168 (786)
T KOG0588|consen 95 PGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKLL 168 (786)
T ss_pred CCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--Cccc
Confidence 9999999998876 7889999999999999999999988 99999999999999999999999999987433 3456
Q ss_pred cccccccccccchhccCCCCC-ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAIT-TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.+.+|.+.|.|||++++.+|. .++||||.||||+.||||+.||+... + .-...++..|..
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------------i-r~LLlKV~~G~f 229 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------------I-RVLLLKVQRGVF 229 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------------H-HHHHHHHHcCcc
Confidence 788999999999999999874 78999999999999999999998311 0 111222233321
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+.....++.+|+.+|+..||++|.++.||+++
T Consensus 230 ----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1233455678899999999999999999999987
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.22 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=200.5
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
+.||+|+||.||+|...++..+|+|.++.... ....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988889999999875432 2346889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
+++......+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999776667899999999999999999999887 99999999999999999999999999975433222222223446
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
..|+|||++.+..++.++||||||+++||+++ |..||..... .........+...
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------------------~~~~~~~~~~~~~----- 213 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-------------------QQAREQVEKGYRM----- 213 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-------------------HHHHHHHHcCCCC-----
Confidence 78999999998899999999999999999998 8888864211 1111122211111
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
..+......+.+++.+|++.+|++||++.+++++|.
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 ----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.22 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=193.8
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||.||++... +++.||+|+++.. ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 5788999999642 23345678899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 99997654 6899999999999999999999988 9999999999999999999999999998543221 12334578
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
|+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+..+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------------------~~-~~~~~~~~~------- 209 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------------------NE-MYRKILQEP------- 209 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------------------HH-HHHHHHcCC-------
Confidence 9999999999999999999999999999999999999964211 01 111111111
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
...+......+.+++..||+.||++||++..+.+.|
T Consensus 210 ---~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 210 ---LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 011223345688999999999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.87 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=200.4
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 526 (804)
..+.++||+|+||.||+|+.. ....||||+++.... ..+.+.+|+.+++++. ||||++++++|......+|
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 345689999999999999753 134699999975432 3456899999999996 9999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC--------------------------------------------------------------
Q 044374 527 VYDYMRNGALSLYLRKDG-------------------------------------------------------------- 544 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 544 (804)
||||+++|+|.++|....
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 999999999999886421
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc
Q 044374 545 ---------------------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 545 ---------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCE
Confidence 23677888999999999999999987 999999999999999999
Q ss_pred eEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCC
Q 044374 592 AKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGG 669 (804)
Q Consensus 592 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 669 (804)
+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--------- 346 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--------- 346 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---------
Confidence 99999999986533211 11223446788999999999899999999999999999997 88888643111
Q ss_pred CCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 670 EHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
......+..+.. ...+......+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 347 ---------~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 ---------STFYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---------HHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 001111121110 1112234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.17 Aligned_cols=241 Identities=25% Similarity=0.319 Sum_probs=198.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 45689999999999999775 5789999999643 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 101 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~ 172 (329)
T PTZ00263 101 VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----T 172 (329)
T ss_pred CCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----c
Confidence 9999999998654 6788889999999999999999988 999999999999999999999999999865432 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.++..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------------------~~~~~~i~~~~~- 232 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------------------FRIYEKILAGRL- 232 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------------------HHHHHHHhcCCc-
Confidence 245689999999999999999999999999999999999999964211 111122222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
..+......+.+++..||+.||.+||+ +.+++++
T Consensus 233 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111122356789999999999999996 6777644
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.10 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=197.0
Q ss_pred ccccccceeEEEEEeC---CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 461 KLGHGGFGAVFQGELS---DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.||+|+||.||+|.+. .+..||+|++..... ..+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 345699999975432 2456899999999999999999999886 457899999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--cccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--VLAT 613 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~ 613 (804)
|.+++......+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999876667899999999999999999999987 999999999999999999999999999865433211 1112
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||.+.+..++.++||||||+++||+++ |+.||...... -....+..+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~~~~-- 216 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------------------EVMSFIEQGKR-- 216 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------------------HHHHHHHCCCC--
Confidence 234578999999988889999999999999999996 99998643211 01112222211
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...+......+.+++..||+.+|++||++.+|++.|+.+
T Consensus 217 -------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 -------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112233456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.82 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=196.2
Q ss_pred ccccccceeEEEEEeC---CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 461 KLGHGGFGAVFQGELS---DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+||+|+||.||+|.+. ++..+|+|+++.... ..+++.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999653 567899999875432 2457899999999999999999999885 45678999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc--cc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--LA 612 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~ 612 (804)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 6899999999999999999999988 9999999999999999999999999998754332211 12
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... -....+..+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------------~~~~~i~~~~~- 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------------------EVTQMIESGER- 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHHCCCC-
Confidence 2234578999999988889999999999999999998 99998742111 01112222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
...+...+..+.+++.+|++.||++||++.+|+++|++
T Consensus 217 --------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 --------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11222345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.15 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=200.0
Q ss_pred cccccccccccceeEEEEEe-----CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||.||+|.. ..+..||+|.++.... ...++.+|+.++++++||||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 35678999999999999974 2457899999975432 2357889999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCce
Q 044374 529 DYMRNGALSLYLRKDG----------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTA 592 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 592 (804)
||+++++|.+++.... ..+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcE
Confidence 9999999999985321 24788889999999999999999987 9999999999999999999
Q ss_pred EEeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCC
Q 044374 593 KVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGE 670 (804)
Q Consensus 593 kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 670 (804)
||+|||+++..... .........++..|+|||++.+..++.++||||||++++||++ |..||.....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----------- 232 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----------- 232 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------
Confidence 99999999865322 1222233445778999999988889999999999999999998 8888864211
Q ss_pred CCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.........+... ..+......+.+++.+|++.+|++||++.+|.++|..
T Consensus 233 --------~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --------QEVIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111122221111 1122234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.43 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=204.9
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.+.||+|+||.||++...++..+|+|.+........+|.+|+.++++++|||++++++++......++||||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34668999999999999988777889999998766667889999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......++++.+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...............
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 99999876667899999999999999999999988 999999999999999999999999999765433222122233
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
++.+|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.++. ...
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~~~--~~~ 221 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------------------EVVETINAGF--RLY 221 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------------------HHHHHHhCCC--CCC
Confidence 5678999999998899999999999999999998 89888642211 0111111110 001
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
. +......+.+++.+|++.+|++||++.+|+++|.
T Consensus 222 ~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 K-------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred C-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 1112467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.52 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=202.7
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||++....+..+|+|.+.......+.+.+|+.++++++|+|++++++++.. ...++||||+++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGS 86 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCC
Confidence 45678999999999999988777789999987655566789999999999999999999998854 56889999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||++..............
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 999997643 45789999999999999999999887 99999999999999999999999999986543322222233
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.++..|+|||++.+..++.++||||||+++|||++ |+.||...... -....+..+..
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------------~~~~~~~~~~~--- 221 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------------------EVLEQVERGYR--- 221 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHHcCCC---
Confidence 46778999999998899999999999999999999 88888642211 01111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
...+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.18 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=197.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 35678999999999999765 67899999996432 23456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 84 PGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 9999999997654 6889999999999999999999988 999999999999999999999999999865432 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------------------~~~~~~i~~~~~- 215 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------------------FGIYEKILAGKL- 215 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhCCc-
Confidence 235689999999999999999999999999999999999999874321 111122222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
.++......+.+++.+||+.||.+||+ +.++++.
T Consensus 216 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112222456889999999999999995 7776654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.41 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=198.2
Q ss_pred cccccccccceeEEEEEeC-CCc----EEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DST----LVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.||+|+||.||+|.+. +++ .+++|.+..... ...++..|+..+++++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 4578999999999999764 333 478888754322 23567888889999999999999998864 557899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-c
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-R 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 609 (804)
+++|+|.+++......+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....... .
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 9999999999877668999999999999999999999987 99999999999999999999999999986543221 1
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------------------~~~~~~~~~ 227 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------------------EVPDLLEKG 227 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------------------HHHHHHHCC
Confidence 2234457789999999999899999999999999999998 99888643211 111112222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.... . +......+..++.+|+..+|++||++.|+++.|+.+.+
T Consensus 228 ~~~~--~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 ERLA--Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CcCC--C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 1 11123456788999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.11 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=208.0
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCe-EEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSH-RLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~ 532 (804)
..+++|+|+||.++..+.+ +...+++|.+.... ...+...+|+.++++++|||||.+.+.+.+++. .+|||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 4578999999999988654 56789999996543 334567899999999999999999999998888 999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
||++.+.|.... ..++++.+..++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.++.+. ...
T Consensus 88 Gg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a 163 (426)
T KOG0589|consen 88 GGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLA 163 (426)
T ss_pred CCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-hhh
Confidence 999999997765 67899999999999999999999877 9999999999999999999999999999987764 235
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
.+.+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. ... .++..+
T Consensus 164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------------------~Li-~ki~~~--- 221 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------------------ELI-LKINRG--- 221 (426)
T ss_pred heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------------------HHH-HHHhhc---
Confidence 6788999999999999999999999999999999999999999864332 111 111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ....+......+..++..|++.+|+.||++.+++.+
T Consensus 222 -----~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -----L-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----c-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 223344566789999999999999999999999976
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.77 Aligned_cols=265 Identities=27% Similarity=0.414 Sum_probs=201.6
Q ss_pred ccccccccccceeEEEEEe-----CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 527 (804)
.+.+.||+|+||+||.+.. .++..||+|.++.... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988643 3567899999975432 456788999999999999999999988653 467899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999999764 5899999999999999999999988 9999999999999999999999999998654322
Q ss_pred c--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 S--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 ~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
. .......++..|+|||.+.+..++.++||||||++++||++|+.|+............. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------------~~~~~ 228 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-------------KQGQM 228 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc-------------ccccc
Confidence 1 11122345677999999998889999999999999999999999986533211000000 00000
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
....+.+.++.......+......+.+++..|++.+|++||++++|+++|+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000111111111111223334567999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=325.68 Aligned_cols=249 Identities=20% Similarity=0.190 Sum_probs=199.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... +++.||||+++... ...+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45679999999999999764 67899999997532 23456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999877567999999999999999999999988 99999999999999999999999999987654332223
Q ss_pred cccccccccccchhcc------CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 612 ATMRGTWGYVAPEWIS------GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~------~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------------------~~~~~i 221 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------------------KTYNNI 221 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------------------HHHHHH
Confidence 3457899999999986 456789999999999999999999999743211 011111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... .. +.-.........+..++..|++ +|.+||++.++++.
T Consensus 222 ~~~~--~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 MNFQ--RF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HcCC--Cc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1110 00 0000111234567888889998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.51 Aligned_cols=196 Identities=24% Similarity=0.397 Sum_probs=170.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+++.. .+..||+|.+..... ....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 34578999999999999765 578899999875422 235789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 88 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 161 (331)
T cd06649 88 GSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161 (331)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---cccc
Confidence 99999997654 6889999999999999999999842 2999999999999999999999999999765332 1234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCc
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPA 658 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~ 658 (804)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 568999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=336.51 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=207.4
Q ss_pred cccccccccceeEEEEEe-CCC----cEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDS----TLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
-.++||+|+||+||||.+ +++ -+||||++... .+...++..|+..|.+++||||+||+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 346899999999999966 333 47999999654 445789999999999999999999999998765 8899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
|+.|+|.++++.++..+-.+..+.+..|||+||.|||++. ++||||.++||||.+-..+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999998889999999999999999999999877 9999999999999999999999999999876553332
Q ss_pred -ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 611 -LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 611 -~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
.....-.+.|||-|.+....|+.++|||||||++||++| |..|++.....
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------------------------- 907 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------------------------- 907 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------------------
Confidence 222334678999999999999999999999999999998 88888764321
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
++.+++....+-..++-+...+..++..||..|+..||.++++.+.+...
T Consensus 908 eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 908 EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 12222222222234556677899999999999999999999998877553
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.74 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=198.9
Q ss_pred cccccccccccceeEEEEEeCC--CcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD--STLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|.... +..||+|++... ......+.+|+.++..++||||+++++++......++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 3467899999999999997543 368999999642 2334568899999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 999999999998654 6889999999999999999999988 999999999999999999999999999865432
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ......+..+.
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------------------~~~~~~i~~~~ 244 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------------------LLIYQKILEGI 244 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------------------HHHHHHHhcCC
Confidence 2345789999999999998899999999999999999999999974321 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
. .++......+..++.+|++.+|++|+ ++.++++.
T Consensus 245 ~----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 I----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 11222345678899999999999995 88888765
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.04 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=206.8
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||+|...++..||||.+........++.+|+.++++++|+|++++++++......++||||+++++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 44678999999999999998888889999998776777889999999999999999999999999899999999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 999997653 46899999999999999999999988 99999999999999999999999999986643322222233
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..+..|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------------------~~~~~~~~~----- 220 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------------------EVLEQVERG----- 220 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHHcC-----
Confidence 35678999999998899999999999999999998 99888642110 011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 ----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111122234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=319.85 Aligned_cols=269 Identities=18% Similarity=0.200 Sum_probs=198.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+++.. +++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 45678999999999999875 57889999997542 234568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++++..+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 84 ~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 84 KNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9877655443 346899999999999999999999887 999999999999999999999999999876433322333
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh-hcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI-IEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 691 (804)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.............. ....++.-..... ......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK----VLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhCCCCHHHHHhhhccchhc
Confidence 45689999999999998999999999999999999999999975322110000000 0000000000000 000000
Q ss_pred eeccccccC------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGG------AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+.... .........+.+++.+||+.||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.06 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=195.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||++... +++.||||++... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 6889999999743 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 9998887654 6889999999999999999999988 9999999999999999999999999987532221 122345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------------------~~~~~~~~~~----- 211 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------KLFELILMED----- 211 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------------------HHHHHhccCC-----
Confidence 6899999999999999999999999999999999999999642211 0011111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
. ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 212 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 -I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 11223345688999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.17 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=204.3
Q ss_pred hhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
....+.++||+|+||.||++...++..+|+|.++........+.+|+.++++++|+|++++.+++.. ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 4455778999999999999988777889999987655556789999999999999999999999887 778999999999
Q ss_pred CChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++... ...+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 9999999764 346788999999999999999999887 999999999999999999999999999765433222222
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||++....++.++||||||++++|+++ |+.||...... -....+..+...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------------------~~~~~~~~~~~~ 222 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------------------EVIRALERGYRM 222 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHhCCCCC
Confidence 3345678999999998889999999999999999999 88888642211 011111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.........+.+++.+|++.+|++||++.++.++|+.
T Consensus 223 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.55 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeCC------CcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||.||+|...+ +..||||+++..... .+.+.+|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 3456789999999999997632 478999999754332 35688999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCce
Q 044374 528 YDYMRNGALSLYLRKD---------------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTA 592 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 592 (804)
+||+++++|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 9999999999998532 124788889999999999999999987 9999999999999999999
Q ss_pred EEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCC
Q 044374 593 KVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGE 670 (804)
Q Consensus 593 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 670 (804)
||+|||+++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------- 232 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----------- 232 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----------
Confidence 999999988653321 112233456789999999988889999999999999999998 7777753211
Q ss_pred CCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.-....+..+... ..+.+.+..+..++..|++.+|++||++.+|++.|+.
T Consensus 233 --------~~~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --------QDVIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111222222211 1223345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.74 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=203.9
Q ss_pred ccccccccccceeEEEEEeC------CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+++.. ++..+++|.++.... ..+.+.+|+.++++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 35578999999999999642 345689999875433 34578999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEE
Q 044374 530 YMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 594 (804)
|+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEE
Confidence 999999999997532 24789999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCC
Q 044374 595 SDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHG 672 (804)
Q Consensus 595 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 672 (804)
+|||++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------------ 232 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------------ 232 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 9999997654321 122234456789999999999999999999999999999999 99988642211
Q ss_pred CccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 673 DKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
-..+.+..+.... .+...+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 233 -------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 -------EVIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -------HHHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112222222211 111234678899999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=325.57 Aligned_cols=241 Identities=25% Similarity=0.330 Sum_probs=194.7
Q ss_pred cccccccceeEEEEEe----CCCcEEEEEEecCC-----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGEL----SDSTLVAVKRLERP-----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.||+|+||.||+++. ..++.||||+++.. ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 35788999999642 12334678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++...+ .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence 99999999997654 6778888899999999999999988 9999999999999999999999999987532221 12
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------------------~~~~~~~~~~~ 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------------------KTIDKILKGKL 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHcCCC
Confidence 23456899999999999988999999999999999999999999742210 11111211111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
..+......+.+++.+|++.+|++|| ++.++++.
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11222345688999999999999999 78877663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.86 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=199.5
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEec-CCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSE-NSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-~~~~~ 525 (804)
..+.+.||+|+||.||+|... .++.||+|+++.... ..+.+..|+.++.++ +|+||++++++|.. ....+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 346789999999999999542 246899999975432 234677899999999 89999999998864 45688
Q ss_pred EEEEEcCCCChhHHHhhCC------------------------------------------------------------C
Q 044374 526 LVYDYMRNGALSLYLRKDG------------------------------------------------------------L 545 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------~ 545 (804)
++|||+++++|.+++.... .
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999999886421 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-ccccccccccccccch
Q 044374 546 NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPE 624 (804)
Q Consensus 546 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE 624 (804)
.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 5788999999999999999999887 99999999999999999999999999986533221 1122345677899999
Q ss_pred hccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCC
Q 044374 625 WISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYK 703 (804)
Q Consensus 625 ~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 703 (804)
++.+..++.++|||||||+++||++ |+.||...... ......+..+... ..+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------------------~~~~~~~~~~~~~---------~~~ 298 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------------------EEFCRRLKEGTRM---------RAP 298 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------------------HHHHHHHhccCCC---------CCC
Confidence 9999999999999999999999998 99888642111 0111122222111 111
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 704 VEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 704 ~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+.+++.+|++.+|++||++.+|+++|+.++.
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2234578899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.48 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=197.9
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||.||+|... .+..||||++..... ...++.+|+.+++.++||||+++++++..+...++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 345689999999999999653 246799999864322 335688999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 528 YDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999987532 23577889999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---------------- 228 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---------------- 228 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------------
Confidence 9875433211 11222345788999999999899999999999999999999 67787532110
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
-......++.... .+......+.+++.+|++.+|++||++.|++++|++
T Consensus 229 ---~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ---QVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111221111 112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=330.26 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=204.6
Q ss_pred cccccccccceeEEEEEeC--CC--cEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS--DS--TLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.|+||+|.||.|++|.|. .| ..||||.++... ....+|.+|+..|.+|+|||+++|+|+..+ ...+||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999775 33 468999998643 356889999999999999999999999987 7789999999
Q ss_pred CCCChhHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-
Q 044374 532 RNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR- 609 (804)
Q Consensus 532 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 609 (804)
+.|+|.+.|++ ....+-.....+++.|||.||.||..++ +|||||..+||||.....+||+||||.+-++.....
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999988 4456778888999999999999999988 999999999999999999999999999987644222
Q ss_pred -cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 610 -VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 610 -~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
......-...|.|||.+....|+.+||||+|||+||||+| |+.|+-+-.. .
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------------~-------- 322 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------------I-------- 322 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------------------H--------
Confidence 2223345778999999999999999999999999999998 6677754211 1
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
++.+.+|..-.-..+..+.+.++++++.||..+|++||++..|.+.
T Consensus 323 -qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 323 -QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1233344333334567889999999999999999999999999754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.54 Aligned_cols=241 Identities=22% Similarity=0.265 Sum_probs=195.3
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++++++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 6889999999743 223456778999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 9998887654 6899999999999999999999988 9999999999999999999999999987532221 122345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------------------~~~~~~~~~~~---- 212 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------RLFELILMEEI---- 212 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHhcCCC----
Confidence 6899999999999999999999999999999999999999643211 01111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
..+......+.+++..||+.||++|| ++.++++.
T Consensus 213 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11223346688999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.00 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=201.2
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
..+.+.||+|+||.||++... ....+|+|.+..... ...++.+|+.++.++ +|+||+++++++......++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 345678999999999999764 236799999875432 235688999999999 79999999999999999999
Q ss_pred EEEEcCCCChhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc
Q 044374 527 VYDYMRNGALSLYLRKD---------------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
+|||+++++|..++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCe
Confidence 99999999999998642 246889999999999999999999887 999999999999999999
Q ss_pred eEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCC
Q 044374 592 AKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGG 669 (804)
Q Consensus 592 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 669 (804)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------- 241 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--------- 241 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---------
Confidence 99999999986543211 11222345678999999999999999999999999999998 88887632110
Q ss_pred CCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 670 EHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.....+..+. ....+......+.+++.+|++.+|++|||+.+|++.|+.++
T Consensus 242 ----------~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ----------ELFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------HHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111222111 11122234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.68 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=191.7
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++... +++.||+|+++.. ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 5788999999753 12334577888888766 899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 99998887654 6899999999999999999999988 9999999999999999999999999987532211 12234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||..|+|||++.+..++.++|||||||++|||++|+.||........ .......+....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~i~~~~~--- 222 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQI--- 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------cccccHHHHHHHHhcCCC---
Confidence 5789999999999999999999999999999999999999964211100 011111222222222211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
..+......+..++.+||+.||++||+.
T Consensus 223 -------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1222334568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=316.90 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=201.5
Q ss_pred ccccccccccceeEEEEEeCC-C---cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-S---TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
...+.||+|+||.||+|.... + ..+|||.++.... ..+++.+|+.++.+++|||++++++++......++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 346789999999999997642 2 3799999875422 345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999876667899999999999999999999987 9999999999999999999999999997654322111
Q ss_pred c--cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 611 L--ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 611 ~--~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
. .....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .-....+..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------------------~~~~~~i~~ 225 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------------------HEVMKAIND 225 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------------------HHHHHHHhc
Confidence 1 11223567999999998889999999999999999998 9999864211 011122221
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+. ......+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 226 ~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GF---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=312.94 Aligned_cols=246 Identities=28% Similarity=0.421 Sum_probs=197.6
Q ss_pred cccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++||+|+||.||+|.+.. +..+|+|.+..... ..+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996532 26899999976544 4567899999999999999999999876 4568999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc--c
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--L 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--~ 611 (804)
++|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 7899999999999999999999887 9999999999999999999999999998654332211 1
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... -....+..+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------------------~~~~~~~~~~~ 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------------------EVIAMLESGER 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------------------HHHHHHHcCCc
Confidence 12234568999999999899999999999999999998 99998643211 01111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011223346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.92 Aligned_cols=248 Identities=23% Similarity=0.264 Sum_probs=200.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||++... +++.||||+++.. ......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 35678999999999999765 6889999999743 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc----
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF---- 607 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 607 (804)
++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 84 PGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999876 47899999999999999999999987 9999999999999999999999999998654332
Q ss_pred ------------------------cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCC
Q 044374 608 ------------------------SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNA 663 (804)
Q Consensus 608 ------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~ 663 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--- 236 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ--- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---
Confidence 11223456899999999999999999999999999999999999999753211
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-MGTVVKM 734 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~~ 734 (804)
.....+.... ..+...........+..++..|++ +|.+||+ +.++++.
T Consensus 237 ----------------~~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ----------------ETYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----------------HHHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0111111100 000000011135668889999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=320.34 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=203.4
Q ss_pred cccccccccccceeEEEEEe------CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.+.||+|+||.||++.. .++..+|+|.+.... .....+.+|+.++.+++||||+++++++...+..++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 34567899999999999974 234568999987543 33567899999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEee
Q 044374 529 DYMRNGALSLYLRKDG------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSD 596 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 596 (804)
||+++++|.+++...+ ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEecc
Confidence 9999999999997543 24899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 597 FGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 597 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
||+++...... ........++..|+|||++.+..++.++||||||++++||++ |+.||......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------------- 229 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------------- 229 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence 99998653321 112233445778999999999899999999999999999998 88888642211
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
-....+..+..... +......+.+++.+|++.+|.+||++.+|++.|+++..
T Consensus 230 -----~~~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 230 -----EVIECITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -----HHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11222222221111 11233568999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.92 Aligned_cols=197 Identities=26% Similarity=0.327 Sum_probs=169.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||+||+|+.. .++.||||++.... .....+++|+.++.+++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 35678999999999999654 67899999996532 23356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc---
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS--- 608 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 608 (804)
++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 84 PGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999997654 6888888999999999999999988 99999999999999999999999999764311000
Q ss_pred -------------------------------------------ccccccccccccccchhccCCCCCccceEEeehhhHH
Q 044374 609 -------------------------------------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLL 645 (804)
Q Consensus 609 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ 645 (804)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012346999999999999999999999999999999
Q ss_pred HhhhCCCCCCCC
Q 044374 646 ELIGGRRNVEAP 657 (804)
Q Consensus 646 elltg~~p~~~~ 657 (804)
||++|+.||...
T Consensus 240 elltG~~Pf~~~ 251 (381)
T cd05626 240 EMLVGQPPFLAP 251 (381)
T ss_pred HHHhCCCCCcCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.90 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=200.7
Q ss_pred cccccccccccceeEEEEEeCC-C---cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD-S---TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|.... + ..||||+++.... ...+|..|+.++++++||||+++++++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4567899999999999997653 2 3699999875422 34579999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|.+++......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999876667899999999999999999999987 999999999999999999999999998765432111
Q ss_pred --ccccc--ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 610 --VLATM--RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 610 --~~~~~--~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
..... ..+..|+|||++.+..++.++||||||+++||+++ |+.||...... -....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------------------~~~~~ 223 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------------------DVINA 223 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------------------HHHHH
Confidence 11111 12457999999999999999999999999999886 99888642211 01111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+... .....+.+.+..+.+++..|++.+|.+||++.+|+++|+.+
T Consensus 224 i~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 224 IEQD---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHcC---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 00111223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=325.01 Aligned_cols=249 Identities=24% Similarity=0.281 Sum_probs=196.1
Q ss_pred ccccccccccceeEEEEEe----CCCcEEEEEEecCC-----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERP-----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
.+.++||+|+||.||+++. ..++.||+|++... ....+.+..|+.++.++ +||||+++++++......++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3568899999999999865 35788999999642 22335678899999999 59999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999987654 6889999999999999999999988 999999999999999999999999999865433
Q ss_pred ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ........+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------------~~~~~~~~~ 223 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---------------TQSEVSRRI 223 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---------------CHHHHHHHH
Confidence 33233346799999999999875 47889999999999999999999996432110 011111111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
... ++ ..+......+.+++.+||+.||++|| ++.++++.
T Consensus 224 ~~~------~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LKC------DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hcC------CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 11 11223345678899999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=332.64 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 526 (804)
..+.++||+|+||.||+|++. .+..||||+++.... ..+.+.+|+.++.++. ||||++++++|......++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 345689999999999999753 346799999975422 2346889999999997 9999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC--------------------------------------------------------------
Q 044374 527 VYDYMRNGALSLYLRKDG-------------------------------------------------------------- 544 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 544 (804)
||||+++|+|.++++...
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 999999999999986432
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 545 -----------------------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 545 -----------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
..+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCC
Confidence 13566778899999999999999877 9999999999999999
Q ss_pred CceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~------- 348 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN------- 348 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-------
Confidence 9999999999986432211 11223356788999999998889999999999999999998 88887642110
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
......+..+. ....+......+.+++..||+.+|++||++++|++.|+.++
T Consensus 349 -----------~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -----------EQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----------HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111111 11112233567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.02 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=196.5
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. +++.||||+++.. ......++.|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999765 5789999999753 22335578899999888 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence 99998887653 7899999999999999999999988 999999999999999999999999998743221 112334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+....... .......+....+.++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~~--- 222 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQNTEDYLFQVILEKQI--- 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc----------ccccchHHHHHHHHcCCC---
Confidence 5789999999999999999999999999999999999999974221100 011112222333322211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT------MGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~eVl~~ 734 (804)
..+......+..++.+||+.||.+||+ +.++++.
T Consensus 223 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 -------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 112223456889999999999999997 5666643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=319.11 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=200.1
Q ss_pred cccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.||+|+||.||+|... ....+|+|.+..... ...++.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999653 235689998875432 24578899999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 530 YMRNGALSLYLRKDG-----------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
|+.+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 999999999986421 24788899999999999999999887 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCc
Q 044374 587 DSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNAN 664 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 664 (804)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||....+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999999976432211 11223345778999999988899999999999999999998 98888642211
Q ss_pred CCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 665 IGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
........+ .....+......+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 237 ---------------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 ---------------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---------------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111111 1111122334678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.12 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred cccccccccceeEEEEEeCC----CcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCe------E
Q 044374 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSH------R 524 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~ 524 (804)
+.+.||+|+||.||+|.... +..||||+++.... ....+.+|+..++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 56789999999999997642 36799999975432 23578999999999999999999999876554 7
Q ss_pred EEEEEEcCCCChhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCC
Q 044374 525 LLVYDYMRNGALSLYLRKD-----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 599 (804)
++++||+++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 9999999999999988543 235889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----------------- 222 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----------------- 222 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----------------
Confidence 986543211 11222335678999999998899999999999999999999 88887532110
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
-.......+... ..+......+.+++.+|++.||.+||++.+|++.|+++
T Consensus 223 --~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 --EIYDYLRHGNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHHHHcCCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011111111111 11223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.37 Aligned_cols=237 Identities=25% Similarity=0.307 Sum_probs=192.6
Q ss_pred cccccccceeEEEEEe----CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 460 EKLGHGGFGAVFQGEL----SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.||+|+||.||+++. ..++.||+|+++... .....+.+|+.++.+++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999997532 233457789999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 999999997653 6899999999999999999999988 9999999999999999999999999998653321 1223
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------------------~~~~~i~~~~~-- 215 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------------------ETMTMILKAKL-- 215 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------------------HHHHHHHcCCC--
Confidence 456899999999999988999999999999999999999999743211 11111111110
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 730 (804)
..+......+..++.+||+.||++||++.+
T Consensus 216 --------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 --------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112223456788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=324.36 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=194.4
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||++.. ..++.||+|+++.. ......+..|+.++..++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 46789999999753 223356788999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|..++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9999887654 68999999999999999999997 56 9999999999999999999999999987532221 12234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... -....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------------------~~~~~i~~~~~--- 213 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------KLFELILMEEI--- 213 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------------------HHHHHHhcCCC---
Confidence 56899999999999999999999999999999999999999642211 01111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
..+......+.+++.+|++.||++|+ ++.++++.
T Consensus 214 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 -------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11222345688899999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.58 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=204.2
Q ss_pred HHHhhcccccccccccceeEEEEEeC--------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEe
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCS 519 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 519 (804)
+......+.+.||+|+||.||++... ....||+|.++.... ..+++.+|+.++.++ +||||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33445567889999999999999642 123689998875432 346789999999999 7999999999999
Q ss_pred cCCeEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 044374 520 ENSHRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584 (804)
Q Consensus 520 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NI 584 (804)
.....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999987532 24788899999999999999999987 99999999999
Q ss_pred EecCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCC
Q 044374 585 LLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRN 662 (804)
Q Consensus 585 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 662 (804)
|++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999986543211 11222334568999999999999999999999999999998 78887532110
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
. ....+..+... ..+......+.+++..|++.+|++||++.+|++.|+.+....
T Consensus 244 ----------------~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ----------------E-LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ----------------H-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 11111111111 112233457889999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.15 Aligned_cols=197 Identities=24% Similarity=0.407 Sum_probs=170.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.++||+|+||.||++... .+..+|+|.++.... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 445689999999999999775 578899998875422 23568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++...+ .+++.....++.+++.||+|||+.. +|+|+||||+|||++.++.+||+|||++...... ...
T Consensus 87 ~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~ 160 (333)
T cd06650 87 GGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (333)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccc
Confidence 999999997654 6888999999999999999999742 2999999999999999999999999999754322 123
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPA 658 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~ 658 (804)
...++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 3468999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=295.45 Aligned_cols=231 Identities=28% Similarity=0.358 Sum_probs=194.7
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.||.|+||+|...+.+ .+..+|+|+++.... ..+...+|..+|+.+.||.++++.+.+.+.+.++|||||.+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 4578999999999999765 678999999975422 23456789999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+|.|..+|++.+ .++++.+..++.+|+.||+|||+.. |++|||||+|||||.+|.+||+|||.|+..... .-
T Consensus 128 GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 128 GGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 999999999865 7899999999999999999999988 999999999999999999999999999976543 45
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
+.+||+.|+|||.+....+...+|-|||||++|||+.|..||....+ .....++.++++
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------------~~iY~KI~~~~v-- 258 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------------IQIYEKILEGKV-- 258 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------------HHHHHHHHhCcc--
Confidence 78899999999999999999999999999999999999999985422 223344444432
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR 725 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 725 (804)
.+|.--...+..|+...++.|-.+|
T Consensus 259 --------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1232333456677777788888877
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.27 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=201.5
Q ss_pred ccccccccccceeEEEEEeC----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||+|... ....+|+|.++.... ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 46689999999999999753 234799999875432 245789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999999999876667899999999999999999999988 9999999999999999999999999998764332211
Q ss_pred c--cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 611 L--ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 611 ~--~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
. ....++..|+|||++.+..++.++||||||++++|+++ |+.||...... -....+.+
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------------------~~~~~~~~ 224 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------------------DVIKAIEE 224 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------------------HHHHHHhC
Confidence 1 12223568999999999899999999999999999886 99998643211 01111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+.. ...+...+..+.+++.+|++.+|++||+|.+|++.|+.+
T Consensus 225 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYR---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 110 011122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=315.40 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=196.2
Q ss_pred cccccccccceeEEEEEeCCC---cEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEE
Q 044374 458 FSEKLGHGGFGAVFQGELSDS---TLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRL 525 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~ 525 (804)
+.++||+|+||.||+|..... ..||+|.++... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 567899999999999987543 268999987542 2345688899999999999999999987532 2468
Q ss_pred EEEEEcCCCChhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 526 LVYDYMRNGALSLYLRKD-----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
++|||+++|+|..++... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887432 235789999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 601 KLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 601 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
+....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------------- 220 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------------- 220 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------------------
Confidence 86543221 11223346778999999999999999999999999999999 7888764211
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
......+..+.... .+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 SEIYDYLRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122222222111 1122345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.81 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=199.7
Q ss_pred cccccccccccceeEEEEEeC-CCc----EEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||+||+|++. ++. .||+|+++.... ..+++.+|+.++..++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 345689999999999999753 333 489999975432 34678899999999999999999999975 4578999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999876667899999999999999999999988 99999999999999999999999999987643321
Q ss_pred c-cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 R-VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 ~-~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... -....+.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------------~~~~~~~ 225 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------------------EIPDLLE 225 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------------------HHHHHHH
Confidence 1 1112234678999999999899999999999999999998 88888642110 0111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+... ..+......+..++..||+.||++||++.++++.|+.+..
T Consensus 226 ~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERL---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111 1112234568899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.11 Aligned_cols=249 Identities=26% Similarity=0.309 Sum_probs=197.0
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---------------CHHHHHHHHHHHcCCCCCCceeeeeEEec
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---------------GEREFRAEVCTIGNIQHVNLVRLRGFCSE 520 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 520 (804)
.+.++||+|.||.|-+|.. .+++.||||++.+... ..+..++||.+|++++|||||+|+.+..+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 3567899999999999965 4789999999954211 12478899999999999999999999876
Q ss_pred C--CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 521 N--SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 521 ~--~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
. +.+|||+|||..|.+...=.. ...+++.++.+++.++..||.|||.++ ||||||||+|+||+++|++||+|||
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred cccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccc
Confidence 4 578999999998877543222 223899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCC----ccccccccccccccccchhccCCC----CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCC
Q 044374 599 LAKLIGRD----FSRVLATMRGTWGYVAPEWISGLA----ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE 670 (804)
Q Consensus 599 la~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~----~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 670 (804)
.+..+... ........+||+.|||||...++. .+.+.||||+||+||.|+.|+.||.....-
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---------- 325 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---------- 325 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----------
Confidence 99865211 222344578999999999887732 356789999999999999999999742110
Q ss_pred CCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
-. ..+++...+.-....++.+.+..|++++|++||+.|.+..+|..+.=
T Consensus 326 ---------~l--------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ---------EL--------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ---------HH--------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 01 12233333332333456788999999999999999999999988753
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.03 Aligned_cols=249 Identities=29% Similarity=0.391 Sum_probs=197.3
Q ss_pred ccccccccccceeEEEEEeCC------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
.+.+.||+|+||.||+|.... +..||+|.+..... ....|.+|+.++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 356789999999999997753 56799998864432 3456899999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCC
Q 044374 529 DYMRNGALSLYLRKDG------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGL 599 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGl 599 (804)
||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999997643 25889999999999999999999987 99999999999998754 699999999
Q ss_pred ccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++....... ........+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----------------- 228 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------------- 228 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------
Confidence 986532211 11122234568999999999999999999999999999997 98888643211
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
. ....+... .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 229 -~-~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -E-VMEFVTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -H-HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 01111111 111122233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.66 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=202.9
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.+.||+|+||.||++... ++.||||.++......+++.+|+.++++++|+||+++++++......++||||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 346789999999999999875 6789999998765566789999999999999999999999999999999999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++...... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~ 159 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSG 159 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----ccC
Confidence 999997654 36899999999999999999999988 9999999999999999999999999998653221 123
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..+..|+|||++....++.++||||||++++||++ |+.||...... ........+.
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~~---- 216 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------------------DVVPHVEKGY---- 216 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHhcCC----
Confidence 34678999999988889999999999999999997 98888642110 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
....+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 -----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111122234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.67 Aligned_cols=268 Identities=21% Similarity=0.257 Sum_probs=196.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... +++.||+|+++.. ......+.+|+.++++++||||+++++++......++||||+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 35678999999999999765 6789999999643 23345678999999999999999999999999999999999985
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++...+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 88 -~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~ 162 (288)
T cd07871 88 -DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSN 162 (288)
T ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccC
Confidence 899988776667889999999999999999999988 9999999999999999999999999997643221 12234
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh-cCccc
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-EGNVA 691 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 691 (804)
..+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+......... .. .+.-.+..+. .....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL--GT--PTEETWPGITSNEEFR 238 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CC--CChHHhhccccchhhh
Confidence 567899999998865 568999999999999999999999997533211000000000 00 0000000000 00000
Q ss_pred eeccccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGGA----YKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111110000 00112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.16 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=199.8
Q ss_pred ccccccccccceeEEEEEeCC-C--cEEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-S--TLVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||+|...+ + ..+++|.++... ...+.+.+|+.++.++ +||||+++++++......++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 356789999999999997753 3 347888887432 2345788999999999 799999999999999999999999
Q ss_pred cCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 531 MRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 531 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEEC
Confidence 99999999997532 24788999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------------- 225 (297)
T cd05089 162 DFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------------- 225 (297)
T ss_pred CcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------------
Confidence 9999864321111 111223567999999998899999999999999999997 99998643211
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCCCC
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAP 744 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~p 744 (804)
-.......+ .....+......+.+++..|++.+|.+||++.+|+++|+.+.....+
T Consensus 226 -----~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 226 -----ELYEKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -----HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 011111111 11111223346688999999999999999999999999987765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.81 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=194.5
Q ss_pred cccccccceeEEEEEeCC-Cc--EEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSD-ST--LVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|...+ +. .+|+|.++... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 57888887432 2345788999999999 899999999999999999999999999
Q ss_pred CChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 534 GALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 534 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 24788999999999999999999887 9999999999999999999999999
Q ss_pred CccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 599 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++...... ........+..|+|||++....++.++||||||++++||++ |..||......
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----------------- 218 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------------- 218 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----------------
Confidence 98632211 11112234567999999988899999999999999999997 99998642110
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....+..+... ..+......+.+++.+|++.+|.+||++.+|++.|+.+.
T Consensus 219 -~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 -E-LYEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -H-HHHHHhCCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 11111111110 111223456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.25 Aligned_cols=248 Identities=21% Similarity=0.230 Sum_probs=197.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+++.. .++.||+|++... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 45678999999999999765 5789999999642 223455788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 126 ~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 126 PGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 999999998764 5788888999999999999999988 99999999999999999999999999986543322223
Q ss_pred cccccccccccchhccCC----CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 612 ATMRGTWGYVAPEWISGL----AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~----~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... -....+..
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------------------~~~~~i~~ 261 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------------------GTYSKIMD 261 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------------------HHHHHHHc
Confidence 456799999999998653 4788999999999999999999999743210 01111211
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM--RPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 734 (804)
+.. .+.-.........+.+++..|++.+|.+ ||++.++++.
T Consensus 262 ~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKN------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 110 0100111123467888999999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=317.74 Aligned_cols=268 Identities=24% Similarity=0.378 Sum_probs=200.4
Q ss_pred cccccccccccceeEEEEEeC-----CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-----DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 527 (804)
..+.+.||+|+||.||++... .+..||||+++.... ..+.+.+|+.++.+++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 345688999999999999753 467899999875432 34678999999999999999999998754 3468999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999876667899999999999999999999988 9999999999999999999999999998754322
Q ss_pred cc--cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 SR--VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 ~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.. ......++..|+|||++.+..++.++||||||++++||++|..++..+.......+ +................
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM---GNDKQGQMIVYHLIELL 239 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhc---ccccccccchHHHHHHH
Confidence 11 11122234569999999988999999999999999999998876543221100000 00000000111111111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
..+ .....+......+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111 11111223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.40 Aligned_cols=243 Identities=25% Similarity=0.350 Sum_probs=205.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
++.+.||+|.||.||.|+.+ .+-.||+|++.+. ..-+.++++|+++...|+||||+++++++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 36789999999999999765 5678999999654 334578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
..|.+...|+... ..+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||-+.... ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 9999999998543 46899999999999999999999887 9999999999999999999999999997643 233
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..+.+||..|.+||...+..++..+|+|++|++.+|++.|.+||+....+ -..+.+..-
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------------------etYkrI~k~-- 237 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------------------ETYKRIRKV-- 237 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------------------HHHHHHHHc--
Confidence 45788999999999999999999999999999999999999999864321 111222111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
++ .++........+++..|+..+|.+|.+..||++.
T Consensus 238 -~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 -DL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -cc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11 1223445678899999999999999999999865
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=340.02 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=198.3
Q ss_pred cccccccccccceeEEEEEeC-C-CcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-D-STLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.+.||+|+||.||+|... + ++.||+|.+..... ....+++|+.+++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 446789999999999999643 3 57788887754332 23467889999999999999999999999999999999999
Q ss_pred CCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 533 NGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 533 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 346889999999999999999999987 99999999999999999999999999987543321
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------------------~~~~~~~~~ 286 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------------------EIMQQVLYG 286 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhC
Confidence 2234456999999999999999999999999999999999999998642110 011111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
... ..+......+.+++..||+.+|++||++.+++.
T Consensus 287 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KYD---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCC---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111 112223456889999999999999999999874
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.66 Aligned_cols=268 Identities=25% Similarity=0.367 Sum_probs=203.4
Q ss_pred hcccccccccccceeEEEEEe-----CCCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRL 525 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 525 (804)
+....++||+|+||.||.+++ ..+..||+|.++... .....+.+|+.++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 344567899999999999974 246789999987442 2345789999999999999999999998775 5689
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999776557899999999999999999999988 99999999999999999999999999986543
Q ss_pred Ccc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
... .......++..|+|||++.+..++.++||||||++++||++++.|...+...... ........... .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~ 237 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK---MIGPTHGQMTV-TRLVR 237 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh---hcccccccccH-HHHHH
Confidence 321 1222345677899999998888999999999999999999987765432111000 00000001111 11111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...++... ..+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111 11223456799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.52 Aligned_cols=249 Identities=21% Similarity=0.231 Sum_probs=194.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.++||+|+||.||+++.. .++.+|+|++... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 345678999999999999775 5788999998642 22345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 125 ~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 125 MPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 9999999999764 5788899999999999999999988 9999999999999999999999999998764332222
Q ss_pred ccccccccccccchhccCCC----CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 611 LATMRGTWGYVAPEWISGLA----ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~----~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... . ....+.
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------------------~-~~~~i~ 260 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------------------G-TYSKIM 260 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------------------H-HHHHHH
Confidence 34567999999999987643 788999999999999999999999743210 0 111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM--RPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 734 (804)
.... .+.-.........+..++..|++.++.+ ||++.+++++
T Consensus 261 ~~~~------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKN------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCc------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1100 0100111123456778888888765544 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=307.58 Aligned_cols=243 Identities=25% Similarity=0.409 Sum_probs=206.7
Q ss_pred cccccccccccceeEEEEE-eCCCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.|.+.||+|.||.|-+|. ...++.||||.+++... ..-.+++||++|..|+||||+.++.+|...+...|||||
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence 4567899999999999994 46899999999976533 223588999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
..+|.|.+|+...+ .|++.+..+++.||..|+.|.|..+ ++|||||.+|||||.|+++||+||||+-++.. ...
T Consensus 135 aS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kf 208 (668)
T KOG0611|consen 135 ASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKF 208 (668)
T ss_pred cCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--ccH
Confidence 99999999998876 7999999999999999999999887 99999999999999999999999999987654 345
Q ss_pred ccccccccccccchhccCCCCC-ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAIT-TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
..+.+|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+... ..+++..|.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------------------lvrQIs~Ga 269 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------------------LVRQISRGA 269 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------------------HHHHhhccc
Confidence 7789999999999999999885 78999999999999999999999653321 122333332
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .++.+....-|+.|||-.||++|.|+.+|...
T Consensus 270 Yr-----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YR-----------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cc-----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 21 12233446678999999999999999999976
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.61 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=190.3
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.++||+|+||.||+++.. +++.||||++..... ....+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999765 678999999965432 2457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.... ..++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 158 ~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 158 SLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred cccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 986432 3567778899999999999999988 99999999999999999999999999986543221 12345
Q ss_pred ccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH--Hhhc
Q 044374 615 RGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR--QIIE 687 (804)
Q Consensus 615 ~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 687 (804)
.||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|... ....
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------------------~~~~~~~~~~~ 290 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------------------DWASLMCAICM 290 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------------------cHHHHHHHHhc
Confidence 78999999998743 23456899999999999999999999732111 11110 0000
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ....+......+.+++.+||+.||++||++.||++.
T Consensus 291 ~~---------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQ---------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011122345678999999999999999999999976
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.46 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=189.9
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcC-CCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGN-IQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|+.. .++.||||+++.. ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 5788999999743 2233445566666654 5899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999987654 6889999999999999999999987 9999999999999999999999999997543221 22344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------------------~~~~~i~~~----- 211 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------------------ELFDSILND----- 211 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHcC-----
Confidence 57899999999999999999999999999999999999999743211 011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG-TVVK 733 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 733 (804)
....+......+.+++..||+.+|++||++. ++++
T Consensus 212 -----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 -----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0111222345678899999999999999876 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.29 Aligned_cols=241 Identities=23% Similarity=0.314 Sum_probs=193.3
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|+.. .++.||||+++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 4789999999743 22345577888888765 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 99999887654 6889999999999999999999988 9999999999999999999999999987532221 12334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... -....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------------------~~~~~i~~~~~--- 213 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------------------DLFESILHDDV--- 213 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHcCCC---
Confidence 56899999999999999999999999999999999999999743211 01111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCC-------CHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-------TMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~eVl~~ 734 (804)
..+......+.+++..||+.+|++|| ++.++++.
T Consensus 214 -------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01112345678899999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.62 Aligned_cols=246 Identities=31% Similarity=0.469 Sum_probs=203.5
Q ss_pred cccccccceeEEEEEeCC----CcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSD----STLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++.... +..||+|.++..... .+.+.+|+..+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997754 788999999765433 57899999999999999999999999999999999999999
Q ss_pred CChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 534 GALSLYLRKD--------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 534 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
++|.+++... ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 467899999999999999999999987 99999999999999999999999999987644
Q ss_pred Cc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.. ........++..|+|||.+....++.++||||||++++||++ |+.||..... .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------------~~~~~ 218 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------------------EEVLE 218 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------------------HHHHH
Confidence 32 122334557889999999988899999999999999999999 5888875311 11122
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
....+.. ...+......+.+++.+|++.+|++||++.+++++|+
T Consensus 219 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRKGYR---------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHcCCC---------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2222111 1112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.59 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=201.9
Q ss_pred hcccccccccccceeEEEEEeCC-----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD-----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 526 (804)
...+.+.||+|+||.||+|...+ +..|++|++..... ....+.+|+.++++++||||+++++++.. +...++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 34466899999999999998765 68899999875422 34568899999999999999999998876 467899
Q ss_pred EEEEcCCCChhHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCC
Q 044374 527 VYDYMRNGALSLYLRKDG-------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 599 (804)
++||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCC
Confidence 999999999999987532 35889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++.+.... ........++..|+|||++.+..++.++||||||+++||+++ |+.||....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------- 226 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----------------- 226 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----------------
Confidence 98653321 112223446778999999999899999999999999999999 99998642110
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....+..+.. + ..+...+..+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 227 -~-~~~~~~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 227 -E-MAAYLKDGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -H-HHHHHHcCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 1111111110 0 011123456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.98 Aligned_cols=246 Identities=28% Similarity=0.407 Sum_probs=197.6
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEe-cCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCS-ENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~~g 534 (804)
..+.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+..++||||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 346689999999999999775 667999998653 34567899999999999999999999764 456789999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++.... ..+++..++.++.+++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 9999997654 35889999999999999999999987 9999999999999999999999999987543221 22
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
...+..|+|||++.+..++.++||||||+++|||++ |+.||...... . ....+..+.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------------------~-~~~~~~~~~--- 216 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------------D-VVPRVEKGY--- 216 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------------------H-HHHHHhcCC---
Confidence 334568999999999899999999999999999998 88887632110 0 111111111
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 217 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 ------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111223356788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.42 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=196.8
Q ss_pred ccccccccccceeEEEEEeC-CCc--EEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DST--LVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||+|... ++. .+|+|.++... .....+.+|+.++.++ +||||+++++++...+..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 46688999999999999764 343 46888776432 2345788999999999 899999999999999999999999
Q ss_pred cCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 531 MRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 531 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
+++++|.+++...+ ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeC
Confidence 99999999997542 25788999999999999999999887 9999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
|||+++...... .......+..|+|||++.+..++.++||||||++++||+| |..||......
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------------- 230 (303)
T cd05088 167 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------------- 230 (303)
T ss_pred ccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------------
Confidence 999986422111 1112234678999999988889999999999999999998 99988642111
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
. .......+ .....+......+.+++.+|++.+|++||++.+++++|+.+..
T Consensus 231 ----~-~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 231 ----E-LYEKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ----H-HHHHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 01111111 0011111234568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.70 Aligned_cols=235 Identities=24% Similarity=0.314 Sum_probs=190.3
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. +++.||||+++.. ....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 5789999999642 23345677888888766 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 99999887654 6889999999999999999999988 9999999999999999999999999987532221 12334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... -....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------------------~~~~~i~~~~~--- 213 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------------------DLFEAILNDEV--- 213 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------------------HHHHHHhcCCC---
Confidence 56899999999999999999999999999999999999999743211 01111211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
..+......+.+++..|++.||++||++
T Consensus 214 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 -------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111234567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.49 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=206.3
Q ss_pred cccccccccccceeEEEEEeC-----CCcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-----DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 526 (804)
..+.+.||+|+||.||++++. .+..+|||+++..... .++|.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999764 3578999999866553 6789999999999999999999999987 567899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999999999877667999999999999999999999987 999999999999999999999999999876532
Q ss_pred cc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 FS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. .......++..|+|||.+.+..++.++||||||++++||++|+.|+........... . ........... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~--~~~~~~~~~~~-~~~ 238 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI-G--IAQGQMIVTRL-LEL 238 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc-c--cccccccHHHH-HHH
Confidence 11 111223456679999999888999999999999999999999998865322211000 0 00000111111 111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+..+ .....+......+.+++.+|++.+|++||+|.+|+++|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 11111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.42 Aligned_cols=253 Identities=19% Similarity=0.320 Sum_probs=202.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|+.. +++.||||.++... .....+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45678999999999999764 67899999886422 22346889999999999999999999999999999999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++++|..++.. ....+++..++.++.|+++||+|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999988853 2345788999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+...
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----------------~~~-~~~~~~~~ 223 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------------LFS-LCQKIEQC 223 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----------------HHH-HHHHHhcC
Confidence 123346888999999999888999999999999999999999998642111 001 11111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
... ..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYP--------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC--------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 111223446789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.29 Aligned_cols=239 Identities=22% Similarity=0.393 Sum_probs=189.6
Q ss_pred cccccccceeEEEEEeCC-------------CcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 460 EKLGHGGFGAVFQGELSD-------------STLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
+.||+|+||.||+|.+.. ...|++|.+..... ....|.+|+.++.+++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997542 23589998865432 3456888999999999999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc-------eEEeecC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT-------AKVSDFG 598 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~DfG 598 (804)
+||||+++++|..++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998876667899999999999999999999987 999999999999987664 8999999
Q ss_pred CccccCCCccccccccccccccccchhcc-CCCCCccceEEeehhhHHHhh-hCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDFSRVLATMRGTWGYVAPEWIS-GLAITTKADVYSYGMTLLELI-GGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~ksDV~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------------- 216 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---------------- 216 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----------------
Confidence 98754322 2345788999999886 467899999999999999998 577776532110
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.......+.. . . .......+..++.+||+.||++||++.+|++.|+
T Consensus 217 ----~~~~~~~~~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 217 ----EKERFYEGQC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----HHHHHHhcCc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0011111111 0 0 1112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=320.16 Aligned_cols=242 Identities=25% Similarity=0.311 Sum_probs=191.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHH---cCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTI---GNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.||+|+||.||++... .++.||||+++.. ....+.+.+|++++ .+++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 5678999999999999765 5789999999743 22334566666554 57789999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 83 ~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 83 YAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred CCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 99999999888653 6899999999999999999999988 999999999999999999999999998753221 12
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... -....+..+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------------------~~~~~i~~~~ 217 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------------------EVFDSIVNDE 217 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCC
Confidence 233467899999999999999999999999999999999999999743211 0111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
. ..+......+.+++.+||+.||.+|| ++.++++.
T Consensus 218 ~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 V----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 11222346678999999999999999 45565543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.54 Aligned_cols=236 Identities=26% Similarity=0.313 Sum_probs=187.4
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHH-HHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVC-TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 57889999996431 22334555554 67889999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST 155 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence 99998887643 6788888999999999999999987 999999999999999999999999998753222 122334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ....+..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------~-~~~~i~~~~---- 212 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------------------Q-MYDNILHKP---- 212 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------------------H-HHHHHhcCC----
Confidence 56899999999999999999999999999999999999999642110 0 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG 729 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 729 (804)
+ ..+......+.+++.+|++.+|.+||+..
T Consensus 213 ----~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ----L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 11223445788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.82 Aligned_cols=196 Identities=26% Similarity=0.399 Sum_probs=167.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|+.. +++.||||+++... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 45689999999999999775 67899999997532 234567889999999999999999999999999999999996
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 162 (303)
T cd07869 87 TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSN 162 (303)
T ss_pred cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCC
Confidence 5777777766567889999999999999999999988 9999999999999999999999999997543221 22234
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
..+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 568899999999865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.53 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=200.6
Q ss_pred cccccccccccceeEEEEEeCC------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.+.||+|+||.||+|.... +..||+|.+..... ....+.+|+.++..++||||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3456889999999999997642 36799999875432 235688999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 528 YDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcc
Confidence 99999999999986532 24678899999999999999999887 9999999999999999999999999
Q ss_pred CccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------------- 228 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---------------- 228 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----------------
Confidence 997653321 122233456789999999998889999999999999999998 88888642211
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
-..+....+.... .+......+.+++..|++.+|++||++.+|++.|+.
T Consensus 229 ---~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 229 ---EVLKFVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111222221111 122235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.52 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=196.6
Q ss_pred hcccccccccccceeEEEEEeCC---------------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD---------------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGF 517 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~ 517 (804)
...+.++||+|+||.||++...+ ...||||.++.... ....|.+|++++.+++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 34566899999999999986532 23589999875422 33568999999999999999999999
Q ss_pred EecCCeEEEEEEEcCCCChhHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 518 CSENSHRLLVYDYMRNGALSLYLRKDG-----------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 518 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
+...+..++||||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||||+|||+
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEE
Confidence 999999999999999999999986532 13678899999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh--CCCCCCCCcCCCCC
Q 044374 587 DSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG--GRRNVEAPASGRNA 663 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~ 663 (804)
+.++.+||+|||++....... ........++..|+|||++.+..++.++||||||++++||++ +..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 999999999999997643221 111223345778999999998899999999999999999998 455655321110
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
............. .......+...+..+.+++.+|++.+|++||+|.+|++.|+.
T Consensus 241 -------------~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 -------------VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -------------HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0000000000000 000011112234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.26 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=202.8
Q ss_pred hcccccccccccceeEEEEEeC--------CCcEEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCe
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSH 523 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 523 (804)
...+.+.||+|+||.||+++.. ++..||+|.++... ...+++.+|+.++..+ +||||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 3446789999999999999641 23579999987532 3346789999999999 89999999999999999
Q ss_pred EEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 524 RLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
.++||||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcC
Confidence 999999999999999997532 24778889999999999999999987 999999999999999
Q ss_pred CCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCC
Q 044374 589 DYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIG 666 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 666 (804)
++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------- 245 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------- 245 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------
Confidence 99999999999986543221 11223345678999999998889999999999999999998 7777753211
Q ss_pred CCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 667 GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
......+..+... ..+......+..++..||+.+|.+||++.+|++.|+.+...
T Consensus 246 ------------~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 ------------EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ------------HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111122222111 11223456788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.85 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=199.6
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
++||+|+||.||++...+++.||+|++..... ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999887789999999876433 3467899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc-cccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV-LATMRG 616 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~g 616 (804)
+++......+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......... ......
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776557889999999999999999999988 9999999999999999999999999998654221111 112234
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
+..|+|||.+.+..++.++||||||++++||++ |..||...... -....+..+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------------------~~~~~~~~~~------ 212 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------------------QTRERIESGY------ 212 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------------------HHHHHHhcCC------
Confidence 667999999998899999999999999999999 78877542211 0111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
....+...+..+.+++.+|++.+|++||++.||++.|+
T Consensus 213 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 ---RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11112233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.92 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=198.5
Q ss_pred ccccccccccceeEEEEEeC------CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.++||+|+||.||++... .+..+|+|.+.... .....+.+|+.++++++|+||+++++++......+++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 35679999999999999642 35679999887543 334679999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 530 YMRNGALSLYLRKDG--------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEEC
Confidence 999999999987643 24788999999999999999999888 9999999999999999999999
Q ss_pred ecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 596 DFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 596 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
|||++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------------- 231 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------------- 231 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------------
Confidence 999997543221 122223345788999999999999999999999999999998 88888532111
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
-.......+... ..+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 232 ------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 ------EAIECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------HHHHHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 011111111110 111223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.91 Aligned_cols=258 Identities=27% Similarity=0.377 Sum_probs=199.4
Q ss_pred cccccccccccceeEEEEEeCC-----------------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeee
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD-----------------STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRG 516 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g 516 (804)
..+.++||+|+||.||++...+ +..||+|++..... ...++.+|+.++++++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3466899999999999986542 24689999875432 3467889999999999999999999
Q ss_pred EEecCCeEEEEEEEcCCCChhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 517 FCSENSHRLLVYDYMRNGALSLYLRKDG----------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 517 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
++......++|+||+++++|..++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceee
Confidence 9999999999999999999999997643 25889999999999999999999987 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh--CCCCCCCCcCCCCC
Q 044374 587 DSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG--GRRNVEAPASGRNA 663 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~ 663 (804)
+.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ +..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---- 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---- 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh----
Confidence 999999999999997643321 122234456789999999988889999999999999999998 5666653211
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.......... ....+.......+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 240 ---------------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ---------------QQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---------------HHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111110 00000000011122234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.90 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=201.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||++... +++.|++|.+... .....++.+|+.++++++|||++++++++......++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35678999999999999765 6788999998643 2345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence 99999999775 457899999999999999999999887 99999999999999999999999999886543321 22
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....++..|+|||++.+..++.++||||||++++||++|+.||..... .........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~~~ 219 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------------------GALILKIIRGVFP 219 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHcCCCC
Confidence 345678899999999999999999999999999999999999874321 1111222222111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+|++.+|++||++.+|++.
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1112334678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.71 Aligned_cols=254 Identities=23% Similarity=0.256 Sum_probs=206.5
Q ss_pred ccccccccccceeEEEEEeCCC-cEEEEEEecC-CCCCHHHHHHHHHHHcCCC-CCCceeeeeE-Eec------CCeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSDS-TLVAVKRLER-PGSGEREFRAEVCTIGNIQ-HVNLVRLRGF-CSE------NSHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------~~~~~l 526 (804)
.+.+.|.+|||+.||.|....+ ..+|+|++-. .+...+..++||.+|++|+ |+|||.+++. ... .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3557899999999999988766 9999999854 3456678999999999997 9999999993 221 136789
Q ss_pred EEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 527 VYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+||||++|.|-+++..+. ..|++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||.+...-.
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 999999999999997542 35999999999999999999999875 7799999999999999999999999999864221
Q ss_pred Cc--c-c-----cccccccccccccchhc---cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 606 DF--S-R-----VLATMRGTWGYVAPEWI---SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 606 ~~--~-~-----~~~~~~gt~~y~aPE~l---~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
.. . . ..-...-|+-|.|||++ .+..+++|+|||+|||+||-|+....||+...
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------------- 262 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------------- 262 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------------
Confidence 11 0 0 01123468999999976 67789999999999999999999999998421
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
-..+++....-........++..||..||+.||.+||++-+|+..+-.+...+
T Consensus 263 ---------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22344444433334567889999999999999999999999999988776544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=326.64 Aligned_cols=191 Identities=25% Similarity=0.292 Sum_probs=165.5
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.++||+|+||.||++.. ..++.||||.... ..+.+|+.++++++||||+++++++......++|+|++. +
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 44668999999999999965 4678899997542 346789999999999999999999999999999999986 6
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|..++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 168 ~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 168 DLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 8888876543 6889999999999999999999987 99999999999999999999999999975433222223446
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 799999999999999999999999999999999999988754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.17 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=204.5
Q ss_pred cccccccccccceeEEEEE-eCCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 528 (804)
+.+.++||+|||+-||.++ ..++..+|+|++.... ++.+..++|++..++++||||+++++++..+ .+.||++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 4467899999999999996 5678899999997654 5677889999999999999999999887544 3589999
Q ss_pred EEcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+|...|+|.+.+.. .+..+++.+.+.|+.+|++||.+||+.. ++++||||||.|||+.+.+.++|.|||.+....-
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 99999999998864 3457899999999999999999999976 4699999999999999999999999999875422
Q ss_pred Ccc--------ccccccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 606 DFS--------RVLATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 606 ~~~--------~~~~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
... .......-|..|.|||.+. +...++++|||||||+||+|+.|..||+..... .
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-G------------ 248 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-G------------ 248 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-C------------
Confidence 111 1122345688999999884 446789999999999999999999999853221 0
Q ss_pred cCchHHHHHHhhcCcc-ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 675 WFFPPWAARQIIEGNV-AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
+.+ ..+....+.-......++.+.+++.+|++.||.+||++.+++..++.+
T Consensus 249 -------------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -------------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 112222222222223567899999999999999999999999999765
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.97 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=200.8
Q ss_pred hcccccccccccceeEEEEEeC--------CCcEEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCe
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSH 523 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 523 (804)
...+.++||+|+||.||++... ....+|+|.++... ....++.+|+.++.++ +||||+++++++.....
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3457789999999999999652 22469999997542 2345688899999999 79999999999999999
Q ss_pred EEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 524 RLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
.++||||+++++|.+++.... ..+++.++++++.|++.||+|||+.+ ++||||||+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcC
Confidence 999999999999999997642 24788999999999999999999887 999999999999999
Q ss_pred CCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCC
Q 044374 589 DYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIG 666 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 666 (804)
++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------- 248 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------- 248 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-------
Confidence 9999999999987653211 111122234578999999999899999999999999999998 8888753211
Q ss_pred CCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 667 GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.-....+..+.. ...+......+.+++..|++.+|++||+|.+|++.|+.+..
T Consensus 249 ------------~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 ------------EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ------------HHHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 011111111111 11222345678889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.90 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=193.3
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||+||++... +++.||||++.... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999764 67899999996432 1235677899999999999999999999999999999999999999
Q ss_pred hHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 537 SLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 537 ~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988753 2346899999999999999999999988 99999999999999999999999999976543222 1234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........ +
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------------------~~~~~~~~----~ 213 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------------------ENKELKQR----I 213 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------------------hHHHHHHh----h
Confidence 568999999999999999999999999999999999999997432110 00000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
..... ..+......+.+++..|++.||++|| ++.+++++
T Consensus 214 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 LNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11100 11223456788999999999999999 66777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.51 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=201.1
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
..+.+.||+|+||.||++... .+..||||+++.... ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 446689999999999999641 245799999875432 235689999999999 79999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 527 VYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
||||+++++|.++++... ..+++.++..++.+++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997643 34899999999999999999999987 99999999999999999999999999986543
Q ss_pred Cccc-cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFSR-VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .-...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------------------~~~~~ 255 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------------------SKFYK 255 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------------------HHHHH
Confidence 3211 1222345778999999999999999999999999999998 99888642211 00111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
....+. ....+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 256 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111 1111112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.99 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=203.3
Q ss_pred ccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhH
Q 044374 461 KLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 538 (804)
.||+|.||+||.|+.. ....+|||-+... ....+.+.+||.+.++++|.|||+++|.|.++++.-|.||.+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999654 5567999999654 4455678999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCccccCCCccccccccc
Q 044374 539 YLRKDGLNL--NWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 539 ~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
+|+..=.++ ++.+.-.+.+||++||.|||+.. |||||||-.||||+ -.|.+||+|||-++.+.. ......+..
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 998775566 78888899999999999999988 99999999999996 578999999999987533 234456788
Q ss_pred cccccccchhccCC--CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 616 GTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 616 gt~~y~aPE~l~~~--~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
||..|||||++..+ .|..++|||||||++.||.||++||-.....+ ++ .+.-|-
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------------------AA-MFkVGm---- 793 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------------------AA-MFKVGM---- 793 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------------------Hh-hhhhcc----
Confidence 99999999999775 58899999999999999999999997532211 10 011111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
-....+.+.+...+...++++|..++|.+||+++++++
T Consensus 794 --yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 --YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11234567788889999999999999999999999885
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.37 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=189.5
Q ss_pred ccccccccccceeEEEEEeC--CCcEEEEEEecCCC---CCHHHHHHHHHHHcCC---CCCCceeeeeEEec-----CCe
Q 044374 457 GFSEKLGHGGFGAVFQGELS--DSTLVAVKRLERPG---SGEREFRAEVCTIGNI---QHVNLVRLRGFCSE-----NSH 523 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~~ 523 (804)
.+.++||+|+||.||+|+.. +++.||||+++... .....+.+|+.+++++ +||||++++++|.. ...
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 35678999999999999763 46789999986432 2234566677766655 79999999999852 356
Q ss_pred EEEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 524 RLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
.++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999997 58888886543 45899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 681 (804)
.... .......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......... +......... ..|.
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~---~~~~ 234 (290)
T cd07862 160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE---EDWP 234 (290)
T ss_pred ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh---hhch
Confidence 5432 22344568999999999998899999999999999999999999997532210000 0000000000 0000
Q ss_pred HHHhhcCccceecccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLG---GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..... .......... .....+....+.+++.+|++.||++||++.++++
T Consensus 235 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcc---cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000000 0001123456788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.52 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=197.2
Q ss_pred ccccccccceeEEEEEe-CCCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
...||+|+||.||.++- ..|..+|+|+++++. ...+..+.|-.+|...++|.||+|+-.|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 46899999999999955 468999999998653 3345688899999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC--------
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-------- 605 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~-------- 605 (804)
|++..+|...+ .|+++....++.+++-|+..||+.+ +|||||||+|+|||..|++||+||||+.-+..
T Consensus 226 GD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 226 GDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred ccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 99999998766 7899999999999999999999988 99999999999999999999999999853210
Q ss_pred ---------------Ccc-----c------------------cccccccccccccchhccCCCCCccceEEeehhhHHHh
Q 044374 606 ---------------DFS-----R------------------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647 (804)
Q Consensus 606 ---------------~~~-----~------------------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~el 647 (804)
+.. . .....+|||.|||||++.+..|+...|.||+|||||||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 000 0 01124699999999999999999999999999999999
Q ss_pred hhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 044374 648 IGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT 727 (804)
Q Consensus 648 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 727 (804)
|.|.+||....+. -.++++..-. ..+..........+...+|.+|+. ||++|--
T Consensus 382 LvGyPPF~s~tp~-------------------~T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 382 LVGYPPFCSETPQ-------------------ETYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HhCCCCCCCCCHH-------------------HHHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999875443 1223222211 011111122334677888999998 9999985
Q ss_pred ---HHHHHHH
Q 044374 728 ---MGTVVKM 734 (804)
Q Consensus 728 ---~~eVl~~ 734 (804)
+.||-++
T Consensus 436 ~~G~~EIK~H 445 (550)
T KOG0605|consen 436 SKGAEEIKKH 445 (550)
T ss_pred cccHHHHhcC
Confidence 5666544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.48 Aligned_cols=195 Identities=25% Similarity=0.326 Sum_probs=169.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.||+|+||+||++... .++.||||+++... .....+++|+.++.+++||||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4678999999999999664 57899999996432 233567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc----
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS---- 608 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~---- 608 (804)
+|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 85 GGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999998654 7899999999999999999999988 99999999999999999999999999875422100
Q ss_pred ------------------------------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 609 ------------------------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 609 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.99 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=193.2
Q ss_pred cccccccceeEEEEEeC----CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEe-cCCeEEEEEEEcC
Q 044374 460 EKLGHGGFGAVFQGELS----DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCS-ENSHRLLVYDYMR 532 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~ 532 (804)
+.||+|+||.||+|... ....||+|++.... ...+.+.+|+.+++.++|||++++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 23579999986432 23467889999999999999999999876 4556899999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc---c
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS---R 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~---~ 609 (804)
+++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876556788888999999999999999887 99999999999999999999999999975432211 1
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCC-CCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR-RNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||++.+..++.++||||||+++|||++|. .||..... .. .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------------------~~-~~~~~~~~ 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------------------FD-ITVYLLQG 218 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------------------HH-HHHHHhcC
Confidence 112334577899999999889999999999999999999964 44542110 00 11111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
... ..+...+..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 219 ~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RRL---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 100 011122456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.94 Aligned_cols=236 Identities=27% Similarity=0.334 Sum_probs=188.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHH-HHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVC-TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||+||+|... +++.||||++... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999775 6889999999642 122334455544 56889999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 99999987654 6888999999999999999999988 999999999999999999999999998753221 122334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------------------~~~~~i~~~~~--- 213 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------------------EMYDNILNKPL--- 213 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------------------HHHHHHHcCCC---
Confidence 56899999999999999999999999999999999999999743211 01111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG 729 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 729 (804)
.+ +......+.+++.+|++.||.+||++.
T Consensus 214 ---~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 ---RL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01 112346688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=316.50 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=192.1
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++... +++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999765 56889999997532 2234578899998888 699999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 99998887654 6899999999999999999999988 999999999999999999999999998753221 112334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~--- 220 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP------------DMNTEDYLFQVILEKPI--- 220 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc------------ccccHHHHHHHHHhCCC---
Confidence 678999999999999999999999999999999999999996432211 11111222222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
..+......+.+++.+||+.||++||++
T Consensus 221 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 -------RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122234567889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.15 Aligned_cols=271 Identities=19% Similarity=0.234 Sum_probs=199.4
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCCCH---HHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEEEEcC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVYDYMR 532 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 532 (804)
.++|++|.||.||+|+.. .++.||+|+++...... -.-.+||.+|.+++|||||.+-.+..- -+..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 358999999999999764 67889999998643221 235789999999999999999888753 357899999998
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+ +|..++...+..+...+..-+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.++... ...+
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T 235 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYT 235 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc-ccCc
Confidence 7 888888887778999999999999999999999887 9999999999999999999999999999887663 3356
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-CCCCccCchHHHHHH-hhcCc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG-EHGDKWFFPPWAARQ-IIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 689 (804)
..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|.+...-.....+... ....+..++.+..-. +..-.
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 67889999999988775 6999999999999999999999888764332111000000 000000111100000 00001
Q ss_pred cceeccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVE-EAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+..-..+...+... ..+.-..++...+..||.+|-|+++.++.
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111112222222222 34566778888999999999999987754
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.65 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=202.0
Q ss_pred hcccccccccccceeEEEEEeCC----CcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
...+.++||+|+||.||+|...+ ...||||...... ...+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 34467899999999999997643 3468999887543 234578999999999999999999999875 5578999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++++|.+++......+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999876667899999999999999999999987 99999999999999999999999999986543322
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......++..|+|||.+....++.++||||||++++|+++ |+.||...... . ....+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------------------~-~~~~~~~ 223 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------------------D-VIGRIEN 223 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------------------H-HHHHHHc
Confidence 21223334568999999988889999999999999999996 99998643211 0 1111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+... ..+...+..+.+++.+|+..+|.+||++.++++.|+++..
T Consensus 224 ~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERL---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1122334678899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.40 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=194.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. .++.||||++... ......+++|+.++..++||||+++++++......++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34678999999999999765 5789999999643 223356788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-- 609 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 609 (804)
++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 84 ~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 84 PGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999997654 6899999999999999999999988 999999999999999999999999998754221000
Q ss_pred -----------------------------------cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 610 -----------------------------------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 610 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
......||+.|+|||++.+..++.++|||||||+++||++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011246899999999999999999999999999999999999999
Q ss_pred CCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC---HHHH
Q 044374 655 EAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT---MGTV 731 (804)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~eV 731 (804)
...... .....+.... ..+.........+.+.+++..|+. +|.+|++ +.++
T Consensus 240 ~~~~~~-------------------~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 240 CSDNPQ-------------------ETYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCCHH-------------------HHHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 743211 0111111110 000000011123456778888886 8999998 8888
Q ss_pred HHH
Q 044374 732 VKM 734 (804)
Q Consensus 732 l~~ 734 (804)
+++
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.95 Aligned_cols=253 Identities=19% Similarity=0.311 Sum_probs=202.4
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++.. .+++.+|||.+.... ....++.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 3557899999999999975 478899999886432 12357889999999999999999999999999999999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++++|.+++.. ....+++..++.++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999998864 2346899999999999999999999988 99999999999999999999999999886543321
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||++.+..++.++||||||+++|||++|..||...... ... ....+...
T Consensus 162 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~-~~~~~~~~ 223 (267)
T cd08229 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------------LYS-LCKKIEQC 223 (267)
T ss_pred -ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----------------HHH-HhhhhhcC
Confidence 123456888999999999989999999999999999999999998642211 000 00111110
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
. .+ ..........+.+++.+|++.+|++||+|.+|+++++++
T Consensus 224 ~-----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 D-----YP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C-----CC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 01 111123456788999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=317.09 Aligned_cols=197 Identities=25% Similarity=0.301 Sum_probs=171.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+++.. .++.||||++... ......+++|+.++..++|+||+++++++...+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999765 5788999999642 223345888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999875557899999999999999999999988 99999999999999999999999999986654433223
Q ss_pred cccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
....||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 34569999999999876 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.80 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=197.6
Q ss_pred cccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecC-CeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSEN-SHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~~~ 525 (804)
..+.+.||+|+||.||+|.. ..++.||||+++.... ....+.+|+.++.++ +||||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45678999999999999963 3467899999975432 345688999999999 789999999988654 5678
Q ss_pred EEEEEcCCCChhHHHhhCC-------------------------------------------------------------
Q 044374 526 LVYDYMRNGALSLYLRKDG------------------------------------------------------------- 544 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 544 (804)
+||||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999986421
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-cccccccccc
Q 044374 545 -----LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTW 618 (804)
Q Consensus 545 -----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~ 618 (804)
..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........ .......++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 13577888999999999999999987 99999999999999999999999999986532211 1122234567
Q ss_pred ccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 619 GYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 619 ~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
.|+|||.+.+..++.++||||||+++|||++ |..||...... ......+.++.....
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~---- 303 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------------EEFCRRLKEGTRMRA---- 303 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------------------HHHHHHHhccCCCCC----
Confidence 8999999999899999999999999999997 88887642110 111122222211111
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+......+.+++..||+.+|++||++.+|++.|+.+.+
T Consensus 304 -----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 -----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123468899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=336.68 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCC--------e
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENS--------H 523 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------~ 523 (804)
+.+.+.||+|+||.||+++. .+++.||||++..... ....+++|+..+..++|+|++++...+.... .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 44668999999999999965 4689999999975432 2356788999999999999999987765332 3
Q ss_pred EEEEEEEcCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 524 RLLVYDYMRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccC
Confidence 68999999999999998753 246889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 601 KLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 601 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------------------~ 251 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------------------E 251 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------------------H
Confidence 8654321 2223456799999999999999999999999999999999999999964211 0
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
........+... ..+......+..++..||+.+|.+||++.+++++
T Consensus 252 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLAGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111111111 1222345678899999999999999999999864
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.47 Aligned_cols=238 Identities=23% Similarity=0.392 Sum_probs=191.5
Q ss_pred cccccccceeEEEEEeCCCc-----------EEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDST-----------LVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
+.||+|+||.||+|...+.. .|++|.+.........|.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999875433 57888876554447789999999999999999999999988 7789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-------ceEEeecCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-------TAKVSDFGLAK 601 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DfGla~ 601 (804)
||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999876657899999999999999999999887 99999999999999888 79999999998
Q ss_pred ccCCCccccccccccccccccchhccCC--CCCccceEEeehhhHHHhhhC-CCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGG-RRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
.... .....++..|+|||++... .++.++||||||+++|||++| ..|+......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~------------------ 213 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------------------ 213 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch------------------
Confidence 6533 1233466789999999876 789999999999999999994 6666532111
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.+ ........ ..+......+.+++..|++.+|.+||++.+|++.|+
T Consensus 214 ~~-~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 EK-ERFYQDQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hH-HHHHhcCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00000000 001111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.91 Aligned_cols=239 Identities=23% Similarity=0.312 Sum_probs=190.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcC-CCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGN-IQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. .++.||||+++.. ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999775 5788999999753 2334556777777765 5899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 99999987653 6889999999999999999999988 999999999999999999999999998743211 112344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------------------~~~~~~~~~~---- 212 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------------------ELFESIRVDT---- 212 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCC----
Confidence 67899999999999999999999999999999999999999742210 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG-TVV 732 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl 732 (804)
+ ..+......+.+++..|++.||++||++. ++.
T Consensus 213 --~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 --P----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 11112345678899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.95 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=191.3
Q ss_pred cccccccceeEEEEEeCC---CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSD---STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 35799999875433 3357889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-c
Q 044374 535 ALSLYLRKDG----LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-R 609 (804)
Q Consensus 535 sL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 609 (804)
+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 24567788899999999999999987 99999999999999999999999999975433211 1
Q ss_pred cccccccccccccchhccCC-------CCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 610 VLATMRGTWGYVAPEWISGL-------AITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~-------~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------------------~ 218 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------------------V 218 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------------------H
Confidence 12234567889999998643 35789999999999999996 999986432110 0
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
......+......++.+.. ...+.+.+++..|+ .+|++||++.+|++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYTVREQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHhhcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0111111112222222211 22345778889998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.95 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=191.0
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcC-CCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGN-IQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|... .++.||||+++.. ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999775 4688999999753 2334456677777765 5899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCT 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceee
Confidence 99999997643 6889999999999999999999988 999999999999999999999999998753211 112234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------------------~~~~~i~~~~---- 212 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------------------ELFQSIRMDN---- 212 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCC----
Confidence 56899999999999999999999999999999999999999742211 0111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG-TVVK 733 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 733 (804)
+ ..+......+.+++.+|++.+|++||++. ++.+
T Consensus 213 --~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 --P----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --C----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 11112345678899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.97 Aligned_cols=266 Identities=24% Similarity=0.253 Sum_probs=189.7
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC-----eEEEEEEEcC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS-----HRLLVYDYMR 532 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~ 532 (804)
.+.+|.|+||.||+|... .++.||||+.-.... .-.+|+.+|++++|||||+|+-++.... ...+|||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 368999999999999775 468999999854322 2246888999999999999998875432 3358999998
Q ss_pred CCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCCcc
Q 044374 533 NGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 533 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~ 608 (804)
. +|.++++. .+..++...+.-+..||++||+|||+.+ |+||||||+|+|+|.+ +.+||||||.|+.+.....
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 77777763 2346777778889999999999999987 9999999999999976 9999999999998765433
Q ss_pred ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC-CCCCCCCccCchHHHHHHhh
Q 044374 609 RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG-GGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 686 (804)
. ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|+..|.+.+.......+ ..........+..+.... .
T Consensus 182 n--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y-~ 258 (364)
T KOG0658|consen 182 N--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY-T 258 (364)
T ss_pred c--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc-c
Confidence 2 345568899999988774 7999999999999999999999998874433111000 000000000000000000 0
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+-...++....+..-.......+.++++.++++.+|.+|.++.|++.+
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 001111111111111233445678899999999999999999999865
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.09 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=198.5
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||.||+|... .+..||+|.++.... ....+.+|+.++++++||||+++++++......++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 446689999999999999643 245799999875432 234678899999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 528 YDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999997532 23466788999999999999999887 9999999999999999999999999
Q ss_pred CccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
+++...... ........++..|+|||.+.+..++.++|||||||+++||++ |..||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---------------- 228 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------------- 228 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------
Confidence 998643321 111223345678999999999899999999999999999998 67777532110
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....+..+... ..+......+.+++.+|++.+|++||++.++++.|++.+
T Consensus 229 --~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 229 --Q-VLKFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --H-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 11111111111 111223467999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.35 Aligned_cols=197 Identities=26% Similarity=0.336 Sum_probs=169.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+++.. .++.||||++... ......+++|+.++.+++||||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 35678999999999999764 5789999999642 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-----
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD----- 606 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~----- 606 (804)
++|+|.+++...+ .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 84 PGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999999997654 6788888999999999999999988 999999999999999999999999997532100
Q ss_pred -------------------------------------ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh
Q 044374 607 -------------------------------------FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 607 -------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
.........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 0000123469999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 044374 650 GRRNVEAP 657 (804)
Q Consensus 650 g~~p~~~~ 657 (804)
|+.||...
T Consensus 240 G~~Pf~~~ 247 (376)
T cd05598 240 GQPPFLAD 247 (376)
T ss_pred CCCCCCCC
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.43 Aligned_cols=238 Identities=24% Similarity=0.389 Sum_probs=187.3
Q ss_pred ccccccceeEEEEEeCC-------------------------CcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceee
Q 044374 461 KLGHGGFGAVFQGELSD-------------------------STLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRL 514 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l 514 (804)
+||+|+||.||+|.+.. ...||+|++..... ...+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13589998865322 23568889999999999999999
Q ss_pred eeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----
Q 044374 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---- 590 (804)
Q Consensus 515 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---- 590 (804)
+++|......++||||+++++|..++......+++..++.++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999876667899999999999999999999887 99999999999997644
Q ss_pred ---ceEEeecCCccccCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhh-hCCCCCCCCcCCCCCcC
Q 044374 591 ---TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELI-GGRRNVEAPASGRNANI 665 (804)
Q Consensus 591 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~ell-tg~~p~~~~~~~~~~~~ 665 (804)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---- 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---- 229 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH----
Confidence 3899999998643221 22346788999998866 56899999999999999995 7888886432110
Q ss_pred CCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
........ ... +......+.+++..||+.+|++||++.+|++.|+
T Consensus 230 ---------------~~~~~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---------------KERFYEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---------------HHHHHHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00000000 001 1112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.74 Aligned_cols=245 Identities=29% Similarity=0.410 Sum_probs=197.9
Q ss_pred cccccccceeEEEEEeCC--C--cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSD--S--TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++||+|++|.||+|.+.. + ..||||.+..... ..+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 3699999976543 45678999999999999999999999988 889999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--c
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--V 610 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~ 610 (804)
++|.+++.... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765 56899999999999999999999987 999999999999999999999999999876442211 1
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh-cC
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-EG 688 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 688 (804)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...... . ....+. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------------~-~~~~~~~~~ 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------------------Q-ILKKIDKEG 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------------------H-HHHHHHhcC
Confidence 223456789999999999899999999999999999999 99998632111 0 111111 11
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.. ...+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 218 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ER---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred Cc---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 0111223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.85 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=192.8
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||.||+++.. .++.||+|++... ......+..|+.++.+++||||+++++++....+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999765 5889999999642 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 537 SLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 537 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 98886543 46889999999999999999999988 9999999999999999999999999997654322 123356
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
++..|+|||++.+..++.++|||||||++|||++|+.||....... . ..........+. +.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--------------~-~~~~~~~~~~~~----~~ 216 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--------------A-KEELKRRTLEDE----VK 216 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--------------h-HHHHHHHhhccc----cc
Confidence 8999999999999899999999999999999999999986421110 0 000001111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
. ........+.+++..||+.||++||++.|+++.+
T Consensus 217 ~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 217 F-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred c-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0 0012245678999999999999999998766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.57 Aligned_cols=269 Identities=18% Similarity=0.250 Sum_probs=193.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 527 (804)
.+.++||+|+||.||+|... +++.||||+++.. ......+.+|+.++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 35678999999999999754 6789999999743 22345688999999999999999999988543 257999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+. ++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 83 FELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 99996 68888887544 6899999999999999999999988 9999999999999999999999999998643221
Q ss_pred --cccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 608 --SRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 608 --~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
........+|..|+|||++.+ ..++.++|||||||++|||++|+.||............... .. ..+.....
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~---~~-~~~~~~~~ 233 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL---LG-TPSPETIS 233 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH---hC-CCCHHHHH
Confidence 112234578999999999876 67899999999999999999999999643211000000000 00 00000000
Q ss_pred HhhcCccceeccc---cccCCC---CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDD---RLGGAY---KVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~---~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+........++. ...... -......+.+++.+||+.+|++||+++++++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111100000000 000000 00123457899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.95 Aligned_cols=241 Identities=26% Similarity=0.335 Sum_probs=194.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++... +++.||||+++.. ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 4788999999743 23345677888888877 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 99999887654 6899999999999999999999988 9999999999999999999999999987532211 11234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------------------~~~~~i~~~~~--- 213 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------------------ELFQSILEDEV--- 213 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------------------HHHHHHHcCCC---
Confidence 56899999999999999999999999999999999999999743211 11111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM-----GTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~~ 734 (804)
..+......+.+++.+||+.||.+||++ .++++.
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 -------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122234568899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.78 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=196.1
Q ss_pred cccccccceeEEEEEeCC-------CcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD-------STLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.||+|+||.||+|+..+ ++.+|||.+.... ....++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2579999886543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-----ceEEeecCC
Q 044374 531 MRNGALSLYLRKD------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-----TAKVSDFGL 599 (804)
Q Consensus 531 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DfGl 599 (804)
+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753 234788999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++..... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----------------- 220 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----------------- 220 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----------------
Confidence 9754322 1111223345788999999999999999999999999999998 99888632110
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
. ....+..+.. ...+...+..+.+++.+||+.+|.+||++.+|+++|++
T Consensus 221 -~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 -E-VLQHVTAGGR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -H-HHHHHhcCCc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 1111111110 01122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.74 Aligned_cols=196 Identities=27% Similarity=0.348 Sum_probs=168.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|+.. .++.||||++.... .....+.+|+.++++++||||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 35678999999999999764 67889999996432 22356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc----
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF---- 607 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 607 (804)
++|+|.+++...+ .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 84 PGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999997654 6788889999999999999999988 9999999999999999999999999975321000
Q ss_pred ------------------------------------------cccccccccccccccchhccCCCCCccceEEeehhhHH
Q 044374 608 ------------------------------------------SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLL 645 (804)
Q Consensus 608 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ 645 (804)
........||+.|+|||++.+..++.++|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012346899999999999999999999999999999
Q ss_pred HhhhCCCCCCC
Q 044374 646 ELIGGRRNVEA 656 (804)
Q Consensus 646 elltg~~p~~~ 656 (804)
||++|+.||..
T Consensus 240 elltG~~Pf~~ 250 (382)
T cd05625 240 EMLVGQPPFLA 250 (382)
T ss_pred HHHhCCCCCCC
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.08 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=202.0
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.++||+|+||.||+|...+ ++.+++|.+..... ..++.+|+.++++++||||+++++++......++++||+++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 355789999999999998765 78899999976533 6789999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........ ......
T Consensus 85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccccc
Confidence 99999876678999999999999999999999988 99999999999999999999999999986543321 223345
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
++..|+|||++.+..++.++||||||+++|||++|+.||....+.... .... ....
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------------------~~~~-----~~~~ 216 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------------------FMIP-----NKPP 216 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------------------hhhc-----cCCC
Confidence 788999999999989999999999999999999999998753221100 0000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..+ ..+......+.+++.+|++.+|++||++.+|++
T Consensus 217 ~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001 112223456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=316.25 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=199.6
Q ss_pred ccccccccccceeEEEEEeC--------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 525 (804)
.+.++||+|+||.||+++.. ....+|+|+++.... ...++.+|+.++.++ +||||+++++++......+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 46789999999999999642 245799999875432 235688999999999 6999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC
Q 044374 526 LVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY 590 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 590 (804)
+||||+++|+|.+++.... ..+++..+.+++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCC
Confidence 9999999999999997532 34788999999999999999999887 99999999999999999
Q ss_pred ceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCC
Q 044374 591 TAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGG 668 (804)
Q Consensus 591 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 668 (804)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--------- 242 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--------- 242 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999986543211 11122234567999999999899999999999999999999 8888754211
Q ss_pred CCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 669 GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.........+... ..+......+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus 243 ----------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 ----------EELFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ----------HHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111112221111 1122334568899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.88 Aligned_cols=248 Identities=25% Similarity=0.298 Sum_probs=197.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
...++||+|+||.||++... +++.||||++.... .....+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34578999999999999764 67899999996432 22345778999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05605 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--c
Confidence 9999998886543 46899999999999999999999988 9999999999999999999999999998653321 1
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ........+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~--- 219 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---------------KREEVERRVKE--- 219 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---------------HHHHHHHHhhh---
Confidence 233468999999999998899999999999999999999999997422110 00000000100
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
....++......+.+++..|++.||++|| ++.++++.
T Consensus 220 -------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01112223456788999999999999999 77788654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=322.77 Aligned_cols=246 Identities=23% Similarity=0.253 Sum_probs=191.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.++||+|+||.||++... +++.||||++... ......+++|+.++.+++||||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4678999999999999654 6789999998642 2233568889999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc----
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS---- 608 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~---- 608 (804)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 85 GGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999997643 6888899999999999999999988 99999999999999999999999999963211000
Q ss_pred ---------c---------------------------------cccccccccccccchhccCCCCCccceEEeehhhHHH
Q 044374 609 ---------R---------------------------------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLE 646 (804)
Q Consensus 609 ---------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~e 646 (804)
. ......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012468999999999999999999999999999999
Q ss_pred hhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC-ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 044374 647 LIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG-NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR 725 (804)
Q Consensus 647 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 725 (804)
|++|+.||...... .....+... ......+ .......+.+++..|++ +|.+|
T Consensus 241 lltG~~Pf~~~~~~-------------------~~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 241 CLIGWPPFCSENSH-------------------ETYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred hhcCCCCCCCCCHH-------------------HHHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhc
Confidence 99999999743211 011111110 0000000 01123567788888997 66654
Q ss_pred ---CCHHHHHHH
Q 044374 726 ---PTMGTVVKM 734 (804)
Q Consensus 726 ---Ps~~eVl~~ 734 (804)
|++.+++++
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 599988876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.24 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=196.8
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCC-ceeeeeEEecCC------eEEEE
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVN-LVRLRGFCSENS------HRLLV 527 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~~~lV 527 (804)
.++||+|+||+||+|+.. .++.||+|++..... ......+|+.++++++|+| |++|++++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 467999999999999654 678999999975433 3355788999999999999 999999998877 78899
Q ss_pred EEEcCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 528 YDYMRNGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
+||++. +|..++.... ..++...+..++.||++||+|||+.+ |+||||||+||||+++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999865 8888887655 35777889999999999999999988 9999999999999999999999999999765
Q ss_pred CCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCCC---CCccC
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGEH---GDKWF 676 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~---~~~~~ 676 (804)
-. .+..+..++|..|.|||++.+. .|+...||||+|||+.||++++..|......+... +.+...+ .....
T Consensus 172 ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 172 IP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred CC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 33 2335667889999999998886 79999999999999999999998887654321100 0000000 00001
Q ss_pred chHHHHHHhhcCccceecccc-ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 677 FPPWAARQIIEGNVAAVVDDR-LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
++.|.. .....-.+. +.... ........+++.+|++.+|.+|.|++.++++
T Consensus 251 ~~~~k~------~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKA------PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccc------cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 000000000 00000 0111467789999999999999999999887
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=318.26 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=191.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||++... .++.||||+++... ...+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 35678999999999999765 56789999997532 2234566777887776 589999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 83 VNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999999987654 6889999999999999999999987 9999999999999999999999999997533221 12
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... -....+.+...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------------------~~~~~i~~~~~ 218 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------------------ELFQSIMEHNV 218 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCCC
Confidence 23456899999999999999999999999999999999999999743211 11111221111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
.++......+..++.+|++.+|++|++.
T Consensus 219 ----------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1222345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=316.78 Aligned_cols=240 Identities=25% Similarity=0.290 Sum_probs=189.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHH-HHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVC-TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. +++.||||++... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 6889999999643 122344555554 57789999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 99998887644 6889999999999999999999988 999999999999999999999999998753221 122334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... -..+.+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------------------~~~~~~~~~~~--- 213 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------------------EMYDNILHKPL--- 213 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------------------HHHHHHHcCCc---
Confidence 57899999999999999999999999999999999999999743211 01112211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.........+.+++..|++.+|.+||++.+.++
T Consensus 214 -------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 214 -------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 011123456778999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.94 Aligned_cols=246 Identities=25% Similarity=0.320 Sum_probs=197.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.||+|++|.||++... .++.||+|.+..... ....+.+|+.++++++||||+++++++......++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4578999999999999754 678999999864321 224688899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++...+ .+++..+..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 86 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 86 MPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred CCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999987654 6888999999999999999999988 9999999999999999999999999997653321111
Q ss_pred c--cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 611 L--ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 611 ~--~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
. ....++..|+|||++.+..++.++||||||+++|||++|+.||...... ..... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------------~~~~~-~~~- 221 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------------------AAIFK-IAT- 221 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------------------HHHHH-Hhc-
Confidence 1 3345788999999999989999999999999999999999998642110 00000 000
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+......+..++..|++.+|++||++.+++++
T Consensus 222 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 -------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111222344568899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.98 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=198.7
Q ss_pred ccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
.+.++||+|+||.||++... .+..||+|++..... ...++.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 35578999999999999753 457899999875432 3467899999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec
Q 044374 529 DYMRNGALSLYLRKDG---------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD 587 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~ 587 (804)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEec
Confidence 9999999999997432 24678889999999999999999987 99999999999999
Q ss_pred CCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcC
Q 044374 588 SDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANI 665 (804)
Q Consensus 588 ~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 665 (804)
.++.+||+|||++....... .........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------ 238 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------ 238 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999987543221 111222334678999999998899999999999999999998 7777753211
Q ss_pred CCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.-....+..+.... .+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 239 -------------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -------------EEVIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------------HHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 01112222222211 112234678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.55 Aligned_cols=197 Identities=25% Similarity=0.298 Sum_probs=170.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+++.. .++.+|+|++... ......+.+|+.++..++|+||+++++++......++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 45679999999999999876 4678999998642 223345888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999999876557899999999999999999999988 99999999999999999999999999976543322223
Q ss_pred cccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 3457999999999986 34678899999999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.30 Aligned_cols=253 Identities=20% Similarity=0.328 Sum_probs=203.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+|... +++.||+|.++.. ......+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 46688999999999999776 7889999988632 123467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++++|..++.. ....+++..++.++.++++||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999998864 2345889999999999999999999988 99999999999999999999999999876543321
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+..+
T Consensus 162 -~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~-~~~~~~~~ 223 (267)
T cd08224 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------------LYS-LCKKIEKC 223 (267)
T ss_pred -ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----------------HHH-HHhhhhcC
Confidence 123345788999999999889999999999999999999999998642110 000 11111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
.... .........+.+++.+|++.+|++||++.+|+++|+++
T Consensus 224 ~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111 11113445788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.40 Aligned_cols=235 Identities=25% Similarity=0.306 Sum_probs=197.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.|.+.||+|.||.|+.+..+ +++.+|||++++. ..+.+..+.|.+++... +||.|++|+.++...++++.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 46789999999999999876 5678999999865 33556788888888777 599999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+.+|++..+++. ..+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|.+||+||||++..-. ....
T Consensus 451 ~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g~~ 524 (694)
T KOG0694|consen 451 VAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QGDR 524 (694)
T ss_pred cCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC-CCCc
Confidence 999995544443 37999999999999999999999998 99999999999999999999999999985321 2234
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..+.+||+.|||||++.+..|+..+|-|||||+|||||.|..||.+.+..
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------------------ 574 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------------------ 574 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------------------
Confidence 67899999999999999999999999999999999999999999864321
Q ss_pred ceecccccc--CCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 691 AAVVDDRLG--GAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 691 ~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
++.|..+. ..+|...+.+.+.|+.+.+.++|++|--+
T Consensus 575 -e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12222221 13455667888999999999999999966
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.04 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=195.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecC------CeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSEN------SHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------~~~~lV~E 529 (804)
+.+.||+|+||.||+|... .++.||+|++........++.+|+.++.++ +|+||+++++++... ...++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 4568999999999999765 578899999987666677899999999998 799999999998653 46799999
Q ss_pred EcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 530 YMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~- 165 (272)
T cd06637 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV- 165 (272)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc-
Confidence 999999999988643 46889999999999999999999987 9999999999999999999999999998653322
Q ss_pred ccccccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 609 RVLATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ....
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------------------~~~~ 226 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------------------RALF 226 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------------------HHHH
Confidence 1233456889999999986 345788999999999999999999998642211 0000
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
......... .........+.+++.+||+.+|.+||++.+|++
T Consensus 227 ~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhcCCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111110001 111123456889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=309.97 Aligned_cols=197 Identities=25% Similarity=0.292 Sum_probs=170.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. +++.||||++... ....+.+++|+.++..++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45688999999999999765 5789999999642 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 999999999875567899999999999999999999988 99999999999999999999999999876543322222
Q ss_pred cccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33568999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.84 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=197.1
Q ss_pred cccccccccccceeEEEEEeC-----------------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeee
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-----------------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRG 516 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g 516 (804)
..+.++||+|+||.||++... +...||+|+++.... ...++.+|+.++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 346789999999999998532 234689999975432 3467899999999999999999999
Q ss_pred EEecCCeEEEEEEEcCCCChhHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 517 FCSENSHRLLVYDYMRNGALSLYLRKDG----------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 517 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEE
Confidence 9999999999999999999999987542 23677889999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh--CCCCCCCCcCCCCC
Q 044374 587 DSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG--GRRNVEAPASGRNA 663 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~ 663 (804)
+.++.+||+|||+++.+..... .......++..|+|||...+..++.++|||||||++|||++ |..||......+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-- 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-- 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--
Confidence 9999999999999986533211 11222344678999999888889999999999999999998 667775322110
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.............. ... ...+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 -------------~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 -------------VIENTGEFFRDQGR-QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -------------HHHHHHHHHhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000111111000 000 01112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.37 Aligned_cols=238 Identities=23% Similarity=0.313 Sum_probs=191.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCC-CceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHV-NLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||+|+.. .++.||||+++.. ....+.+..|+.++..++|+ +|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999765 4678999999643 23445678899999999765 688899999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~ 157 (324)
T cd05587 83 VNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKT 157 (324)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCc
Confidence 99999999987654 6889999999999999999999987 999999999999999999999999998743211 112
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... -....+.+..
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------------------~~~~~i~~~~- 217 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------------ELFQSIMEHN- 217 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHcCC-
Confidence 33456899999999999999999999999999999999999999743211 0111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
...+......+.+++.+|++.+|.+||+.
T Consensus 218 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---------VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122334568899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.26 Aligned_cols=241 Identities=24% Similarity=0.292 Sum_probs=189.6
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHH-HHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEV-CTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+++.. +++.||+|++... .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 5678999999643 12233444444 456889999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 99999997654 5778888889999999999999988 999999999999999999999999999753222 112344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------~~~~~i~~~~~--- 213 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------------------EMYDNILNKPL--- 213 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHhCCc---
Confidence 57999999999999999999999999999999999999999743211 01111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.........+.+++.+|++.+|.+||++.+.+..
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1112334568899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.47 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.++||+|+||.||+|+. .+++.||+|++.... .....+++|+.++.+++||||+++++++...+..++||||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 34567899999999999976 467889999997543 3445688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 91 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~ 165 (267)
T cd06646 91 GSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS 165 (267)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence 99999987543 6889999999999999999999987 99999999999999999999999999986543221 1233
Q ss_pred cccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 614 MRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..++..|+|||.+. ...++.++||||||++++||++|+.|+....+..... .+....
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------------------~~~~~~- 225 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------------------LMSKSN- 225 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------------------eeecCC-
Confidence 46888999999884 3457889999999999999999999986432211000 000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
...+.... .......+.+++.+||+.+|++||++++|++.|
T Consensus 226 --~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 --FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00001100 112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.67 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=193.6
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
..||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 48999999999999754 57789999987543 34567899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCcccccccc
Q 044374 538 LYLRKDGLNL--NWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 538 ~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+++......+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++........ .....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 169 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF 169 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence 9998754445 78888999999999999999887 999999999999976 67999999999876532211 12234
Q ss_pred ccccccccchhccCCC--CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 615 RGTWGYVAPEWISGLA--ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~--~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
.++..|+|||++.+.. ++.++||||||+++|||++|+.||....... ...+. .+ ..
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---------------~~~~~-----~~-~~- 227 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---------------AAMFK-----VG-MF- 227 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---------------hhHhh-----hh-hh-
Confidence 5789999999986643 7899999999999999999999986421110 00000 00 00
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+....+.+..++.+|++.+|.+||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222344668899999999999999999998863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.32 Aligned_cols=249 Identities=20% Similarity=0.223 Sum_probs=194.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+++.. .++.+|+|++... ......+.+|+.+++.++||||+++++.+......++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 345678999999999999775 5788999998642 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 125 ~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 125 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 9999999998764 4788888999999999999999988 9999999999999999999999999998764432222
Q ss_pred ccccccccccccchhccCCC----CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 611 LATMRGTWGYVAPEWISGLA----ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~----~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... -....+.
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------------~~~~~i~ 260 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------------------GTYSKIM 260 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------------------HHHHHHH
Confidence 34567999999999987643 788999999999999999999999743210 0111111
Q ss_pred cC-ccceeccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 044374 687 EG-NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM--RPTMGTVVKML 735 (804)
Q Consensus 687 ~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~L 735 (804)
.. ...... ........+..++..|++.++.+ ||++.+|+++.
T Consensus 261 ~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 001111 11123456778889999854443 78899888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.97 Aligned_cols=197 Identities=29% Similarity=0.417 Sum_probs=172.6
Q ss_pred hcccccccccccceeEEEEE-eCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-C-----CCceeeeeEEecCCeEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-H-----VNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~lV 527 (804)
.+.+.+.||+|.||.|.|+. ...++.||||++++...-..+...|+.+|..|+ | -|+|++++++...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 44567899999999999994 556899999999988777778889999999997 4 3899999999999999999
Q ss_pred EEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC--CceEEeecCCccccC
Q 044374 528 YDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD--YTAKVSDFGLAKLIG 604 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~ 604 (804)
+|.++. +|.++|+.++ ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999855 9999998765 46899999999999999999999988 9999999999999654 379999999998754
Q ss_pred CCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcC
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPAS 659 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~ 659 (804)
.. ..+...+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+...
T Consensus 343 q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 343 QR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred Cc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 33 2255678899999999999999999999999999999999887766544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.29 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=201.4
Q ss_pred ccccccccccceeEEEEEeCC-C----cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-S----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|...+ + ..+|+|.+..... ...++.+|+.++++++||||+++++++.. ...++|||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 456899999999999997642 2 3689998875533 34578899999999999999999999987 78899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++......+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 89 LMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 99999999999887667999999999999999999999977 999999999999999999999999999876433221
Q ss_pred c-ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 610 V-LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 610 ~-~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
. .....++..|+|||.+....++.++||||||++++|+++ |+.||...... .....+..
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~ 226 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------------------EIPDLLEK 226 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------------------HHHHHHhC
Confidence 1 112224578999999988899999999999999999999 99998743211 11112222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+... ..+......+..++..||..+|.+||++.++++.|+.+..
T Consensus 227 ~~~~---------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 GERL---------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1110 1111233567889999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.19 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=188.7
Q ss_pred cccccccceeEEEEEeCC---CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSD---STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
++||+|+||.||+|.... ...+|+|.+..... ....+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996543 35688888764332 3456889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-cc
Q 044374 535 ALSLYLRKDGL----NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SR 609 (804)
Q Consensus 535 sL~~~l~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 609 (804)
+|.+++..... ..++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 3467788999999999999999987 9999999999999999999999999987533221 11
Q ss_pred cccccccccccccchhccC-------CCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 610 VLATMRGTWGYVAPEWISG-------LAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~-------~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
......++..|+|||++.. ..++.++||||||+++|||++ |..||....+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------------------~~ 218 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------------------QV 218 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------------------HH
Confidence 1223345778999998743 356789999999999999999 77777532110 01
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
......+.......+.+. ......+.+++..|+ .||++||++++|++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVREQDIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhhccCccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111222222222 223455677888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.20 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=189.5
Q ss_pred cccccccceeEEEEEeCC--------CcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD--------STLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 2348888886443 2345788999999999999999999999998999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc--------eEEeecCCccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT--------AKVSDFGLAKL 602 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DfGla~~ 602 (804)
+++|+|..++...+..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999877667899999999999999999999988 999999999999987765 69999998875
Q ss_pred cCCCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCC-CCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGR-RNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+....+ .
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------------------~ 212 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------------------Q 212 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------------------H
Confidence 432 1234578899999999874 5789999999999999999995 44432111 0
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
........ . ...+......+.+++..||+.+|++||++.+|++.|+
T Consensus 213 ~~~~~~~~--------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 KKLQFYED--------R--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHHc--------c--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00111110 0 0112223356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.53 Aligned_cols=268 Identities=22% Similarity=0.255 Sum_probs=195.4
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC-----eEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS-----HRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 528 (804)
+.++||+|+||.||++.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999975 468899999996532 23457889999999999999999999998776 789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9997 5777777544 36899999999999999999999988 99999999999999999999999999986543333
Q ss_pred ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH------H
Q 044374 609 RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW------A 681 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 681 (804)
.......+++.|+|||++.+. .++.++|||||||+++||++|+.||....+........... .......+ .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--g~~~~~~~~~~~~~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL--GTPSLEAMRSACEGA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc--CCCCHHHHHHhhHHH
Confidence 333445678999999998774 57899999999999999999999997543221000000000 00000000 0
Q ss_pred HHHhhcCcc-ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNV-AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+..... ...... + ........+.+.+++.+|++.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPV-L-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHH-h-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000 0 01111224668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.87 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+++.. +++.+|+|.++.. ....+.+.+|+.++++++|+||+++++.+......++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 35678999999999999765 6788999998643 23446788999999999999999999999999999999999999
Q ss_pred CChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++... ...+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ....
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYAC 158 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-cccc
Confidence 9999988653 346789999999999999999999988 9999999999999999999999999997654321 1123
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...... . ....+..+....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------------------~-~~~~~~~~~~~~ 219 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------------------N-LILKVCQGSYKP 219 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------------------H-HHHHHhcCCCCC
Confidence 456888999999999989999999999999999999999999742110 0 111111221111
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+......+.+++.+||+.+|++||++.+|+..
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=296.42 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=210.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.++||+|+||.|||+.++ .|..+|||++.. ....+++..|+.+|.+.+.|++|+++|.+.....+++|||||.-|+
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 34679999999999999665 689999999864 4467888999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
..++++.+.+.+.++++..++...++||+|||... -||||||+.||||+.+|.+||+|||.+-.+.+.. ....++.
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccc
Confidence 99999999899999999999999999999999987 8999999999999999999999999998765432 2346788
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
||+.|||||+++.-.|..++||||+|+...||..|++|+..-.+-+....+. ...-
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP------------------------T~PP 246 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP------------------------TKPP 246 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc------------------------CCCC
Confidence 9999999999999999999999999999999999999997644432211100 0000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.. ..+.+....+..+++.||-+.|++|-++.+++++
T Consensus 247 PTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 247 PTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111 2245667889999999999999999999888765
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.35 Aligned_cols=197 Identities=18% Similarity=0.209 Sum_probs=164.8
Q ss_pred cccccccc--cceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 458 FSEKLGHG--GFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.++||+| +|++||++.. .+++.||||+++.... ..+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999966 4688999999975432 2346788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--
Q 044374 532 RNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 532 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 608 (804)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 345899999999999999999999988 99999999999999999999999987543321110
Q ss_pred ----ccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 609 ----RVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 609 ----~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 01122346778999999876 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=322.10 Aligned_cols=191 Identities=25% Similarity=0.257 Sum_probs=164.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.+.||+|+||.||++... .++.||||.... ..+.+|+.++++++|+||+++++++......++|||++. +
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 345678999999999999775 468899996432 346789999999999999999999999999999999995 6
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-ccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~ 613 (804)
+|..++......+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++....... .....
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 888888766557999999999999999999999988 99999999999999999999999999986543221 12234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCC
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVE 655 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~ 655 (804)
..||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 569999999999999999999999999999999999887654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.69 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=197.5
Q ss_pred cccccccccceeEEEEEeC-CCc----EEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DST----LVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.||+|+||.||+|... ++. .||+|.+..... ...++.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 4568999999999999753 333 578998875432 234688999999999999999999998754 56799999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR- 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 609 (804)
+++|+|.+++......+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccccc
Confidence 9999999999877667899999999999999999999987 999999999999999999999999999865433221
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------------------~~~~~~~~~ 227 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------------------EIPDLLEKG 227 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHHCC
Confidence 1122345678999999999999999999999999999998 88888642110 011111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
... ..+......+..++..|+..+|++||++.+++++|+.+.+
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 228 ERL---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 110 0111234568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=301.83 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=200.3
Q ss_pred cccccccccceeEEEEEeCC-----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELSD-----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.||.|+||.||+++..+ +..||+|++..... ..+.+..|+.++.+++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999997754 37899999976543 467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 531 MRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++++|.+++...... +++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999865544 899999999999999999999987 999999999999999999999999999876443221
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||.+.+..++.++||||||++++||++ |+.||..... .........+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------------------~~~~~~~~~~ 220 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------------------EEVLEYLKKG 220 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHhcC
Confidence 1112336789999999988889999999999999999998 7777764211 1111112211
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
... ..+......+.+++.+|+..+|++||++.+++++|
T Consensus 221 ~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRL---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 11112456788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.93 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=198.9
Q ss_pred cccccccccceeEEEEEeC------CCcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.||+|+||.||+|+.. +.+.|++|.+...... ..++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4568999999999999754 3467999998754433 4679999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 530 YMRNGALSLYLRKDG--------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997543 15899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
..............++..|+|||.+.+...+.++||||||++++||++ |..||...... -
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------------------~ 226 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------------------E 226 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------------------H
Confidence 543322222333456778999999988888999999999999999998 77777532110 0
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.......+... ...+...+..+.+++.+|++.+|++||++.+++++|+
T Consensus 227 ~~~~~~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111111 1111223467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=300.33 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=188.5
Q ss_pred cccccccceeEEEEEeCCC---cEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSDS---TLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
++||+|+||.||+|+..++ ..+++|.++... ...+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677765432 24567999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cccc
Q 044374 535 ALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRV 610 (804)
Q Consensus 535 sL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 610 (804)
+|.+++.... ...++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997642 24567778899999999999999887 999999999999999999999999998643211 1112
Q ss_pred ccccccccccccchhccC-------CCCCccceEEeehhhHHHhhhC-CCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 611 LATMRGTWGYVAPEWISG-------LAITTKADVYSYGMTLLELIGG-RRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~-------~~~~~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... .. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------------------~~-~~ 218 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------------------RE-VL 218 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------------------HH-HH
Confidence 234567889999998753 2457899999999999999974 556643211 01 11
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
..+..+......++.+... ....+.+++..|+ .+|++||++.+|++.|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVIKDQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHhhcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112222233334433322 2356777888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.57 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=195.5
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.||+|+||.||++... .++.||||.+..... ....+.+|+.++++++|+|++++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4578999999999999665 678999999864321 23457789999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I 158 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence 999999886543 36889999999999999999999887 99999999999999999999999999876533221 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..-.......
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----------------~~~~~~~~~~---- 218 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----------------KREEVERLVK---- 218 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----------------hHHHHHhhhh----
Confidence 23468999999999999999999999999999999999999997432110 0000000000
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
.. ....+......+.+++..||+.||++||+ +.|++++
T Consensus 219 ~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 EV-----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hh-----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00 00111223456789999999999999999 7787763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.56 Aligned_cols=239 Identities=24% Similarity=0.318 Sum_probs=191.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 529 (804)
.++.+.||+|+||.||++... +++.||||++... ....+.+..|+.++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356789999999999999764 6789999999642 223456778888888875 5778889999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 999999999987654 6899999999999999999999988 9999999999999999999999999987543221 1
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------------------~~~~~i~~~~ 217 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------------------ELFQSIMEHN 217 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCC
Confidence 123456899999999999999999999999999999999999999743211 1111122111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
. ..+......+.+++.+|++.+|.+|++.
T Consensus 218 ~----------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 V----------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1 1122234567889999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.06 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=197.1
Q ss_pred cccccccccceeEEEEEeCC--CcEEEEEEecCCC-----------CCHHHHHHHHHHHcC-CCCCCceeeeeEEecCCe
Q 044374 458 FSEKLGHGGFGAVFQGELSD--STLVAVKRLERPG-----------SGEREFRAEVCTIGN-IQHVNLVRLRGFCSENSH 523 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~-----------~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~ 523 (804)
+.+.||+|+||.||+|.... ++.+|||.+.... ....++.+|+.++.+ ++||||+++++++...+.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45789999999999998765 6789999885321 122456778887764 799999999999999999
Q ss_pred EEEEEEEcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCC
Q 044374 524 RLLVYDYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 599 (804)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||||+|||++.++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999988743 34568899999999999999999996 45 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 600 AKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 600 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------------------~ 220 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------------------S 220 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------------------H
Confidence 98654332 234556889999999999888999999999999999999999998642110 0
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
......++...... .......+.+++.+|++.||++||++.||.++|++
T Consensus 221 -~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 221 -LATKIVEAVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -HHHHHhhccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11111111111110 11224568899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.72 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=198.0
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHH---HHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~---~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||+||+++... ++.+|+|++......... ..+|+.++++++||||+++++++......++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 356899999999999997764 568999999876544333 3459999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+..... ......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFN 156 (260)
T ss_dssp TEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBS
T ss_pred ccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccccc
Confidence 99999999833 37899999999999999999999988 99999999999999999999999999975422 222344
Q ss_pred ccccccccccchhcc-CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWIS-GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~-~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||++. +...+.++||||+|+++++|++|..|+...... -....... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-------------------~~~~~~~~-~~~ 216 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-------------------DQLEIIEK-ILK 216 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------------------HHHHHHHH-HHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccch-------------------hhhhhhhh-ccc
Confidence 567899999999998 888999999999999999999999998753100 00000000 000
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
........ ........+.+++..|++.||++||++.++++
T Consensus 217 ~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 RPLPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp THHHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00011378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.56 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=198.3
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||.||+|.. ..++.||+|.+.... .....+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 3457899999999999975 467899999997543 34567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........ .....
T Consensus 103 ~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (296)
T cd06654 103 SLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (296)
T ss_pred CHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence 999998653 5789999999999999999999988 99999999999999999999999999876433221 12334
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+++.|+|||.+.+..++.++|||||||++|||++|+.||....+.. .+ ......+ .
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----------------~~-~~~~~~~-~---- 233 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----------------AL-YLIATNG-T---- 233 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----------------hH-HHHhcCC-C----
Confidence 68899999999998889999999999999999999999996432210 00 0000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+ ..+......+.+++.+|++.+|++||++.+|++.
T Consensus 234 -~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 -PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 1122334568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.86 Aligned_cols=194 Identities=25% Similarity=0.413 Sum_probs=160.4
Q ss_pred ccccccccceeEEEEEeC---CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGELS---DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~ 533 (804)
.++||+|+||.||+|+.. .++.||+|.++... ....+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 358999999999999764 45789999997543 23557889999999999999999998854 4567899999875
Q ss_pred CChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----cCCCceEEeecCCcc
Q 044374 534 GALSLYLRKD--------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL----DSDYTAKVSDFGLAK 601 (804)
Q Consensus 534 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~ 601 (804)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777776432 125788999999999999999999988 9999999999999 456789999999998
Q ss_pred ccCCCcc--ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 602 LIGRDFS--RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 602 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
....... .......+|+.|+|||++.+. .++.++|||||||+++||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7654322 123346789999999998774 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.33 Aligned_cols=239 Identities=26% Similarity=0.288 Sum_probs=185.2
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCC---CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNI---QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
||+|+||+||+|+.. .++.||||++.... .....+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 57899999996421 1223344566666554 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|..++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 99999987654 6899999999999999999999988 9999999999999999999999999987532221 12334
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..||..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..+.. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------------------~~~~~~i~~~~~-~ 215 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------------------QQMYRNIAFGKV-R 215 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------------------HHHHHHHHcCCC-C
Confidence 5789999999998764 488999999999999999999999964321 111122222211 0
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT----MGTVVK 733 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~eVl~ 733 (804)
+. .......+.+++.+||+.||.+||+ +.++++
T Consensus 216 -----~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 -----FP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----CC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 10 0112456778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=335.69 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=198.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|... .++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 35679999999999999765 578999999975322 2356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 532 RNGALSLYLRKD----------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 532 ~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
++++|.+++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999988642 123566788999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcc-----------------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc
Q 044374 602 LIGRDFS-----------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN 664 (804)
Q Consensus 602 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 664 (804)
....... .......||+.|+|||++.+..++.++|||||||+++||+||+.||........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-- 239 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-- 239 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh--
Confidence 6521100 011234699999999999999999999999999999999999999964221100
Q ss_pred CCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhcccc
Q 044374 665 IGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-TMGTVVKMLEGVLE 740 (804)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~~ 740 (804)
... ... .++.-. ....+.+..+.+++.+|++.||++|| ++.++++.|+..+.
T Consensus 240 ----------------~~~----~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 ----------------SYR----DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ----------------hhh----hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 000 000000 00112345688899999999999996 67777777776543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.08 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=194.6
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|+||.||+|.. ..++.||+|++.... ...+++.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3567899999999999965 467889999986542 2345788999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...... ....
T Consensus 84 ~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (279)
T cd06619 84 GSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152 (279)
T ss_pred CChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccC
Confidence 9997653 4678888999999999999999988 999999999999999999999999999765332 1234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+.-....+....
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~------------~~~~~~~~~~~~~~~---- 216 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG------------SLMPLQLLQCIVDED---- 216 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc------------ccchHHHHHHHhccC----
Confidence 5689999999999998999999999999999999999999975322110 000000011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.+ ........+.+++.+|++.+|++||++.++++.
T Consensus 217 -~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 -PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111 011233568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.35 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=199.3
Q ss_pred ccccccccceeEEEEEe-CCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEec-----CCeEEEEEE
Q 044374 459 SEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSE-----NSHRLLVYD 529 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E 529 (804)
.+.||+|+||.|..+.. .+++.||||++.+. ....+...+|+++|+.++|+||+.+++++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 46799999999999965 46899999999743 2334667789999999999999999999865 357899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FS 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~ 608 (804)
+| ..+|...++.+. .++......++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+..... ..
T Consensus 107 lM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99 558888887654 5888999999999999999999999 999999999999999999999999999986532 22
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
..++..+.|..|.|||++.. ..|+...||||.|||+.||++|+..|.+.+.-....++....... .......+..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP----~~e~l~~i~s 257 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP----SEEDLQKIRS 257 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC----CHHHHHHhcc
Confidence 34567788999999997654 679999999999999999999999998754432221111100000 0111111111
Q ss_pred Cccceeccc-------cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDD-------RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~-------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+.. .+...++ ......++++.+||..||.+|+|++|.++.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111110 0111111 234567789999999999999999999876
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.67 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=197.0
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.||+|+||.||+|... .++.||+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 3467999999999999764 57889999987443 23457899999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++........ .....
T Consensus 88 ~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06642 88 SALDLLKPG--PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred cHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcc
Confidence 999988653 6889999999999999999999887 99999999999999999999999999976543221 12234
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.++..|+|||++.+..++.++||||||++++||++|+.|+....+.. ....+..+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------------------~~~~~~~~~----- 217 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------------------VLFLIPKNS----- 217 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------------------HHhhhhcCC-----
Confidence 57889999999999899999999999999999999999986422110 000011110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...........+.+++.+|++.+|++||+|.+|+++
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 ----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111122334668899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.12 Aligned_cols=244 Identities=29% Similarity=0.415 Sum_probs=196.1
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++.+++|||++++++++... ..++||||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 34668999999999999975 56779999986532 346789999999999999999999998764 4799999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~ 157 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNS 157 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----CCCC
Confidence 999997654 35789999999999999999999887 999999999999999999999999998754322 1223
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..+..|+|||++.+..++.++||||||+++|||++ |+.||...... -.......+..
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~~~~--- 215 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------------------EVKECVEKGYR--- 215 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------------------HHHHHHhCCCC---
Confidence 34568999999998899999999999999999998 88888642110 01111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
...+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 216 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11122334678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=328.77 Aligned_cols=267 Identities=20% Similarity=0.242 Sum_probs=187.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC--------CeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--------SHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~~~l 526 (804)
+.+.++||+|+||.||+|... .++.||||++.... ....+|+.++++++||||+++++++... ...++
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 345689999999999999764 57899999986432 2345799999999999999999876432 24679
Q ss_pred EEEEcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccc
Q 044374 527 VYDYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKL 602 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~ 602 (804)
||||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999985 66665542 3457899999999999999999999988 99999999999999665 799999999986
Q ss_pred cCCCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPW 680 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 680 (804)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.......... +.... .......+
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~---~~p~~~~~ 295 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL---GTPTEDQL 295 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---CCCCHHHH
Confidence 543221 2245679999999998664 68999999999999999999999997532210000 00000 00000000
Q ss_pred HHH--HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 AAR--QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~~~--~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... ...+-....+....+...++...+..+.+++.+||+.||.+||++.|++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 000000000000111111122234578899999999999999999999855
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.91 Aligned_cols=272 Identities=21% Similarity=0.275 Sum_probs=195.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... .++.||+|+++.. ......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 45678999999999999765 5788999999743 22345678899999999999999999999999999999999985
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++...+..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 89 -~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 163 (309)
T cd07872 89 -DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSN 163 (309)
T ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-cccc
Confidence 888888776667899999999999999999999988 99999999999999999999999999976433221 1233
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-CCCCccCchHHHH-HHhhcCcc
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG-EHGDKWFFPPWAA-RQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~ 690 (804)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ........+.... .....-..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 467899999998865 46889999999999999999999999754321100000000 0000000000000 00000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+.. ........+.+++.+|++.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 244 PKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 001224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=303.81 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=196.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+.++||+|+||.||+|... .+..+++|.+.... ...+.+.+|+.+++.++|||++++++++...+..++|+||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 4578999999999999775 46788999986543 334678899999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|..++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....... .......
T Consensus 89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 164 (282)
T cd06643 89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI 164 (282)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence 99988765557899999999999999999999988 9999999999999999999999999987643322 1223456
Q ss_pred cccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 616 GTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 616 gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
++..|+|||++. +..++.++|||||||++|||++|+.||....+. . ..........
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------------~-~~~~~~~~~~ 225 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------------------R-VLLKIAKSEP 225 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------------------H-HHHHHhhcCC
Confidence 889999999984 345778999999999999999999998642211 0 0011111110
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
... ..+......+.+++..||+.+|.+||++.+|++.-
T Consensus 226 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 226 PTL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 000 01112345688999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.65 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=197.2
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.||+|+||.||+|...+++.+|||.++.... ....+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4578999999999999888889999999864321 124588899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC----
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD---- 606 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~---- 606 (804)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 84 VPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999997654 6789999999999999999999887 999999999999999999999999998764211
Q ss_pred -ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 -FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 -~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.........++..|+|||++.+..++.++||||||++++||++|+.||...... .. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~--~~~~ 220 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----------------AA--MFYI 220 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----------------HH--HHHh
Confidence 111223456889999999999989999999999999999999999999643211 00 0000
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
... .... ...+......+..++.+|++.+|++||++.+|++
T Consensus 221 ~~~---~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GAH---RGLM----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhc---cCCC----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000 1112233466889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=299.17 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=201.3
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||.++. .+++.+++|.+... ....+++.+|+.++++++|+||+++++++.+....+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 3567899999999999865 45788999998643 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 99999999765 446899999999999999999999987 99999999999999999999999999986644332 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... . ....+..+...
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------------------~-~~~~~~~~~~~ 219 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------------------N-LVVKIVQGNYT 219 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------------------H-HHHHHHcCCCC
Confidence 3456899999999999888999999999999999999999998642111 1 11111222111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
. .+......+.+++.+|++.+|.+||++.++++.+
T Consensus 220 ~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 P---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 1122345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.10 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||++... .+..+|+|.++.... ...++.+|++++.+++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 35678999999999999765 577899998875422 235688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++... ..+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++...... ...
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~ 156 (308)
T cd06615 84 GSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 156 (308)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---ccc
Confidence 9999999765 3688999999999999999999973 5 999999999999999999999999998754322 123
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCC-CCc-----------cCchHH
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH-GDK-----------WFFPPW 680 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~ 680 (804)
...++..|+|||.+.+..++.++||||||+++|||++|+.||................. ... ......
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 45688999999999888899999999999999999999999865432211100000000 000 000000
Q ss_pred -HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 -AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 -~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+. +.....+.+ ........+.+++.+|++.+|++||++.+|++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDY-IVNEPPPKL---PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHH-HhcCCCccC---cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 000000000 001134568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.00 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=194.9
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.||+|+||+||++... +++.||+|.+.... .....+.+|+.++.+++|+|++++.+.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4578999999999999764 67899999996532 223457889999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence 999998886543 46899999999999999999999988 9999999999999999999999999997643221 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---------------~~~~~~~~~~~~~-- 221 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---------------KREEVDRRVLETE-- 221 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHHhhhccc--
Confidence 34568999999999999899999999999999999999999997432110 0000011111100
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
...+......+.+++..|++.+|++||+ +.++++.
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 --------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112223456788999999999999999 5565543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.54 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=198.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEE---EEEec--CCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCe--EEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVA---VKRLE--RPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSH--RLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~va---vK~l~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 528 (804)
.|.++||+|+|-+||||... .|..|| ||.-+ +.....+.|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 46678999999999999553 455565 22222 223344789999999999999999999999876654 78999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 607 (804)
|.|..|+|..|+++.+ .++.+.+..++.||++||.|||++. ++|||||||..||+|+. .|.|||+|+|||.+.....
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999998876 6888999999999999999999986 67999999999999975 4899999999999876543
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
. ..+.|||.|||||+.. ..|.+.+||||||+.|+||+|+..||..-.. ++...+++..
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------------------~AQIYKKV~S 258 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------------------PAQIYKKVTS 258 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------------------HHHHHHHHHc
Confidence 2 3478999999999988 7899999999999999999999999874321 3455666666
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
|.-...+..- ..+++.+++..|+.. .++|||+.|+++.
T Consensus 259 GiKP~sl~kV--------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 259 GIKPAALSKV--------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCCHHHhhcc--------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 6433332211 124688899999999 9999999999864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.35 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=209.2
Q ss_pred cccccccccccceeEEEEEeCC-CcEEEEEEecCCCC----CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGS----GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.++||+|.||.||+++... ++.+|+|.+.+... ....+.+|+.+|+++. |||||.+.+.+......++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 4566899999999999997765 89999999975432 3468999999999998 9999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC----CceEEeecCCccccCC
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD----YTAKVSDFGLAKLIGR 605 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~~~ 605 (804)
++.+|.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++.....
T Consensus 117 L~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred ecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999876 3999999999999999999999988 9999999999999543 5799999999998765
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......+||+.|+|||++....|+..+||||+||++|.|++|..||....... ....+
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------------------~~~~i 250 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------------------IFLAI 250 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------------------HHHHH
Confidence 445678899999999999999999999999999999999999999998643221 11122
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.. ....+.-......+..++..|+..||.+|+++.+++++
T Consensus 251 ~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 251 LRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 33322 12223333456778899999999999999999999986
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.88 Aligned_cols=239 Identities=29% Similarity=0.369 Sum_probs=198.2
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||.|+||.||-|.. .+.+.||||++.-+.. .-.++..|++.|.+++|||.+.+.||+......+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 4799999999999954 4678999999975432 22468899999999999999999999999999999999995 4
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+-.+++.-..+++-+.++..|..+.+.||+|||+.+ .||||||+.||||.+.|.|||+|||.+.+... ...+
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----AnsF 182 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANSF 182 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----hhcc
Confidence 778888777778999999999999999999999988 99999999999999999999999999987543 4567
Q ss_pred ccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 615 RGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 615 ~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
+|||.|||||++. .+.|+-|+||||+||+..||.-.++|...+..- -+.-.+...+.
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------------------SALYHIAQNes- 242 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------------SALYHIAQNES- 242 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------------------HHHHHHHhcCC-
Confidence 8999999999874 468999999999999999999999987654210 01111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+. ..+....+..++..||++-|.+|||..+++..
T Consensus 243 ----PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 ----PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1121 34678889999999999999999999988764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.18 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=196.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCCC----------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG----------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
+.+.||+|+||.||+|... +++.+|+|.+...... .+.+++|+.++++++||||+++++++......++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4578999999999999764 5788999988643221 1457889999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999999999999997653 6888999999999999999999987 999999999999999999999999999866422
Q ss_pred cc-----ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 607 FS-----RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 607 ~~-----~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------------~~ 220 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------------------QA 220 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------------------HH
Confidence 11 1112345788999999999888999999999999999999999999742110 00
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....... . ....+......+..++.+||+.+|.+||++.+|++
T Consensus 221 ~~~~~~~-----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IFKIGEN-----A----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHhcc-----C----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 1 11122234567889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.35 Aligned_cols=197 Identities=24% Similarity=0.321 Sum_probs=170.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... .++.||||+++.. ......+++|+.++.+++||||+++++.+......++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999765 5789999999642 223456888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc---
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS--- 608 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 608 (804)
++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 84 ~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 84 PGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999997654 6889999999999999999999988 99999999999999999999999999875421100
Q ss_pred -------------------------------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 609 -------------------------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 609 -------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.40 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=200.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.++||+|+||+||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++.....+++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 345678999999999999764 5788999988643 2335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++...+ .+++..+..++.+++.||.|||+. + ++|+||||+||+++.++.++|+|||++....... .
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 87 CGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred CCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 999999887654 689999999999999999999973 5 9999999999999999999999999987542221 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .....+.... ..+.....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~- 230 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-------DDPMGILDLL-QQIVQEPP- 230 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-------hhhhHHHHHH-HHHhhccC-
Confidence 23568999999999988899999999999999999999999997543211000 0000000111 11111100
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
+.+ ...+....+.+++.+|++.||++||++.||+++.
T Consensus 231 ----~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ----PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 001 0112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=312.33 Aligned_cols=189 Identities=24% Similarity=0.324 Sum_probs=162.7
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.+.||+|+||.||+|... .++.||+|+.... ....|+.++++++||||+++++++......++|+||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 3556789999999999999775 4678999975432 23568999999999999999999999999999999995
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~ 215 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLG 215 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccccc
Confidence 5888888776668999999999999999999999988 999999999999999999999999999753322 11234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
..||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 56899999999999999999999999999999999866554
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.14 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=198.9
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..++||+|+||.||+|... .+..||||.+.... .....+.+|+.++++++||||+++++++......++||||++++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3468999999999999765 57889999987542 33467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++.....++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 88 ~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06640 88 SALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccc
Confidence 999998753 5888999999999999999999887 99999999999999999999999999976543221 12234
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.++..|+|||++.+..++.++||||||+++|||++|+.||....+... ......
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------------------~~~~~~------- 215 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------------------LFLIPK------- 215 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------------------hhhhhc-------
Confidence 578899999999988899999999999999999999999864322100 000000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.............+.+++..||+.+|++||++.+|++.
T Consensus 216 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 --NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 01112233456778899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.13 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=199.0
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.||.|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++|+|++++++++......++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 4578999999999999765 57899999987542 33457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....... .....
T Consensus 85 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (274)
T cd06609 85 SCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTF 158 (274)
T ss_pred cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccc
Confidence 999999865 7899999999999999999999987 99999999999999999999999999987654321 22345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.++..|+|||++.+..++.++||||||+++|||++|+.||....+.. ....+..+....
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------------------~~~~~~~~~~~~-- 217 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------------------VLFLIPKNNPPS-- 217 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------------------HHHHhhhcCCCC--
Confidence 67889999999999889999999999999999999999997432110 011111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+... .....+.+++..|++.+|++||+++++++.
T Consensus 218 ---~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 ---LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1100 034568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=297.15 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=198.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 531 (804)
.+.+.||+|++|.||++... +++.||+|++.... ...+.+.+|+.++++++|+|++++++.+.. ....+++|||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 46688999999999999765 56889999996432 234568899999999999999999988764 44679999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++++|.+++... ...+++.++..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 999999998764 346899999999999999999999988 9999999999999999999999999998664332 22
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+++.|+|||++.+..++.++||||||++++||++|+.||...... .. ...+..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------------------~~-~~~~~~~~~ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------------------SL-VYRIIEGKL 219 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------------------HH-HHHHHhcCC
Confidence 33456889999999999999999999999999999999999998642110 11 111122211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..+......+.+++.+|++.+|++||++.+++++
T Consensus 220 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 1122345678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.09 Aligned_cols=271 Identities=21% Similarity=0.257 Sum_probs=193.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+|... ++..||||+++.. ......+.+|+.++.+++||||+++++++..+...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 34578999999999999765 6889999998643 2234678899999999999999999999999999999999998
Q ss_pred CCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 533 NGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....... ..
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 68888876432 46899999999999999999999987 9999999999999999999999999997654321 12
Q ss_pred ccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHHHhhcC
Q 044374 611 LATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
.....+++.|+|||++.+. .++.++||||||++++||++|+.||.......... .............+......-...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2334568899999988654 57889999999999999999999987432110000 000000000000000000000000
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
........... ........++.+++.+||+.||++||++.+|++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.96 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=200.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.+.||+|+||.||++... .++.+|+|.+... ....+.+.+|+.++++++||||+++++++......+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 45678999999999999764 5678999999754 334578999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ .....
T Consensus 86 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 161 (262)
T cd06613 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSF 161 (262)
T ss_pred cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccc
Confidence 999999876557899999999999999999999987 99999999999999999999999999976543221 12345
Q ss_pred ccccccccchhccCC---CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 615 RGTWGYVAPEWISGL---AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
.++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..........
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------------------~~~~~~~~~~- 221 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------------------ALFLISKSNF- 221 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------------------HHHHHHhccC-
Confidence 678899999999877 78899999999999999999999987432110 0000111100
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+ .........+.+++.+|++.+|.+||++.+|+.
T Consensus 222 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 --PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00111 112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.09 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=198.5
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++......++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 3567899999999999975 468899999997543 34466889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .....
T Consensus 102 ~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 175 (297)
T cd06656 102 SLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 175 (297)
T ss_pred CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcc
Confidence 999998754 5788999999999999999999987 99999999999999999999999999876543321 12334
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+...... .. .
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------------------~~-------~ 229 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------------IA-------T 229 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------------------ec-------c
Confidence 678899999999998899999999999999999999999965332110000 00 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
........+......+.+++.+|++.+|++||++.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001122234567889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.14 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=195.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||.||+|... +++.||+|.++... .....+++|+.+++.++||||+++++.+...+..++|+||++++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 35578999999999999764 57889999987543 33456888999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++...+ .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .....
T Consensus 92 ~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 166 (267)
T cd06645 92 SLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKSF 166 (267)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccccc
Confidence 9999987654 6899999999999999999999988 99999999999999999999999999876543221 22345
Q ss_pred ccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 615 RGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 615 ~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
.|+..|+|||++. ...++.++|||||||++|||++|+.||....+... . .........
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------------------~-~~~~~~~~~ 227 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------------------L-FLMTKSNFQ 227 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------------------H-HhhhccCCC
Confidence 6899999999874 45688899999999999999999999864321100 0 000000000
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.... .......+.+++.+|++.+|++||++.+|+++
T Consensus 228 ---~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 ---PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011111 01123467899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.79 Aligned_cols=193 Identities=25% Similarity=0.417 Sum_probs=159.0
Q ss_pred cccccccceeEEEEEeC---CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS---DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~g 534 (804)
.+||+|+||.||+|+.. .+..||+|.++... ....+.+|+.++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 57999999999999864 34789999987543 23467889999999999999999998853 4577999999876
Q ss_pred ChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----cCCCceEEeecCCccc
Q 044374 535 ALSLYLRKD--------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL----DSDYTAKVSDFGLAKL 602 (804)
Q Consensus 535 sL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~~ 602 (804)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 666665421 135788899999999999999999988 9999999999999 5677999999999987
Q ss_pred cCCCcc--ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 603 IGRDFS--RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 603 ~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
...... .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 644322 12234568999999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.22 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=196.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+.++||+|+||.||+|+.. .++.||+|.+.... ...+.+.+|+.++++++|||++++++++......++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 5578999999999999775 47889999997543 234678899999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|..++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .......
T Consensus 96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 171 (292)
T cd06644 96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFI 171 (292)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-cccceec
Confidence 99988766567899999999999999999999887 9999999999999999999999999987543221 1123445
Q ss_pred cccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 616 GTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 616 gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
++..|+|||++. ...++.++|||||||++|||++|+.||...... .....+.....
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------------~~~~~~~~~~~ 232 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------------RVLLKIAKSEP 232 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------------------HHHHHHhcCCC
Confidence 788999999985 345678999999999999999999998642110 01111111110
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .. ..+......+.+++.+|++.+|++||++.+|++.
T Consensus 233 ~-----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 P-----TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred c-----cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00 0112234568889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.88 Aligned_cols=243 Identities=25% Similarity=0.379 Sum_probs=197.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4578999999999999876 78899999986432 1345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 84 VPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 99999999997654 6889999999999999999999988 9999999999999999999999999987654332 2
Q ss_pred ccccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....++..|+|||.+.... ++.++|+||||+++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~~~ 219 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------------------AAVFKIGRSKE 219 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------------------HHHHHHHhccc
Confidence 23456888999999987766 899999999999999999999998643210 00111000011
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
. ...+......+.+++.+|++.+|.+||++.++++
T Consensus 220 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 L---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1112223466788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.51 Aligned_cols=266 Identities=23% Similarity=0.274 Sum_probs=189.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCC---CCCCceeeeeEEec-----CCeE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNI---QHVNLVRLRGFCSE-----NSHR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~~~ 524 (804)
.+.++||+|+||.||+|... +++.||+|.++... .....+.+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 35678999999999999765 67899999986432 2234566677766655 79999999998864 3457
Q ss_pred EEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 525 LLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
++||||+.+ +|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccc
Confidence 999999985 8888886543 35899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......++..|+|||++.+..++.++|||||||+++||++|+.||................ .......|...
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPEDDWPRD 234 (288)
T ss_pred cCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh--CCCChhhCccc
Confidence 4321 1234567899999999999899999999999999999999999986432210000000000 00000000000
Q ss_pred HhhcCccceeccccc---cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDRL---GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. .......+.. ......+..+.+.+++.+|++.||++||++.+++.
T Consensus 235 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VT---LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cc---ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000000 00111123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.08 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=193.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEe-----cCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCS-----ENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-----~~~~~~lV~E 529 (804)
.+.+.||+|+||.||++... .++.+|+|+++.......++.+|+.++.++ +||||+++++++. .+...++|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 34578999999999999764 578899999876554557788999999999 6999999999884 3457899999
Q ss_pred EcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999998763 2346788999999999999999999887 999999999999999999999999998765432
Q ss_pred ccccccccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
.. ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+........
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------------------- 237 (286)
T cd06638 178 RL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------------------- 237 (286)
T ss_pred CC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------------------
Confidence 11 2234568999999998853 4578899999999999999999999864321100
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
.............+ +......+..++.+|++.+|++||++.||++.+
T Consensus 238 ~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKIPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HhhccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000001111 111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=313.60 Aligned_cols=192 Identities=28% Similarity=0.378 Sum_probs=162.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 526 (804)
.+.+.||+|+||.||++... .+..||||++... ......+.+|+.+++.++||||+++++++.... ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 35679999999999999764 5789999999643 223456789999999999999999999986443 5799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++ +|...+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 104 VMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred EEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 9999976 45555543 4788889999999999999999988 999999999999999999999999999754322
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred --ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.08 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=198.8
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||.|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++|||++++++++......++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3457899999999999965 568899999996543 34567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|..++... .+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 102 ~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 175 (296)
T cd06655 102 SLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTM 175 (296)
T ss_pred cHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCc
Confidence 999998754 5899999999999999999999988 99999999999999999999999999876543321 12334
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------------------~~~~~~~~~~~--- 233 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------------------ALYLIATNGTP--- 233 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------------HHHHHHhcCCc---
Confidence 68889999999999889999999999999999999999997532210 00001111000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+ ..+......+.+++.+||+.+|++||++.+|++.
T Consensus 234 --~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 --EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 1112234568889999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.74 Aligned_cols=193 Identities=23% Similarity=0.350 Sum_probs=158.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC------CCCceeeeeEEecC-CeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ------HVNLVRLRGFCSEN-SHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~-~~~~lV 527 (804)
+.+.++||+|+||+||+|... .++.||||+++......+++..|+.++..++ |++++++++++... .+.++|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 445679999999999999764 5788999999764444455666777766664 45688999988754 578999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCC----------------
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDY---------------- 590 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~---------------- 590 (804)
||++ +++|.+++...+ .+++..+..|+.||+.||+|||++ + |+||||||+||||+.++
T Consensus 211 ~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred Eecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 9987 667888876653 689999999999999999999974 6 99999999999998765
Q ss_pred ceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 591 TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 591 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 286 ~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 286 RVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred eEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 234567899999999999999999999999999999999999999754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.80 Aligned_cols=195 Identities=24% Similarity=0.264 Sum_probs=167.4
Q ss_pred hhcccccccccccceeEEEEEeC---CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS---DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.++||+|+||.||++... .+..||||.+... ..+.+|+.++++++||||+++++++......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 34567789999999999999653 3577999988643 3456899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-c
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-R 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 609 (804)
+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 168 ~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 168 YK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred cC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 86 578888843 347899999999999999999999988 99999999999999999999999999976543321 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 223457999999999999999999999999999999999999999754
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.55 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=199.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||++... +++.||+|++... ....+++.+|+.++++++||||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 35678999999999999654 6789999998643 2334578999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........ ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 158 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LA 158 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hh
Confidence 999999987643 35789999999999999999999987 99999999999999999999999999986543221 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....++..|+|||++.+...+.++||||||++++||++|+.||..... .. ....+..+...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------------------~~-~~~~~~~~~~~ 219 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------------------KN-LVLKIIRGSYP 219 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------------------HH-HHHHHhcCCCC
Confidence 234578899999999998999999999999999999999999864211 01 11111112111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+|++.+|.+||+|.+|++.
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 ---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122335668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=283.00 Aligned_cols=246 Identities=24% Similarity=0.276 Sum_probs=199.7
Q ss_pred cccccccccceeEEEEE-eCCCcEEEEEEecC---CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+-+.||+|.|+.||+.. .+.|+.+|+|.+.. ...+.+++.+|+++-+.|+||||++|.+.+.+....+||+|+|.+
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 45789999999999984 45788899998853 344678899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCccccCCCcccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~~ 610 (804)
+.|..-|-.+ ...++..+-..+.||+++|.|.|..+ |||||+||+|+||.+. --+||+|||++..++ ....
T Consensus 95 ~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~ 168 (355)
T KOG0033|consen 95 GELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEA 168 (355)
T ss_pred hHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--Cccc
Confidence 9997655443 35677788899999999999999988 9999999999999543 359999999999877 2334
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....+||++|||||++...+|+..+|||+-||||+-||.|..||...+.. -..+.+..|..
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------------------rlye~I~~g~y 229 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------------------RLYEQIKAGAY 229 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------------------HHHHHHhcccc
Confidence 55678999999999999999999999999999999999999999753321 12233333322
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. +....-....+....++.+||..||.+|.|+.|.++.
T Consensus 230 d------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 D------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 1111122345677889999999999999999988753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.40 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=195.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... .++.||+|.++.. ......+.+|+.++++++||||+++++++......++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 35578999999999999765 5788999998643 2334567889999999999999999999999999999999997
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++......+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++....... .....
T Consensus 88 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (301)
T cd07873 88 KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSN 163 (301)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Ccccc
Confidence 5898888776667899999999999999999999987 9999999999999999999999999997643221 11233
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-CCCCccCchHHHHHHhhcC-cc
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG-EHGDKWFFPPWAARQIIEG-NV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~ 690 (804)
..+++.|+|||.+.+. .++.++||||||+++|||++|+.||............... ..... ..| ..+... ..
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~ 238 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE---ETW--PGILSNEEF 238 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh---hhc--hhhhccccc
Confidence 4578899999988654 5788999999999999999999999753221000000000 00000 000 000000 00
Q ss_pred ceeccccccC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGG----AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...-.+.... .........+.+++.+|++.||.+|||+.||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000 0011224467889999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.03 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=194.7
Q ss_pred cccccccccceeEEEEEeC----CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCC------eE
Q 044374 458 FSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENS------HR 524 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~ 524 (804)
+.+.||+|+||.||+|.+. .++.||||++..... ..+++.+|+.++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999753 357899999975432 3456889999999999999999999886532 34
Q ss_pred EEEEEEcCCCChhHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCC
Q 044374 525 LLVYDYMRNGALSLYLRKD-----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGL 599 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 599 (804)
++++||+.+|+|..++... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence 7899999999999887532 124788899999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 600 AKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 600 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
++...... ........++..|++||.+....++.++||||||+++|||++ |+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----------------- 222 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----------------- 222 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----------------
Confidence 98653321 111223345678999999999899999999999999999999 88887532110
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
-....+..+... ..+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 223 --~~~~~~~~~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 --EIYNYLIKGNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011111111110 01123346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.88 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=189.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC------CHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS------GEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 528 (804)
..+.||+|+||.||+|... .+..||+|++..... ....+.+|+.++++++||||+++++++.. ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4578999999999999764 578999999864321 12458889999999999999999998865 35778999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF- 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~- 607 (804)
||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999997654 5888999999999999999999887 9999999999999999999999999997653211
Q ss_pred -cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 -SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 -~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
........++..|+|||++.+..++.++||||||+++|||++|+.||...... ........
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------------------~~~~~~~~ 223 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------------------AAIFKIAT 223 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------------------HHHHHHhc
Confidence 11122345788999999999988999999999999999999999998642110 00000000
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. .. ...+....+.+..++ .|+..+|++||+++||++
T Consensus 224 ~~-----~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QP-----TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC-----CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 01 111222334455555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.35 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=197.6
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 4578999999999999764 678999999976543 356789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc---
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--- 610 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~--- 610 (804)
++|.+++.... .+++..+..++.++++||+|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 84 GTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999998653 5789999999999999999999988 9999999999999999999999999998764432221
Q ss_pred ccccccccccccchhccCCC---CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH-hh
Q 044374 611 LATMRGTWGYVAPEWISGLA---ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ-II 686 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~---~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 686 (804)
.....++..|+|||++.+.. .+.++||||||++++|+++|+.||...... +.... ..
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------------------~~~~~~~~ 220 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------------------FQIMFHVG 220 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------------------HHHHHHHh
Confidence 12356788999999998766 889999999999999999999999642110 11110 00
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.+.. +.+.. .......+.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~-----~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 221 AGHK-----PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cCCC-----CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0100 01100 1122456788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.10 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=196.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++.+.||+|+||.||++... .+..||+|.++.... ....+.+|+.++++++||||+++++.+...+..++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45678999999999999876 678999999875322 245788999999999999999999999999999999999999
Q ss_pred CChhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 534 GALSLYLRKD--GLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 534 gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|..++... ...+++..+..++.+++.||.|||+. + |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 9999998764 23689999999999999999999974 5 9999999999999999999999999997653221
Q ss_pred ccccccccccccchhccCC------CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 611 LATMRGTWGYVAPEWISGL------AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~------~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------------~~~~~~~ 221 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----------------IFAQLSA 221 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----------------HHHHHHH
Confidence 2334578899999998554 35789999999999999999999986421110 0000011
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+..+.. ...+......+..++.+|++.+|++||++.++++.
T Consensus 222 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVDGDP---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HhhcCC---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111111 11223355678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.00 Aligned_cols=247 Identities=24% Similarity=0.267 Sum_probs=196.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... .++.||+|.+..... ..+.+.+|+.++.+++||||+++++.+......++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 34578999999999999775 488999999975432 3356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--
Q 044374 532 RNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 532 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 608 (804)
.+++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999998754 346899999999999999999999987 99999999999999999999999999875422110
Q ss_pred --------------------------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCC
Q 044374 609 --------------------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRN 662 (804)
Q Consensus 609 --------------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 662 (804)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 01112467889999999999889999999999999999999999997432210
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT----MGTVVK 733 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~eVl~ 733 (804)
....+. +..............+.+++.+|++.+|++||+ +.++++
T Consensus 240 ------------------~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ------------------TFSNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------------------HHHHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 001111 111111111114577999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.65 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=199.2
Q ss_pred cChHHHHHhhccc--ccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecC
Q 044374 446 FSYKELHTVTRGF--SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSEN 521 (804)
Q Consensus 446 ~~~~el~~~t~~~--~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 521 (804)
+...++..++.+| .+.||+|+||.||++... +++.+|+|++........++.+|+.++.++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3344444444444 568999999999999764 678999999976555567788899999998 899999999998653
Q ss_pred -----CeEEEEEEEcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceE
Q 044374 522 -----SHRLLVYDYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAK 593 (804)
Q Consensus 522 -----~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 593 (804)
...++||||+++++|.++++. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 368999999999999998863 3346899999999999999999999887 99999999999999999999
Q ss_pred EeecCCccccCCCccccccccccccccccchhccCC-----CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC
Q 044374 594 VSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-----AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG 668 (804)
Q Consensus 594 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 668 (804)
|+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-------- 239 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-------- 239 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--------
Confidence 999999886543221 12234678899999998653 3688999999999999999999998643211
Q ss_pred CCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 669 GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+..+....+.+ +......+.+++.+|++.+|++||++.++++.
T Consensus 240 -----------~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 -----------KTLFKIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----------HHHHHHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0001111111111111 11233568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.22 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=198.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||.|+||.||++... ++..+|+|.+.... ...+.+.+|+.++++++||||+++++.+......++||||++++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 35578999999999999775 57889999997543 23457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ .....
T Consensus 88 ~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 163 (280)
T cd06611 88 ALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTF 163 (280)
T ss_pred cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-cccee
Confidence 999999876667999999999999999999999988 99999999999999999999999999876433221 12345
Q ss_pred ccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 615 RGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 615 ~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.++..|+|||.+. ...++.++||||||+++|||++|+.||...... -....+..+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~ 224 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------------------RVLLKILKSE 224 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------------------HHHHHHhcCC
Confidence 6889999999875 345678999999999999999999998743211 0111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .+ ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 225 ~~-----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PP-----TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CC-----Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 10 01 0111234567889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.09 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=191.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 526 (804)
.+.+.||+|+||.||++... .++.||||++..... ....+.+|+.+++.++||||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999654 578899999975422 235677899999999999999999988643 35799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 v~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 100 VMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred Ehhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 9999976 56666543 4788899999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CC-CCCCCCCc--cCchHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IG-GGGEHGDK--WFFPPWAA 682 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~-~~~~~~~~--~~~~~~~~ 682 (804)
. ......+|..|+|||++.+..++.++|||||||++|||++|+.||.......... +. ..+..... ..+.....
T Consensus 173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred c--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 1 2234568999999999999999999999999999999999999997532110000 00 00000000 00000000
Q ss_pred HHhhcC-ccc-----eeccccc---cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEG-NVA-----AVVDDRL---GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... ... ......+ ....+......+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000 0000000 001111234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.92 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=193.0
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEec------CCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSE------NSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------~~~~~lV~E 529 (804)
+.+.||+|+||.||+|... .++.+|+|++........++..|+.++.++ +|+||+++++++.. ....+++||
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 4578999999999999764 578899999876655567788999999998 69999999999853 457899999
Q ss_pred EcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 530 YMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 999999999987643 45788889999999999999999987 99999999999999999999999999876532211
Q ss_pred ccccccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 609 RVLATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
......++..|+|||.+. ...++.++|||||||++|||++|+.||....+... ..
T Consensus 177 -~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------------------~~ 236 (282)
T cd06636 177 -RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------------------LF 236 (282)
T ss_pred -CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------------------hh
Confidence 123456889999999875 34578899999999999999999999864321100 00
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..... ....+ ........+.+++..||+.||.+||++.+|++
T Consensus 237 ~~~~~-----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPRN-----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhhC-----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 00000 11123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.85 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=209.8
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|.|..|-.|++ -.|+.||||++.+... ....+.+|++.|+.++|||||+|+.+......+|||+|+=.
T Consensus 21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD 100 (864)
T KOG4717|consen 21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD 100 (864)
T ss_pred hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence 3457899999999999854 4789999999976533 44678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|+|.+||.++...+++....+++.||..|+.|.|+.. +|||||||+||.+- .-|-+||.|||++-.+... ...
T Consensus 101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL 175 (864)
T KOG4717|consen 101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKL 175 (864)
T ss_pred CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--chh
Confidence 99999999988889999999999999999999999988 99999999999875 4578999999999766543 346
Q ss_pred cccccccccccchhccCCCCC-ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAIT-TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.+.+|...|-|||++.+..|. +++||||||||||.|+.|+.||....+.+. +
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------------------L 228 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------------------L 228 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------------------h
Confidence 788999999999999998886 578999999999999999999986443321 2
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
.-++|-.. ..+.-...++..++..||+.||++|.+.++|+.. |+.+
T Consensus 229 TmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 229 TMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred hhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 23333322 3355667889999999999999999999999854 5543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.73 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=199.6
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++++++||||+++++.+......++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4578999999999999776 57889999987543 34467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.+||+|||.+........ ..
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~ 158 (265)
T cd06605 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KT 158 (265)
T ss_pred cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hc
Confidence 9999998765678999999999999999999998 66 99999999999999999999999999876533211 12
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..++..|+|||++.+..++.++||||||++++||++|+.||....... ... ....+.+..+...
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------------~~~-~~~~~~~~~~~~~-- 222 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-------------DGI-FELLQYIVNEPPP-- 222 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-------------ccH-HHHHHHHhcCCCC--
Confidence 567889999999999999999999999999999999999986432110 000 0111111111110
Q ss_pred ccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVE-EAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.. ....+.+++..|++.+|++||++.+++..
T Consensus 223 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 -------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 45668899999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.94 Aligned_cols=192 Identities=28% Similarity=0.392 Sum_probs=162.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 526 (804)
.+.+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 45678999999999999654 57889999997532 2345678899999999999999999987543 35799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++ +|...+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 107 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 107 VMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred EEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 9999976 66666643 4788899999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
. ......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 180 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred C--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 1 223456899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.65 Aligned_cols=269 Identities=19% Similarity=0.242 Sum_probs=196.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++|||++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 35578999999999999876 57899999986432 234568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ ...
T Consensus 84 ~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 84 HTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred ccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 999888776543 6899999999999999999999987 99999999999999999999999999987644321 122
Q ss_pred ccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc-
Q 044374 613 TMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV- 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 690 (804)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ....+.............
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK----TLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----HhCCCChHHhhhccccccc
Confidence 3457889999999876 5678999999999999999999999975332100000000 000000000000000000
Q ss_pred ceeccccccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+......+ ......+.+++.+|++.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 1124568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=294.98 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=194.9
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCC---C--------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---G--------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
.+.||+|+||.||+|... +++.||||.++.... . .+.+.+|+.++++++|||++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 468999999999999654 678999998853211 1 2357889999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999998764 6889999999999999999999987 999999999999999999999999999765432
Q ss_pred ccc-cccccccccccccchhccCCC--CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 607 FSR-VLATMRGTWGYVAPEWISGLA--ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 607 ~~~-~~~~~~gt~~y~aPE~l~~~~--~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
... ......++..|+|||.+.... ++.++||||||+++||+++|+.||...... . ...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------------------~-~~~ 222 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------------------A-AMF 222 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------------------H-HHH
Confidence 211 123456889999999987654 789999999999999999999998632110 0 000
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..........+.. ....+....+.+++..|++.+|.+||++.+|++.
T Consensus 223 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLGNKRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HhhccccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111111111 1112235678889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.33 Aligned_cols=268 Identities=21% Similarity=0.260 Sum_probs=195.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||++... .++.||+|++..... ..+.+.+|+.+++.++||||+++++++......++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 45689999999999999875 578999999864322 34578899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..+..... .+++..++.++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++....... ....
T Consensus 84 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 84 HTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred ccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 999988766543 5899999999999999999999987 9999999999999999999999999998654332 2223
Q ss_pred ccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc-
Q 044374 613 TMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV- 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 690 (804)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||..........-.. .....+.............
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII----KCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH----HHhCCCchhhHHHhccchHh
Confidence 3557889999999876 457889999999999999999998886432110000000 0000000000000000000
Q ss_pred ceeccccccC-----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 691 AAVVDDRLGG-----AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 691 ~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.....+.... .........+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 001123467889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.67 Aligned_cols=267 Identities=21% Similarity=0.241 Sum_probs=196.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|... +++.||||++..... ....+..|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34578999999999999765 678999999975432 23457789999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+ +++|.+++......+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 99 99999999876557899999999999999999999988 99999999999999999999999999986544321
Q ss_pred cccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......++..|+|||.+.+ ..++.++||||||++++||++|..+|....+.......... ........|.. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----~~ 231 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA--LGTPTEENWPG----VT 231 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH--cCCCchhhhhh----cc
Confidence 1223456788999998865 46789999999999999999997777643221000000000 00000000000 00
Q ss_pred ccceeccccccCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGA-----YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
............. ........+.+++.+|++.+|++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 112235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.52 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=191.9
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---C---CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---S---GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 528 (804)
+.+.||+|+||.||+|... ++..||||.+.... . ..+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4578999999999999764 57899999885321 1 134688899999999999999999988663 4678999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF- 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~- 607 (804)
||+++++|.+++.... .+++...++++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 86 EHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 9999999999987654 5788899999999999999999988 9999999999999999999999999997643211
Q ss_pred -cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 -SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 -~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
........++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------------~~~~~~~ 222 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------------------AAIFKIA 222 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------------------HHHHHHh
Confidence 11123346889999999998888999999999999999999999998642110 0001110
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ......+......+..++..|+. +|++||++++|++.
T Consensus 223 ~~--------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQ--------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cC--------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 01112233445667788888885 89999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=303.78 Aligned_cols=270 Identities=20% Similarity=0.267 Sum_probs=193.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+|... .++.||+|+++... .....+.+|+.++++++||||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 35678999999999999765 67899999996432 223567889999999999999999999999999999999997
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+ +|.+++......+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 83 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 83 Q-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 4 787777665557899999999999999999999988 9999999999999999999999999998654322 1123
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCC-cCCCCCCCCCccCchHHHHHH-hhcCc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNA-NIGGGGEHGDKWFFPPWAARQ-IIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~ 689 (804)
...++..|+|||++.+. .++.++|||||||++|||++|..|+......... ....... .......|.... ...-.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh--CCCChHHhHHhhhccccc
Confidence 34578899999998764 4789999999999999999999886532211000 0000000 000000000000 00000
Q ss_pred cceecccccc-CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 690 VAAVVDDRLG-GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.......... ..........+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000 0011123467789999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.78 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=197.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... ++..||||.+.... .....+.+|+.++.+++||||+++++++..+...++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 34578999999999999754 67899999986432 2345788999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++... .+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........ ....
T Consensus 87 ~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06641 87 GSALDLLEPG--PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hhcc
Confidence 9999998753 5889999999999999999999987 99999999999999999999999999876543211 1233
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+..+..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~~--- 218 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------------------KVLFLIPKNNP--- 218 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------------------HHHHHHhcCCC---
Confidence 45788999999998888999999999999999999999998642111 01111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+......+.+++.+|++.+|.+||++.+++++
T Consensus 219 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 ------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122334668889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.32 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=208.7
Q ss_pred HHHHhhcccccccccccceeEEEEEeC--------CCcEEEEEEecCCC--CCHHHHHHHHHHHcCC-CCCCceeeeeEE
Q 044374 450 ELHTVTRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPG--SGEREFRAEVCTIGNI-QHVNLVRLRGFC 518 (804)
Q Consensus 450 el~~~t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 518 (804)
|+......+.+.||+|.||.|++|... ....||||.++... ...+.+..|+.+|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333333356679999999999999643 14579999998643 3467899999999998 599999999999
Q ss_pred ecCCeEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 044374 519 SENSHRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPEN 583 (804)
Q Consensus 519 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~N 583 (804)
...+..++|+||++.|+|..+|+..+ ..++....+.++.|||.||+||++.. ++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999998776 34888999999999999999999987 9999999999
Q ss_pred EEecCCCceEEeecCCccccCCCccccccccc--cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCC
Q 044374 584 ILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR--GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASG 660 (804)
Q Consensus 584 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~ 660 (804)
||+..+..+||+|||+++.............. -+..|||||.+....|+.|||||||||+||||+| |..|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 99999999999999999965433222111112 4567999999999999999999999999999998 6677653110
Q ss_pred CCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 661 RNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
..-..+.+.+|... +.|..+..++..+++.||+.+|++||++.++++.|+..
T Consensus 528 -----------------~~~l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 -----------------TEELLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -----------------HHHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11123344555332 23444567889999999999999999999999999884
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.80 Aligned_cols=270 Identities=22% Similarity=0.281 Sum_probs=199.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+|... +++.||||+++.. ......+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 45678999999999999776 5788999998643 2334678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++.+..++... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++............
T Consensus 84 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 84 RTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 87777665543 46899999999999999999999988 999999999999999999999999999876544332334
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh-cCc-
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-EGN- 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~- 689 (804)
...++..|+|||++.+. .++.++||||||+++|||++|+.||............. .....++......+. ...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ----KCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHhCCCCHHHhhhcccCccc
Confidence 45678899999999888 88999999999999999999999886432110000000 000000000000000 000
Q ss_pred ----cceecccc-ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 ----VAAVVDDR-LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ----~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+..+.. ....++......+.+++..||+.+|++||++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0001122235778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.21 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=197.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~ 530 (804)
.+.+.||.|+||.||++... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 35578999999999999654 678899999975432 23468889999999999999999998754 4567999999
Q ss_pred cCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 531 MRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEEC--RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 531 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+++++|.+++... ...+++..++.++.+++.||+|||..+ ..+|+|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999998653 357899999999999999999999332 23399999999999999999999999999987654
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...... -....+
T Consensus 163 ~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~ 222 (265)
T cd08217 163 DSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------------------QLASKI 222 (265)
T ss_pred Ccc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------------------HHHHHH
Confidence 322 123446889999999999988999999999999999999999998743210 111222
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.. ...+......+.+++.+|++.+|++||++.+|+++
T Consensus 223 ~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 KEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred hcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22211 11223345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=297.24 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=201.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
+.+.||+|+||.||++... ++..|++|++.......+.+.+|+.++++++|+|++++++++......++|+||+++++|
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 3468999999999999876 678899999986544567889999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++......+++..+..++.+++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++........ ......+
T Consensus 103 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 178 (286)
T cd06614 103 TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVG 178 (286)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccC
Confidence 9999876557899999999999999999999977 99999999999999999999999999875543221 1233457
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
+..|+|||++.+..++.++||||||+++|||++|+.||....+. .....+.........
T Consensus 179 ~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~~~~~~-- 237 (286)
T cd06614 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------------------RALFLITTKGIPPLK-- 237 (286)
T ss_pred CcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhcCCCCCc--
Confidence 88999999999888999999999999999999999998642211 000111111111100
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
........+.+++.+|++.+|.+||++.+|++.
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011134678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=291.46 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=199.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||.|+||+||+|... ++..+|+|++.... .....+.+|+..++.++|+|++++++.+...+..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45678999999999999754 67889999996532 3456789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--
Q 044374 534 GALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-- 609 (804)
Q Consensus 534 gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 609 (804)
++|.+++.... ..+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999997642 46899999999999999999999888 999999999999999999999999999765433221
Q ss_pred -cccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 610 -VLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 610 -~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
......++..|+|||++... .++.++||||||+++|||++|+.||......+ ...+. ..
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------------------~~~~~-~~ 221 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------------------VLMLT-LQ 221 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------------------hHHHH-hc
Confidence 22344688999999998877 78999999999999999999999997532210 00000 00
Q ss_pred CccceeccccccCCC-CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 688 GNVAAVVDDRLGGAY-KVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
. ..+.+.... .......+.+++..|++.||++||++.+|++
T Consensus 222 ~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 N-----DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C-----CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 001111110 1133467889999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=296.16 Aligned_cols=270 Identities=21% Similarity=0.260 Sum_probs=199.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++......++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999764 68899999997543 23467899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++......+++.++..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++............
T Consensus 82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99999999876667999999999999999999999987 999999999999999999999999999876544322334
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc-Ccc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE-GNV 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 690 (804)
...++..|+|||.+.+. .++.++||||||++++||++|+.+|............. ..........| ....+ ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~ 234 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF--RTLGTPNEETW--PGLTSLPDY 234 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH--HHcCCCChHHH--hhccCcchh
Confidence 45689999999988654 46899999999999999999977775432110000000 00000000000 00000 000
Q ss_pred ceecccccc----CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLG----GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+..+... .....+....+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00111234778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.66 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=196.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCC------eEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENS------HRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~------~~~lV~ 528 (804)
.+.+.||+|+||.||+|... +++.+++|++.........+.+|+.+++++ +|+||+++++++.... ..++||
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 35678999999999999875 568899999987666677899999999999 6999999999997644 489999
Q ss_pred EEcCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
||+++++|.+++... +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 999999999988653 357899999999999999999999988 99999999999999999999999999876533
Q ss_pred CccccccccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 606 DFSRVLATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
.. .......++..|+|||++.. ..++.++||||||++++||++|+.||...... .
T Consensus 166 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------------~ 225 (275)
T cd06608 166 TL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------------------R 225 (275)
T ss_pred ch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------------------H
Confidence 22 12234568899999998754 34678999999999999999999998642111 0
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+..+... .+ ..+......+.+++.+|+..||++||++.+|++
T Consensus 226 ~~~~~~~~~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALFKIPRNPPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHhhccCCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111111111 11 111224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.91 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=195.7
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+||+|+||.||++... .+..||||.+.... ...+.+.+|+..+.+++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999764 57889999986543 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ......++
T Consensus 108 ~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 108 DIVTHT--RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 988653 5889999999999999999999987 99999999999999999999999999876543322 12345688
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
..|+|||.+.+..++.++||||||++++||++|+.||...... .....+.. .+...
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------------~~~~~~~~-----~~~~~ 237 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------------------QAMRRIRD-----NLPPR 237 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHh-----cCCCc
Confidence 9999999999889999999999999999999999998642110 00111111 11111
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.. .......+..++..|++.+|++||++.+|++.
T Consensus 238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111 11233467889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.50 Aligned_cols=243 Identities=28% Similarity=0.343 Sum_probs=193.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|... +++.||+|++..... ..+++.+|+.+++.++|||++++++++......++|+||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 34578999999999999765 678999999864321 2246889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
. |++.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 98 ~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----- 168 (307)
T cd06607 98 L-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----- 168 (307)
T ss_pred C-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence 7 5777776655557899999999999999999999988 999999999999999999999999998764322
Q ss_pred cccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 612 ATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
....++..|+|||++. ...++.++||||||+++|||++|+.||...... . ........
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------------------~-~~~~~~~~ 229 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------S-ALYHIAQN 229 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------------------H-HHHHHhcC
Confidence 2345788999999874 456889999999999999999999998643211 0 00001111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
... ..........+..++.+||+.+|++||++.+|+.+.
T Consensus 230 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 DSP--------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCC--------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 011122456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.43 Aligned_cols=235 Identities=26% Similarity=0.296 Sum_probs=191.1
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||.|+||.||++... .++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 47889999996532 2346789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99997654 5889999999999999999999987 9999999999999999999999999998764332 1223467
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
+..|+|||.+.+..++.++|+||||+++|||++|+.||...... +......+.. .
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~--------~ 209 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----------------PMEIYNDILK--------G 209 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----------------HHHHHHHHhc--------c
Confidence 88999999998888999999999999999999999999753210 0001111111 0
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPT 727 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 727 (804)
......+......+..++..||+.+|++||+
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence 1111222233567899999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=291.66 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=197.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||++... .++.+|||.+.... .....+.+|+.++++++|||++++++.+......++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 35678999999999999664 67889999986532 234678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCCcccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|.+++.... ..+++..+..++.++++||+|||+.+ |+|+||||+||+++.+ ..+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 999999997653 45899999999999999999999988 9999999999999855 4689999999987643321
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .... .....+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------------------~~~~-~~~~~~~~ 218 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------------------PALV-LKIMSGTF 218 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------------------HHHH-HHHHhcCC
Confidence 2235678899999999988899999999999999999999999864321 1111 11111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .+......+.+++..||+.+|++||++.++++.
T Consensus 219 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 AP---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CC---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=328.40 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=192.8
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 528 (804)
.+.+.++||+|+||+||++... .+..||+|.+..... ....|..|+.++.+++|||||++++++.. ....+|||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 3456789999999999999765 567899999875422 34568899999999999999999998854 45689999
Q ss_pred EEcCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEecCCCCCcEEecC-------------
Q 044374 529 DYMRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECR----DCIIHCDIKPENILLDS------------- 588 (804)
Q Consensus 529 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiH~Dlkp~NILl~~------------- 588 (804)
||+++++|.++|... ...+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 999999999998753 2468999999999999999999998542 34999999999999964
Q ss_pred ----CCceEEeecCCccccCCCccccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCC
Q 044374 589 ----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRN 662 (804)
Q Consensus 589 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 662 (804)
...+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||.....
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--- 248 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248 (1021)
T ss_pred ccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc---
Confidence 2358999999998654321 1234578999999999854 4588999999999999999999999964211
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
+. .....+..+. .+. .......+..|+..||+.+|.+||++.+++.
T Consensus 249 --------------~~-qli~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 --------------FS-QLISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --------------HH-HHHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 01 1111111110 000 0112456889999999999999999999984
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.02 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=195.6
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+.||+|+||.||+|.. .+++.||+|.+... .....++.+|+.++++++ |||++++++++......++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 457899999999999976 46889999998653 334567889999999886 999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++... .+++...+.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06917 85 EGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KR 158 (277)
T ss_pred CCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cc
Confidence 999999998764 6889999999999999999999988 99999999999999999999999999987654322 22
Q ss_pred cccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------------------~~~~~~~-- 217 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------------------MMLIPKS-- 217 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------------------hhccccC--
Confidence 34468889999998865 4578999999999999999999999974322100 0000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.+... .....+.+++.+|++.+|++||++.+++++
T Consensus 218 ---~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 ---KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00111110 134568899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.18 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=196.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+||+|+||.||++... +++.||||.+... ....+.+.+|+.++..++|||++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999764 6789999999643 334567889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
.++... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ ......++
T Consensus 107 ~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 107 DIVSQT--RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 987653 5889999999999999999999988 99999999999999999999999999876543321 12345688
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
..|+|||++.+..++.++||||||++++||++|+.||...... -....+..... ..
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------------~~~~~~~~~~~-----~~ 236 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------------------QAMKRLRDSPP-----PK 236 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHhccCC-----CC
Confidence 9999999999889999999999999999999999998643211 00111111100 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ........+.+++..|++.+|++||++.+|++.
T Consensus 237 ~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 011223567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=288.30 Aligned_cols=246 Identities=28% Similarity=0.407 Sum_probs=201.6
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.||+|++|.||++... +++.+++|++..... ....+.+|+.++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4578999999999999875 678899999976543 56789999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+........ .....
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 99999876567899999999999999999999977 99999999999999999999999999987654321 33456
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
++..|+|||.+.+...+.++||||||++++||++|+.||...... . ...............
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------------~-~~~~~~~~~~~~~~~ 219 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------------------K-ALFKIATNGPPGLRN 219 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------------------H-HHHHHHhcCCCCcCc
Confidence 889999999998888999999999999999999999998743211 0 000011111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+.+++..|++.+|++||++.+|+++
T Consensus 220 -------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124678899999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=295.43 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=189.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHH-HcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCT-IGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||++... +++.||+|+++.... ...++..|+.. ++.++|||++++++++......+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 35678999999999999765 589999999975432 33455556664 667799999999999999999999999997
Q ss_pred CCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 533 NGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 533 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++|.+++.. ....+++..++.++.|++.||+|||+. + ++||||||+|||++.++.+||+|||++.......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 678777754 234689999999999999999999986 5 9999999999999999999999999998653321
Q ss_pred ccccccccccccccchhccC----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 RVLATMRGTWGYVAPEWISG----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... + ... ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~-~~~-~~ 219 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----------------F-QQL-KQ 219 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----------------H-HHH-HH
Confidence 1223457889999998865 45688999999999999999999998632110 0 000 11
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+....+. ....+..+.+++..||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 11134568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.03 Aligned_cols=196 Identities=25% Similarity=0.410 Sum_probs=166.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|++|.||+|... +++.||||.+.... .....+.+|+.++++++|+||+++++++......++||||+.+
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 35678999999999999765 67899999986432 2334577899999999999999999999999999999999985
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++......+++.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 88 -~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07844 88 -DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSN 162 (291)
T ss_pred -CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccc
Confidence 899988776667899999999999999999999987 9999999999999999999999999987543211 11222
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
..++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 346789999998865 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=291.81 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=196.9
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.||+|+||.||++.. .+++.||+|++..... ..+.+++|+.++++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346899999999999965 4678999999964321 23568899999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 608 (804)
|+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 84 WMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred ccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999997654 6889999999999999999999988 99999999999998776 599999999976543311
Q ss_pred ---ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 ---RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 ---~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......++..|+|||.+.+..++.++||||+|++++||++|+.||....... ......+ .
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~-~ 223 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---------------HLALIFK-I 223 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---------------hHHHHHH-H
Confidence 11223467889999999988889999999999999999999999986421110 0000000 0
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. .......+......+.+++.+|++.+|++||++.++++
T Consensus 224 ~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 AS--------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hc--------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 00111223344567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.97 Aligned_cols=244 Identities=22% Similarity=0.289 Sum_probs=198.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... .++.||+|.+.... ...+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 35678999999999999775 57889999996432 34568899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 83 LGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 999999999776 47889999999999999999999987 9999999999999999999999999998654332 22
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~---- 216 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----------------IRDQIRAKQET---- 216 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----------------HHHHHHHHhcc----
Confidence 3456788999999999888999999999999999999999998754321 01111111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH--HHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM--GTVV 732 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~eVl 732 (804)
.....+......+.+++.+|++.+|.+||++ +|++
T Consensus 217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222344778899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=304.52 Aligned_cols=189 Identities=26% Similarity=0.390 Sum_probs=161.2
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLLV 527 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV 527 (804)
+.+.||+|+||.||++.. ..++.||||++.... ...+.+.+|+.++++++||||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 457899999999999965 467889999997532 2335677899999999999999999987543 356899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+|++ +++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 99 TNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred eecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 9987 77888877643 5899999999999999999999988 999999999999999999999999999865432
Q ss_pred cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 608 SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 234568999999999877 5688999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.02 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=197.8
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.++||+||.+.||++...+.+.+|+|++... .+...-|.+|+.+|.+|+ |.+||+|++|-..++.+|||||| ..
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd 443 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GD 443 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-cc
Confidence 45789999999999999988899999988643 334467999999999995 99999999999999999999997 45
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-ccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-VLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~ 612 (804)
.+|..+|+.....++.-.+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+..+... ...
T Consensus 444 ~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 444 IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeec
Confidence 6999999887655553478889999999999999998 99999999999884 679999999999988766443 345
Q ss_pred ccccccccccchhccCCC-----------CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 613 TMRGTWGYVAPEWISGLA-----------ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~-----------~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
..+||+.||+||.+.... .+.+|||||+|||||+|+.|+.||..... .|+
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------------------~~a 580 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------------------QIA 580 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------------------HHH
Confidence 678999999999885432 55789999999999999999999974211 111
Q ss_pred HHHhhcCccceeccccccCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKV-EEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..+.|+.-.-+++. ....+++++++.||+.||.+||+..++++.
T Consensus 581 -------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2334445433222221 112239999999999999999999998875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.46 Aligned_cols=272 Identities=21% Similarity=0.233 Sum_probs=196.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~ 531 (804)
+.++||+|+||.||+|... .++.+|+|++.... .....+.+|+.++++++|+|++++++++... ...++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4678999999999999776 47899999997642 2345688999999999999999999999888 8999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++ +|..++......+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++...........
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 83 DH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 85 888888766557899999999999999999999987 99999999999999999999999999987654432223
Q ss_pred cccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC-CCCCCccCchHHHHH-HhhcC
Q 044374 612 ATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG-GEHGDKWFFPPWAAR-QIIEG 688 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~ 688 (804)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .........+.+... .....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34456888999997765 4678999999999999999999999875332100000000 000000000000000 00000
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.........+...........+.+++..|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000001111112567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=290.91 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=202.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|++|.||++... .++.|+||++.... .....+.+|+..+.+++|+|++++++++......++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 35678999999999999776 48899999997653 3457799999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 84 ~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~ 158 (264)
T cd06623 84 GSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CN 158 (264)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-cc
Confidence 9999999865 478999999999999999999998 87 999999999999999999999999999876433222 22
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
...++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... ....+.....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------------~~~~-~~~~~~~~~~-- 220 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---------------SFFE-LMQAICDGPP-- 220 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------------CHHH-HHHHHhcCCC--
Confidence 456789999999999999999999999999999999999998753210 0000 1111111111
Q ss_pred eccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDRLGGAYKVE-EAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+.. ....+.+++..|++.+|++||++.++++.
T Consensus 221 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.53 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=198.1
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.+.||+|+||.||++.. .++..||+|.+... ....+.+.+|+.++++++|||++++++++...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 3567899999999999965 46788999998643 334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .....
T Consensus 102 ~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 175 (293)
T cd06647 102 SLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 175 (293)
T ss_pred cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccc
Confidence 999998764 4788999999999999999999988 99999999999999999999999999876543321 22334
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+++.|+|||.+.+..++.++||||||+++||+++|+.||........... ....+
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------------------~~~~~------ 231 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------------IATNG------ 231 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------------------hhcCC------
Confidence 688899999999888899999999999999999999999975432110000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+......+.+++..||+.+|++||++.+++.+
T Consensus 232 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 --TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112234568889999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.48 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=198.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... .++.||+|.+.... .....+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 35678999999999999765 46889999986532 22356789999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc----
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF---- 607 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~---- 607 (804)
++++|.+++...+ .+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 84 EGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 9999999997654 6889999999999999999999987 9999999999999999999999999987421100
Q ss_pred ----------cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 608 ----------SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 608 ----------~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
........++..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----------------- 222 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------------- 222 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------
Confidence 00112245788999999998888999999999999999999999998642111
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
........+.. ..+.. .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 --~~~~~~~~~~~---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 --ELFGQVISDDI---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHHHHHHhccc---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 01111111110 00110 01234567899999999999999998888888876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=276.65 Aligned_cols=245 Identities=27% Similarity=0.359 Sum_probs=198.4
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCC-----CCH----HHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEE
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-----SGE----REFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~----~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 527 (804)
.+.||.|..++|.+...+ .+...|+|++.... ... +.-.+|+.+|+++ .||+|+++.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 357999999999988554 67889999995321 112 2356799999998 599999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+|.|+.|.|.++|... ..++++...+|+.|+.+|+.|||... |+||||||+|||++++.++||+|||.+..+...
T Consensus 102 Fdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G- 176 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG- 176 (411)
T ss_pred hhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc-
Confidence 9999999999999864 47899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccccchhccC------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 608 SRVLATMRGTWGYVAPEWISG------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
......+||++|+|||.+.- ..|+..+|+|+.|||||-||.|..||-.... ...
T Consensus 177 -ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------------------mlM 236 (411)
T KOG0599|consen 177 -EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------------------MLM 236 (411)
T ss_pred -hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------------------HHH
Confidence 34667899999999998842 3588899999999999999999998853110 112
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.+.+|... ...+.-.+......+++.+|++.||.+|-|++|++++
T Consensus 237 LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2333444321 1122223456678899999999999999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=289.77 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=196.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~ 531 (804)
.+.++||.|++|.||++... .++.+|+|.+..... ...++.+|++++++++||||+++++++... ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 34578999999999999874 578899999975432 456789999999999999999999998653 4689999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999988753 3346888999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+ .......
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~----~~~~~~~ 223 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL----------GPIEL----LSYIVNM 223 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC----------ChHHH----HHHHhcC
Confidence 1234578899999999999999999999999999999999999975422000 00001 1111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+ .... .......+.+.+++.+|++.+|++||++.||++.
T Consensus 224 ~~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 224 PNPEL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred Cchhh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11111 1110 0011235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.97 Aligned_cols=246 Identities=27% Similarity=0.319 Sum_probs=195.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.||+|+||.||+++.. ++..||+|++..... ....+.+|+.++++++|||++++++++......++||||+.
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 4568999999999999764 678999999864321 23468889999999999999999999999999999999997
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+ +|.+++......+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..... ..
T Consensus 109 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~ 179 (317)
T cd06635 109 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-----AN 179 (317)
T ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----cc
Confidence 4 777777665567899999999999999999999988 99999999999999999999999999875432 22
Q ss_pred ccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 613 TMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...++..|+|||++. ...++.++||||||+++|||++|+.||...... .....+..+.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------------~~~~~~~~~~ 240 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------------SALYHIAQNE 240 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------------------HHHHHHHhcc
Confidence 345788999999874 456889999999999999999999998642110 0011111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ...........+.+++.+|++.+|.+||++.+|++.+--..
T Consensus 241 ~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 S--------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred C--------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 1 00111233456889999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.89 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=197.5
Q ss_pred cccccceeEEEEEeCC-CcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELSD-STLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||.||+++... ++.+|+|.+.... .....+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 8899999996543 2345788999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-------c
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-------R 609 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-------~ 609 (804)
.+++...+ .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998755 7899999999999999999999988 99999999999999999999999999876432211 1
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......++..|+|||.+.....+.++||||||++++||++|+.||...... . .......+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------------------~-~~~~~~~~~ 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------------------E-IFQNILNGK 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------------------H-HHHHHhcCC
Confidence 223455788999999998888999999999999999999999998643211 0 111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
. ...........+..++..|++.+|++||++.+|.+.|+.
T Consensus 218 ~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 218 I--------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c--------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 1 000000125678899999999999999999877777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=294.49 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=196.9
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5899999999999975 467889999986543 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++........ ......++
T Consensus 105 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred HHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 99877 36889999999999999999999988 99999999999999999999999999876543322 12335688
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
..|+|||.+.+..++.++||||||++++||++|+.||....+. .....+..+.. +.
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------------------~~~~~~~~~~~-----~~ 234 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------------QAMKRIRDNLP-----PK 234 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------------------HHHHHHHhcCC-----CC
Confidence 9999999998888999999999999999999999998642110 01111111111 11
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.. +......+.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 235 LKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred Ccc--cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 110 11234578999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.90 Aligned_cols=269 Identities=19% Similarity=0.210 Sum_probs=195.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~ 531 (804)
+.+.||+|+||.||+|... +++.+|+|.++.... ....+.+|+.++.+++||||+++++++... ...++||||+
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 4578999999999999876 578899999974322 234577899999999999999999998877 8999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++ +|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........ ..
T Consensus 89 ~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 163 (293)
T cd07843 89 EH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PY 163 (293)
T ss_pred Cc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-cc
Confidence 85 898888776657899999999999999999999988 99999999999999999999999999986644321 12
Q ss_pred cccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH----Hhh
Q 044374 612 ATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR----QII 686 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 686 (804)
....++..|+|||.+.+. .++.++||||||++++||++|+.||................ ....-..|... ...
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh--CCCchHHHHHhhccchhc
Confidence 334578899999998764 46899999999999999999999987532210000000000 00000000000 000
Q ss_pred cCccceeccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVE-EAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
...........+...++.. ..+.+.+++..|++.+|++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000111111111122221 3566889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=295.33 Aligned_cols=239 Identities=28% Similarity=0.346 Sum_probs=195.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... +++.||+|+++... ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 35678999999999999765 57899999996432 23456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 84 PGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 9999999997764 7899999999999999999999987 999999999999999999999999999875433 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....+++.|+|||.+.+...+.++||||||++++||++|+.||..... .........+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~~- 215 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------------------IQIYEKILEGKV- 215 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHhcCCc-
Confidence 344688999999999888899999999999999999999999864221 111111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVV 732 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl 732 (804)
..+......+.+++.+||+.+|.+|| ++.+++
T Consensus 216 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 ---------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11222346788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=285.35 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=201.7
Q ss_pred cccccccccceeEEEEEeCC-CcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELSD-STLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.||.|.-|+||.+++.+ +..+|+|++.+.. ......+.|-++|+.++||.+..|+..+......|||||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45789999999999998875 4889999997643 233457788999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC------
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR------ 605 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~------ 605 (804)
||+|..+++++. ..+++..+..++.+++-||+|||..| ||+|||||+||||.++|++.|+||.|+.....
T Consensus 161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999999998764 57899999999999999999999988 99999999999999999999999998743200
Q ss_pred ---------------------------Ccc----------------------ccccccccccccccchhccCCCCCccce
Q 044374 606 ---------------------------DFS----------------------RVLATMRGTWGYVAPEWISGLAITTKAD 636 (804)
Q Consensus 606 ---------------------------~~~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~ksD 636 (804)
... ......+||-.|+|||++.+..++.++|
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 000 0112346999999999999999999999
Q ss_pred EEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhh
Q 044374 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIW 716 (804)
Q Consensus 637 V~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 716 (804)
-|+|||+|||||.|+.||.+....+ .+.+++-..+.-.-.......+.+||..
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~---------------------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKE---------------------------TLRNIVGQPLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchh---------------------------hHHHHhcCCCcCCCCCcchhHHHHHHHH
Confidence 9999999999999999998654321 1233333322211122455678899999
Q ss_pred ccccCCCCCCC----HHHHHHH
Q 044374 717 CIQDNEEMRPT----MGTVVKM 734 (804)
Q Consensus 717 Cl~~dP~~RPs----~~eVl~~ 734 (804)
.|.+||.+|-- +.||-++
T Consensus 371 LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HhccChhhhhccccchHHhhcC
Confidence 99999999998 7777755
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.27 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=197.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 35678999999999999775 5788999998643 2345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|.+++.... ..+++..+..++.++++||+|||+.+ ++|+||||+||++++++ .+||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 999999987643 35799999999999999999999987 99999999999999885 579999999986643321 2
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....|++.|+|||++.+..++.++||||||++++||++|+.||..... ...... ...+..
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------------~~~~~~-~~~~~~ 219 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------------------HQLVLK-ICQGYF 219 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------HHHHHH-HhcccC
Confidence 2334688999999999888899999999999999999999999864211 111111 111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .........+.+++.+|++.+|++||++.+|++.
T Consensus 220 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 A---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 1111234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.02 Aligned_cols=247 Identities=29% Similarity=0.395 Sum_probs=202.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~~ 531 (804)
..+.||+|++|.||+|... +++.|++|++.... ...+.+.+|+.++++++||||+++++.+... ...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3468999999999999876 68899999997654 3467789999999999999999999999988 8999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-c
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-V 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 610 (804)
++++|.+++.... .+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......... .
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 84 SGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999998765 7899999999999999999999987 999999999999999999999999999876543221 1
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....++..|+|||.+.....+.++||||||+++++|++|+.||...... ......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~------- 215 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----------------MAALYK------- 215 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----------------HHHHHh-------
Confidence 23456889999999999888999999999999999999999998753210 000111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.........+......+.+++.+|++.+|.+||++.++++.
T Consensus 216 --~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 216 --IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011111112233335779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.73 Aligned_cols=241 Identities=23% Similarity=0.283 Sum_probs=186.8
Q ss_pred ccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHH---HcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCT---IGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.||+|+||.||++... +++.+|+|.+..... ....+.+|..+ +...+|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 578999999864321 12334445433 344579999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++..++ .+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 999999987654 6899999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccccchhcc-CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWIS-GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~-~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||.+. +..++.++|||||||+++||++|+.||....... ........ .
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~~~~~~~----~- 212 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----------------KHEIDRMT----L- 212 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----------------HHHHHHHh----h-
Confidence 346899999999886 4568899999999999999999999997432110 00000000 0
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
......+......+.+++..|++.||++|| ++.+++++
T Consensus 213 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 -----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001112223456788999999999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=290.96 Aligned_cols=196 Identities=24% Similarity=0.370 Sum_probs=164.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++|+||+++.+++......++|+||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 34678999999999999654 6789999999643 2334567889999999999999999999999999999999996
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++......+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++...... .....
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 162 (291)
T cd07870 87 TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSS 162 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCCC
Confidence 6777666655456788888999999999999999987 9999999999999999999999999997643221 11233
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
..++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4578899999998764 5788999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.19 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=189.6
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||+||++... +++.||+|.+... ......+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999654 6889999998642 22344567899999999999999999999999999999999999999
Q ss_pred hHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 537 SLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 537 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99987654 36899999999999999999999988 999999999999999999999999998765432 1223345
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
++..|+|||++.+..++.++||||||++++||++|+.||........ ...+......
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------------~~~~~~~~~~---- 212 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------------------KEELKRRTLE---- 212 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------------------HHHHHhcccc----
Confidence 78899999999888899999999999999999999999965322100 0011111000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 730 (804)
.....+......+.+++..||+.+|++||+..+
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 001112233567889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=294.05 Aligned_cols=266 Identities=17% Similarity=0.139 Sum_probs=191.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecC--CeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSEN--SHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~ 531 (804)
+.++||+|+||.||+|... +++.||+|+++.. ........+|+.++.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 5678999999999999764 6789999999753 223334557888888885 99999999999887 8899999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+ ++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++....... .
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~ 155 (282)
T cd07831 83 D-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--Y 155 (282)
T ss_pred C-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--c
Confidence 7 5788888765557899999999999999999999988 999999999999999 9999999999986543321 1
Q ss_pred cccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....++..|+|||++.. ..++.++|||||||++|||++|+.||.............. ........+ .........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~ 231 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD---VLGTPDAEV-LKKFRKSRH 231 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH---HcCCCCHHH-HHhhccccc
Confidence 23457889999997654 5578899999999999999999999965322100000000 000000001 001111000
Q ss_pred ceeccccccC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGG----AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+.... .........+.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 0011335788999999999999999999998863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.95 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=195.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|++|.||+|+.. +++.||||+++... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 35678999999999999875 57899999997542 2346778899999999999999999999999999999999985
Q ss_pred CChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........ ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 8888876543 46899999999999999999999987 99999999999999999999999999976543211 22
Q ss_pred cccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC--
Q 044374 612 ATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG-- 688 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 688 (804)
....++..|++||.+.+. .++.++||||||+++|||++|+.||................ .......| ..+...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~ 233 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM--GTPTESTW--PGISQLPE 233 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh--CCCChhhH--HHHhcCch
Confidence 334578899999988664 57889999999999999999999987543211000000000 00000000 000000
Q ss_pred ---ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 689 ---NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 689 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
......+... ..........+.+++..|++.+|.+||++.+|++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=296.30 Aligned_cols=271 Identities=18% Similarity=0.264 Sum_probs=192.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.||+|+||.||+|+.. +++.||||+++... .....+.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 4578999999999999765 67899999986432 233578899999999999999999999999999999999996
Q ss_pred CChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT 158 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence 5888887653 346899999999999999999999887 99999999999999999999999999876543211 123
Q ss_pred ccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 613 TMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
...++..|+|||.+.+.. ++.++||||||++++||+||+.||.......... +............+............
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 345688999999887644 6889999999999999999999986432110000 00000000000000000000000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+.. ........+.+++.+|++.||++||++.+++++
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 001123457789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.85 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=201.9
Q ss_pred cccccccccccceeEEEEEeCCC-cEEEEEEecC-CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDS-TLVAVKRLER-PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.++...||-|+||.||+|...+. -..|-|++.. .....++|.-||.+|+..+||+||+|++.+...+.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 34567899999999999987654 3456777764 345567899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|-.+.++-.-+..|.+.++.-++.+++.||.|||+.. |||||||+.|||++-+|.++|+|||.+...... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence 9999998877779999999999999999999999988 999999999999999999999999998653322 122456
Q ss_pred cccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 614 MRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 614 ~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
..||+.|||||+++ ..+|..++||||||++|.||..+.+|-....+ .-+..++...
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------------------MRVllKiaKS 250 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------------------MRVLLKIAKS 250 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------------------HHHHHHHhhc
Confidence 78999999999874 46899999999999999999999988653221 1112222222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.-..++. +......+..++..||.+||..||++++++++
T Consensus 251 ePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 EPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2222222 23456678899999999999999999998864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.37 Aligned_cols=247 Identities=24% Similarity=0.349 Sum_probs=189.8
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.++||+|+||.||++... .++.||+|++.... .....+.+|+.++.++. |+||+++++++......+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 468999999999999764 57899999997543 23456889999999996 99999999999999999999999875
Q ss_pred ChhHH---Hhh-CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 535 ALSLY---LRK-DGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 535 sL~~~---l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
++..+ +.. ....+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 44433 222 234689999999999999999999974 5 99999999999999999999999999976543221
Q ss_pred cccccccccccccchhccCC---CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 VLATMRGTWGYVAPEWISGL---AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...... .. ......
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~-~~~~~~ 224 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----------------FD-QLTQVV 224 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----------------HH-HHhhhc
Confidence 2234578899999998776 6889999999999999999999998642100 00 001111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+. .+.+...........+.+++.+|++.+|++||++.+|++.
T Consensus 225 ~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 KGD-----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCC-----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1111111222345678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=284.43 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=203.6
Q ss_pred cccccccccceeEEEEEeC------CCcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecC-CeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSEN-SHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 528 (804)
....+-+|.||.||+|.|. +.+.|.||.+++.... ...+..|..++..+.|||++.+.+++.+. ...+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3457899999999999664 3456788888765443 35688999999999999999999998654 5779999
Q ss_pred EEcCCCChhHHHh-----hC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 529 DYMRNGALSLYLR-----KD--GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 529 E~~~~gsL~~~l~-----~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
.++.-|+|..+|. +. ...+...+...++.|++.|++|||..+ |||.||.++|++||+..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999998 22 235677888999999999999999888 9999999999999999999999999998
Q ss_pred cc-CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 602 LI-GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 602 ~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
.+ ..++.........+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-++-
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------------------- 505 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------------------- 505 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------------------
Confidence 64 4445555555667889999999999999999999999999999998 88887643321
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.....+.+|- +-..|.+++.++..++.-||...|++||++++++.-|.+
T Consensus 506 Em~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 EMEHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222333331 122355678899999999999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=294.65 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=194.0
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.++||.|++|.||+|... ++..||||++.... .....+.+|+.++++++|||++++++++......+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999764 68999999996432 233578899999999999999999999999999999999995
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 68998887654 46899999999999999999999987 99999999999999999999999999976533211 122
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCC-cCCCCCCCCCccCchHHHHHHhhcC--
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNA-NIGGGGEHGDKWFFPPWAARQIIEG-- 688 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-- 688 (804)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......... .+.......... .|.......+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED---VWPGVTSLPDYK 234 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH---Hhhhhhhchhhh
Confidence 33568899999988664 5789999999999999999999998643221000 000000000000 0000000000
Q ss_pred -ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 -NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 -~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......... ..........+.+++.+|++.+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 01111233568899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=319.19 Aligned_cols=196 Identities=20% Similarity=0.312 Sum_probs=155.8
Q ss_pred hcccccccccccceeEEEEEeCC--CcEEEEE------------------EecCCCCCHHHHHHHHHHHcCCCCCCceee
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD--STLVAVK------------------RLERPGSGEREFRAEVCTIGNIQHVNLVRL 514 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l 514 (804)
.+.+.++||+|+||+||++.... +..+++| .+.........+++|+.++.+++||||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 34567899999999999986532 2222222 122222234568899999999999999999
Q ss_pred eeEEecCCeEEEEEEEcCCCChhHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC
Q 044374 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDG----LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY 590 (804)
Q Consensus 515 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 590 (804)
++++...+..++|+|++.. +|.+++.... ..........++.||+.||+|||+.+ |+||||||+||||+.++
T Consensus 229 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 9999999999999999864 6666664332 12335667789999999999999988 99999999999999999
Q ss_pred ceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 591 TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 591 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999876544333334467999999999999999999999999999999999987543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=287.00 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=190.4
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHH-HcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCT-IGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|... .++.||||.+..... ....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999764 578999999965321 12234445443 4556899999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|..++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999997654 6889999999999999999999987 99999999999999999999999999875432 223
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..++..|+|||.+.+..++.++||||||++++||++|..||...... .....+..+...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~~~-- 211 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------------------AVFDNILSRRIN-- 211 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------------------HHHHHHHhcccC--
Confidence 45788999999998888999999999999999999999998643211 011111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
............+.+++..|++.+|++||++.++.+.|+.
T Consensus 212 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 212 ----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0111111234678899999999999999988777666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=283.96 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=201.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.||.|+||.||++... ++..+|+|++.... ....++.+|++++++++|||++++++.+......++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4578999999999999775 57889999997543 3456788999999999999999999999999999999999999
Q ss_pred CChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 534 GALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 534 gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 9999999865 367899999999999999999999987 9999999999999999999999999998654432 12
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+++.|+|||.+.+..++.++||||||+++++|++|+.||...... . ..........
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------------------~-~~~~~~~~~~ 220 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------------------E-LALKILKGQY 220 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------------------H-HHHHHhcCCC
Confidence 33456888999999999989999999999999999999999998643211 1 1111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..+......+.+++.+|+..+|++||++.++++.
T Consensus 221 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 P---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1122334678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=295.23 Aligned_cols=271 Identities=20% Similarity=0.285 Sum_probs=193.6
Q ss_pred cccccc--cceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHG--GFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++||+| +||+||+++.. .++.||||++...... .+.+++|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999764 7899999998754322 35688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc---
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--- 609 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--- 609 (804)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987643 35888999999999999999999887 999999999999999999999999865432211100
Q ss_pred ---cccccccccccccchhccCC--CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc--CCCCCCCC-CccCchHHH
Q 044374 610 ---VLATMRGTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN--IGGGGEHG-DKWFFPPWA 681 (804)
Q Consensus 610 ---~~~~~~gt~~y~aPE~l~~~--~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~ 681 (804)
......++..|+|||++.+. .++.++|||||||+++||++|+.||.......... +....... +...++ ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP-CE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc-hh
Confidence 01112346679999999764 47899999999999999999999997543211000 00000000 000000 00
Q ss_pred HHH----------------hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQ----------------IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~----------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... +..+....+.+..+...........+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000011111222222233456788999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=295.23 Aligned_cols=198 Identities=23% Similarity=0.362 Sum_probs=164.5
Q ss_pred ccccccccccceeEEEEEeCC---CcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD---STLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 527 (804)
.+.++||+|+||.||+|.... ++.||||.+.... ...+.+.+|+.++.+++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 356789999999999997654 7899999997632 2335678899999999999999999999988 789999
Q ss_pred EEEcCCCChhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC----CCceEEeecCC
Q 044374 528 YDYMRNGALSLYLRKD----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGL 599 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DfGl 599 (804)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999986 565555422 136788999999999999999999988 999999999999999 99999999999
Q ss_pred ccccCCCcc--ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCc
Q 044374 600 AKLIGRDFS--RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPA 658 (804)
Q Consensus 600 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~ 658 (804)
+........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 986543322 12233467889999998866 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=289.01 Aligned_cols=267 Identities=20% Similarity=0.252 Sum_probs=198.3
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.||+|++|.||++... +++.+++|++..... ....+.+|+.++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4568999999999999765 678899999875432 346788899999999999999999999999999999999985
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++......+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... .....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 888888776567899999999999999999999988 9999999999999999999999999998765443 12233
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHHHhhc---C
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAARQIIE---G 688 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~ 688 (804)
..++..|+|||.+.+. .++.++||||||+++++|++|+.||.......... +........ ...+....+ .
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 232 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD-----PEVWPKFTSLARN 232 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc-----hHhcccchhhhhh
Confidence 4578899999998876 78999999999999999999999986432210000 000000000 000000000 0
Q ss_pred ccceeccccc--cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRL--GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+... ...........+.+++..||+.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 001112345678999999999999999999998863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=292.29 Aligned_cols=268 Identities=22% Similarity=0.251 Sum_probs=192.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----------
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS---------- 522 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---------- 522 (804)
.+.++||+|+||.||+|... +++.||||+++.. ......+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 45678999999999999875 5789999999643 223456788999999999999999999987654
Q ss_pred eEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 523 HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
..++|+||+++ ++..++......+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccccc
Confidence 78999999986 676777655557899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-CCCCccCchHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG-EHGDKWFFPPW 680 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 680 (804)
.............++..|+|||.+.+ ..++.++|||||||+++||++|+.||............... .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 242 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW--- 242 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc---
Confidence 64433222233456788999998865 45789999999999999999999998743211000000000 00000000
Q ss_pred HHHHhhcCccceecc------ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 AARQIIEGNVAAVVD------DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.+.......+ ........ ..+..+.+++..||+.+|.+||++.+|++.
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 243 --PDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred --ccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000 00000000 124678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=285.10 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=199.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 35678999999999999654 67889999997532 234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++|..++... ...+++..++.++.++++||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999998652 246889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......++..|+|||.+.+..++.++|+||||++++||++|+.||...... . .......+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------------------~-~~~~~~~~~ 217 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------------------D-LRYKVQRGK 217 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------------H-HHHHHhcCC
Confidence 222345788999999999999999999999999999999999998743210 0 111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ...+......+..++..|++.+|++||++.++++.
T Consensus 218 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 Y---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred C---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 11222445678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=294.11 Aligned_cols=269 Identities=18% Similarity=0.182 Sum_probs=192.2
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.+|.|+++.|+++.. +++.||||++... ....+.+.+|+.++++++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34556666766777655 6888999999754 2344679999999999999999999999999999999999999999
Q ss_pred hhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc------
Q 044374 536 LSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS------ 608 (804)
Q Consensus 536 L~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 608 (804)
|.+++... ...+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999864 346888999999999999999999988 99999999999999999999999998865422111
Q ss_pred ccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 RVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||..............+............ ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 239 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP---LY 239 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh---hh
Confidence 11223457788999999876 35889999999999999999999999753221100000000000000000000 00
Q ss_pred cCccce----ecccc----ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAA----VVDDR----LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... ..+.. ............+.+++.+||+.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000 0111122344678889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=288.24 Aligned_cols=252 Identities=23% Similarity=0.255 Sum_probs=197.9
Q ss_pred ccccccccccceeEEEEEe----CCCcEEEEEEecCC-----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERP-----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
.+.+.||+|+||.||+++. .+++.||||+++.. ....+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3567899999999999864 35678999998643 22335688999999999 59999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999987643 6888999999999999999999887 999999999999999999999999999865443
Q ss_pred ccccccccccccccccchhccCCC--CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLA--ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.........++..|+|||.+.+.. .+.++||||||++++||++|+.||...... ...... .+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------------~~~~~~-~~~ 223 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--------------NSQSEI-SRR 223 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--------------chHHHH-HHH
Confidence 222223346889999999987765 788999999999999999999998632110 000011 111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
.... . ...+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKS------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHcc------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1110 0 11122234567889999999999999999999888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=290.34 Aligned_cols=247 Identities=22% Similarity=0.374 Sum_probs=190.3
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCCCC--CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGS--GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|.... ++.||||+++.... ...++..|+.++.+.+ ||||+++++++......++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 356899999999999998864 88999999975432 3345666777666665 9999999999999999999999985
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+ +|..++......+++..+..++.++++||+|||+. + |+||||+|+||++++++.+||+|||++........ .
T Consensus 98 ~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~ 171 (296)
T cd06618 98 T-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--K 171 (296)
T ss_pred c-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc--c
Confidence 4 77777665455789999999999999999999973 5 99999999999999999999999999976543221 1
Q ss_pred cccccccccccchhccCCC----CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 612 ATMRGTWGYVAPEWISGLA----ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~----~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... . . .......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~-~-~~~~~~~ 233 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----------------F-E-VLTKILQ 233 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----------------H-H-HHHHHhc
Confidence 2335778999999987654 788999999999999999999998642110 0 0 0111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.... +. .......++.+++.+|++.+|++||++.+|+++
T Consensus 234 ~~~~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 EEPPS-----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 00 011234568999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=299.30 Aligned_cols=269 Identities=24% Similarity=0.267 Sum_probs=192.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 526 (804)
...+.||+|+||.||++... .++.||||++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 34578999999999999754 68899999986432 2335677899999999999999999988643 35799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+.+ +|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 99 VMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 9999965 777777643 888899999999999999999987 999999999999999999999999999865433
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCc----hHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFF----PPWAA 682 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 682 (804)
.. .....++..|+|||.+.+..++.++|||||||++++|++|+.||......................+ .....
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 21 2334578899999999999999999999999999999999999864321100000000000000000 00000
Q ss_pred HHhhcCc------cceeccccc----cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGN------VAAVVDDRL----GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....... ..++....+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 001110000 011122345668899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=292.19 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=192.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.||+|+||.||+|+.. ++..+|+|.+.... ....++.+|+.+++.++|+|++++++++......++||||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3468999999999999764 57889999986421 123467889999999999999999999999999999999997
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++|.+++......+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... .
T Consensus 99 -~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~ 169 (308)
T cd06634 99 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (308)
T ss_pred -CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-----c
Confidence 5787777655557899999999999999999999987 999999999999999999999999998765332 2
Q ss_pred ccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 613 TMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...++..|+|||++. ...++.++|||||||++|||++|+.||...... ........+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------------~~~~~~~~~~ 230 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------------SALYHIAQNE 230 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------------------HHHHHHhhcC
Confidence 345788999999874 356788999999999999999999998642110 0001111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
... .........+.+++.+||+.+|++||++.+|++..-
T Consensus 231 ~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 SPA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 110 111233466889999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=289.00 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=190.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|++|.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 35678999999999999765 67899999986432 234678899999999999999999999999999999999996
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCcccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+ +|.+++.... ..+++.....++.||+.||+|||+.+ |+|+||+|+||+++. ++.+||+|||++....... ..
T Consensus 85 ~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (294)
T PLN00009 85 L-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RT 159 (294)
T ss_pred c-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cc
Confidence 4 7777765433 34678888899999999999999987 999999999999985 5679999999997654321 11
Q ss_pred ccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCCC---CCccCchHHHH
Q 044374 611 LATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGEH---GDKWFFPPWAA 682 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~ 682 (804)
.....++..|+|||++.+ ..++.++||||||+++|||+||+.||.......... ....... .....++.+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233457889999998866 457899999999999999999999987432110000 0000000 00000000000
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ........+. .........+.+++.+|++.+|++||++.++++.
T Consensus 240 ~------~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 A------FPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred h------cccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000000000 0011234568889999999999999999999864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=285.03 Aligned_cols=241 Identities=22% Similarity=0.270 Sum_probs=186.8
Q ss_pred ccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHH---HHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEV---CTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei---~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.||+|+||.||++... .++.||+|.+..... ....+..|. ..+...+||||+++++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 578999999864321 122234443 34455689999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..++...+ .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 999999887643 6899999999999999999999987 9999999999999999999999999987553321 22
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...|+..|+|||.+.+. .++.++||||||++++||++|+.||........ .........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~---- 213 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----------------HEIDRMTLT---- 213 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----------------HHHHHHhhc----
Confidence 34689999999998754 688999999999999999999999975322100 000010000
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
... ..+......+.+++..|++.+|.+|| ++.++++.
T Consensus 214 --~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 --MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --cCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 011 11222356788999999999999999 88888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=288.13 Aligned_cols=269 Identities=18% Similarity=0.220 Sum_probs=188.8
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCe-----EEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSH-----RLLV 527 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~-----~~lV 527 (804)
+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++++++ ||||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4578999999999999765 68899999986432 23357888999999995 6999999999877665 8999
Q ss_pred EEEcCCCChhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccc
Q 044374 528 YDYMRNGALSLYLRKD----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKL 602 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~ 602 (804)
|||+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999986 788877643 235799999999999999999999987 999999999999998 89999999999976
Q ss_pred cCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPW 680 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 680 (804)
...... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.......... +...........++..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 533211 1223356788999998865 457899999999999999999999986432110000 0000000000000000
Q ss_pred HHHHhhc-CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 AARQIIE-GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .... ..........+ ..........+.+++..|++.+|.+||++.+++.+
T Consensus 240 ~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 S--KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred h--hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000 00000000000 00011234668899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=288.13 Aligned_cols=256 Identities=19% Similarity=0.232 Sum_probs=181.0
Q ss_pred hcccccccccccceeEEEEEeCC----CcEEEEEEecCCCCCH------------HHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGE------------REFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~------------~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
...+.++||+|+||.||+|...+ +..+|+|+........ .....+...+..++|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 34567899999999999998654 3456666543222110 1122334556678999999999977
Q ss_pred ecCC----eEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEE
Q 044374 519 SENS----HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594 (804)
Q Consensus 519 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 594 (804)
.... ..++++|++.. ++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 5543 34677777644 555555443 24577888999999999999999987 999999999999999999999
Q ss_pred eecCCccccCCCcc------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC
Q 044374 595 SDFGLAKLIGRDFS------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG 668 (804)
Q Consensus 595 ~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 668 (804)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||.......
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~------- 240 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG------- 240 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-------
Confidence 99999986532211 11223469999999999999999999999999999999999999997532110
Q ss_pred CCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 669 GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
.+........ +..+....+. .....+.+.+++..|++.+|++||++.+|++.|+
T Consensus 241 -------~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 -------NLIHAAKCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -------HHHHHhHHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000000000 0011111110 1122467889999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=289.58 Aligned_cols=197 Identities=23% Similarity=0.345 Sum_probs=163.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC--------eE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS--------HR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------~~ 524 (804)
.+.++||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.... ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 45678999999999999765 68899999986432 22345678999999999999999999987654 45
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||+.+ +|...+......+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 95 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 95 YLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred EEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 999999975 788877766557899999999999999999999987 9999999999999999999999999998654
Q ss_pred CCcc---ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 605 RDFS---RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 605 ~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.... .......++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 3221 112334578899999988664 4788999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=294.02 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
..+..+||+|.|+.|..|... .+..||||.+++... ....+.+|+.+|..++|||||+++.+......+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345679999999999999654 678899999976533 2345889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
.+|.+.++|.+++. +.+..+..+..|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+. .....
T Consensus 138 ~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~l 211 (596)
T KOG0586|consen 138 SGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLML 211 (596)
T ss_pred cCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--ccccc
Confidence 99999999998874 445888899999999999999988 9999999999999999999999999998875 33456
Q ss_pred cccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.+.+|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||+...... ..
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------------------Lr 264 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------------------LR 264 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------------------cc
Confidence 77899999999999999876 579999999999999999999998532210 00
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..++-..++ .+.-....+.++++.++-.+|.+|+++.+|.+.
T Consensus 265 ~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111111 122234567788999999999999999999854
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=289.63 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=194.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+||+|+||.||++... +++.||||++.... .....+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999774 68899999986433 34456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
+++... .+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 987643 5789999999999999999999987 99999999999999999999999999876543321 12335678
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
..|+|||++.+..++.++||||||++++||++|+.||...... ........+ . ...
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------------------~~~~~~~~~-~----~~~ 235 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------------KAMKMIRDN-L----PPK 235 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhh-C----Ccc
Confidence 9999999998888999999999999999999999998642110 000111110 1 011
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.. .......+..++.+|++.+|.+||++.+|++.
T Consensus 236 ~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 100 11223457889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=290.73 Aligned_cols=240 Identities=28% Similarity=0.363 Sum_probs=190.4
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.++||+|+||.||+|+.. .++.|++|++..... ....+.+|+.++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 357999999999999764 678899999864321 22467889999999999999999999999999999999996
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++......+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..... ...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 5777777665567899999999999999999999988 99999999999999999999999999864321 234
Q ss_pred cccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 614 MRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..++..|+|||++. ...++.++||||||+++|||++|+.||...... ..... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------------------~~~~~-~~~~~~ 237 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------SALYH-IAQNDS 237 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------------------HHHHH-HHhcCC
Confidence 56888999999984 456888999999999999999999998643211 00111 111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... .......+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11223458889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.61 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=198.7
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.||+|++|.||++... .++.||+|.+..... ....+.+|+.++.+++|+|++++++++...+..+++|||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 4678999999999999765 578899999976543 345789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......... ...
T Consensus 84 ~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 84 GSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred CcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 9999998765 47899999999999999999999887 999999999999999999999999999876443221 234
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..++..|+|||.+.+...+.++||||||++++||++|+.||...... .. .........
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----------------~~--~~~~~~~~~--- 216 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----------------AA--LFRIVQDDH--- 216 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----------------HH--HHHHhccCC---
Confidence 56788999999998888899999999999999999999998642110 00 001111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
...+......+..++.+|++.+|++||++.+++.
T Consensus 217 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223467889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=287.97 Aligned_cols=247 Identities=25% Similarity=0.292 Sum_probs=192.6
Q ss_pred cccccccccceeEEEEEe----CCCcEEEEEEecCCC-----CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPG-----SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++.++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 567899999999999975 367889999996431 2345688899999999 599999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 84 LDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999997654 6888999999999999999999987 9999999999999999999999999998654432
Q ss_pred cccccccccccccccchhccCC--CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 SRVLATMRGTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
........++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ....... ...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------------~~~~~~~-~~~ 224 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--------------NSQAEIS-RRI 224 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--------------ccHHHHH-HHh
Confidence 2223345688999999998753 4678999999999999999999998632110 0001111 111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVK 733 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 733 (804)
... ....+......+..++..|++.+|++|| ++.++++
T Consensus 225 ~~~----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LKS----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hcc----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000 0111223346788999999999999997 5555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=288.75 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=195.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|... .++.||||++..... ......+|+..+.+++ |+|++++++++..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999876 478899999875433 2334567999999999 999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 889988887654 56899999999999999999999988 99999999999999999999999999986543211 2
Q ss_pred cccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....++..|+|||++.. ..++.++||||||++++||++|+.||............... .....-..|..........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV--LGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh--cCCCChhhhhhHhhhhccc
Confidence 23457889999998754 45789999999999999999999988653221100000000 0000000111111011111
Q ss_pred ceecccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLG---GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+..... ..........+.+++.+|++.+|++||++.||+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00001124678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=291.44 Aligned_cols=271 Identities=21% Similarity=0.251 Sum_probs=192.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~ 530 (804)
.+.+.||+|+||.||+|... .++.||+|+++.... ....+.+|+.++.+++|+|++++++++... +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 35678999999999999765 588999999964322 233567899999999999999999998754 568999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++ +|.+++......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 90 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 90 CEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred CCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 975 788888765567899999999999999999999988 9999999999999999999999999998764332 11
Q ss_pred ccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC-CCCCCCccCchHHHHHHhhcC
Q 044374 611 LATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG-GGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 688 (804)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ..........+..... ..-
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 242 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL--PLV 242 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc--ccc
Confidence 223345788999999865 457899999999999999999999997543211000000 0000000000000000 000
Q ss_pred ccceeccccccC--CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGG--AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
............ .......+.+.+++..|++.||++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 0000124567789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.51 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=192.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC------CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP------GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 527 (804)
.+.+.||+|+||.||+|... ++..||+|.+... ......+++|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 45679999999999999764 5889999988532 12235688999999999999999999998654 467899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+||+++++|.+++.... .+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 99999999999987654 5788999999999999999999988 9999999999999999999999999998643211
Q ss_pred --cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 --SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 --~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
........++..|+|||++.+..++.++||||||++++||++|+.||...... ......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~ 221 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------------------AAIFKI 221 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------------------HHHHHH
Confidence 11122346889999999999888999999999999999999999998642110 000111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. .......+....+.+.+++..|++ +|.+||+..++++
T Consensus 222 ~~--------~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 AT--------QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred Hc--------CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 10 001112233445678899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=311.59 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=187.8
Q ss_pred Hhhccccc--ccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEec-------
Q 044374 453 TVTRGFSE--KLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSE------- 520 (804)
Q Consensus 453 ~~t~~~~~--~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------- 520 (804)
+....|.+ .||+||||.|||++.+ ||+.+|||++.... .....+.+|+.++++|+|||||+++....+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34445544 7999999999999876 89999999997653 334568899999999999999987621100
Q ss_pred --------------------------------------------------------------------------------
Q 044374 521 -------------------------------------------------------------------------------- 520 (804)
Q Consensus 521 -------------------------------------------------------------------------------- 520 (804)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred --C------------------------------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044374 521 --N------------------------------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568 (804)
Q Consensus 521 --~------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 568 (804)
+ ..+||=||||+..+|.++++.+...-.....++++.+|++||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 01467899999999999888765322567889999999999999999
Q ss_pred cCCCCeEecCCCCCcEEecCCCceEEeecCCccccC-----------------CCccccccccccccccccchhccCCC-
Q 044374 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG-----------------RDFSRVLATMRGTWGYVAPEWISGLA- 630 (804)
Q Consensus 569 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~~- 630 (804)
++ ||||||||.||+|+++..+||+|||++.... .......+..+||.-|+|||++.+..
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 98 9999999999999999999999999998621 00111345678999999999997754
Q ss_pred --CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHH
Q 044374 631 --ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAE 708 (804)
Q Consensus 631 --~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 708 (804)
|+.|+|+||+|||++||+. ||... .. .......++.+.+..- ..+..+...
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-ME-----------------Ra~iL~~LR~g~iP~~------~~f~~~~~~ 845 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS-ME-----------------RASILTNLRKGSIPEP------ADFFDPEHP 845 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch-HH-----------------HHHHHHhcccCCCCCC------cccccccch
Confidence 9999999999999999985 34321 00 0112223333333221 122333445
Q ss_pred HHHHHHhhccccCCCCCCCHHHHHH
Q 044374 709 RVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 709 ~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.=+.++.+++++||.+|||+.|++.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5678999999999999999998875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=320.61 Aligned_cols=243 Identities=29% Similarity=0.405 Sum_probs=197.9
Q ss_pred cccccccceeEEEEE-eCCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..||.|.||.||.|. ..+|+..|||-++... ...+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 489999999999995 4568889999886432 334568899999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc---ccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF---SRVLA 612 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~---~~~~~ 612 (804)
|.+.+...+ ..++.....+..|++.|++|||+.+ ||||||||.||||+.+|.+|++|||.|.....+. .....
T Consensus 1321 La~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1321 LASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred HHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 999998654 5677777788899999999999998 9999999999999999999999999998775543 23345
Q ss_pred ccccccccccchhccCC---CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH-HhhcC
Q 044374 613 TMRGTWGYVAPEWISGL---AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR-QIIEG 688 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 688 (804)
...||+.|||||++.+. ...-+.||||+|||++||+||++|+...+. .|+.. ++..|
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------------------e~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------------------EWAIMYHVAAG 1457 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------------------hhHHHhHHhcc
Confidence 67899999999999764 456789999999999999999999986433 12221 22223
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... .+|.....+-.+++..|++.||++|.++.|+++.
T Consensus 1458 h~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222 2233345566789999999999999888877664
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=299.81 Aligned_cols=195 Identities=27% Similarity=0.435 Sum_probs=170.2
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 528 (804)
..+.||+|+||.||+|+. ..|+.||||.++.. ....+...+|+++|++++|+|||+++++-... ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 457899999999999985 47899999999764 33456678999999999999999999876543 4678999
Q ss_pred EEcCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--C--CCceEEeecCCccc
Q 044374 529 DYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--S--DYTAKVSDFGLAKL 602 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~--~~~~kl~DfGla~~ 602 (804)
|||.+|+|...|.... ..|++.+.+.++.+++.||.|||+.+ |+||||||.||++- + .-.-||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999998643 57999999999999999999999988 99999999999983 2 33589999999998
Q ss_pred cCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
+.++. .....+||..|.+||++.. ..|+..+|.|||||++||.+||..||.+.
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 76554 4677899999999999995 88999999999999999999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=281.67 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=190.3
Q ss_pred cccccccccceeEEEEEeCC-CcEEEEEEecCCCC---CHHHHHHHHHHHcCC---CCCCceeeeeEEecCCe-----EE
Q 044374 458 FSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGS---GEREFRAEVCTIGNI---QHVNLVRLRGFCSENSH-----RL 525 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~-----~~ 525 (804)
+.+.||+|+||.||+|+... ++.||||+++.... ....+.+|+.++.++ +|+|++++++++..... .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45789999999999998764 88999999974322 234566777766555 69999999999987776 89
Q ss_pred EEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 526 LVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++|||+.+ +|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99999975 7888887643 36899999999999999999999987 9999999999999999999999999997754
Q ss_pred CCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHH
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 683 (804)
.... .....++..|+|||++.+..++.++||||||++++||++|+.||......+... +......... ..|...
T Consensus 159 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 233 (287)
T cd07838 159 FEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE---EEWPRN 233 (287)
T ss_pred CCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh---HhcCCC
Confidence 3321 223357889999999999999999999999999999999998886432210000 0000000000 000000
Q ss_pred Hh-hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QI-IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. ............. .....+....+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0000000000000 1111233467788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=296.21 Aligned_cols=267 Identities=24% Similarity=0.287 Sum_probs=192.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecC--CeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSEN--SHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~lV~E 529 (804)
.+.+.||+|+||.||+|... .++.+|||++... ......+.+|+.+++++ +||||+++++++... ...++|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 34578999999999999765 5788999998542 22345677899999999 999999999998653 46899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|++ ++|..++... .+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 90 ~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 90 YME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred ccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 997 5898888764 6889999999999999999999987 99999999999999999999999999986543221
Q ss_pred ---ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHH
Q 044374 609 ---RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 609 ---~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 683 (804)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....+..... +... .. ....-...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~----~~-~~~~~~~~ 238 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV----IG-PPSAEDIE 238 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH----hC-CCCHHHHH
Confidence 12334568899999998765 457889999999999999999999986432211000 0000 00 00000000
Q ss_pred HhhcCccceecc----cccc--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVD----DRLG--GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.......+++ .... ..........+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000110 0000 00011135678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=287.45 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=198.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++.+++ ||||+++++++...+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 35678999999999999765 6889999999652 223467888999999998 99999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-- 608 (804)
+++++|.+++...+ .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 84 APNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999998764 6999999999999999999999988 99999999999999999999999999986543321
Q ss_pred -----------------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCC
Q 044374 609 -----------------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 609 -----------------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 671 (804)
.......++..|+|||.+.+...+.++||||||++++|+++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------- 228 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----------- 228 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----------
Confidence 1223345788999999998888999999999999999999999998753210
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH----HHHHH
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM----GTVVK 733 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~eVl~ 733 (804)
...+.... .....+....+.+.+++.+|++.+|.+||++ .++++
T Consensus 229 --------~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 --------LTFQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------HHHHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00111111 1111222335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=295.11 Aligned_cols=271 Identities=21% Similarity=0.278 Sum_probs=194.7
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 528 (804)
+.+.||+|+||.||++... .++.||||+++.. ......+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 4568999999999999654 6789999998653 22345677899999999999999999988654 3579999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+. ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 89 ELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred eCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 9996 68888887543 6899999999999999999999987 9999999999999999999999999998654321
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCCCCCccC-c-hHHH
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGEHGDKWF-F-PPWA 681 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~-~-~~~~ 681 (804)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..+.. ...... . ....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP-SEEDLGFIRNEKA 241 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC-ChHHhhhcCchhh
Confidence 22234567889999998865 468899999999999999999999996432110000 00000 000000 0 0000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
.+... ......+..... ........+.+++.+|++.+|++||++.++++. ++.+
T Consensus 242 ~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIR--SLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHH--hcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 000000010000 011234668899999999999999999999987 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=293.39 Aligned_cols=273 Identities=20% Similarity=0.241 Sum_probs=192.8
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 528 (804)
.+.++||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++++++||||+++++++... ...++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 3567899999999999965 46789999999642 22345688899999999999999999987654 3579999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.+ +|..++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 88 e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 88 ELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred hhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99975 777777543 6899999999999999999999988 99999999999999999999999999976533211
Q ss_pred --ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 --RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 --~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.||................ .. . .......+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~--~~-~-~~~~~~~~ 237 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL--GT-P-SQEDLNCI 237 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc--CC-C-CHHHHHHh
Confidence 11233568899999998755 568899999999999999999999986432100000000000 00 0 00000000
Q ss_pred hcCccceeccc-cccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhccc
Q 044374 686 IEGNVAAVVDD-RLGGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVL 739 (804)
Q Consensus 686 ~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~ 739 (804)
........+.. ......+ ......+.+++.+||+.+|++||++.++++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000000 0000000 1124568899999999999999999999987 66543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=287.37 Aligned_cols=266 Identities=24% Similarity=0.260 Sum_probs=196.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.||+|+||.||+|+.. +++.||+|++... ....+.+..|+.++++++|+|++++++++......++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3568999999999999776 4889999999754 2334678889999999999999999999999999999999998
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++......+++..+..++.+++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++....... ....
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 5899999876557999999999999999999999988 99999999999999999999999999986543321 1223
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh-----c
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII-----E 687 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 687 (804)
..++..|+|||.+.+. .++.++||||||++++||++|+.||.............. .........+..+. .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ----ILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH----HhCCCcHHHHHhhccccccc
Confidence 4457789999998776 789999999999999999999988864321100000000 00000000000000 0
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.............. .......+.+++..|++.+|++||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000 0112457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=270.04 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=201.8
Q ss_pred ChHHHHHhhcccccccccccceeEEEE-EeCCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCe
Q 044374 447 SYKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSH 523 (804)
Q Consensus 447 ~~~el~~~t~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 523 (804)
++.++.+.|. +.||+|+++.|-.+ .+..+.++|||++.+. ........+|++++.+.+ |+||+.|++++.++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 4566666664 68999999999988 4568899999999765 445567889999999985 9999999999999999
Q ss_pred EEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCCc
Q 044374 524 RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGLA 600 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla 600 (804)
.|||||-|.+|+|..+|+++. -+++.++-++..+||.||.|||.++ |.||||||+|||-.... -+||+||.|.
T Consensus 151 FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccc
Confidence 999999999999999998765 7899999999999999999999988 99999999999986554 4999999987
Q ss_pred cccC--CC----ccccccccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC
Q 044374 601 KLIG--RD----FSRVLATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG 669 (804)
Q Consensus 601 ~~~~--~~----~~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 669 (804)
.-+. .+ ......+.+|+-.|||||+..- ..|..+.|.||||||||-||+|..||.+.....
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-------- 298 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-------- 298 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------
Confidence 6431 11 2233556789999999997632 357889999999999999999999998765421
Q ss_pred CCCCccCch-------HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 670 EHGDKWFFP-------PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 670 ~~~~~~~~~-------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..|+-- ......+.+|. .+..|..+ .....+...++...+..++.+|-++.+++.
T Consensus 299 ---CGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 ---CGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---CCccCCCccHHHHHHHHHHHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111110 11112222221 12222111 123445566777778899999999999987
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=294.70 Aligned_cols=268 Identities=20% Similarity=0.239 Sum_probs=193.4
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEec----CCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSE----NSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~E 529 (804)
+.+.||+|+||.||++... .++.||+|++.... .....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4578999999999999754 58899999997532 234567889999999999999999988753 356899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|+. ++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 89 LME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred hhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 996 58888886554 5899999999999999999999987 99999999999999999999999999976533211
Q ss_pred --ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 --RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 --~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .....+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~----~~g~~~~~~~~~~ 239 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS----VLGSPSEEVLNRI 239 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH----HhCCChhHhhhhh
Confidence 11234568899999999866 4688999999999999999999999975322100000000 0000000000000
Q ss_pred hcCccceecccc-ccCCC-----CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDR-LGGAY-----KVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+....+.. ..... .......+.+++..|++.+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111111000 00001 11235678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=291.44 Aligned_cols=275 Identities=20% Similarity=0.219 Sum_probs=200.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC-----eEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS-----HRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV 527 (804)
.+.+.||+|+||.||+++.. .++.||||++.... ...+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 35678999999999999875 47899999997542 34467889999999999999999999988765 78999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++ +|.+++.... .+++..+..++.++++||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 83 TELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred ecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999984 7888887654 7899999999999999999999988 9999999999999999999999999998754432
Q ss_pred c--ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 608 S--RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 608 ~--~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
. .......++..|+|||++.+. .++.++||||||+++++|++|+.||................ ... +......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~--~~~~~~~ 233 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL--GTP--SEEDLKF 233 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc--CCC--ChhHhhh
Confidence 1 123345678899999999887 88999999999999999999999997543210000000000 000 0000000
Q ss_pred hhcCccceeccc---cc---cCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcccc
Q 044374 685 IIEGNVAAVVDD---RL---GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~---~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 740 (804)
.........+.. .. ...........+.+++.+||+.+|++||++.++++. +++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000000 00 000011234668899999999999999999999985 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=278.67 Aligned_cols=234 Identities=24% Similarity=0.326 Sum_probs=182.5
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcC-CCCCCceeeeeEEecCCeEEEEEEEcCCCChhHH
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGN-IQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLY 539 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 539 (804)
||+|+||.||++... ++..+|+|.+........ |+..... .+|||++++++.+...+..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 599999999999754 678899999865422221 2222221 2799999999999999999999999999999999
Q ss_pred HhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcccccccccccc
Q 044374 540 LRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRVLATMRGTW 618 (804)
Q Consensus 540 l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~ 618 (804)
+.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++...... ....++.
T Consensus 100 l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~ 170 (267)
T PHA03390 100 LKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTL 170 (267)
T ss_pred HHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCC
Confidence 98764 7899999999999999999999988 99999999999999998 9999999998765432 2235789
Q ss_pred ccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccc
Q 044374 619 GYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRL 698 (804)
Q Consensus 619 ~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 698 (804)
.|+|||++.+..++.++||||||++++||++|+.||...... ......+.... . ...
T Consensus 171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~--~--------~~~ 227 (267)
T PHA03390 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-------------ELDLESLLKRQ--Q--------KKL 227 (267)
T ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-------------hhhHHHHHHhh--c--------ccC
Confidence 999999999999999999999999999999999999743211 00011111110 0 000
Q ss_pred cCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 044374 699 GGAYKVEEAERVALVAIWCIQDNEEMRPT-MGTVVK 733 (804)
Q Consensus 699 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~ 733 (804)
.........+.+++..|++.+|.+||+ ++++++
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 --PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111134567889999999999999995 688774
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=290.37 Aligned_cols=272 Identities=23% Similarity=0.251 Sum_probs=189.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC--------eE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS--------HR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------~~ 524 (804)
.+.++||+|+||.||+|... +++.+|||++.... .....+.+|+.++++++||||+++++++.... ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 35678999999999999765 57889999986432 22346788999999999999999999875433 46
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++|+||+.. +|...+......+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 999999875 677776665557999999999999999999999988 9999999999999999999999999998653
Q ss_pred CCccc----------cccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-CCC
Q 044374 605 RDFSR----------VLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG-EHG 672 (804)
Q Consensus 605 ~~~~~----------~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~ 672 (804)
..... ......+++.|+|||.+.+. .++.++||||||++++||++|+.||............... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 32111 11234568889999987654 5789999999999999999999998753221000000000 000
Q ss_pred CccCchHHHHHHhhcC-ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 673 DKWFFPPWAARQIIEG-NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 673 ~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.....+.|........ .......+.+... .....+.+.+++.+|++.+|++||++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000000 0000000000000 0112256889999999999999999998875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=280.50 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=191.4
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCC------CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERP------GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.++||+|+||.||++.... +..+++|.++.. .....++..|+.++++++||||+++++++.+....++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 356789999999999997653 344666665431 2233457789999999999999999999999999999999
Q ss_pred EcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|+++++|..++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999998864 3357899999999999999999999987 999999999999975 56999999998765332
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........
T Consensus 159 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------------------~~~~~~~~ 218 (260)
T cd08222 159 C-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------------------LSVVLRIV 218 (260)
T ss_pred c-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHHHHH
Confidence 1 122345578899999999888899999999999999999999999863211 00111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.. ...+......+.+++.+|++.+|++||++.+|++.
T Consensus 219 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 EGPT---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cCCC---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 11223445678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=263.07 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=192.5
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+...||.|.-|.|++.... .+..+|||.+..... +.+.+...+.++.+-+ +|.||+.+|+|..+....+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 4567999999999999775 578899999976543 4456777787777665 89999999999999999999998854
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
.++.+|+.-..++++..+-++...+.+||.||.++ ++|+|||+||+|||+|+.|++|++|||++-.+-+. ...+.
T Consensus 176 -C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtr 250 (391)
T KOG0983|consen 176 -CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTR 250 (391)
T ss_pred -HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--ccccc
Confidence 45556665556788888899999999999999884 45999999999999999999999999999765433 33456
Q ss_pred cccccccccchhccCC---CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 614 MRGTWGYVAPEWISGL---AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
..|.+.|||||.+.-. .|..++||||||+.|+||.||+.||...... |.. ..++.+ +.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----------------Fe~--ltkvln-~e 311 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----------------FEV--LTKVLN-EE 311 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----------------HHH--HHHHHh-cC
Confidence 6799999999988543 6888999999999999999999999864322 111 111111 11
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. +.|.+.. .-...+.+++..||++|+.+||...+++++
T Consensus 312 P----P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 P----PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred C----CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 2222111 135678899999999999999999988765
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.68 Aligned_cols=269 Identities=20% Similarity=0.203 Sum_probs=191.1
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---------------HHHHHHHHHHHcCCCCCCceeeeeEEecCC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---------------EREFRAEVCTIGNIQHVNLVRLRGFCSENS 522 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 522 (804)
.+.||+|+||.||+|... .++.||||+++..... ...+.+|+.++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999754 6889999998643221 124778999999999999999999999999
Q ss_pred eEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 523 HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
..++||||+. ++|.+++.... .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 58888886543 6889999999999999999999987 99999999999999999999999999976
Q ss_pred cCCC-------------ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC-C
Q 044374 603 IGRD-------------FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG-G 667 (804)
Q Consensus 603 ~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~ 667 (804)
.... .........++..|+|||++.+. .++.++||||||++++||++|+.||............ .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5411 01112233467889999998764 4689999999999999999999998754221000000 0
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.........++........ ............. ........+.+++..|++.+|++||++.+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLY-TEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccc-cccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0000000000000000000 0000000000000 011224568899999999999999999999975
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=287.63 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=189.5
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEEEE
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLLVY 528 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 528 (804)
.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 468999999999999764 68899999986532 2335688999999999999999999998654 3569999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.. +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 100 PYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred ccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 99974 6666543 25889999999999999999999987 999999999999999999999999998764322
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ......+.+ ......
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~ 244 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK---VTGVPGPEF-VQKLED 244 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hcCCCCHHH-HHHhcc
Confidence 223457889999999876 4688999999999999999999999974321100000000 000000000 000000
Q ss_pred Cccceec-------cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcccc
Q 044374 688 GNVAAVV-------DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVLE 740 (804)
Q Consensus 688 ~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~~ 740 (804)
....... ...+.... ......+.+++..||+.||++||++.+++.. +++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 00000000 0123467899999999999999999999965 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=275.97 Aligned_cols=235 Identities=28% Similarity=0.324 Sum_probs=192.5
Q ss_pred cccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 462 LGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
||+|+||.||++... +++.+|+|.+..... ....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999765 578999999875432 345789999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99998654 6899999999999999999999977 9999999999999999999999999998654321 12334567
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
+..|+|||.+.+...+.++|+||||+++|||++|+.||...... -..+....+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------------------~~~~~~~~~-------- 208 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------------------EIYEKILKD-------- 208 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------------HHHHHHhcC--------
Confidence 88999999998888999999999999999999999998643210 011111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 730 (804)
. ...+......+.+++.+|+..||++||++.+
T Consensus 209 ~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 P--LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 1112223567889999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.96 Aligned_cols=192 Identities=29% Similarity=0.493 Sum_probs=173.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecC---CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+.||+|-||+||-|+.+ .|+.||||++.+ +...+.++++|+.+|.+++||.||.|.-.|+..+..++|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 58999999999999764 789999999964 34566789999999999999999999999999999999999998888
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCccccCCCcccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
|.-+|......+++..-..++.||+.||.|||.++ |+|+||||+||||... -++||+|||.|++++... ...
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRr 724 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRR 724 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--hhh
Confidence 88888877778999999999999999999999988 9999999999999754 369999999999987643 345
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.++||+.|+|||++.+..|...-|+||.|||+|--|+|..||..
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 78899999999999999999999999999999999999999974
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=279.40 Aligned_cols=236 Identities=26% Similarity=0.329 Sum_probs=194.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||-.+.. .|+.+|.|++.+. ..++.-..+|-.+|.+++.+.||.+--.+...+.++||+..|.+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 58999999999998654 6889999998542 345566788999999999999999988899999999999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.-+|.+.+ ..++++.+..++.+|+.||.+||.+. ||+|||||+|||||+.|+++|+|+|||..+..... ...
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~ 345 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IRG 345 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc--ccc
Confidence 9999987665 46899999999999999999999887 99999999999999999999999999987755432 334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+||.+|||||++.+..|+...|-||+||+||||+.|+.||...... .-.+.
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------------------vk~eE 397 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------------------VKREE 397 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------------------hhHHH
Confidence 58999999999999999999999999999999999999999743221 01111
Q ss_pred ccccc---cCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 694 VDDRL---GGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 694 ~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
+|.+. ..+++..-.++...+...-|++||++|--.
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22221 123333445667778888889999998643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.96 Aligned_cols=272 Identities=21% Similarity=0.248 Sum_probs=192.6
Q ss_pred hHHHHHhhccc--ccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecC
Q 044374 448 YKELHTVTRGF--SEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSEN 521 (804)
Q Consensus 448 ~~el~~~t~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 521 (804)
..++...+.+| .+.||+|+||.||++.. .+++.||||+++.... ..+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34445455444 46899999999999965 4688999999975322 245678899999999999999999988643
Q ss_pred ------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 522 ------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 522 ------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 77898887654 5889999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||............... .
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~- 234 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL---V- 234 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---h-
Confidence 99998764322 233467889999999876 56889999999999999999999998643211000000000 0
Q ss_pred cCchHHHHHHhhcCc-------cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 675 WFFPPWAARQIIEGN-------VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+......+.... +......... .........+.+++..|++.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000000 0000000000 0000124567899999999999999999998866
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=265.06 Aligned_cols=197 Identities=25% Similarity=0.390 Sum_probs=164.5
Q ss_pred ccccccccccceeEEEEEeC---C--CcEEEEEEecCCCC--C-HHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS---D--STLVAVKRLERPGS--G-EREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~--~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 527 (804)
+...+||+|.||.||+|.-. + ...+|||+++.... + ....-+|+.+++.++||||+.|..++.. +...+|+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 34578999999999999543 2 23799999986522 1 2456789999999999999999998877 7788999
Q ss_pred EEEcCCCChhHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC----CceEEeecCC
Q 044374 528 YDYMRNGALSLYLRKD----GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD----YTAKVSDFGL 599 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGl 599 (804)
+||.+. +|.++|+.+ ...++...+..|+.||+.|+.|||+.- |+||||||.||||..+ |.+||+|||+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999987 666666533 246888999999999999999999887 9999999999999877 9999999999
Q ss_pred ccccCCCccc--cccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 600 AKLIGRDFSR--VLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 600 a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
++++...... ....++-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++.|...
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9988665332 24567789999999998875 6899999999999999999999888654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=284.29 Aligned_cols=262 Identities=20% Similarity=0.239 Sum_probs=189.3
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLLV 527 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~lV 527 (804)
+.+.||+|+||.||++.. .++..||||++..... ....+.+|+.++++++||||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 457899999999999965 4688999999864322 2346889999999999999999999987543 45899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+ +++|..++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 99 MPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE- 171 (343)
T ss_pred EecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence 9998 67888887643 6889999999999999999999987 999999999999999999999999999865332
Q ss_pred cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||.............. .....+.-....+.
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 244 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK----VTGTPSKEFVQKLQ 244 (343)
T ss_pred ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hcCCCCHHHHHhhc
Confidence 223457889999999876 4588999999999999999999999874321100000000 00000000000000
Q ss_pred cCccce-------eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAA-------VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... .....+ ..........+.+++.+|++.||++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 00011233468899999999999999999999943
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.14 Aligned_cols=221 Identities=24% Similarity=0.171 Sum_probs=176.8
Q ss_pred ccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhC
Q 044374 465 GGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKD 543 (804)
Q Consensus 465 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~ 543 (804)
|.||.||++... +++.+|+|++.... .+.+|...+....|||++++++++......++||||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999654 67899999997543 2344555556667999999999999999999999999999999998765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccccccccc
Q 044374 544 GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623 (804)
Q Consensus 544 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 623 (804)
. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|+||
T Consensus 80 ~-~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP 151 (237)
T cd05576 80 L-NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP 151 (237)
T ss_pred c-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence 4 5899999999999999999999987 999999999999999999999999988655432 2233456789999
Q ss_pred hhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCC
Q 044374 624 EWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYK 703 (804)
Q Consensus 624 E~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 703 (804)
|.+.+..++.++||||+|++++||++|+.|+....... ... . ....+
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------------~~~-----~----~~~~~ 198 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------------NTH-----T----TLNIP 198 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------------ccc-----c----ccCCc
Confidence 99988889999999999999999999998765321100 000 0 00111
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHH
Q 044374 704 VEEAERVALVAIWCIQDNEEMRPTMGT 730 (804)
Q Consensus 704 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 730 (804)
......+.+++.+|++.||++||++.+
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 123456888999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=280.00 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=189.6
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 532 (804)
+.+.||.|+||.||++... +++.||||++... ....+.+.+|+.++.+++||||+++++++.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 4578999999999999654 7889999998643 2234678899999999999999999998865 56789999998
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..++... .+++.....++.|+++||+|||+.+ |+|+||+|+|||++.++.+||+|||++...... ..
T Consensus 93 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~ 163 (328)
T cd07856 93 GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MT 163 (328)
T ss_pred ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC----cC
Confidence 45888887643 5788888899999999999999988 999999999999999999999999999754322 22
Q ss_pred ccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||............. . .....+.-....+..+...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT---D-LLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---H-HhCCCCHHHHHhccchhhH
Confidence 3456889999998766 568999999999999999999999986432110000000 0 0000000000000000001
Q ss_pred eeccc-cccCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDD-RLGGAYKV-----EEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+.. ......+. .....+.+++.+|++.+|++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11000 00011111 124678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=288.22 Aligned_cols=267 Identities=20% Similarity=0.220 Sum_probs=188.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecC-------------
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------------- 521 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------------- 521 (804)
.+.+.||.|+||.||+|... .++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 45678999999999999764 57899999986543 3456788999999999999999999776543
Q ss_pred -CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCC
Q 044374 522 -SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGL 599 (804)
Q Consensus 522 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGl 599 (804)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCccc
Confidence 35789999997 5888887643 5889999999999999999999988 99999999999997 456799999999
Q ss_pred ccccCCCccc--cccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 600 AKLIGRDFSR--VLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 600 a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+......... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~ 238 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE---SVPVV 238 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hcCCC
Confidence 9765432111 1123457889999998654 5688899999999999999999999975322100000000 00000
Q ss_pred chHHHHHHhhcCccceecc-ccccCCC-----CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 677 FPPWAARQIIEGNVAAVVD-DRLGGAY-----KVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d-~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... ....... ...... ....... .......+.+++..|++.||++||++.+|++.
T Consensus 239 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REED-RNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHH-hhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 0000000 000000 0000000 01223567889999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=279.76 Aligned_cols=268 Identities=19% Similarity=0.186 Sum_probs=188.2
Q ss_pred ccccccccccceeEEEEEeC-C--CcEEEEEEecCCC---CCHHHHHHHHHHHcCC-CCCCceeeeeEEecC----CeEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-D--STLVAVKRLERPG---SGEREFRAEVCTIGNI-QHVNLVRLRGFCSEN----SHRL 525 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~~~ 525 (804)
.+.+.||+|+||.||++... . +..||||++.... ...+.+.+|+.++.++ +||||+++++++... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 35678999999999999765 3 6789999986432 2345678899999999 599999999875432 4578
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+++||+. ++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 83 LYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 8889886 5888888654 36899999999999999999999988 99999999999999999999999999986543
Q ss_pred Ccc---ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 606 DFS---RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 606 ~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
... .......|+..|+|||++.+ ..++.++||||||++++||++|+.||............. ..... .+.-.
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~-~~~~~ 233 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL---QVLGT-PDEET 233 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH---HHhCC-CCHHH
Confidence 211 11233568999999998766 468899999999999999999999986432100000000 00000 00000
Q ss_pred HHHhhcCccc-------eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVA-------AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+...... ......+. .........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000000 0001124568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.69 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=191.0
Q ss_pred ccccccccceeEEEE-EeCCCcEEEEEEecCCCCC--------HHHHHHHHHHHcCCCCCCceeeeeEEe-cCCeEEEEE
Q 044374 459 SEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSG--------EREFRAEVCTIGNIQHVNLVRLRGFCS-ENSHRLLVY 528 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 528 (804)
...||+|||+.|||| .+...+.||||+-...... .+...+|.++.+.|+||.||++++++. +.+..|-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 357999999999999 5667889999987533211 134668999999999999999999986 556789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~ 605 (804)
|||++-+|+.||+.+. .++++++..|+.||..||.||.+.. ++|||-||||.||||-. -|.+||.||||++++..
T Consensus 548 EYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 9999999999998765 7899999999999999999999875 67999999999999954 47899999999999865
Q ss_pred Cccc------cccccccccccccchhccC----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 606 DFSR------VLATMRGTWGYVAPEWISG----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 606 ~~~~------~~~~~~gt~~y~aPE~l~~----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
+... ......||..|++||.+.- ..++.|+||||.|||+|..+.|++||........
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd------------- 692 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD------------- 692 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-------------
Confidence 5332 2344679999999997643 2578999999999999999999999986433211
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
-+.+..+...-.-.. ...+....+...++.+||+...++|....++.
T Consensus 693 --------ILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 --------ILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --------HHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111111111 11223345677899999999999997665543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=283.00 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=190.2
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCe------EEEE
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSH------RLLV 527 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~lV 527 (804)
+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++|||++++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4578999999999999775 57889999986532 223567789999999999999999988766554 8999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 99 ~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 99 THLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 9998 56898888753 6899999999999999999999987 999999999999999999999999999865432
Q ss_pred cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||............... .....+.+ ...+.
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~---~~~~~~~~-~~~~~ 244 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL---VGTPDEEL-LQKIS 244 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh---cCCCCHHH-Hhhcc
Confidence 233457889999998865 46789999999999999999999998643221000000000 00000000 00000
Q ss_pred cCccceecc-------ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVD-------DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+. ..+... .......+.+++.+|++.+|++||++.+|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 000000 01125678899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=261.04 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=194.9
Q ss_pred cccChHHHHHhhcccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHc-CCCCCCceeeeeEEe
Q 044374 444 KVFSYKELHTVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIG-NIQHVNLVRLRGFCS 519 (804)
Q Consensus 444 ~~~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~ 519 (804)
-.|+-++|+.. ..||.|+||+|+|-.++ .++..|||++.... .+.+++..|..... .-+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 33555555543 47999999999998654 68999999997543 34566777877654 447999999999999
Q ss_pred cCCeEEEEEEEcCCCChhHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 520 ENSHRLLVYDYMRNGALSLYLR----KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 520 ~~~~~~lV~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
.++.-++.||.|.- ||+.+-. .+...+++...-.|.....+||.||..+- .||||||||+||||+..|.+|||
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeee
Confidence 99999999999954 5554322 12346888888899999999999998754 39999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
|||++-.+.... ..+...|...|||||.+.. ..|..+|||||||++|+|+.||+.|+.....
T Consensus 211 DFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------------- 274 (361)
T KOG1006|consen 211 DFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------------- 274 (361)
T ss_pred cccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------------
Confidence 999997654432 2345578899999998854 3588999999999999999999999874321
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.--....+..|+...+..+. -..+....+..++..|+.+|..+||...++.++
T Consensus 275 ----vfeql~~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 ----VFEQLCQVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----HHHHHHHHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111223334333332221 122345678899999999999999999998765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=300.17 Aligned_cols=141 Identities=27% Similarity=0.423 Sum_probs=126.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|... .++.||||+++.... ....+.+|+.++..++||||+++++++......+|||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 35689999999999999775 678999999975322 2356888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
.+++|..++...+ .+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999997654 6788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=285.03 Aligned_cols=236 Identities=25% Similarity=0.289 Sum_probs=190.6
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+...+|.|+|+.|-.+.. ...+..+||++... ..+-.+|+.++.+. +|||++++.+.+.++.+.++|||.+.++
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 3556799999999999855 46788999999765 22334566454444 7999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe-cCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL-DSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
-+.+.+.... .....+..|+.+|+.|+.|||+++ ||||||||+|||+ ++.++++|+|||.++..... ..+
T Consensus 402 ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 402 ELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred HHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 8888887654 222677789999999999999988 9999999999999 69999999999999876554 344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+-|..|.|||++....+++++|+||||++|||||+|+.||.....+ ......+.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i~------- 527 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRIQ------- 527 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhhc-------
Confidence 56788999999999999999999999999999999999999864332 00111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.+....+....+|+.+||+.||.+||+|.++...
T Consensus 528 -----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 -----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 122234556778899999999999999999998864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=283.75 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=207.1
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEec-----CCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSE-----NSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-----~~~~~lV~ 528 (804)
..|.+.||+|.+|.||+++. ++++.+|||++.......++++.|..+++.. +|||++.++|++.. +++++|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 45778999999999999965 4788899999988888888999999999887 69999999999853 46899999
Q ss_pred EEcCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||.+||..+++++. +..+.|..+.-|+..++.||++||... ++|||||-.|||++.++.+||.|||.+..+...-
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999999998754 457899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccccccchhccCC-----CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 608 SRVLATMRGTWGYVAPEWISGL-----AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
. ...+..||+.|||||++.-. .|+.++|+||||++..||--|.+|+..+.+.+...++
T Consensus 178 g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---------------- 240 (953)
T KOG0587|consen 178 G-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------------- 240 (953)
T ss_pred c-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----------------
Confidence 2 24567899999999998543 4678899999999999999999999876654322111
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .+...-..+....+++.+++..|+.+|-++||++.+++++
T Consensus 241 --------pR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --------PR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------CC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 1111122355678899999999999999999999988754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=255.14 Aligned_cols=245 Identities=24% Similarity=0.241 Sum_probs=195.8
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEec----CCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSE----NSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E~~~~ 533 (804)
++||-|-.|.|-....+ .++.+|+|++.+.. ..++|+++.-.. .|||||++++++.. ...+++|||.|++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 68999999999998554 67889999997653 346677765444 69999999998853 3467899999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 609 (804)
|.|...++.++ ..+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||+|+.... ..
T Consensus 144 GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~ 218 (400)
T KOG0604|consen 144 GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PG 218 (400)
T ss_pred hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC--Cc
Confidence 99999998776 46899999999999999999999988 999999999999964 45799999999997543 33
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...+.+-|+.|.|||++....|....|+||+||++|-||.|.+||..... ..+++-..+.+..|.
T Consensus 219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---------------~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---------------LAISPGMKRRIRTGQ 283 (400)
T ss_pred cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---------------ccCChhHHhHhhccC
Confidence 46677889999999999999999999999999999999999999976432 112222334444432
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. +..++. -...++...++++..|..+|.+|.++.++++.
T Consensus 284 y-~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2 222221 12446677889999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=266.87 Aligned_cols=277 Identities=21% Similarity=0.245 Sum_probs=205.1
Q ss_pred cChHHHHHhhcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC--C----CceeeeeEE
Q 044374 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQH--V----NLVRLRGFC 518 (804)
Q Consensus 446 ~~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~ 518 (804)
+...+.....+.+..++|+|.||.|-+.... .+..||||+++....-.+..+-|+.++.++.+ | -+|.+.+++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 4444554555566789999999999998443 46899999998766666777889999999942 2 267778889
Q ss_pred ecCCeEEEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---------
Q 044374 519 SENSHRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS--------- 588 (804)
Q Consensus 519 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~--------- 588 (804)
.-.++.|||+|.+ +-|+.++|..++ .+++...+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 9999999999987 448899998755 57889999999999999999999988 999999999999932
Q ss_pred -----------CCceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 589 -----------DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 589 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
+..+||+|||.|.....+. ...+.|..|.|||++.+..++.++||||+||||.|+.||...|...
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3469999999998754442 5677899999999999999999999999999999999999999866
Q ss_pred cCCCCCcCCCCCCCCCccCchHHHHHHh------hcCcc-----------ceeccccc----cCCCCHHHHHHHHHHHhh
Q 044374 658 ASGRNANIGGGGEHGDKWFFPPWAARQI------IEGNV-----------AAVVDDRL----GGAYKVEEAERVALVAIW 716 (804)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~~~ 716 (804)
+..+..++-+. -...+|....... ..+.+ ..+.++.. .-.....+..+|.+|+..
T Consensus 313 en~EHLaMMer----IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 313 ENLEHLAMMER----ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CcHHHHHHHHH----hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 54321110000 0011222222111 11110 00111000 001133556789999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 044374 717 CIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 717 Cl~~dP~~RPs~~eVl~~ 734 (804)
|+..||.+|+|+.|++..
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=262.15 Aligned_cols=237 Identities=28% Similarity=0.372 Sum_probs=192.1
Q ss_pred cceeEEEEEeCC-CcEEEEEEecCCCC-C-HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhh
Q 044374 466 GFGAVFQGELSD-STLVAVKRLERPGS-G-EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK 542 (804)
Q Consensus 466 ~fg~Vy~~~~~~-~~~vavK~l~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 542 (804)
+||.||+|...+ ++.+|+|++..... . .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998864 88999999975433 2 57899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccccccccc
Q 044374 543 DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622 (804)
Q Consensus 543 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 622 (804)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 54 3889999999999999999999987 9999999999999999999999999998764432 2334567889999
Q ss_pred chhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCC
Q 044374 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY 702 (804)
Q Consensus 623 PE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 702 (804)
||.+.+..++.++||||||++++||++|..||...... ....+....+.... ...
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------------------~~~~~~~~~~~~~~-------~~~ 209 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------------------LELFKKIGKPKPPF-------PPP 209 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------------------HHHHHHHhccCCCC-------ccc
Confidence 99999888999999999999999999999998642110 01111111111100 000
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 703 KVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 703 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.......+.+++.+|+..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0003467889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=257.04 Aligned_cols=198 Identities=26% Similarity=0.339 Sum_probs=172.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.|.+.||+|.||.|-..+-+ .++.+|+|++++... +...-..|-++|+..+||.+..|.-.+...+++|+||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 35689999999999999654 688999999986422 2234567889999999999999988899999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
.+|.|.-+|.... .+++.....+...|..||.|||+.+ ||.||||.+|.|||.+|++||+|||+.+..- ......
T Consensus 251 nGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~ 325 (516)
T KOG0690|consen 251 NGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTT 325 (516)
T ss_pred cCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-ccccee
Confidence 9999999988754 6788888889999999999999988 9999999999999999999999999998532 233456
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcC
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPAS 659 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~ 659 (804)
.+.+||+.|+|||++....|...+|-|.+||+||||+.|+.||...+.
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 788999999999999999999999999999999999999999986544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=289.70 Aligned_cols=261 Identities=17% Similarity=0.205 Sum_probs=165.2
Q ss_pred ccccccccccceeEEEEEeC-C----CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeE------EecCCeEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-D----STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF------CSENSHRL 525 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~~~~~~~ 525 (804)
.+.++||+|+||.||+|... + +..||||++......+ .+..| .+....+.++..++.. +......+
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 45679999999999999775 3 6889999986533221 11111 1112222222222111 24566889
Q ss_pred EEEEEcCCCChhHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 526 LVYDYMRNGALSLYLRKDGLNL-------------------NWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
+||||+.+++|.+++....... ....+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEE
Confidence 9999999999999987543111 12345679999999999999987 9999999999999
Q ss_pred cC-CCceEEeecCCccccCCCccccccccccccccccchhccCC----------------------CCCccceEEeehhh
Q 044374 587 DS-DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL----------------------AITTKADVYSYGMT 643 (804)
Q Consensus 587 ~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~ksDV~S~Gvv 643 (804)
+. ++.+||+|||+++.+............+++.|+|||.+... .+..++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 58999999999986544333334456789999999965322 23456799999999
Q ss_pred HHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCC--CHHHHHHHHHHHhhccccC
Q 044374 644 LLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY--KVEEAERVALVAIWCIQDN 721 (804)
Q Consensus 644 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~d 721 (804)
||||+++..+++.........+ ......+..|... .... ..+.+...+ .........+|+.+||+.|
T Consensus 369 L~el~~~~~~~~~~~~~~~~~l-----~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 369 FLQMAFPNLRSDSNLIQFNRQL-----KRNDYDLVAWRKL--VEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHhCcCCCchHHHHHHHHH-----HhcCCcHHHHHHh--hccc----cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999987655432100000000 0000111111110 0000 000000000 0011223458999999999
Q ss_pred CCCCCCHHHHHHH
Q 044374 722 EEMRPTMGTVVKM 734 (804)
Q Consensus 722 P~~RPs~~eVl~~ 734 (804)
|++|||+.+++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=263.82 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=195.1
Q ss_pred HHHHhhcccccccccccceeEEEEEeCC-CcEEEEEEecCCC----CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCe
Q 044374 450 ELHTVTRGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPG----SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSH 523 (804)
Q Consensus 450 el~~~t~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 523 (804)
.++....+|...||+|+||.|-.|..+. .+.+|||++++.. ...+--+.|-++|+.. +-|.++++..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455557889999999999999997654 5789999998642 2233346677888777 46789999999999999
Q ss_pred EEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 524 RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
+|+||||+.+|+|--+++.-+ .+.+..+..++.+||-||-+||+++ ||.||||..|||||.+|.+||+|||+.+.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999998888765 6778888999999999999999988 999999999999999999999999999852
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
-- ......+.+||+.|+|||++...+|...+|-|||||+||||+.|+.||+..+..+ ..+
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------------------lF~ 560 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------------------LFQ 560 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHH
Confidence 11 1223456889999999999999999999999999999999999999999754321 111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP 726 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 726 (804)
.+.+.. -.++...+.+...+...-+.+.|.+|.
T Consensus 561 --------aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 --------AIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --------HHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 122221 134555566777777778888888885
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=277.08 Aligned_cols=259 Identities=21% Similarity=0.209 Sum_probs=173.7
Q ss_pred ccccccccccceeEEEEEe-----------------CCCcEEEEEEecCCCCC-HH--------------HHHHHHHHHc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-----------------SDSTLVAVKRLERPGSG-ER--------------EFRAEVCTIG 504 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~~--------------~~~~Ei~~l~ 504 (804)
.+.++||+|+||.||+|.. ..++.||||++....+. .+ .+..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3557999999999999964 23467999999653321 12 2344777777
Q ss_pred CCCCCCc-----eeeeeEEec--------CCeEEEEEEEcCCCChhHHHhhCC-----------------------CCCC
Q 044374 505 NIQHVNL-----VRLRGFCSE--------NSHRLLVYDYMRNGALSLYLRKDG-----------------------LNLN 548 (804)
Q Consensus 505 ~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~ 548 (804)
+++|.++ ++++++|.. ....+|||||+++++|.++++... ..++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 7776654 677888753 356899999999999999987421 1235
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccC
Q 044374 549 WDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628 (804)
Q Consensus 549 ~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 628 (804)
+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+|||.+..
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 6778899999999999999987 9999999999999999999999999997654322211222345789999998754
Q ss_pred CCC----------------------CccceEEeehhhHHHhhhCCC-CCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 629 LAI----------------------TTKADVYSYGMTLLELIGGRR-NVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 629 ~~~----------------------~~ksDV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
... ..+.||||+||+++||++|.. |+.....-.. . .......+..| +..
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~-----~~~~~~~~~~~--r~~ 456 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-E-----LRQYDNDLNRW--RMY 456 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-H-----HhhccchHHHH--Hhh
Confidence 321 134799999999999999875 5542110000 0 00000011111 111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNE---EMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~eVl~~ 734 (804)
..... +-. ..........+++..++..+| .+|+|+.|++++
T Consensus 457 ~~~~~----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKY----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCC----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11110 000 011224556778888888765 689999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=288.53 Aligned_cols=196 Identities=26% Similarity=0.287 Sum_probs=175.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.|...+.. .++.||+|++.+. ......|+.|-.+|..-+.+-|+.++-.|.+..++|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 35678999999999999775 5788999999752 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+||+|-.++.+.. .++++.+..++..|.-||.-||+.| +|||||||+|||||..|++||+|||.+-.+..+..-..
T Consensus 158 pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred cCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999999887 8999999999999999999999988 99999999999999999999999999887776655556
Q ss_pred cccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
...+|||.|++||++.. +.|....|-||+||++||||.|..||..
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 67889999999999853 4688999999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-30 Score=251.59 Aligned_cols=266 Identities=21% Similarity=0.332 Sum_probs=191.7
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecC--CCCC-HHHHHHHHHHHcCCCCCCceeeeeEEecC--------CeEEEE
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLER--PGSG-EREFRAEVCTIGNIQHVNLVRLRGFCSEN--------SHRLLV 527 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~~~lV 527 (804)
.+||+|.||.||+|+.. .++.||+|++-. ...+ .....+|+.+|..++|+|++.++..|... ...+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 47999999999999765 467789887632 2222 23457799999999999999999988532 357999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+.+|+. +|.-+|.+....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.+....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSK 178 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence 999987 788888877778999999999999999999999887 9999999999999999999999999998764331
Q ss_pred ---cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCCCCCcc----
Q 044374 608 ---SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGEHGDKW---- 675 (804)
Q Consensus 608 ---~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~---- 675 (804)
....+..+-|..|.+||.+.+ ..++++.|||.-|||+.||+|+.+.+.......... +++.... +.|
T Consensus 179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk-evWP~~d 257 (376)
T KOG0669|consen 179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK-EVWPNVD 257 (376)
T ss_pred ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc-ccCCCcc
Confidence 222445667999999998776 579999999999999999999998887654432111 1111100 111
Q ss_pred CchHHHHHH---hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 676 FFPPWAARQ---IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 676 ~~~~~~~~~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.++-|..-. +.++.. ..+..++... -.....++++..++..||.+|+++.+++..
T Consensus 258 ~lpL~~sie~ePl~~~~~-rkv~n~~kp~---~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQK-RKVKNRLKPY---VKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cchHHHhccCCCCCcchh-hhhhhhcccc---cCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111110 001100 1111111110 011356778889999999999999998765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=276.00 Aligned_cols=239 Identities=27% Similarity=0.362 Sum_probs=183.1
Q ss_pred ccccccccee-EEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGA-VFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
+.+|.|+-|+ ||+|.+ +++.||||++-.. -....++|+..|+.- +||||||+++.-.+...+||..|.|.. +|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence 5789999986 799998 5678999998532 223467899998877 599999999998999999999999965 899
Q ss_pred HHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-----CCceEEeecCCccccCCCccc
Q 044374 538 LYLRKDGLNL---NWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-----DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 538 ~~l~~~~~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++....... .-...+.+..|++.||++||+.+ ||||||||+||||.. ..+++|+|||+++.+......
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9998742111 11345778899999999999988 999999999999976 357999999999987554322
Q ss_pred --cccccccccccccchhccCCCCCccceEEeehhhHHHhhhC-CCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 --VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG-RRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 --~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
......||-+|+|||++....-+.++||||+|||+|+.++| ..||...... ..++ .
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI--------------------l 726 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI--------------------L 726 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh--------------------h
Confidence 24567799999999999999888999999999999999996 8999753221 1111 1
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.+.. .+. .+.. ..++ +..+++..|+.++|..||++.+|+.
T Consensus 727 ~~~~-~L~--~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 TGNY-TLV--HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cCcc-cee--eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1100 000 0111 1111 6778999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=230.41 Aligned_cols=194 Identities=28% Similarity=0.410 Sum_probs=161.3
Q ss_pred ccccccccceeEEEEEe-CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 459 SEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP--GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.||+|++|.|-+-++ ++|...|+|++... .+..+....|+.+..+- .+|.+|.++|...+....++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 35799999999988865 47899999999754 34456677788776554 799999999999999999999999964
Q ss_pred ChhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 535 ALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 535 sL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
||+.+-+ +++..+++..+-+|+..+..||.|||++ ..+||||+||+|||++.+|++||||||++-.+.+... .
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--k 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--K 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--H
Confidence 6665433 3456789999999999999999999995 3499999999999999999999999999987654322 2
Q ss_pred cccccccccccchhccC----CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWISG----LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~----~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
+...|...|||||.+.. ..|+.||||||||+.+.||.+++.|++..
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 33568889999998854 36899999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=223.99 Aligned_cols=190 Identities=26% Similarity=0.470 Sum_probs=162.9
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
|+||+|.||+||||+.. ..+.||+|+++.... -.....+|+-+++.++|+|||+++++...+..+-+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 68999999999999765 568899999964322 235678899999999999999999999999999999999964 6
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|..+...-...++.+....++.|+++||.+.|+.+ +.|||+||+|.||+.+|++|++|||+++.++-... .....+
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr-cysaev 162 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAEV 162 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeecee
Confidence 77776665668999999999999999999999988 99999999999999999999999999998876532 334456
Q ss_pred cccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCC
Q 044374 616 GTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 616 gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
-|..|.+|.++.+. .|+...|+||-|||+.|+....+|.
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 78999999998875 5788999999999999999744443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-30 Score=249.57 Aligned_cols=267 Identities=22% Similarity=0.254 Sum_probs=194.6
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCC-----eEEEEEE
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENS-----HRLLVYD 529 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E 529 (804)
.+-||.|+||.||....+ +++.||+|++.+-- ...+.+.+|+++|+.++|.|++..+++..... +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 357999999999998654 78999999996532 24467888999999999999999998775442 5677888
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
.|.. +|..+|-.. ..++.+.+.-++.||++||.|||+.+ |.||||||.|.|++.|..+||+|||+++....+...
T Consensus 138 LmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8754 566655543 36888888899999999999999988 999999999999999999999999999987766666
Q ss_pred cccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch-HHHHHHhhc
Q 044374 610 VLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP-PWAARQIIE 687 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 687 (804)
-++..+-|..|.|||.+++. .|+...||||.|||+.||+..+..|....+-+...++. +...-+ ..+.+..-+
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt-----dLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII-----DLLGTPSQEAMKYACE 287 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH-----HHhCCCcHHHHHHHhh
Confidence 66777789999999999885 68999999999999999999998887654432211110 000001 112222223
Q ss_pred CccceeccccccC---------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 688 GNVAAVVDDRLGG---------AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 688 ~~~~~~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
|--..++....+. ..+.....+...+...++..+|.+|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 3222222111110 01112223455667778899999999988877664
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=215.56 Aligned_cols=110 Identities=36% Similarity=0.940 Sum_probs=102.3
Q ss_pred EecCCCCCceeecccccccceeEEEeeecCCCcceeEEEeeccCCCCCCCCeeEEEEccCCcEEEEEEecCCCceEEEEe
Q 044374 171 WSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQYTWSQQTDYWNMFWS 250 (804)
Q Consensus 171 w~sg~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~~G~l~~y~w~~~~~~W~~~~~ 250 (804)
||+|+|||..|+++|+|....++.+.|+.+ ..+.+++|... +.+ .++|++||.+|++++|+|++..+.|.+.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~-~~e~~~t~~~~--~~s---~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~ 74 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSN-NEEVYYTYSLS--NSS---VLSRLVLDSDGQLQRYIWNESTQSWSVFWS 74 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEEC-CCeEEEEEecC--CCc---eEEEEEEeeeeEEEEEEEecCCCcEEEEEE
Confidence 899999999999999999888899999977 88889999877 444 389999999999999999999999999999
Q ss_pred ccCCCcccccCCCCCccccCCCCCCCCCCCCCcccC
Q 044374 251 QPEDICRVHGLCGNFGFCKSSLLRPCMCFDGFRPVD 286 (804)
Q Consensus 251 ~p~~~C~~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 286 (804)
+|.|+||+|+.||+||+|+.+..+.|.||+||+|++
T Consensus 75 ~p~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 75 APKDQCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred ecccCCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999999999988889999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=263.60 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=198.6
Q ss_pred cccccccceeEEEEEeCCCc-EEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSDST-LVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..||-|+||.|=..+..... .+|+|++++.. ..++....|-.+|...+.|.||+|+-.+.+....|++||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 47999999999998776544 48999887531 23345778999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
.|...|++++ .++......++..+.+|++|||.++ ||+|||||+|.+|+.+|-+||.|||.|+.++.. ...-+.
T Consensus 506 ElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwTF 579 (732)
T KOG0614|consen 506 ELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWTF 579 (732)
T ss_pred hhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cceeee
Confidence 9999999876 6788888889999999999999988 999999999999999999999999999987654 335678
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
+||+.|.|||++.+..+...+|.||+|++++|||+|.+||...++-.. ...+..| +
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------------------Yn~ILkG-----i 635 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------------------YNLILKG-----I 635 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------------------HHHHHhh-----h
Confidence 999999999999999999999999999999999999999997654322 1222222 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
| .-.+|....+...+++++.+..+|.+|-- +.+|-++
T Consensus 636 d---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 D---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 11234444566777888888899999975 5666544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=233.87 Aligned_cols=210 Identities=36% Similarity=0.570 Sum_probs=184.6
Q ss_pred cccccceeEEEEEeCC-CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhH
Q 044374 462 LGHGGFGAVFQGELSD-STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 538 (804)
||+|.+|.||++...+ ++.+++|++..... ....+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 88899999986544 25789999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCccccccccccc
Q 044374 539 YLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 539 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
++......+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99876456899999999999999999999987 999999999999999 89999999999986543321 12335578
Q ss_pred cccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 618 WGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 618 ~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
..|++||.+... ..+.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999887 888999999999999998
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=254.47 Aligned_cols=216 Identities=27% Similarity=0.377 Sum_probs=178.3
Q ss_pred cccccChHHHHHhhcc---c--ccccccccceeEEEE-EeCCCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCc
Q 044374 442 NLKVFSYKELHTVTRG---F--SEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNL 511 (804)
Q Consensus 442 ~~~~~~~~el~~~t~~---~--~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~ni 511 (804)
..+...|..|+++.-. | .+.||-|+||.|..+ +.+....+|+|.+++... .....+.|-.+|+.-+.+-|
T Consensus 612 ~QKESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV 691 (1034)
T KOG0608|consen 612 QQKESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV 691 (1034)
T ss_pred HhhhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce
Confidence 3355566667665422 2 357999999999999 455567899999976432 23457789999999999999
Q ss_pred eeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc
Q 044374 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 512 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
|+|+-.|.+.+.+|+||||+++|++-.+|-+.+ .+.++.+..++.++..|+++.|..+ +|||||||+|||||.+|.
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCc
Confidence 999999999999999999999999999887765 6788888889999999999999988 999999999999999999
Q ss_pred eEEeecCCccccC-----------CC--------------cc----------------ccccccccccccccchhccCCC
Q 044374 592 AKVSDFGLAKLIG-----------RD--------------FS----------------RVLATMRGTWGYVAPEWISGLA 630 (804)
Q Consensus 592 ~kl~DfGla~~~~-----------~~--------------~~----------------~~~~~~~gt~~y~aPE~l~~~~ 630 (804)
+||.||||..-+. ++ .. ......+||+.|+|||++....
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 9999999975430 00 00 0112346999999999999999
Q ss_pred CCccceEEeehhhHHHhhhCCCCCCCCcCCC
Q 044374 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGR 661 (804)
Q Consensus 631 ~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 661 (804)
++...|-||.||||+||+.|+.||-...+.+
T Consensus 848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 9999999999999999999999998776654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=217.13 Aligned_cols=103 Identities=45% Similarity=0.782 Sum_probs=75.5
Q ss_pred CCcEEEecCCCCCCCCC-CCcEEEEeccccEEEecCCCcEEEEe-ccC-C--ceeEEEEccCCcEEEecCCCCeeecccC
Q 044374 42 TPTYVWVANREKSVADV-TQSTLLITEKGKLAIKDSQNSIIWQS-TNT-E--KATDMYLLETGNLVLLSSAGSLVWQSFD 116 (804)
Q Consensus 42 ~~~~vW~anr~~p~~~~-~~~~l~~~~~g~l~l~~~~~~~~w~~-~~~-~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd 116 (804)
++||||+|||++|+... ...+|.|+.||||+|+|..|+++|++ +.. . .+..|.|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 37999999999999543 35789999999999999999999999 422 2 4789999999999999999999999999
Q ss_pred CCcccccCCCcccc----c--eeeeeccCCCCCC
Q 044374 117 HPTDTWLPGMNISV----G--GSITSWKSLFDPS 144 (804)
Q Consensus 117 ~PTDTlLpg~~l~~----~--~~L~Sw~s~~dps 144 (804)
|||||+||||+|+. + ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999885 3 3599999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=236.27 Aligned_cols=243 Identities=20% Similarity=0.291 Sum_probs=193.6
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEc
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+...||+|+|..|-.+++. ..+.+|+|++++. .+...-.+.|-.+..+- +||.+|.|..++...+.+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4578999999999999876 4578999999753 23334466777776665 6999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|--+++.+. .++++.+..+..+|.-||.|||+.+ ||.||||..|||||..|.+||.|+|+.+.--.+ ....
T Consensus 334 ~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred cCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 9999988887765 6788888889999999999999988 999999999999999999999999999864332 2345
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
.+.+||+.|+|||++.+..|...+|-|++||+|+||+.|+.||+.--.+ ..+.+-..+..+.+.+.++
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-----------n~d~ntedylfqvilekqi- 476 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-----------NPDMNTEDYLFQVILEKQI- 476 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-----------CcccchhHHHHHHHhhhcc-
Confidence 6789999999999999999999999999999999999999999853211 1222333444444444322
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP 726 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 726 (804)
..+.....+...+++.-+.+||.+|.
T Consensus 477 ---------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 12333345566788888999999885
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=204.89 Aligned_cols=113 Identities=37% Similarity=0.631 Sum_probs=101.1
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|++|++|+|++|.|++|||++....+.+++|||.+++ +++||.||++.|.. ..+.|.|+.||+|+|+|.+|.++|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~--~~~~l~l~~dGnLvl~~~~g~~vW 78 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSG--SSCTLTLQSDGNLVIYDGSGTVVW 78 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCC--CCEEEEEecCCCeEEEcCCCcEEE
Confidence 468899999999999999999996554599999999887 89999999999843 346899999999999999999999
Q ss_pred EeccC--CceeEEEEccCCcEEEecCCCCeeecccCCC
Q 044374 83 QSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHP 118 (804)
Q Consensus 83 ~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~P 118 (804)
+|+.. ....+|+|+|+|||||++..+.+||||||||
T Consensus 79 ~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 79 SSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred EecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 99844 4567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=230.21 Aligned_cols=196 Identities=36% Similarity=0.559 Sum_probs=171.8
Q ss_pred cccccccccceeEEEEEeCC-CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 458 FSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|+..+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999998875 78899999976543 4678899999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..............
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 999999876533889999999999999999999987 99999999999999999999999999987654321123445
Q ss_pred ccccccccchhc-cCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 615 RGTWGYVAPEWI-SGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 615 ~gt~~y~aPE~l-~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 678899999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=246.72 Aligned_cols=190 Identities=23% Similarity=0.306 Sum_probs=163.4
Q ss_pred ccccccccceeEEEEEeCC-CcEEEEEEecCCCCCH---------HHHHHHHHHHcCCC---CCCceeeeeEEecCCeEE
Q 044374 459 SEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGE---------REFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~---------~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~ 525 (804)
.+.+|+|+||.|+.+.++. ...|+||.+.+...-. -..-.||.+|+.++ |+||++++++|++++.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 3579999999999997764 5679999886543221 13557999999997 999999999999999999
Q ss_pred EEEEEcC-CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 526 LVYDYMR-NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 526 lV~E~~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
|+||-.. +.+|.++|..+. .+++.+...|..|++.|+++||+.+ |||||||-+||.++.+|-+||+|||.+....
T Consensus 646 l~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999864 558899997654 7999999999999999999999998 9999999999999999999999999997643
Q ss_pred CCccccccccccccccccchhccCCCCC-ccceEEeehhhHHHhhhCCCCCC
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAIT-TKADVYSYGMTLLELIGGRRNVE 655 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~ksDV~S~Gvvl~elltg~~p~~ 655 (804)
. ......+||..|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus 722 s---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 S---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred C---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 2 235678899999999999998874 56799999999999999888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=228.91 Aligned_cols=264 Identities=23% Similarity=0.257 Sum_probs=186.0
Q ss_pred ccccccceeEEEE-EeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEEEEEE
Q 044374 461 KLGHGGFGAVFQG-ELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLLVYDY 530 (804)
Q Consensus 461 ~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~lV~E~ 530 (804)
-+|.|.- .|-.+ ..-.+++||+|++..+ ....+...+|..++..++|+|+++++.++.... +.|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4677777 44444 3335788999998643 334466788999999999999999999986543 56999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
|.. +|...+.. .++-+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++....+ -.
T Consensus 103 m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 103 MDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred hhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 954 77777763 4677788899999999999999988 999999999999999999999999999865443 34
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCcc---CchHHHHHHhh
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKW---FFPPWAARQII 686 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~ 686 (804)
++..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-..-. +.......+.. .+.+-+.....
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 566788999999999999899999999999999999999998887432211000 00000001100 00000110000
Q ss_pred cC------cccee-ccccccC--CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EG------NVAAV-VDDRLGG--AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~------~~~~~-~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ...+. .|..... +.+......+..++.+||-.+|++|-+..+++++
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00011 1111111 1112233456778999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=233.82 Aligned_cols=131 Identities=26% Similarity=0.395 Sum_probs=108.4
Q ss_pred hhcccccccccccceeEEEE-EeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----C---CCceeeeeEEec----
Q 044374 454 VTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----H---VNLVRLRGFCSE---- 520 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~---- 520 (804)
..+-..++||=|.|++||.+ ..++.+.||+|+.+....-.+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 33445689999999999999 5567889999999876666677888999999884 3 479999999964
Q ss_pred CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 521 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
+.+.|||+|++..-.|.-+....-..++...+.+|+.||+.||.|||.++ +|||-||||+|||+
T Consensus 158 G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45899999998664444444444567999999999999999999999987 49999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-26 Score=239.48 Aligned_cols=207 Identities=24% Similarity=0.291 Sum_probs=174.3
Q ss_pred ChHHHHHhhcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC------CCCceeeeeEEe
Q 044374 447 SYKELHTVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ------HVNLVRLRGFCS 519 (804)
Q Consensus 447 ~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~ 519 (804)
.+.|+....+.+....|+|-|++|.+|... .+..||||++.+.+.-.+.=+.|+++|++|+ .-|+++|+-.|.
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345555555556667899999999999654 5679999999987776777788999999995 348999999999
Q ss_pred cCCeEEEEEEEcCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEee
Q 044374 520 ENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSD 596 (804)
Q Consensus 520 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~D 596 (804)
..+++|||+|-+. .+|.+.|++-+ ..|....+..++.|+.-||..|...+ |+|.||||.||||++. ..+||||
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence 9999999999874 48999998765 46788899999999999999999888 9999999999999875 5699999
Q ss_pred cCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCC
Q 044374 597 FGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASG 660 (804)
Q Consensus 597 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~ 660 (804)
||.|...+... .+...-+..|.|||++.+.+|....|+||.||.||||.||+..|.+....
T Consensus 581 fGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 581 FGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred Ccccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 99998765432 23334566899999999999999999999999999999999999876554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-26 Score=273.64 Aligned_cols=196 Identities=16% Similarity=0.218 Sum_probs=140.6
Q ss_pred CCCC-CCceeeeeEE-------ecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 044374 505 NIQH-VNLVRLRGFC-------SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576 (804)
Q Consensus 505 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 576 (804)
.++| +||+++++++ .+....++++|++ .++|.++|......+++.+++.++.||++||+|||+.+ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4556 6888888887 2234567788887 55999999876567999999999999999999999988 999
Q ss_pred cCCCCCcEEecC-------------------CCceEEeecCCccccCCCc---------------ccccccccccccccc
Q 044374 577 CDIKPENILLDS-------------------DYTAKVSDFGLAKLIGRDF---------------SRVLATMRGTWGYVA 622 (804)
Q Consensus 577 ~Dlkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~y~a 622 (804)
|||||+||||+. ++.+||+|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 4456666777665321100 000112357889999
Q ss_pred chhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCC
Q 044374 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY 702 (804)
Q Consensus 623 PE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 702 (804)
||++.+..++.++|||||||+||||++|..|+..... ....+... .+.+..
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------------------~~~~~~~~----~~~~~~---- 234 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------------------TMSSLRHR----VLPPQI---- 234 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------------------HHHHHHHh----hcChhh----
Confidence 9999999999999999999999999998877542100 00111110 011110
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 703 KVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 703 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.........++.+||+++|.+||+|.||+++
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1122345678889999999999999999864
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=195.03 Aligned_cols=111 Identities=38% Similarity=0.648 Sum_probs=100.4
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|+++++|+|+++.|++|||.+. ....+.+|||++.+ +++||+|||+.|+.+. ..|.++.||+|+|+|.+|.++|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~-~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~--~~l~l~~dGnLvl~~~~g~~vW 77 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSS-RTVVWVANRDNPVSDS--CTLTLQSDGNLVLYDGDGRVVW 77 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccC-CCCCEEEEEEECCC-CcEEEECCCCCCCCCC--EEEEEeCCCCEEEEeCCCCEEE
Confidence 568999999999999999999995 45799999999887 8999999999998763 6899999999999999999999
Q ss_pred EeccC--CceeEEEEccCCcEEEecCCCCeeecccCC
Q 044374 83 QSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDH 117 (804)
Q Consensus 83 ~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~ 117 (804)
+|+.. ....+++|+|+|||||++..+.+|||||||
T Consensus 78 ~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 78 SSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred EecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 99853 456789999999999999999999999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=210.82 Aligned_cols=265 Identities=15% Similarity=0.215 Sum_probs=186.7
Q ss_pred cccccccccceeEEEEE-eCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecC--CeEEEEEEEcCC
Q 044374 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSEN--SHRLLVYDYMRN 533 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E~~~~ 533 (804)
+.+++|+|.++.||.|. ..+.+.++||+++.. ..+.+++|+.+|..+. ||||++|+++..+. ..+.||+||..+
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 45689999999999995 457788999999743 4577899999999997 99999999998765 456899999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
.+...+-. .++...+...+.+++.||.|.|+.| |+|||+||.||+||.. -.++|+|+|+|.+..... ...
T Consensus 120 ~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~--eYn 190 (338)
T KOG0668|consen 120 TDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYN 190 (338)
T ss_pred ccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc--eee
Confidence 88765543 4666777889999999999999998 9999999999999865 569999999998764332 233
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc--Cc
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE--GN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 689 (804)
..+.+..|.-||.+-.. .|...-|+|||||+|.+|+..+.||....+...+...-. ..-....+..+..+...+ ..
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa-kVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA-KVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH-HHhChHHHHHHHHHHccCCChh
Confidence 45667889999988664 577888999999999999999999975433211000000 000001111111111100 00
Q ss_pred cceecccccc--------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLG--------GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+++....+ .+-..-..++.+.++...+..|-.+|||+.|....
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111110 00011113567788888999999999999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=242.65 Aligned_cols=247 Identities=22% Similarity=0.278 Sum_probs=196.0
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
....+|+|.+|.|||++. ..++..|||+++.. .....-.++|+-+++..+||||+.++|.+......++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 356899999999999965 46788999999854 4455667889999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+.-+..+ ++++.++..+.+...+||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.++.... ......
T Consensus 99 lQdiy~~Tg-plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krksfi 173 (829)
T KOG0576|consen 99 LQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFI 173 (829)
T ss_pred ccceeeecc-cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh-hhhccc
Confidence 999877665 7889999999999999999999988 89999999999999999999999999876554322 234567
Q ss_pred cccccccchhc---cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 616 GTWGYVAPEWI---SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 616 gt~~y~aPE~l---~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
||+.|||||+. ..+.|..++|||+.|+...|+---+.|.....+ .....+... .
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------------------mr~l~LmTk---S 230 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------------------MRALFLMTK---S 230 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------------------HHHHHHhhc---c
Confidence 99999999976 445789999999999999999777666432211 111111111 1
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..++--. +-.....+.+-++++.|+-++|++||++..+++
T Consensus 231 ~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1121111 112345667889999999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=211.94 Aligned_cols=249 Identities=19% Similarity=0.312 Sum_probs=187.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeE-EecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGF-CSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E~~~~ 533 (804)
++.+.||+|.||.+-.++++ .++.+++|-+..+....++|.+|...--.| .|.||+.-++. +...+.+++++||++.
T Consensus 27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~ 106 (378)
T KOG1345|consen 27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPR 106 (378)
T ss_pred hHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCcc
Confidence 45678999999999999776 467899999998888899999998765555 58999987764 5556688899999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--CCCceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--SDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
|+|..-+... .+.+....+++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+.+..+.. .
T Consensus 107 gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----V 177 (378)
T KOG1345|consen 107 GDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----V 177 (378)
T ss_pred chhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce----e
Confidence 9999888764 4777788899999999999999998 99999999999993 3458999999999865432 1
Q ss_pred cccccccccccchhccCC-----CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 612 ATMRGTWGYVAPEWISGL-----AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~-----~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
....-+..|.+||..... ...+.+|||.||+|++.++||+.|+..... ..-+-|.+.++.
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---------------~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---------------MDKPYWEWEQWL 242 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---------------cCchHHHHHHHh
Confidence 223346689999976442 345778999999999999999999974221 122445555665
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKML 735 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L 735 (804)
.+....+.+.- .. -.+++..+-++-+.++|++|=-..++.++-
T Consensus 243 ~rk~~~~P~~F--~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 243 KRKNPALPKKF--NP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cccCccCchhh--cc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 55444332211 11 234566666778889999996555655553
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=209.24 Aligned_cols=167 Identities=23% Similarity=0.209 Sum_probs=127.0
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|.+++...+..+++.+++.++.|+++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876667999999999999999999999865 999999999999999 99998754321
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|||||++.+..++.++|||||||++|||++|+.||...... .... ..+..+.....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----------------~~~~-~~~~~~~~~~~ 125 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----------------SAIL-EILLNGMPADD 125 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----------------cHHH-HHHHHHhccCC
Confidence 25889999999999999999999999999999999999998643211 0111 11111100000
Q ss_pred ccccccCCCCHHHH--HHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 694 VDDRLGGAYKVEEA--ERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 694 ~d~~l~~~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
... ........ ..+.+++.+|++.+|++||++.++++++..+
T Consensus 126 ~~~---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 126 PRD---RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccc---cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000 00111222 2689999999999999999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=218.96 Aligned_cols=194 Identities=26% Similarity=0.362 Sum_probs=161.0
Q ss_pred ccccccccceeEEEEEeC----CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.++||+|.|++||++... ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+++..++...+|+||+++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 468999999999999654 357899999975433 345889999999985 99999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccC--------
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIG-------- 604 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~-------- 604 (804)
....++... ++...+..++..+..||+++|..+ ||||||||+|+|.+. .+.-.|.|||++....
T Consensus 120 ~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 120 DRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred cCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999988874 668888999999999999999988 999999999999975 4678999999997210
Q ss_pred -C----Cc------------------------------cccccccccccccccchhccCC-CCCccceEEeehhhHHHhh
Q 044374 605 -R----DF------------------------------SRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELI 648 (804)
Q Consensus 605 -~----~~------------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~ell 648 (804)
. .. ........||++|.|||++... ..+.++||||-|||++-++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 00 0011224599999999998664 5789999999999999999
Q ss_pred hCCCCCCCCcCC
Q 044374 649 GGRRNVEAPASG 660 (804)
Q Consensus 649 tg~~p~~~~~~~ 660 (804)
+++.||.....+
T Consensus 273 s~~~PFf~a~dd 284 (418)
T KOG1167|consen 273 SRRYPFFKAKDD 284 (418)
T ss_pred ccccccccCccc
Confidence 999999765443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-24 Score=209.51 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=193.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.++..+|.+...|..|+|+++.+. +++|+++-. ....++|.+|.-.|+.+.||||+.++|.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 356678999999999999997665 566777543 3345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
.|+|...|+... ...+-.+..+++.++|+|++|||+..+ .|..--|.++.|++|++.+++|+ .+-+++.-. .
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kfsfq-----e 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-----E 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cccceeeee-----c
Confidence 999999998764 457888999999999999999999763 35555799999999999999985 122221101 1
Q ss_pred cccccccccccchhccCCCC---CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 612 ATMRGTWGYVAPEWISGLAI---TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~---~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
....-.+.||+||.++..+- -..+|+|||+++||||.|...||....+-+- |
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------------------------g 398 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------------------------G 398 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------------------------h
Confidence 12234678999999987653 3578999999999999999999975433210 0
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
.++.-..++...++.....+.+++.-|+..||.+||.+..|+-.||..
T Consensus 399 --mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 399 --MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 111112233445666678899999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=213.85 Aligned_cols=169 Identities=21% Similarity=0.190 Sum_probs=128.7
Q ss_pred cccccccccccceeEEEEEeC--CCcEEEEEEecCCC------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS--DSTLVAVKRLERPG------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.+.||+|+||+||+|... +++.||||++.... ...+.|++|++++++++|+|+++.+.. ....+||
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 345678999999999999764 56778999875321 124568999999999999999853322 2457999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCcEEecCCCceEEeecCCccccCCC
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI-KPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|||+++++|... ... . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+++.+...
T Consensus 97 mE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 97 RGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 999999999632 111 1 1467889999999999988 999999 999999999999999999999976443
Q ss_pred cc-------ccccccccccccccchhccCCC------CCccceEE
Q 044374 607 FS-------RVLATMRGTWGYVAPEWISGLA------ITTKADVY 638 (804)
Q Consensus 607 ~~-------~~~~~~~gt~~y~aPE~l~~~~------~~~ksDV~ 638 (804)
.. .......+++.|+|||++.... .+..+|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 21 1124567889999999986542 33446766
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-19 Score=191.77 Aligned_cols=256 Identities=30% Similarity=0.404 Sum_probs=195.8
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCC-CceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHV-NLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.||.|+|+.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+++......++++|++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4568999999999999876 7799999975432 366799999999999988 79999999977777899999999
Q ss_pred CCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~ 609 (804)
++++.+++.... ..+.......++.+++.++.|+|..+ ++||||||+||+++... .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999997776654 26889999999999999999999988 99999999999999998 7999999999865443221
Q ss_pred -----cccccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 610 -----VLATMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 610 -----~~~~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
......++..|+|||.+.+ .......|+||+|++++++++|..|+...... ......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------------~~~~~~ 223 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------------SATSQT 223 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------------ccHHHH
Confidence 3456789999999999988 57889999999999999999999996543210 001111
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+...... .................+..++..|+..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111111 000000000002223567888999999999999999887764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=195.00 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=189.5
Q ss_pred hcccccccccccceeEEEEEeCCC--cEEEEEEecCCC-CCHHHHHHHHHHHcCCCC----CCceeeeeEE-ecCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDS--TLVAVKRLERPG-SGEREFRAEVCTIGNIQH----VNLVRLRGFC-SENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 526 (804)
...+.++||+|+||.||.+..... ..+|+|...... .....+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 344678999999999999976543 478888876542 222267888888888863 5888888888 47778899
Q ss_pred EEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-----CceEEeecCCc
Q 044374 527 VYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-----YTAKVSDFGLA 600 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfGla 600 (804)
||+.+ +.+|.++..... ..++..+.++|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 668888776554 67999999999999999999999988 9999999999999765 46999999999
Q ss_pred c--ccCCCc------ccc-ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCC
Q 044374 601 K--LIGRDF------SRV-LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 601 ~--~~~~~~------~~~-~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 671 (804)
+ ...... .+. ....+||.+|.+++...+...+.+.|+||++.++.|++.|..|+........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--------- 245 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--------- 245 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---------
Confidence 8 321111 111 2345699999999999999999999999999999999999999864322100
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
............... .....+..+..+...+-..+..++|....+...|++...
T Consensus 246 ----------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 246 ----------KSKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred ----------HHHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 000000000111110 111223455566666666899999999999999877544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-20 Score=214.32 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=185.0
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecC---CCCCHH----HHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLER---PGSGER----EFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~----~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+|.|++|.|+.... ...+..+.|.+.. ....++ .+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 346899999998887743 2333344443321 112222 24567777788999999888877776666666699
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|++. +|..++.... .+...++..+..|+..|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 9999987753 5778888999999999999999998 99999999999999999999999999987654433
Q ss_pred --ccccccccccccccchhccCCCCCc-cceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 --RVLATMRGTWGYVAPEWISGLAITT-KADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 --~~~~~~~gt~~y~aPE~l~~~~~~~-ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
......+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||..+....... ...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------------------~~~ 538 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------------------KTN 538 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------------------hhh
Confidence 4456678999999999999999876 4799999999999999999998654432110 000
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....-..+... ......+.+.+...++.++++.+|.+|-+|.+|++.
T Consensus 539 ~~~~~~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 539 NYSDQRNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccccccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000000000 011122445667789999999999999999999853
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=179.44 Aligned_cols=138 Identities=13% Similarity=0.123 Sum_probs=108.0
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCC---C-------HHH-----------------HHHHHHHHcCCCCCCc
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS---G-------ERE-----------------FRAEVCTIGNIQHVNL 511 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~-------~~~-----------------~~~Ei~~l~~l~H~ni 511 (804)
.+.||+|+||.||+|...+|+.||||+++.... . ... ...|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999888899999999964321 1 112 2349999999987776
Q ss_pred eeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCcEEecCCC
Q 044374 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYL-HEECRDCIIHCDIKPENILLDSDY 590 (804)
Q Consensus 512 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlkp~NILl~~~~ 590 (804)
.....+.. ...+|||||++++++...+... ..++......++.|++.+|.|| |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 44333222 2238999999998776553322 3688899999999999999999 6777 99999999999998 47
Q ss_pred ceEEeecCCcccc
Q 044374 591 TAKVSDFGLAKLI 603 (804)
Q Consensus 591 ~~kl~DfGla~~~ 603 (804)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=197.11 Aligned_cols=218 Identities=22% Similarity=0.373 Sum_probs=165.3
Q ss_pred HcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 044374 503 IGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPE 582 (804)
Q Consensus 503 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~ 582 (804)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......+++.....++.+|+.||+|||... ...|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 45789999999999999999999999999999999999988888999999999999999999999854 2399999999
Q ss_pred cEEecCCCceEEeecCCccccCCC-ccccccccccccccccchhccCC-------CCCccceEEeehhhHHHhhhCCCCC
Q 044374 583 NILLDSDYTAKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGL-------AITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 583 NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-------~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
|+++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999876421 11112222345679999999764 1467899999999999999999999
Q ss_pred CCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 655 EAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+....... +.-....+.. .-...+.+.+... .+..+.+..++..||..+|++||++.+|-..
T Consensus 159 ~~~~~~~~---------------~~eii~~~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 159 DLRNLVED---------------PDEIILRVKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccccCC---------------hHHHHHHHHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 86332210 0011111111 0111111221111 0333478999999999999999999999999
Q ss_pred Hhcccc
Q 044374 735 LEGVLE 740 (804)
Q Consensus 735 L~~~~~ 740 (804)
++.+..
T Consensus 221 ~~~~~~ 226 (484)
T KOG1023|consen 221 LLTINK 226 (484)
T ss_pred hhhhcc
Confidence 887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=179.26 Aligned_cols=170 Identities=11% Similarity=0.084 Sum_probs=130.6
Q ss_pred HhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHH----------HHHHHHHHcCCCCCCceeeeeEEecC-
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE----------FRAEVCTIGNIQHVNLVRLRGFCSEN- 521 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~Ei~~l~~l~H~niv~l~g~~~~~- 521 (804)
.......+.||.|+||.||.... ++..+|||.+.......+. +++|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 33445567999999999999766 4667999999754322222 68999999999999999998885532
Q ss_pred -------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEE
Q 044374 522 -------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594 (804)
Q Consensus 522 -------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 594 (804)
...+|||||+++.+|.++.. ++. ....+++.+|..+|..+ ++|||+||+||+++.++ ++|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEE
Confidence 35789999999999987732 222 34568999999999988 99999999999999988 999
Q ss_pred eecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh
Q 044374 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 595 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
+|||.......+... ..++....+..++|+|+||+.+..+..
T Consensus 176 iDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999998754322111 114455566789999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=174.45 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=110.8
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCC---------------------------HHHHHHHHHHHcCCCCCCc
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---------------------------EREFRAEVCTIGNIQHVNL 511 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~Ei~~l~~l~H~ni 511 (804)
...||+|+||.||+|...+|+.||||+++..... ...++.|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999998878999999999753211 1123578899999999987
Q ss_pred eeeeeEEecCCeEEEEEEEcCCCChhHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCC
Q 044374 512 VRLRGFCSENSHRLLVYDYMRNGALSLY-LRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 512 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~ 589 (804)
.....+... ..+|||||++++++... +.. ..++......++.+++.++.+||+ .+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 554444332 34899999998865443 332 357788899999999999999999 77 99999999999999 8
Q ss_pred CceEEeecCCccccCC
Q 044374 590 YTAKVSDFGLAKLIGR 605 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~ 605 (804)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-19 Score=206.49 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=179.3
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCC--CCCHHHHHHHHHH--HcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERP--GSGEREFRAEVCT--IGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||++.|=.|.+|+.++|. |+||++-+. ....+.|+++++- ...++|||.+++.-.-......|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 35678999999999999998887 999999543 3445555554433 456689999998777666666678878876
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc--cCC----C
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL--IGR----D 606 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~--~~~----~ 606 (804)
+ +|.+.|..+. .+...+..-|+.|++.||.-.|..+ |.|||||.+||||+.-.-+.|+||...+- +.. +
T Consensus 105 h-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 105 H-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred h-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 5 7778776543 5677778889999999999999988 99999999999999999999999987753 222 2
Q ss_pred ccccccccccccccccchhccCC----------C-CCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 607 FSRVLATMRGTWGYVAPEWISGL----------A-ITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~----------~-~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
+.....+...-..|+|||.+-.. . .+++-||||+||++.||++ |+++|+..
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------------- 242 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------------- 242 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----------------
Confidence 23334445556689999977431 2 5678899999999999998 57777631
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
.... .+.+. .......|... +...+..+++.|++.||++|-++.+.++.-.++
T Consensus 243 ----QL~a--Yr~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 ----QLLA--YRSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ----HHHh--HhccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1110 01111 11111111110 112577899999999999999999999886554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=172.89 Aligned_cols=198 Identities=24% Similarity=0.324 Sum_probs=165.7
Q ss_pred ccccccccccceeEEEEE-eCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|.||.++.|+ +-++++||||.-. ......+++.|.+..+.|. .+.|-..+-|-.++-+-.||+|.+ +-
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 467899999999999995 5688999999543 3444556777888777774 688888887777888889999987 55
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-----CceEEeecCCccccCCCcc-
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-----YTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DfGla~~~~~~~~- 608 (804)
||+++..-.+..++.+++..+|.|++.-++|+|++. +|.|||||+|.||... ..+.|+|||||+...+...
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 899988877778999999999999999999999988 9999999999999643 4589999999997654322
Q ss_pred -----ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcC
Q 044374 609 -----RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPAS 659 (804)
Q Consensus 609 -----~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~ 659 (804)
+......||-+||+-....+.+.+.+-|.=|+|-++.+.|-|..|+.....
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 223456699999999999999999999999999999999999999986533
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=166.54 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=189.9
Q ss_pred hcccccccccccceeEEEEE-eCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC-CCceeeeeEEecCCeEEEEEEEcC
Q 044374 455 TRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-VNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
...+.++||+|+||.+|.|. ...|+.||||+-... ....++..|..+...++| ..|-.+.-+..+..+-.|||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 34567899999999999995 567899999976543 334556778888888875 45666677778888899999987
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCccccCCCc--
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLIGRDF-- 607 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~-- 607 (804)
+-+|+++..--...++.++.+-++-|++.-++|+|..+ +|||||||+|.|..-+ ..+.++|||+|+...+..
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 55888888766667999999999999999999999988 9999999999998643 468999999998754321
Q ss_pred ----cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 608 ----SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 608 ----~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.+......||.+|.+-....+...+.+-|+=|+|.+|.++.-|..|+....... .....+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t----------------k~QKyE 234 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT----------------KKQKYE 234 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh----------------HHHHHH
Confidence 123345679999999998888888999999999999999999999998643321 111223
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
++.|..+...+ ..+...+| .++...+.-|-+.--++-|.-.-+-++..
T Consensus 235 kI~EkK~s~~i-e~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 235 KISEKKMSTPI-EVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHhhcCCCH-HHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 33333222111 22223333 34566667787777788887766655544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=164.55 Aligned_cols=182 Identities=18% Similarity=0.101 Sum_probs=137.9
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHH-----HHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcC
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGER-----EFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
...|++|+||+||.+.- .+.+++.+.++....-.+ .+++|+++|++++ |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997766 667788888876544333 5889999999995 5889999886 45699999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCcEEecCCCceEEeecCCccccCCCccc--
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI-KPENILLDSDYTAKVSDFGLAKLIGRDFSR-- 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~~~~~-- 609 (804)
+.+|...+.. ....+..+++++|.++|+.+ |+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9998754321 12357789999999999988 999999 799999999999999999999865432210
Q ss_pred --c--------ccccccccccccchhccCC-CCC-ccceEEeehhhHHHhhhCCCCCCC
Q 044374 610 --V--------LATMRGTWGYVAPEWISGL-AIT-TKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 610 --~--------~~~~~gt~~y~aPE~l~~~-~~~-~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
. ......++.|++|+...-. ..+ ...+-++-|.-+|.++|++.+.-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 1112357778888754322 222 566888999999999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=170.91 Aligned_cols=227 Identities=25% Similarity=0.315 Sum_probs=147.5
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCC----------CCceeeeeEE----
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQH----------VNLVRLRGFC---- 518 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~---- 518 (804)
..+.||.|+++.||.++.. .++++|||++.... ...+++++|...+..+.+ -.++-.++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3568999999999999776 47999999985332 234667777766655433 1222222221
Q ss_pred -----ecC---C-----eEEEEEEEcCCCChhHHHh---hCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 044374 519 -----SEN---S-----HRLLVYDYMRNGALSLYLR---KDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI 579 (804)
Q Consensus 519 -----~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 579 (804)
... + ..+++|+-+ .++|..++. ... ..+....++.+..|+.+.+++||..+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 1 236677776 557777653 222 12445667788899999999999988 999999
Q ss_pred CCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccC--------CCCCccceEEeehhhHHHhhhCC
Q 044374 580 KPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG--------LAITTKADVYSYGMTLLELIGGR 651 (804)
Q Consensus 580 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~ksDV~S~Gvvl~elltg~ 651 (804)
||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.+++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999887765433221 334578999997643 24788999999999999999999
Q ss_pred CCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 044374 652 RNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR 725 (804)
Q Consensus 652 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 725 (804)
.||+...+... . .+ .-..+. +.++.+..++..+|+.+|++|
T Consensus 248 lPf~~~~~~~~----------~-----~~-----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEAD----------P-----EW-----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGST----------S-----GG-----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccc----------c-----cc-----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986533210 0 00 112344 667889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=160.95 Aligned_cols=132 Identities=17% Similarity=0.253 Sum_probs=103.7
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCC-CCCHHHHHHHHHHHcCC-----CCCCceeeeeEEecCC---e-EEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERP-GSGEREFRAEVCTIGNI-----QHVNLVRLRGFCSENS---H-RLLVYD 529 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV~E 529 (804)
+.||+|+||.||. .+.....+||++... ....+.+.+|+.++..+ .||||++++|++..+. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5899999999996 433333479988643 33457799999999999 5799999999998764 3 337899
Q ss_pred E--cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCcEEecC----CCceEEeecCCc
Q 044374 530 Y--MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI-AYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGLA 600 (804)
Q Consensus 530 ~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DfGla 600 (804)
| +.+++|.+++.+. .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +..++|+||+-+
T Consensus 86 ~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5689999999763 35544 35677888777 9999988 999999999999974 348999995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-17 Score=191.90 Aligned_cols=196 Identities=21% Similarity=0.238 Sum_probs=154.9
Q ss_pred HHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEEE
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 527 (804)
+......+.+.||+|+||+||+|...+++.||+|+=+... .++|.--.+++.+|+ -+-|+.+.....-.+.-+||
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3334445677999999999999988889999999876543 344444444555555 12333344444455667899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-------CCceEEeecCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-------DYTAKVSDFGLA 600 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl~DfGla 600 (804)
+||.+.|+|.+++.. .+.+++...+.++.|+++.+.+||..+ |||+||||+|.||.. +..++|+|||.+
T Consensus 773 ~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999999999999984 458999999999999999999999988 999999999999943 346999999999
Q ss_pred cccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCC
Q 044374 601 KLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652 (804)
Q Consensus 601 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~ 652 (804)
..+.-- ........++|-.+-.+|...+++++..+|-|.|+.+++-||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 754211 1123556778999999999999999999999999999999999973
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.8e-18 Score=186.19 Aligned_cols=185 Identities=28% Similarity=0.333 Sum_probs=153.0
Q ss_pred ccccccceeEEEEE----eCCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGE----LSDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+|+|.||.|+... .+.+..+|+|++++... .......|..++..++ ||.+|++.-.+......+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998762 23467789998865321 1114456777788887 9999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+|.|...+.+.. ..++.........++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999988887654 4556666667788999999999988 99999999999999999999999999987543321
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
.+||..|||||++. .....+|-||||++++||+||..||..
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17999999999998 677899999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=158.97 Aligned_cols=133 Identities=17% Similarity=0.289 Sum_probs=113.4
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCC---------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.||+|++|.||+|.. .+..|+||+....... ...+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5667999987542211 13577899999999999998888777777888999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+++++|.+++.... . .+..++.+++.+|++||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 78899999999999999988 99999999999999 78999999999874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.9e-16 Score=177.76 Aligned_cols=130 Identities=19% Similarity=0.280 Sum_probs=108.4
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEE-ecCCCC--------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKR-LERPGS--------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.++||+|+||.||+|.+.+.. +++|+ +..... ..+.+.+|+.++.+++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999886554 34443 222111 12457899999999999999988888877778899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
|+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999998885 35678999999999999988 9999999999999 678999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-16 Score=159.39 Aligned_cols=141 Identities=15% Similarity=0.143 Sum_probs=108.4
Q ss_pred ccccccccccceeEEEEE--eCCCcEEEEEEecCCCCC-------------------------HHHHHHHHHHHcCCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGE--LSDSTLVAVKRLERPGSG-------------------------EREFRAEVCTIGNIQHV 509 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~Ei~~l~~l~H~ 509 (804)
.+.+.||+|+||.||+|. ..+++.||||+++..... ...++.|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 356789999999999998 568899999998743210 02256799999998753
Q ss_pred --CceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec
Q 044374 510 --NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD 587 (804)
Q Consensus 510 --niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~ 587 (804)
.+.+++++ ...++||||+++.+|...+.... .+.......++.|++.++++||+.++ |+||||||+||+++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~ 183 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH 183 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE
Confidence 33344443 23589999999998876553322 45566678999999999999997652 99999999999999
Q ss_pred CCCceEEeecCCccccCC
Q 044374 588 SDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 588 ~~~~~kl~DfGla~~~~~ 605 (804)
++.++|+|||++.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 88999999999986443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.6e-16 Score=155.02 Aligned_cols=129 Identities=17% Similarity=0.278 Sum_probs=106.7
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCC--CC-------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPG--SG-------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.||+|+||.||+|.+ ++..|++|+..... .. ...+.+|+.++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 56779999865321 11 245778999999999887666655666667779999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
++++|.+++..... .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988765321 78999999999999988 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.7e-16 Score=155.28 Aligned_cols=136 Identities=16% Similarity=0.132 Sum_probs=107.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC-----------------------HHHHHHHHHHHcCCCCCC--
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG-----------------------EREFRAEVCTIGNIQHVN-- 510 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------~~~~~~Ei~~l~~l~H~n-- 510 (804)
..+.+.||+|+||.||++...+++.||||++...... ...+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3456789999999999998888999999987643210 113567888888888774
Q ss_pred ceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC
Q 044374 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY 590 (804)
Q Consensus 511 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 590 (804)
+.+.++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+|+||||+||++++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 444443 2345899999999998765431 345678899999999999977 99999999999999999
Q ss_pred ceEEeecCCccccCC
Q 044374 591 TAKVSDFGLAKLIGR 605 (804)
Q Consensus 591 ~~kl~DfGla~~~~~ 605 (804)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-17 Score=173.40 Aligned_cols=121 Identities=29% Similarity=0.459 Sum_probs=106.1
Q ss_pred eEEEEEEEcCCCChhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 523 HRLLVYDYMRNGALSLYLRKD--GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
.+++.|++|...+|.++|..+ ....++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999644 3567888899999999999999 55 999999999999999999999999998
Q ss_pred cccCCCc-----cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh
Q 044374 601 KLIGRDF-----SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 601 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
....... ....+...||..||+||.+.+..|+.|+||||||+||+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7654332 233556789999999999999999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.4e-15 Score=155.30 Aligned_cols=197 Identities=21% Similarity=0.279 Sum_probs=137.3
Q ss_pred CCCCceeeeeEEecC---------------------------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHH
Q 044374 507 QHVNLVRLRGFCSEN---------------------------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGT 559 (804)
Q Consensus 507 ~H~niv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 559 (804)
+|||||+++++|.+. ..+|+||.-... +|++++..+ ..+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 699999998876432 245788876644 889998865 36667777899999
Q ss_pred HHHHHHHhhcCCCCeEecCCCCCcEEe--cCCC--ceEEeecCCccccCC-----CccccccccccccccccchhccCCC
Q 044374 560 ARGIAYLHEECRDCIIHCDIKPENILL--DSDY--TAKVSDFGLAKLIGR-----DFSRVLATMRGTWGYVAPEWISGLA 630 (804)
Q Consensus 560 a~gL~yLH~~~~~~iiH~Dlkp~NILl--~~~~--~~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~l~~~~ 630 (804)
++|+.|||.++ |.|||+|++|||| |.+. .+.|+|||++-.... ++....-...|.-.-||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999988 9999999999998 3444 478899998743221 1111112234667789999886543
Q ss_pred ------CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCH
Q 044374 631 ------ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKV 704 (804)
Q Consensus 631 ------~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 704 (804)
...|+|.|+.|.+.||+++...||...-. ..+. .+...+.++. ..+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---------------m~L~---~r~Yqe~qLP---------alp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---------------MLLD---TRTYQESQLP---------ALPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch---------------heec---hhhhhhhhCC---------CCcc
Confidence 23689999999999999999999975110 0000 0111222222 1223
Q ss_pred HHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 705 EEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 705 ~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
..+..+.+++...++.||.+||+..-....|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 34456778888899999999999876666653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.8e-15 Score=146.99 Aligned_cols=135 Identities=18% Similarity=0.183 Sum_probs=96.1
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHH-------------------------HHHHHHHcCCCCC--Cc
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREF-------------------------RAEVCTIGNIQHV--NL 511 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~-------------------------~~Ei~~l~~l~H~--ni 511 (804)
.+.||+|+||.||+|...+++.||||++.......... ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988888999999986532211111 2344445444333 23
Q ss_pred eeeeeEEecCCeEEEEEEEcCCCChhH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCC
Q 044374 512 VRLRGFCSENSHRLLVYDYMRNGALSL-YLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 512 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~ 589 (804)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ |+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 333332 24689999999954332 111111 11 5678899999999999998 76 99999999999999 9
Q ss_pred CceEEeecCCccccC
Q 044374 590 YTAKVSDFGLAKLIG 604 (804)
Q Consensus 590 ~~~kl~DfGla~~~~ 604 (804)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-14 Score=135.81 Aligned_cols=134 Identities=18% Similarity=0.160 Sum_probs=114.8
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC--CCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH--VNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.+.||+|.++.||++...+ ..++||....... ...+.+|+..+..++| .++.+++++....+..++++||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3679999999999998855 6799999876543 5678999999999976 5899999988888889999999998877
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
..+ +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 644 4566778899999999999986545699999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.9e-15 Score=171.80 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=185.3
Q ss_pred ccccccccccceeEEEEEeC--CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS--DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.||+|+|+.|-..... ....+|+|.+...... ......|..+-..+. |+|++++++.....+..+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 45567999999999888653 3456777777654322 233455777777776 99999999999999999999999
Q ss_pred cCCCChhHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCC--
Q 044374 531 MRNGALSLYL-RKDGLNLNWDVRFRIAVGTARGIAYLH-EECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGR-- 605 (804)
Q Consensus 531 ~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~-- 605 (804)
..++++.+.+ .......+....-.+..|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999988 443335667777889999999999999 776 99999999999999999 999999999987655
Q ss_pred Ccccccccccc-ccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFSRVLATMRG-TWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.+......
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------------- 239 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------------- 239 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------------
Confidence 33344455677 9999999998885 4567889999999999999999998865443211
Q ss_pred HhhcCccceecccc--ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDR--LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
........ ...............+...++..+|..|.+.+++..
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 ------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------ceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111110 001111122344566777788899999998877653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=141.49 Aligned_cols=134 Identities=19% Similarity=0.212 Sum_probs=104.6
Q ss_pred cccc-cccceeEEEEEeCCCcEEEEEEecCCC--------------CCHHHHHHHHHHHcCCCCCCc--eeeeeEEecCC
Q 044374 460 EKLG-HGGFGAVFQGELSDSTLVAVKRLERPG--------------SGEREFRAEVCTIGNIQHVNL--VRLRGFCSENS 522 (804)
Q Consensus 460 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~ 522 (804)
..|| .|+.|+||+.... +..++||++.... .....+.+|+.++.+++|+++ .+.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999875 5668999885311 123457889999999998775 67777654322
Q ss_pred ----eEEEEEEEcCC-CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeec
Q 044374 523 ----HRLLVYDYMRN-GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597 (804)
Q Consensus 523 ----~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 597 (804)
..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 6898888653 34433 3568999999999988 999999999999999999999999
Q ss_pred CCcccc
Q 044374 598 GLAKLI 603 (804)
Q Consensus 598 Gla~~~ 603 (804)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.5e-14 Score=162.44 Aligned_cols=162 Identities=25% Similarity=0.322 Sum_probs=115.7
Q ss_pred cccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 458 FSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
-.+.|..|++|.||..++.. .+.+|+|.-++.-. .++ ++.....|.+| |+-
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~li----lRn---ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI----LRN---ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccchh----hhc---cccccCCccee---------------------chh
Confidence 35789999999999997763 56678743222110 000 22222333333 444
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc---------
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF--------- 607 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~--------- 607 (804)
...++..+ .++. +++.+++|||+.+ |+|||+||+|.||+.=|.+|+.|||+++......
T Consensus 139 ~tllk~~g-~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 139 ATLLKNIG-PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhcccCC-CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 44444332 2222 2277899999888 9999999999999999999999999998642110
Q ss_pred ----cc-cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcC
Q 044374 608 ----SR-VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPAS 659 (804)
Q Consensus 608 ----~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~ 659 (804)
.. ....++||+.|+|||++....|...+|-|++|+|+||.+-|..||....+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 01 12235799999999999999999999999999999999999999986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.4e-12 Score=142.21 Aligned_cols=139 Identities=23% Similarity=0.259 Sum_probs=99.8
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCH-----------------------------------------HHHHH
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE-----------------------------------------REFRA 498 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----------------------------------------~~~~~ 498 (804)
+.||.|++|.||+|++.+|+.||||+.+...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 3699999999999999999999999985421100 02444
Q ss_pred HHHHHcCC----CCCCceeeeeEEe-cCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhhcCCC
Q 044374 499 EVCTIGNI----QHVNLVRLRGFCS-ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR-GIAYLHEECRD 572 (804)
Q Consensus 499 Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~~ 572 (804)
|...+.++ +|.+-+.+-.++. ..+..+|||||+++++|.++........ .+.+++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC--
Confidence 55544444 3333344433332 2456799999999999988765432122 24456666666 467888877
Q ss_pred CeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 573 ~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++|+|+||.||+++.++.++|+|||++..+.
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-12 Score=131.51 Aligned_cols=152 Identities=19% Similarity=0.286 Sum_probs=117.1
Q ss_pred HHHcCCCCCCceeeeeEEecC-----CeEEEEEEEcCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 044374 501 CTIGNIQHVNLVRLRGFCSEN-----SHRLLVYDYMRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRD 572 (804)
Q Consensus 501 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 572 (804)
..|-++.|.|||+++.|..+. ....++.|||+.|++..+|++. ...+......+++.||..||.|||+-. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566799999999887644 3568999999999999999854 346777788899999999999999865 7
Q ss_pred CeEecCCCCCcEEecCCCceEEeecCCcccc---CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh
Q 044374 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLI---GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 573 ~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
+|+|+++..+-|++..++-+||.--.-.... ............+-++|.|||+=.....+..+|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 7999999999999999998888532111110 0011112233456789999998877788889999999999999988
Q ss_pred CCCC
Q 044374 650 GRRN 653 (804)
Q Consensus 650 g~~p 653 (804)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-11 Score=120.34 Aligned_cols=130 Identities=17% Similarity=0.076 Sum_probs=97.9
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCce-eeeeEEecCCeEEEEEEEcCCCChhH
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGFCSENSHRLLVYDYMRNGALSL 538 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 538 (804)
+.|+.|.++.||+++.. +..+++|...........+..|+..+..+.+.+++ +++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 56899999999999875 66799999865433334567889888888665544 444443 234589999999988764
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 539 YLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC--RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 539 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 111245678999999999876 33469999999999999 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.4e-12 Score=137.74 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=184.1
Q ss_pred ChHHHHHhhccccccccc--ccceeEEEEEe---CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCC-CCCceeeeeE
Q 044374 447 SYKELHTVTRGFSEKLGH--GGFGAVFQGEL---SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQ-HVNLVRLRGF 517 (804)
Q Consensus 447 ~~~el~~~t~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~ 517 (804)
...+......++.+.+|. |.+|.||.+.. .+...+|+|+-+... .....-.+|+....+++ |+|.++....
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 445566666778889999 99999999976 357789999854332 22233345666666664 9999998888
Q ss_pred EecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCcEEecCC-Cce
Q 044374 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR----GIAYLHEECRDCIIHCDIKPENILLDSD-YTA 592 (804)
Q Consensus 518 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~ 592 (804)
....+..++-+|++. .+|..+.+.....++....+.+..+..+ ||.++|... ++|-|+||.||++..+ ...
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence 889999999999986 6787777766656777788888888888 999999988 9999999999999999 899
Q ss_pred EEeecCCccccCCCc-cc---cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC
Q 044374 593 KVSDFGLAKLIGRDF-SR---VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG 668 (804)
Q Consensus 593 kl~DfGla~~~~~~~-~~---~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 668 (804)
+++|||+...++... .. ......+...|++||.+.+ .++..+|+|++|.+..|..++.........
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------- 332 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------- 332 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC---------
Confidence 999999998775442 11 1223357788999998765 567899999999999999998766543211
Q ss_pred CCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 669 GEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..|. .++.+. +..++-.....++..++..+++.+|..|++...+..+
T Consensus 333 ---------~~W~--~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 ---------SSWS--QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---------CCcc--cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111 111111 1111111112334447888999999999988766543
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.2e-12 Score=101.28 Aligned_cols=62 Identities=27% Similarity=0.520 Sum_probs=52.9
Q ss_pred ccCCCcceeeeeeecccc--eeeccccChhhhHHhhcccCCccceeecc--cCccccccccccccc
Q 044374 307 CDQSDWFEEVGVVEFIGA--VTESFSAGRSICERSCLANCSCIGLYHDV--RTNLCKNLYGELLNL 368 (804)
Q Consensus 307 C~~~~~f~~~~~~~~~~~--~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~l~~~ 368 (804)
|+..+.|.+++.+++|.. .....+.++++|+..|++||||+||+|.. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 456789999999999954 33446689999999999999999999974 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-10 Score=129.15 Aligned_cols=138 Identities=19% Similarity=0.260 Sum_probs=90.4
Q ss_pred cccccccceeEEEEEeCC-CcEEEEEEecCCCC---------------------------C--------H------HHHH
Q 044374 460 EKLGHGGFGAVFQGELSD-STLVAVKRLERPGS---------------------------G--------E------REFR 497 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------------------------~--------~------~~~~ 497 (804)
+.||+|++|.||+|++.+ |+.||||+.+.... . . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 369999999999999987 99999999964310 0 0 1134
Q ss_pred HHHHHHcCC----CCCCceeeeeEEec-CCeEEEEEEEcCCCChhHHH--hhCCCCCCHHHHHHHHHHHHHH-HHHHhhc
Q 044374 498 AEVCTIGNI----QHVNLVRLRGFCSE-NSHRLLVYDYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARG-IAYLHEE 569 (804)
Q Consensus 498 ~Ei~~l~~l----~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~ 569 (804)
+|+..+.++ .+.+.+.+-.++.+ ....+|||||++++.+.++. ...+ .+... ++...++. +.-++..
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~---la~~~v~~~~~Qif~~ 279 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKL---LAERGVEVFFTQVFRD 279 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHH---HHHHHHHHHHHHHHhC
Confidence 455444444 24444554444433 45678999999999998753 3222 22111 22211111 1222334
Q ss_pred CCCCeEecCCCCCcEEecCCC----ceEEeecCCccccCC
Q 044374 570 CRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLIGR 605 (804)
Q Consensus 570 ~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~~~ 605 (804)
+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 280 G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 280 G---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred C---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 99999999999999988 999999999986643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.8e-10 Score=112.30 Aligned_cols=141 Identities=19% Similarity=0.242 Sum_probs=110.4
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCC--CCceeeeeEEecCC---eEEEEEEEcC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQH--VNLVRLRGFCSENS---HRLLVYDYMR 532 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 532 (804)
+.|+.|..+.||++...+++.+++|....... ....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887767899999865433 45678899999999876 34566777766542 5689999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC------------------------------------------ 570 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------ 570 (804)
+.++...+.. ..++...+..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988775532 24677778888888888888888531
Q ss_pred -----------CCCeEecCCCCCcEEecC--CCceEEeecCCccc
Q 044374 571 -----------RDCIIHCDIKPENILLDS--DYTAKVSDFGLAKL 602 (804)
Q Consensus 571 -----------~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~ 602 (804)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.5e-09 Score=119.34 Aligned_cols=166 Identities=16% Similarity=0.210 Sum_probs=122.5
Q ss_pred EeCCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHH
Q 044374 474 ELSDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR 552 (804)
Q Consensus 474 ~~~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~ 552 (804)
+..++.+|.|...+.... .....++-++.|+.++||||++++.........|||+|.+.- |..++...+ ....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~----~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG----KEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH----HHHH
Confidence 445778899998876544 234467788999999999999999999999999999998743 555555432 4455
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccCCCCC
Q 044374 553 FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632 (804)
Q Consensus 553 ~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 632 (804)
.-.+.||+.||.|||+.+. ++|++|.-..|+|++.|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 5677899999999997653 99999999999999999999999998864322111 001111122455666543322
Q ss_pred ccceEEeehhhHHHhhhC
Q 044374 633 TKADVYSYGMTLLELIGG 650 (804)
Q Consensus 633 ~ksDV~S~Gvvl~elltg 650 (804)
-..|.|.||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 345999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.8e-09 Score=103.59 Aligned_cols=134 Identities=15% Similarity=0.155 Sum_probs=96.4
Q ss_pred cccccccceeEEEEEeCC-------CcEEEEEEecCCCC-----------C------------HHHH----HHHHHHHcC
Q 044374 460 EKLGHGGFGAVFQGELSD-------STLVAVKRLERPGS-----------G------------EREF----RAEVCTIGN 505 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~-----------~------------~~~~----~~Ei~~l~~ 505 (804)
..||.|.=+.||.|.-.+ +..+|||+.+.... . .+.+ ++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47899998742110 0 1122 378888888
Q ss_pred CCC--CCceeeeeEEecCCeEEEEEEEcCCCChhH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCC
Q 044374 506 IQH--VNLVRLRGFCSENSHRLLVYDYMRNGALSL-YLRKDGLNLNWDVRFRIAVGTARGIAYL-HEECRDCIIHCDIKP 581 (804)
Q Consensus 506 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~Dlkp 581 (804)
+.. -++-+++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |..+ |+|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 753 345555554 45689999998764422 2322 1344556677889999999999 7777 99999999
Q ss_pred CcEEecCCCceEEeecCCcccc
Q 044374 582 ENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 582 ~NILl~~~~~~kl~DfGla~~~ 603 (804)
.|||++ ++.+.|+|||.+...
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 468999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.4e-10 Score=123.03 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=168.0
Q ss_pred ccccccccccceeEEEEEeC--CCcEEEEEEecCCCCCH-H--HHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS--DSTLVAVKRLERPGSGE-R--EFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~-~--~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
++..+||.|.|+.|++...+ ++..+++|.+.+.-... . .-..|+.+...+ .|.|+++....+....+.++--||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34568999999999998543 56789999886542221 1 123455555555 588889888888777888899999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCCccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~~ 609 (804)
++++++...+. -...+++..++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||+...+.-.
T Consensus 348 ~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--- 420 (524)
T KOG0601|consen 348 CEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--- 420 (524)
T ss_pred hcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccccee---
Confidence 99999887662 2236788889999999999999999877 9999999999999886 88999999998642111
Q ss_pred cccccccccccc--cchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 610 VLATMRGTWGYV--APEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 610 ~~~~~~gt~~y~--aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......-+++ +++......+..+.|++|||.-+.|.+++..--..... +..+..
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------------------~~~i~~ 477 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------------------SLTIRS 477 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------------------ceeeec
Confidence 11111223344 55566677889999999999999999998753321100 011111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
+.... .+ .....+..+...++.+++..||++.+...+.+
T Consensus 478 ~~~p~---------~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 478 GDTPN---------LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccccC---------CC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 11 11245666777788899999999988766554
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.7e-10 Score=94.11 Aligned_cols=80 Identities=28% Similarity=0.450 Sum_probs=61.1
Q ss_pred cccccCC---CcceeeeeeecccceeeccccChhhhHHhhcccCCccceeecccCcccccccccccccccccCCCCccce
Q 044374 304 KVLCDQS---DWFEEVGVVEFIGAVTESFSAGRSICERSCLANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDI 380 (804)
Q Consensus 304 ~l~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~l~~~~~~~~~~~~~~~ 380 (804)
+++|... +.|..+..+++|.........++++|++.|++||+|+||+|..++++|.+|.+.+.+.+.. ......
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~---~~~~~~ 78 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSL---SSGGGT 78 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEee---cCCCcE
Confidence 4567543 6888999999984322226779999999999999999999987788999999988886652 222467
Q ss_pred eEeecC
Q 044374 381 LYVRAP 386 (804)
Q Consensus 381 lyvr~~ 386 (804)
+|+|++
T Consensus 79 ~yiKv~ 84 (84)
T cd01098 79 LYLRLA 84 (84)
T ss_pred EEEEeC
Confidence 888864
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-09 Score=97.31 Aligned_cols=140 Identities=20% Similarity=0.255 Sum_probs=103.4
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEE-ecCCCC--------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKR-LERPGS--------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.|-+|+-+.|+++.++. +...||. +.+... ..+..++|++.+.+++--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3578899999999999854 4455553 332211 22456789999988865454444445666777789999
Q ss_pred EcCC-CChhHHHhhCCCCCCHHHH-HHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCCccc
Q 044374 530 YMRN-GALSLYLRKDGLNLNWDVR-FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGLAKL 602 (804)
Q Consensus 530 ~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~ 602 (804)
|+++ .++.+++......-..+.. ..++..|-+.+.-||... |+|+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 4788888765443333343 788899999999999988 99999999999997655 458999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-08 Score=96.49 Aligned_cols=129 Identities=19% Similarity=0.270 Sum_probs=98.0
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEe-cCCCCC--------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRL-ERPGSG--------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l-~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+++|+-..+|.+.+.+.. +++|.- ++.... ...-.+|.+++.+++--.|--..=+..+.....|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775434 556643 222111 123567899998886555444444556777788999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888764 2567777888889999988 99999999999997765 99999999985
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-09 Score=90.77 Aligned_cols=71 Identities=13% Similarity=0.104 Sum_probs=56.5
Q ss_pred ccCCCcceeeeeeecccceeeccccChhhhHHhhcc---cCCccceeecccCcccccccccc-cccccccCCCCccceeE
Q 044374 307 CDQSDWFEEVGVVEFIGAVTESFSAGRSICERSCLA---NCSCIGLYHDVRTNLCKNLYGEL-LNLRNLTSDSTNEDILY 382 (804)
Q Consensus 307 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~C~~~~~~l-~~~~~~~~~~~~~~~ly 382 (804)
|.....|.++..+++|.... .++++|++.|++ ||||+||+|...+++|.+|++++ .+++.. ...+.++|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~---~~~g~~Ly 77 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKE---FSHGFDLY 77 (80)
T ss_pred eecCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhc---cCCCceeE
Confidence 34556788888888874332 689999999999 99999999975567899999999 888764 23467888
Q ss_pred ee
Q 044374 383 VR 384 (804)
Q Consensus 383 vr 384 (804)
+|
T Consensus 78 ~r 79 (80)
T cd00129 78 EN 79 (80)
T ss_pred eE
Confidence 87
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.8e-09 Score=123.61 Aligned_cols=196 Identities=22% Similarity=0.257 Sum_probs=135.8
Q ss_pred ccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 461 KLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
-+-+|.++.++-++-. .+...++|+..... ...+....+-.++-..+||-+++..--+.......||++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4667778877766322 22223333332211 111122222222222345666655544455677899999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC-----------
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG----------- 604 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~----------- 604 (804)
|...|+..+ ..+.......+..+.+++.|||... +.|+|++|.|+|...++..+++|||.....+
T Consensus 891 ~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 891 LPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred chhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 999998765 3444444556667888999999876 8999999999999999999999998432210
Q ss_pred ----------CC---------ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCC
Q 044374 605 ----------RD---------FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASG 660 (804)
Q Consensus 605 ----------~~---------~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~ 660 (804)
.. ..+......+|+.|.+||.+.+......+|.|++|++++|.++|..||....+.
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 00 001123456899999999999999999999999999999999999999876554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=93.94 Aligned_cols=125 Identities=21% Similarity=0.239 Sum_probs=82.7
Q ss_pred eEEEEEeCCCcEEEEEEecCCCCC---------------------------HHHHHHHHHHHcCCCCC--CceeeeeEEe
Q 044374 469 AVFQGELSDSTLVAVKRLERPGSG---------------------------EREFRAEVCTIGNIQHV--NLVRLRGFCS 519 (804)
Q Consensus 469 ~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 519 (804)
.||.|...++..+|||..+..... ....++|.+.|.++..- ++-+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999889999999987531100 12357899999999765 455555442
Q ss_pred cCCeEEEEEEEcC--CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCcEEecCCCceEEee
Q 044374 520 ENSHRLLVYDYMR--NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY-LHEECRDCIIHCDIKPENILLDSDYTAKVSD 596 (804)
Q Consensus 520 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 596 (804)
...|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 3479999999 55554433321 2244556677788885555 57777 9999999999999988 999999
Q ss_pred cCCccccC
Q 044374 597 FGLAKLIG 604 (804)
Q Consensus 597 fGla~~~~ 604 (804)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2e-07 Score=97.31 Aligned_cols=131 Identities=16% Similarity=0.084 Sum_probs=95.7
Q ss_pred eeEEEEEeCCCcEEEEEEecCCCC------------CHHHHHHHHHHHcCCCCC--CceeeeeEEec-----CCeEEEEE
Q 044374 468 GAVFQGELSDSTLVAVKRLERPGS------------GEREFRAEVCTIGNIQHV--NLVRLRGFCSE-----NSHRLLVY 528 (804)
Q Consensus 468 g~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~-----~~~~~lV~ 528 (804)
..|.+..+ +|+.+.||+...... ....+.+|...+.++... ...+++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667766 566799997743321 112477888888777432 23344555533 23568999
Q ss_pred EEcCCC-ChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-------CCceEEeecCC
Q 044374 529 DYMRNG-ALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-------DYTAKVSDFGL 599 (804)
Q Consensus 529 E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl~DfGl 599 (804)
|++++. +|.+++... ....+...+..++.+++..++-||..+ |+|+|++++|||++. +..+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999986 899888532 234556777899999999999999998 999999999999975 56899999998
Q ss_pred ccc
Q 044374 600 AKL 602 (804)
Q Consensus 600 a~~ 602 (804)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=101.75 Aligned_cols=165 Identities=19% Similarity=0.258 Sum_probs=124.8
Q ss_pred eeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEe----cCCeEEEEEEEcCC-CChhHHH
Q 044374 468 GAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCS----ENSHRLLVYDYMRN-GALSLYL 540 (804)
Q Consensus 468 g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l 540 (804)
.+.||+.. .+|..|++|+++.. .+.......-+++++++.|+|+|++..++. ....+++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788844 48999999999543 222223344577899999999999988876 34578999999886 4676654
Q ss_pred hh--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 541 RK--------------DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 541 ~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
.. .+...++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 32 1234678899999999999999999998 888999999999999999999998888765544
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCC
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRN 653 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p 653 (804)
.. |-+.+ -.+-|.=.||.+++.|.||...
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 21 11111 2356777899999999999654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1e-07 Score=107.16 Aligned_cols=153 Identities=19% Similarity=0.331 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-------c-ccccccccccccccch
Q 044374 553 FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-------S-RVLATMRGTWGYVAPE 624 (804)
Q Consensus 553 ~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-------~-~~~~~~~gt~~y~aPE 624 (804)
+.-+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+....... . ....-..-...|.|||
T Consensus 102 f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 344456669999999854 49999999999999999999999999876543210 0 1111123466899999
Q ss_pred hccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCC
Q 044374 625 WISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYK 703 (804)
Q Consensus 625 ~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 703 (804)
++.+...+.++|+||+|++++-+.. |+.-+....... .+.. +....+.-. ..++
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----------------~~~~----~~~~~~~~~----~~~s 234 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----------------SYSF----SRNLLNAGA----FGYS 234 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCcc-----------------hhhh----hhccccccc----cccc
Confidence 9999888999999999999999994 544443221110 0000 000000000 1112
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 704 VEEAERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 704 ~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
.+.+.++.+=+.+.+..++.-||++.++.
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 33445566666778889999999777665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.3e-07 Score=101.31 Aligned_cols=143 Identities=20% Similarity=0.236 Sum_probs=94.5
Q ss_pred ccc-cccccccceeEEEEEeCCCcEEEEEEecCCCCCH-------------------------------H----------
Q 044374 457 GFS-EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE-------------------------------R---------- 494 (804)
Q Consensus 457 ~~~-~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~---------- 494 (804)
.|. +-|+.++-|.||+|++++|+.||||+.+...... +
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 354 4699999999999999999999999985432110 0
Q ss_pred HHHHHHHHHcCC----CCCCceeeeeEEe-cCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHhh
Q 044374 495 EFRAEVCTIGNI----QHVNLVRLRGFCS-ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARG-IAYLHE 568 (804)
Q Consensus 495 ~~~~Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~g-L~yLH~ 568 (804)
++.+|...+.++ ++..-+++=.++. -.+...|+|||++|..+.+....+....+.+. ++..++++ +..+-.
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh
Confidence 133444444433 2333333333443 35678999999999999888543333455333 33333332 122222
Q ss_pred cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 569 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
.+ ++|.|..|.||+++.++++.+.|||+...+..
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33 99999999999999999999999999876543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.6e-06 Score=87.84 Aligned_cols=134 Identities=18% Similarity=0.138 Sum_probs=92.1
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCC-----------------C------CHHHHHHHHHHHcCCCCC--C
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG-----------------S------GEREFRAEVCTIGNIQHV--N 510 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~------~~~~~~~Ei~~l~~l~H~--n 510 (804)
..+.++||-|.-+.||.|..+++.++|||.=+.-. . .....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999999999999999532100 0 012367888888888654 5
Q ss_pred ceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC
Q 044374 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY 590 (804)
Q Consensus 511 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~ 590 (804)
+-+.+++ +...+||||.++-.|...- ++....-.++..|++-+.-+-..+ |||+|+++=||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 5555543 5568999999997665332 112222233333333333333444 99999999999999999
Q ss_pred ceEEeecCCccc
Q 044374 591 TAKVSDFGLAKL 602 (804)
Q Consensus 591 ~~kl~DfGla~~ 602 (804)
.+.++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.3e-06 Score=90.61 Aligned_cols=257 Identities=17% Similarity=0.199 Sum_probs=154.0
Q ss_pred cccccccccceeEEEE-EeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEE-------ecCCeEEEEE
Q 044374 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFC-------SENSHRLLVY 528 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~ 528 (804)
.+..||+|+-+.+|.- ... . .+-|+.+...-..+.- .+..|.+. .||-+-.-+.+= ..+...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhh--c-hhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3568999999999964 222 1 2347776544332221 22333333 465433311110 1112245667
Q ss_pred EEcCCC-ChhHHHhh----C-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 529 DYMRNG-ALSLYLRK----D-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 529 E~~~~g-sL~~~l~~----~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
..+.+. -...+... + -...+|+..++.+..+|.+.+.||+.+ .+-+|+.++|+|+.+++.+.|.|-....+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 666554 22222221 1 134689999999999999999999998 88999999999999999999998654433
Q ss_pred cCCCccccccccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhC-CCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGG-RRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
. .........+|...|.+||.-. +..-+...|-|.+|++++++|-| +.||..-...... ....
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a--------p~p~- 235 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA--------PNPL- 235 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC--------CCcc-
Confidence 2 1223344567899999999643 34556789999999999999876 9999764322110 0000
Q ss_pred chHHHHHHhhcCccceeccccc-----cCCCCHH-HHHHHHHHHhhcccc--CCCCCCCHHHHHHHHhcc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRL-----GGAYKVE-EAERVALVAIWCIQD--NEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l-----~~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPs~~eVl~~L~~~ 738 (804)
...+..|.....-|.+. ....+.+ ....+..+-.+|... ++.-||+.+..+..|..+
T Consensus 236 -----E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 236 -----ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred -----hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00111121111111111 0112222 234455566677754 467899999999887654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.7e-06 Score=81.10 Aligned_cols=136 Identities=18% Similarity=0.157 Sum_probs=103.6
Q ss_pred cccccceeEEEEEeCCCcEEEEEEecCC-------CCCHHHHHHHHHHHcCCCC--CCceeeeeEEecC-----CeEEEE
Q 044374 462 LGHGGFGAVFQGELSDSTLVAVKRLERP-------GSGEREFRAEVCTIGNIQH--VNLVRLRGFCSEN-----SHRLLV 527 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~-----~~~~lV 527 (804)
-|+||-+.|++-.+.+. .+-+|+-.+. ..+...|.+|+..|.++.. -.+.+++ ++... -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56799999999887554 5888877521 3366789999999988853 2344444 33211 245899
Q ss_pred EEEcCC-CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc--eEEeecCCccc
Q 044374 528 YDYMRN-GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT--AKVSDFGLAKL 602 (804)
Q Consensus 528 ~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 602 (804)
+|-+++ .+|.+++.... ...+...+..++.++++.++-||+.+ +.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 48888886543 35677888899999999999999988 999999999999986667 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.2e-06 Score=84.50 Aligned_cols=107 Identities=21% Similarity=0.239 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHcCCCC--CCceeeeeEEecC----CeEEEEEEEcCCC-ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 044374 493 EREFRAEVCTIGNIQH--VNLVRLRGFCSEN----SHRLLVYDYMRNG-ALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565 (804)
Q Consensus 493 ~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 565 (804)
.....+|...+.++.. -...+.+++.... ..-+||+|++++. +|.+++..... ++......++.++++.++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457778877776642 3345556665542 2448999999984 89999876432 6667788999999999999
Q ss_pred HhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCCcccc
Q 044374 566 LHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGLAKLI 603 (804)
Q Consensus 566 LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 603 (804)
||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.9e-06 Score=76.90 Aligned_cols=85 Identities=24% Similarity=0.425 Sum_probs=61.5
Q ss_pred EEEeccccEEEecCC-CcEEEEeccC---CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 63 LLITEKGKLAIKDSQ-NSIIWQSTNT---EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 63 l~~~~~g~l~l~~~~-~~~~w~~~~~---~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
+.++.||+||+++.. +.++|+++.. .....+.|+++|||||++.++.++|+|=..
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~--------------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTT--------------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEeccc---------------------
Confidence 556689999999865 5899999832 223678999999999999888999987110
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTG 174 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg 174 (804)
...|.|.+.++++|.. ++.-....+.|.|-
T Consensus 83 ----~~~~~~~~~L~ddGnl--vl~~~~~~~~W~Sf 112 (114)
T smart00108 83 ----GANGNYVLVLLDDGNL--VIYDSDGNFLWQSF 112 (114)
T ss_pred ----CCCCceEEEEeCCCCE--EEECCCCCEEeCCC
Confidence 1356789999999753 32223345778653
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.6e-06 Score=73.18 Aligned_cols=101 Identities=21% Similarity=0.373 Sum_probs=72.8
Q ss_pred CCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEec-CCCCCCCCCCCcEEEEeccccEEEecCCCcEEEEecc
Q 044374 8 NSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVA-NREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTN 86 (804)
Q Consensus 8 ~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~a-nr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~ 86 (804)
++.+.+.+|.+.|-|...|+ |-|.-. ..+++|.. +....-. ....+.|..+|||||+|..+.++|+|..
T Consensus 11 ~~p~~~~s~~~~L~l~~dGn-----Lvl~~~---~~~~iWss~~t~~~~~--~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 11 NSPLTSSSGNYTLILQSDGN-----LVLYDS---NGSVIWSSNNTSGRGN--SGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp TEEEEECETTEEEEEETTSE-----EEEEET---TTEEEEE--S-TTSS---SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred ccccccccccccceECCCCe-----EEEEcC---CCCEEEEecccCCccc--cCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 34666656999999999986 777644 35779999 4333321 2468999999999999999999999975
Q ss_pred CCceeEEEEcc--CCcEEEecCCCCeeecccCCCc
Q 044374 87 TEKATDMYLLE--TGNLVLLSSAGSLVWQSFDHPT 119 (804)
Q Consensus 87 ~~~~~~~~l~~--~gnlv~~~~~~~~~WqSFd~PT 119 (804)
....+.+..++ .||++ ......+.|.|=+.|.
T Consensus 81 ~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 55667778887 89999 6666788999877763
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.4e-06 Score=75.32 Aligned_cols=85 Identities=22% Similarity=0.467 Sum_probs=62.2
Q ss_pred EEEec-cccEEEecCC-CcEEEEeccC---CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 63 LLITE-KGKLAIKDSQ-NSIIWQSTNT---EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 63 l~~~~-~g~l~l~~~~-~~~~w~~~~~---~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
+.++. ||+|++++.. +.++|+++.. .....+.|+++|||||.+.++.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~-------------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc--------------------
Confidence 44565 8999999765 5899999842 345678999999999999989999986311
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEe-CcEEEEecCC
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYN-GTIVYWSTGN 175 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~-~~~~yw~sg~ 175 (804)
.+.+.+.+.|+++|.. + +++ ...+.|.|..
T Consensus 84 -----~~~~~~~~~L~ddGnl--v-l~~~~~~~~W~Sf~ 114 (116)
T cd00028 84 -----RVNGNYVLVLLDDGNL--V-LYDSDGNFLWQSFD 114 (116)
T ss_pred -----CCCCceEEEEeCCCCE--E-EECCCCCEEEcCCC
Confidence 1257789999999753 2 333 3567787654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=79.22 Aligned_cols=138 Identities=12% Similarity=0.144 Sum_probs=85.2
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC--ceeeeeEEecCCeEEEEEEEcCCCC-h
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN--LVRLRGFCSENSHRLLVYDYMRNGA-L 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-L 536 (804)
+.||+|..+.||+. .+..+++|..... .......+|.+++..+..-. +.+.+++....+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 47899999999984 2445778877643 34456788999988876433 4567777777778889999999963 2
Q ss_pred hHHH---------------------hhCC-CCCCHHHHH-HHHH----------HHHH-HHHHHhh-cCCCCeEecCCCC
Q 044374 537 SLYL---------------------RKDG-LNLNWDVRF-RIAV----------GTAR-GIAYLHE-ECRDCIIHCDIKP 581 (804)
Q Consensus 537 ~~~l---------------------~~~~-~~l~~~~~~-~i~~----------~ia~-gL~yLH~-~~~~~iiH~Dlkp 581 (804)
...+ +.-. ......... ++.. .+.+ ...+|.. .....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 1100 001111100 0000 0111 1222221 1234578999999
Q ss_pred CcEEecCCCceEEeecCCccc
Q 044374 582 ENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 582 ~NILl~~~~~~kl~DfGla~~ 602 (804)
.||++++++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-06 Score=97.91 Aligned_cols=183 Identities=18% Similarity=0.147 Sum_probs=134.3
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC-ceeeeeEEecCCeEEEEEEEcCCC-Chh
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-LVRLRGFCSENSHRLLVYDYMRNG-ALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL~ 537 (804)
..+++|+++.++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 457889999999886544444445555433 45566889999999999 777888888888889999999887 222
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT 617 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 617 (804)
.-.......+...+...+...-+++++|||+.. =+|+| ||+..+ ...|..||+....+.+.. ......++
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~ 393 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGT 393 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccCCCC
Confidence 211111122333444556667788999999854 48888 777655 789999999987765443 24456789
Q ss_pred cccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCC
Q 044374 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656 (804)
Q Consensus 618 ~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~ 656 (804)
+.++|||+.....+..+.|+|+.++--.++--|-.|-..
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 999999999999999999999999977777777766554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.5e-05 Score=88.16 Aligned_cols=145 Identities=20% Similarity=0.214 Sum_probs=93.3
Q ss_pred ccc-cccccccceeEEEEEeCCCcEEEEEEecCCCCCH----------------------------H----------HHH
Q 044374 457 GFS-EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE----------------------------R----------EFR 497 (804)
Q Consensus 457 ~~~-~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------~----------~~~ 497 (804)
.|. +.||.-+.+.||+|++++|+.||||+-+..-... + +|.
T Consensus 163 ~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred hcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 455 4799999999999999999999999876432110 0 133
Q ss_pred HHHHHHc----CCCCCCc---eeeeeEEe-cCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044374 498 AEVCTIG----NIQHVNL---VRLRGFCS-ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569 (804)
Q Consensus 498 ~Ei~~l~----~l~H~ni---v~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 569 (804)
+|.+-.. .+.|-++ |++=.++. -...+.|+||||+|..+.+...-....++...+..-+.++..-+-+-
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~--- 319 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK--- 319 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh---
Confidence 4443332 2335552 22223332 23578999999999988765443333455554444333332222222
Q ss_pred CCCCeEecCCCCCcEEecC----CCceEEeecCCccccCCC
Q 044374 570 CRDCIIHCDIKPENILLDS----DYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 570 ~~~~iiH~Dlkp~NILl~~----~~~~kl~DfGla~~~~~~ 606 (804)
.+++|+|-.|.||+++. ++.+.+-|||+...+...
T Consensus 320 --~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 --TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 23999999999999983 678999999999866443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.3e-05 Score=76.89 Aligned_cols=138 Identities=14% Similarity=0.109 Sum_probs=83.9
Q ss_pred cccccc-eeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCCChhHH
Q 044374 462 LGHGGF-GAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNGALSLY 539 (804)
Q Consensus 462 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 539 (804)
|-.|.. ..||+....+ ..+.||+..... ..++.+|+.++..+. +--+.+++++....+..++|||++++.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444444 7899997654 678888876443 345677888887774 33455677777666678999999999877643
Q ss_pred H-------------------hhCC---CCCC--HHHHHHHHH--------------------HHHHHHHHHhh----cCC
Q 044374 540 L-------------------RKDG---LNLN--WDVRFRIAV--------------------GTARGIAYLHE----ECR 571 (804)
Q Consensus 540 l-------------------~~~~---~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~ 571 (804)
. +.-. .... ....+.... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 0000 0000 000000000 01111222211 123
Q ss_pred CCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 572 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4589999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.4e-05 Score=76.37 Aligned_cols=103 Identities=22% Similarity=0.310 Sum_probs=83.2
Q ss_pred HHHHHHHcCCCC-CCceeeeeEEecCCeEEEEEEEcCCCChhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044374 497 RAEVCTIGNIQH-VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLR--KDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573 (804)
Q Consensus 497 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 573 (804)
..|..++..+++ +++.+++|+|-. ++|.||...+++...-. .+-...+|..|.+||.++++.+.+|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 699999999954 78999999876642200 00124689999999999999999999865555
Q ss_pred eEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 574 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.3e-05 Score=77.73 Aligned_cols=141 Identities=21% Similarity=0.195 Sum_probs=84.1
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC--CceeeeeEEec---CCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV--NLVRLRGFCSE---NSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~E~~~~g 534 (804)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.+... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999999877 57999997654 4456778888888777533 34566664432 33578999999999
Q ss_pred ChhH----------------HH---hhC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHhh--
Q 044374 535 ALSL----------------YL---RKD---GLNLNWDV---------RFRI------------AVGTAR-GIAYLHE-- 568 (804)
Q Consensus 535 sL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-- 568 (804)
.+.. .+ +.. ........ .... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 11 111 00111000 0000 111222 2333332
Q ss_pred --cCCCCeEecCCCCCcEEec-CCCceEEeecCCccc
Q 044374 569 --ECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKL 602 (804)
Q Consensus 569 --~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~ 602 (804)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 666678999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0001 Score=74.21 Aligned_cols=134 Identities=20% Similarity=0.215 Sum_probs=86.8
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCCCCHH----------H---------------HHHHHHHHcCCC--CCCcee
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGER----------E---------------FRAEVCTIGNIQ--HVNLVR 513 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------~---------------~~~Ei~~l~~l~--H~niv~ 513 (804)
.|++|.-..||+|.-.++..+|||+++......+ . .++|..-|.++. +-.+-+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5778888999999888899999999965322111 1 133444444442 222222
Q ss_pred eeeEEecCCeEEEEEEEcCCCC-hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCc
Q 044374 514 LRGFCSENSHRLLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 514 l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
.+++. .-.|||||+.... -.-.|..- .+.......+..++++.+.-|-. .+ +||+||+.=|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCe
Confidence 22222 3479999987642 11122221 22333566666777777776665 44 99999999999999 889
Q ss_pred eEEeecCCccccC
Q 044374 592 AKVSDFGLAKLIG 604 (804)
Q Consensus 592 ~kl~DfGla~~~~ 604 (804)
+.|+||+.+....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00022 Score=71.18 Aligned_cols=130 Identities=17% Similarity=0.173 Sum_probs=81.4
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCC-HHHH---------HHHHHHHcCCCC---CCceeeeeEEe-----c
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG-EREF---------RAEVCTIGNIQH---VNLVRLRGFCS-----E 520 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~---------~~Ei~~l~~l~H---~niv~l~g~~~-----~ 520 (804)
.+.+-......|.+-.. ++..+++|........ ++.| .+++..+.+++. -....++.+.. -
T Consensus 36 ~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 36 IKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred EEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 34555555666666666 4566888887643222 2222 233333333322 22222222221 2
Q ss_pred CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 521 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
....+|+|||++|..|.++.. ++. .++..+++++.-||+.| ++|+|..|.|++++.+ .++++||+..
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccc
Confidence 235579999999988876542 221 34566778899999988 9999999999999855 4999999887
Q ss_pred cc
Q 044374 601 KL 602 (804)
Q Consensus 601 ~~ 602 (804)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 64
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0004 Score=69.07 Aligned_cols=126 Identities=22% Similarity=0.302 Sum_probs=89.0
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCC-----------------CCHHHHHHHHHHHcCCC------CCCceeeee
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPG-----------------SGEREFRAEVCTIGNIQ------HVNLVRLRG 516 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~~~~~~~~Ei~~l~~l~------H~niv~l~g 516 (804)
..||+|+.-.||. +++.....||+..... ...+++.+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4799999999996 4455557888886543 23456677776555554 889999999
Q ss_pred EEecCCeEEEEEEEcCCC------ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-
Q 044374 517 FCSENSHRLLVYDYMRNG------ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD- 589 (804)
Q Consensus 517 ~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~- 589 (804)
+...+...-+|+|...+. +|.++++.. .++. ...+.+.+.. .||-+.. |+.+|++|+||++...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f~---~~l~~~~---Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEFK---RYLLDHH---IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHHH---HHHHHcC---CeecCCCcccEEEEecC
Confidence 999999999999987532 677888654 3444 4444444444 4555555 9999999999999543
Q ss_pred --C-ceEEee
Q 044374 590 --Y-TAKVSD 596 (804)
Q Consensus 590 --~-~~kl~D 596 (804)
. .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00032 Score=85.74 Aligned_cols=77 Identities=12% Similarity=0.333 Sum_probs=56.9
Q ss_pred cccccccceeEEEEEeCCC---cEEEEEEecCCC--CCHHHHHHHHHHHcCCC-CCCc--eeeeeEEecC---CeEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDS---TLVAVKRLERPG--SGEREFRAEVCTIGNIQ-HVNL--VRLRGFCSEN---SHRLLVY 528 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV~ 528 (804)
+.|+.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5789999999999877654 357777764322 23457889999999985 6654 7788888764 4678999
Q ss_pred EEcCCCCh
Q 044374 529 DYMRNGAL 536 (804)
Q Consensus 529 E~~~~gsL 536 (804)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00066 Score=72.59 Aligned_cols=75 Identities=12% Similarity=0.115 Sum_probs=55.6
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC---CCceeeeeEEecC---CeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH---VNLVRLRGFCSEN---SHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E~~~~ 533 (804)
+.||.|..+.||+....+++ +.+|..+. ......+..|...++.+.- ..+.+++++|... +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 47999999999998776664 66676433 2244678899988887753 3577788877543 568999999998
Q ss_pred CCh
Q 044374 534 GAL 536 (804)
Q Consensus 534 gsL 536 (804)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00053 Score=70.69 Aligned_cols=139 Identities=14% Similarity=0.128 Sum_probs=80.1
Q ss_pred cccccccceeEEEEEeCC--CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 460 EKLGHGGFGAVFQGELSD--STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
+.|..|-...+|+....+ +..+++|+........-...+|+.++..+....+ .++++... ..+||||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999987764 5678899775432222233568878777753333 34444332 2489999998776
Q ss_pred hHH--------------H---hhCCCC----------CC-HHHHHHHHH----------------------HHHHHHHHH
Q 044374 537 SLY--------------L---RKDGLN----------LN-WDVRFRIAV----------------------GTARGIAYL 566 (804)
Q Consensus 537 ~~~--------------l---~~~~~~----------l~-~~~~~~i~~----------------------~ia~gL~yL 566 (804)
... + +..... .. ++.+..+.. .+.+.+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 1 111101 11 111111111 111111122
Q ss_pred ----hhc-CCCCeEecCCCCCcEEecC-CCceEEeecCCccc
Q 044374 567 ----HEE-CRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKL 602 (804)
Q Consensus 567 ----H~~-~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~ 602 (804)
... ....++|+|+.+.|||++. +..+.|+||..+..
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111 2345999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00042 Score=71.52 Aligned_cols=73 Identities=15% Similarity=0.153 Sum_probs=44.5
Q ss_pred cccccccce-eEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC---CceeeeeEEecC---CeEEEEEEEcC
Q 044374 460 EKLGHGGFG-AVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV---NLVRLRGFCSEN---SHRLLVYDYMR 532 (804)
Q Consensus 460 ~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~~ 532 (804)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+.+..+... .+-++++..... ...+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456777776 58875 23466776554 33455788899888776521 233334333322 23488999999
Q ss_pred CCChh
Q 044374 533 NGALS 537 (804)
Q Consensus 533 ~gsL~ 537 (804)
+.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00016 Score=60.28 Aligned_cols=59 Identities=25% Similarity=0.336 Sum_probs=44.2
Q ss_pred Ccceeeeeeecccc-eeeccccChhhhHHhhcc-cCCccceeecccCccccccc-ccccccc
Q 044374 311 DWFEEVGVVEFIGA-VTESFSAGRSICERSCLA-NCSCIGLYHDVRTNLCKNLY-GELLNLR 369 (804)
Q Consensus 311 ~~f~~~~~~~~~~~-~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~C~~~~-~~l~~~~ 369 (804)
..|..++.+.+++. .......++++|++.|++ +|+|.|+.|...++.|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 34677777777622 222346799999999999 99999999976678899998 6655554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0016 Score=64.38 Aligned_cols=132 Identities=29% Similarity=0.449 Sum_probs=92.5
Q ss_pred ccccChHHHHHhhcccccccccccc-eeEEEEEeCCCcEEEEEEecC-----CC-----CC------------HHHHHHH
Q 044374 443 LKVFSYKELHTVTRGFSEKLGHGGF-GAVFQGELSDSTLVAVKRLER-----PG-----SG------------EREFRAE 499 (804)
Q Consensus 443 ~~~~~~~el~~~t~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~-----~~-----~~------------~~~~~~E 499 (804)
+..|+. +.....|.+.||.|.- |.||+.++ +++.+|+|.++. .. .. ...|..|
T Consensus 29 L~~F~~---h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E 104 (207)
T PF13095_consen 29 LEPFTH---HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE 104 (207)
T ss_pred cCCcCC---CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence 344554 3366778899999999 99999999 556899999421 00 00 1247889
Q ss_pred HHHHcCCC---CCCc--eeeeeEEecC------------------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHH
Q 044374 500 VCTIGNIQ---HVNL--VRLRGFCSEN------------------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA 556 (804)
Q Consensus 500 i~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~ 556 (804)
.+...+|+ +.++ |+.+|+..-. ....||.||.+... ....+-+
T Consensus 105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~~ 170 (207)
T PF13095_consen 105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRDI 170 (207)
T ss_pred HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhHH
Confidence 99888775 4466 8999987322 12357888776533 1123345
Q ss_pred HHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCc
Q 044374 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLA 600 (804)
Q Consensus 557 ~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 600 (804)
.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 171 ~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 56777788899888 999999999985 5689999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0017 Score=62.02 Aligned_cols=127 Identities=18% Similarity=0.209 Sum_probs=85.5
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCcee-eeeEEecCCeEEEEEEEcCCCChh
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVR-LRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+.|++|.+|.||.+.+.++ .+|+|+-.. +.....++.|++++..+.-.++-+ ++.+-. -.+.|||..+-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchh
Confidence 46799999999999999655 688886653 445678889999998887665554 333322 24559999997776
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCcEEecCCCceEEeecCCccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIK-PENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DfGla~~ 602 (804)
..-... +.+. +..+++.---|...+ |-|+.|. |...+|-.+..+.|+||.-|.+
T Consensus 101 ~~~~~~----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 544321 2222 233444434444445 8898886 5555555555999999999874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=68.51 Aligned_cols=136 Identities=13% Similarity=0.090 Sum_probs=77.3
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCCCCH-HHHHHHHHHHcCCCCCCce-eeeeEEecCCeEEEEEEEcCCCChhH
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE-REFRAEVCTIGNIQHVNLV-RLRGFCSENSHRLLVYDYMRNGALSL 538 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL~~ 538 (804)
.+..|-...+|+... ++..+++|......... -...+|..+++.+....+. +++.... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677889998874 45678888765432221 2357788888877543332 3333322 368999999876542
Q ss_pred H-----------------HhhCC---CCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCCeEecCCCCCc
Q 044374 539 Y-----------------LRKDG---LNLNWDVR-FRIAVG---------TARGIAYLHEE-----CRDCIIHCDIKPEN 583 (804)
Q Consensus 539 ~-----------------l~~~~---~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiH~Dlkp~N 583 (804)
. |+... ..++...+ .....+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11121111 111111 11112222211 12358999999999
Q ss_pred EEecCCCceEEeecCCccc
Q 044374 584 ILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 584 ILl~~~~~~kl~DfGla~~ 602 (804)
|+++.++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0023 Score=68.81 Aligned_cols=138 Identities=20% Similarity=0.229 Sum_probs=81.1
Q ss_pred ccccccceeEEEEEeCC-------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCce-eeeeEEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGELSD-------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 532 (804)
.|..|--..+|+....+ ++.+++|+.........+..+|..++..+....+. ++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899987765 47789999765433334556777777766433333 44555432 35899998
Q ss_pred CCChhHH-----------------HhhCCCC--------CC--HHHHHH--------------------------HHHHH
Q 044374 533 NGALSLY-----------------LRKDGLN--------LN--WDVRFR--------------------------IAVGT 559 (804)
Q Consensus 533 ~gsL~~~-----------------l~~~~~~--------l~--~~~~~~--------------------------i~~~i 559 (804)
+..+... ++..... .+ +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766421 1111000 00 101000 11122
Q ss_pred HHHHHHHhh------cCCCCeEecCCCCCcEEecCC----CceEEeecCCccc
Q 044374 560 ARGIAYLHE------ECRDCIIHCDIKPENILLDSD----YTAKVSDFGLAKL 602 (804)
Q Consensus 560 a~gL~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~ 602 (804)
..-+..|.. ..+..++|+|+.+.|||++.+ +.++|+||..+..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 222334432 134569999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.002 Score=69.00 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=84.7
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC--CceeeeeE------EecCCeEEEEEEEc
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV--NLVRLRGF------CSENSHRLLVYDYM 531 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E~~ 531 (804)
+.|..|....+|+....++ .+++|+... ........|+.++..+++. .+.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4577787889999876554 588898764 3345566777777776432 23444331 12344568999999
Q ss_pred CCCChhH----H----------HhhC--C--------CCCCHHHHH----------HHHHHHHHHHHHHhhc----CCCC
Q 044374 532 RNGALSL----Y----------LRKD--G--------LNLNWDVRF----------RIAVGTARGIAYLHEE----CRDC 573 (804)
Q Consensus 532 ~~gsL~~----~----------l~~~--~--------~~l~~~~~~----------~i~~~ia~gL~yLH~~----~~~~ 573 (804)
++..+.. . ++.. . ....|.... .....+..++.++... ....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9877532 0 1110 0 011121110 1112233445555531 2345
Q ss_pred eEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 574 IIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 574 iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987789999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0017 Score=77.82 Aligned_cols=196 Identities=18% Similarity=0.160 Sum_probs=134.3
Q ss_pred HHHHHHHHcCCCCCCceeeeeEEecCCeEE----EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044374 496 FRAEVCTIGNIQHVNLVRLRGFCSENSHRL----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571 (804)
Q Consensus 496 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 571 (804)
...|+..+.++.|+|+++++.+-.+....- +..|++..-++...+..-+ .++......+..++.+||+|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 345677888999999999999876654332 4457788888877777644 6778888889999999999999875
Q ss_pred CCeEecCCCCC---cEEecCCCceEEe--ecCCccccCCCccccccccccccccccchhccCCCCCc--cceEEeehhhH
Q 044374 572 DCIIHCDIKPE---NILLDSDYTAKVS--DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT--KADVYSYGMTL 644 (804)
Q Consensus 572 ~~iiH~Dlkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--ksDV~S~Gvvl 644 (804)
..|.-+..+ +-..+.++...++ ||+.++....... .....-+..+.+||......... ..|+|.+|..+
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 555555444 5555667777777 9988876543322 11223455678888877665544 47999999999
Q ss_pred HHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCC
Q 044374 645 LELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM 724 (804)
Q Consensus 645 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 724 (804)
..+..|..+-.... ....+++. ... .........|+..++++
T Consensus 383 ~~~~~~~~i~~~~~------------------------------~~~~~l~~----~~~----~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA------------------------------VPVSLLDV----LST----SELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc------------------------------chhhhhcc----ccc----hhhhhhhhhhcchhhhh
Confidence 99998865433110 00111111 100 13556677899999999
Q ss_pred CCCHHHHHHHH
Q 044374 725 RPTMGTVVKML 735 (804)
Q Consensus 725 RPs~~eVl~~L 735 (804)
|++..+++.+.
T Consensus 425 Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 425 RLSALELLTHP 435 (1351)
T ss_pred ccchhhhhhch
Confidence 99999998875
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.015 Score=62.87 Aligned_cols=140 Identities=16% Similarity=0.185 Sum_probs=76.7
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-----CCCCceeee-e--EEecCCeEEEEEEEc
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-----QHVNLVRLR-G--FCSENSHRLLVYDYM 531 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~E~~ 531 (804)
+.|+.|....+|+.+..++ .+++|+++. ........|+.++..+ ..|.+++-. | +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3567777789999887666 588898862 2233334444444444 233333211 1 122345678999999
Q ss_pred CCCChh-----------HHH---hhCCC----------CCCH-HHHHH------------HH-HHHHHHHHHHhhc----
Q 044374 532 RNGALS-----------LYL---RKDGL----------NLNW-DVRFR------------IA-VGTARGIAYLHEE---- 569 (804)
Q Consensus 532 ~~gsL~-----------~~l---~~~~~----------~l~~-~~~~~------------i~-~~ia~gL~yLH~~---- 569 (804)
++..+. ..| +.... .+.| ..... .. ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 987542 111 11000 1111 11111 11 1111222333211
Q ss_pred CCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 570 ~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
-+.+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776668999998863
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.023 Score=62.86 Aligned_cols=74 Identities=14% Similarity=0.134 Sum_probs=52.3
Q ss_pred cccccccceeEEEEEeCCC-cEEEEEEecCC--------CCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERP--------GSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 527 (804)
+.||.|.+..||+....++ +.|+||.-... ....+.+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 48999985311 123456677777777652 2356666665 34557899
Q ss_pred EEEcCCCC
Q 044374 528 YDYMRNGA 535 (804)
Q Consensus 528 ~E~~~~gs 535 (804)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.02 Score=62.57 Aligned_cols=138 Identities=19% Similarity=0.138 Sum_probs=78.3
Q ss_pred ccccccceeEEEEEeCC-----CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCce-eeeeEEecCCeEEEEEEEcCCC
Q 044374 461 KLGHGGFGAVFQGELSD-----STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.|-.|-.-.+|+..+.+ ++.|++|+........-+-.+|..++..+...++- ++++.+..+ .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45557778899987542 35788898764332222236677777777543333 345555332 589999877
Q ss_pred ChhHH-----------------HhhCC----C-CCCHHHHHHHHHH-----------------HHHHHHHHh----h-cC
Q 044374 535 ALSLY-----------------LRKDG----L-NLNWDVRFRIAVG-----------------TARGIAYLH----E-EC 570 (804)
Q Consensus 535 sL~~~-----------------l~~~~----~-~l~~~~~~~i~~~-----------------ia~gL~yLH----~-~~ 570 (804)
+|... ++... . ...+.+...+..+ +...+..|. . ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 11111 0 1112222222211 111122222 1 12
Q ss_pred CCCeEecCCCCCcEEecC-CCceEEeecCCccc
Q 044374 571 RDCIIHCDIKPENILLDS-DYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~ 602 (804)
...++|+|+++.|||+++ ++.++|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 345899999999999986 47899999988864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.036 Score=59.63 Aligned_cols=141 Identities=13% Similarity=0.201 Sum_probs=81.3
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC--CceeeeeE------EecCCeEEEEEEEc
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV--NLVRLRGF------CSENSHRLLVYDYM 531 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E~~ 531 (804)
+.++.|....+|+.+..++ .+++|+.+... ...+...|+.++..|... .+.+++.. ....+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 3567777789999876555 47788775422 234455666666655321 23333331 12245678999999
Q ss_pred CCCChhH-----------H---HhhCCCC-----------CCHHHHH------------HHHHHHHHHHHHHhh----cC
Q 044374 532 RNGALSL-----------Y---LRKDGLN-----------LNWDVRF------------RIAVGTARGIAYLHE----EC 570 (804)
Q Consensus 532 ~~gsL~~-----------~---l~~~~~~-----------l~~~~~~------------~i~~~ia~gL~yLH~----~~ 570 (804)
++..+.. . ++..... ..|.... .....+.+.+++|.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8865321 1 1111000 1111110 011123344555543 22
Q ss_pred CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 35699999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.031 Score=59.04 Aligned_cols=31 Identities=32% Similarity=0.595 Sum_probs=26.1
Q ss_pred CCeEecCCCCCcEEecCCCc-eEEeecCCccc
Q 044374 572 DCIIHCDIKPENILLDSDYT-AKVSDFGLAKL 602 (804)
Q Consensus 572 ~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~ 602 (804)
..++|+|+++.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0044 Score=51.00 Aligned_cols=35 Identities=17% Similarity=0.468 Sum_probs=30.5
Q ss_pred ccChhhhHHhhcccCCccceeecccCccccccccc
Q 044374 330 SAGRSICERSCLANCSCIGLYHDVRTNLCKNLYGE 364 (804)
Q Consensus 330 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~ 364 (804)
..+.++|+..|+.+|+|.||.|..+.+.|+++.+.
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 56889999999999999999998778899877553
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.019 Score=60.86 Aligned_cols=72 Identities=15% Similarity=0.313 Sum_probs=45.8
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.|+.|....+|+.. .+++.+.||+-.. .....|..|..-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999988 5677899998872 23345777777776663 445677888887777779999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.0033 Score=65.56 Aligned_cols=131 Identities=15% Similarity=0.112 Sum_probs=86.5
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecC-----------------CCCCHH------HHHHHHHHHcCCC-CC-Cc
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLER-----------------PGSGER------EFRAEVCTIGNIQ-HV-NL 511 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~-----------------~~~~~~------~~~~Ei~~l~~l~-H~-ni 511 (804)
.+.++||-|.-+.||.+...+|++.++|.-.. .....+ ...+|...|+.|. |- -+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 46789999999999999999999988884311 011111 2456777777774 22 23
Q ss_pred eeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc
Q 044374 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 512 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
-+.++ .+..++|||++.+-.|...-+- .+..++..- +..-+--|...+ +||+|..-=||+++++..
T Consensus 175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly~~---lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 175 PKPID----HNRHCVVMELVDGYPLRQVRHV----EDPPTLYDD---LMGLIVRLANHG---LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCccc----ccceeeHHHhhcccceeeeeec----CChHHHHHH---HHHHHHHHHHcC---ceecccchheeEEecCCC
Confidence 33333 3456899999988777654332 222333222 222233444455 999999999999999999
Q ss_pred eEEeecCCcc
Q 044374 592 AKVSDFGLAK 601 (804)
Q Consensus 592 ~kl~DfGla~ 601 (804)
++++||-...
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999996543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.075 Score=57.27 Aligned_cols=32 Identities=19% Similarity=0.331 Sum_probs=28.7
Q ss_pred CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+..++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44699999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.086 Score=56.29 Aligned_cols=133 Identities=22% Similarity=0.342 Sum_probs=75.3
Q ss_pred eEEEEEeCCCcEEEEEEecC---CCCCHHHHHHHHHHHcCCCC--CCceeeeeEEecCC--eEEEEEEEcCCCChhHH--
Q 044374 469 AVFQGELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQH--VNLVRLRGFCSENS--HRLLVYDYMRNGALSLY-- 539 (804)
Q Consensus 469 ~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~-- 539 (804)
.+|..... ++++++. ... .........+|..+|+.+.- .-+-+.+++|.++. ..+.||+|.++..+...
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34444333 6667777 321 12233456677777776642 23445577777766 67999999998432211
Q ss_pred ----------------Hhh-C-----C------------CC-CCHHHHHHHHH--------HHHHHHHHHhhcC-----C
Q 044374 540 ----------------LRK-D-----G------------LN-LNWDVRFRIAV--------GTARGIAYLHEEC-----R 571 (804)
Q Consensus 540 ----------------l~~-~-----~------------~~-l~~~~~~~i~~--------~ia~gL~yLH~~~-----~ 571 (804)
|.. + + .. ..|...++.+. ....-..+|+... +
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 110 0 0 00 01111111000 1122244454432 3
Q ss_pred CCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 572 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
..++|+|+.+.||+++.+.-+=|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 56999999999999999988999999999753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.022 Score=57.63 Aligned_cols=121 Identities=18% Similarity=0.157 Sum_probs=60.0
Q ss_pred CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEEcCCCChhH-------HH---------
Q 044374 478 STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDYMRNGALSL-------YL--------- 540 (804)
Q Consensus 478 ~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~-------~l--------- 540 (804)
.+.|+|++........-....|..+++.+....+ .++++++.. .+|+||+++..|.. .+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4568888887665555666778888877754444 345555433 25779997666432 11
Q ss_pred -hh--C---C-CCCCHHHHHHH----------------------HHHHHHHHHHHhh----cC-CCCeEecCCCCCcEEe
Q 044374 541 -RK--D---G-LNLNWDVRFRI----------------------AVGTARGIAYLHE----EC-RDCIIHCDIKPENILL 586 (804)
Q Consensus 541 -~~--~---~-~~l~~~~~~~i----------------------~~~ia~gL~yLH~----~~-~~~iiH~Dlkp~NILl 586 (804)
+. . . ...-+.....+ ...+..-+..+.+ .. ...+.|+|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 00 0 0 00011111111 0111122222221 11 1348999999999999
Q ss_pred -cCCCceEEeecCCccc
Q 044374 587 -DSDYTAKVSDFGLAKL 602 (804)
Q Consensus 587 -~~~~~~kl~DfGla~~ 602 (804)
+.++.++++||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.052 Score=57.88 Aligned_cols=137 Identities=17% Similarity=0.220 Sum_probs=90.8
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCC----------CCHHH-----------------HHHHHHHHcCCCCCCce
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPG----------SGERE-----------------FRAEVCTIGNIQHVNLV 512 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------~~~~~-----------------~~~Ei~~l~~l~H~niv 512 (804)
-.|..|.-..||.+.-.+|..+|||+++.+. .++.. ...|++-|.+++.-.|-
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4688999999999999999999999886421 11111 23466666666432211
Q ss_pred eeeeEEecCCeEEEEEEEcCCCChh-HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc
Q 044374 513 RLRGFCSENSHRLLVYDYMRNGALS-LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT 591 (804)
Q Consensus 513 ~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 591 (804)
-.--+.. ....|||+|+...... -.|+. ..++...+..+-.+++.-|.-|-+.++ +||.||.-=|+|+. +|.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-CCE
Confidence 1000001 1347899998643221 12222 356666777788888888888887775 99999999999985 578
Q ss_pred eEEeecCCcccc
Q 044374 592 AKVSDFGLAKLI 603 (804)
Q Consensus 592 ~kl~DfGla~~~ 603 (804)
+.|+|-+.+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999887643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.099 Score=56.87 Aligned_cols=138 Identities=14% Similarity=0.203 Sum_probs=76.4
Q ss_pred ccccccceeEEEEEeCC----CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCce-eeeeEEecCCeEEEEEEEcCCCC
Q 044374 461 KLGHGGFGAVFQGELSD----STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.|..|-...+|+....+ +..|++|+........-.-.+|..+++.+..-++- ++++++. +. +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 45557777889886543 23788898764322222335677777777544443 4555553 22 5899997766
Q ss_pred hhH-------HH----------hhCCCC----C-CHHHHHHHHHH----------------------HHHHHHHHhh---
Q 044374 536 LSL-------YL----------RKDGLN----L-NWDVRFRIAVG----------------------TARGIAYLHE--- 568 (804)
Q Consensus 536 L~~-------~l----------~~~~~~----l-~~~~~~~i~~~----------------------ia~gL~yLH~--- 568 (804)
|.. .+ +....+ . -+....++..+ +.+-+..++.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 531 11 111100 1 12222222111 1111222211
Q ss_pred -c-CCCCeEecCCCCCcEEecC-CCceEEeecCCccc
Q 044374 569 -E-CRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKL 602 (804)
Q Consensus 569 -~-~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~ 602 (804)
. ....+.|.|+.+.|||+++ ++.++++||..+..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1234799999999999975 57899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.22 Score=53.99 Aligned_cols=73 Identities=14% Similarity=0.108 Sum_probs=46.0
Q ss_pred cccccccceeEEEEEeCCC-cEEEEEEecC--C------CCCHHHHHHHHHHHcCCC--CCC-ceeeeeEEecCCeEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLER--P------GSGEREFRAEVCTIGNIQ--HVN-LVRLRGFCSENSHRLLV 527 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~--~------~~~~~~~~~Ei~~l~~l~--H~n-iv~l~g~~~~~~~~~lV 527 (804)
++||-|-...||++..+++ +.|+||.-.. . .........|...|.... -|. +.+++ ..+.+...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceeh
Confidence 3689999999999988754 5799997631 1 222344455666665542 343 33343 3345556799
Q ss_pred EEEcCCC
Q 044374 528 YDYMRNG 534 (804)
Q Consensus 528 ~E~~~~g 534 (804)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.21 Score=53.93 Aligned_cols=138 Identities=21% Similarity=0.276 Sum_probs=83.4
Q ss_pred cccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC---CCC---ceeeee----EEecCCeEEEEEEEc
Q 044374 462 LGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ---HVN---LVRLRG----FCSENSHRLLVYDYM 531 (804)
Q Consensus 462 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---H~n---iv~l~g----~~~~~~~~~lV~E~~ 531 (804)
|.+ .-..+|+....+++. ++|..+.. ....++..|+..+..+. .+= +..+=| ........+-|++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789998888876 88888766 66677777777776663 111 222212 111123778899999
Q ss_pred CCCChhH-H--------------Hhh--------CC---CCCCHHH-------------HHHHHHHHHHHHHHHhhc---
Q 044374 532 RNGALSL-Y--------------LRK--------DG---LNLNWDV-------------RFRIAVGTARGIAYLHEE--- 569 (804)
Q Consensus 532 ~~gsL~~-~--------------l~~--------~~---~~l~~~~-------------~~~i~~~ia~gL~yLH~~--- 569 (804)
+|..+.. . |+. +. ....|.. ......++...+..+++.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 1 110 00 1223331 011223334444444432
Q ss_pred -CCC---CeEecCCCCCcEEecCCCc-eEEeecCCccc
Q 044374 570 -CRD---CIIHCDIKPENILLDSDYT-AKVSDFGLAKL 602 (804)
Q Consensus 570 -~~~---~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~ 602 (804)
-+. .+||+|+.|.|||++.+.. +.++||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 122 2999999999999999885 99999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 804 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-59 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 804 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-132 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-111 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-109 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-64 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-56 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-55 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-52 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-51 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-51 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-48 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-48 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-48 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-47 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-46 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-45 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-44 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-44 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-39 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-37 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-37 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-36 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-36 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-36 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-36 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-36 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-35 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-35 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-34 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-34 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-34 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-33 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-33 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 9e-33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-32 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-32 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-32 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-32 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-32 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-32 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-30 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-30 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-30 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-30 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-29 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-29 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-29 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-29 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-29 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-29 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-29 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-29 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-29 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-28 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-28 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-28 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-28 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-28 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-28 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-28 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-27 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-27 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-27 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-27 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-27 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-26 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-25 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-25 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-25 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-25 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-24 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-23 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-23 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-23 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-22 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-22 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-22 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-22 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-22 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-22 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-22 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-21 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-21 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-21 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-20 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-20 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-19 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-19 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-19 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-19 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-19 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-19 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-18 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-18 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-18 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-18 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 7e-17 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-16 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-16 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-16 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-16 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-16 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-15 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-15 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-13 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-13 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 8e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-13 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-12 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 6e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-07 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 1e-05 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 1e-04 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 2e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-132
Identities = 136/316 (43%), Positives = 182/316 (57%), Gaps = 19/316 (6%)
Query: 431 DVDEEDV--FPVLNLKVFSYKELHTVTRGFSE--KLGHGGFGAVFQGELSDSTLVAVKRL 486
DV E+ + LK FS +EL + FS LG GGFG V++G L+D TLVAVKRL
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 487 ERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLR--- 541
+ + GE +F+ EV I H NL+RLRGFC + RLLVY YM NG+++ LR
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 542 KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601
+ L+W R RIA+G+ARG+AYLH+ C IIH D+K NILLD ++ A V DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGR 661
L+ + V +RGT G++APE++S + K DV+ YG+ LLELI G+R +
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL----- 237
Query: 662 NANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDN 721
+ D W + E + A+VD L G YK EE E++ VA+ C Q +
Sbjct: 238 -----ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 722 EEMRPTMGTVVKMLEG 737
RP M VV+MLEG
Sbjct: 293 PMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-111
Identities = 103/323 (31%), Positives = 153/323 (47%), Gaps = 35/323 (10%)
Query: 433 DEEDVFPVLNLKVFSYKELHTVTRGFSE--------KLGHGGFGAVFQGELSDSTLVAVK 484
++ FS+ EL VT F E K+G GGFG V++G + ++T VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 485 RLERPGS-----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS-- 537
+L +++F E+ + QH NLV L GF S+ LVY YM NG+L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597
L L+W +R +IA G A GI +LHE + IH DIK NILLD +TAK+SDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDF 177
Query: 598 GLAKLIGRDFSRVLATM-RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656
GLA+ + V+ + GT Y+APE + G IT K+D+YS+G+ LLE+I G V+
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVD- 235
Query: 657 PASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIW 716
+ + +D ++ E + VA
Sbjct: 236 -EHREPQLLLD-------IKEEIEDEE----KTIEDYIDKKMND-ADSTSVEAMYSVASQ 282
Query: 717 CIQDNEEMRPTMGTVVKMLEGVL 739
C+ + + RP + V ++L+ +
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-109
Identities = 102/325 (31%), Positives = 153/325 (47%), Gaps = 22/325 (6%)
Query: 424 KKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEK--LGHGGFGAVFQGELSDSTLV 481
K D +L T F K +GHG FG V++G L D V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 482 AVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYL 540
A+KR S G EF E+ T+ +H +LV L GFC E + +L+Y YM NG L +L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 541 ---RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597
++++W+ R I +G ARG+ YLH IIH D+K NILLD ++ K++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183
Query: 598 GLAKLI-GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEA 656
G++K D + + ++GT GY+ PE+ +T K+DVYS+G+ L E++ R +
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 657 PASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIW 716
N+ WA G + +VD L + E + A+
Sbjct: 244 SLPREMVNLA------------EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291
Query: 717 CIQDNEEMRPTMGTVVKMLEGVLEV 741
C+ + E RP+MG V+ LE L +
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-64
Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 30/317 (9%)
Query: 446 FSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTI 503
+ L+ + E G FG V++ +L + VAVK + EV ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEYEVYSL 72
Query: 504 GNIQHVNLVRLRGFCSENSH----RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGT 559
++H N+++ G + L+ + G+LS +L+ + ++W+ IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETM 130
Query: 560 ARGIAYLHEE-------CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612
ARG+AYLHE+ + I H DIK +N+LL ++ TA ++DFGLA S
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 613 TMR-GTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG 666
+ GT Y+APE + G + D+Y+ G+ L EL + P
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF- 249
Query: 667 GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAER-VALVAIWCIQDNEEMR 725
++ + + E V L ++ + C + E R
Sbjct: 250 ------EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 726 PTMGTVVKMLEGVLEVT 742
+ G V + + + +T
Sbjct: 304 LSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-56
Identities = 82/303 (27%), Positives = 125/303 (41%), Gaps = 49/303 (16%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRL 514
EK+G G FG V + E + VAVK L EF EV + ++H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRK--DGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
G ++ + +V +Y+ G+L L K L+ R +A A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
I+H ++K N+L+D YT KV DFGL++L F + GT ++APE +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSN 217
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNAN--IGGGGEHGD-----KWFFPPWAARQI 685
K+DVYS+G+ L EL + P N + G + P A I
Sbjct: 218 EKSDVYSFGVILWELATL----QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA--AI 271
Query: 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPP 745
IE C + RP+ T++ +L +++ PP
Sbjct: 272 IE----------------------------GCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
Query: 746 PPR 748
P R
Sbjct: 304 PNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 5e-55
Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 42/317 (13%)
Query: 442 NLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVC 501
+L + YKE+ E +G G FG V + + VA+K++ S + F E+
Sbjct: 1 SLHMIDYKEIE-----VEEVVGRGAFGVVCKAKWRA-KDVAIKQI-ESESERKAFIVELR 53
Query: 502 TIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGT 559
+ + H N+V+L G C LV +Y G+L L +
Sbjct: 54 QLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYT-AKVSDFGLAKLIGRDFSRVLATMRGTW 618
++G+AYLH +IH D+KP N+LL + T K+ DFG A D + +G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSA 167
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678
++APE G + K DV+S+G+ L E+I P P
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITR----RKPFDEIG--------------GP 209
Query: 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738
+ + R + + + + C + RP+M +VK++ +
Sbjct: 210 AFRIMWAVHNGT------RPPLIKNLPKP--IESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
Query: 739 LEVTAPPPPRLIQALVS 755
+ L
Sbjct: 262 MRYFPGADEPLQYPCQH 278
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-52
Identities = 71/337 (21%), Positives = 119/337 (35%), Gaps = 51/337 (15%)
Query: 446 FSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAE--VC 501
+ E E +G G +GAV++G L + VAVK + + F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVF--SFANRQNFINEKNIY 59
Query: 502 TIGNIQHVNLVRLRGFCSENS-----HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA 556
+ ++H N+ R + LLV +Y NG+L YL +W R+A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLA 117
Query: 557 VGTARGIAYLHEE------CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610
RG+AYLH E + I H D+ N+L+ +D T +SDFGL+ + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 611 LA-------TMRGTWGYVAPEWISGL-------AITTKADVYSYGMTLLELIGGRRNVEA 656
+ GT Y+APE + G + + D+Y+ G+ E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF-------- 229
Query: 657 PASGRNANIGGGGEHGDKWFFPPWAARQ-IIEGNVAAVVDDRL----GGAYKVEEAERVA 711
G + F E V ++ A+K +
Sbjct: 230 --MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 712 LVAI--WCIQDNEEMRPTMGTVVKMLEGVLEVTAPPP 746
L C + E R T + + ++ +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 47/312 (15%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTL-VAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLR 515
E LG G FG + ++ + +K L R +R F EV + ++H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
G ++ + +Y++ G L ++ W R A A G+AYLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-------------RVLATMRGTWGYVA 622
H D+ N L+ + V+DFGLA+L+ + + + T+ G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682
PE I+G + K DV+S+G+ L E+IG R + G
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-RTMDFGLNVRGF---------L 240
Query: 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV---L 739
+ N + + C + E RP+ + LE + L
Sbjct: 241 DRYCPPNC----------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 740 EVTAPPPPRLIQ 751
P P+L Q
Sbjct: 285 AGHLPLGPQLEQ 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 438 FPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE--- 493
FP L + E+ + +++G GGFG V +G + D ++VA+K L S
Sbjct: 8 FPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 494 -----REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLN 548
+EF+ EV + N+ H N+V+L G +V +++ G L L +
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 549 WDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-----DYTAKVSDFGLAKLI 603
W V+ R+ + A GI Y+ I+H D++ NI L S AKV+DFGL+
Sbjct: 121 WSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--- 176
Query: 604 GRDFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRR 652
+ ++ + G + ++APE I + T KAD YS+ M L ++ G
Sbjct: 177 -QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE-----REFRAEVCTIGNIQHVNLV 512
E +G GGFG V++ VAVK + R E ++H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
LRG C + + LV ++ R G L+ L + D+ AV ARG+ YLH+E
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 573 CIIHCDIKPENILLD--------SDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
IIH D+K NIL+ S+ K++DFGLA+ R + G + ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM---SAAGAYAWMAPE 184
Query: 625 WISGLAITTKADVYSYGMTLLELIGGR 651
I + +DV+SYG+ L EL+ G
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHVNLVRL 514
+++G G FG V++G+ VAVK L + F+ EV + +HVN++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G+ + +V + +L +L IA TARG+ YLH + I
Sbjct: 86 MGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAI-- 631
IH D+K NI L D T K+ DFGLA R S + G+ ++APE I
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 632 -TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690
+ ++DVY++G+ L EL+ G+ P++ + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL--------------------------PYSNINNRDQII 235
Query: 691 AAVV-DDRLGGAYKVEEA--ERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
V KV +R+ + C++ + RP+ ++ +E
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 448 YKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE---REFRAEVCTIG 504
+K+L+ F KL G +++G + VK L+ R+F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 505 NIQHVNLVRLRGFCSE--NSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTAR 561
H N++ + G C H L+ +M G+L L + ++ + A+ AR
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+A+LH I + ++++D D TA++S + FS +V
Sbjct: 123 GMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWV 175
Query: 622 APEWISG---LAITTKADVYSYGMTLLELIGGR 651
APE + AD++S+ + L EL+
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 49/295 (16%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRL 514
E +G G FG V+ G VA++ ++ E + F+ EV +H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C H ++ + L +R + L+ + +IA +G+ YLH + I
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF----SRVLATMRGTWGYVAPEWISGLA 630
+H D+K +N+ D + ++DFGL + G L G ++APE I L+
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 631 I---------TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681
+ +DV++ G EL E P P A
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAR----EWPFKT----------------QPAEA 250
Query: 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
+ + ++ + ++ + ++C +E RPT ++ MLE
Sbjct: 251 I-------IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-46
Identities = 67/302 (22%), Positives = 109/302 (36%), Gaps = 38/302 (12%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+++G G +G V+ G+ VAVK E+ ++H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 518 CSENSHR----LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE---- 569
+ + L+ DY NG+L YL+ L+ ++A + G+ +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 570 -CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM---RGTWGYVAPEW 625
+ I H D+K +NIL+ + T ++D GLA D + V GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 626 ISGLAI------TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679
+ AD+YS+G+ L E+ R GG E +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVA------------RRCVSGGIVEEYQLPYHDL 265
Query: 680 WAARQIIEGNVAAVVDDRL-----GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734
+ E V +L E ++ + C N R T V K
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 735 LE 736
L
Sbjct: 326 LA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-44
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 42/304 (13%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAE--VCTIGNIQHVNLVRLR 515
E +G G FG V++G+ VAVK ER + E + ++H N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE-VAVKIF--SSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 516 GFCSENS----HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-- 569
++++ LV DY +G+L YL + + + ++A+ TA G+A+LH E
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 570 ---CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM---RGTWGYVAP 623
+ I H D+K +NIL+ + T ++D GLA + GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 624 EWISGLAI------TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFF 677
E + +AD+Y+ G+ E+ R +IGG E ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIA------------RRCSIGGIHEDYQLPYY 268
Query: 678 PPWAARQIIEGNVAAVVDDRL-----GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV 732
+ +E V + +L E +A + C N R T +
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 733 KMLE 736
K L
Sbjct: 329 KTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 64/302 (21%), Positives = 108/302 (35%), Gaps = 38/302 (12%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
E +G G +G V++G VAVK E+ ++H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 518 CSENSHR----LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE---- 569
+ H L+ Y G+L YL+ L+ RI + A G+A+LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 570 -CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM---RGTWGYVAPEW 625
+ I H D+K +NIL+ + ++D GLA + + +++ GT Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 626 ISG------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679
+ + D++++G+ L E+ R G E F+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVA------------RRMVSNGIVEDYKPPFYDV 236
Query: 680 WAARQIIEGNVAAVVDDRL-----GGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734
E V D+ + +A + C N R T + K
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 735 LE 736
L
Sbjct: 297 LT 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-39
Identities = 72/303 (23%), Positives = 118/303 (38%), Gaps = 66/303 (21%)
Query: 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHVNLVR 513
E++G G FG VF G L +D+TLVAVK R +F E + H N+VR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
L G C++ +V + ++ G +LR +G L ++ A G+ YL + C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV-----APEWISG 628
IH D+ N L+ K+SDFG+++ G V APE ++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY----AASGGLRQVPVKWTAPEALNY 289
Query: 629 LAITTKADVYSYGMTLLELI-GGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687
++++DV+S+G+ L E G P +P + +Q E
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGAS----P-------------------YPNLSNQQTRE 326
Query: 688 GNVAAVVDDRLGGAYKVEEAER--------VALVAI--WCIQDNEEMRPTMGTVVKMLEG 737
VE+ R A+ + C RP+ T+ + L+
Sbjct: 327 ---------------FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
Query: 738 VLE 740
+ +
Sbjct: 372 IRK 374
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 5/192 (2%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
KLG G FG V+ G + +T VA+K L+ F E + ++H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 518 CSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
SE +V +YM G+L +L+ G L +A A G+AY+ +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D++ NIL+ + KV+DFGLA+LI + + + APE T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 637 VYSYGMTLLELI 648
V+S+G+ L EL
Sbjct: 364 VWSFGILLTELT 375
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
++LG G FG V G+ VAVK + + GS + F E T+ + H LV+ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
CS+ +V +Y+ NG L YLR G L + G+A+L E IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQF-IH 127
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEWISGLAI 631
D+ N L+D D KVSDFG+ + + D + GT W APE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKW--SAPEVFHYFKY 182
Query: 632 TTKADVYSYGMTLLELI 648
++K+DV+++G+ + E+
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 5/192 (2%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
KLG G FG V+ G + +T VA+K L+ F E + ++H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 518 CSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
SE +V +YM G+L +L+ G L +A A G+AY+ +H
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D++ NIL+ + KV+DFGLA+LI + + + APE T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 637 VYSYGMTLLELI 648
V+S+G+ L EL
Sbjct: 447 VWSFGILLTELT 458
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHV 509
LG G FG V + VAVK L +P SG + + E+ + N+ H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHE 83
Query: 510 NLVRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
N+V+ +G C+E+ L+ +++ +G+L YL K+ +N + + AV +G+ YL
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAP 623
R + H D+ N+L++S++ K+ DFGL K I D W AP
Sbjct: 144 S--RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW--YAP 198
Query: 624 EWISGLAITTKADVYSYGMTLLELI 648
E + +DV+S+G+TL EL+
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELL 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLR 515
KLG G +G V++G S VAVK L + + E E F E + I+H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C+ ++ ++M G L YLR+ + ++ V +A + + YL ++
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
IH ++ N L+ ++ KV+DFGL++L+ D A + + APE ++ + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 635 ADVYSYGMTLLELI 648
+DV+++G+ L E+
Sbjct: 400 SDVWAFGVLLWEIA 413
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
F +++G G FG V G + VA+K + R G+ E F E + + H LV+L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
C E + LV ++M +G LS YLR + + + G+AYL EE +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIH 127
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEWISGLAI 631
D+ N L+ + KVSDFG+ + + D + GT W +PE S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKW--ASPEVFSFSRY 182
Query: 632 TTKADVYSYGMTLLELI 648
++K+DV+S+G+ + E+
Sbjct: 183 SSKSDVWSFGVLMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 69/309 (22%), Positives = 128/309 (41%), Gaps = 51/309 (16%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVN 510
F ++LG G FG+V + +VAVK+L + + E R+F E+ + ++QH N
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDN 103
Query: 511 LVRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+V+ +G C R L+ +Y+ G+L YL+K ++ + +G+ YL
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPE 624
+ I H D+ NIL++++ K+ DFGL K++ +D G W APE
Sbjct: 164 --KRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW--YAPE 218
Query: 625 WISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684
++ + +DV+S+G+ L EL ++P + IG
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK-------QGQMIVFH 271
Query: 685 IIEGNVAAVVDDRLGGAYKVEEAER----------VALVAIWCIQDNEEMRPTMGTVVKM 734
+IE ++ R + ++ C +N RP+ +
Sbjct: 272 LIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316
Query: 735 LEGVLEVTA 743
++ + + A
Sbjct: 317 VDQIRDQMA 325
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
F ++LG G FG V G+ VA+K + + GS + F E + N+ H LV+L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
C++ ++ +YM NG L YLR+ + + YL E + +H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLH 143
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEWISGLAI 631
D+ N L++ KVSDFGL++ + D + G+ W PE +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRW--SPPEVLMYSKF 198
Query: 632 TTKADVYSYGMTLLELI 648
++K+D++++G+ + E+
Sbjct: 199 SSKSDIWAFGVLMWEIY 215
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 68/306 (22%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVN 510
F ++LG G FG+V + +VAVK+L + + E R+F E+ + ++QH N
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDN 72
Query: 511 LVRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+V+ +G C R L+ +Y+ G+L YL+K ++ + +G+ YL
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPE 624
+ I H D+ NIL++++ K+ DFGL K++ +D G W APE
Sbjct: 133 --KRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW--YAPE 187
Query: 625 WISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684
++ + +DV+S+G+ L EL ++P + IG
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK-------QGQMIVFH 240
Query: 685 IIEGNVAAVVDDRLGGAYKVEEAER----------VALVAIWCIQDNEEMRPTMGTVVKM 734
+IE ++ R + ++ C +N RP+ +
Sbjct: 241 LIE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 735 LEGVLE 740
++ + +
Sbjct: 286 VDQIRD 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVN 510
+ +G G G V G L VA+K L + G E R+F +E +G H N
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
++RL G + ++V +YM NG+L +LR + G G+ YL +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDL 170
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWI 626
+H D+ N+L+DS+ KVSDFGL++++ D T G W APE I
Sbjct: 171 G--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW--TAPEAI 226
Query: 627 SGLAITTKADVYSYGMTLLELI 648
+ ++ +DV+S+G+ + E++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVL 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 461 KLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRL 514
+LG G FG+V QG VA+K L + G+ + E E + + + +VRL
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C + +LV + G L +L + + + G+ YL EE
Sbjct: 76 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN--F 131
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWISGLA 630
+H D+ N+LL + + AK+SDFGL+K +G D S A G W APE I+
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW--YAPECINFRK 189
Query: 631 ITTKADVYSYGMTLLELI 648
++++DV+SYG+T+ E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVN 510
+ +G G FG V G L VA+K L + G E R+F E +G H N
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
++RL G +++ ++V +YM NG+L +LRK + G A G+ YL +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDM 166
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWI 626
+H D+ NIL++S+ KVSDFGL +++ D T G W +PE I
Sbjct: 167 G--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW--TSPEAI 222
Query: 627 SGLAITTKADVYSYGMTLLELI 648
+ T+ +DV+SYG+ L E++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVM 244
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNL 511
+ +LG G FG+V + LVAVK+L+ G +R+F+ E+ + + +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 512 VRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
V+ RG + LV +Y+ +G L +L++ L+ + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GS 145
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEW 625
R +H D+ NIL++S+ K++DFGLAKL+ D + G W APE
Sbjct: 146 RR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW--YAPES 201
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
+S + ++DV+S+G+ L EL
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHV 509
+ LG G FG V++G VA+K L R + +E E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNP 77
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++ RL G C ++ L+ M G L Y+R+ N+ V A+G+ YL E+
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-ED 135
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG----TWGYVAPEW 625
R ++H D+ N+L+ + K++DFGLAKL+G + + G W +A E
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKW--MALES 190
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I T ++DV+SYG+T+ EL+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 17/198 (8%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRG 516
E+LG G FG V+ G + T VAVK L + GS + F AE + +QH LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
++ ++ +YM NG+L +L+ G+ L + +A A G+A++ E R+ I
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNY-I 131
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEWISGLA 630
H D++ NIL+ + K++DFGLA+LI + G W APE I+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKW--TAPEAINYGT 186
Query: 631 ITTKADVYSYGMTLLELI 648
T K+DV+S+G+ L E++
Sbjct: 187 FTIKSDVWSFGILLTEIV 204
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 5/192 (2%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+KLG G FG V+ + T VAVK ++ F AE + +QH LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 518 CSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
++ ++ ++M G+L +L+ +G + A G+A++ E R+ IH
Sbjct: 252 VTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNY-IH 307
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D++ NIL+ + K++DFGLA++I + + + APE I+ + T K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 637 VYSYGMTLLELI 648
V+S+G+ L+E++
Sbjct: 368 VWSFGILLMEIV 379
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+ +G G FG V G+ + VAVK + + + + F AE + ++H NLV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
E L +V +YM G+L YLR L D + ++ + YL E + +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV- 311
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+ N+L+ D AKVSDFGL ++ S T + + APE + +TK+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 636 DVYSYGMTLLELI 648
DV+S+G+ L E+
Sbjct: 368 DVWSFGILLWEIY 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 458 FSEKLGHGGFGAVFQGELSDST-----LVAVKRLERPGSGERE---FRAEVCTIGNIQHV 509
+ +G G FG V++G L S+ VA+K L + G E++ F E +G H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
N++RL G S+ +++ +YM NGAL +LR+ + + G A G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-AN 165
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEW 625
+H D+ NIL++S+ KVSDFGL++++ D T G W APE
Sbjct: 166 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW--TAPEA 221
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
IS T+ +DV+S+G+ + E++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVM 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGS-----GEREFRAEVCTIGNIQH 508
EKLG G FG V +GE + VAVK L +P +F EV + ++ H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
NL+RL G +V + G+L LRK + R AV A G+ YL E
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL-E 138
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY--VAPEWI 626
R IH D+ N+LL + K+ DFGL + + ++ + + APE +
Sbjct: 139 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 627 SGLAITTKADVYSYGMTLLELI 648
+ +D + +G+TL E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMF 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 458 FSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHV 509
LG G FG V +VAVK L + +G ++ E+ + + H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHE 93
Query: 510 NLVRLRGFCSENSHR--LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
++++ +G C + LV +Y+ G+L YL + + L + F A G+AYLH
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLH 151
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAP 623
+ I H D+ N+LLD+D K+ DFGLAK + G W AP
Sbjct: 152 A--QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW--YAP 206
Query: 624 EWISGLAITTKADVYSYGMTLLELI 648
E + +DV+S+G+TL EL+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELL 231
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNI-QHVNLVRL 514
+LGHG +G VF+ D L AVKR P G ++ AEV + + QH VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
E L + +L + G +L + T +A+LH + +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---L 178
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
+H D+KP NI L K+ DFGL +G + G Y+APE + G + T
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELLQG-SYGTA 235
Query: 635 ADVYSYGMTLLELIGGR 651
ADV+S G+T+LE+
Sbjct: 236 ADVFSLGLTILEVACNM 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+ +G G FG V G+ + VAVK + + + + F AE + ++H NLV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK-VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
E L +V +YM G+L YLR L D + ++ + YL E + +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV- 139
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEWISGLA 630
H D+ N+L+ D AKVSDFGL ++ +T W APE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT----KE---ASSTQDTGKLPVKW--TAPEALREKK 190
Query: 631 ITTKADVYSYGMTLLELI 648
+TK+DV+S+G+ L E+
Sbjct: 191 FSTKSDVWSFGILLWEIY 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLR 515
KLG G +G V++G S VAVK L + + E E F E + I+H NLV+L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C+ ++ ++M G L YLR+ + ++ V +A + + YL E ++
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNF- 132
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWISGLA 630
IH D+ N L+ ++ KV+DFGL++L+ D A W APE ++
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAGAKFPIKW--TAPESLAYNK 188
Query: 631 ITTKADVYSYGMTLLELI 648
+ K+DV+++G+ L E+
Sbjct: 189 FSIKSDVWAFGVLLWEIA 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-33
Identities = 72/327 (22%), Positives = 122/327 (37%), Gaps = 19/327 (5%)
Query: 330 SAGRSICERSCLANCSCIGLYHDVRTNLCKNLYGELLNLRNLTSDSTNEDILYVRAPRGG 389
+ I E + + L G + L+ +S+ + AP
Sbjct: 218 AGKYCIPEGTKFDT------LWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLP 271
Query: 390 TERKNISTLMVLVAGIVGSIAALVLAAVMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYK 449
++ + + A + + V E LK
Sbjct: 272 AHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 450 ELHTVTRGFSEKLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGE---REFRAEVCTI 503
+LG G FG+V QG VA+K L + G+ + E E +
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIM 390
Query: 504 GNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI 563
+ + +VRL G C + +LV + G L +L + + + G+
Sbjct: 391 HQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 564 AYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY--V 621
YL EE +H ++ N+LL + + AK+SDFGL+K +G D S A G W
Sbjct: 450 KYL-EEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 622 APEWISGLAITTKADVYSYGMTLLELI 648
APE I+ ++++DV+SYG+T+ E +
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRL---ERPGSGEREFRAEVCTIGNIQHVNLVR 513
F ++G G F V++G + + VA L + S + F+ E + +QH N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 514 LRGFC---SENSHRLLVY-DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+ +++ + M +G L YL++ + V +G+ +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT- 147
Query: 570 CRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
IIH D+K +NI + + K+ D GLA L F++ + GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 629 LAITTKADVYSYGMTLLELIGGR 651
DVY++GM +LE+
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSE 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSDS-----TLVAVKRL-ERPGSGER-EFRAEVCTIGNIQHVN 510
+ LG G FG V +G V +K + ++ G + IG++ H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+VRL G C +S LV Y+ G+L ++R+ L + V A+G+ YL EE
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL-EEH 134
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT-----WGYVAPEW 625
++H ++ N+LL S +V+DFG+A L+ D ++L + W +A E
Sbjct: 135 G--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKW--MALES 188
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I T ++DV+SYG+T+ EL+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELM 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVN 510
F+E +G G FG V+ G L D AVK L + E F E + + H N
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 511 LVRLRGFCSENSH-RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++ L G C + L+V YM++G L ++R + N + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGT----WGYVAPE 624
+ + H D+ N +LD +T KV+DFGLA+ + +++ V W +A E
Sbjct: 147 -KKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW--MALE 202
Query: 625 WISGLAITTKADVYSYGMTLLELI 648
+ TTK+DV+S+G+ L EL+
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
LG G FG V + DS A+K++ +EV + ++ H +VR
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 519 SENSHRL-------------LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
E + + + +Y NG L + + LN D +R+ ++Y
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV-------------LA 612
+H + IIH D+KP NI +D K+ DFGLAK + R + L
Sbjct: 132 IHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 613 TMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLEL 647
+ GT YVA E + G K D+YS G+ E+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSD-----STLVAVKRLERPGSGE---REFRAEVCTIGNIQHV 509
+ LG G FG V++G VA+K L R + +E E + ++ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNP 77
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++ RL G C ++ L+ M G L Y+R+ N+ V A+G+ YL E+
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-ED 135
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG----TWGYVAPEW 625
R ++H D+ N+L+ + K++DFGLAKL+G + + G W +A E
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKW--MALES 190
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I T ++DV+SYG+T+ EL+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 461 KLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGER----EFRAEVCTIGNIQHVNLVR 513
+LG G FG V +G VAVK L + + + E AE + + + +VR
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573
+ G C S +LV + G L+ YL+++ ++ + + G+ YL EE
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL-EESN-- 137
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWISGL 629
+H D+ N+LL + + AK+SDFGL+K + D + A G W APE I+
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW--YAPECINYY 195
Query: 630 AITTKADVYSYGMTLLELI 648
++K+DV+S+G+ + E
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVN 510
+G G FG V+ GE D A+K L + ++ F E + + H N
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 511 LVRLRGFCS-ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++ L G ++ YM +G L ++R N + ARG+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL--A 141
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGT----WGYVAPE 624
+ + H D+ N +LD +T KV+DFGLA+ I R++ V W A E
Sbjct: 142 EQKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW--TALE 198
Query: 625 WISGLAITTKADVYSYGMTLLELI 648
+ TTK+DV+S+G+ L EL+
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 458 FSEKLGHGGFGAVFQGEL--------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQ 507
F+E LG G F +F+G T V +K L F + +
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFEAASMMSKLS 70
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
H +LV G C +LV ++++ G+L YL+K+ +N + +A A + +L
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 568 EECRDCIIHCDIKPENILLDSDYT--------AKVSDFGLAKLI-GRDFSRVLATMRGTW 618
EE +IH ++ +NILL + K+SD G++ + +D + R W
Sbjct: 130 EENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE----RIPW 183
Query: 619 GYVAPEWIS-GLAITTKADVYSYGMTLLELI 648
V PE I + D +S+G TL E+
Sbjct: 184 --VPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 31/245 (12%)
Query: 423 RKKRKKRKDVDEEDVFPVLNLKVFSY---KELHTVTRGFSEKLGHGGFGAVFQG-ELSDS 478
+ +R + D E V LK Y +E+H +T ++G G FG V + +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRVGRGSFGEVHRMKDKQTG 83
Query: 479 TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538
AVK++ E + + +V L G E + + + G+L
Sbjct: 84 FQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 539 YLRKDGLNLNWDVRF---RIAVGTA---RGIAYLHEECRDCIIHCDIKPENILLDSD-YT 591
+++ G R G+ YLH I+H D+K +N+LL SD
Sbjct: 140 LIKQMG-------CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSR 189
Query: 592 AKVSDFGLAKLIGRDFSRVLA----TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
A + DFG A + D + GT ++APE + G K D++S +L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
Query: 648 IGGRR 652
+ G
Sbjct: 250 LNGCH 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGER---EFRAEVCTIGNIQHVN 510
+G G FG V QG + VA+K + + + +F E T+ H +
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+L G +EN ++ + G L +L+ +L+ A + +AYL E
Sbjct: 78 IVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESK 135
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----WGYVAPEWI 626
R +H DI N+L+ S+ K+ DFGL++ + +G W +APE I
Sbjct: 136 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKW--MAPESI 189
Query: 627 SGLAITTKADVYSYGMTLLELI 648
+ T+ +DV+ +G+ + E++
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNL--VRL 514
+++G GG VFQ + A+K + + + +R E+ + +Q + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + + +V + N L+ +L+K +++ R + +H+ I
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISG----- 628
+H D+KP N L+ K+ DFG+A + D S V + GT Y+ PE I
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 629 ------LAITTKADVYSYGMTLLELIGGR 651
I+ K+DV+S G L + G+
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVN 510
F+E +G G FG V+ G L D AVK L + E F E + + H N
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 511 LVRLRGFCSENSH-RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++ L G C + L+V YM++G L ++R + N + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS- 210
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGT----WGYVAPE 624
+ + H D+ N +LD +T KV+DFGLA+ + ++F V W +A E
Sbjct: 211 -KKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW--MALE 266
Query: 625 WISGLAITTKADVYSYGMTLLELI 648
+ TTK+DV+S+G+ L EL+
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHVN 510
+ LG G FG V++G + VAVK + +F +E + N+ H +
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+L G E ++ + G L YL ++ +L ++ + +AYL E
Sbjct: 75 IVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESI 132
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT------WGYVAPE 624
+H DI NIL+ S K+ DFGL++ I + W ++PE
Sbjct: 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKW--MSPE 184
Query: 625 WISGLAITTKADVYSYGMTLLELI 648
I+ TT +DV+ + + + E++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEIL 208
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNL--VRL 514
+++G GG VFQ + A+K + + + +R E+ + +Q + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + + +V + N L+ +L+K +++ R + +H+ I
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISG----- 628
+H D+KP N L+ K+ DFG+A + D S V + GT Y+ PE I
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 629 ------LAITTKADVYSYGMTLLELIGGR 651
I+ K+DV+S G L + G+
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNL--VRL 514
+++G GG VFQ + A+K + + + +R E+ + +Q + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + + +V + N L+ +L+K +++ R + +H+ I
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISG----- 628
+H D+KP N L+ K+ DFG+A + D S V + G Y+ PE I
Sbjct: 177 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 629 ------LAITTKADVYSYGMTLLELIGGR 651
I+ K+DV+S G L + G+
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNIQH 508
LGHG FG V++G++S VAVK L E++ F E I H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 92
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK------DGLNLNWDVRFRIAVGTARG 562
N+VR G ++ R ++ + M G L +LR+ +L +A A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 563 IAYLHEECRDCIIHCDIKPENILLD---SDYTAKVSDFGLAKLIGR-DFSRVLATMRGTW 618
YL E IH DI N LL AK+ DFG+A+ I R + R +G
Sbjct: 153 CQYL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-----KGGC 204
Query: 619 GYV-----APEWISGLAITTKADVYSYGMTLLELI 648
+ PE T+K D +S+G+ L E+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 37/283 (13%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRL---ERPGSGEREF-RAEVCTIGNIQHVNLVRL 514
+K+G G F V++ L D VA+K++ + + R E+ + + H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
E++ +V + G LS + +K + ++ V + ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
++H DIKP N+ + + K+ D GL + + ++ GT Y++PE I
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGY 213
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691
K+D++S G L E+ + P G N+ ++I + +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQS----PFYGDKMNLYS-------------LCKKIEQCDYP 256
Query: 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734
+ D + LV CI + E RP + V +
Sbjct: 257 PLPSDHYSEELR-------QLVN-MCINPDPEKRPDVTYVYDV 291
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 458 FSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQHVN 510
+G G FG V QG + + VA+K + + + +F E T+ H +
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+L G +EN ++ + G L +L+ +L+ A + +AYL E
Sbjct: 453 IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESK 510
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV-----APEW 625
R +H DI N+L+ S+ K+ DFGL++ + + + G + APE
Sbjct: 511 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPES 563
Query: 626 ISGLAITTKADVYSYGMTLLELI 648
I+ T+ +DV+ +G+ + E++
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHV 509
+LG G FG VF E D LVAVK L + + ++F+ E + N+QH
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHE 77
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR--------------- 554
++V+ G C + ++V++YM++G L+ +LR G + V +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 555 IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614
IA A G+ YL + +H D+ N L+ ++ K+ DFG++ RD
Sbjct: 138 IASQIASGMVYL--ASQHF-VHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYR 190
Query: 615 RGTWGYV-----APEWISGLAITTKADVYSYGMTLLELI 648
G + PE I TT++DV+S+G+ L E+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 31/217 (14%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRG 516
+ LG GGFG VF+ + D A+KR+ P + EV + ++H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 517 FCSEN---------SHRLLVY---DYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARG 562
E S ++ +Y R L ++ R V I + A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-----------VL 611
+ +LH + ++H D+KP NI D KV DFGL + +D
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
GT Y++PE I G + + K D++S G+ L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 35/218 (16%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHV 509
+LG G FG VF E D LVAVK L + S ++F+ E + +QH
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQ 103
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR--------------FRI 555
++VR G C+E L+V++YMR+G L+ +LR G + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 556 AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615
A A G+ YL +H D+ N L+ K+ DFG++ RD
Sbjct: 164 ASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS----RDIYSTDYYRV 216
Query: 616 GTWGYV-----APEWISGLAITTKADVYSYGMTLLELI 648
G + PE I TT++DV+S+G+ L E+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 14/196 (7%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G FG V+ E ++A+K +LE+ G + R EV +++H N++RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
G+ + + L+ +Y G + L+K + A ++Y H +I
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVI 131
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H DIKPEN+LL S K++DFG + SR + GT Y+ PE I G K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHA--PSSR-RTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 636 DVYSYGMTLLELIGGR 651
D++S G+ E + G+
Sbjct: 189 DLWSLGVLCYEFLVGK 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 13/200 (6%)
Query: 460 EKLGHGGFGAVFQGELSDSTL---VAVKRLERPGSGEREFRA----EVCTIGNIQHVNLV 512
+G GG G V++ E D+ VA+K + S + FR E T G +Q ++V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+ F + + + L+ LR+ G L I + H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
H D+KPENIL+ +D A + DFG+A + L GT Y+APE S T
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 633 TKADVYSYGMTLLELIGGRR 652
+AD+Y+ L E + G
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 35/243 (14%)
Query: 423 RKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTLVA 482
++ D DEE V+ + S+ + LGHG G + + D+ VA
Sbjct: 3 SSPSLEQDDGDEET--SVVIVGKISFC--------PKDVLGHGAEGTIVYRGMFDNRDVA 52
Query: 483 VKRLERPGSGEREFRAEVCTIGNI-----QHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537
VKR+ EV + +H N++R + + + + L
Sbjct: 53 VKRILP--ECFSFADREV----QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105
Query: 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL-----DSDYTA 592
Y+ + + T G+A+LH I+H D+KP NIL+ A
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162
Query: 593 KVSDFGLAKLIGRDFS--RVLATMRGTWGYVAPEWISGLAI---TTKADVYSYGMTLLEL 647
+SDFGL K + + + GT G++APE +S T D++S G +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 648 IGG 650
I
Sbjct: 223 ISE 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 61/214 (28%), Positives = 86/214 (40%), Gaps = 31/214 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNIQH 508
LGHG FG V++G++S VAVK L E++ F E I H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 133
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF------RIAVGTARG 562
N+VR G ++ R ++ + M G L +LR+ + +A A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 563 IAYLHEECRDCIIHCDIKPENILLD---SDYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
YL E IH DI N LL AK+ DFG+A RD R +G
Sbjct: 194 CQYL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYRKGGCA 246
Query: 620 YV-----APEWISGLAITTKADVYSYGMTLLELI 648
+ PE T+K D +S+G+ L E+
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNI-Q 507
F + LG G FG V + VAVK L + + E +E+ + ++ Q
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQ 108
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF-------------R 554
H N+V L G C+ L++ +Y G L +LR+ L D F
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 555 IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614
+ A+G+A+L ++CI H D+ N+LL + + AK+ DFGLA+ I D S +
Sbjct: 169 FSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKG 224
Query: 615 RGT----WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
W +APE I T ++DV+SYG+ L E+
Sbjct: 225 NARLPVKW--MAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNIQH 508
S +LG G FG V++G T VA+K + + RE F E +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNC 87
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR---------IAVGT 559
++VRL G S+ L++ + M G L YLR + + +A
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
A G+AYL +H D+ N ++ D+T K+ DFG+ RD +G G
Sbjct: 148 ADGMAYL--NANKF-VHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYRKGGKG 200
Query: 620 YV-----APEWISGLAITTKADVYSYGMTLLELI 648
+ +PE + TT +DV+S+G+ L E+
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 49/226 (21%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSGER---EFRAEVCTIGNIQH 508
F E+LG FG V++G L + VA+K L + + EFR E +QH
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQH 71
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR-------------- 554
N+V L G +++ +++ Y +G L +L + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 555 -IAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613
+ A G+ YL + H D+ N+L+ K+SD GL + + ++
Sbjct: 132 HLVAQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYK 185
Query: 614 MRGT------WGYVAPEWISGLAI-----TTKADVYSYGMTLLELI 648
+ G W +APE AI + +D++SYG+ L E+
Sbjct: 186 LLGNSLLPIRW--MAPE-----AIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 460 EKLGHGGFGAVFQGELSDSTL---VAVKRLERPGSGERE----FRAEVCTIGNIQHVNLV 512
+KLG GG V+ E D+ L VA+K + P + E F EV + H N+V
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+ E+ LV +Y+ LS Y+ G L+ D GI + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DM 130
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
I+H DIKP+NIL+DS+ T K+ DFG+AK + + GT Y +PE G A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 633 TKADVYSYGMTLLELIGGRR 652
D+YS G+ L E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 458 FSEKLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGERE---FRAEVCTIGNI-QHVN 510
F + +G G FG V + + A+KR+ + + + + F E+ + + H N
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---------------DGLNLNWDVRFRI 555
++ L G C + L +Y +G L +LRK L+
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 556 AVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615
A ARG+ YL + IH D+ NIL+ +Y AK++DFGL+ R +
Sbjct: 148 AADVARGMDYL--SQKQF-IHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTM 200
Query: 616 GT----WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
G W +A E ++ TT +DV+SYG+ L E++
Sbjct: 201 GRLPVRW--MAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVN 510
+ LG G FG+V +G L S VAVK ++ S +RE F +E + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 511 LVRLRGFCSEN-----SHRLLVYDYMRNGALSLYLRK-----DGLNLNWDVRFRIAVGTA 560
++RL G C E +++ +M+ G L YL ++ + V A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWG 619
G+ YL R+ + H D+ N +L D T V+DFGL+K I D+ R +G
Sbjct: 158 LGMEYL--SNRNFL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRIA 209
Query: 620 YV-----APEWISGLAITTKADVYSYGMTLLELI 648
+ A E ++ T+K+DV+++G+T+ E+
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE-REFRAEVCTIGNIQHVNLVRLRGF 517
LG G +G V+ G +LS+ +A+K + S + E+ +++H N+V+ G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTA---RGIAYLHEECRDCI 574
SEN + + + G+LS LR L + + I T G+ YLH+ I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQ---I 143
Query: 575 IHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI-- 631
+H DIK +N+L+++ K+SDFG +K + + T GT Y+APE I
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 632 TTKADVYSYGMTLLELIGGRR 652
AD++S G T++E+ G+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
E +G GGFG VF+ + D +KR++ + EV + + HVN+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 519 SENSHRL----------------LVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTAR 561
+ + ++ G L ++ K G L+ + + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
G+ Y+H + +I+ D+KP NI L K+ DFGL + D R +GT Y+
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYM 188
Query: 622 APEWISGLAITTKADVYSYGMTLLELI 648
+PE IS + D+Y+ G+ L EL+
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG GGF F+ +D+ + A K L +P E+ E+ ++ H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
GF +N +V + R +L ++ + R G YLH R+ +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+K N+ L+ D K+ DFGLA + D R + GT Y+APE +S + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 636 DVYSYGMTLLELIGGR 651
DV+S G + L+ G+
Sbjct: 197 DVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG GGF F+ + + A K L +P E+ E+ ++ H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
GF +N +V + R +L ++ + R G YLH R+ +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+K N+ L+ D K+ DFGLA + D R + GT Y+APE +S + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 636 DVYSYGMTLLELIGGR 651
DV+S G + L+ G+
Sbjct: 223 DVWSIGCIMYTLLVGK 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 30/214 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGSGERE---FRAEVCTIGNIQHVN 510
LG G FG+V + +L VAVK L+ + F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 511 LVRLRGFCSEN------SHRLLVYDYMRNGALSLYLRK-----DGLNLNWDVRFRIAVGT 559
+ +L G + +++ +M++G L +L + NL R V
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGT- 617
A G+ YL R+ I H D+ N +L D T V+DFGL++ I D+ R
Sbjct: 147 ACGMEYL--SSRNFI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKL 201
Query: 618 ---WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
W +A E ++ T +DV+++G+T+ E++
Sbjct: 202 PVKW--LALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 12/195 (6%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRG 516
LG G FG V+ E + ++A+K L + E + R E+ +++H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + L+ ++ G L L+K G + A + Y H +IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCH---ERKVIH 137
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
DIKPEN+L+ K++DFG + TM GT Y+ PE I G K D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 637 VYSYGMTLLELIGGR 651
++ G+ E + G
Sbjct: 195 LWCAGVLCYEFLVGM 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 460 EKLGHGGFGAVFQGELSDSTL---VAVKRLERPGSGERE----FRAEVCTIGNIQHVNLV 512
E LG GG V D VAVK L + + FR E + H +V
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 513 RL--RGFCSENSHRL--LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+ G + L +V +Y+ L + +G + + + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH- 133
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT--MRGTWGYVAPEWI 626
++ IIH D+KP NI++ + KV DFG+A+ I + V T + GT Y++PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 627 SGLAITTKADVYSYGMTLLELIGGRR 652
G ++ ++DVYS G L E++ G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 12/204 (5%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRLR 515
+G G +G + SD ++ K L+ E E +EV + ++H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 516 G-FCSENSHRL-LVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+ L +V +Y G L+ + K+ L+ + R+ + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 571 RDC--IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
++H D+KP N+ LD K+ DFGLA+++ D S T GT Y++PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNR 190
Query: 629 LAITTKADVYSYGMTLLELIGGRR 652
++ K+D++S G L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 9/198 (4%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRA---EVCTIGNIQHVNLVRLR 515
+K+G G FG + D +K + +E EV + N++H N+V+ R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
EN +V DY G L + G+ D V + ++H+ I
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---I 146
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
+H DIK +NI L D T ++ DFG+A+++ + GT Y++PE K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICENKPYNNK 205
Query: 635 ADVYSYGMTLLELIGGRR 652
+D+++ G L EL +
Sbjct: 206 SDIWALGCVLYELCTLKH 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNI-Q 507
F + LG G FG V + + VAVK L +P + E +E+ + +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGN 85
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK-----------------DGLNLNWD 550
H+N+V L G C+ L++ +Y G L +LR+ D L L+ +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 551 VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD---F 607
+ A+G+A+L ++CI H D+ NILL K+ DFGLA+ I D
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELI 648
+ A + W +APE I T ++DV+SYG+ L EL
Sbjct: 203 VKGNARLPVKW--MAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 41/285 (14%), Positives = 81/285 (28%), Gaps = 65/285 (22%)
Query: 453 TVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQ 507
T+ RG LG A + + V P + ++ + EV + ++
Sbjct: 74 TLVRG--TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 508 -------------------------HVNLVRLRGFCSENSHRLLVYDYMRN--------G 534
++R+R + + Y R
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594
L + L R ++ + R +A LH ++H ++P +I+LD +
Sbjct: 192 VLLSHSSTHKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 247
Query: 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS-----------GLAITTKADVYSYGMT 643
+ F G + G+ PE + +T D ++ G+
Sbjct: 248 TGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 644 LLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
+ + P + A G P R ++EG
Sbjct: 303 IYWIWCAD----LPITKDAALGGSEWIFRSCKNIPQP-VRALLEG 342
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 35/313 (11%), Positives = 69/313 (22%), Gaps = 53/313 (16%)
Query: 422 LRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTL 480
L++ + V V S E L G VF ++
Sbjct: 30 LKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLED 89
Query: 481 VAVK----RLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC------------------ 518
A+K E S + + R
Sbjct: 90 FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 519 --------SENSHRLLVYDYM-----RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAY 565
++ LL+ + ++ + + R A
Sbjct: 150 QLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
L + ++H P+N+ + D + D +G Y E+
Sbjct: 210 LQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREF 262
Query: 626 I--SGLAITTKADVYSYGMTLLELIGGRR---NVEAPASGRNANIGGGGEHGDKWFFPPW 680
+ S T + + G+++ + V G D F
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322
Query: 681 -----AARQIIEG 688
+ +I
Sbjct: 323 TPLPDFVKTLIGR 335
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNIQH 508
+ LG G FG V + T VAVK L + + E +E + + H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNH 85
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK-----------------------DGL 545
++++L G CS++ LL+ +Y + G+L +LR+ D
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 546 NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605
L A ++G+ YL + H D+ NIL+ K+SDFGL+ R
Sbjct: 146 ALTMGDLISFAWQISQGMQYL--AEMKLV-HRDLAARNILVAEGRKMKISDFGLS----R 198
Query: 606 DFSRVLATMRGTWGYV-----APEWISGLAITTKADVYSYGMTLLELI 648
D + ++ + G + A E + TT++DV+S+G+ L E++
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G F V++ + VA+K + + G +R + EV ++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ ++++ LV + NG ++ YL+ + + G+ YLH I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+ N+LL + K++DFGLA + + T+ GT Y++PE + A ++
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYTLCGTPNYISPEIATRSAHGLES 193
Query: 636 DVYSYGMTLLELIGGR 651
DV+S G L+ GR
Sbjct: 194 DVWSLGCMFYTLLIGR 209
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 63/326 (19%), Positives = 102/326 (31%), Gaps = 74/326 (22%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGF 517
+KLG GGF V E L D A+KR+ +RE + E H N++RL +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 518 CSE----NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF------RIAVGTARGIAYLH 567
C L+ + + G L + + + + +G RG+ +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIER---LKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--------LATMRGTWG 619
+ H D+KP NILL + + D G A R T
Sbjct: 152 AKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 620 YVAPEWI---SGLAITTKADVYSYGMTLLELIGGR---RNVEAPASGRNANIGGGGEHGD 673
Y APE S I + DV+S G L ++ G V +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN------ 262
Query: 674 KWFFPPW-----AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728
+ P A Q++ + + RP +
Sbjct: 263 QLSIPQSPRHSSALWQLLN----------------------------SMMTVDPHQRPHI 294
Query: 729 GTVVKMLEGVLEVTAPPPPRLIQALV 754
++ LE + P P + ++
Sbjct: 295 PLLLSQLE---ALQPPAPGQHTTQIL 317
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-28
Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 21/210 (10%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
E+LG GGFG V + VA+K+ + P + ER E+ + + H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVS 76
Query: 514 L------RGFCSENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAY 565
+ N LL +Y G L YL + L + + + Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 566 LHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
LHE IIH D+KPENI+L K+ D G AK + + + GT Y+A
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLA 191
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGRR 652
PE + T D +S+G E I G R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 461 KLGHGGFGAVFQGELSDSTLVAVKRLER------------------PGSGEREFRAEVCT 502
L G F + E D+ A+K+ E+ S +F+ E+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 503 IGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR- 561
I +I++ + G + ++Y+YM N ++ + L+ + I + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKC 155
Query: 562 -------GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614
+Y+H I H D+KP NIL+D + K+SDFG ++ + + +
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKGS 210
Query: 615 RGTWGYVAPEWISGLAIT--TKADVYSYGMTLLELIGGR 651
RGT+ ++ PE+ S + K D++S G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 45/228 (19%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNI-Q 507
F + LG G FG V S VAVK L + + E +E+ + +
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGS 107
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK----------------------DGL 545
H N+V L G C+ + L+++Y G L YLR D
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 546 NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605
L ++ A A+G+ +L E + C+ H D+ N+L+ K+ DFGLA R
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCV-HRDLAARNVLVTHGKVVKICDFGLA----R 220
Query: 606 DFSRVLATMRGTWGYV-----APEWISGLAITTKADVYSYGMTLLELI 648
D + + APE + T K+DV+SYG+ L E+
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 458 FSEKLGHGGFGAVFQGELSD--------STLVAVKRLERPGSGERE---FRAEVCTIGNI 506
+ LG G FG V E + VAVK L + + E++ +E+ + I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMI 97
Query: 507 -QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---------------DGLNLNWD 550
+H N++ L G C+++ ++ +Y G L YLR + +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 551 VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSR 609
ARG+ YL + CI H D+ N+L+ + K++DFGLA+ I D+ +
Sbjct: 158 DLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 610 VLATMRGT----WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
T G W +APE + T ++DV+S+G+ + E+
Sbjct: 215 --KTTNGRLPVKW--MAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 26/214 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
S+ LG G VF+G L A+K + + R E + + H N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVK 71
Query: 514 LRGF--CSENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEE 569
L + H++L+ ++ G+L L + L + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 570 CRDCIIHCDIKPENILL----DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
I+H +IKP NI+ D K++DFG A+ + D ++ GT Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186
Query: 626 ISGLAITT--------KADVYSYGMTLLELIGGR 651
+ D++S G+T G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 33/217 (15%), Positives = 65/217 (29%), Gaps = 26/217 (11%)
Query: 458 FSEKLGHGGFGAVFQGELSDST------LVAVKRLERPGSGERE-FRAEVCTIGNIQHVN 510
LG G F V++ D +K + E + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN----LNWDVRFRIAVGTARGIAYL 566
++ + +LV + G L + + + A+ I +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 567 HEECRDCIIHCDIKPENILLDSDYTA-----------KVSDFGLAK-LIGRDFSRVLATM 614
H+ IIH DIKP+N +L + + + D G + + +
Sbjct: 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
T G+ E +S + D + T+ ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 57/234 (24%)
Query: 458 FSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSGERE---FRAEVCTIGNIQH 508
+ +G G FG VFQ T+VAVK L + + F+ E + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDN 109
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--------------- 553
N+V+L G C+ L+++YM G L+ +LR + +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 554 --------RIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605
IA A G+AYL R +H D+ N L+ + K++DFGL++ I
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL--SERKF-VHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 606 -DFSRVLATMRGTWGYV-----APEWISGLAI-----TTKADVYSYGMTLLELI 648
D+ + + PE +I TT++DV++YG+ L E+
Sbjct: 227 ADYYKA-----DGNDAIPIRWMPPE-----SIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 458 FSEKLGHGGFGAVFQGELSD--------STLVAVKRLERPGSGERE---FRAEVCTIGNI 506
+ LG G FG V E + VAVK L + + E++ +E+ + I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMI 143
Query: 507 -QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---------------DGLNLNWD 550
+H N++ L G C+++ ++ +Y G L YLR + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 551 VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSR 609
ARG+ YL + CI H D+ N+L+ + K++DFGLA+ I D+ +
Sbjct: 204 DLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 610 VLATMRGT------WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
W +APE + T ++DV+S+G+ + E+
Sbjct: 261 K----TTNGRLPVKW--MAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 46/204 (22%), Positives = 77/204 (37%), Gaps = 26/204 (12%)
Query: 460 EKLGHGGFGAVFQGELSDSTL----VAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVR 513
+ HGG G ++ D + V +K L G E AE + + H ++V+
Sbjct: 86 GCIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 514 LRGFCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+ F +V +Y+ +L + L + ++YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH- 199
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
+++ D+KPENI+L + K+ D G I + GT G+ APE +
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRT 251
Query: 629 LAITTKADVYSYGMTLLELIGGRR 652
T D+Y+ G TL L
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLP 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 458 FSEKLGHGGFGAVFQGEL--------SDSTLVAVKRLERPGSGERE---FRAEVCTIGNI 506
+ LG G FG V E + T VAVK L + + E++ +E+ + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMI 131
Query: 507 -QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK---------------DGLNLNWD 550
+H N++ L G C+++ ++ +Y G L YL+ L+
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 551 VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610
A ARG+ YL + C IH D+ N+L+ D K++DFGLA RD +
Sbjct: 192 DLVSCAYQVARGMEYL--ASKKC-IHRDLAARNVLVTEDNVMKIADFGLA----RDIHHI 244
Query: 611 LATMRGTWGYV-----APEWISGLAITTKADVYSYGMTLLELI 648
+ T G + APE + T ++DV+S+G+ L E+
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA---EVCTIGNI-QHVNLVRL 514
EK+G G FG+VF+ + D + A+KR ++P +G + + EV + QH ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNW---DVRFRIAVGTARGIAYLHEECR 571
+E+ H L+ +Y G+L+ + ++ +++ + + RG+ Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 572 DCIIHCDIKPENILLDSD-------------------YTAKVSDFGLAKLIGRDFSRVLA 612
++H DIKP NI + K+ D G I
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----Q 188
Query: 613 TMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGR 651
G ++A E + KAD+++ +T++ G
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSGERE---FRAEVCTIGNI-Q 507
+ LG G FG V + + + VAVK L + G+ E +E+ + +I
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 508 HVNLVRLRGFCS-ENSHRLLVYDYMRNGALSLYLRK---------------DGLNLNWDV 551
H+N+V L G C+ +++ ++ + G LS YLR L +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 552 RFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611
+ A+G+ +L R CI H D+ NILL K+ DFGLA+ I +D
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKD----- 201
Query: 612 ATMRGT--------WGYVAPEWISGLAITTKADVYSYGMTLLELI 648
W +APE I T ++DV+S+G+ L E+
Sbjct: 202 PDYVRKGDARLPLKW--MAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 48/223 (21%), Positives = 78/223 (34%), Gaps = 36/223 (16%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCT-IGNIQHVNLVRLRG 516
+ LG+G G V VAVKR+ E+ + H N++R
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF------RIAVGTARGIAYLHEEC 570
+ + + + N L + ++ + A G+A+LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 571 RDCIIHCDIKPENILLDS-------------DYTAKVSDFGLAKLIGRD---FSRVLATM 614
IIH D+KP+NIL+ + + +SDFGL K + F L
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 615 RGTWGYVAPEWISGLAI-------TTKADVYSYGMTLLELIGG 650
GT G+ APE + T D++S G ++
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 26/214 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
S+ LG G VF+G L A+K + + R E + + H N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVK 71
Query: 514 LRGF--CSENSHRLLVYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEE 569
L + H++L+ ++ G+L L + L + G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 570 CRDCIIHCDIKPENILL----DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
I+H +IKP NI+ D K++DFG A+ + D ++ GT Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186
Query: 626 ISGLAITT--------KADVYSYGMTLLELIGGR 651
+ D++S G+T G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
EK+G G G V+ +++ VA++++ + + E+ + ++ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDCI 574
+V +Y+ G+L+ + + ++ IA + + +LH +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLHSNQ---V 137
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
IH DIK +NILL D + K++DFG I + S+ +TM GT ++APE ++ A K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 635 ADVYSYGMTLLELIGG 650
D++S G+ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 75/334 (22%), Positives = 116/334 (34%), Gaps = 58/334 (17%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQ-HVNLVRLRG 516
L GGF V++ + + A+KRL R EVC + + H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 517 FCSENSHR--------LLVYDYMRNGALS-LYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
S LL+ + + + L + L+ D +I T R + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-----------GRDFSRVLATMRG 616
+ IIH D+K EN+LL + T K+ DFG A I R T
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 617 TWGYVAPEWI---SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673
T Y PE I S I K D+++ G L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH----P---------------- 252
Query: 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
F A +I+ G + D + +L+ +Q N E R ++ VV
Sbjct: 253 ---FEDGAKLRIVNGKYSIPPHDTQYTVFH-------SLIR-AMLQVNPEERLSIAEVVH 301
Query: 734 MLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSS 767
L+ + P I L+ +G S
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
K+G G G V E VAVK ++ R EV + + QH N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDCI 574
++ ++++ GAL+ + + LN IA + +AYLH + +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLHAQG---V 162
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
IH DIK ++ILL D K+SDFG I +D + ++ GT ++APE IS T+
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATE 221
Query: 635 ADVYSYGMTLLELIGG 650
D++S G+ ++E++ G
Sbjct: 222 VDIWSLGIMVIEMVDG 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 42/284 (14%), Positives = 78/284 (27%), Gaps = 64/284 (22%)
Query: 453 TVTRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQ 507
T+ RG LG A + V + EV + ++
Sbjct: 79 TLVRG--TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 508 -------------------------HVNLVRLRGFCSENSHRLLVYDYMRN--------G 534
++R+R + + Y R
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594
L + L R ++ + R +A LH ++H ++P +I+LD +
Sbjct: 197 VLLSHSSTHKS-LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 252
Query: 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG----------LAITTKADVYSYGMTL 644
+ F G A G+ PE + +T D ++ G+ +
Sbjct: 253 TGFEHLVRDGAS-----AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 645 LELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
+ P + A +GG P R ++EG
Sbjct: 308 YWIWCAD----LPNTDDAA-LGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKR--LERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
EK+G G FG VF+G + +VA+K LE + + E+ + + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDC 573
+++ ++ +Y+ G+ L L+ IA +G+ YLH E
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLHSEK--- 139
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT--WGYVAPEWISGLAI 631
IH DIK N+LL K++DFG+A + + T GT W +APE I A
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFW--MAPEVIKQSAY 196
Query: 632 TTKADVYSYGMTLLELIGG 650
+KAD++S G+T +EL G
Sbjct: 197 DSKADIWSLGITAIELARG 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 65/324 (20%), Positives = 128/324 (39%), Gaps = 30/324 (9%)
Query: 422 LRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGEL-SDSTL 480
L ++RK ++ + + + +LG G G VF+ +
Sbjct: 7 LELDEQQRKRLEAFLTQKQKVGE-LKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLV 60
Query: 481 VAVK--RLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538
+A K LE + + E+ + +V G + + ++M G+L
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 539 YLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598
L+K G + + ++++ +G+ YL E+ + I+H D+KP NIL++S K+ DFG
Sbjct: 121 VLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPA 658
++ G+ + + GT Y++PE + G + ++D++S G++L+E+ GR + P
Sbjct: 178 VS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 659 SGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYK-----VEEAERVALV 713
+ + G GD PP N + ++ V E
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 714 AIW----------CIQDNEEMRPT 727
++ C+ N R
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERAD 318
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
+KLG G +G V + A+K + + S + EV + + H N+++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLH 567
L F + + LV + + G L + +F A + G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRM-------KFNEVDAAVIIKQVLSGVTYLH 153
Query: 568 EECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
+ I+H D+KPEN+LL+S D K+ DFGL+ + + + + GT Y+APE
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE 208
Query: 625 WISGLAITTKADVYSYGMTLLELIGGRR 652
+ K DV+S G+ L L+ G
Sbjct: 209 VLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 61/204 (29%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
LG G +G V VAVK ++ E + E+C + H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLHEE 569
E + + L +Y G L + D + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVAPEWISG 628
I H DIKPEN+LLD K+SDFGLA + + R+L M GT YVAPE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 629 LAIT-TKADVYSYGMTLLELIGGR 651
DV+S G+ L ++ G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/204 (29%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
LG G +G V VAVK ++ E + E+C + H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLHEE 569
E + + L +Y G L + D + A+ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GRDFSRVLATMRGTWGYVAPEWISG 628
I H DIKPEN+LLD K+SDFGLA + + R+L M GT YVAPE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 629 LAIT-TKADVYSYGMTLLELIGGR 651
DV+S G+ L ++ G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLV 512
LG G FG V + AVK + + ++ EV + + H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYL 566
+L F + + LV + G L + RF A R GI Y+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-------RFSEVDAARIIRQVLSGITYM 142
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
H+ I+H D+KPEN+LL+S D ++ DFGL+ + S+ + GT Y+AP
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 624 EWISGLAITTKADVYSYGMTLLELIGGR 651
E + G K DV+S G+ L L+ G
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLSGC 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 46/232 (19%), Positives = 95/232 (40%), Gaps = 23/232 (9%)
Query: 424 KKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFS------EKLGHGGFGAVFQG-ELS 476
+ + +++ D F K + + + E+LG G FG V + E +
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 477 DSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535
+ K + P ++ + E+ + + H L+ L + +L+ +++ G
Sbjct: 75 TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 536 LSLYLRKDGLNLNWDVRFRIAVGTAR----GIAYLHEECRDCIIHCDIKPENILLDS--D 589
L + + ++ + R G+ ++HE I+H DIKPENI+ ++
Sbjct: 135 LFDRIAAEDYKMSE----AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187
Query: 590 YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYG 641
+ K+ DFGLA + D ++ T + APE + + D+++ G
Sbjct: 188 SSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 41/191 (21%), Positives = 78/191 (40%), Gaps = 16/191 (8%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+E LG G FG V + E S K ++ G+ + + E+ + +H N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR----GIAYLHEECRD 572
+++++++ + + LN R V + +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNE----REIVSYVHQVCEALQFLHSHN-- 122
Query: 573 CIIHCDIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
I H DI+PENI+ + ++ K+ +FG A+ + + Y APE
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDV 179
Query: 631 ITTKADVYSYG 641
++T D++S G
Sbjct: 180 VSTATDMWSLG 190
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 23/200 (11%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLE------RPGSGEREFRAEVCTIGNIQHVN 510
E +G G F V + AVK ++ PG + + E ++H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIA 564
+V L S + +V+++M L + K + + +A R +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA---DAGFVYSEAVASHYMRQILEALR 144
Query: 565 YLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
Y H+ IIH D+KP +LL S K+ FG+A +G V GT ++
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFM 200
Query: 622 APEWISGLAITTKADVYSYG 641
APE + DV+ G
Sbjct: 201 APEVVKREPYGKPVDVWGCG 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
LG G FG V + + AVK + + EV + + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLH 567
L ++S +V + G L + K RF A + GI Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQVFSGITYMH 138
Query: 568 EECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPE 624
+ I+H D+KPENILL+S D K+ DFGL+ + + GT Y+APE
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE 193
Query: 625 WISGLAITTKADVYSYGMTLLELIGGRR 652
+ G K DV+S G+ L L+ G
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 27/198 (13%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
E+LG G F V + + A K + ++ E +QH N+VR
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 514 LRGFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
L E S LV+D + G L Y D + + + IAY
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILE---SIAYC 121
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
H I+H ++KPEN+LL S K++DFGLA + GT GY++P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSP 176
Query: 624 EWISGLAITTKADVYSYG 641
E + + D+++ G
Sbjct: 177 EVLKKDPYSKPVDIWACG 194
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
LG G FG V + + AVK + + EV + + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 514 LRGFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
L ++S +V + G L + D + + GI Y+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYM 137
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
H+ I+H D+KPENILL+S D K+ DFGL+ ++ + GT Y+AP
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAP 192
Query: 624 EWISGLAITTKADVYSYG 641
E + G K DV+S G
Sbjct: 193 EVLRG-TYDEKCDVWSAG 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER--------------PGSGEREFRAEVCT 502
KLG G +G V E + + A+K +++ E E+
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 503 IGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTA 560
+ ++ H N+++L + + LV ++ G L + +F A
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-------KFDECDAANIM 152
Query: 561 R----GIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLAT 613
+ GI YLH+ I+H DIKPENILL++ K+ DFGL+ L
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRD 207
Query: 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR 652
GT Y+APE + K DV+S G+ + L+ G
Sbjct: 208 RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGEREFRAEVCTIGNIQHVNLVRLR 515
F E LG G F VF + L A+K ++ P + E+ + I+H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 516 GFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
+H LV + G L +Y KD + + + + YLHE
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS---AVKYLHE 124
Query: 569 ECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
I+H D+KPEN+L + + ++DFGL+K+ +++T GT GYVAPE
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEV 178
Query: 626 ISGLAITTKADVYSYG 641
++ + D +S G
Sbjct: 179 LAQKPYSKAVDCWSIG 194
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 457 GFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRL 514
+E LG G FG V + E + +A K ++ G ++E + E+ + + H NL++L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR----GIAYLHEEC 570
+ +LV +Y+ G L + + NL + + GI ++H+
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT----ELDTILFMKQICEGIRHMHQMY 207
Query: 571 RDCIIHCDIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
I+H D+KPENIL + K+ DFGLA+ L GT ++APE ++
Sbjct: 208 ---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNY 262
Query: 629 LAITTKADVYSYG 641
++ D++S G
Sbjct: 263 DFVSFPTDMWSVG 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKR--LERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
E +G G V VA+KR LE+ + E E+ + H N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 517 FCSENSHRLLVYDYMRNGALS-LYLRKDGLNLNWDVRFR---IAV---GTARGIAYLHEE 569
LV + G++ + + IA G+ YLH+
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFG----LAKLIGRDFSRVLATMRGT--WGYVAP 623
IH D+K NILL D + +++DFG LA ++V T GT W +AP
Sbjct: 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW--MAP 195
Query: 624 EWIS-GLAITTKADVYSYGMTLLELIGGRRNVEAP 657
E + KAD++S+G+T +EL G AP
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATG----AAP 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 55/212 (25%), Positives = 78/212 (36%), Gaps = 44/212 (20%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK----------RLERPGSGEREFRAEVCTIGNI 506
E LG G V + AVK E EV +I
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV----DI 76
Query: 507 -----QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGT 559
H N+++L+ N+ LV+D M+ G L YL + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKI 129
Query: 560 AR----GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615
R I LH+ I+H D+KPENILLD D K++DFG + + L +
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVC 184
Query: 616 GTWGYVAPEWISGLAITT------KADVYSYG 641
GT Y+APE I + D++S G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G +G V + AVK +L R +GE + E+ + ++H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 516 G-FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAY 565
+E ++ +V +Y G + L+ R V A G+ Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEM--------LDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPE 624
LH I+H DIKP N+LL + T K+S G+A+ + + T +G+ + PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 625 WISGLAI--TTKADVYSYGMTLLELIGGR 651
+GL K D++S G+TL + G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 27/198 (13%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
E+LG G F V + + A K + ++ E +QH N+VR
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 514 LRGFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
L E S LV+D + G L Y D + + + IAY
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILE---SIAYC 144
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
H I+H ++KPEN+LL S K++DFGLA + GT GY++P
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSP 199
Query: 624 EWISGLAITTKADVYSYG 641
E + + D+++ G
Sbjct: 200 EVLKKDPYSKPVDIWACG 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-23
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPG----SGEREFRAE---VCTIGNIQHVNLVR 513
+G GGFG V+ +D+ + A+K L++ GE E + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 514 LRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+ + +L + D M G L +L + G+ D+RF A G+ ++H
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF-- 312
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS-GLAI 631
+++ D+KP NILLD ++SD GLA + GT GY+APE + G+A
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAY 368
Query: 632 TTKADVYSYGMTLLELIGGR 651
+ AD +S G L +L+ G
Sbjct: 369 DSSADWFSLGCMLFKLLRGH 388
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+LG G V++ + A+K L++ ++ R E+ + + H N+++L+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 517 FCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+ LV + + G L Y +D + + + +AYLHE
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILE---AVAYLHEN 167
Query: 570 CRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
I+H D+KPEN+L D K++DFGL+K++ ++ T+ GT GY APE +
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEIL 222
Query: 627 SGLAITTKADVYSYG 641
G A + D++S G
Sbjct: 223 RGCAYGPEVDMWSVG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
EKLG G +G+V++ +VA+K++ S +E E+ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 519 SENSHRLLVYDYMRNGALS--LYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDC 573
+N+ +V +Y G++S + LR L + IA T +G+ YLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEYLHFMR--- 145
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
IH DIK NILL+++ AK++DFG+A + ++ T+ GT ++APE I +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYNC 204
Query: 634 KADVYSYGMTLLELIGG 650
AD++S G+T +E+ G
Sbjct: 205 VADIWSLGITAIEMAEG 221
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-------RLERPGSGEREFRAEVCTIGNIQHV 509
E+LG G F V + E S A K R R G E EV + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GI 563
N++ L + +L+ + + G L +L + A + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQILDGV 128
Query: 564 AYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
YLH + I H D+KPENI+L K+ DFGLA I + + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPE 183
Query: 620 YVAPEWISGLAITTKADVYSYG 641
+VAPE ++ + +AD++S G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIG 205
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-------RLERPGSGEREFRAEVCTIGNIQHV 509
E+LG G F V + E S A K R R G E EV + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GI 563
N++ L + +L+ + + G L +L + A + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQILDGV 128
Query: 564 AYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
YLH + I H D+KPENI+L K+ DFGLA I + + GT
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPE 183
Query: 620 YVAPEWISGLAITTKADVYSYG 641
+VAPE ++ + +AD++S G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIG 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 65/264 (24%), Positives = 110/264 (41%), Gaps = 44/264 (16%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGEREFRAEV-CTIG------NIQHVNLVR 513
+G G FG V + +D+ + A+K + + ER EV ++H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN---EVRNVFKELQIMQGLEHPFLVN 79
Query: 514 LRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECR 571
L + ++ + +V D + G L +L+++ V+ I + A + YL +
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDYLQNQR- 135
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
IIH D+KP+NILLD ++DF +A ++ R+ + TM GT Y+APE S
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKG 191
Query: 632 T--TKA-DVYSYGMTLLELIGGRRNVEAPASGRNA--------NIGGGGEHGDKWFFPPW 680
+ A D +S G+T EL+ GRR P R++ +P
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR----PYHIRSSTSSKEIVHTF-----ETTVVTYPSA 242
Query: 681 ---AARQIIEGNVAAVVDDRLGGA 701
+++ + D R
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQL 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 72/255 (28%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 462 LGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
LG G F V EL+ S A+K LE+ + E + + H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECRDCI 574
F ++ +L Y +NG L Y+RK G RF A + +A + YLH + I
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHG--KG-I 151
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEWISGLAITT 633
IH D+KPENILL+ D +++DFG AK++ + + A + GT YV+PE ++ +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 634 KADVYSYGMTLLELIGGRRNVEAPASGRNA-----NIGGGGEHGDKWFFPPW---AARQI 685
+D+++ G + +L+ G P N I ++ FP AR +
Sbjct: 212 SSDLWALGCIIYQLVAGL----PPFRAGNEYLIFQKIIKL-----EYDFPEKFFPKARDL 262
Query: 686 IEGNVAAVVDDRLGG 700
+E + RLG
Sbjct: 263 VEKLLVLDATKRLGC 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGF 517
+LG G FG V++ L A K +E E E + E+ + H +V+L G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV---GTARGIAYLHEECRDCI 574
+ ++ ++ GA+ + + L +I V + +LH + I
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQVVCRQMLEALNFLHSKR---I 138
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT--WGYVAPEWISGLAIT 632
IH D+K N+L+ + +++DFG++ + + + GT W +APE + +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSFIGTPYW--MAPEVVMCETMK 195
Query: 633 -----TKADVYSYGMTLLELIGG 650
KAD++S G+TL+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQI 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 51/247 (20%), Positives = 83/247 (33%), Gaps = 56/247 (22%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-----RLERPGSGERE-FRAEVCTIGNIQHVN 510
+G G +G V E + A+K ++ + + E + EV + + H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------- 561
+ RL + + LV + G L L + +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 562 ------------------------------GIAYLHEECRDCIIHCDIKPENILLDSDYT 591
+ YLH + I H DIKPEN L ++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 592 A--KVSDFGLAKLIGR---DFSRVLATMRGTWGYVAPEWISGLA--ITTKADVYSYGMTL 644
K+ DFGL+K + + T GT +VAPE ++ K D +S G+ L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 645 LELIGGR 651
L+ G
Sbjct: 267 HLLLMGA 273
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 26/198 (13%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVR 513
E+LG G F V + ++ A + ++ E ++H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 514 LRGFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
L SE H L++D + G L Y D + + + + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHC 126
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAP 623
H+ ++H ++KPEN+LL S K++DFGLA + + + GT GY++P
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSP 182
Query: 624 EWISGLAITTKADVYSYG 641
E + D+++ G
Sbjct: 183 EVLRKDPYGKPVDLWACG 200
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 24/195 (12%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLR 515
+G G +G V + A K++ + + + F+ E+ + ++ H N++RL
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLHEE 569
+N+ LV + G L + F A + +AY H+
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKR-------VFRESDAARIMKDVLSAVAYCHKL 125
Query: 570 CRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
+ H D+KPEN L + D K+ DFGLA +++ T GT YV+P+ +
Sbjct: 126 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVL 180
Query: 627 SGLAITTKADVYSYG 641
G + D +S G
Sbjct: 181 EG-LYGPECDEWSAG 194
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGN-IQHVNLVRLR 515
++G G G V++ ++AVK R + ++ + +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
G N+ + + M A L R G + + ++ V + + YL E+ +I
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKHG--VI 147
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI---- 631
H D+KP NILLD K+ DFG++ + D ++ G Y+APE I
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPD 205
Query: 632 -TTKADVYSYGMTLLELIGGR 651
+ADV+S G++L+EL G+
Sbjct: 206 YDIRADVWSLGISLVELATGQ 226
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-------RLERPGSGEREFRAEVCTIGNIQHV 509
E+LG G F V + + A K R G E EV + I+H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GI 563
N++ L + +L+ + + G L +L + A + G+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-------SLTEDEATQFLKQILDGV 121
Query: 564 AYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
YLH + I H D+KPENI+L + K+ DFG+A I + + GT
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPE 176
Query: 620 YVAPEWISGLAITTKADVYSYG 641
+VAPE ++ + +AD++S G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIG 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 23/233 (9%)
Query: 423 RKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFS------EKLGHGGFGAVFQG-EL 475
+ R K D + K + + + E+LG G FG V + E
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 476 SDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534
+ A K + P ++E R E+ T+ ++H LV L +++ +++Y++M G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 535 ALSLYLRKDGLNLNWDVRFRIAVGTAR----GIAYLHEECRDCIIHCDIKPENILLDS-- 588
L + + ++ AV R G+ ++HE +H D+KPENI+ +
Sbjct: 240 ELFEKVADEHNKMSE----DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR 292
Query: 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYG 641
K+ DFGL + D + + GT + APE G + D++S G
Sbjct: 293 SNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G FG V GE VAVK ++ + R E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLH 567
S + +V +Y+ G L Y+ K G R+ AR + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCH 128
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R ++H D+KPEN+LLD+ AK++DFGL+ ++ L T G+ Y APE IS
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVIS 183
Query: 628 GLAIT-TKADVYSYGMTLLELIGGR 651
G + D++S G+ L L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 37/207 (17%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-----RLERPGSGERE----FRAEVCTIGNIQ 507
S+ LG G G V E VA+K + + E + E+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTA 560
H +++++ F + +V + M G L F +
Sbjct: 74 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL-- 125
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGT 617
+ YLHE IIH D+KPEN+LL S D K++DFG +K++G ++ T+ GT
Sbjct: 126 -AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGT 179
Query: 618 WGYVAPEWISGLAI---TTKADVYSYG 641
Y+APE + + D +S G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLG 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+G G F V + VA+K +++ P S ++ FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLHE 568
L+ +Y G + YL G R+ AR + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCH- 131
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
+ I+H D+K EN+LLD+D K++DFG + L G Y APE G
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQG 187
Query: 629 LAIT-TKADVYSYGMTLLELIGGR 651
+ DV+S G+ L L+ G
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 26/202 (12%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520
+G G FG LVAVK +ER + + + E+ +++H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLHEECRD 572
+H ++ +Y G L + G R + AR G++Y H
Sbjct: 88 PTHLAIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCH---SM 135
Query: 573 CIIHCDIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
I H D+K EN LLD K+ DFG +K + GT Y+APE +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQE 193
Query: 631 IT-TKADVYSYGMTLLELIGGR 651
ADV+S G+TL ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 28/199 (14%)
Query: 459 SEKLGHGGFGAVFQG-ELSDSTLVAVKRLE---RPGSGEREFRAEVCTIGNIQHV-NLVR 513
S++LG G F V Q S A K L+ R E E+ + + ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 514 LRGFCSENSHRLLVYDYMRNGAL--SLYLRKDGLNLNWDVRF--RIAVGTAR----GIAY 565
L S +L+ +Y G + + + G+ Y
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYY 146
Query: 566 LHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
LH+ I+H D+KP+NILL K+ DFG+++ I + L + GT Y+A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLA 201
Query: 623 PEWISGLAITTKADVYSYG 641
PE ++ ITT D+++ G
Sbjct: 202 PEILNYDPITTATDMWNIG 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRAEVCTI-GNIQHVNLVRLR 515
++G G +G+V + ++AVK R +++ ++ + + +V+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 516 GFCSENSHRLLVYDYMRNGALSLY---LRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
G + + M Y + ++ +I + T + + +L E +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI- 631
IIH DIKP NILLD K+ DFG++ + ++ G Y+APE I A
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASR 203
Query: 632 ---TTKADVYSYGMTLLELIGGR 651
++DV+S G+TL EL GR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 56/256 (21%), Positives = 97/256 (37%), Gaps = 49/256 (19%)
Query: 420 MILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRG-----------FSEKLGHGGFG 468
++ + KR+ + E + KVF + +L + S+ LG G G
Sbjct: 91 LVGKGKRRPLNNNSEI-ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACG 149
Query: 469 AVFQG-ELSDSTLVAVKRLERPGSGERE---------FRAEVCTIGNIQHVNLVRLRGFC 518
V E VA++ + + E+ + + H +++++ F
Sbjct: 150 EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209
Query: 519 SENSHRLLVYDYMRNGAL-------SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ +V + M G L F + + YLHE
Sbjct: 210 DAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYLHENG- 259
Query: 572 DCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
IIH D+KPEN+LL S D K++DFG +K++G ++ T+ GT Y+APE +
Sbjct: 260 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVS 315
Query: 629 LAI---TTKADVYSYG 641
+ D +S G
Sbjct: 316 VGTAGYNRAVDCWSLG 331
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 49/200 (24%), Positives = 77/200 (38%), Gaps = 29/200 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE--FRAEVCTIGNIQHVNLVRL 514
F KLG G FG V E S +K + + S AE+ + ++ H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 515 RGFCSENSHRLLVYDYMRNGAL----SLYLRKDGLNLNWDVRF--RIAVGTAR----GIA 564
+ + +V + G L + + +A
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-------ALSEGYVAELMKQMMNALA 138
Query: 565 YLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV 621
Y H + ++H D+KPENIL K+ DFGLA+L D GT Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYM 193
Query: 622 APEWISGLAITTKADVYSYG 641
APE +T K D++S G
Sbjct: 194 APEVFKR-DVTFKCDIWSAG 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 30/202 (14%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVK-------RLERPGSGEREFRAEVCTIGNIQHV 509
E+LG G F V + E S A K + R G + EV + IQH
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GI 563
N++ L + +L+ + + G L +L + A + G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILNGV 127
Query: 564 AYLHEECRDCIIHCDIKPENILLDS----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWG 619
YLH I H D+KPENI+L K+ DFGLA I DF + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 182
Query: 620 YVAPEWISGLAITTKADVYSYG 641
+VAPE ++ + +AD++S G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIG 204
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 67/259 (25%), Positives = 101/259 (38%), Gaps = 36/259 (13%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRG 516
LG GGFG V ++ + + A K+LE+ GE E + + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNL--NWDVRFRIAVGTARGIAYLHEECRDC 573
+ E L LV M G L ++ G F A G+ LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER--- 306
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
I++ D+KPENILLD ++SD GLA + + + GT GY+APE + T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 634 KADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF---------FPPW---A 681
D ++ G L E+I G+ +P R I ++ +
Sbjct: 365 SPDWWALGCLLYEMIAGQ----SPFQQRKKKI-----KREEVERLVKEVPEEYSERFSPQ 415
Query: 682 ARQIIEGNVAAVVDDRLGG 700
AR + + +RLG
Sbjct: 416 ARSLCSQLLCKDPAERLGC 434
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVR---- 513
E +G+G +G V++G + L A+K ++ G E E + E+ + H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 514 -LRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFR---IAV---GTARGIAY 565
++ +L LV ++ G+++ D + + IA RG+++
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVT-----DLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT--WGYVAP 623
LH+ +IH DIK +N+LL + K+ DFG++ + R R T GT W +AP
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYW--MAP 198
Query: 624 EWISGLAIT-----TKADVYSYGMTLLELIGG 650
E I+ K+D++S G+T +E+ G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK----RLERPGSGEREFRAEVCTIGNIQHVNLVRL 514
++GHG FGAV+ ++ +S +VA+K ++ ++ EV + ++H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAV---GTARGIAYLHEEC 570
RG LV +Y A L L IA G +G+AYLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLHSHN 174
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGL-AKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
+IH D+K NILL K+ DFG + + + + GT ++APE I +
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAM 225
Query: 630 ---AITTKADVYSYGMTLLELIGG 650
K DV+S G+T +EL
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAER 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLER--------PGSGEREFRAEVCTIGNIQHV- 509
LG GGFG+V+ G +SD+ VA+K +E+ +G R EV + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGF 107
Query: 510 -NLVRLRGFCSENSHRLLVYDYMRN-GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
++RL + +L+ + L ++ + G L ++ + + H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH 166
Query: 568 EECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
++H DIK ENIL+D + K+ DFG L+ GT Y PEWI
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 220
Query: 627 SGLAIT-TKADVYSYGMTLLELIGGR 651
A V+S G+ L +++ G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 35/207 (16%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLER---------PGSGEREFRAEVCTIGNI- 506
+ +G G V + + AVK +E R E + +
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 507 QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR--- 561
H +++ L +S LV+D MR G L YL + + R
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-------ALSEKETRSIMRSLL 210
Query: 562 -GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGY 620
+++LH I+H D+KPENILLD + ++SDFG + + L + GT GY
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGY 265
Query: 621 VAPEWISGLAITT------KADVYSYG 641
+APE + T + D+++ G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRA-----EVCTIGNIQHVNLVR 513
+LG G +G V + + ++AVKR+ R +E + ++ ++ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDI-SMRTVDCPFTVT 70
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLY--LRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
G + + M Y + G + D+ +IAV + + +LH +
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGL-AKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
+IH D+KP N+L+++ K+ DFG+ L+ G Y+APE I+
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPEL 185
Query: 631 I----TTKADVYSYGMTLLELIGGR 651
+ K+D++S G+T++EL R
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILR 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 24/194 (12%)
Query: 459 SEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRG 516
+ LG G F + + AVK + + E + E+ + + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLHEEC 570
+ H LV + + G L ++K F A R ++++H+
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKK-------HFSETEASYIMRKLVSAVSHMHDV- 125
Query: 571 RDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
++H D+KPEN+L + + K+ DFG A+L ++ L T T Y APE ++
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPELLN 182
Query: 628 GLAITTKADVYSYG 641
D++S G
Sbjct: 183 QNGYDESCDLWSLG 196
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 49/267 (18%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIG------NIQHVNLVRL 514
LG GGFG VF ++ + L A K+L + +R+ + + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKVHSRFIVSL 250
Query: 515 RGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAY 565
+ E L LV M G + ++ + F+ A G+ +
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVD---EDNPGFQEP--RAIFYTAQIVSGLEH 304
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
LH+ II+ D+KPEN+LLD D ++SD GLA + ++ GT G++APE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-KGYAGTPGFMAPEL 360
Query: 626 ISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF--------- 676
+ G D ++ G+TL E+I R P R + +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR----GPFRARGEKV-----ENKELKQRVLEQAVT 411
Query: 677 FPPW---AARQIIEGNVAAVVDDRLGG 700
+P A++ E + + RLG
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGF 438
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G FG V G+ VAVK ++ + R E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLH 567
S S +V +Y+ G L Y+ K+G R+ +R G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCH 133
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R ++H D+KPEN+LLD+ AK++DFGL+ ++ L T G+ Y APE IS
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVIS 188
Query: 628 GLA-ITTKADVYSYGMTLLELIGGR 651
G + D++S G+ L L+ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-21
Identities = 43/181 (23%), Positives = 70/181 (38%), Gaps = 19/181 (10%)
Query: 484 KRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY---DYMRNGALSLYL 540
+ + P S A I + + G +S ++ +Y R L ++
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 541 --RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598
R + V I + A + +LH + ++H D+KP NI D KV DFG
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 599 LAKLIGRD-----------FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLEL 647
L + +D GT Y++PE I G + K D++S G+ L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 648 I 648
+
Sbjct: 270 L 270
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 1e-20
Identities = 43/212 (20%), Positives = 69/212 (32%), Gaps = 28/212 (13%)
Query: 460 EKLGHG--GFGAVFQG-ELSDSTLVAVKR--LER-PGSGEREFRAEVCTIGNIQHVNLVR 513
+G G V V V+R LE + E+ H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 514 LRGFCSENSHRLLVYDYMRNGALSLYLR---KDGLNLNWDVRFRIAV---GTARGIAYLH 567
R ++ +V +M G+ + DG+N IA G + + Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIH 145
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYV------ 621
+H +K +IL+ D +S + R V
Sbjct: 146 HMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 622 APEWISGLAI--TTKADVYSYGMTLLELIGGR 651
+PE + K+D+YS G+T EL G
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLER----------PGSGEREFRAEVCTIGNIQH 508
LG G FG V+ + V VK +++ + E+ + ++H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEH 88
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
N++++ LV + +G L ++ + L+ + I + YL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR 147
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
IIH DIK ENI++ D+T K+ DFG A + R ++ T GT Y APE +
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPEVLM 202
Query: 628 GLA-ITTKADVYSYGMTLLELIGGR 651
G + +++S G+TL L+
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 45/196 (22%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIG-NIQHVNLVRLR 515
E +G G + + + + AVK +++ +R+ E+ + QH N++ L+
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLK 82
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLHEE 569
+ + +V + M+ G L + + F R A + YLH +
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQK-------FFSEREASAVLFTITKTVEYLHAQ 135
Query: 570 CRDCIIHCDIKPENILLDSD----YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
++H D+KP NIL + + ++ DFG AK + R + +L T T +VAPE
Sbjct: 136 ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTANFVAPEV 191
Query: 626 ISGLAITTKADVYSYG 641
+ D++S G
Sbjct: 192 LERQGYDAACDIWSLG 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 56/205 (27%), Positives = 82/205 (40%), Gaps = 33/205 (16%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLE-RPGSGEREFRAEVCTIGNIQ-HVNLVRLRG 516
+ LG G V L S AVK +E +PG EV + Q H N++ L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLHEEC 570
F E LV++ MR G++ ++ K F A + + +LH +
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRR-------HFNELEASVVVQDVASALDFLHNK- 130
Query: 571 RDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLI--GRDFSRV----LATMRGTWGYV 621
I H D+KPENIL + K+ DF L I D S + L T G+ Y+
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 622 APEWISGLAITTK-----ADVYSYG 641
APE + + D++S G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 56/207 (27%), Positives = 80/207 (38%), Gaps = 22/207 (10%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTI-----------GNIQ 507
LG GGFG VF G L+D VA+K + R ++ T
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
H ++RL + +LV + L Y+ + G L I +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC 155
Query: 567 HEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEW 625
H ++H DIK ENIL+D AK+ DFG L+ + GT Y PEW
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEW 209
Query: 626 ISGLAIT-TKADVYSYGMTLLELIGGR 651
IS A V+S G+ L +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 462 LGHGGFGAVFQGE-LSDSTLVAVK-----RLERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G FG V VA+K L++ R R E+ + ++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTAR--------GIAYLH 567
+ + ++V +Y G L Y+ + R+ R I Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCH 125
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
R I+H D+KPEN+LLD + K++DFGL+ ++ L T G+ Y APE I+
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVIN 180
Query: 628 GLAIT-TKADVYSYGMTLLELIGGR 651
G + DV+S G+ L ++ GR
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVK-----RLERPGSGEREFRA--------------- 498
+++G G +G V +D+T A+K +L R R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 499 -------EVCTIGNIQHVNLVRLRG--FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNW 549
E+ + + H N+V+L H +V++ + G + L+ +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED- 137
Query: 550 DVRFRIAVGTAR--------GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601
AR GI YLH IIH DIKP N+L+ D K++DFG++
Sbjct: 138 ---------QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAIT---TKADVYSYGMTLLELIGGR 651
+L+ GT ++APE +S DV++ G+TL + G+
Sbjct: 186 EFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 28/253 (11%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
LG G FG V + + A+K L++ ++ E + N +H L L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + RL V +Y G L +L ++ + RF A + YLH E ++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVV 271
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+K EN++LD D K++DFGL K G + T GT Y+APE +
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AARQIIE 687
D + G+ + E++ GR P ++ I ++ FP A+ ++
Sbjct: 331 DWWGLGVVMYEMMCGR----LPFYNQDHEKLFELI-----LMEEIRFPRTLGPEAKSLLS 381
Query: 688 GNVAAVVDDRLGG 700
G + RLGG
Sbjct: 382 GLLKKDPKQRLGG 394
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 31/219 (14%)
Query: 437 VFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE 495
+F K ++ + + +++ + LG G G V + A+K L +E
Sbjct: 15 LFQGPEPKKYAVTDDYQLSK---QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE 71
Query: 496 FRAEVCTIGNIQHVNLVRLRGFCSENSHR----LLVYDYMRNGALSLYLRKDGLNLNWDV 551
G ++V + H L++ + M G L +++ G D
Sbjct: 72 VDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG-----DQ 123
Query: 552 RF--RIAVGTAR----GIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKL 602
F R A R I +LH I H D+KPEN+L + D K++DFG AK
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYG 641
++ L T T YVAPE + D++S G
Sbjct: 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 39/298 (13%), Positives = 76/298 (25%), Gaps = 67/298 (22%)
Query: 460 EKLGHGGFGAVFQGELSDSTL---VAVKRLERPGSGEREFRAEVC----TIGNIQHVNLV 512
G +Q D+ L VA+ ++ G + E + I +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
R+ + L+V +++R G+L + + R A H R
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
+ P + + D ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------N 180
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692
+ D+ G +L L+ R P G D P I +
Sbjct: 181 PQDDIRGIGASLYALLVNRW----PLPEAGVRSGLAPAERDTAGQPI-EPADIDRD-IPF 234
Query: 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP--TMGTVVKMLEGVLEVTAPPPPR 748
+ VA +Q + +R T+ +++ V + T P
Sbjct: 235 QISA----------------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPI 276
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCS 519
+ +G+G FG VFQ +L +S VA+K++ + + R E+ + ++H N+V L+ F
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDK--RFKNR-ELQIMRIVKHPNVVDLKAFFY 102
Query: 520 ENSHRL------LVYDYMRNGALSLY-----LRKDGLNLNWD-VRFRIAVGTARGIAYLH 567
N + LV +Y+ ++Y K + ++ + R +AY+H
Sbjct: 103 SNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYIH 158
Query: 568 EECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPE 624
I H DIKP+N+LLD K+ DFG AK++ G + + R + Y APE
Sbjct: 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS-R--Y-YRAPE 211
Query: 625 WISGLAI-TTKADVYSYGMTLLELIGGR 651
I G TT D++S G + EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKR-LERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
G G FG V G+ + VA+K+ ++ P RE + + + + H N+V+L+ +
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSY 87
Query: 518 CSENSHR-------LLVYDYMRNGALSLY-----LRKDGLNLNWD-VRFRIAVGTARGIA 564
R +V +Y+ +L+ + + ++ + R I
Sbjct: 88 FYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKVFL-FQLIRSIG 143
Query: 565 YLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDFSRV--LATMRGTWGYV 621
LH + + H DIKP N+L++ +D T K+ DFG AK + V + + R + Y
Sbjct: 144 CLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS-R--Y-YR 198
Query: 622 APEWISGLAI-TTKADVYSYGMTLLELIGGR 651
APE I G TT D++S G E++ G
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
+G G + V L + + A+K +++ + E ++ H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLV 73
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEEC 570
L C + RL V +Y+ G L ++++ RF A + A + YLHE
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG 130
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
II+ D+K +N+LLDS+ K++D+G+ K G +T GT Y+APE + G
Sbjct: 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF---------FPPW- 680
D ++ G+ + E++ GR +P ++ D F P
Sbjct: 187 YGFSVDWWALGVLMFEMMAGR----SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
Query: 681 --AARQIIEGNVAAVVDDRLGGAYKVEEAE 708
A +++ + +RLG + A+
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFAD 272
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 5e-19
Identities = 67/257 (26%), Positives = 109/257 (42%), Gaps = 36/257 (14%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
LG G FG V E + L AVK L++ + + +V CT+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD---DVECTMVEKRVLALPGKPPFLT 405
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+L C + RL V +Y+ G L ++++ G F A A G+ +L +
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKG- 462
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
II+ D+K +N++LDS+ K++DFG+ K T GT Y+APE I+
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AAR 683
D +++G+ L E++ G+ AP G + +I +P A
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ----APFEGEDEDELFQSI-----MEHNVAYPKSMSKEAV 570
Query: 684 QIIEGNVAAVVDDRLGG 700
I +G + RLG
Sbjct: 571 AICKGLMTKHPGKRLGC 587
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 73/264 (27%), Positives = 110/264 (41%), Gaps = 38/264 (14%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
+G G FG V AVK L++ +++ E + N++H LV
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLV 102
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEEC 570
L F + + +L V DY+ G L +L+++ L RF A + +A + YLH
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYLHSLN 159
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
I++ D+KPENILLDS ++DFGL K + + +T GT Y+APE +
Sbjct: 160 ---IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AA 682
D + G L E++ G P RN NI P +A
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGL----PPFYSRNTAEMYDNI-----LNKPLQLKPNITNSA 266
Query: 683 RQIIEGNVAAVVDDRLGGAYKVEE 706
R ++EG + RLG E
Sbjct: 267 RHLLEGLLQKDRTKRLGAKDDFME 290
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 29/253 (11%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
LG G FG V + A+K L + ++ E + N +H L L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ + RL V +Y G L +L ++ + RF A + YLH ++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD---VV 127
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ DIK EN++LD D K++DFGL K G + T GT Y+APE +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AARQIIE 687
D + G+ + E++ GR P ++ I ++ FP A+ ++
Sbjct: 187 DWWGLGVVMYEMMCGR----LPFYNQDHERLFELI-----LMEEIRFPRTLSPEAKSLLA 237
Query: 688 GNVAAVVDDRLGG 700
G + RLGG
Sbjct: 238 GLLKKDPKQRLGG 250
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 61/270 (22%), Positives = 110/270 (40%), Gaps = 37/270 (13%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
+G G + V L + + A++ +++ + E ++ H LV
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLV 116
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEEC 570
L C + RL V +Y+ G L ++++ RF A + A + YLHE
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG 173
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA 630
II+ D+K +N+LLDS+ K++D+G+ K G +T GT Y+APE + G
Sbjct: 174 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF---------FPPW- 680
D ++ G+ + E++ GR +P ++ D F P
Sbjct: 230 YGFSVDWWALGVLMFEMMAGR----SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
Query: 681 --AARQIIEGNVAAVVDDRLGGAYKVEEAE 708
A +++ + +RLG + A+
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFAD 315
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 36/258 (13%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
LG G FG VF E + A+K L++ + +V CT+ +H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLAWEHPFLT 81
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ + L V +Y+ G L +++ F A G+ +LH +
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLHSKG- 138
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
I++ D+K +NILLD D K++DFG+ K T GT Y+APE + G
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AAR 683
D +S+G+ L E++ G+ +P G++ +I D F+P W A+
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ----SPFHGQDEEELFHSI-----RMDNPFYPRWLEKEAK 246
Query: 684 QIIEGNVAAVVDDRLGGA 701
++ + RLG
Sbjct: 247 DLLVKLFVREPEKRLGVR 264
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 61/253 (24%), Positives = 100/253 (39%), Gaps = 32/253 (12%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
LG G FG V + +S A+K L++ + + E + + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECRDCII 575
+NS+ +V +Y+ G + +LR+ G RF A + YLH +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSLD---LI 163
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+KPEN+L+D +V+DFG AK + T+ GT +APE I
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRNA-----NIGGGGEHGDKWFFPPW---AARQIIE 687
D ++ G+ + E+ G P I G K FP + ++
Sbjct: 220 DWWALGVLIYEMAAGY----PPFFADQPIQIYEKIVSG-----KVRFPSHFSSDLKDLLR 270
Query: 688 GNVAAVVDDRLGG 700
+ + R G
Sbjct: 271 NLLQVDLTKRFGN 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
K+G G +G VF+ D+ +VA+K+ + P + R E+ + ++H NLV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 67
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
LV++Y + + L + + + I T + + + H +
Sbjct: 68 LEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNC 123
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISGLAI 631
IH D+KPENIL+ K+ DFG A+L+ + +AT W Y +PE + G
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---W-YRSPELLVGDTQ 179
Query: 632 -TTKADVYSYGMTLLELIGGR 651
DV++ G EL+ G
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 67/257 (26%), Positives = 109/257 (42%), Gaps = 36/257 (14%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
LG G FG V E + L AVK L++ + + +V CT+ + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD---DVECTMVEKRVLALPGKPPFLT 84
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+L C + RL V +Y+ G L ++++ G F A A G+ +L +
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKG- 141
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
II+ D+K +N++LDS+ K++DFG+ K T GT Y+APE I+
Sbjct: 142 --IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQPY 198
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AAR 683
D +++G+ L E++ G+ AP G + +I +P A
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ----APFEGEDEDELFQSI-----MEHNVAYPKSMSKEAV 249
Query: 684 QIIEGNVAAVVDDRLGG 700
I +G + RLG
Sbjct: 250 AICKGLMTKHPGKRLGC 266
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
EK+G G +G VF+ +VA+K RL+ P S RE +C + ++H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNI 63
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
VRL + LV+++ + L Y +L+ ++ +G+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISG 628
++H D+KP+N+L++ + K+++FGLA+ G R +S + T+ W Y P+ + G
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---W-YRPPDVLFG 175
Query: 629 LAI-TTKADVYSYGMTLLELIGGRR 652
+ +T D++S G EL R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVK------RLERPGSGEREF-----RAEVCTIGNIQ 507
KLG G F V+ + + ++T VA+K E + A+ ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 508 HVNLVRLRG---FCSEN-SHRLLVYDYMRNGALSLY-LRKD----GLNLNWDVRFRIAVG 558
++++L N H ++V++ + +L L K G+ L V+ +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLG---ENLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLD------SDYTAKVSDFGLAKLIGRDFSRVLA 612
G+ Y+H C IIH DIKPEN+L++ + K++D G A ++ +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
T R Y +PE + G AD++S + ELI G
Sbjct: 198 T-R---EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 39/259 (15%)
Query: 462 LGHGGFGAVFQGELSDS----TLVAVKRLERPGSGEREFRAEVCTIG------NIQHVNL 511
LG G FG VF + L A+K L++ R+ V T + H +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 512 VRLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEE 569
V+L + + +L L+ D++R G L L K+ + DV+F +A + A + +LH
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA--LDHLHSL 145
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
II+ D+KPENILLD + K++DFGL+K D + + GT Y+APE ++
Sbjct: 146 G---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 630 AITTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---A 681
T AD +S+G+ + E++ G P G++ I K P +
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGT----LPFQGKDRKETMTMI-----LKAKLGMPQFLSPE 252
Query: 682 ARQIIEGNVAAVVDDRLGG 700
A+ ++ +RLG
Sbjct: 253 AQSLLRMLFKRNPANRLGA 271
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 32/253 (12%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPG---SGERE-FRAEVCTIGNIQHVNLVRLRG 516
LG G FG V + A+K L++ + E E + + H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECRDCII 575
+ ++ DY+ G L LRK N +F A V A + YLH + II
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSKD---II 128
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
+ D+KPENILLD + K++DFG AK + V T+ GT Y+APE +S
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPYNKSI 184
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRNA-----NIGGGGEHGDKWFFPPW---AARQIIE 687
D +S+G+ + E++ G P N I + FPP+ + ++
Sbjct: 185 DWWSFGILIYEMLAGY----TPFYDSNTMKTYEKILNA-----ELRFPPFFNEDVKDLLS 235
Query: 688 GNVAAVVDDRLGG 700
+ + RLG
Sbjct: 236 RLITRDLSQRLGN 248
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 36/265 (13%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEV-CTIG-------NIQHVNLV 512
LG G FG V + ++ L AVK L++ + + +V CT+ H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD---DVECTMTEKRILSLARNHPFLT 87
Query: 513 RLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+L C + RL V +++ G L +++K RF A + +LH++
Sbjct: 88 QLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EIISALMFLHDKG- 144
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
II+ D+K +N+LLD + K++DFG+ K G AT GT Y+APE + +
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---AAR 683
D ++ G+ L E++ G AP N I D+ +P W A
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH----APFEAENEDDLFEAI-----LNDEVVYPTWLHEDAT 252
Query: 684 QIIEGNVAAVVDDRLGGAYKVEEAE 708
I++ + RLG + E
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHA 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 58/249 (23%), Positives = 94/249 (37%), Gaps = 31/249 (12%)
Query: 462 LGHGGFGAVFQGELSDSTLV-AVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G F V ++ + V A+K + + +R FR E + N + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWD-VRFRIAVGTARGIAYLHEECRDCI 574
F ++ + L LV +Y G L L K G + + RF +A I +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---Y 183
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
+H DIKP+NILLD +++DFG + D + GT Y++PE + +
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 635 ADVY-------SYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW-- 680
Y + G+ E+ G + P + I EH
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYG----QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 681 -AARQIIEG 688
AR I+
Sbjct: 300 EEARDFIQR 308
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVK--RLER----PGSGEREFRAEVCTIGNIQHVNLV 512
+KLG G + V++G+ + LVA+K RLE P + RE V + +++H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
L LV++Y+ + L YL G +N RG+AY H R
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQ 119
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISGL 629
++H D+KP+N+L++ K++DFGLA+ + + + T+ W Y P+ + G
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---W-YRPPDILLGS 175
Query: 630 AI-TTKADVYSYGMTLLELIGGR 651
+T+ D++ G E+ GR
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 460 EKLGHGGFGAVFQGELSDST--LVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVN 510
EK+G G +G V++ + ++ A+K RLE+ P + RE + + ++H N
Sbjct: 8 EKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKHSN 61
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+V+L +LV++++ L L L + GIAY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWIS 627
++H D+KP+N+L++ + K++DFGLA+ G R ++ + T+ W Y AP+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL---W-YRAPDVLM 173
Query: 628 GLAI-TTKADVYSYGMTLLELIGGR 651
G +T D++S G E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 41/214 (19%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG-F 517
+ +G+G FG V+Q +L DS LVA+K++ + + R E+ + + H N+VRLR F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNR-ELQIMRKLDHCNIVRLRYFF 116
Query: 518 CSENSHRL-----LVYDYMRNGALSLY-----LRKDGLNLNWD-VRFRIAVGTARGIAYL 566
S + LV DY+ ++Y + L V+ + R +AY+
Sbjct: 117 YSSGEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYI 172
Query: 567 HEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRD-------FSRVLATMRGTW 618
H I H DIKP+N+LLD D K+ DFG AK + R SR +
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--------Y 221
Query: 619 GYVAPEWISGLAI-TTKADVYSYGMTLLELIGGR 651
Y APE I G T+ DV+S G L EL+ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
+G G +G V + +VA+K+ + + R E+ + ++H NLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNL 89
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
C + LV++++ + + L L++ V + GI + H I
Sbjct: 90 LEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNI 145
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISGLAI 631
IH DIKPENIL+ K+ DFG A+ + + +AT W Y APE + G
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---W-YRAPELLVGDVK 201
Query: 632 TTKA-DVYSYGMTLLELIGGR 651
KA DV++ G + E+ G
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNLV 512
EK+G G +G V++ + S +VA+K RL+ P + RE + + + H N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIV 82
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
L LV+++M L L ++ L RG+A+ H +
Sbjct: 83 SLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QH 138
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISGL 629
I+H D+KP+N+L++SD K++DFGLA+ G R ++ + T+ W Y AP+ + G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL---W-YRAPDVLMGS 194
Query: 630 AI-TTKADVYSYGMTLLELIGGR 651
+T D++S G E+I G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 37/259 (14%)
Query: 462 LGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGEREFRAEVCTIG------NIQHVNL 511
LG GG+G VFQ + + A+K L++ T ++H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAERNILEEVKHPFI 83
Query: 512 VRLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEE 569
V L + + +L L+ +Y+ G L + L ++G+ + F +A + A + +LH++
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA--LGHLHQK 140
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
II+ D+KPENI+L+ K++DFGL K V T GT Y+APE +
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 630 AITTKADVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPW---A 681
D +S G + +++ G P +G N I K PP+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGA----PPFTGENRKKTIDKI-----LKCKLNLPPYLTQE 247
Query: 682 ARQIIEGNVAAVVDDRLGG 700
AR +++ + RLG
Sbjct: 248 ARDLLKKLLKRNAASRLGA 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 59/238 (24%), Positives = 89/238 (37%), Gaps = 40/238 (16%)
Query: 423 RKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQG-ELSDSTLV 481
+ + + V L +K + + + V S+ LG G G V Q
Sbjct: 34 QPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKF 90
Query: 482 AVKRLERPGSGEREFRAEVCTIGNI-----QHVNLVRLRGFC----SENSHRLLVYDYMR 532
A+K L+ + R EV + Q ++VR+ + L+V + +
Sbjct: 91 ALKMLQD----CPKARREV----ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142
Query: 533 NGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYLHEECRDCIIHCDIKPENILL 586
G L ++ G D F R A + I YLH I H D+KPEN+L
Sbjct: 143 GGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 194
Query: 587 DS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYG 641
S + K++DFG AK L T T YVAPE + D++S G
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREFRA----EVCTIGNIQHVNLV 512
+ LG G F V++ + + + +VA+K +L + E+ + + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
L S+ LV+D+M L + ++ + L L + T +G+ YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAPEWISGL 629
I+H D+KP N+LLD + K++DFGLAK G R ++ + T W Y APE + G
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---W-YRAPELLFGA 187
Query: 630 AI-TTKADVYSYGMTLLELIGGR 651
+ D+++ G L EL+
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 462 LGHGGFGAVFQGELSDS-TLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V +L ++ + A+K L + +R FR E + N + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRK-DGLNLNWDVRFRIA-VGTARGIAYLHEECRDC 573
+ ++ + L LV DY G L L K + RF +A + A I +H+
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQLH--- 195
Query: 574 IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITT 633
+H DIKP+NIL+D + +++DFG + D + + GT Y++PE + +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 634 K-----ADVYSYGMTLLELIGGR 651
D +S G+ + E++ G
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 462 LGHGGFGAVFQ-GELSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRLRG 516
+G G FG V S + A+K L + +R F E + +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHEECRDCI 574
+ ++ L +V +YM G L + + W RF A V A + +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFYTAEVVLA--LDAIHSMG---F 189
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
IH D+KP+N+LLD K++DFG + ++ T GT Y++PE +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 635 ----ADVYSYGMTLLELIGGR 651
D +S G+ L E++ G
Sbjct: 250 YGRECDWWSVGVFLYEMLVGD 270
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 462 LGHGGFGAVFQGELSDS----TLVAVKRLERPGSGEREFRAEVCTIG--NI-QHVN---- 510
LG G +G VF L A+K L++ ++ E T + +H+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLEHIRQSPF 120
Query: 511 LVRLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIA-VGTARGIAYLHE 568
LV L + + +L L+ DY+ G L +L + +V+ + + A + +LH+
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA--LEHLHK 177
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
II+ DIK ENILLDS+ ++DFGL+K D + GT Y+AP+ + G
Sbjct: 178 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 629 LAI--TTKADVYSYGMTLLELIGGR 651
D +S G+ + EL+ G
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 448 YKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE------------ 493
ELH + ++ + G +GAV G S+ VA+KR+ S
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 494 -REFRAEVCTIGNIQHVNLVRLRG-FCSENSHRL----LVYDYMRNGALSLYLRKDGLNL 547
R R E+ + + H N++ LR F + LV + MR L+ + + +
Sbjct: 74 KRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVI 131
Query: 548 NWD-VRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606
+ +++ G+ LHE ++H D+ P NILL + + DF LA+ D
Sbjct: 132 SPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 607 FSRV--LATMRGTWGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
++ + W Y APE + TK D++S G + E+ +
Sbjct: 188 ANKTHYVTHR---W-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-------- 510
+G G FG V + + VA+K ++ + + + ++ +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 511 -LVRLRGFCSENSHRLLVYDYMRNGALSLY--LRKD---GLNLNWDVRFRIAVGTARGIA 564
+V L+ +H LV++ + + +LY LR G++LN R + A +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLN-LTR-KFAQQMCTALL 171
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
+L IIHCD+KPENILL + + K+ DFG + +G+ + + + R Y +
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-R---FYRS 226
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGR 651
PE + G+ D++S G L+E+ G
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRL 514
+ +G G +GAV + VA+K+L RP +R +R E+ + +++H N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 515 RG-FCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLH 567
F + + LV +M L ++ + L + R + + +G+ Y+H
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLRYIH 145
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
IIH D+KP N+ ++ D K+ DFGLA+ + + + T W Y APE I
Sbjct: 146 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR---W-YRAPEVIL 198
Query: 628 GLAITTKA-DVYSYGMTLLELIGGR 651
T+ D++S G + E+I G+
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-------- 510
+ +G G FG V + VA+K + + +R R I ++H+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 511 -LVRLRGFCSENSHRLLVYDYMRNGALSLY--LRKD---GLNLNWDVRFRIAVGTARGIA 564
++ + + +H + ++ + +++LY ++K+ G +L VR + A + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLP-LVR-KFAHSILQCLD 214
Query: 565 YLHEECRDCIIHCDIKPENILLDSDYTA--KVSDFGLAKLIGRDFSRVLATMRGTWGYVA 622
LH+ R IIHCD+KPENILL + KV DFG + + + + Y A
Sbjct: 215 ALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----YRA 267
Query: 623 PEWISGLAITTKADVYSYGMTLLELIGGR 651
PE I G D++S G L EL+ G
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER----PGSGEREFRAEVCTIGNIQHVNLV 512
EKLG+G + V++G + VA+K +L+ P + RE + + ++H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVG------TARGIAYL 566
RL + LV+++M + L Y+ N + + +G+A+
Sbjct: 67 RLYDVIHTENKLTLVFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---RDFSRVLATMRGTWGYVAP 623
H + I+H D+KP+N+L++ K+ DFGLA+ G FS + T+ W Y AP
Sbjct: 125 H---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL---W-YRAP 177
Query: 624 EWISGLAI-TTKADVYSYGMTLLELIGGR 651
+ + G +T D++S G L E+I G+
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRL 514
+ +G G G V + VA+K+L RP +R +R E+ + + H N++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 515 RG-FCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLH 567
F + S +V + M + L ++ + R + GI +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH 144
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
IIH D+KP NI++ SD T K+ DFGLA+ G F ++ T Y APE I
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 199
Query: 628 GLAITTKADVYSYGMTLLELIGGR 651
G+ D++S G + E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 48/218 (22%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLER-----PGSGEREFRAEVCTIGNIQHVNL 511
KLG G +G V++ + + VA+K RLE PG+ RE V + +QH N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHRNI 95
Query: 512 VRLRGFCSENSHRLLVYDYM---------RNGALSLYLRKDGLNLNWDVRFRIAVGTARG 562
+ L+ N L+++Y +N +S+ + K G
Sbjct: 96 IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIK-----------SFLYQLING 144
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTA-----KVSDFGLAKLIG---RDFSRVLATM 614
+ + H +H D+KP+N+LL + K+ DFGLA+ G R F+ + T+
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 615 RGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGR 651
W Y PE + G +T D++S E++
Sbjct: 202 ---W-YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 453 TVTRGFS--EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE----REFRAEVCTIGN 505
TV + + + +G G G V + VA+K+L RP + R +R E+ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117
Query: 506 IQHVNLVRLRG-FCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAV-G 558
+ H N++ L F + + LV + M + L ++ + R +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERMSYLLYQ 172
Query: 559 TARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW 618
GI +LH IIH D+KP NI++ SD T K+ DFGLA+ G F ++ T
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTR 227
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
Y APE I G+ D++S G + E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRL 514
+G G +G+V S VA+K+L RP +R +R E+ + ++QH N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 515 RG-FCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE 568
F +S R LV +M L + +++ + +G+ Y+H
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEK--IQY-LVYQMLKGLKYIHS 144
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
++H D+KP N+ ++ D K+ DFGLA+ + + + T W Y APE I
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---W-YRAPEVILS 197
Query: 629 LAITTKA-DVYSYGMTLLELIGGR 651
+ D++S G + E++ G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 460 EKLGHGGFGAVFQG---ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
K+G G +G V++ + D A+K++E G R E+ + ++H N++ L+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 517 -FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTA--------RGIAYL 566
F S ++ L++DY + L ++ + ++ G GI YL
Sbjct: 86 VFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 567 HEECRDCIIHCDIKPENILLDSDYTA----KVSDFGLAKLIGR------DFSRVLATMRG 616
H + ++H D+KP NIL+ + K++D G A+L D V+ T
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF-- 199
Query: 617 TWGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
W Y APE + G TKA D+++ G EL+
Sbjct: 200 -W-YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRL 514
+G G +G+V + + VAVK+L RP +R +R E+ + +++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 515 RG-FCSENSHRL-----LVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLH 567
F S LV M L+ ++ L D + + RG+ Y+H
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLT---DDHVQFLIYQILRGLKYIH 149
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
IIH D+KP N+ ++ D K+ DFGLA+ + + +AT W Y APE +
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR---W-YRAPEIML 202
Query: 628 GLAITTKA-DVYSYGMTLLELIGGR 651
+ D++S G + EL+ GR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGEREF-----RAEVCT---IGNIQH 508
++G G +G V++ + VA+K R+ G G R EV + +H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEH 73
Query: 509 VNLVRLRGFCSENSHRL-----LVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARG 562
N+VRL C+ + LV++++ + L YL K L + + RG
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG--RDFSRVLATMRGTWGY 620
+ +LH +CI+H D+KPENIL+ S T K++DFGLA++ + V+ T+ W Y
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL---W-Y 185
Query: 621 VAPEWISGLAITTKADVYSYGMTLLELIGGR 651
APE + T D++S G E+ +
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 460 EKLGHGGFGAVFQGELSDST--LVAVK--RLER-----PGSGEREFRAEVCT---IGNIQ 507
++G G +G VF+ + VA+K R++ P S RE V + +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFE 72
Query: 508 HVNLVRLR----GFCSENSHRL-LVYDYMRNGALSLYL---RKDGLNLNWDVRFRIAVGT 559
H N+VRL ++ +L LV++++ + L+ YL + G+ ++ +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE-TIK-DMMFQL 129
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG--RDFSRVLATMRGT 617
RG+ +LH ++H D+KP+NIL+ S K++DFGLA++ + V+ T+
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL--- 183
Query: 618 WGYVAPEWISGLAITTKADVYSYGMTLLELIGGR 651
W Y APE + + T D++S G E+ +
Sbjct: 184 W-YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRL---ERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
LG G +G V + +VA+K++ ++P R R E+ + + +H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIF 75
Query: 516 G-FCSENSHRL----LVYDYM--------RNGALSLYLRKDGLNLNWDVRFR-IAVGTAR 561
++ ++ + M LS D + T R
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS------------DDHIQYFIYQTLR 123
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW--- 618
+ LH +IH D+KP N+L++S+ KV DFGLA++I +
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 619 GYV------APEWISGLAITTKA-DVYSYGMTLLELIGGR 651
+V APE + A ++A DV+S G L EL R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 36/216 (16%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVK--RLERPGSGERE------FRAEVCTIGNIQHVN 510
K+G G FG VF+ VA+K +E E+E R E+ + ++H N
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALR-EIKILQLLKHEN 77
Query: 511 LVRLRGFCSENSHRL--------LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARG 562
+V L C + LV+D+ + L+ L + R+ G
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGT----- 617
+ Y+H R+ I+H D+K N+L+ D K++DFGLA+ + T
Sbjct: 137 LYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNRVVT 191
Query: 618 -WGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGR 651
W Y PE + G D++ G + E+
Sbjct: 192 LW-YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRL---ERPGSGEREFRAEVCTIGNIQHVNLVRLR 515
+G G +G V + + VA+K++ E +R R E+ + +H N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 516 G-FCSENSHRL----LVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLHEE 569
+ ++ +V D M L L+ L+ + RG+ Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLS---NDHICYFLYQILRGLKYIHSA 147
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL------ATMRGTWGYVAP 623
++H D+KP N+LL++ K+ DFGLA++ D AT W Y AP
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR---W-YRAP 200
Query: 624 EWISGLAITTKA-DVYSYGMTLLELIGGR 651
E + TK+ D++S G L E++ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 50/244 (20%), Positives = 88/244 (36%), Gaps = 58/244 (23%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRL 514
+G G +G V+ ++ VA+K++ R R R E+ + ++ ++RL
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRL 90
Query: 515 RG-FCSENSHRL----LVYDYM---------RNGALSLYLRKDGLNLNWDVRFR-IAVGT 559
++ + +V + L+ + + I
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT------------EEHIKTILYNL 138
Query: 560 ARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW- 618
G ++HE IIH D+KP N LL+ D + KV DFGLA+ I + +
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 619 --------------GYV------APEWISGLAITTKA-DVYSYGMTLLELIGGRRNVEAP 657
+V APE I TK+ D++S G EL+ ++
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 658 ASGR 661
+ R
Sbjct: 256 PTNR 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/228 (22%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 460 EKLGHGGFGAVFQG--ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVN----- 510
LG G FG V + + VA+K R + + A I ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKE 79
Query: 511 ----LVRLRGFCSENSHRLLVYDYMRNGALSLY--LRK---DGLNLNWDVRFRIAVGTAR 561
V + + + + H + ++ + + + L++ L VR +A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLG---KNTFEFLKENNFQPYPLP-HVR-HMAYQLCH 134
Query: 562 GIAYLHEECRDCIIHCDIKPENILL-DSDYTA------------------KVSDFGLAKL 602
+ +LH E + + H D+KPENIL +S++ +V+DFG A
Sbjct: 135 ALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
+ ++AT R Y PE I L DV+S G L E G
Sbjct: 192 DHEHHTTIVAT-R---HYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRL--ERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+ LG GG G VF +D VA+K++ P S + R E+ I + H N+V++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFE 75
Query: 517 -FCSENSHRL-------------LVYDYM--------RNGALSLYLRKDGLNLNWDVRFR 554
S +V +YM G L + R
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL------------EEHAR 123
Query: 555 -IAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRV-- 610
RG+ Y+H ++H D+KP N+ +++ D K+ DFGLA+++ +S
Sbjct: 124 LFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 611 ----LATMRGTWGYVAPEWISGLAITTKA-DVYSYGMTLLELIGGR 651
L T + W Y +P + TKA D+++ G E++ G+
Sbjct: 181 LSEGLVT-K--W-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 52/232 (22%), Positives = 90/232 (38%), Gaps = 58/232 (25%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVN------ 510
K+G G FG V + + + AVK R + ++ R+ ++ +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINN 95
Query: 511 --LVRLRGFCSENSHRLLVYDYMRNGALSLY--LRK---DGLNLNWDVRFRIAVGTARGI 563
+V+ G H L+++ + SLY + + +G ++ D++ + + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLG---PSLYEIITRNNYNGFHIE-DIK-LYCIEILKAL 150
Query: 564 AYLHEECRDCIIHCDIKPENILL-DSDYTA------------------------KVSDFG 598
YL + + H D+KPENILL D + K+ DFG
Sbjct: 151 NYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
A ++ T R Y APE I L +D++S+G L EL G
Sbjct: 208 CATFKSDYHGSIINT-R---QYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 57/270 (21%), Positives = 89/270 (32%), Gaps = 85/270 (31%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGSGEREFRA------------- 498
+ LG G FG V + + + VAVK L + G+ E RA
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 84
Query: 499 ----------------------EVCTIGNIQH---VNLVRLRGFCSENSHRLLVYDYMRN 533
E C GN+ + ++ + DY+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 534 GALSLYLRKDGLNLNWDVR--------------------------------FRIAVGTAR 561
+ L R D + + + A+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 562 GIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD---FSRVLATMRGTW 618
G+ +L R CI H D+ NILL K+ DFGLA+ I +D + A + W
Sbjct: 205 GMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLELI 648
+APE I T ++DV+S+G+ L E+
Sbjct: 262 --MAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 54/228 (23%)
Query: 460 EKLGHGGFGAVFQG--ELSDSTLVAVK--RLERPGSGEREFRAEVCTIGNIQHVN----- 510
+ LG G FG V + + VAVK + + +R A I ++H+N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 511 ----LVRLRGFCSENSHRLLVYDYMRNGALSLY--LRKD---GLNLNWDVRFRIAVGTAR 561
V++ + + H +V++ + LS Y ++++ L+ +R ++A +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLG---LSTYDFIKENGFLPFRLD-HIR-KMAYQICK 129
Query: 562 GIAYLHEECRDCIIHCDIKPENILL-DSDYTA------------------KVSDFGLAKL 602
+ +LH + + H D+KPENIL SDYT KV DFG A
Sbjct: 130 SVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG 650
S +++T R Y APE I L + DV+S G L+E G
Sbjct: 187 DDEHHSTLVST-R---HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 55/237 (23%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
+ LG G FG V + +S A+K++ + + R E+ + + HVN+++L +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNR-ELDIMKVLDHVNIIKLVDYF 69
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVG-------------------- 558
+ L + +G+N +
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 559 --------------------TARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDF 597
R + ++H I H DIKP+N+L++S D T K+ DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 598 GLAKLIGRDFSRV--LATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGR 651
G AK + V + + + Y APE + G T D++S G ELI G+
Sbjct: 187 GSAKKLIPSEPSVAYICS---RF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 54/230 (23%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE----REFRAEVCTIGNIQ-HVNLVR 513
+KLG G +G V++ + +VAVK++ R FR E+ + + H N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 514 LRG-FCSENSHRL-LVYDYM--------RNGALSLYLRKDGLNLNWDVRFR-IAVGTARG 562
L ++N + LV+DYM R L V + + +
Sbjct: 74 LLNVLRADNDRDVYLVFDYMETDLHAVIRANILE------------PVHKQYVVYQLIKV 121
Query: 563 IAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW---- 618
I YLH ++H D+KP NILL+++ KV+DFGL++
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 619 ----------GYV------APEWISGLAITTKA-DVYSYGMTLLELIGGR 651
YV APE + G TK D++S G L E++ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 41/158 (25%), Positives = 58/158 (36%), Gaps = 25/158 (15%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
S+ LG G G V Q A+K L+ RE ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVD 78
Query: 517 FC----SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF--RIAVGTAR----GIAYL 566
+ L+V + + G L + D F R A + I YL
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL-----FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 567 HEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAK 601
H I H D+KPEN+L S + K++DFG AK
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 50/240 (20%), Positives = 93/240 (38%), Gaps = 45/240 (18%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRL----ERPGSGEREFRAEVCTIGNIQHVNLVRL 514
+G G +G V + + + +VA+K++ E +R R E+ + + H ++V++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKV 117
Query: 515 RG-FCSENSHRL----LVYDYMRNGALSLYLRKDGLNLNWD-VRFRIAVGTARGIAYLHE 568
++ + +V + + R + L ++ + G+ Y+H
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKT-LLYNLLVGVKYVHS 174
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTW---------- 618
I+H D+KP N L++ D + KV DFGLA+ + +
Sbjct: 175 AG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 619 ----------GYV------APEWISGLAITTKA-DVYSYGMTLLELIGGRRNVEAPASGR 661
G+V APE I T+A DV+S G EL+ + A + R
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 54/260 (20%), Positives = 82/260 (31%), Gaps = 80/260 (30%)
Query: 461 KLGHGGFGAVFQGE-LSDSTLVAVK---RLERPG-SGEREFRAEVC-TIGNIQHVN---L 511
KLG G F V+ + VA+K E + E R + N +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 512 VRLRG---FCSEN-SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRF------RIAVGTAR 561
V+L N +H +V++ + L + + +I +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLG---HHLL---KWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 562 GIAYLHEECRDCIIHCDIKPENILL----------------------------------- 586
G+ YLH +CR IIH DIKPENILL
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 587 --------------DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
K++D G A + + F+ + T Y + E + G
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR----QYRSLEVLIGSGYN 271
Query: 633 TKADVYSYGMTLLELIGGRR 652
T AD++S EL G
Sbjct: 272 TPADIWSTACMAFELATGDY 291
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 47/201 (23%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRG- 516
KLG G + VF+ ++++ V VK L +P ++ R E+ + N++ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKR-EIKILENLRGGPNIITLADI 99
Query: 517 FCSENSHRL-LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
S LV++++ N + L D+RF + + + Y H I+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQT--LTDY-DIRFYM-YEILKALDYCHSMG---IM 152
Query: 576 HCDIKPENILLDSDYTA-KVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEWISGLAIT 632
H D+KP N+++D ++ ++ D+GLA+ G++++ +A+ R + + PE + +
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-R--Y-FKGPELLVDYQMY 208
Query: 633 TKA-DVYSYGMTLLELIGGRR 652
+ D++S G L +I +
Sbjct: 209 DYSLDMWSLGCMLASMIFRKE 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 35/161 (21%), Positives = 60/161 (37%), Gaps = 36/161 (22%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-VNLVRLRGF 517
+K+G G FG + G+ L + VA+K LE S + E + + ++ F
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR------------FRIAVGTARGIAY 565
+ +V + + G +L D+ IA+ + Y
Sbjct: 74 GPCGKYNAMVLELL------------GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAKVS-----DFGLAK 601
+H + +I+ D+KPEN L+ DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 35/148 (23%), Positives = 60/148 (40%), Gaps = 12/148 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-VNLVRLRGF 517
K+G G FG ++ G ++ VA+K E + + E +Q V + +R
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 518 CSENSHRLLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+E + ++V + + G L + +A I Y+H + IH
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 577 CDIKPENILLDSDYTAK---VSDFGLAK 601
D+KP+N L+ + DFGLAK
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 38/161 (23%), Positives = 63/161 (39%), Gaps = 36/161 (22%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGF 517
++G G FG +F+G L ++ VA+K E S + R E T + + + F
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR------------FRIAVGTARGIAY 565
E H +LV D + G +L D+ A +
Sbjct: 75 GQEGLHNVLVIDLL------------GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 566 LHEECRDCIIHCDIKPENILLDSDYTAK-----VSDFGLAK 601
+HE+ +++ DIKP+N L+ + V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 12/148 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLV-RLRGF 517
K+G G FG ++ G + + VA+K E + + E +Q + +R F
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 518 CSENSHRLLVYDYMRNGA-LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
E + +LV D + G L L+ +A + ++H + +H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 577 CDIKPENILLDSDYTAK---VSDFGLAK 601
DIKP+N L+ A + DFGLAK
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 3e-09
Identities = 35/205 (17%), Positives = 52/205 (25%), Gaps = 49/205 (23%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVK--RLERPGSGE-------REFRAEVC--------- 501
EK+G G FG VFQ D T VA+K +E P E E+
Sbjct: 26 EKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 502 TIGNIQHVNLVRLRGFC----SENSHRLLVYDYMRNGALSLYLRKDGLN----------- 546
+ + L S L +D+ + S R D
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 547 -------------LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAK 593
+ I +A R H D+ N+LL K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKK 202
Query: 594 VSDFGLAKLIGRDFSRVLATMRGTW 618
+ K + ++
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 23/178 (12%), Positives = 52/178 (29%), Gaps = 52/178 (29%)
Query: 460 EKLGHGGFGAVFQGE---------LSDSTLVAVKRLERPGSGEREFR-----------AE 499
G +++ ++K + G E +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 500 VCTIGNIQHVNLVRLRGF-CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR------ 552
+ + + + GF ++ +R LV + G +L
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL------------GRSL-QSALDVSPKH 154
Query: 553 -------FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV--SDFGLAK 601
++A + +LHE +H ++ ENI +D + ++V + +G A
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 31/174 (17%), Positives = 63/174 (36%), Gaps = 47/174 (27%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVK--RLERPGSG--EREFR-----------AEVCTI 503
+K+G GGFG ++ + A ++E +G E + +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 504 GNIQHVNLVRLRGF----CSENSHRLLVYDYMRNGALSLYLRKDGLNL----NWDVRF-- 553
+ ++ + G S+R +V + + G++L + F
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL------------GIDLQKISGQNGTFKK 150
Query: 554 ----RIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV--SDFGLAK 601
++ + + Y+HE +H DIK N+LL +V +D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 30/178 (16%), Positives = 61/178 (34%), Gaps = 52/178 (29%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRL-------ERPGSGEREFR-----------AEVC 501
+G GGFG ++ +++ S V G E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 502 TIGNIQHVNLVRLRGF----CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVR----- 552
++++ + + G + S+R ++ D G +L +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF------------GSDL-QKIYEANAK 147
Query: 553 -------FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV--SDFGLAK 601
++++ + Y+HE +H DIK N+LL+ +V D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 83/566 (14%), Positives = 150/566 (26%), Gaps = 168/566 (29%)
Query: 158 NQIELVYNGTIVYW---STGNWTGNAFVN-VPEMTIPYI---YKFHFLNPYTSKASFGYT 210
+ + ++W S FV V + ++ K P +
Sbjct: 59 DAVSGTL---RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 211 EKPLDNGQKPPLSRFHV---DPSGQLKQYTWSQQTDYWNMFWSQPEDICRVHGLCGNFGF 267
L N ++++V P +L+Q + +P + G+ G
Sbjct: 116 RDRLYNDN-QVFAKYNVSRLQPYLKLRQ--ALLEL--------RPAKNVLIDGV---LGS 161
Query: 268 CKSSL---------LRPCMCFDGFRPVDCYGWNSGDYSGGCSRESKV------LCDQSD- 311
K+ + ++ M F F W + C+ V L Q D
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIF-------WLN---LKNCNSPETVLEMLQKLLYQIDP 211
Query: 312 -WFEEVGVVEFIGAVTESFSAG-RSICERSCLANCSCIGLYHDVRT-------NL-CKNL 361
W I S A R + + NC + L +V+ NL CK L
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV-L-LNVQNAKAWNAFNLSCKIL 269
Query: 362 YGELLNLRNLTSDSTNEDIL---------YVRAPRGGTERKNISTLMVLVAGI------- 405
T D L T + S L++
Sbjct: 270 L--------TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS-LLLKYLDCRPQDLPR 320
Query: 406 -VGSIAALVLAAVMLMILRKKRKKRKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGH 464
V + L+ +I R D N K + +L T+ L
Sbjct: 321 EVLTTNPRRLS----IIAESIRDGLATWD--------NWKHVNCDKLTTIIESSLNVLEP 368
Query: 465 GGFGAVFQGELS---DSTLVAVKRLE-------------------RPGSGEREFRAEVCT 502
+ +F LS S + L + E++ + +
Sbjct: 369 AEYRKMFD-RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 503 IGNIQ-------------HVNLVR----LRGFCSENSHRLLVYDY-----------MRNG 534
I +I H ++V + F S++ + Y + +
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 535 ALSLYLRKDGLNLNW-DVRFRIAVGTAR-GIAYLHEECRDCIIH----CDIKPENILLDS 588
R L+ + + + R TA + + + CD P+ L +
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIR-HDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
Query: 589 DYTAKVSDFGL---AKLIGRDFSRVL 611
DF LI ++ +L
Sbjct: 547 AIL----DFLPKIEENLICSKYTDLL 568
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 1e-05
Identities = 34/263 (12%), Positives = 72/263 (27%), Gaps = 31/263 (11%)
Query: 8 NSTIISQNQTFRLGFFATNGESSWYLG---IWYASIPTPTYVWVANREK--SVADVTQST 62
++S NQ F+L +G +W A+ P + R K +A Q
Sbjct: 26 GQYLLSPNQRFKLLLQ-GDGNLVIQDNGATVWVANEQQPFSSTIPLRNKKAPLAFYVQYG 84
Query: 63 LLITEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTW 122
+ + + + + NS S + T + L + GN+VL+ S
Sbjct: 85 AFLDDYSRRRVWLTDNSTFT-SNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGA 143
Query: 123 LPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTG-NWTGNAF 181
+ + ++ G + + +L G + W+ G G
Sbjct: 144 IDSLLLAPGSELVQGVVYGAGAS-----KLVFQGDGNLVAYGPNGAATWNAGTQGKGAVR 198
Query: 182 VNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDPSGQLKQY----T 237
+Y + S + + + +G +
Sbjct: 199 AVFQGDGNLVVYGAGNAVLWHS------------HTGGHASAVLRLQANGSIAILDEKPV 246
Query: 238 WSQQTDYWNMFWSQPEDICRVHG 260
W++ + + I
Sbjct: 247 WARFG--FQPTYRHIRKINPDQK 267
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 14/102 (13%), Positives = 31/102 (30%), Gaps = 13/102 (12%)
Query: 14 QNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAI 73
+ + Y VW + + L + G L I
Sbjct: 17 AEGGYLFIIQ-NDCNLVLYDN--------NRAVWASGTNGKASG---CVLKMQNDGNLVI 64
Query: 74 KDSQNSIIWQSTNTEKATDMYLLE-TGNLVLLSSAGSLVWQS 114
+I +TN + +L+ N+V+ ++ + +W +
Sbjct: 65 YSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 26/145 (17%), Positives = 44/145 (30%), Gaps = 36/145 (24%)
Query: 35 IWYASIPT---PTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTNTEKAT 91
I ++ P P + + + ++ L + D+ N+ IW +
Sbjct: 3 IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGN 61
Query: 92 DMY--LLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYS 149
L G LV++++ VWQ S + K G Y
Sbjct: 62 GCRAVLQPDGVLVVITNENVTVWQ-------------------SPVAGK------AGHYV 96
Query: 150 LRLSPTGYNQIELVYNGTIVYWSTG 174
L L P +V G W+T
Sbjct: 97 LVLQPDRN----VVIYGD-ALWATQ 116
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 804 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.77 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.76 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.63 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.55 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.53 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.5 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.5 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.37 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.24 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.07 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.03 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.8 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.04 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.47 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.64 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.69 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.08 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.86 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.12 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.71 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.44 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 82.19 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 81.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.22 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.02 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=455.80 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=217.1
Q ss_pred ChHHHHHhhcccccccccccceeEEEEEeC------CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 447 SYKELHTVTRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 447 ~~~el~~~t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
++.|+...+..|.++||+|+||+||+|.+. +++.||||+++.. ....++|++|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 344555566778999999999999999873 4678999999754 33467899999999999999999999999
Q ss_pred ecCCeEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 044374 519 SENSHRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPEN 583 (804)
Q Consensus 519 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~N 583 (804)
.+.+..+||||||++|+|.++|..+. ..+++..+++|+.|||+||+|||+.+ ||||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccc
Confidence 99999999999999999999996532 35899999999999999999999988 9999999999
Q ss_pred EEecCCCceEEeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCC
Q 044374 584 ILLDSDYTAKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGR 661 (804)
Q Consensus 584 ILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~ 661 (804)
|||++++++||+|||+++..... .........||++|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999999875433 2333455679999999999999999999999999999999999 8999975321
Q ss_pred CCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 662 NANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
......+..+... ..+.+.+..+.+|+.+||+.||++||||.||+++|+...
T Consensus 254 -----------------~~~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 -----------------QDVVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -----------------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----------------HHHHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1122333333322 223345677899999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=447.78 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=210.9
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||+||+|++. ++..||||+++... ...++|.+|+.+|++++|||||+++|+|.+.+..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 346789999999999999864 46789999997643 23567999999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEee
Q 044374 529 DYMRNGALSLYLRKDG------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSD 596 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 596 (804)
|||++|+|.++|+..+ ..+++.++++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECC
Confidence 9999999999997642 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 597 FGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 597 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
||+|+..... .........||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------------- 236 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------------- 236 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------------
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------------
Confidence 9999876443 2223344579999999999999999999999999999999999 8999975321
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+... ..+...++.+.+|+.+||+.||++||||.+|++.|+++..
T Consensus 237 ----~~~~~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 237 ----NEVIECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1123333333322 1233445678999999999999999999999999998654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=449.38 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=204.5
Q ss_pred ccccccccccceeEEEEEeC------CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.++||+|+||+||+|++. +++.||||+++... ...++|++|+.+|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45689999999999999864 46889999997543 335679999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 530 YMRNGALSLYLRKDG--------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
||++|+|.++|+... ..+++.++++|+.|||+||+|||+.+ |+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEc
Confidence 999999999997642 35899999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 596 DFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 596 DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
|||+++..... .........||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------------- 266 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------------- 266 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------------
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------------
Confidence 99999876433 2233445679999999999999999999999999999999999 8999974321
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+... ..+...++.+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 267 -----~~~~~~i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 -----TEAIDCITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -----HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1122333333221 2233445678999999999999999999999999998765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=437.50 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=203.7
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.++||+|+||+||+|++.+ .||||+++.... ..++|++|+.++++++|||||+++|+|.+ +..+||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 3477899999999999998754 599999975433 23579999999999999999999999865 56899999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-ccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~ 611 (804)
+|+|.++|+.....+++.++++|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+..... .....
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999999887778999999999999999999999987 999999999999999999999999999876433 22334
Q ss_pred cccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 612 ATMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
....||+.|||||++.+ ..++.++|||||||+||||+||+.||...... ......+..+
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------------------~~~~~~~~~~ 253 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------------------DQIIFMVGRG 253 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------------HHHHHHHHTT
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------------------HHHHHHHhcC
Confidence 55789999999999964 46899999999999999999999999743221 1122222222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
... +.+ ...+.+.++.+.+|+.+||+.||++||||.||+++|+.+..
T Consensus 254 ~~~----p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 254 YAS----PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCC----CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCC----CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111 111 12233455778999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=425.60 Aligned_cols=273 Identities=23% Similarity=0.263 Sum_probs=203.8
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~ 532 (804)
.+.++||+|+||+||+|++ .++.||||+++........++.|+..+.+++|||||+++|+|.+.+ .++||||||+
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 4568999999999999998 5788999999754433344556777778899999999999998653 6799999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC-----RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+|+|.++|+.. .++++.+++++.|+|+||+|||+.. .++|+||||||+||||+.++++||+|||+++......
T Consensus 85 ~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 85 HGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 99999999875 5899999999999999999999862 2359999999999999999999999999998764432
Q ss_pred cc---cccccccccccccchhccCC------CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 608 SR---VLATMRGTWGYVAPEWISGL------AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 608 ~~---~~~~~~gt~~y~aPE~l~~~------~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
.. ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.. ...........
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p---~~~~~~~~~~~- 238 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSDPSV- 238 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT---TTTTSCSSCCH-
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc---chhcccccchH-
Confidence 21 23346799999999999764 4678999999999999999999887643322110 00000011111
Q ss_pred HHHHHHhhcCccceeccccccCC-CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGA-YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+.++. +++.+... .+.+..+.+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 239 ~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111121211 22222111 123566789999999999999999999999999988654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=433.20 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=211.9
Q ss_pred HHHhhcccccccccccceeEEEEEeCC------CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCC-CCceeeeeEEecC
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGS--GEREFRAEVCTIGNIQH-VNLVRLRGFCSEN 521 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~ 521 (804)
+......+.++||+|+||+||+|.+.. ++.||||+++.... ..++|.+|+.+|.++.| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 334445677899999999999997642 36799999976433 34679999999999965 8999999999764
Q ss_pred -CeEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 044374 522 -SHRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENIL 585 (804)
Q Consensus 522 -~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NIL 585 (804)
+..+||||||++|+|.++|+... ..+++..++.++.|||+||+|||+.+ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 57899999999999999997532 34899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCC
Q 044374 586 LDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNA 663 (804)
Q Consensus 586 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 663 (804)
|++++.+||+|||+|+....+.. .......||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--- 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654322 23345679999999999999999999999999999999998 89999753221
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+.++.... .+...++++.+++..||+.||++||||.+|+++|+.+++
T Consensus 295 ---------------~~~~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 ---------------EEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ---------------HHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 22333344433222 223345678899999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=419.58 Aligned_cols=249 Identities=22% Similarity=0.246 Sum_probs=203.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.++||+|+||.||+|+.. .++.||||+++.... +.+|+.++++++|||||++++++.+.+..+||||||++|+
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 34578999999999999764 689999999976433 2469999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcc----cc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFS----RV 610 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~----~~ 610 (804)
|.++|+..+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..+.. ..
T Consensus 137 L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 137 LGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999998754 7999999999999999999999988 99999999999999987 699999999987654321 11
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....+||+.|||||++.+..++.++|||||||+||||++|+.||....... + ...+..+..
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------------~----~~~i~~~~~ 273 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---------------L----CLKIASEPP 273 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---------------C----HHHHHHSCC
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------------H----HHHHHcCCC
Confidence 234579999999999999999999999999999999999999997543221 0 111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....+......+.+++.+||+.||++|||+.||++.|...+
T Consensus 274 ~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 274 P-------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp G-------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0 01123344567889999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=422.07 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=200.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+.++||+|+||+||+|+.. +++.||||+++..... .+.+++|+.++++++|||||++++++.+.+..|||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 345689999999999999764 6899999999754332 356899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|+|.++|..++ ..+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 181 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-EL 181 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-cc
Confidence 9999999997654 45789999999999999999999988 9999999999999999999999999998764321 22
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..+..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------------------~~~~~~i~~~~~ 242 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------------------KNLVLKIISGSF 242 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHHHHHHTCC
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------------HHHHHHHHcCCC
Confidence 3456799999999999999999999999999999999999999975321 112222333322
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 122334678899999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=410.37 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=197.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEec----CCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSE----NSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 528 (804)
.|.++||+|+||+||+|... .+..||||++..... ..+.|.+|+.++++++|||||++++++.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999765 578999999965432 34568999999999999999999999864 34679999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 607 (804)
|||++|+|.++|...+ .+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999998654 7899999999999999999999865 35999999999999984 799999999999864332
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.....+||+.|||||++.+ .++.++|||||||+||||+||+.||..... .....+.+..
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------------------~~~~~~~i~~ 244 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------------------AAQIYRRVTS 244 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------------------HHHHHHHHTT
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------------------HHHHHHHHHc
Confidence 2345789999999999875 699999999999999999999999964221 1112222222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+..... .+....+.+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 GVKPAS--------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGG--------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCC--------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 211111 111223468899999999999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=415.20 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=205.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 345678999999999999765 6899999999643 34456789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 156 g~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 156 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999764 5899999999999999999999988 99999999999999999999999999987654322 2456
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..+..
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------------~~~~~~i~~~~~--- 287 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------------------LKAMKMIRDNLP--- 287 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------------HHHHHHHHHSSC---
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------------HHHHHHHHcCCC---
Confidence 7899999999999999999999999999999999999999974321 111122222211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+ .........+.+|+.+||+.||++|||+.|++++
T Consensus 288 --~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 --PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 1122345678899999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=406.50 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=206.3
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||+||+|+.. +++.||||+++. .....+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 457789999999999999764 689999999964 244567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-cc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 609 (804)
+++|+|.++|...+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus 114 ~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 114 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999998754 7999999999999999999999988 9999999999999999999999999999765432 23
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...+.+||+.|||||++.+..++.++||||+||+||||++|+.||..... ......+..+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------------~~~~~~i~~~~ 250 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------------------GLIFAKIIKLE 250 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHTC
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 34567899999999999999999999999999999999999999975321 11222233222
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
. .++....+.+.+++.+||+.||++|||+.|++
T Consensus 251 ~----------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 Y----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C----------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C----------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 11223345688999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=414.31 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=205.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 345679999999999999765 6899999999754 34456789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 233 G~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 233 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 9999999764 5899999999999999999999988 99999999999999999999999999987654322 2456
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..+..
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------------~~~~~~i~~~~~--- 364 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------------------LKAMKMIRDNLP--- 364 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------------HHHHHHHHHSCC---
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------------HHHHHHHHcCCC---
Confidence 7899999999999999999999999999999999999999974321 111222222211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+. ........+.+|+.+||+.||++|||+.|++++
T Consensus 365 --~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 --PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 112234678899999999999999999998874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=393.22 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=190.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.++||+|+||+||+|... +++.||||+++.. ......+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999764 6899999999653 23356799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+ +|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..... ..
T Consensus 95 ~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~ 167 (275)
T 3hyh_A 95 A-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF 167 (275)
T ss_dssp C-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred C-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence 9 689999998764 7999999999999999999999988 999999999999999999999999999875432 22
Q ss_pred ccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....||+.|||||++.+..+ +.++||||+||++|||++|+.||..... ....+.+..+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------------------~~~~~~i~~~~ 228 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------------------PVLFKNISNGV 228 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHTC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 345789999999999998876 5799999999999999999999974211 11122222222
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..+....+.+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 Y----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1122234668899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=401.24 Aligned_cols=244 Identities=24% Similarity=0.283 Sum_probs=194.7
Q ss_pred cccccccccccceeEEEEEeC----CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
+.+.++||+|+||+||+|+.. .++.||||+++... .....+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 457789999999999999752 46789999996432 22346888999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|.++|.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 106 Ey~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp CCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999999998754 7999999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......+||+.|||||++.+..++.++|||||||+||||+||+.||...... .....+..+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-------------------~~~~~i~~~ 241 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-------------------ETMTMILKA 241 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------HHHHHHHHC
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------------------HHHHHHHcC
Confidence 2234578999999999999999999999999999999999999999753211 112222222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM-----GTVVK 733 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 733 (804)
.. .++...++.+.+++.+||+.||++|||+ +|+++
T Consensus 242 ~~----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 KL----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CC----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 1122345678899999999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=391.56 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=184.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCC----------
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENS---------- 522 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---------- 522 (804)
..+.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 345689999999999999764 688999999975432 3357899999999999999999999986543
Q ss_pred --eEEEEEEEcCCCChhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 523 --HRLLVYDYMRNGALSLYLRKDGL--NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 523 --~~~lV~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
..++||||+++|+|.+++..... ..++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999987542 3456678899999999999999988 9999999999999999999999999
Q ss_pred CccccCCCccc-----------cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 599 LAKLIGRDFSR-----------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 599 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
+|+........ .....+||+.|||||++.+..++.++|||||||+||||++ ||.....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-------- 232 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-------- 232 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--------
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--------
Confidence 99876443211 1234579999999999999999999999999999999996 6642100
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+....... ......+.+..++.+||+.||++|||+.|+++.
T Consensus 233 ----------~~~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 ----------RVRTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ----------HHHHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------HHHHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000111111111110 112233456789999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=378.73 Aligned_cols=288 Identities=46% Similarity=0.751 Sum_probs=241.4
Q ss_pred ccccccChHHHHHhhcccc--cccccccceeEEEEEeCCCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeee
Q 044374 441 LNLKVFSYKELHTVTRGFS--EKLGHGGFGAVFQGELSDSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRG 516 (804)
Q Consensus 441 ~~~~~~~~~el~~~t~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g 516 (804)
...+.+++.++.....+|. +.||+|+||.||+|...+++.||||++.... .....+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456789999998887764 6899999999999998889999999997542 23347899999999999999999999
Q ss_pred EEecCCeEEEEEEEcCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceE
Q 044374 517 FCSENSHRLLVYDYMRNGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAK 593 (804)
Q Consensus 517 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 593 (804)
++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998653 3489999999999999999999998322399999999999999999999
Q ss_pred EeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 594 VSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 594 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
|+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+...... ..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------~~ 244 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN----------DD 244 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT----------TS
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc----------cc
Confidence 99999998775544444555679999999999998899999999999999999999999996322110 12
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...+..|.........+..+.+..+....+.+....+.+++.+||+.||++|||+.+|+++|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 22334444444555566677777777778888999999999999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=371.65 Aligned_cols=278 Identities=35% Similarity=0.620 Sum_probs=233.8
Q ss_pred HHHHhhccc--ccccccccceeEEEEEeCCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 450 ELHTVTRGF--SEKLGHGGFGAVFQGELSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 450 el~~~t~~~--~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
++...+.+| .+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 333344443 46899999999999998889999999987543 345779999999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 527 VYDYMRNGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999997643 35899999999999999999999988 999999999999999999999999999865
Q ss_pred CCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 604 GRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 604 ~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
... .........||+.|+|||++.+..++.++||||||+++|||++|+.||....+. .......|..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~------------~~~~~~~~~~ 257 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR------------EMVNLAEWAV 257 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS------------SCCCHHHHTH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH------------HHHHHHHHhh
Confidence 432 222234456899999999999999999999999999999999999999754332 1223344555
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
.....+.+...+++.+......+....+.+++.+||+.||++||++.+|+++|+.+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 555666677777777777778888999999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=381.68 Aligned_cols=270 Identities=18% Similarity=0.239 Sum_probs=196.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEec------CCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSE------NSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~~ 525 (804)
+.+.++||+|+||+||+|... +++.||||+++..... .+.+.+|+.+|++++|||||++++++.. ....|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 346689999999999999764 6899999999765433 3467899999999999999999998753 35789
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
||||||+ |+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 136 ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9999996 67999987654 7999999999999999999999988 99999999999999999999999999987643
Q ss_pred C---ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 606 D---FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 606 ~---~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
. ........+||+.|||||++.+. .++.++||||+|||+|||++|+.||.................... ...
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~----~~~ 286 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS----PAV 286 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC----GGG
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC----hHH
Confidence 2 12234567899999999998875 568999999999999999999999975322100000000000000 000
Q ss_pred HHHhhcCccceeccccc-cCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRL-GGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
............+.... ....+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000000 00000 1123567889999999999999999998875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.60 Aligned_cols=194 Identities=24% Similarity=0.343 Sum_probs=166.1
Q ss_pred cccccccccccceeEEEEEeC----CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.++||+|+||+||+|+.. .++.||||++... .....+.+|+.++.++ +||||+++++++.+.++.+|||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 456789999999999999642 4678999999654 3456788999999988 699999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccCCCcc-
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~~~~- 608 (804)
+++|+|.+++. .+++.++..++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+.......
T Consensus 102 ~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 102 LEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 99999999984 4889999999999999999999988 9999999999999877 7999999999986432211
Q ss_pred --------------------------ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 609 --------------------------RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 609 --------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
......+||+.|||||++.+. .++.++||||+||+++||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 112345799999999999876 4899999999999999999999999643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=360.83 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=215.7
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.++||+|+||.||+|...+++.||||++.......+++.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 44668999999999999999888899999999877778899999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..............
T Consensus 92 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (269)
T 4hcu_A 92 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168 (269)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred HHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence 99999877778999999999999999999999988 999999999999999999999999999876544333344456
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
+|+.|+|||.+.+..++.++||||||++++||++ |+.||..... ......+..+.
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------------------~~~~~~~~~~~----- 224 (269)
T 4hcu_A 169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------------------SEVVEDISTGF----- 224 (269)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------------HHHHHHHHTTC-----
T ss_pred cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------------------HHHHHHHhcCc-----
Confidence 7889999999999999999999999999999999 9999874321 11112222211
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+......+.+++..|++.||++||++.+++++|+++.+
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 225 ----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111122234668899999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=359.71 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=216.0
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.+.||+|+||.||+|+..++..||||+++......+++.+|+.++.+++||||+++++++......++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 34567899999999999999988889999999887777889999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..............
T Consensus 89 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 89 CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 999999887667999999999999999999999988 99999999999999999999999999987655433333445
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+|+.|+|||.+.+..++.++||||||++++||++ |+.||...... .....+..+...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------------------~~~~~~~~~~~~-- 224 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------------------EVVLKVSQGHRL-- 224 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------------------HHHHHHHTTCCC--
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------------------HHHHHHHcCCCC--
Confidence 56788999999999899999999999999999999 99998743211 111122221110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
..+......+.+++..||+.+|++||++.+|++.|+.+.+.
T Consensus 225 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11112245688999999999999999999999999987653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=397.46 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=206.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|... .++.||||++..... ..+.+++|+.+|++++|||||++++++.+....+||||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 356789999999999999764 689999999976433 345688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC--CceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD--YTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~~~~~~~ 611 (804)
|+|.++|......+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+... ...
T Consensus 239 g~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~ 313 (573)
T 3uto_A 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSV 313 (573)
T ss_dssp CBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEE
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cce
Confidence 9999999876668999999999999999999999988 9999999999999854 89999999999976543 223
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+..+...
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------------------~~~~~i~~~~~~ 374 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------------------ETLRNVKSCDWN 374 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHHHHHTTCCC
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------------HHHHHHHhCCCC
Confidence 4568999999999999999999999999999999999999999753221 111222222110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.........+.+.+|+.+||+.||++||++.|++++
T Consensus 375 ------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 ------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111234568899999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.71 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=208.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 45689999999999999775 5889999998653 234567999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-----
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR----- 609 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~----- 609 (804)
+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 93 TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp BHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 999999987678999999999999999999999988 999999999999999999999999999875433211
Q ss_pred --------cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 610 --------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 610 --------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
......||+.|+|||++.+..++.++||||||+++|||++|..|+......... ......
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---------~~~~~~--- 237 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------FGLNVR--- 237 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---------SSBCHH---
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---------Hhhhhh---
Confidence 111457999999999999999999999999999999999999988653322110 000000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
...+. ..+...+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 238 ----------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 238 ----------GFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------HHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------ccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00111 11122335688999999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.03 Aligned_cols=262 Identities=29% Similarity=0.434 Sum_probs=200.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.++||+|+||.||+|+. .++.||||++...... .+++.+|+.++++++||||+++++++......++||||++
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 34568999999999999987 5788999999765433 3468899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 533 NGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 533 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~ 195 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LS 195 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cc
Confidence 999999998654 24899999999999999999999865 349999999999999999999999999998654332 12
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------------------~~~~~~~~~~- 255 (309)
T 3p86_A 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------------------QVVAAVGFKC- 255 (309)
T ss_dssp ------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------------------HHHHHHHHSC-
T ss_pred cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhcC-
Confidence 34467899999999999999999999999999999999999999743211 0111111000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCCCCCCC
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPP 747 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~p~~p 747 (804)
.....+......+.+++.+||+.||++||++.+|++.|+.+.....||++
T Consensus 256 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 256 -------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred -------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 01112223446788999999999999999999999999998776655544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=389.98 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=197.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHH---HHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFR---AEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~---~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
.+.+.||+|+||.||+++.. .++.||||+++.. ......+. .++.+++.++|||||++++++.+.+.+||||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45689999999999999765 6899999999632 23333333 4467788899999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|..+|...+ .+++..+..++.||+.||+|||+.+ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 272 Ey~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp CCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999998754 6999999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
..+.+||+.|||||++.. ..|+.++|+|||||+||||++|+.||....... .....+....
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----------------~~~i~~~i~~ 408 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----------------KHEIDRMTLT 408 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----------------HHHHHHHHHH
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----------------HHHHHHhhcC
Confidence 345689999999999964 579999999999999999999999997432210 0011111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
.. ..++......+.+|+..||+.||++|++ +.||.++
T Consensus 409 ~~----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 409 MA----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CC----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 1122234567889999999999999998 6777754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=386.62 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=213.4
Q ss_pred hhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
....+.++||+|+||.||+|.+.++..||||+++......+.|.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 344567899999999999999988889999999877777889999999999999999999999987 5678999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...........
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 99999997543 36889999999999999999999988 999999999999999999999999999876543222233
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...++..|+|||++....++.++|||||||+||||++ |+.||..... ......+..+..
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------------------~~~~~~i~~~~~- 403 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------------------PEVIRALERGYR- 403 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------------------HHHHHHHHHTCC-
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcCCC-
Confidence 4456789999999998999999999999999999999 9999974321 111222222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
...+...+..+.+++.+||+.||++||++.+|+++|+.+...
T Consensus 404 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 --------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 112233456789999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.82 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=208.4
Q ss_pred hcccccccccccceeEEEEEeC----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
...+.+.||+|+||.||+|... .+..||||+++.... ..+.+.+|+.++++++||||+++++++......++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3445678999999999999874 345699999976432 3457899999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999877668999999999999999999999988 99999999999999999999999999987654322
Q ss_pred c--cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 R--VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 ~--~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------------------~~~~~~~ 267 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------------------RDVISSV 267 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------------------HHHHHHH
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------------------HHHHHHH
Confidence 1 2223446788999999999999999999999999999999 9999864321 1111222
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
..+. ....+......+.+++..||+.||++||++.+|+++|+.+...
T Consensus 268 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 268 EEGY---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HcCC---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 2221 1112233456789999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.89 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=212.5
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.++||+|+||.||+++..++..||||+++......+++.+|+.++.+++||||+++++++......++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 34466899999999999999988889999999987777889999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp BHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 999999876667999999999999999999999988 99999999999999999999999999987654433333445
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+.
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------------------~~~~~~~~~~~---- 238 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------------------SETAEHIAQGL---- 238 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------------------HHHHHHHHTTC----
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------------------hHHHHHHhccc----
Confidence 57889999999998899999999999999999998 9999874321 11112222221
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+....+.+.+++.+||+.+|++||++.++++.|+++.+
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 -----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 111122234678899999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=387.41 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=215.9
Q ss_pred HhhcccccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.....+.++||+|+||.||+|.+.. +..||||+++......++|.+|+.++++++||||++++++|......++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3445667899999999999998864 788999999877777889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999999998643 46899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||...... .....+..+
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------------------~~~~~~~~~- 435 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKD- 435 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------------------GHHHHHHTT-
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHHcC-
Confidence 344556789999999999999999999999999999999 99998753211 111222211
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+...+..+.+++.+||+.||++||++.+|+++|+.+..
T Consensus 436 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 --------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1112233445678999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=361.61 Aligned_cols=273 Identities=26% Similarity=0.371 Sum_probs=207.8
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~ 531 (804)
..+.++||+|+||.||+|+.. ++.||||++.........+..|+.++.+++||||+++++++.... ..++||||+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 345689999999999999875 788999999765555566778999999999999999999998744 479999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE----------CRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
++|+|.+++... .+++..++.++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 105 EKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999999875 589999999999999999999987 6 9999999999999999999999999998
Q ss_pred ccCCCcc-ccccccccccccccchhccCC-----CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 602 LIGRDFS-RVLATMRGTWGYVAPEWISGL-----AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 602 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-----~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. ......
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--~~~~~~ 257 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE--EIGQHP 257 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH--HHCSSC
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh--hhccCC
Confidence 7654322 223346799999999999873 56678999999999999999999997643321110000 000000
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+ ............+.... ........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 258 ~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDM-QEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHH-HHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhh-hhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11111111111111111 122456779999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.10 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=207.9
Q ss_pred cccccccccccceeEEEEEeC--------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 524 (804)
..+.+.||+|+||.||+|+.. .+..||||+++.... ..+.+.+|+.+++++ +||||+++++++...+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 346789999999999999752 346799999976433 235789999999999 899999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 525 LLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
++||||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+||||+.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCC
Confidence 99999999999999998653 24789999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~------- 312 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------- 312 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 999999999998654332 122334567889999999999999999999999999999999 99998743211
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+..+.. ...+......+.+++..||+.||++||++.||++.|+.++.
T Consensus 313 ------------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ------------ELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ------------GHHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01122222211 11223345678999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=374.19 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=209.0
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
...+.++||+|+||.||+|... +++.||||+++.... ...+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 3446789999999999999886 688999999975432 2246889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-c
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR-V 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 610 (804)
++|+|.+++...+..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999999999877667999999999999999999999988 999999999999999999999999999865433211 1
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+.
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------------------~~~~~~~~~~~ 332 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------------------QQTREFVEKGG 332 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------------------HHHHHHHHTTC
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 122346788999999998899999999999999999998 9999874321 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
. ...+...+..+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 333 ~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 R---------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1 11222345678899999999999999999999999988643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.82 Aligned_cols=278 Identities=37% Similarity=0.585 Sum_probs=224.3
Q ss_pred cccccChHHHHHhhcccc--------cccccccceeEEEEEeCCCcEEEEEEecCCC-----CCHHHHHHHHHHHcCCCC
Q 044374 442 NLKVFSYKELHTVTRGFS--------EKLGHGGFGAVFQGELSDSTLVAVKRLERPG-----SGEREFRAEVCTIGNIQH 508 (804)
Q Consensus 442 ~~~~~~~~el~~~t~~~~--------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~H 508 (804)
....|++.++.+++.+|. +.||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 346789999999999886 4599999999999987 57789999996432 234678999999999999
Q ss_pred CCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKD--GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 509 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
|||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999998743 346899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcC
Q 044374 587 DSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI 665 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 665 (804)
+.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---- 241 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---- 241 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS----
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH----
Confidence 9999999999999987544322 22334578999999998865 58899999999999999999999997543221
Q ss_pred CCCCCCCCccCchHHHHHHh-hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 666 GGGGEHGDKWFFPPWAARQI-IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.+..+..... ....+...++..+ ...+......+.+++..||+.+|++||++.+|+++|+++.
T Consensus 242 ----------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 ----------LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp ----------BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ----------HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111111 1112223333333 2345667888999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=374.17 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=198.3
Q ss_pred hcccccccccccceeEEEEEeC----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
...+.+.||+|+||.||+|+.. .+..||||+++.... ..++|.+|+.++++++||||+++++++......++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3446689999999999999765 467799999975432 3457999999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++++|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999887778999999999999999999999988 99999999999999999999999999987654322
Q ss_pred cc--ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 RV--LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 ~~--~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------------------~~~~~~i 263 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------------------QDVIKAV 263 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------------------HHHHHHH
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHH
Confidence 11 122345778999999999999999999999999999998 9999864321 1111222
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
..+ .....+...+..+.+++..||+.||++||++.+|+++|+.+..
T Consensus 264 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 264 DEG---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HTT---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcC---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 221 1112233445678999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=381.93 Aligned_cols=257 Identities=29% Similarity=0.390 Sum_probs=207.9
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.++||+|+||.||+|.+.++..||||+++......++|.+|+.++++++||||+++++++.+ +..++||||+++|
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 345678999999999999999888889999998766677889999999999999999999999976 6789999999999
Q ss_pred ChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++... +..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++............
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 999999753 346899999999999999999999988 9999999999999999999999999998765433222334
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+..
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------------------~~~~~~i~~~~~-- 399 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------------REVLDQVERGYR-- 399 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------------HHHHHHHHTTCC--
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcCCC--
Confidence 457889999999999999999999999999999999 9999864321 111222222211
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCCC
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTA 743 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~ 743 (804)
...+...++.+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 400 -------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 400 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 12233445678999999999999999999999999998765443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.46 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=214.3
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
..+.+.||+|+||.||++...+++.||||++.......+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34668999999999999998888899999998877778899999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMR 615 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 615 (804)
|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...............
T Consensus 90 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 166 (267)
T 3t9t_A 90 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166 (267)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred HHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence 99999887667999999999999999999999988 999999999999999999999999999876543322333456
Q ss_pred cccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 616 GTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 616 gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+..
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------------~~~~~~i~~~~~---- 223 (267)
T 3t9t_A 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------------------SEVVEDISTGFR---- 223 (267)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------------HHHHHHHHTTCC----
T ss_pred ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------------------HHHHHHHhcCCc----
Confidence 7889999999998899999999999999999999 8999874211 111122222211
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
...+......+.+++.+|++.||++||++.+++++|+.+.+
T Consensus 224 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122234678899999999999999999999999998654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.95 Aligned_cols=219 Identities=16% Similarity=0.245 Sum_probs=166.8
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCC---CCcEEEEeccccEEE--ecCCC
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADV---TQSTLLITEKGKLAI--KDSQN 78 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~---~~~~l~~~~~g~l~l--~~~~~ 78 (804)
.|++|++|||++|.|+||||+++ ++|| |+ |.+ +||+|||++|+.++ .+++|+|+.||+|+| .|++|
T Consensus 22 ~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~ 92 (276)
T 3m7h_A 22 TLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSR 92 (276)
T ss_dssp EBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGG
T ss_pred EecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCC
Confidence 57889999999999999999543 6787 77 778 99999999999874 245899999999999 78889
Q ss_pred cEEEEeccC-------CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCc----cccceeeeeccCCCCCCCcc
Q 044374 79 SIIWQSTNT-------EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMN----ISVGGSITSWKSLFDPSPGF 147 (804)
Q Consensus 79 ~~~w~~~~~-------~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~----l~~~~~L~Sw~s~~dps~G~ 147 (804)
.+||+|+.. ..++.|+|+|+|||||++ +.+|||| ||||||||||| |..+++| ++.+||++|.
T Consensus 93 ~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L---~S~~dps~G~ 165 (276)
T 3m7h_A 93 RRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL---VQGVVYGAGA 165 (276)
T ss_dssp TEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE---CTTCEEEETT
T ss_pred CEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc---ccCCCCCCce
Confidence 999999843 235789999999999998 7899999 99999999999 6677888 5678999999
Q ss_pred eeeeeCCCCCceEEEEEeCcEEEEecCCCCCceeecccccccceeEEEeeecCCCcceeEEEeeccCCCCCCCCeeEEEE
Q 044374 148 YSLRLSPTGYNQIELVYNGTIVYWSTGNWTGNAFVNVPEMTIPYIYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHV 227 (804)
Q Consensus 148 ys~~~~~~g~~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L 227 (804)
|+++++++| .+++.+++..+||++|+|++..... .++.... +.+.+... ..+-++.. ... ..+|++|
T Consensus 166 fsl~l~~dG--nlvLy~~~~~~yW~Sgt~~~~~~~l--~l~~dGn--Lvl~d~~~--~~vWsS~t--~~~---~~~rl~L 232 (276)
T 3m7h_A 166 SKLVFQGDG--NLVAYGPNGAATWNAGTQGKGAVRA--VFQGDGN--LVVYGAGN--AVLWHSHT--GGH---ASAVLRL 232 (276)
T ss_dssp EEEEECTTS--CEEEECTTSSEEEECCCTTTTCCEE--EECTTSC--EEEECTTS--CEEEECSC--TTC---TTCEEEE
T ss_pred EEEeecCCc--eEEEEeCCCeEEEECCCCCCccEEE--EEcCCCe--EEEEeCCC--cEEEEecC--CCC---CCEEEEE
Confidence 999999997 3544445578999999997643111 1221111 11122211 11222222 111 2489999
Q ss_pred ccCCcEEEEEEecCCCceEEEEeccCC
Q 044374 228 DPSGQLKQYTWSQQTDYWNMFWSQPED 254 (804)
Q Consensus 228 d~~G~l~~y~w~~~~~~W~~~~~~p~~ 254 (804)
+.||+|++|.| ...|..+|.+|..
T Consensus 233 d~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 233 QANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp CTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred cCCccEEEEcC---CCeEEccCccCCc
Confidence 99999999999 3568888877765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=373.01 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=205.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC-eEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS-HRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~g 534 (804)
..+.++||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.... ..++||||+++|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 345679999999999999885 6789999998644 5678999999999999999999999987665 789999999999
Q ss_pred ChhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDGL-NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++...+. .+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 345 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 345 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccC
Confidence 99999987653 4799999999999999999999988 999999999999999999999999999854322 223
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||.+.+..++.++||||||++||||++ |+.||....... ....+..+..
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------------------~~~~i~~~~~-- 404 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------------VVPRVEKGYK-- 404 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------------------HHHHHHTTCC--
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------------------HHHHHHcCCC--
Confidence 357889999999999999999999999999999998 999997532210 1122222211
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
...+...+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus 405 -------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 -------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12233445678999999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.62 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=211.3
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.+.||+|+||.||+|...++..||||+++......+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence 345678999999999999998888899999998777778899999999999999999999999874 5689999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.............
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9999997543 36899999999999999999999988 9999999999999999999999999998765443333344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..++..|+|||.+.+..++.++||||||++++||++ |+.||..... ......+..+..
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------------------~~~~~~~~~~~~-- 228 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------------------PEVIQNLERGYR-- 228 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------------HHHHHHHHTTCC--
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------------------HHHHHHHhcccC--
Confidence 557889999999998899999999999999999999 8988864211 111122222211
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
...+......+.+++..|++.||++||++.+|++.|+.+...
T Consensus 229 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 -------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 111223346788999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.14 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=201.4
Q ss_pred cccccccccccceeEEEEEeC-CCc----EEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||.||+|... +++ .||+|.+... ....+++.+|+.++++++||||++++++|.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 445689999999999999764 333 4688888643 345678999999999999999999999998765 78999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.+|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999999987778999999999999999999999988 99999999999999999999999999987654322
Q ss_pred -ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 -RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------------------~~~~~~~ 233 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------------EISSILE 233 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------------GHHHHHH
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-------------------HHHHHHH
Confidence 22234456889999999999999999999999999999999 99999753221 0111122
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+. ....+......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 234 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 234 KGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTC---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 111223345678899999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.90 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=211.9
Q ss_pred cccChHHHHHhhcc------------cccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCC
Q 044374 444 KVFSYKELHTVTRG------------FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHV 509 (804)
Q Consensus 444 ~~~~~~el~~~t~~------------~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~ 509 (804)
..++++++..++.. +.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888877653 3458999999999999876 6899999999754 44567799999999999999
Q ss_pred CceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 510 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998754 6899999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC
Q 044374 590 YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG 669 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 669 (804)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---------- 246 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---------- 246 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------
Confidence 9999999999987654322 23456799999999999999999999999999999999999999974311
Q ss_pred CCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 670 EHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+...... .+. ........+.+++.+||+.||++||++.++++.
T Consensus 247 ---------~~~~~~~~~~~~~-----~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 ---------VQAMKRLRDSPPP-----KLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---------HHHHHHHHHSSCC-----CCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---------HHHHHHHhcCCCC-----CcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111222221111 111 112234568899999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=349.19 Aligned_cols=246 Identities=21% Similarity=0.271 Sum_probs=203.6
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 4567899999999999975 56889999999643 445677899999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .....
T Consensus 103 ~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 176 (297)
T 3fxz_A 103 SLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (297)
T ss_dssp BHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence 999999875 5899999999999999999999988 99999999999999999999999999987654322 23456
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...... .........+ ...
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------------~~~~~~~~~~-~~~-- 235 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------------------RALYLIATNG-TPE-- 235 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------------HHHHHHHHHC-SCC--
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------------------HHHHHHHhCC-CCC--
Confidence 7999999999999999999999999999999999999999743211 0011111111 100
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+......+.+++.+||+.||++||++.|+++.
T Consensus 236 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 -----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122345668899999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.48 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=215.2
Q ss_pred HhhcccccccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.....+.+.||+|+||.||+|.... +..||||+++......+.+.+|+.++++++||||+++++++......++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 3344567899999999999998764 788999999877667788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 9999999998643 46899999999999999999999998 9999999999999999999999999998776554444
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-------------------~~~~~~~~~- 228 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKD- 228 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------------------GHHHHHHTT-
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------------------HHHHHHhcc-
Confidence 455667889999999999999999999999999999999 99998753221 011111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+...+..+.+++..|++.||++||++.+|+++|+.+..
T Consensus 229 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 229 --------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1112223345678999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=384.88 Aligned_cols=258 Identities=29% Similarity=0.386 Sum_probs=213.9
Q ss_pred HhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.....+.++||+|+||.||+|.+.++..||||+++......++|.+|+.+|++++||||+++++++.+ +..+|||||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 33445678999999999999999888889999998766677899999999999999999999999976 67899999999
Q ss_pred CCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|+|.++|... +..+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99999999753 346899999999999999999999988 99999999999999999999999999987654322223
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....++..|+|||.+.+..++.++|||||||+||||++ |+.||..... ......+..+..
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------------------~~~~~~i~~~~~ 482 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------------REVLDQVERGYR 482 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------------------HHHHHHHHTTCC
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcCCC
Confidence 33456789999999999999999999999999999999 8999864321 111222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
...+......+.+|+..||+.||++||++.+|+++|+.+....
T Consensus 483 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 ---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1122334567889999999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.39 Aligned_cols=272 Identities=23% Similarity=0.379 Sum_probs=205.9
Q ss_pred hhcccccccccccceeEEEEEe-----CCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRL 525 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 525 (804)
....+.++||+|+||.||++++ ..++.||||++..... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 3445678999999999999984 3578999999975432 346789999999999999999999998653 5689
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999999999887767999999999999999999999988 99999999999999999999999999987644
Q ss_pred Ccc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
... .......++..|+|||.+.+..++.++||||||+++|||++|..|+............. .............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN---DKQGQMIVFHLIE 243 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT---TCCTHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC---ccccchhHHHHHH
Confidence 321 22334457788999999999999999999999999999999999886432110000000 0000000001111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+..+ .....+...+..+.+++..||+.||++||++.+|+++|+.+.+
T Consensus 244 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111 1112233445778999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=348.64 Aligned_cols=259 Identities=28% Similarity=0.399 Sum_probs=204.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||.||++... .++.||||++..... ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 345689999999999999754 688999999965322 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 93 IEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 99999999998654 6899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...+..
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------------~~~~~-~~~~~~ 229 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------------SIAIK-HIQDSV 229 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------------------HHHHH-HHSSCC
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------------HHHHH-HhhccC
Confidence 44567999999999999999999999999999999999999999753211 11111 111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccccCC
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-TMGTVVKMLEGVLEVT 742 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~~~~ 742 (804)
... ........+..+.+++.+|++.||++|| ++.++.+.|+.++...
T Consensus 230 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 230 PNV-----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCH-----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CCc-----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 111 0111223346788999999999999999 9999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=349.73 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=195.7
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHc--CCCCCCceeeeeEEec----CCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIG--NIQHVNLVRLRGFCSE----NSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~----~~~~~lV~E 529 (804)
..+.++||+|+||.||+|+. +++.||||++... ....+..|.+++. +++||||+++++++.. ....++|||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 34668999999999999988 6888999999653 3344555555544 4899999999998754 346899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH--------EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
|+++|+|.++++.. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999999654 6899999999999999999999 666 9999999999999999999999999998
Q ss_pred ccCCCccc---cccccccccccccchhccCC------CCCccceEEeehhhHHHhhhC----------CCCCCCCcCCCC
Q 044374 602 LIGRDFSR---VLATMRGTWGYVAPEWISGL------AITTKADVYSYGMTLLELIGG----------RRNVEAPASGRN 662 (804)
Q Consensus 602 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~~ksDV~S~Gvvl~elltg----------~~p~~~~~~~~~ 662 (804)
........ ......||+.|+|||++.+. .++.++||||||+++|||++| +.||......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~-- 239 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN-- 239 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS--
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC--
Confidence 65443222 12334799999999999876 456799999999999999999 5565432211
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...................... ...+......+.+++.+||+.||++|||+.+|+++|+.+
T Consensus 240 -----------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 -----------DPSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -----------SCCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------CcchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111111111111111111 112335678899999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.42 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=195.8
Q ss_pred hcccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
...+.+.||+|+||.||+|.... +..||||+++.... ..+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 34567899999999999997643 45799999875432 2456899999999999999999999985 46789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999877667999999999999999999999988 99999999999999999999999999987654433
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-------------------~~~~~i~~ 232 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------------------DVIGRIEN 232 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------------GHHHHHHT
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-------------------HHHHHHHc
Confidence 33344557889999999998999999999999999999996 99998753221 01112222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+... ..+...+..+.+++..|++.||++||++.+|++.|+.+.+
T Consensus 233 ~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 233 GERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2111 1222345678899999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=364.12 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=210.5
Q ss_pred hhcccccccccccceeEEEEEeC--------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCC
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENS 522 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 522 (804)
....+.++||+|+||.||+|+.. .+..||||+++.... ..+.+.+|+.+++++ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34556789999999999999752 235799999976533 236788999999999 9999999999999999
Q ss_pred eEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec
Q 044374 523 HRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD 587 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~ 587 (804)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEc
Confidence 9999999999999999998653 35899999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcC
Q 044374 588 SDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANI 665 (804)
Q Consensus 588 ~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 665 (804)
.++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------ 299 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 299 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999998664332 122344567889999999999999999999999999999999 9999864211
Q ss_pred CCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
......+..+... ..+......+.+++..||+.||++||++.+|++.|+.+....
T Consensus 300 -------------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 -------------EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -------------HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -------------HHHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1122222222211 112233467889999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.82 Aligned_cols=251 Identities=22% Similarity=0.230 Sum_probs=202.1
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||+||+|+... ++.||||+++.. ......+++|+.++.+++||||+++++++.+.+..+|||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 345799999999999998764 788999999642 223345889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 999999999876668999999999999999999999988 99999999999999999999999999987655444334
Q ss_pred cccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 612 ATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+.
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------------------~~~~~i~ 294 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------------------ETYGKIM 294 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHH
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------------------HHHHhhh
Confidence 4568999999999987 567899999999999999999999999753211 0111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM--RPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 734 (804)
.... .. .+ ..........+.+++.+||+.+|++ ||++.||++.
T Consensus 295 ~~~~-~~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKE-RF---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHH-HC---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccc-cc---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 00 00 0001123456888999999888888 9999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.06 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=205.7
Q ss_pred hcccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCC-eE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENS-HR 524 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-~~ 524 (804)
...+.++||+|+||.||+|++ .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++.+.+ ..
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 345678999999999999973 2457899999976433 235689999999999 7999999999998755 48
Q ss_pred EEEEEEcCCCChhHHHhhCCC-----------------------------------------------------------
Q 044374 525 LLVYDYMRNGALSLYLRKDGL----------------------------------------------------------- 545 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 545 (804)
++||||+++|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999976532
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-ccccccccccc
Q 044374 546 ------NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTW 618 (804)
Q Consensus 546 ------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~ 618 (804)
.+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ........+|+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 1889999999999999999999988 9999999999999999999999999998654332 22334567899
Q ss_pred ccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecccc
Q 044374 619 GYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697 (804)
Q Consensus 619 ~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 697 (804)
.|+|||++.+..++.++||||||+++|||++ |+.||...... ......+..+...
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------------~~~~~~~~~~~~~------ 315 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------------EEFCRRLKEGTRM------ 315 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------------------HHHHHHHHHTCCC------
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------------------HHHHHHHHcCCCC------
Confidence 9999999999999999999999999999998 99999753221 1122222222211
Q ss_pred ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 698 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
..+......+.+++..||+.||++||++.+|+++|+.++.
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1122234568899999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=348.33 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=202.3
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 4568999999999999976 5789999999975432 23568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 98 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~ 171 (328)
T 3fe3_A 98 GGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLD 171 (328)
T ss_dssp TCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGG
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cccc
Confidence 999999997654 6899999999999999999999988 999999999999999999999999999865433 2245
Q ss_pred ccccccccccchhccCCCCC-ccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAIT-TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...||+.|+|||++.+..+. .++|||||||++|||++|+.||..... ......+..+..
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------------------~~~~~~i~~~~~- 231 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------------------KELRERVLRGKY- 231 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCCC-
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhCCC-
Confidence 56799999999999888765 799999999999999999999975321 111122222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ---------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234568899999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.48 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=207.5
Q ss_pred cccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 44668999999999999975 2457899999975432 336788999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 044374 528 YDYMRNGALSLYLRKDG-----------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NI 584 (804)
|||+++++|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheE
Confidence 99999999999998643 23789999999999999999999988 99999999999
Q ss_pred EecCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCC
Q 044374 585 LLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRN 662 (804)
Q Consensus 585 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 662 (804)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 259 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-- 259 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999986643322 12234457889999999999999999999999999999999 99998743221
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+..+.. ...+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 260 -----------------~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 -----------------RLFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp -----------------GHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------HHHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122222211 11222345678899999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.33 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=206.4
Q ss_pred hhcccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
....+.++||+|+||.||+|++. .++.||||+++.... ....+.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 34456789999999999999853 456899999975432 3456889999999999999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEee
Q 044374 526 LVYDYMRNGALSLYLRKDG------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSD 596 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~D 596 (804)
+||||+++|+|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997643 35889999999999999999999988 99999999999999554 599999
Q ss_pred cCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCc
Q 044374 597 FGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 597 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------------- 292 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------------- 292 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence 9999854322 2222344567899999999999999999999999999999998 9999874321
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+.. ...+......+.+++..||+.||++||++.+|++.|+.+..
T Consensus 293 ----~~~~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 293 ----QEVLEFVTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ----HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 111122222211 11122334668899999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.42 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=207.6
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.+.||+|+||.||+|+.. .++.||||+++.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 345689999999999999874 347899999975432 245789999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 044374 528 YDYMRNGALSLYLRKDG-----------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NI 584 (804)
|||+++++|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceE
Confidence 99999999999997642 46899999999999999999999988 99999999999
Q ss_pred EecCCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCC
Q 044374 585 LLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRN 662 (804)
Q Consensus 585 Ll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 662 (804)
|++.++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh---
Confidence 99999999999999998654321 122344568899999999999899999999999999999999 9999864211
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+.... .+......+.+++..||+.||++||++.+|+++|+.+..
T Consensus 283 ----------------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 ----------------EEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ----------------HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----------------HHHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11222233332211 122334678899999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.63 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=205.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.+.||+|+||.||++... +++.||+|.++........+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 345689999999999999765 5789999999866555667899999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC--CCceEEeecCCccccCCCcccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS--DYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... ...
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 161 (321)
T 1tki_A 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFR 161 (321)
T ss_dssp BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEE
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccc
Confidence 999999877667999999999999999999999988 999999999999987 7899999999998764332 234
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+...
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------------~~~~~i~~~~~~- 221 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------------QIIENIMNAEYT- 221 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHHHTCCC-
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------------------HHHHHHHcCCCC-
Confidence 567899999999999988999999999999999999999999743211 111222222110
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+... .......+.+++.+||+.||++|||+.|+++.
T Consensus 222 -~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 -FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000 01224568899999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.21 Aligned_cols=250 Identities=29% Similarity=0.422 Sum_probs=194.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCC-----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG-----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|... ++.||||+++... ...+.+++|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 345689999999999999875 7889999996532 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC--------CCceEEeecCCccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS--------DYTAKVSDFGLAKL 602 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~DfGla~~ 602 (804)
+++++|.+++... .+++..++.++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+|||+++.
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 88 ARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred CCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999999643 6899999999999999999999987556899999999999986 77899999999986
Q ss_pred cCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
..... .....||+.|+|||.+.+..++.++||||||++++||++|+.||...... ...
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------------~~~ 223 (271)
T 3dtc_A 166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------------------AVA 223 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------------------HHH
T ss_pred ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHH
Confidence 54332 22456899999999999999999999999999999999999999743211 011
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
....... .....+......+.+++.+|++.||++||++.+|+++|+.+
T Consensus 224 ~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNK--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCC--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111 11112233456788999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.98 Aligned_cols=251 Identities=30% Similarity=0.502 Sum_probs=201.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CH------HHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GE------REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~------~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
..+.+.||+|+||.||+|+.. +++.||||++..... .. +.+.+|+.++++++||||+++++++.... ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 345689999999999999774 688999999964322 11 67899999999999999999999997655 69
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc-----eEEeecCCcc
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT-----AKVSDFGLAK 601 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~ 601 (804)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 99999999999999877778999999999999999999999865 34999999999999988776 9999999998
Q ss_pred ccCCCccccccccccccccccchhc--cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWI--SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||....... ..
T Consensus 178 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----------------~~ 237 (287)
T 4f0f_A 178 QSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----------------IK 237 (287)
T ss_dssp CCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----------------HH
T ss_pred ccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----------------HH
Confidence 54332 3446789999999998 45567899999999999999999999997532210 00
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
......... .....+......+.+++..||+.||++||++.+|++.|+++
T Consensus 238 -~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 -FINMIREEG--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHHHHHHSC--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -HHHHHhccC--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 11122233456789999999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.03 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=207.0
Q ss_pred hhcccccccccccceeEEEEEe------CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERP--GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 524 (804)
....+.+.||+|+||.||+|.. ..+..||||+++.. ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3445678999999999999975 24568999999753 23456799999999999 899999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 044374 525 LLVYDYMRNGALSLYLRKDGL----------------------NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPE 582 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~ 582 (804)
++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChh
Confidence 999999999999999986542 3789999999999999999999988 999999999
Q ss_pred cEEecCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCC
Q 044374 583 NILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASG 660 (804)
Q Consensus 583 NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~ 660 (804)
|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986543322 22334567889999999999999999999999999999998 99999753221
Q ss_pred CCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 661 RNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+. ....+......+..++..||+.||.+||++.+|+++|+.+..
T Consensus 282 ------------------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 282 ------------------ANFYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ------------------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------------------HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11112222211 111222335678899999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.84 Aligned_cols=272 Identities=21% Similarity=0.249 Sum_probs=199.0
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||+||+|+..+++.||||++..... ....+.+|+.++++++||||+++++++......++||||+++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 103 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC
Confidence 35679999999999999988899999999975422 236788999999999999999999999999999999999985
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 104 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 178 (311)
T 3niz_A 104 -DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTH 178 (311)
T ss_dssp -EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C---C
T ss_pred -CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-ccccC
Confidence 888888777667999999999999999999999988 9999999999999999999999999998764332 22344
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC-CCCCCccCchHHHH-HHhhcCcc
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG-GEHGDKWFFPPWAA-RQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 690 (804)
..+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .........+.... ..+... .
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~ 257 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR-T 257 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC-C
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc-c
Confidence 578999999999876 5689999999999999999999999975433211000000 00000000000000 000000 0
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+............+.+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000011223567899999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.84 Aligned_cols=271 Identities=25% Similarity=0.359 Sum_probs=209.0
Q ss_pred HhhcccccccccccceeEEEEEe-----CCCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecC--Ce
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN--SH 523 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~ 523 (804)
.....+.++||+|+||.||++++ ..++.||||+++.. ....+.+.+|+.++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 33455678999999999999984 36789999999743 34557899999999999999999999999876 66
Q ss_pred EEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 524 RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
.++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999776667999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 604 GRDFS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 604 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+............. ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP----THGQMTVTRL 252 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS----CCGGGHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC----cccccCHHHH
Confidence 54322 22344568889999999999999999999999999999999998865321100000000 0000000001
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
...+..+ .....+......+.+++.+||+.||++||++.+|+++|+.++
T Consensus 253 ~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111 111223344567899999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.77 Aligned_cols=248 Identities=27% Similarity=0.343 Sum_probs=199.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... +++.||||++.... ...+.+++|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 45689999999999999765 78899999996432 2346689999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~ 612 (804)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 90 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 90 GELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp EEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 99999997654 6899999999999999999999988 999999999999999999999999999865422 222334
Q ss_pred ccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .....+.....
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------------------~~~~~~~~~~~- 226 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT- 226 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------------------HHHHHHHTTCT-
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------------------HHHHHHhcccc-
Confidence 5679999999999988775 789999999999999999999997533210 01111111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...........+.+++.+||+.||++||++.|+++.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 -------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112234567889999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.24 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=201.0
Q ss_pred ccccccccccceeEEEEEeC-CCc----EEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|... +++ .||+|.+... ......+.+|+.++++++||||+++++++. ....++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 45678999999999999764 333 3888888543 233456788999999999999999999986 466899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999999877668999999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------------~~~~~~~~ 232 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------------------EVPDLLEK 232 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------------------HHHHHHHT
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------------------HHHHHHHc
Confidence 22345567889999999999999999999999999999999 99999753221 11122222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+.... .+......+.+++..||+.||++||++.+|+++|+.+..
T Consensus 233 ~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 233 GERLA---------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TCBCC---------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCC---------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 21111 111223457789999999999999999999999988643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.20 Aligned_cols=281 Identities=17% Similarity=0.200 Sum_probs=202.0
Q ss_pred cccccccccc--cceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHG--GFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.++||+| +||.||+++.. +++.||||+++..... .+.+++|+.++++++||||+++++++...+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 3466899999 99999999876 6899999999754322 3567889999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-
Q 044374 530 YMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF- 607 (804)
Q Consensus 530 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~- 607 (804)
|+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 99999999999765 246899999999999999999999988 9999999999999999999999999986542211
Q ss_pred -----cccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCC---ccCc
Q 044374 608 -----SRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD---KWFF 677 (804)
Q Consensus 608 -----~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 677 (804)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................... ....
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 111233478999999999987 679999999999999999999999997543321110000000000 0000
Q ss_pred hHH-----HHHHhhcCccceeccc---c------ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhccc
Q 044374 678 PPW-----AARQIIEGNVAAVVDD---R------LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVL 739 (804)
Q Consensus 678 ~~~-----~~~~~~~~~~~~~~d~---~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~ 739 (804)
+.. ...........+.+.. . .....+......+.+++.+||+.||++|||+.|+++. ++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000 0000000000000000 0 0001122234568899999999999999999999876 55543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.63 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=208.8
Q ss_pred hcccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 525 (804)
...+.+.||+|+||.||+|.. ..++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 345678999999999999974 3467899999975433 346789999999999 9999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 526 LVYDYMRNGALSLYLRKDGL-----------------NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
+||||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcC
Confidence 99999999999999986542 4899999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCccccCCCccc-cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCC
Q 044374 589 DYTAKVSDFGLAKLIGRDFSR-VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIG 666 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 666 (804)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------ 254 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------ 254 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch------
Confidence 999999999999876544221 2334557889999999999999999999999999999999 99998753211
Q ss_pred CCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 667 GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.........+. ....+......+.+++.+|++.||.+||++.+|+++|+++..
T Consensus 255 ------------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 ------------SKFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ------------HHHHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------hHHHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11112222111 111122334678899999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.35 Aligned_cols=245 Identities=21% Similarity=0.262 Sum_probs=203.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+++.. +++.||||+++. .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 345689999999999999765 688999999964 234567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|..++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 87 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 99999999997654 6899999999999999999999988 9999999999999999999999999998643221 22
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------------~~~~~~i~~~~~ 222 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------------------ERLFELILMEEI 222 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCCC
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------------------HHHHHHHHcCCC
Confidence 3456799999999999999999999999999999999999999974321 111112221111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
.++......+.+++..||+.||++|| ++.+|+++
T Consensus 223 ----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223346788999999999999999 89999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.17 Aligned_cols=276 Identities=22% Similarity=0.253 Sum_probs=199.7
Q ss_pred hhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHc--CCCCCCceeeeeEEecC----CeEEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIG--NIQHVNLVRLRGFCSEN----SHRLLV 527 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~----~~~~lV 527 (804)
....+.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++. .++||||+++++++... ...++|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 34556789999999999999885 7889999996543 334444555544 45999999999999877 789999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC-----RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
|||+++|+|.+++... .+++..++.++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 114 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 9999999999999765 5899999999999999999999871 11399999999999999999999999999976
Q ss_pred cCCCccc---cccccccccccccchhccCCCCCcc------ceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 603 IGRDFSR---VLATMRGTWGYVAPEWISGLAITTK------ADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 603 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k------sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
....... ......||+.|+|||++.+.....+ +|||||||++|||++|..|+........ ........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~---p~~~~~~~ 268 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL---PYHDLVPS 268 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC---TTTTTSCS
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc---cHhhhcCC
Confidence 5433221 1224579999999999988766655 9999999999999999555432111100 00000000
Q ss_pred ccCchHHHHHHhhcCccceeccccccCC-CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGA-YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
.... ............ .+.+... ...+....+.+++.+||+.||++||++.+|+++|+.+.+..
T Consensus 269 ~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 DPSY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 0111 111111111111 1111111 12356788999999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=378.37 Aligned_cols=248 Identities=26% Similarity=0.346 Sum_probs=202.2
Q ss_pred ccccccceeEEEEEeC---CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 461 KLGHGGFGAVFQGELS---DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+||+|+||.||+|.+. ++..||||+++.. ....++|.+|+.++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 4567999999754 3356789999999999999999999999976 56899999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--cccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--VLAT 613 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~ 613 (804)
|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999877778999999999999999999999988 999999999999999999999999999876433221 1223
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .....+..+..
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------------------~~~~~i~~~~~-- 557 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------------------EVMAFIEQGKR-- 557 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------------------HHHHHHHTTCC--
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------------------HHHHHHHcCCC--
Confidence 345689999999999999999999999999999998 99999753221 12222333221
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
...+...+..+.+++..||+.+|++||++.+|++.|+.+..
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12233445778999999999999999999999999988643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.07 Aligned_cols=266 Identities=16% Similarity=0.216 Sum_probs=205.1
Q ss_pred hcccccccccccceeEEEEEeCC------CcEEEEEEecCCCCC------------HHHHHHHHHHHcCCCCCCceeeee
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGSG------------EREFRAEVCTIGNIQHVNLVRLRG 516 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~------------~~~~~~Ei~~l~~l~H~niv~l~g 516 (804)
.+.+.++||+|+||.||+|.... ++.||||++...... ...+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 34567899999999999998754 467999998754321 112345666788899999999999
Q ss_pred EEecC----CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--CCC
Q 044374 517 FCSEN----SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--SDY 590 (804)
Q Consensus 517 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~~~ 590 (804)
++... ...+|||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCC
Confidence 98764 4589999999 99999999887678999999999999999999999988 99999999999999 889
Q ss_pred ceEEeecCCccccCCCccc------cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc
Q 044374 591 TAKVSDFGLAKLIGRDFSR------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN 664 (804)
Q Consensus 591 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 664 (804)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~---- 267 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD---- 267 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC----
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC----
Confidence 9999999999875433111 123345999999999999999999999999999999999999999742211
Q ss_pred CCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 665 IGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
........... ...+..+++..+.. ...+..+.+++..|++.+|++||++.+|++.|+.++...
T Consensus 268 ----------~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 ----------PKYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp ----------HHHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----------HHHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00111111111 11233333333321 123467889999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=347.66 Aligned_cols=257 Identities=16% Similarity=0.188 Sum_probs=205.7
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++......++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 4568999999999999975 578899999997543 234688999999999 9999999999999999999999999 99
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc-----eEEeecCCccccCCCccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT-----AKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~~~~~~~~~ 609 (804)
+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 90 SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 999999876668999999999999999999999988 999999999999999887 999999999875433211
Q ss_pred ------cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 610 ------VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 610 ------~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---------------~-~~~~~ 230 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---------------L-KERYQ 230 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---------------H-HHHHH
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---------------H-HHHHH
Confidence 1245679999999999999999999999999999999999999997542210 0 01111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+....... ....+... .+ .+.+++..|++.+|.+||++.+|++.|+++..
T Consensus 231 ~i~~~~~~~-~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 231 KIGDTKRAT-PIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHHHS-CHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhhccC-CHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 111110000 00001111 12 78999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.86 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=208.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC--eEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS--HRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~ 530 (804)
+.+.++||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 345689999999999999776 4889999999753 345677889999999999999999999998665 78999999
Q ss_pred cCCCChhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----cCCCceEEeecCCccccC
Q 044374 531 MRNGALSLYLRKDGL--NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL----DSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~~~~ 604 (804)
+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999986542 3899999999999999999999988 9999999999999 888899999999998765
Q ss_pred CCccccccccccccccccchhcc--------CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 605 RDFSRVLATMRGTWGYVAPEWIS--------GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------~ 231 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--------------R 231 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--------------G
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--------------h
Confidence 4322 23456899999999986 5788999999999999999999999997532211 0
Q ss_pred chHHHHHHhhcCccce----ec---------ccc--ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 677 FPPWAARQIIEGNVAA----VV---------DDR--LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~----~~---------d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
....... +..+.... +. ... ............+..++..||+.||++||++.|+++..++.
T Consensus 232 ~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 232 NKEVMYK-IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CHHHHHH-HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hHHHHHH-HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111 11111100 00 001 11234567778899999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=353.42 Aligned_cols=267 Identities=25% Similarity=0.365 Sum_probs=207.6
Q ss_pred ccccccccccceeEEEEEeC-----CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-----DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 527 (804)
.+.++||+|+||.||++.+. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 46789999999999998653 578899999976532 24568999999999999999999999987 4678999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999875 4899999999999999999999988 9999999999999999999999999998765432
Q ss_pred c--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 S--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 ~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
. .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........... ........
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~---- 256 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI--------GIAQGQMT---- 256 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH--------CSCCHHHH----
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh--------cccccchh----
Confidence 2 223445678899999999999999999999999999999999999874321100000 00000000
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
...+.+.++.......+......+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 257 -VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp -HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 0011111222222223334557799999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.17 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=193.8
Q ss_pred cccccccccccceeEEEEEeCCCc----EEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE----
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDST----LVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR---- 524 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 524 (804)
..+.+.||+|+||.||+|...... .||||+++.. ....+.+.+|+.++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 345689999999999999875432 7999999753 23346799999999999999999999999877655
Q ss_pred --EEEEEEcCCCChhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeec
Q 044374 525 --LLVYDYMRNGALSLYLRKDG-----LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597 (804)
Q Consensus 525 --~lV~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 597 (804)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999986432 25899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 598 GLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 598 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
|+++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------------- 246 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------------- 246 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------------
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---------------
Confidence 9998654332 222334457889999999999999999999999999999999 89998753221
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
.....+..+.. ...+......+.+++.+||+.||++||++.++++.|++++...
T Consensus 247 ----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 ----EIYNYLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----GHHHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----HHHHHHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01122222111 1112234467899999999999999999999999999877643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=355.40 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=194.4
Q ss_pred ccccccccccceeEEEEEeC--CC--cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS--DS--TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|... ++ ..||||.++.... ..++|.+|+.++++++||||+++++++.. .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 45678999999999999763 22 4689999975432 34679999999999999999999999764 457899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999887778899999999999999999999988 99999999999999999999999999986543211
Q ss_pred --ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 --RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 --~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---------------~----~~~~~ 309 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------D----ITVYL 309 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---------------C----HHHHH
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---------------H----HHHHH
Confidence 11233457889999999999999999999999999999999 66666542211 0 11112
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
..+... ..+...+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 310 ~~~~~~---------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 310 LQGRRL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222111 1122234678899999999999999999999999998654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=347.56 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=201.0
Q ss_pred hcccccccccccceeEEEEEeCC-C-------cEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD-S-------TLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
...+.+.||+|+||.||+|.... + ..||+|++... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 34567899999999999996543 2 57999999654 345577999999999999999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc--------eEEeec
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT--------AKVSDF 597 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~Df 597 (804)
+||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999887666999999999999999999999988 999999999999998887 999999
Q ss_pred CCccccCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 598 GLAKLIGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 598 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
|++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+......
T Consensus 166 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---------------- 224 (289)
T 4fvq_A 166 GISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---------------- 224 (289)
T ss_dssp CSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------------
T ss_pred cccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----------------
Confidence 999754322 23457899999999987 67899999999999999999965554321110
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
.......... . ..+......+.+++..||+.||++||++.+|++.|+.+...
T Consensus 225 --~~~~~~~~~~--~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 225 --QRKLQFYEDR--H---------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --HHHHHHHHTT--C---------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --HHHHHHhhcc--C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0011111110 0 01111134578899999999999999999999999997753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.94 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=205.3
Q ss_pred cccccccceeEEEEEeC---CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS---DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||+|... .+..||||+++.... ..+.+.+|+.++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999753 577899999986432 346789999999999999999999999 456789999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc--ccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--VLA 612 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~ 612 (804)
+|.+++......+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999877667999999999999999999999988 999999999999999999999999999876443221 123
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+..
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------------------~~~~~i~~~~~- 231 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------------------EVMAFIEQGKR- 231 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------------------HHHHHHHTTCC-
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------------------HHHHHHhcCCc-
Confidence 3456889999999998899999999999999999999 99998743211 11122222211
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
...+...+..+.+++..||+.+|++||++.+|+++|+.+..
T Consensus 232 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11223345678999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.03 Aligned_cols=248 Identities=26% Similarity=0.343 Sum_probs=195.2
Q ss_pred HHHHhhcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCH---HHHHHHHHHHcCC-CCCCceeeeeEEecCCeE
Q 044374 450 ELHTVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGE---REFRAEVCTIGNI-QHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 450 el~~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 524 (804)
++......+.++||+|+||+||+|... +++.||||++....... ..+..|+..+.++ +||||+++++++.+....
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344445667789999999999999876 68999999987654333 2344555555444 899999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||+ +++|.+++...+..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999 67999988877778999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ....
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------------------~~~~ 263 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------------------GWQQ 263 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------------------HHHH
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------------------HHHH
Confidence 332 2334568999999999876 78999999999999999999977664311 1122
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+..+.... . .+......+.+++.+||+.||++||++.|+++.
T Consensus 264 ~~~~~~~~----~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 264 LRQGYLPP----E----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTTCCCH----H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCc----c----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 22221111 1 111234678899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.50 Aligned_cols=278 Identities=24% Similarity=0.327 Sum_probs=196.0
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec-----CCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE-----NSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+|+. +++.||||++............|+..+..++||||+++++.+.. ....++||||+
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4568999999999999977 67889999997543222223344444566899999999986532 23668999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC------RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
++|+|.+++... ..++..+..++.||++||+|||+.. +.+|+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 95 PNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172 (336)
T ss_dssp TTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence 999999999765 3588999999999999999999871 01399999999999999999999999999987643
Q ss_pred Cc-------cccccccccccccccchhccC-------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCC
Q 044374 606 DF-------SRVLATMRGTWGYVAPEWISG-------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH 671 (804)
Q Consensus 606 ~~-------~~~~~~~~gt~~y~aPE~l~~-------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 671 (804)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 252 (336)
T 3g2f_A 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252 (336)
T ss_dssp SSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred ccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence 21 112234569999999999987 4567799999999999999999887754322211100000000
Q ss_pred CCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+... ............+.... .........+.+++.+||+.||++|||+.||++.|+.++.
T Consensus 253 ~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 253 GNHPTFEDM-QVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CSSCCHHHH-HHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCchHHHH-HhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 000001111 11111111111111111 1123466789999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=350.76 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=200.6
Q ss_pred ccccccccccceeEEEEEeCC-----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|.... +..||||+++.... ....+.+|+.++++++||||+++++++......++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345789999999999997643 24699999975432 23468899999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999887668999999999999999999999988 999999999999999999999999999876443221
Q ss_pred --cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 --VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 --~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------------------~~~~~~~~ 264 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------------------HEVMKAIN 264 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------------HHHHHHHH
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------------------HHHHHHHH
Confidence 1223346789999999999999999999999999999999 9999864211 11122222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+.. ...+......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 265 ~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 265 DGFR---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TTCC---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCc---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2211 11122345678899999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.95 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=208.2
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.++.++ +|+|++++++++......++||||+ +
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 34568999999999999975 578999999996532 334688899999999 7999999999999999999999999 9
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc-----eEEeecCCccccCCCcc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT-----AKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla~~~~~~~~ 608 (804)
++|.+++...+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.......
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 90 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9999999887667999999999999999999999988 999999999999987776 99999999987654322
Q ss_pred ------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 609 ------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 609 ------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----------------~~~~~ 230 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----------------NKQKY 230 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC----------------HHHHH
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc----------------cHHHH
Confidence 12345679999999999999999999999999999999999999997532210 01111
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
..+..+..... .+.+. ...++.+.+++..||+.||++||++.+|++.|+.+...
T Consensus 231 ~~~~~~~~~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 231 ERIGEKKQSTP-LRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHHHHSC-HHHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhhccCcc-HHHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11111100000 00011 12346788999999999999999999999999987653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=340.73 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=196.8
Q ss_pred HHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+......+.++||+|+||.||+|+... .||||+++..... .+.+.+|+.++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 333445567899999999999998643 5999999755433 35689999999999999999999976 45568999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD- 606 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~- 606 (804)
|||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999999877778999999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------------~~~~~ 236 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------------DQIIE 236 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------------------HHHHH
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------------------HHHHH
Confidence 122234457899999999986 567889999999999999999999999743211 11222
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+.....+. ......+..+.+++..||+.+|++||++.+|+++|+.+.+
T Consensus 237 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 237 MVGRGSLSPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHTSCCCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HhcccccCcchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222222211111 1122345678999999999999999999999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=347.51 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=199.3
Q ss_pred cccccccccccceeEEEEEeC-CCc----EEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||.||+|... +++ .||+|.+... ....+.+.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 345689999999999999764 333 4688887543 446688999999999999999999999998765 78999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.+|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999999887778999999999999999999999988 99999999999999999999999999987643322
Q ss_pred -ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 -RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------------------~~~~~~~ 233 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------------EISSILE 233 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------------GHHHHHH
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------------------HHHHHHH
Confidence 22233456889999999999999999999999999999999 99999753221 0111122
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+. ....+......+.+++..||+.||++||++.+|++.|+.+..
T Consensus 234 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGE---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 111222344568899999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.68 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.+.||+|+||.||++... +++.||||+++.... ..+.+.+|+.++.+++||||+++++++......++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 346789999999999999765 688999999975322 357899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----ceEEeecCCcccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLI 603 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~ 603 (804)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 94 LELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999997654 7899999999999999999999988 99999999999998877 7999999999876
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... -...
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------------------~~~~ 228 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------------------ETLA 228 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHH
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHH
Confidence 4432 234567999999999999999999999999999999999999999753211 1111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..+... .++.. .......+.+++..||+.||++||++.|+++.
T Consensus 229 ~i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 229 NITAVSYD--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHTTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCC--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22221110 00000 11224568899999999999999999998863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=346.39 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=193.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----------
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS---------- 522 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---------- 522 (804)
..+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 345689999999999999876 7899999999743 334567999999999999999999999986543
Q ss_pred -----------------------------------------------eEEEEEEEcCCCChhHHHhhCC--CCCCHHHHH
Q 044374 523 -----------------------------------------------HRLLVYDYMRNGALSLYLRKDG--LNLNWDVRF 553 (804)
Q Consensus 523 -----------------------------------------------~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~ 553 (804)
..++||||+++++|.+++.... ...++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 3799999999999999998754 234566789
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-----------cccccccccccccc
Q 044374 554 RIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-----------RVLATMRGTWGYVA 622 (804)
Q Consensus 554 ~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y~a 622 (804)
.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....... .......||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999988 99999999999999999999999999987654321 12234569999999
Q ss_pred chhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCC
Q 044374 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAY 702 (804)
Q Consensus 623 PE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 702 (804)
||++.+..++.++||||||+++|||++|..|+... ............. ..
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------------------~~~~~~~~~~~~~---------~~ 294 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------------------VRIITDVRNLKFP---------LL 294 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------------------HHHHHHHHTTCCC---------HH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------------------HHHHHHhhccCCC---------cc
Confidence 99999999999999999999999999987654310 0011111111110 11
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 703 KVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 703 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+.+++..||+.||++||++.|+++.
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 12334567889999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.78 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=202.0
Q ss_pred cccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|.... +..||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 3456899999999999997543 24699999976432 34678999999999999999999999865 45689999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|.+++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999877667999999999999999999999988 999999999999999999999999999876544333
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-------------------~~~~~~~~~ 230 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-------------------DVIGVLEKG 230 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-------------------GHHHHHHHT
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-------------------HHHHHHhcC
Confidence 3344567889999999998899999999999999999998 99998643211 011122222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
... ..+....+.+.+++.+|++.||++||++.+|+++|+.+..
T Consensus 231 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 231 DRL---------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111 1112234668899999999999999999999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.00 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=202.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.+.||+|+||.||++... +++.||||+++.... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999775 588999999965321 357899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----ceEEeecCCcccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLI 603 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~ 603 (804)
|||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999997643 7899999999999999999999988 99999999999999887 8999999999876
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------------~~~~ 227 (326)
T 2y0a_A 169 DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------------------ETLA 227 (326)
T ss_dssp CTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHH
T ss_pred CCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------------------HHHH
Confidence 4322 233467999999999999999999999999999999999999999643210 0111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..... ...+ . ........+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~~~~~~-~~~~-~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 228 NVSAVNY-EFED-E----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTCC-CCCH-H----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCC-CcCc-c----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111110 0000 0 011224568899999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.54 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=195.5
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.+.+.||+|+||.||+++.. ++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||||+++++|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L 86 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence 45689999999999999885 678999999643 345679999999999999999999998874 47999999999999
Q ss_pred hHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc-eEEeecCCccccCCCccccccc
Q 044374 537 SLYLRKDGL--NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT-AKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 537 ~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~~~~~~~~~~~~ 613 (804)
.+++..... .+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~ 162 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTN 162 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----ccc
Confidence 999986542 4788999999999999999999943334999999999999998886 799999999765432 233
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..........+....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~- 224 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----------------AFRIMWAVHNGTRPP- 224 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----------------HHHHHHHHHTTCCCC-
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----------------HHHHHHHHhcCCCCC-
Confidence 46899999999999999999999999999999999999999742211 000111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
.....+..+.+++.+||+.||++||++.+|+++|+.+...
T Consensus 225 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 225 --------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp --------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred --------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1122345688999999999999999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=335.99 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecC--CeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSEN--SHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|+.. ++.||||+++..... .+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 346689999999999999985 788999999765432 35689999999999999999999999887 788999999
Q ss_pred cCCCChhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 531 MRNGALSLYLRKDGL-NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ ..|+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---- 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---- 165 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc----
Confidence 999999999987653 5899999999999999999999864 3499999999999999999999999988764322
Q ss_pred cccccccccccccchhccCCCCCc---cceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 VLATMRGTWGYVAPEWISGLAITT---KADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~---ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||...... ........
T Consensus 166 --~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------------~~~~~~~~ 225 (271)
T 3kmu_A 166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------------------EIGMKVAL 225 (271)
T ss_dssp --TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------------------HHHHHHHH
T ss_pred --cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------------------HHHHHHHh
Confidence 2346899999999998766554 799999999999999999999743211 11111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+ .....+......+.+++..||+.||++||++.+|++.|+.+.+
T Consensus 226 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EG---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 1112222345678899999999999999999999999988643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=350.05 Aligned_cols=247 Identities=22% Similarity=0.314 Sum_probs=194.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCC--CCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQH--VNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.++||+|+||.||++...+++.||||++...... .+.+.+|+.++.+++| |||+++++++......++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 3456899999999999999888999999999754433 3568899999999976 999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc-
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR- 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 609 (804)
+.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+ ++.+||+|||+++........
T Consensus 90 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 90 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 67889999998754 7899999999999999999999988 99999999999997 678999999999876543222
Q ss_pred cccccccccccccchhccC-----------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 610 VLATMRGTWGYVAPEWISG-----------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------------ 226 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------------ 226 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------------------
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------------------
Confidence 2345679999999999865 67889999999999999999999999642110
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... ..++++......+......+.+++..||+.||++||++.++++.
T Consensus 227 ~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ISKL--------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHH--------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH--------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0001 11112222222222334568899999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.42 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=193.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
+.+.++||+|+||.||+++.. .++.||||++.......+.+++|+.++++++||||+++++++......++||||+++|
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 446789999999999999775 6889999999876666788999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc--eEEeecCCccccCCCcccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT--AKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~~~~~~~~~~ 612 (804)
+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..... ....
T Consensus 102 ~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 175 (361)
T 3uc3_A 102 ELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 175 (361)
T ss_dssp BHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCCC
Confidence 9999997654 6899999999999999999999988 999999999999987765 999999999753222 1233
Q ss_pred ccccccccccchhccCCCCCcc-ceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAITTK-ADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~k-sDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...||+.|+|||++.+..+..+ +|||||||++|||++|+.||....... .+... ...+...
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------------~~~~~-~~~~~~~--- 237 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--------------DYRKT-IQRILSV--- 237 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--------------CHHHH-HHHHHTT---
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--------------HHHHH-HHHHhcC---
Confidence 4569999999999988887665 899999999999999999997532211 01111 1111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.............+.+++.+||+.||++|||+.|++++
T Consensus 238 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11101111234668899999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.93 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=197.1
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|+...++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 4568999999999999988888999999996542 2346788999999999999999999999999999999999986
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++......+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (288)
T 1ob3_A 85 -DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH 159 (288)
T ss_dssp -EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cccc
Confidence 899998876667999999999999999999999988 99999999999999999999999999987643321 2334
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc---
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN--- 689 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 689 (804)
..+|+.|+|||++.+. .++.++||||||+++|||++|+.||........ .....+......
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---------------LMRIFRILGTPNSKN 224 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---------------HHHHHHHHCCCCTTT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHHHHCCCChhh
Confidence 5689999999998764 589999999999999999999999975321100 000000000000
Q ss_pred ---cce--ecccccc-------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 ---VAA--VVDDRLG-------GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ---~~~--~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+ ..++... ..........+.+++.+||+.||++||++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000000 01111234668899999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.35 Aligned_cols=270 Identities=23% Similarity=0.341 Sum_probs=209.1
Q ss_pred hcccccccccccceeEEEEEe-----CCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEe--cCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCS--ENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~l 526 (804)
...+.++||+|+||.||++++ ..++.||||++..... ..+.+.+|+.++++++||||+++++++. .....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 345678999999999999984 3678999999976533 3456899999999999999999999986 4567899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999876667999999999999999999999988 999999999999999999999999999876433
Q ss_pred cc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 FS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. .......+|..|+|||.+.+..++.++||||||++++||++|+.||............. .............
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC----ERDVPALSRLLEL 256 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--------CCHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc----ccccccHHHHHHH
Confidence 22 12334568888999999999999999999999999999999999986432110000000 0000000011111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
. ........+......+.+++..||+.||++||++.+|+++|+.+..
T Consensus 257 ~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 L---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp H---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred h---------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 1111222233455778999999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.64 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=200.6
Q ss_pred cccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEe-cCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCS-ENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 528 (804)
..+.+.||+|+||.||+|...+ ...||||.++.... ..+.+.+|+.++++++||||+++++++. .....++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456899999999999997643 23689999976433 3457899999999999999999999875 456789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999877778899999999999999999999988 99999999999999999999999999986543321
Q ss_pred ---ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhC-CCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 ---RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGG-RRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ---~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.......+|+.|+|||.+.+..++.++||||||++++||++| ..||...... . ....
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~------------------~-~~~~ 244 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------------D-ITVY 244 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT------------------T-HHHH
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH------------------H-HHHH
Confidence 123345678899999999999999999999999999999995 4555432111 0 1111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+..+... ..+...+..+.+++..||+.||++||++.+|+++|+.+..
T Consensus 245 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 245 LLQGRRL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111110 1112234568899999999999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.34 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=203.4
Q ss_pred cccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE-EEEEEE
Q 044374 458 FSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR-LLVYDY 530 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV~E~ 530 (804)
..++||+|+||.||+|...+ +..||+|+++.... ..+.+.+|+.++++++||||+++++++...+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 45789999999999997532 23799999976433 336788999999999999999999999876655 999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc---
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF--- 607 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~--- 607 (804)
+.+++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999999887778999999999999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
........+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ......+..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~------------------~~~~~~~~~ 243 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------------------FDLTHFLAQ 243 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG------------------GGHHHHHHT
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH------------------HHHHHHhhc
Confidence 12233456789999999999999999999999999999999966665422110 001111222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
+.. ...+......+.+++..|++.||.+|||+.+++++|+.+...
T Consensus 244 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 244 GRR---------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC---------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 111222346788999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.22 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=192.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---------------------------CHHHHHHHHHHHcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---------------------------GEREFRAEVCTIGNIQ 507 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~Ei~~l~~l~ 507 (804)
+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 345689999999999999764 678999999965321 1246889999999999
Q ss_pred CCCceeeeeEEec--CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 044374 508 HVNLVRLRGFCSE--NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENIL 585 (804)
Q Consensus 508 H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NIL 585 (804)
||||+++++++.. ....++||||+++++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 9999999999986 5688999999999999887643 36899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeecCCccccCCCccccccccccccccccchhccCCC---CCccceEEeehhhHHHhhhCCCCCCCCcCCCC
Q 044374 586 LDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLA---ITTKADVYSYGMTLLELIGGRRNVEAPASGRN 662 (804)
Q Consensus 586 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 662 (804)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--- 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--- 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence 99999999999999987644322 234567999999999997765 47889999999999999999999974211
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
......+...... . .........+.+++.+||+.||++||++.||++
T Consensus 246 ----------------~~~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ----------------MCLHSKIKSQALE-F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----------------HHHHHHHHHCCCC-C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----------------HHHHHHHhcccCC-C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111112211110 0 011123456889999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=350.76 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=205.2
Q ss_pred hcccccccccccceeEEEEEeCC------CcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 525 (804)
...+.+.||+|+||.||+|.... ...||||+++.... ..+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 34566899999999999997642 24799999976432 345689999999999 8999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCce
Q 044374 526 LVYDYMRNGALSLYLRKD-------------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTA 592 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 592 (804)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeE
Confidence 999999999999998753 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCC
Q 044374 593 KVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGE 670 (804)
Q Consensus 593 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 670 (804)
||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------- 273 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---------- 273 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----------
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----------
Confidence 9999999986543322 22334567889999999999999999999999999999999 99898743211
Q ss_pred CCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.........+. ....+......+.+++..||+.||.+||++.+|+++|+.+.
T Consensus 274 --------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 274 --------SKFYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp --------HHHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111112111 11112223467889999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=348.91 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=207.8
Q ss_pred hhcccccccccccceeEEEEEeC--------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCC
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS--------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENS 522 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 522 (804)
....+.+.||+|+||.||+|+.. ++..||||+++.... ..+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 34556789999999999999763 467899999975432 235688999999999 8999999999999999
Q ss_pred eEEEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec
Q 044374 523 HRLLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD 587 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~ 587 (804)
..++||||+++++|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEc
Confidence 9999999999999999998653 24889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcC
Q 044374 588 SDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANI 665 (804)
Q Consensus 588 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 665 (804)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------ 265 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 265 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH------
Confidence 999999999999987644321 22233457889999999998899999999999999999999 9999864211
Q ss_pred CCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
......+..+... ..+......+.+++..||+.+|.+||++.+|++.|+.+...
T Consensus 266 -------------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 266 -------------EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -------------HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111222222111 11223346788999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.37 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=199.4
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+|.. ..++.||||++... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 4568999999999999976 56889999999632 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 92 -~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~ 164 (336)
T 3h4j_B 92 -GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFL 164 (336)
T ss_dssp -CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTT
T ss_pred -CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--ccc
Confidence 688888887654 6899999999999999999999998 999999999999999999999999999875433 223
Q ss_pred cccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..........
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------------------- 218 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------------------- 218 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------------------
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------------------
Confidence 45679999999999988776 689999999999999999999997543221100
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.... ...+......+.+++.+||+.||.+|||+.||++.
T Consensus 219 -~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 -KVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000000 01122234568899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.05 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=197.0
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.+.||+|+||.||+|... +++.||||+++... ...+++.+|+.++++++||||+++++++...+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999764 68899999997643 3456799999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe--cCCCceEEeecCCccccCCCcccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL--DSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
.+++......+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...... .....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 9999877667999999999999999999999988 9999999999999 677899999999998764432 22345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... ...
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------------------~~~~~i~~~~~-~~~ 308 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------------------ETLNNILACRW-DLE 308 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHHHTCC-CSC
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhccC-CCC
Confidence 6999999999999999999999999999999999999999743211 11111111111 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .........+.+++.+||+.||++||++.|+++.
T Consensus 309 ~-----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 D-----EEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp S-----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0111234678899999999999999999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=346.91 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=200.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.++||+|+||.||+++.. +++.||||+++... ...+.+.+|..++.++ +||||+++++++...+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 346689999999999999875 57889999997532 2234578899988876 89999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|..++...+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 134 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~ 208 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 208 (396)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-CC
Confidence 999999999998654 6899999999999999999999988 999999999999999999999999999853222 22
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+.+..+.
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~----------~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------------CCHHHHHHHHHHCC
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc----------cchhhHHHHHHHHhccc
Confidence 24556899999999999999999999999999999999999999975322110 00111122222222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM------GTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~~ 734 (804)
. .++......+..++..||+.||++||++ .||+++
T Consensus 279 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 I----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred c----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1 1222345678899999999999999985 566543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.01 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=207.0
Q ss_pred hcccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
...+.+.||+|+||.||+|... .++.||||++..... ....+.+|+.++++++||||+++++++......++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3456789999999999999654 367899999975433 23468899999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeec
Q 044374 527 VYDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 597 (804)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcC
Confidence 999999999999987532 35689999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 598 GLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 598 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
|+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------------- 246 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------------- 246 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----------------
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----------------
Confidence 9998654332 122334467889999999999999999999999999999999 8888864211
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+.... .+......+.+++.+||+.||++||++.+|++.|++...
T Consensus 247 ---~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 ---EQVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11222222222211 122334668899999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.02 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=197.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||+||+|... +++.||||+++.... ....+.+|+.++++++||||+++++++......++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 45679999999999999775 588999999975432 23678899999999999999999999999999999999998
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+ +|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 85 ~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 159 (292)
T 3o0g_A 85 Q-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence 6 555555555557999999999999999999999988 9999999999999999999999999998764332 2234
Q ss_pred ccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc---C
Q 044374 613 TMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE---G 688 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 688 (804)
...+|+.|+|||++.+.. ++.++|||||||+++||++|..|+....... .......+.... .
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--------------~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--------------DQLKRIFRLLGTPTEE 225 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--------------HHHHHHHHHHCCCCTT
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--------------HHHHHHHHHhCCCChh
Confidence 557899999999998765 7999999999999999999988864321110 000000000000 0
Q ss_pred c---cceecc---------ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 N---VAAVVD---------DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~---~~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .....+ ..............+.+++..||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000 000011122345678899999999999999999998864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=344.96 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecC------CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER------PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
.+.+.+.||+|+||.||++... +++.||||++.. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3556789999999999999764 689999999853 123567899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc---eEEeecCCcc
Q 044374 528 YDYMRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT---AKVSDFGLAK 601 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~ 601 (804)
|||+++++|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999998887643 235899999999999999999999988 999999999999987655 9999999998
Q ss_pred ccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------------~~~ 240 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------------------ERL 240 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------------------HHH
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------------------HHH
Confidence 765432 22345679999999999999999999999999999999999999997421 111
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+..+.... .+.. .......+.+++.+||+.||++||++.++++.
T Consensus 241 ~~~i~~~~~~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 241 FEGIIKGKYKM--NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHTCCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCC--Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12222221110 0000 01124568899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.88 Aligned_cols=262 Identities=16% Similarity=0.213 Sum_probs=197.2
Q ss_pred hcccccccccccceeEEEEEeC----CCcEEEEEEecCCCCC------------HHHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSG------------EREFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~------------~~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
.+.+.+.||+|+||.||+|... .+..||||++...... ...+.+|+..+..++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 3456789999999999999875 4678999999754321 23466788999999999999999999
Q ss_pred ec----CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC--ce
Q 044374 519 SE----NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY--TA 592 (804)
Q Consensus 519 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~ 592 (804)
.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 87 67899999999 999999998765 7999999999999999999999988 99999999999999887 99
Q ss_pred EEeecCCccccCCCcc------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC
Q 044374 593 KVSDFGLAKLIGRDFS------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG 666 (804)
Q Consensus 593 kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 666 (804)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------ 266 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD------ 266 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC------
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc------
Confidence 9999999987543211 1124457999999999999999999999999999999999999999632111
Q ss_pred CCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 667 GGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.. ........... .+...+..... ....+..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 267 -------~~-~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 -------PV-AVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -------HH-HHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -------cH-HHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00 00001111111 11111110000 0123457899999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.72 Aligned_cols=248 Identities=20% Similarity=0.216 Sum_probs=201.3
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.++||+|+||.||+++.. +++.||||+++.. ......+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34579999999999999875 5789999999641 233455889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 152 ~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 152 PGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp TTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999764 5889999999999999999999988 99999999999999999999999999987655433334
Q ss_pred cccccccccccchhccCCC----CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 612 ATMRGTWGYVAPEWISGLA----ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~----~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
....||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... -....+..
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------------~~~~~i~~ 287 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------------------GTYSKIMN 287 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHHT
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------------------hHHHHHHh
Confidence 4678999999999998765 789999999999999999999999743211 11111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM--RPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVl~~ 734 (804)
+.. .+.-.........+..++..||+.+|++ ||++.||+++
T Consensus 288 ~~~------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100 0000001123466889999999999998 9999999976
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.49 Aligned_cols=242 Identities=25% Similarity=0.331 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345689999999999999775 6889999999642 34567788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 88 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 99999999998754 6899999999999999999999988 999999999999999999999999999875432
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------------------~~~~~~i~~~~~ 220 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------------------MKTYEKILNAEL 220 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------------HHHHHHHHHCCC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhCCC
Confidence 2356799999999999999999999999999999999999999974211 111122222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
.++......+.+++.+|++.||++|| ++.+|+++
T Consensus 221 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11222345688999999999999999 88888854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=375.49 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=199.2
Q ss_pred cccccccceeEEEEEeC---CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS---DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++||+|+||.||+|.+. .++.||||+++... ...+++.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 45789999997532 235789999999999999999999999965 558899999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--ccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS--RVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~ 611 (804)
|+|.+++.... .+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 6899999999999999999999988 99999999999999999999999999987644321 223
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... ......+..+..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------------------~~~~~~i~~~~~ 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------------SEVTAMLEKGER 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------------HHHHHHHHTTCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcCCC
Confidence 33457889999999999999999999999999999998 9999975321 112222222221
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ..+...+..+.+++..||+.||++||++.+|+++|+.+.
T Consensus 591 ~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 591 M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 223344577899999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=349.34 Aligned_cols=249 Identities=18% Similarity=0.290 Sum_probs=204.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|... +++.||+|++..... ....+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 446689999999999999765 678999999975432 345789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC--CCceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS--DYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 133 g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~ 207 (387)
T 1kob_A 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 207 (387)
T ss_dssp CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CE
T ss_pred CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc--ce
Confidence 9999999877667999999999999999999999988 999999999999974 5789999999998765432 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------------------~~~~~i~~~~~~ 268 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------------------ETLQNVKRCDWE 268 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHHHHHHCCCC
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCCCC
Confidence 3457999999999999999999999999999999999999999743210 011111111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
............+.+++.+||+.||++||++.++++.
T Consensus 269 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 ------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0111112334678899999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=339.74 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=199.4
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEe----cCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCS----ENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++||||+++++++. .....++|||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 44678999999999999976 57899999998643 234567899999999999999999999987 3457899999
Q ss_pred EcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|+++++|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999999999875 3457999999999999999999999988 999999999999999999999999998764321
Q ss_pred ccc--------cccccccccccccchhccCCC---CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 607 FSR--------VLATMRGTWGYVAPEWISGLA---ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 607 ~~~--------~~~~~~gt~~y~aPE~l~~~~---~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------------- 254 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------------- 254 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-------------
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-------------
Confidence 111 112345799999999987654 68899999999999999999999863211000
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
. ....... .............+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 255 ~----~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 S----VALAVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp C----HHHHHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred h----hhHHhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 0011111 0111111233467899999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.98 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=198.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|..++.++ +||||+++++++...+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 456789999999999999765 5789999999642 33456788899999987 79999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 105 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~ 179 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GV 179 (353)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-Cc
Confidence 999999999997654 6899999999999999999999988 999999999999999999999999999854322 12
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------------------~~~~~~i~~~~ 240 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------------------DDLFEAILNDE 240 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 23456799999999999998999999999999999999999999975321 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM------GTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~~ 734 (804)
. .++......+..++..||+.||++||++ .+|+++
T Consensus 241 ~----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 241 V----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 1122234568899999999999999998 677653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.15 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=201.2
Q ss_pred cccc-ccccccceeEEEEEeC---CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSE-KLGHGGFGAVFQGELS---DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+ .||+|+||.||+|... .++.||||+++.... ..+++.+|+.++++++||||+++++++ ..+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3455 8999999999999542 457899999975432 246799999999999999999999999 5677899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 98 MAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp CCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred eCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999999998754 6899999999999999999999988 999999999999999999999999999876443221
Q ss_pred --cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 610 --VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 610 --~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------------~~~~~~~~ 234 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------------SEVTAMLE 234 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------------HHHHHHHH
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------------------HHHHHHHH
Confidence 1223446789999999998889999999999999999999 9999874321 11122222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+.. ...+......+.+++..||+.||++||++.+|++.|+.+..
T Consensus 235 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 235 KGER---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2211 11223345678999999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=351.50 Aligned_cols=249 Identities=21% Similarity=0.227 Sum_probs=202.0
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+.++||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 45678999999999999965 4688999999976543 2356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec---CCCceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD---SDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~~~~~~ 608 (804)
++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.......
T Consensus 93 ~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 93 TGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp BCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999998764 6899999999999999999999988 99999999999998 567899999999987654322
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+
T Consensus 169 -~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------------------~~~~~~i~~~ 228 (444)
T 3soa_A 169 -AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------------------HRLYQQIKAG 228 (444)
T ss_dssp -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHHHHHHT
T ss_pred -eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------------------HHHHHHHHhC
Confidence 23456799999999999999999999999999999999999999964321 1112222222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... ...+. .......+.+++..||+.||++||++.|+++.
T Consensus 229 ~~~-~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 AYD-FPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCC-CCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-CCccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 211 11111 11234668899999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.67 Aligned_cols=248 Identities=28% Similarity=0.409 Sum_probs=196.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC-CeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-SHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~g 534 (804)
..+.+.||+|+||.||+++.. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+. ...++||||++++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 346689999999999999874 7889999997543 557799999999999999999999997654 4789999999999
Q ss_pred ChhHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDGL-NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~ 173 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 173 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----ccC
Confidence 99999976542 3789999999999999999999988 999999999999999999999999999865432 223
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+..+.
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------------------~-~~~~~~~~~--- 231 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------------D-VVPRVEKGY--- 231 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------------------G-HHHHHTTTC---
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------------------H-HHHHHhcCC---
Confidence 457889999999999999999999999999999998 99998743211 0 111122211
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+...+..+.+++..||+.||++||++.+|++.|+.+..
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 ------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 111222345678899999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.05 Aligned_cols=241 Identities=23% Similarity=0.256 Sum_probs=202.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 45679999999999999875 6889999999642 345677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 124 ~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~ 195 (350)
T 1rdq_E 124 AGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T 195 (350)
T ss_dssp TTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence 9999999998754 6899999999999999999999988 999999999999999999999999999875432 2
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------------~~~~~~i~~~~~- 255 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------------------IQIYEKIVSGKV- 255 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCCC-
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------------------HHHHHHHHcCCC-
Confidence 345799999999999999999999999999999999999999974321 112222222221
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
.++......+..++.+||+.||++||+ +.+|+++
T Consensus 256 ---------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ---------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112233466889999999999999998 8888754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.84 Aligned_cols=243 Identities=28% Similarity=0.352 Sum_probs=198.2
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
....+.||+|+||.||+|.. .+++.||||++...... .+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 34567899999999999975 57899999999754332 24688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+. |+|.+++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 98 6888888766668999999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 611 LATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ... ...+..
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------------------~~~-~~~~~~ 267 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------------MSA-LYHIAQ 267 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------------HHH-HHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------------------HHH-HHHHHh
Confidence 3456899999999984 56789999999999999999999999864211 011 111122
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+..... .+......+.+++..||+.||++||++.++++.
T Consensus 268 ~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 268 NESPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp SCCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred cCCCCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111 111234568899999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.78 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=187.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.+.||+|+||.||+|+.. .++.||||+++... ..+.+++|+.++.+++||||+++++++......++||||++++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 345679999999999999876 57889999997643 3467889999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..... ...
T Consensus 134 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 207 (349)
T 2w4o_A 134 ELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLM 207 (349)
T ss_dssp BHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc--ccc
Confidence 9999997654 6899999999999999999999988 999999999999975 889999999999865432 123
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+..+...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------------~~~~~~i~~~~~~ 269 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------------------QFMFRRILNCEYY 269 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------------------HHHHHHHHTTCCC
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------------------HHHHHHHHhCCCc
Confidence 4567899999999999999999999999999999999999999643211 1122222222111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ..........+.+++.+||+.||++||++.++++.
T Consensus 270 -~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 -FI-----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CC-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cC-----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 11112334678899999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.43 Aligned_cols=257 Identities=23% Similarity=0.325 Sum_probs=193.6
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 526 (804)
+.+.+.||+|+||.||+++. .+++.||||+++..... ...+.+|+.++.+++||||+++++++.... ..++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 34568999999999999975 57889999999764322 246889999999999999999999987654 3499
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++...+ .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999998654 6899999999999999999999988 999999999999999999999999999865433
Q ss_pred cc--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 FS--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------------~~~~~~ 231 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------------SVAYQH 231 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------------HHHHHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------------HHHHHH
Confidence 21 1223456899999999999999999999999999999999999999743211 111111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH-HHHhccccC
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV-KMLEGVLEV 741 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl-~~L~~~~~~ 741 (804)
....... .... .......+.+++.+||+.||++||++.+++ ..|..+...
T Consensus 232 ~~~~~~~---~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 232 VREDPIP---PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHCCCCC---HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred hcCCCCC---cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 1111110 0000 112345688999999999999999666555 456554443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.20 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=196.6
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 45678999999999999976 4788999999975321 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 531 MRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 531 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999864 3456899999999999999999999988 9999999999999999999999999998654332
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ......+..
T Consensus 191 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~-~~~~~~~~~ 252 (310)
T 2wqm_A 191 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------------L-YSLCKKIEQ 252 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----------------H-HHHHHHHHT
T ss_pred c-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----------------H-HHHHHHhhc
Confidence 1 223456899999999999999999999999999999999999998642111 0 111122222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
+...... .......+.+++.+||+.||++||++.+|+++|+.+....
T Consensus 253 ~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 253 CDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TCSCCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 2221111 1123457889999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.33 Aligned_cols=249 Identities=24% Similarity=0.260 Sum_probs=202.6
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.+.||+|+||.||++... +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3456789999999999999765 6889999999765433 35688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCCccccCCCc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~~~~~ 607 (804)
+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++.......
T Consensus 110 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 110 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999987654 6899999999999999999999988 99999999999998654 59999999998765332
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------------------~~~~~~i~~ 244 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------------HRLYAQIKA 244 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHH
T ss_pred --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHHh
Confidence 23456799999999999999999999999999999999999999974321 111222222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+... ...+ ........+.+++.+||+.||++||++.++++.
T Consensus 245 ~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GAYD-YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TCCC-CCTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCC-CCcc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2111 0000 011234668899999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=349.66 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=195.0
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCC--CCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQ--HVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.++||+|+||.||++....++.||||++...... .+.+.+|+.++.+++ ||||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4456899999999999999888999999999754332 356899999999996 5999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-c
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-R 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 609 (804)
+.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+ ++.+||+|||+++....... .
T Consensus 137 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 67889999998765 7888999999999999999999988 99999999999995 58999999999987644322 1
Q ss_pred cccccccccccccchhccC-----------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 610 VLATMRGTWGYVAPEWISG-----------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------------ 273 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------------ 273 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------------------
Confidence 2345679999999999875 36889999999999999999999999642110
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..... .++++......+......+.+++.+||+.||++||++.||++.
T Consensus 274 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ISKLH--------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHH--------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH--------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00011 1111111111222224568899999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.21 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=181.6
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
+.||+|+||.||++... +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999775 5789999999643 4567889999999997 999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeecCCccccCCCcccccccc
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 95 ~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 169 (325)
T 3kn6_A 95 ERIKKKK-HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTP 169 (325)
T ss_dssp HHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccccc
Confidence 9998754 7999999999999999999999988 99999999999997765 89999999998654332 223455
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+|+.|+|||++.+..++.++||||||+++|||++|+.||........ ..........+..+...
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------~~~~~~~~~~i~~~~~~--- 234 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT------------CTSAVEIMKKIKKGDFS--- 234 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------------------CCCHHHHHHHHTTTCCC---
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc------------cccHHHHHHHHHcCCCC---
Confidence 689999999999999999999999999999999999999975432100 00111122222222211
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..........+.+.+++..||+.||++||++.++++.
T Consensus 235 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 ---FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0000011234678899999999999999999998854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=330.61 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=181.4
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 4567899999999999976 47889999999642 234577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 169 (278)
T 3cok_A 94 HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KH 169 (278)
T ss_dssp TTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cc
Confidence 999999999887668999999999999999999999988 99999999999999999999999999987543222 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------------------~ 222 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------------------N 222 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------------------
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------------------H
Confidence 3456899999999999999999999999999999999999999753321100 0
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.+..... ..+......+.+++.+||+.||++||++.+|++
T Consensus 223 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 KVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000000 112223456889999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=337.38 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=196.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345689999999999999865 688999999975422 136788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 116 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 116 INGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999999998654 6899999999999999999999988 9999999999999999999999999998765443333
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.. ..
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------------~~~~~~~~~-~~ 251 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------------------SVMGAHINQ-AI 251 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------------------HHHHHHHHS-CC
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------------------HHHHHHhcc-CC
Confidence 4456789999999999999999999999999999999999999974211 111111111 11
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccccCC
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-TMGTVVKMLEGVLEVT 742 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~~~~ 742 (804)
.. . ...+...+..+.+++.+||+.||++|| ++.++++.|+..+...
T Consensus 252 ~~---~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 252 PR---P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CC---G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CC---c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00 0 011223345688999999999999999 9999999999866543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.72 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=206.2
Q ss_pred hcccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCC-eE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENS-HR 524 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-~~ 524 (804)
...+.+.||+|+||.||+|.. ..++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 345678999999999999974 3467899999976433 235688999999999 7999999999987654 58
Q ss_pred EEEEEEcCCCChhHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLN---------------LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
++||||+++++|.+++...... +++..++.++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCC
Confidence 9999999999999999865422 889999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------- 257 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------- 257 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-------
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-------
Confidence 9999999999986543322 22334567899999999999999999999999999999998 99998643211
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+.... .+......+.+++..||+.||++||++.+|++.|+.++.
T Consensus 258 -----------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 258 -----------EEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -----------HHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11222222222111 122234568899999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.42 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=193.6
Q ss_pred cccccccccccceeEEEEEeC----CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCC-----e
Q 044374 456 RGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENS-----H 523 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~ 523 (804)
..+.+.||+|+||.||+|... .+..||||+++..... .+.+.+|+.++++++||||+++++++.... .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 345678999999999999664 2457999999754333 356889999999999999999999998765 3
Q ss_pred EEEEEEEcCCCChhHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 524 RLLVYDYMRNGALSLYLRK-----DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
.++||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecC
Confidence 4999999999999999853 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
+++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------------- 256 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---------------- 256 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----------------
Confidence 998654332 122334557889999999999999999999999999999999 88888643211
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+..+... ..+......+.+++..||+.||++||++.+|+++|+.+..
T Consensus 257 ---~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 257 ---EMYDYLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---GHHHHHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011122222111 1122334678999999999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.34 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=202.4
Q ss_pred hhcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec------------
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE------------ 520 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------------ 520 (804)
....+.+.||+|+||.||+|... +++.||||+++... ..+.+|+.++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 34456789999999999999876 78999999997543 457889999999999999999998854
Q ss_pred ----CCeEEEEEEEcCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 521 ----NSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 521 ----~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEEC
Confidence 44579999999999999999754 357899999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCcc
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKW 675 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 675 (804)
|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 165 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------------------ 224 (284)
T 2a19_B 165 DFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------------------ 224 (284)
T ss_dssp CCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------------------
T ss_pred cchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------------------
Confidence 9999987654321 23456899999999999999999999999999999999998776421
Q ss_pred CchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 676 FFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
......+..+. +.. .....+.+++.+||+.||++||++.++++.|+.+...
T Consensus 225 ---~~~~~~~~~~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 ---SKFFTDLRDGI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---HHHHHHHHTTC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---HHHHHHhhccc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00111122111 111 1234578899999999999999999999999886543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.37 Aligned_cols=270 Identities=23% Similarity=0.386 Sum_probs=207.0
Q ss_pred cccccccccccceeEEEEEe-----CCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCC--eEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-----SDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENS--HRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 527 (804)
..+.++||+|+||.||++++ .+++.||||++..... ..+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45678999999999999984 3678999999976433 3467999999999999999999999987654 67999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999887667999999999999999999999988 9999999999999999999999999998765432
Q ss_pred c--ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 608 S--RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 608 ~--~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+............ ...............+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG---NDKQGQMIVFHLIELL 276 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC---TTCCTHHHHHHHHHHH
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc---cccchhhhHHHHHHHh
Confidence 2 1123345778899999999888999999999999999999999887642110000000 0000000000001111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
..+ .....+...+..+.+++.+||+.||++||++.+|++.|+.+.+
T Consensus 277 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111223345678999999999999999999999999988643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.57 Aligned_cols=260 Identities=18% Similarity=0.235 Sum_probs=204.6
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEE-ecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC-SENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~~g 534 (804)
.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..+.++ ......++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 4567999999999999976 578999999987543 234688999999999998877766665 5667889999999 99
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCCcc---
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFS--- 608 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~~~--- 608 (804)
+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 999999866668999999999999999999999988 9999999999999 4889999999999987654322
Q ss_pred ---ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 609 ---RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 609 ---~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ...+
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~----~~~~ 230 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------------RQK----YERI 230 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS------------SSH----HHHH
T ss_pred cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh------------hhh----hhhh
Confidence 112456799999999999999999999999999999999999999975432210 000 0111
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
..+.... ..+.+. ...+..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 231 ~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 231 SEKKMST-PIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHS-CHHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccCC-chHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1100000 000011 122356889999999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.87 Aligned_cols=249 Identities=15% Similarity=0.149 Sum_probs=202.7
Q ss_pred cccccccccccceeEEEEE------eCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGE------LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l 526 (804)
..+.++||+|+||.||+|. ...++.||||+++.. ...++..|+.++.+++ |+||+++++++...+..++
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 4456789999999999993 446788999999753 4667888888888887 9999999999999999999
Q ss_pred EEEEcCCCChhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-----------CCc
Q 044374 527 VYDYMRNGALSLYLRK----DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-----------DYT 591 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-----------~~~ 591 (804)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||||+. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999975 3357999999999999999999999988 999999999999998 899
Q ss_pred eEEeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCC
Q 044374 592 AKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE 670 (804)
Q Consensus 592 ~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 670 (804)
+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------
Confidence 999999999764321 2233455679999999999999999999999999999999999999986432210
Q ss_pred CCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCC-CCHHHHHHHHhccccCC
Q 044374 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR-PTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~eVl~~L~~~~~~~ 742 (804)
..+...+... ...+.+.+++..|++.+|.+| |++.++.+.|++.+...
T Consensus 293 ---------------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ---------------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111111 124567788899999999998 58888999998866543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=334.37 Aligned_cols=260 Identities=18% Similarity=0.235 Sum_probs=203.1
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEE-ecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC-SENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E~~~~ 533 (804)
..+.+.||+|+||.||+|.. ..++.||||++..... ...+.+|+.++.+++|+|++..+..+ ......++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 34568999999999999975 5788999998764322 23578899999999988877776665 6677889999999 9
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCCcc--
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~~~-- 608 (804)
++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 89 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 9999999876668999999999999999999999988 9999999999999 7899999999999987644322
Q ss_pred ----ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 ----RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ----~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ...
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~----~~~ 229 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK------------RQK----YER 229 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS------------SSH----HHH
T ss_pred cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh------------hhh----hhh
Confidence 123356799999999999999999999999999999999999999975432211 000 001
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
+....... ..+.+.. ..+..+.+++..|++.||++||++.+|++.|+.+...
T Consensus 230 ~~~~~~~~-~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 230 ISEKKMST-PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHS-CHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhcccccc-hhhhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00000000 0000111 1235788999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.32 Aligned_cols=269 Identities=22% Similarity=0.323 Sum_probs=188.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 35678999999999999765 5889999999753 2344678899999999999999999999999999999999998
Q ss_pred CChhHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 534 GALSLYLRKDG-----LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 534 gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 162 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV- 162 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc-
Confidence 59999886532 35889999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC-CCCCCccCchHHHHH-Hh
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG-GEHGDKWFFPPWAAR-QI 685 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~ 685 (804)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ........++..... ..
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 12334578999999999876 4689999999999999999999999975322100000000 000000000000000 00
Q ss_pred h-------cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 686 I-------EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 686 ~-------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ...+.+.+.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000001111 11223568899999999999999999998864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.80 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=198.6
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 525 (804)
+.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++++++||||+++++++......+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 44567999999999999975 4688999999975432 2335788999999999999999999999999999
Q ss_pred EEEEEcCCC-ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 526 LVYDYMRNG-ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 526 lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
+||||+..| +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 999999877 9999997654 6899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 182 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------- 236 (335)
T 3dls_A 182 RGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------- 236 (335)
T ss_dssp TTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------
T ss_pred CCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------
Confidence 432 2334679999999999988876 88999999999999999999999642110
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..... ..+......+.+++..||+.||++||++.++++.
T Consensus 237 ----------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011124568899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.09 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=201.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||++... .++.||||++... ....+.+.+|+.++.+++||||+++++++......++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 346689999999999999765 5788999999642 34567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+.+|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 97 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 170 (384)
T 4fr4_A 97 LLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQ 170 (384)
T ss_dssp CTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cc
Confidence 99999999998654 6899999999999999999999988 999999999999999999999999999876433 22
Q ss_pred ccccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 611 LATMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----------------~~~~~~~~~~ 234 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----------------SKEIVHTFET 234 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----------------HHHHHHHHHH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----------------HHHHHHHHhh
Confidence 345679999999999864 458999999999999999999999997432210 0111111111
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-MGTVVK 733 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVl~ 733 (804)
.. ..++......+..++..||+.||++||+ +.+|.+
T Consensus 235 ~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TV----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cc----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 10 1122234567889999999999999998 777664
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.95 Aligned_cols=250 Identities=20% Similarity=0.189 Sum_probs=199.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. +++.||||+++... .....+++|..++.+++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34578999999999999875 68999999996421 22345788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++...+..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999999999876667999999999999999999999988 99999999999999999999999999987654433333
Q ss_pred cccccccccccchhcc-------CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 612 ATMRGTWGYVAPEWIS-------GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~-------~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------------------~~~~~ 281 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------------------ETYGK 281 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHH
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------------------HHHHH
Confidence 4568999999999987 457899999999999999999999999753211 01111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR---PTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~eVl~~ 734 (804)
+..... ...-+. .+......+.+++.+||+ +|++| |++.||+++
T Consensus 282 i~~~~~-~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKE-HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHH-HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhccc-CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111000 000000 111234678899999999 99998 689998865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=341.64 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=200.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|+.. +++.||||+++.. ......+..|..++.++ +||||+++++++...+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345689999999999999875 5789999999643 34566788899988876 99999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 173 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 173 (345)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-C
Confidence 999999999998654 6899999999999999999999988 9999999999999999999999999998643221 1
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------------~~~~~~i~~~~ 234 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------------------EELFHSIRMDN 234 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------------------HHHHHHHHhCC
Confidence 23456799999999999999999999999999999999999999974321 11112222211
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG-TVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 733 (804)
. .++......+.+++.+||+.||++||++. +|++
T Consensus 235 ~----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 P----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 11222346688999999999999999997 6653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.65 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=200.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+++.. +++.||||+++.... ..+.+.+|+.++.++ +||||+++++++......++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 345689999999999999875 578999999975422 234578899999887 89999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 91 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 999999999997654 6899999999999999999999988 9999999999999999999999999998543221 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............+..+.
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------------CHHHHHHHHHHCC
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc----------cccccHHHHHHHHHcCC
Confidence 23456799999999999999999999999999999999999999974321100 00011112222222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM------GTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVl~~ 734 (804)
. ..+......+..++.+||+.||++||++ .+|+++
T Consensus 236 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 I----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1 1222334668899999999999999995 566543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.27 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=192.2
Q ss_pred cccccccccccceeEEEEEe----CCCcEEEEEEecCCC-----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERPG-----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 526 (804)
..+.+.||+|+||.||+++. ..++.||||+++... .....+.+|+.++++++||||+++++++...+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 45678999999999999976 468899999997542 234567889999999999999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 999999999999997654 6889999999999999999999988 999999999999999999999999999754322
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------~~~~~~i~ 234 (327)
T 3a62_A 175 G-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------------------KKTIDKIL 234 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHHHHH
T ss_pred C-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHH
Confidence 1 123445799999999999999999999999999999999999999974321 01111222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
.+.. ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 235 ~~~~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 KCKL----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HTCC----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred hCCC----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111 11223346788999999999999999 67777764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=340.26 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=202.3
Q ss_pred cccccccccccceeEEEEEeC-CCcE--EEEEEecCC--CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTL--VAVKRLERP--GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|+.. ++.. ||||+++.. ....+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 346789999999999999764 4554 599999753 33446789999999999 89999999999999999999999
Q ss_pred EcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEE
Q 044374 530 YMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKV 594 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 594 (804)
|+++++|.+++.... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEE
Confidence 999999999997653 36899999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 595 SDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 595 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------------- 247 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------------- 247 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------------
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------------
Confidence 999999743221 11233457889999999998899999999999999999998 9999864321
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
......+..+. ....+......+.+++.+||+.||++||++.++++.|+.+...
T Consensus 248 -----~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 248 -----AELYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -----HHHHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11112222221 1112223346788999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.37 Aligned_cols=255 Identities=27% Similarity=0.319 Sum_probs=184.6
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCC-CCCceeeeeEEe--------cCCe
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQ-HVNLVRLRGFCS--------ENSH 523 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~--------~~~~ 523 (804)
...+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 3456789999999999999864 68899999986443 33467889999999996 999999999994 3345
Q ss_pred EEEEEEEcCCCChhHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 524 RLLVYDYMRNGALSLYLRK--DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
.++||||+. |+|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccce
Confidence 799999996 789888864 3346999999999999999999999864 349999999999999999999999999998
Q ss_pred ccCCCccc-----------cccccccccccccchhc---cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 602 LIGRDFSR-----------VLATMRGTWGYVAPEWI---SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 602 ~~~~~~~~-----------~~~~~~gt~~y~aPE~l---~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
........ ......+|+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------ 260 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------ 260 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------
Confidence 76433211 11244589999999998 56678999999999999999999999996432110
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCC
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVT 742 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 742 (804)
++...............+..++..||+.||++||++.++++.|+.+....
T Consensus 261 -------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 -------------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00000100111112234778999999999999999999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.19 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=201.4
Q ss_pred cccccccccccceeEEEEEeCC-CcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD-STLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+++... ++.||||+++.. ....+.+..|..++..+ +||||+++++++...+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 4566899999999999998764 788999999642 34567788999999988 89999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 102 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 999999999998654 6899999999999999999999988 9999999999999999999999999998643221 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------------------~~~~~~i~~~~ 237 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------------------DELFQSIMEHN 237 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------------------HHHHHHHHhCC
Confidence 23456799999999999999999999999999999999999999974321 11112222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
. .++......+..++..||+.||++||+ +.+|+++
T Consensus 238 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 V----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 122234567889999999999999995 4666654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.27 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=204.2
Q ss_pred HHHhhcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcC--CCCCCceeeeeEEecCC----eE
Q 044374 451 LHTVTRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGN--IQHVNLVRLRGFCSENS----HR 524 (804)
Q Consensus 451 l~~~t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~ 524 (804)
.......+.+.||+|+||.||+|+. .++.||||++... ....+.+|++++.. ++||||+++++++.... ..
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3344556778999999999999988 5888999999643 34667778877766 79999999999998776 78
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCcEEecCCCceEEee
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH--------EECRDCIIHCDIKPENILLDSDYTAKVSD 596 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 596 (804)
++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||||+.++.+||+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEE
Confidence 9999999999999999764 5899999999999999999999 656 99999999999999999999999
Q ss_pred cCCccccCCCccc---cccccccccccccchhccCC------CCCccceEEeehhhHHHhhhC----------CCCCCCC
Q 044374 597 FGLAKLIGRDFSR---VLATMRGTWGYVAPEWISGL------AITTKADVYSYGMTLLELIGG----------RRNVEAP 657 (804)
Q Consensus 597 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~~ksDV~S~Gvvl~elltg----------~~p~~~~ 657 (804)
||++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999876443221 23445799999999999776 334789999999999999999 4555432
Q ss_pred cCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCC-CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 044374 658 ASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGA-YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736 (804)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~ 736 (804)
... ...... ....+...... +.+... ...+....+.+++.+||+.||++||++.+|+++|+
T Consensus 271 ~~~-------------~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 271 VPS-------------DPSVEE-MRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp SCS-------------SCCHHH-HHHHHTTSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CcC-------------cccHHH-HHHHHHHHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 111 011111 11112121111 111111 12356778999999999999999999999999999
Q ss_pred cccc
Q 044374 737 GVLE 740 (804)
Q Consensus 737 ~~~~ 740 (804)
.+.+
T Consensus 333 ~i~~ 336 (342)
T 1b6c_B 333 QLSQ 336 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=346.03 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=209.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC--eEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS--HRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E~ 530 (804)
+.+.++||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 345689999999999999776 4889999999753 345677889999999999999999999998755 77999999
Q ss_pred cCCCChhHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----cCCCceEEeecCCccccC
Q 044374 531 MRNGALSLYLRKDGL--NLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL----DSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~~~~ 604 (804)
+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999976532 3899999999999999999999988 9999999999999 788889999999998764
Q ss_pred CCccccccccccccccccchhccC--------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISG--------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-------------- 231 (396)
T 4eut_A 168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-------------- 231 (396)
T ss_dssp CGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--------------
T ss_pred CCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--------------
Confidence 432 2334569999999999865 5678899999999999999999999975322110
Q ss_pred chHHHHHHhhcCccceec-------------ccc--ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 677 FPPWAARQIIEGNVAAVV-------------DDR--LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~-------------d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
.... ...+..+.....+ ... ............+..++..||+.||++||++.++++.|+.++..
T Consensus 232 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 232 NKEV-MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CHHH-HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hHHH-HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0111 1111111111000 001 11233466778899999999999999999999999999887653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.89 Aligned_cols=260 Identities=14% Similarity=0.143 Sum_probs=203.0
Q ss_pred cccccccccccceeEEEEEeCC---------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCcee-------------
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD---------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVR------------- 513 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~------------- 513 (804)
+.+.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 3466899999999999998763 788999999754 46889999999999999988
Q ss_pred --eeeEEec-CCeEEEEEEEcCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 514 --LRGFCSE-NSHRLLVYDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 514 --l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
+++++.. ....++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence 6777765 77899999999 99999999875 357999999999999999999999988 9999999999999999
Q ss_pred C--ceEEeecCCccccCCCcc------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCC
Q 044374 590 Y--TAKVSDFGLAKLIGRDFS------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGR 661 (804)
Q Consensus 590 ~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 661 (804)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 999999999987543321 11234579999999999999999999999999999999999999997532110
Q ss_pred CCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 662 NANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
..+.. ....+ ......+.+.... .......+.+++..||+.||++||++.+|+++|+.+...
T Consensus 276 -------------~~~~~-~~~~~-~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 276 -------------EDIMK-QKQKF-VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp -------------HHHHH-HHHHH-HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHH-HHHhc-cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 01111 1111222221110 011246788999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.30 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=196.0
Q ss_pred hcccccccccccceeEEEEEe-CCCcEEEEEEecCCC------CCHHHHHHHHHHHcCCC---CCCceeeeeEEecCC--
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG------SGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENS-- 522 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~-- 522 (804)
.+.+.++||+|+||+||+|+. .+++.||||+++... .....+.+|+.++++++ ||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 445678999999999999986 468899999996321 22356777887777664 999999999997755
Q ss_pred ---eEEEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 523 ---HRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 523 ---~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5799999998 59999998754 34899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 599 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 166 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---------------~ 228 (308)
T 3g33_A 166 LARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---------------L 228 (308)
T ss_dssp CTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---------------H
T ss_pred cccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---------------H
Confidence 998654332 23456789999999999999999999999999999999999999975322100 0
Q ss_pred HHHHHHhhc---Cccc---eecccccc-------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIE---GNVA---AVVDDRLG-------GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~---~~~~---~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......... .... ........ .....+..+.+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000000 0000 00000000 00011234678899999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.22 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=201.3
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.++||+|+||.||+|... .+..||+|++... ....+.+.+|+.++++++||||+++++++......++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 446689999999999999775 4678999999753 45678899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCCcccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 91 ~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~ 164 (277)
T 3f3z_A 91 GELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--M 164 (277)
T ss_dssp CBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--C
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--c
Confidence 99999887654 6899999999999999999999988 9999999999999 888999999999998754332 2
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+|+.|+|||.+.+. ++.++||||||++++||++|+.||..... ......+..+..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~~ 224 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------------------SEVMLKIREGTF 224 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCCC
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHHhCCC
Confidence 3455789999999998764 89999999999999999999999975321 111222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ...... ......+.+++..|++.||++||++.++++.
T Consensus 225 ~-~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 T-FPEKDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C-CCHHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C-CCchhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 000000 0224678899999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.30 Aligned_cols=257 Identities=27% Similarity=0.378 Sum_probs=202.4
Q ss_pred HhhcccccccccccceeEEEEEeC------CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 524 (804)
.....+.+.||+|+||.||+|+.. .++.||||++.... ....++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 334556789999999999999742 46789999997543 2345788999999999999999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEe
Q 044374 525 LLVYDYMRNGALSLYLRKDG------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVS 595 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~ 595 (804)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998654 35889999999999999999999988 999999999999984 4569999
Q ss_pred ecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCC
Q 044374 596 DFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGD 673 (804)
Q Consensus 596 DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 673 (804)
|||+++..... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------------- 251 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------------- 251 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------------
Confidence 99999865332 1222334567899999999999999999999999999999998 9888864211
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+..+... ..+......+.+++..||+.||.+||++.+|++.|+.+..
T Consensus 252 -----~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 252 -----QEVLEFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -----HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111222222111 1122334678899999999999999999999999987644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.42 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=202.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.+.||+|+||.||++... +++.||||+++.... ..+++.+|+.++.+++||||+++++++......++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456789999999999999765 688999999965321 357899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----ceEEeecCCcccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLI 603 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~ 603 (804)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp ECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999997643 6899999999999999999999988 99999999999999888 7999999999876
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------------~~~~ 228 (321)
T 2a2a_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------------------ETLA 228 (321)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHH
T ss_pred Cccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------------------HHHH
Confidence 5432 223456899999999999999999999999999999999999999743211 0111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..... . .++.. .......+.+++.+||+.||++||++.++++.
T Consensus 229 ~i~~~~~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 NITSVSY-D-FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTCC-C-CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHhccc-c-cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111110 0 00000 01223568899999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.04 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=202.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45689999999999999875 6899999999642 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 99 ~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~ 172 (476)
T 2y94_A 99 SGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFL 172 (476)
T ss_dssp SSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCB
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--ccc
Confidence 9999999997654 6899999999999999999999988 999999999999999999999999999876432 223
Q ss_pred cccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+..+..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------------------~~~~~~i~~~~~ 233 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------------------PTLFKKICDGIF 233 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------------------HHHHHHHHTTCC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------------------HHHHHHHhcCCc
Confidence 45679999999999988765 6899999999999999999999974321 111222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++..||+.||++|||+.+|++.
T Consensus 234 ----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111234568899999999999999999999973
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.74 Aligned_cols=277 Identities=21% Similarity=0.254 Sum_probs=194.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||.||+|... +++.||||++...... ...+.+|+.++++++||||+++++++......++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 45679999999999999875 6889999999653322 2245679999999999999999999999999999999998
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++...+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 159 (324)
T 3mtl_A 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDN 159 (324)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccccc
Confidence 5899998887778999999999999999999999988 9999999999999999999999999998654322 22334
Q ss_pred cccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC-CCCCCccCchHHH-HHHhhcCcc
Q 044374 614 MRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG-GEHGDKWFFPPWA-ARQIIEGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~ 690 (804)
..+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ........++... ......-..
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 568999999999876 5689999999999999999999999975322100000000 0000000000000 000000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhccc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVL 739 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~ 739 (804)
.......+ ..........+.+++.+||+.||++|||+.|+++. +.++.
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 240 PKYRAEAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccchhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00000000 00011223567899999999999999999999974 55543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.67 Aligned_cols=245 Identities=21% Similarity=0.262 Sum_probs=192.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.++||+|+||.||++... +++.||||+++. .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 345689999999999999764 688999999964 233445678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 230 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 304 (446)
T 4ejn_A 230 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 304 (446)
T ss_dssp CSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence 99999999997654 78999999999999999999998 77 9999999999999999999999999998643322 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....+..+.
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------------------~~~~~i~~~~ 365 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------KLFELILMEE 365 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------HHHHHHHHCC
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------------------HHHHHHHhCC
Confidence 234567999999999999999999999999999999999999999743211 1111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
. .++......+.+++..||+.||.+|| ++.|++++
T Consensus 366 ~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 I----------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 11223346788999999999999999 99999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.77 Aligned_cols=249 Identities=27% Similarity=0.352 Sum_probs=201.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 446789999999999999775 6889999999643 2345778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-cccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 611 (804)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 89 GGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp TEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99999998754 36899999999999999999999988 9999999999999999999999999998653321 2223
Q ss_pred cccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....|++.|+|||.+.+..+ +.++||||||++++||++|+.||....... . ....+.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~--~~~~~~~~~~ 226 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----------------Q--EYSDWKEKKT 226 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----------------H--HHHHHHTTCT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----------------H--HHHHhhhccc
Confidence 45678999999999988765 789999999999999999999997532210 0 1111111110
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..........+.+++..||+.||++||++.+|++.
T Consensus 227 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 Y--------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp T--------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 00111234568899999999999999999998863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.82 Aligned_cols=258 Identities=24% Similarity=0.267 Sum_probs=194.3
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
+.||+|+||.||++... +++.||||+++.. ......+.+|+.++.++ +||||+++++++...+..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999754 6889999999754 34567899999999884 799999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc---eEEeecCCccccCCCc------
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT---AKVSDFGLAKLIGRDF------ 607 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~~~~~~------ 607 (804)
.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.......
T Consensus 99 ~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 99 LSHIHKRR-HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 99998754 6899999999999999999999988 999999999999998776 9999999997653221
Q ss_pred cccccccccccccccchhccC-----CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch---H
Q 044374 608 SRVLATMRGTWGYVAPEWISG-----LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP---P 679 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 679 (804)
........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ......+ .
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~ 247 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW-------DRGEACPACQN 247 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----------CCHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc-------cccccchhHHH
Confidence 111234569999999999875 458899999999999999999999997643321000 0000000 0
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+..+.. ....... ......+.+++.+||+.||++||++.|+++.
T Consensus 248 ~~~~~i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11122222211 0000000 1124568899999999999999999999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=335.34 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=194.8
Q ss_pred cccccccccccceeEEEEEeC--CC--cEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS--DS--TLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.+.||+|+||.||+|++. ++ ..||||+++... ...+.+.+|+.++++++||||+++++++.... .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 456789999999999999753 23 368999987532 23467899999999999999999999998765 8899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+||+++++|.+++......+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999876667999999999999999999999988 9999999999999999999999999998764432
Q ss_pred cc--cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 608 SR--VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 608 ~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------------~-~~~~ 236 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------------------Q-ILHK 236 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------------H-HHHH
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------------------H-HHHH
Confidence 21 2234457889999999998889999999999999999999 99998743210 1 1111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+..... ....+......+.+++..||+.||++||++.+|++.|+++..
T Consensus 237 ~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 237 IDKEGE--------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHTSCC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHccCC--------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111110 011122345678999999999999999999999999988543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.79 Aligned_cols=194 Identities=26% Similarity=0.357 Sum_probs=172.0
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----CCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----HVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.++||+|+||.||+|+. .+++.||||+++......+.+..|+.++.+++ ||||+++++++...+..++|||
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 44568999999999999977 46789999999865555667888999998886 9999999999999999999999
Q ss_pred EcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC--------------------
Q 044374 530 YMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-------------------- 588 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-------------------- 588 (804)
|+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99 999999998654 35899999999999999999999988 999999999999975
Q ss_pred -----CCceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 589 -----DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 589 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999864432 23457899999999999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=344.60 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=200.7
Q ss_pred cccccccccccceeEEEEEe----CCCcEEEEEEecCC-----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL----SDSTLVAVKRLERP-----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 525 (804)
..+.+.||+|+||.||+++. ..++.||||+++.. ....+.+.+|+.++.++ +||||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34668999999999999977 36889999998642 23445677899999999 6999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+||||+++++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 136 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 9999999999999998654 6899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......+
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------------~~~~~~~ 276 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---------------SQAEISR 276 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---------------CHHHHHH
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---------------hHHHHHH
Confidence 43333445679999999999986 357899999999999999999999997432210 0111111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKML 735 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~L 735 (804)
..... ....+......+.+++.+||+.||++|| ++.++++..
T Consensus 277 ~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 RILKS----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHhcc----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111 0112233446688999999999999999 899988764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.27 Aligned_cols=269 Identities=20% Similarity=0.240 Sum_probs=195.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 45689999999999999875 5889999999765433 3567899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 160 (311)
T 4agu_A 86 HTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160 (311)
T ss_dssp EEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence 999999887543 6899999999999999999999988 99999999999999999999999999987643322 234
Q ss_pred ccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
...+|+.|+|||++.+ ..++.++||||||+++|||++|+.||............. .....+.+............
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR----KTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HHHCSCCHHHHHHHHTCGGG
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHhccccccccccccccccc
Confidence 4578999999999876 578999999999999999999999997532210000000 00000000000000000000
Q ss_pred ---eeccccccCC---CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 ---AVVDDRLGGA---YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ---~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+.++..... ........+.+++..||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 001234568899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.67 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=199.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC-------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.+.||+|+||.||++... +++.||||+++... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 456789999999999999876 68899999996432 1367899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----ceEEeecCCcccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLI 603 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~ 603 (804)
|||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 87 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 99999999999997643 6899999999999999999999988 99999999999998877 8999999999865
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------~~~~ 221 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------------------ETLT 221 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHH
T ss_pred cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------------------HHHH
Confidence 4322 223456899999999999999999999999999999999999999743211 1111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+...... ..... .......+.+++.+|++.||++||++.++++.
T Consensus 222 ~~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 222 NISAVNYD--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHTTCCC--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HhHhcccC--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11111100 00000 11224568899999999999999999999973
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=347.93 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=203.4
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC-CCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-VNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|.. .+++.||||++..... ..++..|+.++..++| +++..+..++......+|||||+ +
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 34568999999999999976 5688999998865432 3457889999999987 55556666777888999999999 9
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCCcc--
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~~~-- 608 (804)
++|.+++......+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.......
T Consensus 87 ~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 9999999876668999999999999999999999988 9999999999999 6889999999999987654322
Q ss_pred ----ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 ----RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ----~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.......||..|+|||++.+..++.++|||||||+||||++|+.||....... .......
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----------------~~~~~~~ 227 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----------------KKQKYEK 227 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----------------HHHHHHH
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh----------------HHHHHHH
Confidence 12235679999999999999999999999999999999999999997543211 0111111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
+.+......+.. +.. .....+.+++..||+.+|++||++.+|+++|+.+.
T Consensus 228 i~~~~~~~~~~~-l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 228 ISEKKVATSIEA-LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHHHHSCHHH-HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HhhccccccHHH-Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111111111 111 12457899999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.56 Aligned_cols=251 Identities=21% Similarity=0.229 Sum_probs=194.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC------CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP------GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 456789999999999999764 6788999998532 334567999999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044374 529 DYMRNGALSLYLRKD---------------------------------------GLNLNWDVRFRIAVGTARGIAYLHEE 569 (804)
Q Consensus 529 E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~ 569 (804)
||+++|+|.+++... ...+++..+..++.||++||+|||+.
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999998521 11235677889999999999999998
Q ss_pred CCCCeEecCCCCCcEEecCCC--ceEEeecCCccccCCC---ccccccccccccccccchhccC--CCCCccceEEeehh
Q 044374 570 CRDCIIHCDIKPENILLDSDY--TAKVSDFGLAKLIGRD---FSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGM 642 (804)
Q Consensus 570 ~~~~iiH~Dlkp~NILl~~~~--~~kl~DfGla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gv 642 (804)
+ |+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||.+.+ ..++.++||||||+
T Consensus 188 ~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 G---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp T---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred C---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 8 99999999999998776 8999999999865332 1112345679999999999875 67889999999999
Q ss_pred hHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCC
Q 044374 643 TLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNE 722 (804)
Q Consensus 643 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 722 (804)
++|||++|+.||...... .....+..+... ............+.+++..||+.||
T Consensus 265 il~el~~g~~pf~~~~~~-------------------~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDA-------------------DTISQVLNKKLC------FENPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHSSCSSCCSSHH-------------------HHHHHHHHCCCC------TTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHCCCCCCCCChH-------------------HHHHHHHhcccc------cCCcccccCCHHHHHHHHHHcCCCh
Confidence 999999999999743211 111111111110 0001111234678899999999999
Q ss_pred CCCCCHHHHHHH
Q 044374 723 EMRPTMGTVVKM 734 (804)
Q Consensus 723 ~~RPs~~eVl~~ 734 (804)
++||++.++++.
T Consensus 320 ~~Rps~~~~l~h 331 (345)
T 3hko_A 320 DERFDAMRALQH 331 (345)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCCCHHHHhcC
Confidence 999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=345.43 Aligned_cols=249 Identities=12% Similarity=0.073 Sum_probs=181.3
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----CHHHHHHH---HHHHcCCCCCCceeee-------eEEec
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----GEREFRAE---VCTIGNIQHVNLVRLR-------GFCSE 520 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E---i~~l~~l~H~niv~l~-------g~~~~ 520 (804)
..+.++||+|+||.||+|... +++.||||++..... ..+.+++| +..++. +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 345679999999999999865 788999999987543 23456777 455666 799987754 45443
Q ss_pred C-----------------CeEEEEEEEcCCCChhHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeEec
Q 044374 521 N-----------------SHRLLVYDYMRNGALSLYLRKDGLNLNWDVR------FRIAVGTARGIAYLHEECRDCIIHC 577 (804)
Q Consensus 521 ~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iiH~ 577 (804)
. ...++||||++ ++|.+++...+..+.+..+ +.++.||++||+|||+.+ |+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 2 34799999999 8999999876555667777 888899999999999988 9999
Q ss_pred CCCCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCCC
Q 044374 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNVE 655 (804)
Q Consensus 578 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~~ 655 (804)
||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865432 124456799999999987 679999999999999999999999998
Q ss_pred CCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 656 APASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
...+....... .......................+.+++.+||+.||++||++.++++
T Consensus 295 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGSWK--------------------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTCCC--------------------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccchh--------------------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 65332111000 00000000111111111233567889999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.19 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 35679999999999999765 5678999998542 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~ 164 (279)
T 3fdn_A 92 PLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 164 (279)
T ss_dssp TTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence 9999999997654 6899999999999999999999987 999999999999999999999999998654332 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~-- 223 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------------------QETYKRISRVE-- 223 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------------HHHHHHHHHTC--
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------------------HHHHHHHHhCC--
Confidence 345689999999999999999999999999999999999999974321 11111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+......+.+++..||+.||++||++.||++.
T Consensus 224 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 --------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11122234568899999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.58 Aligned_cols=243 Identities=25% Similarity=0.292 Sum_probs=190.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHH-HcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCT-IGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+++.. +++.||||+++... .....+.+|..+ ++.++||||+++++++...+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456789999999999999875 57889999996532 233456667766 577899999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 120 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 120 YINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 999999999998654 6889999999999999999999988 9999999999999999999999999998643221 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------------------~~~~~~i~~~~ 255 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------------------AEMYDNILNKP 255 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------------------HHHHHHHHHSC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------------------HHHHHHHHhcc
Confidence 24456799999999999999999999999999999999999999974321 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
. .++......+.+++..||+.||++||++.+.+
T Consensus 256 ~----------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 L----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp C----------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred c----------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1 11222345688999999999999999985433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=341.88 Aligned_cols=245 Identities=25% Similarity=0.259 Sum_probs=189.0
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHH-cCCCCCCceeeeeEEec----CCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTI-GNIQHVNLVRLRGFCSE----NSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++... +++.||||+++. ...+.+|+.++ +..+||||+++++++.. ....+|||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 68999999999999765 678999999974 24677888876 45589999999998865 5678999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..... .
T Consensus 144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--~ 218 (400)
T 1nxk_A 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--N 218 (400)
T ss_dssp EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC--C
Confidence 99999998754 46899999999999999999999988 999999999999998 789999999999865432 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+..+.
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------------~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------------ISPGMKTRIRMGQ 283 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS---------------SCCSHHHHHHHTC
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc---------------ccHHHHHHHHcCc
Confidence 2345678999999999999999999999999999999999999997532211 0000112222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ...+ ........+.+++..||+.||++||++.+|++.
T Consensus 284 ~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 YE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 0000 011234678899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=369.13 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=203.9
Q ss_pred hhcccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
....+.+.||+|+||.||+|.... +..||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 345567899999999999997642 46799999875432 23678999999999999999999999854 568999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999877667999999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------------------~~~~~~i~ 606 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------------------NDVIGRIE 606 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------------HHHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------------------HHHHHHHH
Confidence 333344567889999999999999999999999999999997 9999874321 11112222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+... ..+...+..+.+++.+||+.||++||++.+|++.|+.+++
T Consensus 607 ~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 607 NGERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 22111 1222345678899999999999999999999999988653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.67 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=195.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|... +++.||||+++... ....++.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 445689999999999999775 68999999997542 2345788899999988 999999999999999999999999
Q ss_pred cCCCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-------------------
Q 044374 531 MRNGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS------------------- 588 (804)
Q Consensus 531 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~------------------- 588 (804)
+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999997642 46899999999999999999999988 999999999999984
Q ss_pred CCceEEeecCCccccCCCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|..++....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------- 235 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------- 235 (289)
T ss_dssp CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred ceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence 4479999999998764432 23589999999999776 66789999999999999999987654210
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+..+.... .+......+.+++.+||+.||++||++.++++.
T Consensus 236 -------------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -------------QWHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------------HHHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------------HHHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 122222222211 122234678899999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.94 Aligned_cols=247 Identities=24% Similarity=0.264 Sum_probs=200.5
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++......++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 45679999999999999765 5889999999754332 3568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc---eEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT---AKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~~~~~~~~ 609 (804)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.......
T Consensus 89 ~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-- 162 (284)
T 3kk8_A 89 GGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162 (284)
T ss_dssp SCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence 999998887654 6899999999999999999999988 999999999999987655 9999999998654332
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------------~~~~~~~~~~~ 223 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------------HRLYAQIKAGA 223 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHTC
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------------------hHHHHHHHhcc
Confidence 22346789999999999999999999999999999999999999964321 11112222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ...+ ........+.+++..||+.||++||++.++++.
T Consensus 224 ~~-~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 YD-YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CC-CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cc-CCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1111 111234568899999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.02 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=193.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.++||+|+||.||++... ++..||+|++... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 456789999999999999764 6789999999653 3456889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCC
Q 044374 533 NGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 533 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 606 (804)
+++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999988643 357999999999999999999999988 9999999999999 55688999999999865433
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. ......+|+.|+|||.+. ..++.++||||||++++||++|+.||...... . ......
T Consensus 181 ~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------------------~-~~~~~~ 238 (285)
T 3is5_A 181 E--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------------------E-VQQKAT 238 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------H-HHHHHH
T ss_pred c--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------------------H-HHhhhc
Confidence 2 234556899999999986 46889999999999999999999999743211 1 111111
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..... .... .......+.+++..||+.||++||++.||++
T Consensus 239 ~~~~~------~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 YKEPN------YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HCCCC------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCcc------cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 0000 0012356789999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.83 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=200.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEe--cCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCS--ENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~ 530 (804)
.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++. .....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 45689999999999999775 688999999975433 2356889999999999999999999875 46789999999
Q ss_pred cCCCChhHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 531 MRNGALSLYLRKD---GLNLNWDVRFRIAVGTARGIAYLHEEC--RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 531 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+++++|.+++... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 9999999999753 235899999999999999999999876 23499999999999999999999999999987543
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~~i 228 (279)
T 2w5a_A 169 DTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------------KELAGKI 228 (279)
T ss_dssp -CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHH
T ss_pred ccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------------------HHHHHHH
Confidence 321 22345689999999999999999999999999999999999999874311 1122223
Q ss_pred hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 686 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
..+.... .+......+.+++.+||+.||++||++.+|++.+..
T Consensus 229 ~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 229 REGKFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhccccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 3332211 122334678899999999999999999999988754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=330.05 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=202.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++......++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 45678999999999999764 6889999999754 34567899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 105 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 178 (303)
T 3a7i_A 105 GSALDLLEPG--PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 178 (303)
T ss_dssp EEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence 9999999753 6899999999999999999999988 99999999999999999999999999987644321 2344
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~~--- 236 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------------------MKVLFLIPKNNP--- 236 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------------HHHHHHHHHSCC---
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------------------HHHHHHhhcCCC---
Confidence 5789999999999999999999999999999999999999864211 011111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+ +......+..++..||+.||++||++.+|++.
T Consensus 237 --~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 --PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 11234568899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.18 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 345689999999999999775 5788999999532 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++...+ .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 96 APRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 99999999998654 6899999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------------~~~~~~~~~~~ 229 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------------------ETHRRIVNVDL 229 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHHTTCC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------------------HHHHHHhcccc
Confidence 23456899999999999999999999999999999999999999743211 11111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+|++.||.+||++.++++.
T Consensus 230 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 ----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1122234568899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.18 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
..+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++.+++||||+++++++......++||||++++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 446689999999999999775 58899999997643 4567899999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++......+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........ .....
T Consensus 110 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 185 (314)
T 3com_A 110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTV 185 (314)
T ss_dssp EHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCC
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCcc
Confidence 999999866668999999999999999999999988 99999999999999999999999999986543322 23345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceec
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVV 694 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 694 (804)
.+++.|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~~~~-- 244 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------------------RAIFMIPTNPPPT-- 244 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------------------HHHHHHHHSCCCC--
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------------------HHHHHHhcCCCcc--
Confidence 6899999999999999999999999999999999999998742110 0011111111100
Q ss_pred cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 695 DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 695 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..+......+.+++..||+.||++||++.++++.
T Consensus 245 ---~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 ---F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 1122234678899999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.82 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=197.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.+.||+|+||.||++... +++.||||+++.... .+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 445689999999999999775 578999999976433 234677777777 799999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC----CceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD----YTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~~~~~~~ 609 (804)
|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||+..+ +.+||+|||+++.......
T Consensus 101 g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 101 GELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp CBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 99999997654 6899999999999999999999988 9999999999998443 3599999999987544322
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+..+.
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~~~~i~~~~ 239 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----------------TPEEILARIGSGK 239 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----------------CHHHHHHHHHHCC
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----------------CHHHHHHHHccCC
Confidence 234567899999999998888999999999999999999999999742111 1111222233222
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. +...........+.+++..||+.||++||++.++++.
T Consensus 240 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 FS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1111122345678899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.37 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=195.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEec----CCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSE----NSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 528 (804)
.+.++||+|+||.||+|... .+..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 35568999999999999764 578899999975432 34568899999999999999999999865 35689999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~ 607 (804)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999997653 6899999999999999999999865 3499999999999997 78999999999997654332
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.....||+.|+|||.+.+ .++.++||||||++++||++|+.||...... .........
T Consensus 187 ---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------~~~~~~~~~ 244 (290)
T 1t4h_A 187 ---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------------------AQIYRRVTS 244 (290)
T ss_dssp ---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------------HHHHHHHTT
T ss_pred ---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------------------HHHHHHHhc
Confidence 234568999999998875 5899999999999999999999999643211 111122222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.... ..+......+.+++..||+.||++||++.+|++.
T Consensus 245 ~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 245 GVKPA--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCG--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCcc--------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 21111 1111223568899999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=346.94 Aligned_cols=234 Identities=15% Similarity=0.148 Sum_probs=184.5
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHH---HHHcCCCCCCceeee-------eEEecCC
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEV---CTIGNIQHVNLVRLR-------GFCSENS 522 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~~~~~~ 522 (804)
+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+ .++++++||||++++ +++...+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 457899999999999986 46899999999632 23346789999 566667899999998 6666543
Q ss_pred -----------------eEEEEEEEcCCCChhHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 044374 523 -----------------HRLLVYDYMRNGALSLYLRKDG------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI 579 (804)
Q Consensus 523 -----------------~~~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 579 (804)
..++||||+ +|+|.+++...+ ..+++..++.|+.||+.||+|||+.+ |+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 278999999 689999997643 12346888999999999999999988 999999
Q ss_pred CCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccCC-----------CCCccceEEeehhhHHHhh
Q 044374 580 KPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-----------AITTKADVYSYGMTLLELI 648 (804)
Q Consensus 580 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~ksDV~S~Gvvl~ell 648 (804)
||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999986432 2334567 999999999887 8999999999999999999
Q ss_pred hCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 044374 649 GGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728 (804)
Q Consensus 649 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 728 (804)
+|+.||........ ...+.. . .......+.+++.+||+.||++||++
T Consensus 308 tg~~Pf~~~~~~~~---------------------------~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 308 CADLPITKDAALGG---------------------------SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HSSCCC------CC---------------------------SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HCCCCCcccccccc---------------------------hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 99999975322110 000000 0 01223568899999999999999999
Q ss_pred HHHHH
Q 044374 729 GTVVK 733 (804)
Q Consensus 729 ~eVl~ 733 (804)
.++++
T Consensus 355 ~e~l~ 359 (377)
T 3byv_A 355 LQAME 359 (377)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=354.56 Aligned_cols=248 Identities=25% Similarity=0.287 Sum_probs=203.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 35578999999999999775 6899999999642 345677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|+|.+++...+ ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~ 341 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 341 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc--c
Confidence 9999999997654 35899999999999999999999988 9999999999999999999999999998764332 2
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+...
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~---------------~~~~i~~~i~~~-- 404 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---------------KREEVERLVKEV-- 404 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC---------------CHHHHHHHHHHC--
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch---------------hHHHHHHHhhcc--
Confidence 334579999999999999999999999999999999999999997532210 011111111111
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
...++......+..++..||+.||++|| ++.||+++
T Consensus 405 --------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0112223346788999999999999999 77888754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.45 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=182.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.+.||+|+||.||+|... +++.||||++... ....+++.+|+.++.+++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 345689999999999999764 6789999998643 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 533 NGALSLYLRK-------DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 533 ~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9999999874 2346899999999999999999999988 99999999999999999999999999976543
Q ss_pred Cc----cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 606 DF----SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 606 ~~----~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
.. ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------------~ 235 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------------------V 235 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------------------H
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------------------H
Confidence 21 112234568999999999876 568999999999999999999999997532210 0
Q ss_pred HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 681 AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 681 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... ...+.....................+.+++.+||+.||.+||++.++++.
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 LML-TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHH-HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH-HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011 11111111100000011111223568899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=327.05 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=192.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec-------------C
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE-------------N 521 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------------~ 521 (804)
..+.+.||+|+||.||+|+.. +++.||||++.......+.+.+|+.++++++||||+++++++.+ .
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 345689999999999999864 78899999997654455778999999999999999999998865 3
Q ss_pred CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 522 SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 522 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
...++||||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred CceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 5779999999999999999877767889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCc-------------cccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 602 LIGRDF-------------SRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 602 ~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
...... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-------- 233 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-------- 233 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--------
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--------
Confidence 654221 1123345689999999999865 68999999999999999998 4432100
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.......+... ...+....+......+.+++.+||+.||.+||++.++++.
T Consensus 234 ----------~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ----------RVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----------HHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----------HHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00011111111 1111222333445678899999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.95 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=196.8
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.++||+|+||.||+|... +++.||||+++.. .....++.+|+.++.++ +||||+++++++......++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 378999999999999765 5889999999753 23467899999999998 569999999999999999999999999
Q ss_pred CChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 609 (804)
++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-- 188 (327)
T 3lm5_A 114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188 (327)
T ss_dssp EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--
Confidence 9999998654 357899999999999999999999988 999999999999998 7899999999998764332
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+....
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------------------~~~~~i~~~~ 249 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------------------ETYLNISQVN 249 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------HHHHHHHHTC
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------------------HHHHHHHhcc
Confidence 123457999999999999999999999999999999999999999753211 1111111111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. .............+.+++..||+.||++||++.++++.
T Consensus 250 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 V------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 01111112334668899999999999999999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.24 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=202.6
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
...+.+.||+|+||.||+++.. +++.||||+++... ...+.+.+|+.++.+++||||+++++++......++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3456789999999999999775 68899999997543 344678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+++|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 90 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 90 GGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp SCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred CccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 999999987654 6899999999999999999999988 9999999999999 78899999999999764332
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------------~~~~~~i~~~~ 223 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------------------SKLFEKIKEGY 223 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------------------HHHHHHHHHCC
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 23345689999999999999999999999999999999999999874211 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEG 737 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~ 737 (804)
.. ............+.+++.+|++.||++||++.++++. +++
T Consensus 224 ~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 224 YE------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp CC------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred CC------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 10 0111112334678899999999999999999999974 554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.06 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=182.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCH---HHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
..+.++||+|+||.||++.. .+++.||||+++...... +.+.++...++.++||||+++++++...+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 44668999999999999976 478899999997543222 23455556688899999999999999999999999999
Q ss_pred CCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 532 RNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 532 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
++ +|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 89 DT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp SE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred cc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 84 88777654 445799999999999999999999997 7 9999999999999999999999999998764432
Q ss_pred cccccccccccccccchhc----cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 608 SRVLATMRGTWGYVAPEWI----SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l----~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
. .....||+.|+|||++ .+..++.++||||||+++|||++|+.||..... ......
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------------~~~~~~ 224 (290)
T 3fme_A 165 A--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------------------PFQQLK 224 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------------------HHHHHH
T ss_pred c--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------------------hHHHHH
Confidence 2 2334689999999996 556789999999999999999999999974211 111111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.......... ........+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 225 QVVEEPSPQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHSCCCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhccCCCCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111111 11123456889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=342.31 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=188.6
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCC---------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 524 (804)
.+.+.++||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.. +..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence 4556789999999999999764 57899999996421 112248899999999999999999999854 568
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCcc
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAK 601 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~ 601 (804)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 99999999999999887654 6899999999999999999999988 9999999999999754 459999999998
Q ss_pred ccCCCccccccccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---------------- 352 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---------------- 352 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----------------
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----------------
Confidence 76532 22345679999999999854 5788999999999999999999999975322100
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+..+..... . .. .......+.+++.+||+.||++||++.++++.
T Consensus 353 --~~~~i~~~~~~~~-~-~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 353 --LKDQITSGKYNFI-P-EV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHHHHHTTCCCCC-H-HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHhcCCCCCC-c-hh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1112222211100 0 00 01224578899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.85 Aligned_cols=195 Identities=25% Similarity=0.414 Sum_probs=171.3
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.++||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 345678999999999999775 678999999976432 23578999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+++|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||++...... ..
T Consensus 115 ~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 115 GGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp TCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 999999998754 689999999999999999999985 7 999999999999999999999999999754322 12
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3457899999999999999999999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=333.30 Aligned_cols=273 Identities=20% Similarity=0.230 Sum_probs=188.8
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+.++||+|+||.||+|... +++.||||+++.... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 345689999999999999754 688999999975432 2356789999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe-----cCCCceEEeecCCccccCCC
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL-----DSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl-----~~~~~~kl~DfGla~~~~~~ 606 (804)
++ +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 116 ~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 116 EN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp SE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 85 9999998754 6899999999999999999999988 9999999999999 45566999999999876433
Q ss_pred ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC-CCCCCCCccCchHHHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG-GGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 684 (804)
.. ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||............ ...........+......
T Consensus 191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 22 23445689999999999874 5899999999999999999999999753221000000 000000000000000000
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.............+...........+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000000000000111134568899999999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.03 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=200.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... .++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 45679999999999999776 57889999986532 22456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 98 ~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (294)
T 2rku_A 98 RRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 172 (294)
T ss_dssp TTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc-cc
Confidence 9999999887643 6899999999999999999999988 99999999999999999999999999987543221 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||.+.+..++.++||||||++++||++|+.||...... .....+..+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------------~~~~~~~~~~~- 232 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------------------ETYLRIKKNEY- 232 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHHHTTCC-
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHhhccC-
Confidence 3456899999999999999999999999999999999999999743210 01111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+|++.||++||++.++++.
T Consensus 233 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ---------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112234568899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.46 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=200.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC----CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 45679999999999999775 57889999996432 23456889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 124 ~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (335)
T 2owb_A 124 RRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RK 198 (335)
T ss_dssp TTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cc
Confidence 9999999887643 6899999999999999999999988 99999999999999999999999999987643321 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||..|+|||++.+..++.++||||||+++|||++|+.||...... . ....+..+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------------~-~~~~~~~~~~- 258 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------------------E-TYLRIKKNEY- 258 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------------------H-HHHHHHHTCC-
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------------------H-HHHHHhcCCC-
Confidence 3456899999999999999999999999999999999999999742110 0 1111111111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......+.+++.+||+.||++||++.++++.
T Consensus 259 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233568889999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.52 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=194.4
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
..||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999976 467899999997643 34577999999999999999999999999999999999999999999
Q ss_pred HHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCccccCCCcccccccc
Q 044374 538 LYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 538 ~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++. ++.+||+|||++....... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccccc
Confidence 9998653 34568889999999999999999988 999999999999987 8999999999998654321 123345
Q ss_pred ccccccccchhccCCC--CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccce
Q 044374 615 RGTWGYVAPEWISGLA--ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~--~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (804)
.|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~---- 242 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----------------QAAMFKVGMFK---- 242 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----------------HHHHHHHHHHC----
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----------------hHHHHhhcccc----
Confidence 6899999999987653 789999999999999999999998632110 00000000000
Q ss_pred eccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+......+.+++.+||+.||++||++.++++.
T Consensus 243 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 -----VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -----ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111222344678899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.59 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=198.1
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
..+.+.||+|+||.||+|.... .||||+++.. ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3456899999999999998754 4999999643 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC----cc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD----FS 608 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~----~~ 608 (804)
+++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..... ..
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 99999999887667999999999999999999999988 99999999999998 679999999998764321 11
Q ss_pred ccccccccccccccchhccC---------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchH
Q 044374 609 RVLATMRGTWGYVAPEWISG---------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~---------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (804)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------------~ 249 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------------------E 249 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------------------H
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------------H
Confidence 22334568999999999864 4578899999999999999999999974321 1
Q ss_pred HHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
.....+..+....... ......+.+++..||+.||++||++.+|+++|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 AIIWQMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1112222222111111 11234588999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=339.29 Aligned_cols=196 Identities=28% Similarity=0.412 Sum_probs=157.5
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCC-CCCceeeeeEEecCC--eEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQ-HVNLVRLRGFCSENS--HRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~lV~ 528 (804)
+.+.++||+|+||.||+|.. ..++.||||++...... ...+.+|+.++.++. ||||+++++++...+ ..++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 44668999999999999975 46889999999654332 345778999999997 999999999997544 789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC--
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-- 606 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-- 606 (804)
||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 91 e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 91 DYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp ECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred cccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 9998 5899988764 6889999999999999999999988 999999999999999999999999999865321
Q ss_pred ------------------ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 607 ------------------FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 607 ------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.........||+.|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1112344679999999999876 67899999999999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.15 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=199.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---------HHHHHHHHHHHcCC-CCCCceeeeeEEecCCeE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---------EREFRAEVCTIGNI-QHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 524 (804)
+.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++.++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 345579999999999999875 6899999999754321 34578899999998 799999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999997643 6899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccchhccC------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISG------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------------------- 310 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------------------- 310 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------------------
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------------------
Confidence 332 2345679999999999863 3588999999999999999999999964211
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+..+.... ..+.. ......+.+++.+||+.||++||++.++++.
T Consensus 311 ~~~~~~i~~~~~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 ILMLRMIMEGQYQF-SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHTCCCC-CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCC-CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112222221110 00000 0123568899999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=331.86 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=195.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||++... +++.||||++...... .+.+.+|+.++++++||||+++++++......++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 35679999999999999775 4889999999755433 3457899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 108 ~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 182 (331)
T 4aaa_A 108 HTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYD 182 (331)
T ss_dssp EEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred cchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccC
Confidence 999988876543 6899999999999999999999988 9999999999999999999999999998654332 2234
Q ss_pred ccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc-c
Q 044374 613 TMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN-V 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 690 (804)
...+|+.|+|||++.+. .++.++||||||+++|||++|+.||............. .......+.....+.... .
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM----MCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HHHCSCCHHHHHHHHHCGGG
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----HHhCCCChhhhhHhhhcccc
Confidence 45689999999999875 78999999999999999999999997532210000000 000000000001111100 0
Q ss_pred ceeccccccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 691 AAVVDDRLGGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+.+....+ ....+.+.+++.+||+.||++||++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011111111111 1235678999999999999999999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=331.91 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=193.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEec------CCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSE------NSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~------~~~~~lV~ 528 (804)
.+.+.||+|+||.||+|... +++.||||++.........+.+|+.++.++ +||||+++++++.. ....++||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 35689999999999999774 688999999987766778899999999998 89999999999976 46889999
Q ss_pred EEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 9999999999998653 46899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cccccccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 608 SRVLATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
. ......|++.|+|||++. +..++.++||||||+++|||++|+.||...... ...
T Consensus 184 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------~~~ 243 (326)
T 2x7f_A 184 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------------------RAL 243 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------------------HHH
T ss_pred c-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------------------HHH
Confidence 1 223456899999999987 567889999999999999999999998642110 011
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+......... .......+.+++.+||+.||++||++.++++.
T Consensus 244 ~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FLIPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHSCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhcCccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111111 11224578899999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=330.21 Aligned_cols=198 Identities=23% Similarity=0.325 Sum_probs=168.8
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEec--------CCe
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSE--------NSH 523 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~~~ 523 (804)
+.+.++||+|+||.||+|.. .+++.||||++.... .....+.+|+.++++++||||+++++++.. .+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 34568999999999999977 468899999996432 234678899999999999999999999976 446
Q ss_pred EEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcccc
Q 044374 524 RLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 603 (804)
.++||||+++ +|...+......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 8999999985 777777766667999999999999999999999988 999999999999999999999999999875
Q ss_pred CCC---ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 604 GRD---FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 604 ~~~---~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
... .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 422 1222345678999999999876 46899999999999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=347.69 Aligned_cols=269 Identities=22% Similarity=0.232 Sum_probs=189.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 526 (804)
.+.++||+|+||.||+|... .++.||||++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 45678999999999999654 68899999997542 2345688999999999999999999999654 46799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||++++ |.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 v~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 145 VMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred EEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 99999875 5555543 4889999999999999999999988 999999999999999999999999999875432
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcC----CCCCCCCCccCchHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI----GGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 682 (804)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||........... .+.........+.....
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp --CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred --cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 224456799999999999999999999999999999999999999975321100000 00000000000000000
Q ss_pred HHhhcCc------cceeccccccC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGN------VAAVVDDRLGG---AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~------~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....... ........+.. .........+.+|+.+||+.||++|||+.|++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000000000 0011225678999999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.39 Aligned_cols=244 Identities=27% Similarity=0.392 Sum_probs=193.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 345689999999999999875 6889999999642 34456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....... .
T Consensus 93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 93 VSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred cCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 99999999997654 6899999999999999999999998 9999999999999999999999999998754331 2
Q ss_pred ccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....+++.|+|||.+.+..+ +.++||||||++++||++|+.||..... ......+..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------------~~~~~~~~~~~ 227 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------------------PTLFKKIRGGV 227 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------------------HHHHHHhhcCc
Confidence 234568999999999988765 6899999999999999999999864211 11112222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
. ..+......+.+++.+|++.||++||++.+|++.
T Consensus 228 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 F----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 0112234568899999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.84 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=201.1
Q ss_pred cccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 458 FSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++......++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 4568999999999999875 6899999999642 3456778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKDG---LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~- 344 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT- 344 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence 999999997643 46899999999999999999999988 99999999999999999999999999987644322
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.+..+.
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---------------~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---------------ENKELKQRVLEQA 409 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---------------CHHHHHHHHHHCC
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---------------hHHHHHHHHhhcc
Confidence 1234579999999999999999999999999999999999999997532110 0111112222111
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM-----GTVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 733 (804)
. .++......+..++..||+.||++||++ .+|++
T Consensus 410 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 V----------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c----------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 1222345678899999999999999975 55654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.11 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=203.5
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.+.||+|+||.||++... .++.||||++... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3456789999999999999775 6889999999643 3456789999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe---cCCCceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL---DSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~~~~ 606 (804)
|+.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 107 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 107 VYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999987654 6899999999999999999999988 9999999999999 56789999999999876443
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+.
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------------~~~~~~i~ 240 (484)
T 3nyv_A 183 K--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------------------YDILKKVE 240 (484)
T ss_dssp C--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHH
T ss_pred c--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHH
Confidence 2 2345679999999999876 689999999999999999999999975321 11122222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+...-. ........+.+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFE------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCC------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCC------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 2221100 01112334678899999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.33 Aligned_cols=249 Identities=19% Similarity=0.286 Sum_probs=197.2
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
..+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 345678999999999999876 5789999999754 44567899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 101 GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC---
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccccc
Confidence 9999999876667999999999999999999999988 9999999999999999999999999986432111 11234
Q ss_pred cccccccccchhc-----cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 614 MRGTWGYVAPEWI-----SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 614 ~~gt~~y~aPE~l-----~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
..||+.|+|||++ ....++.++||||||+++|||++|+.||...... .....+..+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------~~~~~~~~~ 237 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------------RVLLKIAKS 237 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------------HHHHHHHHS
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------------------HHHHHHhcc
Confidence 5689999999998 4667899999999999999999999998743210 111111111
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..... ..+......+.+++.+||+.||++||++.+|++.
T Consensus 238 ~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 238 DPPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CCccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111 1122334678899999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.79 Aligned_cols=259 Identities=24% Similarity=0.286 Sum_probs=197.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC------CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS------GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++++++||||+++++++......++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 345679999999999999875 588999999964321 1246889999999999999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++ +|..++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 99986 888888877667999999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......+|+.|+|||++.+. .++.++|||||||++|||++|..||........ + .........
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--------------~-~~i~~~~~~ 231 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--------------L-TRIFETLGT 231 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------H-HHHHHHHCC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--------------H-HHHHHHcCC
Confidence 223456789999999998764 588999999999999999999998865321100 0 000000000
Q ss_pred ---Cc---cceecccc---ccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 ---GN---VAAVVDDR---LGGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ---~~---~~~~~d~~---l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. .....+.. .....+ ......+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000000 000001 1224678999999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.60 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=198.3
Q ss_pred hcccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC--------CCCceeeeeEEe----cC
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ--------HVNLVRLRGFCS----EN 521 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~----~~ 521 (804)
.+.+.++||+|+||.||+|.. .+++.||||+++......+.+.+|+.++++++ |+||+++++++. ..
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 345678999999999999975 46789999999865545577889999998885 788999999987 56
Q ss_pred CeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCC----------
Q 044374 522 SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDY---------- 590 (804)
Q Consensus 522 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~---------- 590 (804)
...++||||+.++.+..++......+++..+..++.||+.||+|||+. + |+||||||+||||+.++
T Consensus 118 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred ceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 688999999954444444444445799999999999999999999997 7 99999999999999775
Q ss_pred ---------------------------------------ceEEeecCCccccCCCccccccccccccccccchhccCCCC
Q 044374 591 ---------------------------------------TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631 (804)
Q Consensus 591 ---------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 631 (804)
.+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999999875433 334578999999999999999
Q ss_pred CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH--------HhhcCc-----------cce
Q 044374 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR--------QIIEGN-----------VAA 692 (804)
Q Consensus 632 ~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----------~~~ 692 (804)
+.++|||||||+||||++|+.||.......... .......... .+..+. ...
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTR---------DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH---------HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc---------hHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999997543221000 0000000000 000000 000
Q ss_pred ecccc---------ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 693 VVDDR---------LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 693 ~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.+.. -....+......+.+|+.+||+.||++|||+.||++.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 0112345677889999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=356.14 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=202.3
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++...+..+||||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 456679999999999999765 5788999999642 34456788899999987 79999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|..++...+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... .
T Consensus 423 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 497 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 497 (674)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-C
T ss_pred CcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC-c
Confidence 999999999998754 6899999999999999999999988 9999999999999999999999999998643222 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+.++.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------------------~~~~~~i~~~~ 558 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------------------DELFQSIMEHN 558 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHSSC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------------------HHHHHHHHhCC
Confidence 24456799999999999999999999999999999999999999975321 11222222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM-----GTVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVl~ 733 (804)
. .++......+.+|+..||+.||++||++ .||++
T Consensus 559 ~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 V----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 1223345678899999999999999997 67764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=340.90 Aligned_cols=197 Identities=25% Similarity=0.337 Sum_probs=165.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 526 (804)
+.+.+.||+|+||.||+|... .++.||||+++..... .+.+.+|+.++++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 345689999999999999765 5788999999764333 35688999999999999999999999766 57899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||++ ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 108 v~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 999987 5999998764 36899999999999999999999988 999999999999999999999999999876432
Q ss_pred cc---------------------ccccccccccccccchhc-cCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 607 FS---------------------RVLATMRGTWGYVAPEWI-SGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 607 ~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
.. .......||+.|+|||++ ....++.++|||||||++|||++|..|+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 11 123566799999999986 5667999999999999999999987777644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=343.80 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=198.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC--------------CCHHHHHHHHHHHcCCCCCCceeeeeEEec
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--------------SGEREFRAEVCTIGNIQHVNLVRLRGFCSE 520 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 520 (804)
+.+.++||+|+||+||+|... .++.||||++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 345689999999999999775 57899999997532 235678999999999999999999999999
Q ss_pred CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC---ceEEeec
Q 044374 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY---TAKVSDF 597 (804)
Q Consensus 521 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~Df 597 (804)
....++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999987654 6899999999999999999999988 99999999999998776 6999999
Q ss_pred CCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCc
Q 044374 598 GLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFF 677 (804)
Q Consensus 598 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 677 (804)
|+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.....
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------------ 252 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND------------------ 252 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------------
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------------------
Confidence 9998765432 2345679999999999874 689999999999999999999999975321
Q ss_pred hHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 678 PPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 678 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+..+...-.. +. .......+.+++..||+.||.+|||+.|+++.
T Consensus 253 -~~~~~~i~~~~~~~~~-~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 -QDIIKKVEKGKYYFDF-ND-----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHHHHHHHHCCCCCCH-HH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCCCCc-cc-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1122222222211000 00 01124568899999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=342.38 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=196.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+.++||+|+||.||+|... .+..||||++... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 456789999999999999775 6789999999753 334577899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCccccCCCcc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~~ 608 (804)
++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 119 ~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 119 KGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999887654 6899999999999999999999988 9999999999999764 559999999998765432
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......||+.|+|||++. ..++.++|||||||++|||++|+.||..... ......+..+
T Consensus 194 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------------~~~~~~i~~~ 252 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------------------QEILRKVEKG 252 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHT
T ss_pred -cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhC
Confidence 234567999999999986 4689999999999999999999999975321 1122222222
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... ...+. .......+.+++..||+.||++|||+.++++.
T Consensus 253 ~~~-~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYT-FDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCC-CCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC-CCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 211 00111 11234568899999999999999999999854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=323.29 Aligned_cols=263 Identities=16% Similarity=0.176 Sum_probs=197.6
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEec--CCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSE--NSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~ 531 (804)
..+.++||+|+||.||+|.. .+++.||||+++. ...+.+.+|+.++.+++ ||||+++++++.. ....++||||+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 34568999999999999975 5788999999974 34678999999999997 9999999999987 66789999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 610 (804)
++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 116 ~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~ 186 (330)
T 3nsz_A 116 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--E 186 (330)
T ss_dssp CCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--C
T ss_pred CchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--c
Confidence 9999999885 3888999999999999999999988 99999999999999776 89999999998654332 2
Q ss_pred ccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC-
Q 044374 611 LATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG- 688 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 688 (804)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............. ....-.......+...
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~-----~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-----AKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH-----HHHHCHHHHHHHHHHTT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH-----HHhcCCchhhhHHHHhc
Confidence 334578999999999877 678999999999999999999999996422110000000 0000000000000000
Q ss_pred -------------ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 -------------NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 -------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....................+.+++..||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0001111111112222245778999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.63 Aligned_cols=246 Identities=23% Similarity=0.276 Sum_probs=194.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC-----CCCHHHHHHHHHHHcCCCCCCceeeeeEEe--cCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-----GSGEREFRAEVCTIGNIQHVNLVRLRGFCS--ENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV 527 (804)
+.+.+.||+|+||.||++... +++.||||+++.. ......+.+|+.++++++||||+++++++. .....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 345689999999999999874 6789999999642 234577999999999999999999999984 45678999
Q ss_pred EEEcCCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 528 YDYMRNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|||++++ |.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999987 66666543 457899999999999999999999988 999999999999999999999999999875432
Q ss_pred -ccccccccccccccccchhccCCC--CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 607 -FSRVLATMRGTWGYVAPEWISGLA--ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 607 -~~~~~~~~~gt~~y~aPE~l~~~~--~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
.........||+.|+|||++.+.. .+.++||||||+++|||++|+.||..... .....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------------~~~~~ 223 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------------------YKLFE 223 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------------------HHHHH
Confidence 122234556899999999997654 47899999999999999999999974211 11112
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..+.. ..+......+.+++.+||+.||++||++.++++.
T Consensus 224 ~i~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 224 NIGKGSY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHCCC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHhcCCC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2222211 1122234568899999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.97 Aligned_cols=194 Identities=25% Similarity=0.335 Sum_probs=169.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCC------CCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNI------QHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~~lV~ 528 (804)
+.+.++||+|+||.||+|... .++.||||+++......+++.+|+.++..+ +|+||+++++++......++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 446689999999999999665 578999999986554456777888877766 5789999999999999999999
Q ss_pred EEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc--eEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT--AKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~~~ 605 (804)
||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 179 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp CCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred eccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9996 68988887654 45899999999999999999999998 999999999999999987 99999999976443
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 255 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 255 R----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp C----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 2 33457899999999999999999999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.19 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCC--C----------------HHHHHHHHHHHcCCCCCCceeeeeE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS--G----------------EREFRAEVCTIGNIQHVNLVRLRGF 517 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~----------------~~~~~~Ei~~l~~l~H~niv~l~g~ 517 (804)
..+.+.||+|+||.||+|.. +++.||||++..... . .+.+.+|+.++.+++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34567999999999999988 889999999963211 1 1789999999999999999999999
Q ss_pred EecCCeEEEEEEEcCCCChhHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCC
Q 044374 518 CSENSHRLLVYDYMRNGALSLY------LRKD-GLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 518 ~~~~~~~~lV~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~ 589 (804)
+...+..++||||+++++|.++ +... ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence 9999999999999999999998 5543 4578999999999999999999998 77 9999999999999999
Q ss_pred CceEEeecCCccccCCCccccccccccccccccchhccCC-CCCc-cceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-AITT-KADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------- 258 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------- 258 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-------
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-------
Confidence 99999999999875433 23456789999999999887 6666 999999999999999999999754321
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccc-------c---ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDD-------R---LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-------~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+..+... .... . ............+.+++.+||+.||++||++.++++.
T Consensus 259 -----------~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -----------VELFNNIRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -----------HHHHHHHTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -----------HHHHHHHhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011111111110 0000 0 0000012234678899999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=341.95 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=201.0
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecC---CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER---PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.+.++||+|+||+||++... +++.||||++.. .......+.+|+.++++++||||+++++++......++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 3556789999999999999765 688999999953 244567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec---CCCceEEeecCCccccCCCc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD---SDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~~~~~ 607 (804)
+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++......
T Consensus 103 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999999887654 6899999999999999999999988 99999999999995 45679999999998664332
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+..
T Consensus 179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------------~~~~~~i~~ 236 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------------------YDILKRVET 236 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHH
T ss_pred --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHh
Confidence 2345679999999999876 589999999999999999999999974321 111222222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+..... ..........+.+++..||+.||++|||+.++++.
T Consensus 237 ~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSC------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 221100 00111234678899999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=330.48 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=192.7
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 526 (804)
.+.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 4567899999999999976 46899999999654333 356889999999999999999999997653 4699
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp EEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 99999 88999999864 6899999999999999999999988 999999999999999999999999999875432
Q ss_pred ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.............. .....+......+
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~----~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK----VTGTPPAEFVQRL 253 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCCCCHHHHHTC
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hcCCCCHHHHHHh
Confidence 334578999999999877 6799999999999999999999999975322100000000 0000000000000
Q ss_pred hcC-------ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 686 IEG-------NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 686 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
... .+.......+. .........+.+++.+||+.||++|||+.+++++ ++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000 00000001110 1112234678899999999999999999999985 5543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.73 Aligned_cols=278 Identities=20% Similarity=0.208 Sum_probs=193.9
Q ss_pred hHHHHHhhcc--cccccccccceeEEEEEeCCCcEEEEEEecCCCCC------------HHHHHHHHHHHcCCCCCCcee
Q 044374 448 YKELHTVTRG--FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG------------EREFRAEVCTIGNIQHVNLVR 513 (804)
Q Consensus 448 ~~el~~~t~~--~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~Ei~~l~~l~H~niv~ 513 (804)
..++.....+ +.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3445554444 45799999999999998888999999999642211 267899999999999999999
Q ss_pred eeeEEec-----CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 514 LRGFCSE-----NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 514 l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
+++++.. ....++||||++ |+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcC
Confidence 9999843 346899999998 6888888876668999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCccccCCCccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC
Q 044374 589 DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG 667 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 667 (804)
++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.............
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998543322 2334568999999999877 678999999999999999999999997532110000000
Q ss_pred CCCCCCccCchHH------HHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 668 GGEHGDKWFFPPW------AARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 668 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.. ........+ .................. ..........+.+++..||+.||++|||+.++++.
T Consensus 248 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EV--VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HH--HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--cCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 000000000 000000000000000000 00011224568899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.27 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=193.9
Q ss_pred hcccccccccccceeEEEEEeC-CCcEEEEEEecCCC---------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG---------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 524 (804)
.+.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 4556789999999999999765 57899999996432 12235889999999999999999999987655 8
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc---eEEeecCCcc
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT---AKVSDFGLAK 601 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~ 601 (804)
++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 99999999999999987643 7899999999999999999999988 999999999999987664 9999999998
Q ss_pred ccCCCccccccccccccccccchhcc---CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~-- 227 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--------------S-- 227 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--------------C--
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--------------H--
Confidence 76433 1223456899999999874 5678899999999999999999999997432210 0
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+..+..... +.. .......+.+++.+||+.||++||++.++++
T Consensus 228 --~~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 --LKDQITSGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHHHHHHTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHhCccccC--chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111222211100 000 0122467889999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=340.19 Aligned_cols=194 Identities=24% Similarity=0.341 Sum_probs=151.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 526 (804)
+.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 346789999999999999754 6889999999754333 35688999999999999999999998433 57899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 135 v~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999975 6898888764 36999999999999999999999988 999999999999999999999999999875422
Q ss_pred cc--------------------------ccccccccccccccchhc-cCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 607 FS--------------------------RVLATMRGTWGYVAPEWI-SGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 607 ~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
.. ......+||+.|+|||++ ....++.++||||||||||||++|..++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 11 123445789999999976 5667999999999999999999954443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.28 Aligned_cols=268 Identities=22% Similarity=0.254 Sum_probs=200.4
Q ss_pred hcccccccccccceeEEEEEe--CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC------CceeeeeEEecCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL--SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV------NLVRLRGFCSENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~~~l 526 (804)
.+.+.++||+|+||.||++.. .+++.||||+++......+.+.+|+.++.+++|+ +++++++++...+..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 345678999999999999976 3678999999986554556788999998888655 49999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-----------------
Q 044374 527 VYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS----------------- 588 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~----------------- 588 (804)
||||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 889999987654 36889999999999999999999988 999999999999987
Q ss_pred --CCceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC
Q 044374 589 --DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG 666 (804)
Q Consensus 589 --~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 666 (804)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 678999999999864432 23457899999999999999999999999999999999999999753221000000
Q ss_pred CCCCCCCccCchHHHHHHhhcCccc------------------eeccccc-cCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 044374 667 GGGEHGDKWFFPPWAARQIIEGNVA------------------AVVDDRL-GGAYKVEEAERVALVAIWCIQDNEEMRPT 727 (804)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 727 (804)
. .....++............. ....+.. .........+.+.+++.+||+.||++|||
T Consensus 247 ~----~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 247 E----RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp H----HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred H----HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 0 00000000000000000000 0000000 01113345678999999999999999999
Q ss_pred HHHHHHH
Q 044374 728 MGTVVKM 734 (804)
Q Consensus 728 ~~eVl~~ 734 (804)
+.||++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.46 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=192.3
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCC--CCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQ--HVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++.+++ ||||+++++++......++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4456899999999999999888999999999754332 356889999999997 5999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-c
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-R 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~ 609 (804)
+.+++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|||+++....... .
T Consensus 109 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 109 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 67889999998754 7899999999999999999999988 999999999999964 8999999999987643322 1
Q ss_pred cccccccccccccchhccC-----------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 610 VLATMRGTWGYVAPEWISG-----------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~-----------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------------ 245 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------------ 245 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------------------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------------------
Confidence 2234568999999999876 46888999999999999999999999642110
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....... ++.......+......+.+++.+||+.||++||++.++++.
T Consensus 246 ~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ISKLHAI--------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHH--------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHH--------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0011111 11111111222224578899999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=334.55 Aligned_cols=194 Identities=25% Similarity=0.418 Sum_probs=152.4
Q ss_pred ccccccccceeEEEEEeC---CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEe--cCCeEEEEEEEcCC
Q 044374 459 SEKLGHGGFGAVFQGELS---DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCS--ENSHRLLVYDYMRN 533 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~ 533 (804)
.++||+|+||.||+|+.. .++.||||++..... ...+.+|+.++++++||||+++++++. .....++||||+++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 458999999999999865 467899999975433 456889999999999999999999995 46789999999975
Q ss_pred CChhHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe----cCCCceEEeecCCcc
Q 044374 534 GALSLYLRKD--------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL----DSDYTAKVSDFGLAK 601 (804)
Q Consensus 534 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla~ 601 (804)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 777766522 124899999999999999999999988 9999999999999 778999999999998
Q ss_pred ccCCCcc--ccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 602 LIGRDFS--RVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 602 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 7653321 223456789999999999874 5899999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.35 Aligned_cols=266 Identities=19% Similarity=0.180 Sum_probs=190.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec--------------
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE-------------- 520 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------------- 520 (804)
+.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+.++++++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 44668999999999999975 5789999999965422 23479999999999999999999843
Q ss_pred ------------------------CCeEEEEEEEcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044374 521 ------------------------NSHRLLVYDYMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEECRDC 573 (804)
Q Consensus 521 ------------------------~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 573 (804)
....++||||++ ++|.+.+.. ....+++..+..++.||++||+|||+.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--- 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--- 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 334789999999 587777653 3457999999999999999999999988
Q ss_pred eEecCCCCCcEEec-CCCceEEeecCCccccCCCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCC
Q 044374 574 IIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGR 651 (804)
Q Consensus 574 iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~ 651 (804)
|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999998 68999999999998754332 23345689999999998775 4899999999999999999999
Q ss_pred CCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc----CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 044374 652 RNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE----GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT 727 (804)
Q Consensus 652 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 727 (804)
.||.............. ........ ....... -.........+....+......+.+++.+||+.||++|||
T Consensus 240 ~pf~~~~~~~~~~~i~~---~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQ---IMGTPTKE-QMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp CSSCCSSHHHHHHHHHH---HHCCCCHH-HHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCCCCCChHHHHHHHHH---HhCCCCHH-HHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 99975322100000000 00000000 0000000 0000000111111122234466889999999999999999
Q ss_pred HHHHHHH
Q 044374 728 MGTVVKM 734 (804)
Q Consensus 728 ~~eVl~~ 734 (804)
+.|+++.
T Consensus 316 ~~e~l~h 322 (383)
T 3eb0_A 316 PYEAMAH 322 (383)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=339.90 Aligned_cols=271 Identities=22% Similarity=0.232 Sum_probs=193.2
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~lV~E 529 (804)
+.+.+.||+|+||.||+|+...+..||+|++..... ...+|+.++++++||||+++++++.... ..++|||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 446689999999999999988777799998864322 1236999999999999999999986543 3789999
Q ss_pred EcCCCChhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLR--KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~ 606 (804)
|++++.+..... .....+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 999865554432 23457899999999999999999999988 99999999999999 7999999999999875433
Q ss_pred ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQI 685 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 685 (804)
.. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||................ ... .......+
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~--g~p--~~~~~~~~ 269 (394)
T 4e7w_A 196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL--GTP--SREQIKTM 269 (394)
T ss_dssp CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH--CCC--CHHHHHHH
T ss_pred CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CCC--CHHHHHhh
Confidence 22 2345689999999998765 58999999999999999999999997532110000000000 000 00000000
Q ss_pred h----cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 686 I----EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 686 ~----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
. +..........+...+.......+.+++.+||+.||++||++.|++++ ++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0 000000000000111122234678999999999999999999999975 5544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=329.56 Aligned_cols=269 Identities=23% Similarity=0.259 Sum_probs=188.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 526 (804)
.+.+.||+|+||.||+|... .++.||||++...... .+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 45678999999999999754 6889999999764332 356889999999999999999999997654 7899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++ +|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 108 VMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred EEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 9999985 67777753 5889999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCC-CCCCCC--ccCchHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGG-GGEHGD--KWFFPPWAA 682 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~-~~~~~~--~~~~~~~~~ 682 (804)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +.. .+.... ...+.....
T Consensus 181 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 181 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred c--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 1 2334678999999999999999999999999999999999999997542210000 000 000000 000000000
Q ss_pred HHhhcCc------cceeccccccC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGN------VAAVVDDRLGG---AYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~------~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....... ........... .........+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 00000000000 0112235678999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=319.95 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=198.6
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC----------CHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS----------GEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 524 (804)
.+.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|+.++.++. ||||+++++++......
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 35678999999999999775 678999999975431 1245788999999995 99999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999998653 6899999999999999999999988 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccchhcc------CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 605 RDFSRVLATMRGTWGYVAPEWIS------GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
... ......+++.|+|||++. ...++.++||||||++++||++|+.||.....
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------------- 234 (298)
T 1phk_A 176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------------- 234 (298)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------
T ss_pred CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------------------
Confidence 332 233456899999999885 45688999999999999999999999864211
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
......+..+... . ...........+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 MLMLRMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111222222111 0 00111233567889999999999999999999886
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=330.79 Aligned_cols=277 Identities=21% Similarity=0.258 Sum_probs=200.5
Q ss_pred hcccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----------CCCceeeeeEEecCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----------HVNLVRLRGFCSENS 522 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~~ 522 (804)
.+.+.+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++.+++ ||||+++++++....
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 345678999999999999976 46889999999865545667889999988876 899999999987654
Q ss_pred ----eEEEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEec------CCC
Q 044374 523 ----HRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLD------SDY 590 (804)
Q Consensus 523 ----~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~------~~~ 590 (804)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+. + |+||||||+||||+ ..+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcc
Confidence 789999999 899999997643 4689999999999999999999997 7 99999999999994 445
Q ss_pred ceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCC-
Q 044374 591 TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGG- 669 (804)
Q Consensus 591 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~- 669 (804)
.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 8999999999875433 23457899999999999999999999999999999999999999754321000000000
Q ss_pred -CCCCccCchHHHHHH-------hhc-Cccceecc-------cc--ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 044374 670 -EHGDKWFFPPWAARQ-------IIE-GNVAAVVD-------DR--LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTV 731 (804)
Q Consensus 670 -~~~~~~~~~~~~~~~-------~~~-~~~~~~~d-------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 731 (804)
.......++...... +.. +....+.. .. -....+......+.+++.+||+.||++|||+.||
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 000000000000000 000 00000000 00 0112455677889999999999999999999999
Q ss_pred HHH--Hhccc
Q 044374 732 VKM--LEGVL 739 (804)
Q Consensus 732 l~~--L~~~~ 739 (804)
++. +.+..
T Consensus 332 l~hp~f~~~~ 341 (373)
T 1q8y_A 332 VNHPWLKDTL 341 (373)
T ss_dssp HTCGGGTTCT
T ss_pred hhChhhhccc
Confidence 874 44433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.18 Aligned_cols=269 Identities=20% Similarity=0.214 Sum_probs=195.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 527 (804)
+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 345679999999999999764 678899999975432 236788999999999999999999999655 368999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 109 ~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99998 4899988764 5899999999999999999999988 9999999999999999999999999998764332
Q ss_pred c--ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 608 S--RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 608 ~--~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .....+......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~ 258 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG----ILGSPSQEDLNC 258 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH----HHCSCCHHHHHT
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH----HhCCCCHHHHHH
Confidence 2 12345579999999998654 5589999999999999999999999975432110000000 000000000000
Q ss_pred hhcCc----cceecccccc--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 685 IIEGN----VAAVVDDRLG--GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 685 ~~~~~----~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
+.... .......... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000 00011224568899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=334.20 Aligned_cols=256 Identities=26% Similarity=0.294 Sum_probs=188.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 528 (804)
+.+.+.||+|+||.||+|+.. .++.||||++..... .+.+|+.++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 345678999999999999875 589999999965322 234799999999999999999998532 2367999
Q ss_pred EEcCCCChhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-CceEEeecCCccccC
Q 044374 529 DYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIG 604 (804)
Q Consensus 529 E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~ 604 (804)
||+++ +|.+.+. .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 5555443 23457999999999999999999999988 9999999999999965 678999999998754
Q ss_pred CCccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH-
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA- 682 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 682 (804)
.... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+.....
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--------------~l~~i~~~ 272 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--------------QLVEIIKV 272 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------HHHHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHHHH
Confidence 3322 2345789999999998765 78999999999999999999999997532110 0000000
Q ss_pred ------HHhh--cCccceecccccc-----CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 ------RQII--EGNVAAVVDDRLG-----GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ------~~~~--~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+. .....+..-+.+. ..+.......+.+|+.+||+.||++||++.|++++
T Consensus 273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000 0001111001110 01112234678899999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.97 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=200.3
Q ss_pred hhcccccccccccceeEEEEEeC-CCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 454 VTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
..+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 34566789999999999999875 6889999999643 3456789999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC---CceEEeecCCccccCCC
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD---YTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~ 606 (804)
|+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999887654 6899999999999999999999988 9999999999999764 47999999999875433
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
.. .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+.
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------------~~~~~~~~ 235 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------------------YDILKRVE 235 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHH
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHH
Confidence 21 233458999999999876 488999999999999999999999874311 11122222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+...... +. .......+.+++.+||+.||++||++.++++.
T Consensus 236 ~~~~~~~~-~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 236 TGKYAFDL-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HCCCCCCS-GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCCCCCCc-hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 22211000 00 01224568899999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.36 Aligned_cols=273 Identities=20% Similarity=0.182 Sum_probs=185.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCe-------EEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSH-------RLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-------~~lV 527 (804)
..+.+.||+|+||.||+|+.. +++.||||++.........+.+|+..+..++||||+++++++..... .++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 345689999999999999875 68899999997665555667788888999999999999999865433 7899
Q ss_pred EEEcCCCChhHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCcEEecC-CCceEEeecCCcc
Q 044374 528 YDYMRNGALSLYLR---KDGLNLNWDVRFRIAVGTARGIAYLH--EECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAK 601 (804)
Q Consensus 528 ~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 601 (804)
|||++++ |...+. .....+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.+||+|||+++
T Consensus 105 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 105 MEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred eeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 9999975 443332 23457889999999999999999999 777 999999999999997 8999999999998
Q ss_pred ccCCCccccccccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW 680 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (804)
....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.............. .....+..
T Consensus 181 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~----~~~~~~~~ 254 (360)
T 3e3p_A 181 KLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR----VLGCPSRE 254 (360)
T ss_dssp CCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCCCCHH
T ss_pred ecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH----HcCCCCHH
Confidence 7654322 23456899999999986654 89999999999999999999999975322100000000 00000000
Q ss_pred HHHHhhcCcc-ceecc------ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 681 AARQIIEGNV-AAVVD------DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 681 ~~~~~~~~~~-~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
....+..... ....+ ..............+.+++.+||+.||++||++.|+++. ++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0000000000 00000 000111122346789999999999999999999999975 5543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.12 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=194.8
Q ss_pred cccccccccccceeEEEEEe--CCCcEEEEEEecCC---CCCHHHHHHHHHHHcCC---CCCCceeeeeEEe-----cCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL--SDSTLVAVKRLERP---GSGEREFRAEVCTIGNI---QHVNLVRLRGFCS-----ENS 522 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~-----~~~ 522 (804)
+.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34568999999999999987 46789999999632 22234566777766655 8999999999987 556
Q ss_pred eEEEEEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCcc
Q 044374 523 HRLLVYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAK 601 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 601 (804)
..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 69999997654 35899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||....... .....
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~~~~i 231 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---------------QLGKI 231 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------HHHHH
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHH
Confidence 654321 2345678999999999999999999999999999999999999997532110 00000
Q ss_pred HHHhhc---Cccc-------eec---cccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIE---GNVA-------AVV---DDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~---~~~~-------~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... .... ... ...............+.+++.+||+.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000 000 0000011122334678899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.65 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=174.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHH-HHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVC-TIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|... +++.||||+++.... ...++..|+. +++.++||||+++++++...+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34578999999999999875 688999999976432 2334555655 7888899999999999999999999999998
Q ss_pred CCChhHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 533 NGALSLYLRK----DGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 533 ~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 6 77777653 235789999999999999999999997 7 9999999999999999999999999998654332
Q ss_pred cccccccccccccccchhc----cCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 608 SRVLATMRGTWGYVAPEWI----SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l----~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
. .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......... + .
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~-----------------~ 240 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-L-----------------T 240 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------------C
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-H-----------------H
Confidence 1 2334689999999998 4567899999999999999999999999753211000 0 0
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
....+.. +.+...........+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000 11111111223467889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.54 Aligned_cols=195 Identities=24% Similarity=0.351 Sum_probs=167.1
Q ss_pred hcccccccccccceeEEEEEeC-C-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC------ceeeeeEEecCCeEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS-D-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVN------LVRLRGFCSENSHRLL 526 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~~~l 526 (804)
.+.+.+.||+|+||.||++... . ++.||||+++......+.+.+|+.++++++|+| ++.+.+++......++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 3456789999999999999764 3 368999999865555667888999999887665 8999999999999999
Q ss_pred EEEEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe-------------------
Q 044374 527 VYDYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL------------------- 586 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl------------------- 586 (804)
||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 556666665443 57899999999999999999999987 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 587 DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 66889999999999864432 23457899999999999999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.66 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=190.4
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCeE------EE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSHR------LL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~------~l 526 (804)
.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++...... ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 35678999999999999764 6889999999765433 35688999999999999999999999877654 99
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 125 v~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp EEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 999998 588777743 5899999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC----CCCCCCCccCchHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG----GGGEHGDKWFFPPWA 681 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 681 (804)
.....+|+.|+|||++.+ ..++.++||||||++++||++|+.||............ +.........+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 334568999999999887 68899999999999999999999999753211000000 000000000000000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... .+.......+. .........+.+++..||+.||++||++.|+++.
T Consensus 274 ~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 274 AKSYIQ-SLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHH-HSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhh-ccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00000000000 0011234678899999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.38 Aligned_cols=196 Identities=24% Similarity=0.360 Sum_probs=167.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CC-----CceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HV-----NLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~~~lV~ 528 (804)
+.+.++||+|+||.||+|... +++.||||+++.......++..|+.++..++ |+ +++++++++......++||
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 345679999999999999765 6788999999865444567788888888774 44 4999999999999999999
Q ss_pred EEcCCCChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--CCCceEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--SDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~ 605 (804)
||++ ++|.+++.... ..+++..+..++.|++.||+|||... .+|+||||||+||||+ .++.+||+|||+++....
T Consensus 136 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp ECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred ecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 9996 59999988654 46899999999999999999999521 2399999999999994 578899999999987643
Q ss_pred CccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 214 ~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 214 R----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp C----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3 23457899999999999999999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.50 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=177.2
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 526 (804)
.+.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|+.++++++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 4567899999999999975 46889999999764332 35678999999999999999999999654 56799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
|+|++ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 112 v~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 112 VTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp EEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----------
T ss_pred Eeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 99999 68999988763 6899999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcC----CCCCCCCCccCchHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI----GGGGEHGDKWFFPPWA 681 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 681 (804)
.....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||........... .+.........+....
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 334578999999999877 6789999999999999999999999975322100000 0000000000000000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..... +.......+.. ........+.+|+.+||+.||++|||+.++++.
T Consensus 262 ~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 262 ARNYIQS-LTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHT-SCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhc-cCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 00000000000 001123568899999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.56 Aligned_cols=249 Identities=22% Similarity=0.240 Sum_probs=171.2
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEec----CCeEEEEEEEcCCC
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSE----NSHRLLVYDYMRNG 534 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~g 534 (804)
+.||+|+||.||+|... +++.||||++.... ....+....+..++||||+++++++.. ....++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 46999999999999776 68899999997532 222333344667799999999999876 45689999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCcccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..... .
T Consensus 112 ~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~ 185 (336)
T 3fhr_A 112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---A 185 (336)
T ss_dssp EHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccc---c
Confidence 9999998764 46999999999999999999999988 999999999999976 455999999999865432 2
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....+|+.|+|||++.+..++.++||||||+++|||++|+.||......... ......+..+.
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~~~~~~- 249 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---------------PGMKRRIRLGQ- 249 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------------
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---------------hhHHHhhhccc-
Confidence 33456899999999999989999999999999999999999999753321100 00000000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
..............+.+++..||+.||++||++.++++. +++.
T Consensus 250 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 -----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 001111112335678899999999999999999999984 5553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=318.52 Aligned_cols=267 Identities=19% Similarity=0.231 Sum_probs=187.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCCCCceeeeeEEe--------------c
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-SGEREFRAEVCTIGNIQHVNLVRLRGFCS--------------E 520 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--------------~ 520 (804)
.+.+.||+|+||.||+|... .++.||||++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 35678999999999999876 48899999997543 23467889999999999999999999874 3
Q ss_pred CCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCC
Q 044374 521 NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGL 599 (804)
Q Consensus 521 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGl 599 (804)
....++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 467899999998 6999998753 6889999999999999999999988 99999999999997 567999999999
Q ss_pred ccccCCCcc--ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 600 AKLIGRDFS--RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 600 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~ 243 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE----SIPV 243 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HSCC
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hcCC
Confidence 987643221 12234567899999998865 6789999999999999999999999975322100000000 0000
Q ss_pred chHHHHHHhhcCccceeccccccC-C-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGG-A-----YKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
........+. ..+...+...... . ........+.+++.+||+.||++||++.++++.
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 0000000000000 0 011234678899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=331.05 Aligned_cols=245 Identities=24% Similarity=0.273 Sum_probs=184.9
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +||||+++++++......++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998776668899999998643 245678899999876 89999999999999999999999996 6999
Q ss_pred HHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC-------------CceEEeecC
Q 044374 538 LYLRKDGLN------LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD-------------YTAKVSDFG 598 (804)
Q Consensus 538 ~~l~~~~~~------l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~kl~DfG 598 (804)
+++...... ..+..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999865421 133456789999999999999988 9999999999999654 589999999
Q ss_pred CccccCCCccc---cccccccccccccchhccC-------CCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 599 LAKLIGRDFSR---VLATMRGTWGYVAPEWISG-------LAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 599 la~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------- 246 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR------- 246 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-------
Confidence 99876543221 2234579999999999976 578999999999999999999 99998642111
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
...+..+... . +.+....+......+.+++.+||+.||++||++.+|++
T Consensus 247 --------------~~~i~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 --------------ESNIIRGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------------HHHHHHTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------HHHHhcCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111111110 0 11111223456678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=330.42 Aligned_cols=245 Identities=24% Similarity=0.274 Sum_probs=185.2
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.+.||+|+||+|+.....+++.||||++.... ...+.+|+.+++++ +||||+++++++.+....++||||+. |+
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 3457899999999766555678899999996532 23356899999988 79999999999999999999999997 59
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-----CCceEEeecCCccccCCCcc--
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-----DYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~~~~~~-- 608 (804)
|.+++......+.+..++.++.||++||+|||+.+ |+||||||+||||+. ...+||+|||+++.......
T Consensus 104 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 99999877656666677899999999999999988 999999999999953 34688999999987643311
Q ss_pred ccccccccccccccchhcc---CCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 RVLATMRGTWGYVAPEWIS---GLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~---~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.......||+.|+|||++. ...++.++|||||||++|||++ |+.||...... .. ..
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------------------~~-~~ 240 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------------------QA-NI 240 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------------------HH-HH
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------------------HH-HH
Confidence 2234567999999999997 4567889999999999999999 88888532111 00 11
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
........ .. .........+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~~----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 LLGACSLD----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HTTCCCCT----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhccCCcc----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11000000 00 112234556789999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=322.33 Aligned_cols=237 Identities=25% Similarity=0.413 Sum_probs=194.4
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC-------CHHHHHHHHHHHcCCC--CCCceeeeeEEecCCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS-------GEREFRAEVCTIGNIQ--HVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~ 525 (804)
..+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++++++ ||||+++++++...+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 44668999999999999975 4688999999964321 2245778999999986 599999999999999999
Q ss_pred EEEEEcCC-CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCcccc
Q 044374 526 LVYDYMRN-GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLI 603 (804)
Q Consensus 526 lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~ 603 (804)
+|+|++.+ ++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 125 lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 99999986 89999998654 6899999999999999999999988 99999999999999 7899999999999876
Q ss_pred CCCccccccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 201 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------------------ 253 (320)
T 3a99_A 201 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------------ 253 (320)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------------
T ss_pred cccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------------------
Confidence 5332 234568999999999877665 688999999999999999999986321
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....+.. ..+......+.+++.+||+.||++||++.+|++.
T Consensus 254 -~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 -EIIRGQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHHCCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhhcccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111110 0111223568899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.55 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=177.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCH---HHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.+.||+|+||.||+|... +++.||||++....... +.+.++..+++.++||||+++++++...+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 35678999999999999875 68899999997653322 23445556788899999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
++.+..+.......+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++....... ..
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AK 181 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cc
Confidence 5566666555455799999999999999999999985 7 9999999999999999999999999997654322 22
Q ss_pred cccccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 612 ATMRGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
....+|+.|+|||++. ...++.++||||||+++|||++|+.||...... ........
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------------~~~~~~~~ 243 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------------------FEVLTKVL 243 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------------------HHHHHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------------------HHHHHHHh
Confidence 3456899999999984 456889999999999999999999999742110 11111222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+...... . .......+.+++.+||+.||.+||++.+|++.
T Consensus 244 ~~~~~~~~-----~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 244 QEEPPLLP-----G--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HSCCCCCC-----S--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCCCCCC-----c--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22111110 0 11234568899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=320.91 Aligned_cols=270 Identities=21% Similarity=0.247 Sum_probs=193.8
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~ 528 (804)
.+.+.||+|+||.||+|... +++.||||+++.... ....+.+|+.++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 45679999999999999875 688999999975432 235678999999999999999999998754 6789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+. ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 94 ELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred eccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 9998 5899988764 6899999999999999999999988 99999999999999999999999999987643211
Q ss_pred c---------cccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc----CCCCCC-CCC
Q 044374 609 R---------VLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN----IGGGGE-HGD 673 (804)
Q Consensus 609 ~---------~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~-~~~ 673 (804)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..+... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1 1223468999999998765 678999999999999999999999997532110000 000000 000
Q ss_pred ccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 674 KWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
............... +.......+. .........+.+++.+||+.||++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 248 LRCIESPRAREYIKS-LPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTCCCHHHHHHHHT-SCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhHHhhc-ccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000 0000000000 0011234568899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.17 Aligned_cols=239 Identities=26% Similarity=0.402 Sum_probs=189.6
Q ss_pred hhcccccccccccceeEEEEEe-CCCcEEEEEEecCCCC-------CHHHHHHHHHHHcCC----CCCCceeeeeEEecC
Q 044374 454 VTRGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS-------GEREFRAEVCTIGNI----QHVNLVRLRGFCSEN 521 (804)
Q Consensus 454 ~t~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l----~H~niv~l~g~~~~~ 521 (804)
..+.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 3455678999999999999976 4678999999965432 123356788888877 899999999999999
Q ss_pred CeEEEEEEE-cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCC
Q 044374 522 SHRLLVYDY-MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGL 599 (804)
Q Consensus 522 ~~~~lV~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGl 599 (804)
+..++|+|| +.+++|.+++.... .+++..++.++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 999999999 78999999998754 6899999999999999999999998 99999999999999 889999999999
Q ss_pred ccccCCCccccccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 600 AKLIGRDFSRVLATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 600 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------------- 243 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------------- 243 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------------
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------------------
Confidence 98765432 234568999999999877666 458999999999999999999986310
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
....... ..+......+.+++.+||+.||++||++.++++.
T Consensus 244 -----~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -----EILEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----HHHHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----HHhhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111100 1112234568899999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=319.30 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=191.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCCe------EEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENSH------RLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l 526 (804)
.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++..... .++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 35678999999999999764 6889999999765433 3568899999999999999999999987654 499
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 107 v~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp EEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred Eecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 999998 588877753 4899999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC--CCCCCCc--cCchHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG--GGEHGDK--WFFPPWA 681 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~ 681 (804)
.....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||............. .+..... ..+....
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 234568999999999877 678999999999999999999999997532110000000 0000000 0000000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... .+.......+ ..........+.+++.+||+.||++||++.++++.
T Consensus 256 ~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 256 AKSYIQ-SLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHH-TSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHH-hCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000000001 01112345678999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.31 Aligned_cols=227 Identities=13% Similarity=0.088 Sum_probs=180.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||.||+|... .++.||||++...... .+.+.+|+..+.+++||||+++++++...+..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 456689999999999999875 4889999999765332 26789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++++|.+++... ....++.+++.|++.||+|||+.+ |+||||||+||||+.++.+||++++
T Consensus 113 ~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred cCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999643 355678899999999999999988 9999999999999999999998543
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
|++ .++.++||||||+++|||++|+.||.............
T Consensus 175 ---------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----------------------- 215 (286)
T 3uqc_A 175 ---------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----------------------- 215 (286)
T ss_dssp ---------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----------------------
T ss_pred ---------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----------------------
Confidence 333 36889999999999999999999998643321110000
Q ss_pred ceecccccc--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 691 AAVVDDRLG--GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 691 ~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
..+..... ..........+.+++.+||+.||++| |+.++++.|+.+...
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 216 -RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00000000 00011234568899999999999999 999999999986543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=341.75 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=189.3
Q ss_pred cccccccccccceeEEEEEeC--CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCe-----EEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS--DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSH-----RLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~l 526 (804)
+.+.+.||+|+||.||+|... +++.||||++..... ....+.+|+.++.+++||||+++++++...+. .+|
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 446689999999999999875 578999999975432 23568899999999999999999999987655 799
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ .+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 9999999999988765 6899999999999999999999988 9999999999999986 9999999999875432
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
....||+.|+|||++.+.. +.++|||||||+++||++|..|+.......
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------------- 283 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------------- 283 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------------
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------------
Confidence 3456999999999987754 889999999999999999988876421110
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-TMGTVVKMLEGVL 739 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~ 739 (804)
+ . ...........+..++.+||+.||++|| ++.++.+.|.+++
T Consensus 284 ---~---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ---L---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---C---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---c---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0 0000112235688999999999999999 5666666676543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=335.40 Aligned_cols=270 Identities=24% Similarity=0.308 Sum_probs=198.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEec------CCeEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSE------NSHRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~~l 526 (804)
+.+.++||+|+||.||+|... +++.||||+++.... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 456789999999999999764 688999999975422 24568899999999999999999998765 677899
Q ss_pred EEEEcCCCChhHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCc---eEEeecCCcc
Q 044374 527 VYDYMRNGALSLYLRKDG--LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYT---AKVSDFGLAK 601 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~ 601 (804)
||||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999998654 36889999999999999999999988 999999999999997665 9999999998
Q ss_pred ccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHH
Q 044374 602 LIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681 (804)
Q Consensus 602 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 681 (804)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ .
T Consensus 173 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~--~~~i~~~~-------~ 241 (676)
T 3qa8_A 173 ELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW--HGKVREKS-------N 241 (676)
T ss_dssp BTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS--STTCC-----------
T ss_pred cccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh--hhhhhccc-------c
Confidence 764432 234467899999999999999999999999999999999999999643110000 00000000 0
Q ss_pred HHHhhcCcccee--cccc--ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH-----HHHHHhccc
Q 044374 682 ARQIIEGNVAAV--VDDR--LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT-----VVKMLEGVL 739 (804)
Q Consensus 682 ~~~~~~~~~~~~--~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-----Vl~~L~~~~ 739 (804)
............ .... ............+.+++..||+.||++||++.+ ..+.++.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000000000000 0000 012234456788999999999999999999977 344554443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=317.28 Aligned_cols=234 Identities=15% Similarity=0.123 Sum_probs=175.3
Q ss_pred cccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCC-CCcee---------eeeE-----
Q 044374 458 FSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQH-VNLVR---------LRGF----- 517 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H-~niv~---------l~g~----- 517 (804)
..+.||+|+||.||+|.. .+++.||||++... ....+.+++|+.++..++| +|... .+..
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 456899999999999985 46889999999732 2235779999999999987 32211 1111
Q ss_pred -------Eec-----CCeEEEEEEEcCCCChhHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 044374 518 -------CSE-----NSHRLLVYDYMRNGALSLYLR------KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDI 579 (804)
Q Consensus 518 -------~~~-----~~~~~lV~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dl 579 (804)
... ....+++|++ ..++|.+++. .....+++..++.++.||++||+|||+.+ |+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 111 1234666665 4689998884 22346788999999999999999999988 999999
Q ss_pred CCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhc----------cCCCCCccceEEeehhhHHHhhh
Q 044374 580 KPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI----------SGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 580 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999865433 344567 999999999 55668899999999999999999
Q ss_pred CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 044374 650 GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG 729 (804)
Q Consensus 650 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 729 (804)
|+.||........ ...++... . ..++.+.+++..||+.||++||++.
T Consensus 313 g~~Pf~~~~~~~~---------------------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGG---------------------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSC---------------------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhh---------------------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999975322110 00111100 1 1235688999999999999999987
Q ss_pred HHHH
Q 044374 730 TVVK 733 (804)
Q Consensus 730 eVl~ 733 (804)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.62 Aligned_cols=224 Identities=23% Similarity=0.267 Sum_probs=176.6
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHH-cCCCCCCceeeeeEEec----CCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTI-GNIQHVNLVRLRGFCSE----NSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6799999999999976 4688999999974 35677888887 66799999999999876 6778999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 609 (804)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----- 171 (299)
T 3m2w_A 100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171 (299)
T ss_dssp CBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-----
Confidence 99999998754 46899999999999999999999988 999999999999998 7899999999987532
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
+..++.++||||||+++|||++|+.||.......... ..
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------------------~~ 210 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------------------GM 210 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------------------CS
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------------------HH
Confidence 2346789999999999999999999997543211000 00
Q ss_pred cceeccccccCCCC----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 690 VAAVVDDRLGGAYK----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 690 ~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
...+..... ..+ ......+.+++..||+.||++||++.|+++. +.+.
T Consensus 211 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 211 KTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 000000000 001 1234678899999999999999999999974 5543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=286.98 Aligned_cols=200 Identities=14% Similarity=0.181 Sum_probs=149.5
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|.+|++| ++|.|+||||.+++ +.+|+. +|+||+|||+.| .++.|.|+.||||||+|++|.+||+
T Consensus 16 ~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~~----~~~vW~an~~~~----~~~~l~l~~dGnLvl~d~~~~~vW~ 80 (236)
T 1dlp_A 16 TLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA----TGCRAVLQSDGLLVILTAQNTIRWS 80 (236)
T ss_dssp CCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC----SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred EECCCCEE--EcCCEEEEECCCCc-----EEEEEC----CEEEEECCCCCC----CCeEEEEcCCCcEEEEcCCCcEEEe
Confidence 57789998 59999999998765 444443 799999999998 2468999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccc----------cCCCccccc-eeeeeccCCCCCCCcceee
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTW----------LPGMNISVG-GSITSWKSLFDPSPGFYSL 150 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTl----------Lpg~~l~~~-~~L~Sw~s~~dps~G~ys~ 150 (804)
|+.. .....|+|+|+|||||++. ++||||||||||+ +|||+++.+ ++|+| .+||++|.|++
T Consensus 81 s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l 154 (236)
T 1dlp_A 81 SGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---TQSLQLSPYRL 154 (236)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---SCCCBCSSCEE
T ss_pred CCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---CcEeecCcEEE
Confidence 9843 2345799999999999954 8999999998655 777766643 46774 78999999999
Q ss_pred eeCCCCCceEEEEEeCcEEEEecCCCCCceeecccccccce-eEEEeeecCCCcceeEEEeeccCCCCCCCCeeEEEEcc
Q 044374 151 RLSPTGYNQIELVYNGTIVYWSTGNWTGNAFVNVPEMTIPY-IYKFHFLNPYTSKASFGYTEKPLDNGQKPPLSRFHVDP 229 (804)
Q Consensus 151 ~~~~~g~~~~~~~~~~~~~yw~sg~w~g~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~ 229 (804)
+++++| +++ ++++..+||++++|++. +...++|.... .+.+. .+ ..+....|+.. . . ..+|++||+
T Consensus 155 ~l~~dG--~Lv-L~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~--~~-~~~vw~s~~~~--~-~---~~~rl~Ld~ 221 (236)
T 1dlp_A 155 SMETDC--NLV-LFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLT--NQ-NIAVWTSGNSR--S-A---GRYVFVLQP 221 (236)
T ss_dssp EEETTT--EEE-EEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEE--TT-TEEEEECCCCC--S-S---SCCEEEECS
T ss_pred EECCCC--cEE-EEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEe--CC-CcEEEEeCCCC--C-C---CCEEEEEcC
Confidence 999997 554 57777899999999754 55667775433 23332 12 22333332221 1 1 258999999
Q ss_pred CCcEEEEE
Q 044374 230 SGQLKQYT 237 (804)
Q Consensus 230 ~G~l~~y~ 237 (804)
||++++|.
T Consensus 222 dG~l~ly~ 229 (236)
T 1dlp_A 222 DRNLAIYG 229 (236)
T ss_dssp SSCEEEEC
T ss_pred CCcEEEeC
Confidence 99999994
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-33 Score=305.93 Aligned_cols=238 Identities=15% Similarity=0.138 Sum_probs=180.4
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCC---------CCHHHHHHHHHHHcCCC---------CCCceeeeeE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG---------SGEREFRAEVCTIGNIQ---------HVNLVRLRGF 517 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~---------H~niv~l~g~ 517 (804)
..+.++||+|+||.||+|+. +++.||||+++... ...+.+.+|+.++++++ ||||+++.++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 34678999999999999987 67999999997432 22377889999888775 7777777776
Q ss_pred Ee------------------------------cCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044374 518 CS------------------------------ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567 (804)
Q Consensus 518 ~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 567 (804)
+. .....+|||||+++|++.+.+.+ ..+++..+..++.||+.||+|||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence 43 26789999999999976666644 36899999999999999999999
Q ss_pred -hcCCCCeEecCCCCCcEEecCCC--------------------ceEEeecCCccccCCCccccccccccccccccchhc
Q 044374 568 -EECRDCIIHCDIKPENILLDSDY--------------------TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626 (804)
Q Consensus 568 -~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l 626 (804)
+.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+|||++
T Consensus 179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 888 99999999999999887 9999999999875432 34799999999999
Q ss_pred cCCCCCccceEEeehhh-HHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHH
Q 044374 627 SGLAITTKADVYSYGMT-LLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVE 705 (804)
Q Consensus 627 ~~~~~~~ksDV~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 705 (804)
.+.. +.++|||||+++ .+++++|..||.... ........+..... ............
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------------------~~~~~~~~~~~~~~---~~~~~~~~~~~~ 307 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------------------WLHYLTDKMLKQMT---FKTKCNTPAMKQ 307 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------------------HHHHHHHHHHHTCC---CSSCCCSHHHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchh------------------hhhHHHHhhhhhhc---cCcccchhhhhh
Confidence 8776 899999998777 778889988874200 00001111111100 001111112335
Q ss_pred HHHHHHHHHhhccccCCCCCCCHHHHH
Q 044374 706 EAERVALVAIWCIQDNEEMRPTMGTVV 732 (804)
Q Consensus 706 ~~~~l~~l~~~Cl~~dP~~RPs~~eVl 732 (804)
....+.+++.+||+.| |+.|++
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cCHHHHHHHHHHhccC-----CHHHHH
Confidence 6778999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=282.73 Aligned_cols=186 Identities=16% Similarity=0.081 Sum_probs=132.5
Q ss_pred cccccccceeEEEE-EeCCCcEEEEEEecCCCC-----------CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEE
Q 044374 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGS-----------GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLL 526 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~-~~~~~~~vavK~l~~~~~-----------~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 526 (804)
..++.|++|.+..+ +..-++.+|||++..... ..++|++|+.+|+++ +|+||+++++++.+....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45777888777665 334577899999965321 124699999999999 79999999999999999999
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||++|++|.++|...+ .++.. +|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999998764 55543 58899999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
.. .....+||+.|||||++.+. +..++|+||+|++++++.++..++
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Cc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 22 24457899999999999764 567899999999999988775544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-25 Score=253.26 Aligned_cols=181 Identities=15% Similarity=0.180 Sum_probs=145.8
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCC---------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSG---------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.||+|+||.||+|.. .++.+++|+....... .+.+.+|+.++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45899999999999955 4677899987543221 2347899999999999999977777777778899999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++++|.+++.. +..++.|+++||+|||+.+ |+||||||+|||++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999876 5689999999999999988 999999999999998 9999999999987543221
Q ss_pred ------cccccccccccccchhccC--CCCCccceEEeehhhHHHhhhCCCCC
Q 044374 610 ------VLATMRGTWGYVAPEWISG--LAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 610 ------~~~~~~gt~~y~aPE~l~~--~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.++
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235679999999999987 56888899999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.6e-22 Score=208.34 Aligned_cols=141 Identities=16% Similarity=0.106 Sum_probs=115.6
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCCCC-------------------CHHHHHHHHHHHcCCCCCCceeeeeEE
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-------------------GEREFRAEVCTIGNIQHVNLVRLRGFC 518 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~Ei~~l~~l~H~niv~l~g~~ 518 (804)
+.+.||+|+||.||+|...+++.||||+++.... ....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4579999999999999887789999999964221 1346889999999999 5 6666655
Q ss_pred ecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 519 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
.. +..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred ec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 43 55699999999999988 422 234579999999999999988 99999999999999 9999999999
Q ss_pred CccccCCCccccccccccccccccchhccC
Q 044374 599 LAKLIGRDFSRVLATMRGTWGYVAPEWISG 628 (804)
Q Consensus 599 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 628 (804)
+++. +..++|||++..
T Consensus 238 ~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TCEE--------------TTSTTHHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHHH
Confidence 9973 345789998854
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-18 Score=150.90 Aligned_cols=96 Identities=17% Similarity=0.344 Sum_probs=82.1
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|.+|++|+| |.|.|.|+.+++ |.++.. .++||+|||++|..+ +..|.|+.||||||+|+++.+||
T Consensus 8 ~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~----~~~vW~ant~~~~~~--~~~L~l~~dGnLvL~d~~~~~vW 74 (105)
T 4h3o_A 8 EGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH----STSTWASNTEIGGKS--GCSAVLQSDGNFVVYDSSGRSLW 74 (105)
T ss_dssp EEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCCCTTCC--SCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC----CEEEEEecCCCCCCc--cEEEEEeCCccEEEECCCcEEEE
Confidence 35778899988 889999999987 888764 589999999999765 36899999999999999999999
Q ss_pred EeccC--CceeEEEEccCCcEEEecCCCCeeecc
Q 044374 83 QSTNT--EKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 83 ~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
+|+.. .....|+|+|+|||||++. .||||
T Consensus 75 ss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 75 ASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp ECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred EecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99743 3456799999999999964 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-18 Score=153.57 Aligned_cols=96 Identities=17% Similarity=0.354 Sum_probs=82.2
Q ss_pred eecCCCEEE--eCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEE
Q 044374 4 IIKGNSTII--SQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSII 81 (804)
Q Consensus 4 ~~~~~~~~~--s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~ 81 (804)
.|.+|++|+ |++|.|+|+|+++|+ | +||++ +++||+||++.|- .+..|.|+.||||||+|.++.++
T Consensus 16 ~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~~---~~~~l~l~~dGNLVl~d~~~~~l 83 (119)
T 1b2p_A 16 ILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGLG---NGCRAVLQPDGVLVVITNENVTV 83 (119)
T ss_dssp EEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTSC---SSCEEEECTTSCEEEECTTCCEE
T ss_pred EEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccCC---CceEEEEccCCEEEEEeCCCcEE
Confidence 578999999 999999999999875 3 68875 7999999998772 24689999999999999999999
Q ss_pred EEecc--CCceeEEEEccCCcEEEecCCCCeeecc
Q 044374 82 WQSTN--TEKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 82 w~~~~--~~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
|+|.. ..+...++|+|+|||||++ .++|||
T Consensus 84 W~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 84 WQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99973 2345679999999999997 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.9e-18 Score=150.44 Aligned_cols=99 Identities=22% Similarity=0.419 Sum_probs=84.4
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|.+|++|+ ++|.|+|+|+.+|+ | |||+ .+++||.||++.|- .+..+.|..||||||+|.+|.++|+
T Consensus 9 ~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~---~~~~l~l~~dGNLVl~~~~~~~~W~ 75 (110)
T 3a0c_A 9 SLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG---SGCRLTLHNNGNLVIYDQSNRVIWQ 75 (110)
T ss_dssp EECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC---SSCEEEECTTSCEEEECTTCCEEEE
T ss_pred EECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC---CcEEEEEeCCCCEEEECCCCcEEEe
Confidence 578999999 99999999998876 4 6776 37999999998763 2458999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecccCCC
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHP 118 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~P 118 (804)
|... .+...++|+|+|||||++. ++||||+||
T Consensus 76 S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~ 109 (110)
T 3a0c_A 76 TKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGP 109 (110)
T ss_dssp CCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC
T ss_pred cCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcC
Confidence 9732 2345799999999999975 899999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-18 Score=179.90 Aligned_cols=134 Identities=17% Similarity=0.141 Sum_probs=104.8
Q ss_pred ccccccccccceeEEEEEe-CCCcE--EEEEEecCCCCC-------------------------HHHHHHHHHHHcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTL--VAVKRLERPGSG-------------------------EREFRAEVCTIGNIQH 508 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~Ei~~l~~l~H 508 (804)
.+.+.||+|+||.||+|.. .+++. ||||+++..... ...+.+|+..+.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999987 67888 999997543111 1257889999999988
Q ss_pred CCc--eeeeeEEecCCeEEEEEEEcCC-C----ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCC
Q 044374 509 VNL--VRLRGFCSENSHRLLVYDYMRN-G----ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH-EECRDCIIHCDIK 580 (804)
Q Consensus 509 ~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~Dlk 580 (804)
+++ ..++++ ...+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.+ |+|||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 754 334432 356899999952 4 66655432 235577899999999999999 887 9999999
Q ss_pred CCcEEecCCCceEEeecCCcccc
Q 044374 581 PENILLDSDYTAKVSDFGLAKLI 603 (804)
Q Consensus 581 p~NILl~~~~~~kl~DfGla~~~ 603 (804)
|.|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=6.5e-17 Score=145.53 Aligned_cols=101 Identities=17% Similarity=0.336 Sum_probs=83.4
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|.+|++|+ +|.|+|+|+.+|+ |- +|+ ..++||+||++.|.. +..|.|+.+|||||+|.++.++|
T Consensus 9 q~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~---~~~~vW~sn~~~~~~---~~~l~l~~~GnLvl~d~~~~~vW 74 (115)
T 2dpf_A 9 QTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ---NGRQIWASNTDRRGS---GCRLTLLSDGNLVIYDHNNNDVW 74 (115)
T ss_dssp CEEETTEEEE--ETTEEEEECTTSC-----EE-EEE---TTEEEEECSCTTSCS---SCEEEECTTSCEEEECTTCCEEE
T ss_pred CEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe---CCEEEEeCCCCCCCC---ceEEEECCCCcEEEECCCceEEE
Confidence 3578899998 8999999998865 33 365 479999999998832 45899999999999999899999
Q ss_pred EeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcc
Q 044374 83 QSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120 (804)
Q Consensus 83 ~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTD 120 (804)
+|... .+...++|+|+|||||++. ++||||.+++.
T Consensus 75 ~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 75 GSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp ECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 99743 3346799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-16 Score=142.73 Aligned_cols=101 Identities=15% Similarity=0.333 Sum_probs=83.5
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|.+|++| ++|.|+|+|+.+|+ | +||++ +++||+||++.+ + .+..+.|..+|||||+| ++.++|
T Consensus 8 q~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~-~~~~l~l~~~GNLvl~d-~~~~~W 72 (112)
T 1xd5_A 8 HQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--A-SGCVLKMQNDGNLVIYS-GSRAIW 72 (112)
T ss_dssp EEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--C-SSEEEEECTTSCEEEEE-TTEEEE
T ss_pred CEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--C-CCEEEEEeCCCCEEEEc-CCEEEE
Confidence 467889999 58999999999976 4 35764 689999999764 2 24689999999999999 889999
Q ss_pred Eecc--CCceeEEEEccCCcEEEecCCCCeeecccCCC
Q 044374 83 QSTN--TEKATDMYLLETGNLVLLSSAGSLVWQSFDHP 118 (804)
Q Consensus 83 ~~~~--~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~P 118 (804)
+|.. ..+...++|+++|||||++..+.++||||++.
T Consensus 73 ~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 73 ASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp ECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred ECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 9873 23345799999999999987788999999985
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.63 E-value=8.4e-16 Score=137.64 Aligned_cols=90 Identities=23% Similarity=0.407 Sum_probs=75.3
Q ss_pred CcEEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 60 QSTLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 60 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
..+|.|+.||||+|++. +.+||+++.. .....|+|+++|||||++ ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------------
Confidence 46899999999999987 8899999843 234689999999999999 7889999994
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCCCC
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTG 178 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w~g 178 (804)
||++|.|+++++++|. +++...+..+||++++|+|
T Consensus 77 ----~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4578999999999975 4443345789999999987
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=134.33 Aligned_cols=96 Identities=18% Similarity=0.294 Sum_probs=78.0
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|.+|++|+ +|.|+|+|+.+|+ |-+ |.. .++||+||++.+ + .+..|.|+.||||||+|.++.++|
T Consensus 8 q~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~-~~~~l~l~~dGNLvl~~~~~~~~W 73 (109)
T 3dzw_A 8 ETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--D-RRCHLSMQSDGNLVVYSPRNNPIW 73 (109)
T ss_dssp EEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--S-SSCEEEECTTSCEEEECTTSCEEE
T ss_pred CEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--C-CCEEEEEeCCCCEEEECCCCCEEE
Confidence 3577888886 7999999998875 444 654 589999999876 2 245899999999999999999999
Q ss_pred EeccCC--ceeEEEEccCCcEEEecCCCCeeeccc
Q 044374 83 QSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSF 115 (804)
Q Consensus 83 ~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSF 115 (804)
+|+... ...+|+|+|+|||||++. ++|||=
T Consensus 74 ~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 74 ASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp ECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred ECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 997432 346799999999999974 899984
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=9.8e-15 Score=129.97 Aligned_cols=87 Identities=22% Similarity=0.460 Sum_probs=72.5
Q ss_pred CcEEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 60 QSTLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 60 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
..+|.|+.||||||+| .+.+||+++.. .....++|+|+|||||++.++.++||||
T Consensus 21 ~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~---------------------- 77 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK---------------------- 77 (110)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC----------------------
T ss_pred CEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC----------------------
Confidence 4689999999999998 58999999843 2346899999999999998899999999
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCCC
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWT 177 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w~ 177 (804)
++|++|.|+++++++|. ++ +|++ +||+++++.
T Consensus 78 ---t~~~~g~~~l~l~~dGn--lv-l~~~--~~W~S~~~~ 109 (110)
T 3a0c_A 78 ---TNGKEDHYVLVLQQDRN--VV-IYGP--VVWATGSGP 109 (110)
T ss_dssp ---CCCSSSCCEEEECTTSC--EE-EECS--EEEECSCCC
T ss_pred ---CCCCCCCEEEEEeCCcc--EE-EECC--CEecCCCcC
Confidence 35678999999999975 33 4665 899999763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=7.8e-16 Score=166.74 Aligned_cols=135 Identities=12% Similarity=0.055 Sum_probs=95.6
Q ss_pred cccccccccccceeEEEEEeCCCcEEEEEEecCCC---------------CCHHHH--------HHHHHHHcCCCCCCce
Q 044374 456 RGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG---------------SGEREF--------RAEVCTIGNIQHVNLV 512 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------------~~~~~~--------~~Ei~~l~~l~H~niv 512 (804)
+.+...||+|+||.||+|...+|+.||||+++... ...... ..|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 34667999999999999999899999999875321 011122 2344555555433321
Q ss_pred eeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC--
Q 044374 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-- 590 (804)
Q Consensus 513 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 590 (804)
-..-+.. ...+|||||++++.|..+.. ......++.|++.+|.|||+.+ ||||||||.||||++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 1111111 12379999999988865432 2234568899999999999988 99999999999998876
Q ss_pred --------ceEEeecCCccc
Q 044374 591 --------TAKVSDFGLAKL 602 (804)
Q Consensus 591 --------~~kl~DfGla~~ 602 (804)
.+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999998864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.6e-14 Score=128.89 Aligned_cols=84 Identities=25% Similarity=0.481 Sum_probs=70.8
Q ss_pred cEEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
..|.|..||||+|++. +.+||+++.. .....++|+|+|||||++.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 5799999999999987 8999999842 2346899999999999999899999999
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
+||++|.|+++++++|. ++ +|+ .+||++|+
T Consensus 88 --~~~~~g~~~l~l~~~Gn--lv-l~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --VAGKAGHYVLVLQPDRN--VV-IYG--DALWATQT 117 (119)
T ss_dssp --CCCCSSCEEEEECTTSC--EE-EEE--SEEEECCC
T ss_pred --CCCCCCCEEEEEECCCc--EE-EEC--ccEeCCCC
Confidence 45678999999999985 43 454 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-14 Score=127.09 Aligned_cols=89 Identities=30% Similarity=0.438 Sum_probs=74.2
Q ss_pred CcEEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 60 QSTLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 60 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
...|.|+.||||+|++ .+.+||+++.. .....++|+++|||||++.++.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~-------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW-------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC--------------------
Confidence 3579999999999998 58899999833 234689999999999999888999999998
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCCCCc
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTGN 179 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w~g~ 179 (804)
|++|.|++.++++|. ++ +|++ +||++++|...
T Consensus 80 -----~~~g~~~l~l~~dGn--lv-l~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----GDNGKYALVLQKDGR--FV-IYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----CSSSCCEEEECTTSC--EE-EECS--EEECSSTTCBC
T ss_pred -----CCCCCEEEEEeCCCe--EE-EECC--CEEECCCCCCc
Confidence 357899999999985 43 5655 89999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.50 E-value=9.4e-14 Score=123.44 Aligned_cols=93 Identities=22% Similarity=0.438 Sum_probs=74.3
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|..|++|+| |.|+|-|...|+ |.| |.. ++||.+|++.. + .+..|.|+.||||||+|.++.++|+
T Consensus 14 ~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~-~~~~l~l~~dGNLvl~d~~~~~iW~ 78 (110)
T 3r0e_B 14 VLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--G-EHCFLRLNHKGELIIKDDDFKTIWS 78 (110)
T ss_dssp EEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--S-SSCEEEECTTSCEEEECTTCCEEEE
T ss_pred EecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--C-cCEEEEEeCCCcEEEEeCCCCEEEE
Confidence 4677888887 559998877765 666 654 47999999863 2 2358999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecc
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
|+.. ....+|+|+|+|||||++ ..+|+|
T Consensus 79 S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 79 SRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred cCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 9742 234689999999999998 489987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.4e-13 Score=121.51 Aligned_cols=96 Identities=18% Similarity=0.306 Sum_probs=77.4
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|..|+.|. +|.|.|-|..+|+ |-++..+ ..++||.+|+..+- .+..|.|+.+|||||+|.++.++|+
T Consensus 14 ~L~~g~~L~--~g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~~---~~~~l~l~~dGNLVl~d~~~~~iW~ 81 (113)
T 3mez_B 14 VMYDNAQLA--TRDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGRG---QHCFMRLGHSGELDITDDRLNTVFV 81 (113)
T ss_dssp EEETTCEEE--ETTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTSC---SSCEEEECTTSCEEEECTTSCEEEE
T ss_pred EECCCCEeE--cCCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccCC---cCEEEEEeCCCcEEEECCCCCEEEE
Confidence 455666665 4899999998876 8886542 36899999998762 2458999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecc
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
|+.. .+..+|+|+|+|||||++ ..+|+|
T Consensus 82 S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 82 SNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp CSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9843 234689999999999997 689987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.5e-12 Score=114.02 Aligned_cols=97 Identities=24% Similarity=0.488 Sum_probs=75.2
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|..|+.| .+|.|.|.|+.+|+ |-+ |.. +|.+|+..+ + .+..|.|+.||||||+|.++.++|+
T Consensus 11 ~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~-~~~~l~l~~dGnLvl~d~~~~~vWs 73 (109)
T 3r0e_A 11 TLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--G-RDCKLTLTDYGELVIKNGDGSTVWK 73 (109)
T ss_dssp EECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--C-SSCEEEECTTSCEEEECTTSCEEEE
T ss_pred CcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--C-CcEEEEEcCCCeEEEEeCCCCEEEc
Confidence 45556666 47999999998876 544 432 699998765 2 2468999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCC
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPG 125 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg 125 (804)
|+.. ....+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 74 s~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 74 SGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp CCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 8743 234679999999999997 689997 555554
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.7e-11 Score=107.68 Aligned_cols=93 Identities=13% Similarity=0.292 Sum_probs=72.8
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCc-EEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNS-IIW 82 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~-~~w 82 (804)
.|..|+.| .+|.|.|-|..+|+ |-+ |.. .. ||.+|+..+-. +..|.|+.+|||||+|.++. ++|
T Consensus 10 ~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~~~---~~~l~l~~dGNLVl~~~~~~~~vW 74 (111)
T 3mez_A 10 VIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGRGV---DCTLRLNNRGQLEIHSANSNTPVW 74 (111)
T ss_dssp EECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTSCS---SCEEEECTTSCEEEECSSCSSCSE
T ss_pred EeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccCCc---CEEEEEcCCCcEEEEeCCCCEEEE
Confidence 46677777 37899999998876 655 543 23 99999987622 35899999999999998876 599
Q ss_pred EeccC----CceeEEEEccCCcEEEecCCCCeeecc
Q 044374 83 QSTNT----EKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 83 ~~~~~----~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
+|+.. ....++.|+++|||||++ ..+|+|
T Consensus 75 ~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 75 VYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp EESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 99731 234679999999999997 789987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.19 E-value=7.1e-11 Score=105.40 Aligned_cols=93 Identities=24% Similarity=0.354 Sum_probs=70.7
Q ss_pred CCCCCCCCCcEEEEeccccEEEecC-CCcEEEEeccCC--ceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCcc
Q 044374 52 EKSVADVTQSTLLITEKGKLAIKDS-QNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNI 128 (804)
Q Consensus 52 ~~p~~~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l 128 (804)
++|+.+. ...|.++.||||||++. .+.++|+++... ....++|+++|||||++.++.++|||-.+-
T Consensus 18 g~~L~~g-~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~---------- 86 (113)
T 3mez_B 18 NAQLATR-DYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG---------- 86 (113)
T ss_dssp TCEEEET-TEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC----------
T ss_pred CCEeEcC-CEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC----------
Confidence 4455443 46899999999999998 589999998432 346899999999999998889999983321
Q ss_pred ccceeeeeccCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 129 SVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 129 ~~~~~L~Sw~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
..|.|.+.++.+|... +|+ .+.|.+|+
T Consensus 87 ---------------~~~~~~~~L~~dGnlv---ly~--~~~W~s~~ 113 (113)
T 3mez_B 87 ---------------QEGDYVLILQINGQAV---VYG--PAVWSTAA 113 (113)
T ss_dssp ---------------SSSCCEEEECTTSCEE---EEC--SEEEESCC
T ss_pred ---------------CCCCEEEEEcCCceEE---Eec--CCEecCCC
Confidence 1356899999997532 444 58898875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.6e-10 Score=118.48 Aligned_cols=138 Identities=12% Similarity=0.010 Sum_probs=107.9
Q ss_pred cccccccccceeEEEEEeCCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 458 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+...++.|+.+.||+.... ++.+++|+..... .....+.+|+.+++.+. |.++.++++++...+..++||||+++.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 4567888888999999764 5789999986421 22345888999988874 6778889999988889999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE---------------------------------------------- 569 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 569 (804)
|.+.+. +......++.+++++|+.||+.
T Consensus 97 l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 97 CSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 887632 1223457889999999999981
Q ss_pred ----------CCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 570 ----------CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 570 ----------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
....++|+|++|.|||++.+..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766677999998754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.07 E-value=5.1e-10 Score=99.41 Aligned_cols=86 Identities=20% Similarity=0.325 Sum_probs=66.3
Q ss_pred CcEEEEeccccEEEecCCCcEEEEeccCC--ceeEEEEccCCcEEEecCCCC-eeecccCCCcccccCCCccccceeeee
Q 044374 60 QSTLLITEKGKLAIKDSQNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGS-LVWQSFDHPTDTWLPGMNISVGGSITS 136 (804)
Q Consensus 60 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~-~~WqSFd~PTDTlLpg~~l~~~~~L~S 136 (804)
...|.++.||||||++.++ +|+++... ....++|+++|||||++.++. ++|||.-+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 3689999999999999877 99997432 246899999999999998765 59999721
Q ss_pred ccCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 137 WKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 137 w~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
.....|.|.+.++++|... +|. .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlv---ly~--~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVT---IYG--PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEE---EEC--SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEE---Eec--cCEEccCC
Confidence 1113578999999997533 444 68998874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=8.1e-10 Score=97.91 Aligned_cols=84 Identities=23% Similarity=0.438 Sum_probs=65.0
Q ss_pred cEEEEeccccEEEecCCCcEEEEeccCC--ceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
..|.|+.||||+|++. +.++|+++... ....+.|+++|||||++.++.++|||....
T Consensus 21 ~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~-------------------- 79 (109)
T 3dzw_A 21 YVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-------------------- 79 (109)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC--------------------
T ss_pred EEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC--------------------
Confidence 5799999999999987 78999998432 346899999999999998889999985322
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
..+.|.+.++++|... +++. +.|.++.
T Consensus 80 -----~~~~~~~~L~ddGNlv---ly~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----ENGNYVCVLQKDRNVV---IYGT--ARWATGT 106 (109)
T ss_dssp -----SSSCEEEEECTTSCEE---EEES--CCCCCCC
T ss_pred -----CCCCEEEEEeCCCEEE---EECC--CEEeCCC
Confidence 2356899999997532 4443 6677664
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=9.2e-10 Score=114.30 Aligned_cols=102 Identities=16% Similarity=0.390 Sum_probs=76.0
Q ss_pred eecCCCEEEeCCCeEEEeeecCC--CCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATN--GESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSII 81 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~--~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~ 81 (804)
.|..|++|+|+ ..++.|+|... .....+ +| .+ ..+++|.+++.++ +. ..|.++.+|+|+++|.++.++
T Consensus 148 ~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--Ly-~~--~~~~yW~Sgt~~~--~~--~~l~l~~dGnLvl~d~~~~~v 217 (276)
T 3m7h_A 148 LLAPGSELVQG-VVYGAGASKLVFQGDGNLV--AY-GP--NGAATWNAGTQGK--GA--VRAVFQGDGNLVVYGAGNAVL 217 (276)
T ss_dssp EECSSEEECTT-CEEEETTEEEEECTTSCEE--EE-CT--TSSEEEECCCTTT--TC--CEEEECTTSCEEEECTTSCEE
T ss_pred ccccCcccccC-CCCCCceEEEeecCCceEE--EE-eC--CCeEEEECCCCCC--cc--EEEEEcCCCeEEEEeCCCcEE
Confidence 36777888654 56666666532 122333 43 32 3588999999876 22 579999999999999988999
Q ss_pred EEeccC-CceeEEEEccCCcEEEecCCCCeeecccCC
Q 044374 82 WQSTNT-EKATDMYLLETGNLVLLSSAGSLVWQSFDH 117 (804)
Q Consensus 82 w~~~~~-~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~ 117 (804)
|++... ....+|+|+++||||+++. .++||||||
T Consensus 218 WsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 218 WHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp EECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 999732 3347899999999999976 689999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=6.4e-10 Score=115.00 Aligned_cols=131 Identities=15% Similarity=0.092 Sum_probs=98.7
Q ss_pred ccc-cccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC--ceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 461 KLG-HGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN--LVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 461 ~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.++ .|..+.||+....+++.++||..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+++.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 55669999998877788999998654 2345788888888885444 456888888778899999999998884
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC----------------------------------------------- 570 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 570 (804)
... . ....++.++++.|+.||+..
T Consensus 104 --~~~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 --SSH----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp --TSC----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred --cCc----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 1 12356778888888888643
Q ss_pred --------CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 --------RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 --------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+..++|+|++|.|||++.+..++|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876678999999864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.8e-09 Score=95.71 Aligned_cols=83 Identities=20% Similarity=0.368 Sum_probs=64.3
Q ss_pred cEEEEeccccEEEecCCCcEEEEeccCC--ceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
-.|.++.||||+|++. .++|+++... ....++|+++|||||++.++.++|||-.+-
T Consensus 26 ~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~-------------------- 83 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS-------------------- 83 (110)
T ss_dssp CEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------
T ss_pred EEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC--------------------
Confidence 5899999999999987 5899998432 236899999999999998889999985321
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
..|.|.+.++++|... +|+ .+.|.+|+
T Consensus 84 -----~~~~~~~~L~~dGNlv---ly~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -----KQGEYVLILQDDGFGV---IYG--PAIFETSS 110 (110)
T ss_dssp -----SSSCCEEEECTTSCEE---EEC--SEEEESCC
T ss_pred -----CCCCEEEEEcCCccEE---Eec--CCEecCCC
Confidence 2356899999997532 455 37898763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.2e-09 Score=115.68 Aligned_cols=139 Identities=15% Similarity=0.226 Sum_probs=105.4
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEec--CCC--CCHHHHHHHHHHHcCCC--CCCceeeeeEEecC---CeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLE--RPG--SGEREFRAEVCTIGNIQ--HVNLVRLRGFCSEN---SHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E~ 530 (804)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +.++.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 578999999999998765 568888776 322 22356788999988886 45678889888776 458999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC---------------------------------------- 570 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 570 (804)
+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 99988754221 24677888899999999999999731
Q ss_pred ---------------CCCeEecCCCCCcEEecCCCc--eEEeecCCccc
Q 044374 571 ---------------RDCIIHCDIKPENILLDSDYT--AKVSDFGLAKL 602 (804)
Q Consensus 571 ---------------~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~ 602 (804)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.87 E-value=4.9e-09 Score=92.71 Aligned_cols=83 Identities=24% Similarity=0.507 Sum_probs=64.3
Q ss_pred CcEEEEeccccEEEecCCCcEEEEeccCC--ceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 60 QSTLLITEKGKLAIKDSQNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 60 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
.-.|.++.||||||+++ +|+|+... ....++|+++|||||++.++.++|+|-..
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------------- 77 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC--------------------
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc--------------------
Confidence 45899999999999984 79998432 34689999999999999888999976210
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCC
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNW 176 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w 176 (804)
...+.|.+.++++|. ++ +++ .+.|.+++|
T Consensus 78 -----~~~~~~~~~L~~dGN--lv-ly~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 -----SVKGNYAAVVHPDGR--LV-VFG--PSVFKIDPW 106 (109)
T ss_dssp -----CSSSCCEEEEETTTE--EE-EEC--SEEEEECTT
T ss_pred -----CCCcCEEEEEcCCCe--EE-EEe--cCEECCCCc
Confidence 124678999999974 32 444 589999987
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.80 E-value=2.2e-08 Score=87.82 Aligned_cols=82 Identities=26% Similarity=0.493 Sum_probs=61.8
Q ss_pred cEEEEeccccEEEecCCCcEEEEecc---CCceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTN---TEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~---~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
-.|.++.||||||++. +.+||+++. ......+.|+++|||||+|.++.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 4699999999999974 679999973 233467999999999999999999998621
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEec
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWST 173 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~s 173 (804)
....+.|.+.++++|.. + +++. ..|.|
T Consensus 79 ----~~~~~~~~l~L~ddGNl--V-ly~~--~~W~S 105 (105)
T 4h3o_A 79 ----TRGSGNYILILQDDGNV--I-IYGS--DIWST 105 (105)
T ss_dssp ----CCCSSCEEEEECTTSCE--E-EEES--EEEEC
T ss_pred ----CCCCCCEEEEEeCCCeE--E-EECC--cEecC
Confidence 12356789999999753 2 3432 46653
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=3.9e-08 Score=100.11 Aligned_cols=87 Identities=24% Similarity=0.434 Sum_probs=69.0
Q ss_pred cEEEEeccccEEEecCCCcEEEEeccC-CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeeccC
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTNT-EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWKS 139 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~~-~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~s 139 (804)
-.|.|..+|||+|++. +.+||.++.. .....++|+++|||||++.++.+||+|+++.
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~--------------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG--------------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC---------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc---------------------
Confidence 5788999999999986 7899999832 2456799999999999999999999998751
Q ss_pred CCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCCCC
Q 044374 140 LFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNWTG 178 (804)
Q Consensus 140 ~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w~g 178 (804)
++|.|.+.++.+|. +++ ++. +||.+..+..
T Consensus 86 ----~~~~~~~~l~d~Gn--lvl-~~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 86 ----SIGNYVLVLQPDRT--VTI-YGP--GLWDSGTSNK 115 (236)
T ss_dssp ----CSSCCEEEECSSSC--EEE-ECS--EEEECSCCCS
T ss_pred ----cCCcEEEEEeCCCC--EEE-ecC--CEEECCCCCC
Confidence 35678999999975 333 332 8999987753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=3.3e-09 Score=112.66 Aligned_cols=185 Identities=18% Similarity=0.197 Sum_probs=120.6
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCC--ceeeeeEEecCC---eEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVN--LVRLRGFCSENS---HRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~~~ 533 (804)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..++|||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 45888886532 23457889999987773 322 334444433333 34889999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-------------------------------------------- 569 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 569 (804)
..|...... .++..++..++.++++.|+.||+.
T Consensus 101 ~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 988754432 467777888888888888888861
Q ss_pred -----------CCCCeEecCCCCCcEEecC--CCceEEeecCCccccCCCcccccc-------------cccccccccc-
Q 044374 570 -----------CRDCIIHCDIKPENILLDS--DYTAKVSDFGLAKLIGRDFSRVLA-------------TMRGTWGYVA- 622 (804)
Q Consensus 570 -----------~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~-------------~~~gt~~y~a- 622 (804)
....++|+|++|.||+++. +..+.|+||+.+........-... ......+...
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence 1235899999999999998 566889999998753221100000 0000011112
Q ss_pred chhccCCCCCccceEEeehhhHHHhhhCCCCC
Q 044374 623 PEWISGLAITTKADVYSYGMTLLELIGGRRNV 654 (804)
Q Consensus 623 PE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~ 654 (804)
|+..... ....+.|+++.++|++.+|..++
T Consensus 258 ~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 258 PTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 2222111 12358899999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.8e-06 Score=88.23 Aligned_cols=135 Identities=19% Similarity=0.169 Sum_probs=92.4
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCC---CceeeeeEEe-cCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHV---NLVRLRGFCS-ENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~gs 535 (804)
+.++.|....||+. +..++||+... ......+.+|..++..+.+. .+-+++.++. ..+..++|||++++..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899987 45588887532 22345788999999988653 3455666664 4456789999999988
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE---------------------------------------------- 569 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 569 (804)
+...... .++...+..++.++++.|+.||+.
T Consensus 100 l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 8763221 234444555555555555555542
Q ss_pred -----------CCCCeEecCCCCCcEEecC---CCc-eEEeecCCccc
Q 044374 570 -----------CRDCIIHCDIKPENILLDS---DYT-AKVSDFGLAKL 602 (804)
Q Consensus 570 -----------~~~~iiH~Dlkp~NILl~~---~~~-~kl~DfGla~~ 602 (804)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 355 58999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.2e-05 Score=81.22 Aligned_cols=135 Identities=14% Similarity=0.131 Sum_probs=95.7
Q ss_pred ccccccce-eEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCCChh
Q 044374 461 KLGHGGFG-AVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNGALS 537 (804)
Q Consensus 461 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 537 (804)
.+..|..+ .||+.... ++..++||+-... ...++.+|...|+.+. +-.+-++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 44455555 68987654 4567888886532 2456788888887664 334667888898889999999999998887
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 044374 538 LYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC----------------------------------------------- 570 (804)
Q Consensus 538 ~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 570 (804)
+..... ......+..++++.|+-||...
T Consensus 109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 655321 1233455666666667676421
Q ss_pred --------CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 --------RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 --------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=7.4e-06 Score=88.68 Aligned_cols=78 Identities=9% Similarity=0.041 Sum_probs=53.6
Q ss_pred ccc-ccccceeEEEEEeC-------CCcEEEEEEecCCC---C-CHHHHHHHHHHHcCCC-C--CCceeeeeEEecC---
Q 044374 460 EKL-GHGGFGAVFQGELS-------DSTLVAVKRLERPG---S-GEREFRAEVCTIGNIQ-H--VNLVRLRGFCSEN--- 521 (804)
Q Consensus 460 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--- 521 (804)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998764 25678888765322 1 1245677888877774 2 3466777777655
Q ss_pred CeEEEEEEEcCCCChh
Q 044374 522 SHRLLVYDYMRNGALS 537 (804)
Q Consensus 522 ~~~~lV~E~~~~gsL~ 537 (804)
...++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.6e-05 Score=79.48 Aligned_cols=138 Identities=17% Similarity=0.241 Sum_probs=80.1
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCC-----CCCCceeee-e--EEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNI-----QHVNLVRLR-G--FCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~E~~~ 532 (804)
.|+.|..+.||+....++. +++|+.... ..++..|+.++..+ ..|.++... | +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4666778999999876554 889998752 33444455554433 234444311 1 1234567899999999
Q ss_pred CCChh--------------HHHhhC--CC-----------CCCHHHH-------------------------------HH
Q 044374 533 NGALS--------------LYLRKD--GL-----------NLNWDVR-------------------------------FR 554 (804)
Q Consensus 533 ~gsL~--------------~~l~~~--~~-----------~l~~~~~-------------------------------~~ 554 (804)
+..+. ..++.. .. ...|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 111111 00 0122211 01
Q ss_pred HHHHHHHHHHHHhh----------cCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 555 IAVGTARGIAYLHE----------ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 555 i~~~ia~gL~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+...+.+++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11223446667763 1245699999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00014 Score=79.86 Aligned_cols=73 Identities=15% Similarity=0.117 Sum_probs=47.3
Q ss_pred cccccccceeEEEEEeC-CCcEEEEEEecCCC--------CCHHHHHHHHHHHcCCCC--CCce-eeeeEEecCCeEEEE
Q 044374 460 EKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--------SGEREFRAEVCTIGNIQH--VNLV-RLRGFCSENSHRLLV 527 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~lV 527 (804)
+.||.|..+.||++... +++.++||...... .....+..|..++..+.. +..+ +++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57999999999999764 46789999864321 123456778888776632 3333 45543 33456899
Q ss_pred EEEcCCC
Q 044374 528 YDYMRNG 534 (804)
Q Consensus 528 ~E~~~~g 534 (804)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00038 Score=73.46 Aligned_cols=135 Identities=21% Similarity=0.229 Sum_probs=90.0
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC---CCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ---HVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
+.|+.|....+|+... ++..++||+.... ....+..|...|+.+. ...+.+++.++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4689999999999986 4567888987642 3566888988887773 35677888888878889999999998865
Q ss_pred hH-----------HHhhCCC---------------------CCCHHHHH---HHHH--H--------------HHHH-HH
Q 044374 537 SL-----------YLRKDGL---------------------NLNWDVRF---RIAV--G--------------TARG-IA 564 (804)
Q Consensus 537 ~~-----------~l~~~~~---------------------~l~~~~~~---~i~~--~--------------ia~g-L~ 564 (804)
.. .|+.... .-+|...+ ++.. + +.+. ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 01343221 1111 1 1111 22
Q ss_pred HHhh-cCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 565 YLHE-ECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 565 yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
.|.. ..++.++|+|+.+.||+++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3432 2346799999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00076 Score=70.37 Aligned_cols=73 Identities=22% Similarity=0.295 Sum_probs=52.7
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCC-CCHHHHHHHHHHHcCCCC---CCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPG-SGEREFRAEVCTIGNIQH---VNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
+.+|.|..+.||+.++.+|+.|.||+..... .....|..|...|+.+.- -.+.+++++. ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 5789999999999999999999999876432 334567889888876642 1234444432 2478999998765
Q ss_pred h
Q 044374 536 L 536 (804)
Q Consensus 536 L 536 (804)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0012 Score=72.94 Aligned_cols=80 Identities=14% Similarity=0.057 Sum_probs=48.9
Q ss_pred CCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccccccccccccchhccCC---CCCccceEEeehhhHHHh
Q 044374 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL---AITTKADVYSYGMTLLEL 647 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~el 647 (804)
...++|+|++|.|||++.++ ++|+||+.+........-......-...|.+|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45699999999999998876 99999999875322111000000112456777665321 112234555777778877
Q ss_pred hhCC
Q 044374 648 IGGR 651 (804)
Q Consensus 648 ltg~ 651 (804)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0011 Score=69.66 Aligned_cols=136 Identities=14% Similarity=0.104 Sum_probs=72.6
Q ss_pred ccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEEc-CCCCh
Q 044374 459 SEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDYM-RNGAL 536 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gsL 536 (804)
.+.|+.|....+|+. ..+++|+............+|+.+++.+....+ -+++++. .+.-++|+||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 357888999999998 458888876432111123457666665532222 3445443 33457899999 55444
Q ss_pred hHH------------------HhhCCCCC----C-HHHHHHHHH--------------HHHHHH----HHHhh-cCCCCe
Q 044374 537 SLY------------------LRKDGLNL----N-WDVRFRIAV--------------GTARGI----AYLHE-ECRDCI 574 (804)
Q Consensus 537 ~~~------------------l~~~~~~l----~-~~~~~~i~~--------------~ia~gL----~yLH~-~~~~~i 574 (804)
... ++.....+ + +.....+.. .+.+.+ ..|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 310 11111101 1 011111100 011111 11111 123458
Q ss_pred EecCCCCCcEEecCCCceEEeecCCccc
Q 044374 575 IHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 575 iH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5667789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0043 Score=65.76 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=81.5
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC--CCceeeeeE-----EecCCeEEEEEEEcCC
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH--VNLVRLRGF-----CSENSHRLLVYDYMRN 533 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~E~~~~ 533 (804)
.|+ |....||+....+++.+++|...........+..|..++..+.. -.+.+++.. ....+..++|||++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 455 77889999877777779999987444456677778877766632 123334332 1224566889999988
Q ss_pred CChh-----H------H---Hhh--CC------CCCCHHHH----HHH---------------HHHHHHHHHHHhhc---
Q 044374 534 GALS-----L------Y---LRK--DG------LNLNWDVR----FRI---------------AVGTARGIAYLHEE--- 569 (804)
Q Consensus 534 gsL~-----~------~---l~~--~~------~~l~~~~~----~~i---------------~~~ia~gL~yLH~~--- 569 (804)
..+. . . ++. .. ...++... ..+ ...+.+.++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 1 1 111 00 01121110 000 11111223333221
Q ss_pred -CCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 570 -CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 570 -~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0021 Score=69.61 Aligned_cols=139 Identities=17% Similarity=0.141 Sum_probs=81.4
Q ss_pred cccccccceeEEEEEeCC--------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC-ceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD--------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-LVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~ 530 (804)
+.|..|-...+|+....+ ++.+++|+..........+.+|..+++.+.-.. .-++++++.. .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 457778888899988752 467899986443334566778988887774222 2456666544 299999
Q ss_pred cCCCChhHH-----------------HhhCC----CCCC--HHHHHHHHHHHH-------------------HHHHHHh-
Q 044374 531 MRNGALSLY-----------------LRKDG----LNLN--WDVRFRIAVGTA-------------------RGIAYLH- 567 (804)
Q Consensus 531 ~~~gsL~~~-----------------l~~~~----~~l~--~~~~~~i~~~ia-------------------~gL~yLH- 567 (804)
+++..|..- |+... .... +.++.++..++. +.+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998665311 11111 1111 334444443332 1223332
Q ss_pred ---hc-CCCCeEecCCCCCcEEecCC----CceEEeecCCccc
Q 044374 568 ---EE-CRDCIIHCDIKPENILLDSD----YTAKVSDFGLAKL 602 (804)
Q Consensus 568 ---~~-~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~ 602 (804)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23459999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0019 Score=71.45 Aligned_cols=72 Identities=21% Similarity=0.261 Sum_probs=49.0
Q ss_pred cccccccceeEEEEEeCC--------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD--------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 530 (804)
+.|+.|....||+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.. .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 467888889999998753 467999988542 222556678888887753333 456666543 389999
Q ss_pred cCCCCh
Q 044374 531 MRNGAL 536 (804)
Q Consensus 531 ~~~gsL 536 (804)
+++..|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0094 Score=63.34 Aligned_cols=33 Identities=30% Similarity=0.324 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCcEEecCC----CceEEeecCCcccc
Q 044374 571 RDCIIHCDIKPENILLDSD----YTAKVSDFGLAKLI 603 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~ 603 (804)
...++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4569999999999999875 68999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0021 Score=67.99 Aligned_cols=141 Identities=13% Similarity=0.183 Sum_probs=78.5
Q ss_pred cccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----CCCceeee-e--EEecCCeEEEEEEEc
Q 044374 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----HVNLVRLR-G--FCSENSHRLLVYDYM 531 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~E~~ 531 (804)
+.|+.|....+|+....++ .+++|..... ....++..|+.++..+. -|.++... | +....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3567788899999987666 4888988652 12234555666665543 33333211 1 112235678999999
Q ss_pred CCCChhH--------------HHhhC--C--CC-------CCHHHHHH------------HHHHHHHHHHHHhhc----C
Q 044374 532 RNGALSL--------------YLRKD--G--LN-------LNWDVRFR------------IAVGTARGIAYLHEE----C 570 (804)
Q Consensus 532 ~~gsL~~--------------~l~~~--~--~~-------l~~~~~~~------------i~~~ia~gL~yLH~~----~ 570 (804)
++..+.. .++.. . .. ..|...+. +...+.+.++.|+.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 11111 0 00 11222110 011234455566532 2
Q ss_pred CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34599999999999999876668999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0069 Score=67.40 Aligned_cols=73 Identities=10% Similarity=0.010 Sum_probs=46.3
Q ss_pred cccccccceeEEEEEeCC-CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 460 EKLGHGGFGAVFQGELSD-STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
+.|+.|-...+|+....+ +..+++|+........-+..+|..++..+...++ .++++++. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 468888889999998865 4678888875322111122578888877764444 45677663 2 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0021 Score=69.55 Aligned_cols=73 Identities=12% Similarity=0.095 Sum_probs=42.0
Q ss_pred cccccccceeEEEEEeCC---------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD---------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 529 (804)
+.|+.|....+|+....+ ++.+++|+.........+...|..++..+...++ .++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 467788888999987754 2578888875422111123567777766643333 3555543 2 268999
Q ss_pred EcCCCCh
Q 044374 530 YMRNGAL 536 (804)
Q Consensus 530 ~~~~gsL 536 (804)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0042 Score=60.74 Aligned_cols=100 Identities=12% Similarity=0.014 Sum_probs=67.6
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
.-+|.++|...+.++++++++.++.|.+.+|.-+-... . -..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 44899999998889999999999999999987762211 1 11233457999999999988764 1111
Q ss_pred ccccccccccchhccCCCCCccceEEeehhhHHHhhh
Q 044374 613 TMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG 649 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt 649 (804)
.....+.|||... ...+.+.=|||+|++||..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123567888763 345678899999999999885
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.64 E-value=0.044 Score=58.33 Aligned_cols=32 Identities=22% Similarity=0.403 Sum_probs=28.1
Q ss_pred CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.69 E-value=0.039 Score=60.51 Aligned_cols=73 Identities=7% Similarity=0.073 Sum_probs=45.1
Q ss_pred cccccccceeEEEEEeCC--------CcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCC-ceeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD--------STLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-LVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~ 530 (804)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+...+ ..++++.+. -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 357778888999998763 577888886442221122356777776664222 334554332 2789999
Q ss_pred cCCCCh
Q 044374 531 MRNGAL 536 (804)
Q Consensus 531 ~~~gsL 536 (804)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.67 E-value=0.22 Score=34.90 Aligned_cols=29 Identities=21% Similarity=0.586 Sum_probs=14.4
Q ss_pred eeehhhhhHHHHHHHHHHHHHHhhhcccc
Q 044374 401 LVAGIVGSIAALVLAAVMLMILRKKRKKR 429 (804)
Q Consensus 401 iv~~i~~~~~~l~~~~~~~~~~rr~rk~~ 429 (804)
++.++++.++++++++++++++|||+.++
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~~ 42 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQKI 42 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSCC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhhc
Confidence 44455554444444445555555555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.08 E-value=0.19 Score=54.64 Aligned_cols=29 Identities=28% Similarity=0.378 Sum_probs=25.1
Q ss_pred eEecCCCCCcEEe------cCCCceEEeecCCccc
Q 044374 574 IIHCDIKPENILL------DSDYTAKVSDFGLAKL 602 (804)
Q Consensus 574 iiH~Dlkp~NILl------~~~~~~kl~DfGla~~ 602 (804)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.86 E-value=0.2 Score=35.20 Aligned_cols=30 Identities=23% Similarity=0.500 Sum_probs=15.8
Q ss_pred EeeehhhhhHHHHH-HHHHHHHHHhhhcccc
Q 044374 400 VLVAGIVGSIAALV-LAAVMLMILRKKRKKR 429 (804)
Q Consensus 400 ~iv~~i~~~~~~l~-~~~~~~~~~rr~rk~~ 429 (804)
.|+.++++++++++ +++++++++|||++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 35556666555544 4444455566555443
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.12 E-value=3.7 Score=41.68 Aligned_cols=64 Identities=9% Similarity=0.100 Sum_probs=37.5
Q ss_pred CCcEEEecCCCCCCCC----CCCcEEEEeccc-cEEEecCC-CcEEEEeccC-------CceeEEEEccCCcEEEec
Q 044374 42 TPTYVWVANREKSVAD----VTQSTLLITEKG-KLAIKDSQ-NSIIWQSTNT-------EKATDMYLLETGNLVLLS 105 (804)
Q Consensus 42 ~~~~vW~anr~~p~~~----~~~~~l~~~~~g-~l~l~~~~-~~~~w~~~~~-------~~~~~~~l~~~gnlv~~~ 105 (804)
...++|...+..+... ..+..+....++ .++..|.+ |.++|.-... ...+.+.++.+||+++.+
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 3677888775432221 113344444433 47777877 8888886421 114567778888888865
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.71 E-value=0.66 Score=32.55 Aligned_cols=29 Identities=28% Similarity=0.582 Sum_probs=15.2
Q ss_pred eeehhhhhHHHHH-HHHHHHHHHhhhcccc
Q 044374 401 LVAGIVGSIAALV-LAAVMLMILRKKRKKR 429 (804)
Q Consensus 401 iv~~i~~~~~~l~-~~~~~~~~~rr~rk~~ 429 (804)
|+.++++.+++++ +++++++++|||++++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 5556666555543 4444455555555443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.44 E-value=2.2 Score=41.69 Aligned_cols=84 Identities=12% Similarity=0.080 Sum_probs=62.3
Q ss_pred CCCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCcEE
Q 044374 507 QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIA-YLHEECRDCIIHCDIKPENIL 585 (804)
Q Consensus 507 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiH~Dlkp~NIL 585 (804)
.||++ -..+-.+.+...+.|+.-+++.=...++ .++...+++++..|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 67887 4444566777777777764543333443 4778899999999888766 5654 678889999999
Q ss_pred ecCCCceEEeecCCcc
Q 044374 586 LDSDYTAKVSDFGLAK 601 (804)
Q Consensus 586 l~~~~~~kl~DfGla~ 601 (804)
++.++.++|.-.|+-.
T Consensus 117 f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE 132 (219)
T ss_dssp ECTTCCEEESCCEETT
T ss_pred EeCCCcEEEEEcCCcc
Confidence 9999999998887654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=82.19 E-value=7.6 Score=39.27 Aligned_cols=41 Identities=5% Similarity=0.090 Sum_probs=29.2
Q ss_pred eccccEEEecCCCcEEEEeccCCceeEEEEccCCcEEEecC
Q 044374 66 TEKGKLAIKDSQNSIIWQSTNTEKATDMYLLETGNLVLLSS 106 (804)
Q Consensus 66 ~~~g~l~l~~~~~~~~w~~~~~~~~~~~~l~~~gnlv~~~~ 106 (804)
..+|.++..|.+|..+|.-........+..+.+||+++.+.
T Consensus 143 ~~~~~v~~~d~~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~ 183 (276)
T 3no2_A 143 FATSEVREIAPNGQLLNSVKLSGTPFSSAFLDNGDCLVACG 183 (276)
T ss_dssp TTTTEEEEECTTSCEEEEEECSSCCCEEEECTTSCEEEECB
T ss_pred cCCCEEEEECCCCCEEEEEECCCCccceeEcCCCCEEEEeC
Confidence 35677888898899999886443344456677888887653
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=81.65 E-value=0.57 Score=37.93 Aligned_cols=34 Identities=26% Similarity=0.503 Sum_probs=30.0
Q ss_pred ccChhhhHHhhcccCCccceeecccCcccccccc
Q 044374 330 SAGRSICERSCLANCSCIGLYHDVRTNLCKNLYG 363 (804)
Q Consensus 330 ~~~~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~ 363 (804)
..++++|++.|+.+=.|.+|.|......|++..+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 5689999999999999999999888888987643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.22 E-value=1.9 Score=42.00 Aligned_cols=84 Identities=10% Similarity=0.123 Sum_probs=61.6
Q ss_pred CCCCceeeeeEEecCCeEEEEEEEcCCC-ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEE
Q 044374 507 QHVNLVRLRGFCSENSHRLLVYDYMRNG-ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENIL 585 (804)
Q Consensus 507 ~H~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NIL 585 (804)
.||+++.. .+-.+.+...+.|+.-+.+ ++.. ++ .++...+++++..|+....+++. -+|--|.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 68888866 4556666666666654433 2222 33 46788899999999988866654 578899999999
Q ss_pred ecCCCceEEeecCCcc
Q 044374 586 LDSDYTAKVSDFGLAK 601 (804)
Q Consensus 586 l~~~~~~kl~DfGla~ 601 (804)
++.++.++|.-.|+-.
T Consensus 112 f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQN 127 (215)
T ss_dssp ECTTSCEEESCCEETT
T ss_pred EcCCCCEEEEEccCcc
Confidence 9999999998877654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.02 E-value=0.25 Score=54.81 Aligned_cols=60 Identities=10% Similarity=0.039 Sum_probs=19.0
Q ss_pred ccccccccccceeEEEEEeCC-CcEEEE------EEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEe
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-STLVAV------KRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCS 519 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 519 (804)
.+.++|| ||.||+|.+.. ..+||| |..+.. ......|.+|..++.+++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556787 99999998864 367888 766542 223346888999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 804 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-12 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 9e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 7e-62
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 36/290 (12%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRL 514
+++G G FG V++G+ VAVK L + F+ EV + +HVN++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G+ + +V + +L +L IA TA+G+ YLH + I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLATMRGTWGYVAPEWISGL---A 630
IH D+K NI L D T K+ DFGLA + R S + G+ ++APE I
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 631 ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690
+ ++DVY++G+ L EL+ G+ P S N ++
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQL----PYSNIN---------------NRDQIIFMVGRGY 226
Query: 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
+ ++ + + + + C++ + RP ++ +E +
Sbjct: 227 LSPDLSKV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-61
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 32/284 (11%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
F +++G G FG V G + VA+K + E +F E + + H LV+L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C E + LV+++M +G LS YLR + + + G + C+IH
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHR 125
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D+ N L+ + KVSDFG+ + + D + + +PE S ++K+DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 638 YSYGMTLLELIGGRRNVEAPASGRN-ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696
+S+G+ + E+ + P R+ + + G + + P A+ + +
Sbjct: 186 WSFGVLMWEVFSEGK---IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ--------- 233
Query: 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
+ C ++ E RP +++ L + E
Sbjct: 234 ----------------IMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-60
Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 30/279 (10%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
F ++LG G FG V G+ VA+K ++ E EF E + N+ H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
C++ ++ +YM NG L YLR+ + + YL +H
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
D+ N L++ KVSDFGL++ + D + + PE + ++K+D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 638 YSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDR 697
+++G+ + E+ + P+ E A +
Sbjct: 185 WAFGVLMWEIYSLGK-------------------------MPYERFTNSE--TAEHIAQG 217
Query: 698 LGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
L +E+V + C + + RPT ++ +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-60
Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 32/280 (11%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
E+LG G FG V+ G + T VAVK L++ F AE + +QH LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 518 CSENSHRLLVYDYMRNGALSLYLRK-DGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
++ ++ +YM NG+L +L+ G+ L + +A A G+A++ E IH
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D++ NIL+ + K++DFGLA+LI + + + APE I+ T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696
V+S+G+ L E++ R P G P + + G D+
Sbjct: 193 VWSFGILLTEIVTHGR---IPYPGMT---------------NPEVIQNLERGYRMVRPDN 234
Query: 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
E + + C ++ E RPT + +LE
Sbjct: 235 ---------CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-60
Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 30/300 (10%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCS 519
E +G G FG V++G+ VAVK AE+ ++H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 520 EN----SHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDC-- 573
++ + LV DY +G+L YL + + + ++A+ TA G+A+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT--VEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 574 ---IIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD---FSRVLATMRGTWGYVAPEWIS 627
I H D+K +NIL+ + T ++D GLA GT Y+APE +
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 628 G------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWA 681
+AD+Y+ G+ E+ + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--------LVPSDPS 237
Query: 682 ARQIIEGNVAAVVDDRLGGAYKVEEAER-VALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
++ + + + ++ EA R +A + C N R T + K L + +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 4e-59
Identities = 69/316 (21%), Positives = 131/316 (41%), Gaps = 51/316 (16%)
Query: 446 FSYKELHTVTRGFS-----------EKLGHGGFGAVFQGELSDS----TLVAVKRLERPG 490
F++++ + R F+ + +G G FG V G L VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 491 S--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLN 548
+ R+F +E +G H N++ L G ++++ +++ ++M NG+L +LR++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 549 WDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608
+ G A G+ YL +H D+ NIL++S+ KVSDFGL++ + D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 609 RVLAT----MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN 664
T + + APE I T+ +DV+SYG+ + E++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 665 IGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEM 724
P+ + V ++ ++ + + + C Q +
Sbjct: 232 -------------RPYWDMTNQD--VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 725 RPTMGTVVKMLEGVLE 740
RP G +V L+ ++
Sbjct: 277 RPKFGQIVNTLDKMIR 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 32/290 (11%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
KLG G FG V+ G + +T VA+K L+ F E + ++H LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 518 CSENSHRLLVYDYMRNGALSLY-LRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
SE +V +YM G+L + + G L +A A G+AY+ R +H
Sbjct: 81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D++ NIL+ + KV+DFGLA+LI + + + APE T K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696
V+S+G+ L EL R +P R++++ V+
Sbjct: 197 VWSFGILLTELTTKGRV----------------------PYPGMVNREVLD-----QVER 229
Query: 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPP 746
E E + + C + E RPT + LE T P
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 58/287 (20%), Positives = 116/287 (40%), Gaps = 24/287 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVRLRG 516
+LG G G VF+ ++A K + + E+ + +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+ + ++M G+L L+K G + + ++++ +G+ YL E+ + I+H
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMH 128
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+KP NIL++S K+ DFG++ + + + GT Y++PE + G + ++D
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSVQSD 185
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW-----------AARQI 685
++S G++L+E+ GR + P + + G GD PP
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 686 IEGNVAAVVDDRLGGAYKVEEAERVALVAI----WCIQDNEEMRPTM 728
+ ++D + + +L C+ N R +
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 5e-57
Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 32/285 (11%)
Query: 458 FSEKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
KLG G +G V++G VAVK L+ EF E + I+H NLV+L G
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 517 FCSENSHRLLVYDYMRNGALSLYL-RKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
C+ ++ ++M G L YL + ++ V +A + + YL ++ I
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+ N L+ ++ KV+DFGL++L+ D A + + APE ++ + K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695
DV+++G+ L E+ +P Q+ E +++
Sbjct: 198 DVWAFGVLLWEIATYG----------------------MSPYPGIDLSQVYE-----LLE 230
Query: 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
E+V + C Q N RP+ + + E + +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 1e-55
Identities = 69/315 (21%), Positives = 122/315 (38%), Gaps = 62/315 (19%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHV 509
+ +G G FG VFQ T+VAVK L+ S + +F+ E + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN----------------------- 546
N+V+L G C+ L+++YM G L+ +LR +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 547 LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI-GR 605
L+ + IA A G+AYL E +H D+ N L+ + K++DFGL++ I
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 606 DFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI 665
D+ + ++ PE I TT++DV++YG+ L E+ P G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMA--- 247
Query: 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR 725
+ +GN+ A ++ + + C R
Sbjct: 248 ------------HEEVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPADR 286
Query: 726 PTMGTVVKMLEGVLE 740
P+ ++ ++L+ + E
Sbjct: 287 PSFCSIHRILQRMCE 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 4e-54
Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 458 FSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
+ +G G FG V G+ VAVK + + + + F AE + ++H NLV+L G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRG-NKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 518 CSENSHRL-LVYDYMRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRDCII 575
E L +V +YM G+L YLR G + L D + ++ + YL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 125
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+ N+L+ D AKVSDFGL K T + + APE + +TK+
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKS 181
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695
DV+S+G+ L E+ R P ++ +G D
Sbjct: 182 DVWSFGILLWEIYSFGR---VPYPRIP---------------LKDVVPRVEKGYKMDAPD 223
Query: 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738
Y+ V C + MRP+ + + LE +
Sbjct: 224 GCPPAVYE---------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 38/283 (13%)
Query: 461 KLGHGGFGAVFQGEL---SDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVRLR 515
+LG G FG+V QG VA+K L++ E E + + + +VRL
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
G C + +LV + G L +L + + + G+ YL E+ +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 131
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRD--FSRVLATMRGTWGYVAPEWISGLAITT 633
H D+ N+LL + + AK+SDFGL+K +G D + + + + APE I+ ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 634 KADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693
++DV+SYG+T+ E + + P P I +G
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---KPYKKMK---------------GPEVMAFIEQGKRMEC 233
Query: 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
+ + + C E RP TV + +
Sbjct: 234 PPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 2e-53
Identities = 69/303 (22%), Positives = 130/303 (42%), Gaps = 41/303 (13%)
Query: 458 FSEKLGHGGFGAVFQGELSDST-----LVAVKRLERPGS--GEREFRAEVCTIGNIQHVN 510
+ +G G FG V++G L S+ VA+K L+ + +F E +G H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 511 LVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
++RL G S+ +++ +YM NGAL +LR+ + + G A G+ YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT--MRGTWGYVAPEWISG 628
+H D+ NIL++S+ KVSDFGL++++ D T + + APE IS
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
T+ +DV+S+G+ + E++ + + ++++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGE----------------------RPYWELSNHEVMK- 224
Query: 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPR 748
++D ++ + + + C Q RP +V +L+ ++ AP +
Sbjct: 225 ----AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR--APDSLK 278
Query: 749 LIQ 751
+
Sbjct: 279 TLA 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-53
Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 458 FSEKLGHGGFGAVFQGELSDS----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNL 511
F+E +G G FG V+ G L D+ AVK L R +F E + + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 512 VRLRGFCSE-NSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+ L G C L+V YM++G L ++R + N + A+G +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---MKFLA 147
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLI---GRDFSRVLATMRGTWGYVAPEWIS 627
+H D+ N +LD +T KV+DFGLA+ + D + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 628 GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687
TTK+DV+S+G+ L EL+ PP+ +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-------------------------PPYPDVNTFD 242
Query: 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
V + RL + + V + C EMRP+ +V + +
Sbjct: 243 ITVYLLQGRRLLQPEYC--PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (459), Expect = 9e-52
Identities = 70/282 (24%), Positives = 107/282 (37%), Gaps = 44/282 (15%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRL 514
++GHG FGAV+ + +S +VA+K++ G E EV + ++H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
RG LV +Y A L L + G +G+AYLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHN---M 136
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL---AI 631
IH D+K NILL K+ DFG A ++ + GT ++APE I +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFVGTPYWMAPEVILAMDEGQY 191
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691
K DV+S G+T +EL + P N A I +
Sbjct: 192 DGKVDVWSLGITCIELAERKP----PLFNMN---------------AMSALYHIAQNESP 232
Query: 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
A+ E C+Q + RPT ++K
Sbjct: 233 ALQSGHWS-----EYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 75/352 (21%), Positives = 132/352 (37%), Gaps = 68/352 (19%)
Query: 437 VFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGELSDSTL---VAVKRLERPGS-- 491
++PVL+ F + +G G FG V + + L A+KR++ S
Sbjct: 3 IYPVLDWNDIK----------FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 52
Query: 492 GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN---- 546
R+F E+ + + H N++ L G C + L +Y +G L +LRK +
Sbjct: 53 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 547 -----------LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595
L+ A ARG+ YL ++ IH D+ NIL+ +Y AK++
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 169
Query: 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVE 655
DFGL++ + R ++A E ++ TT +DV+SYG+ L E++
Sbjct: 170 DFGLSRGQEVYVKKT--MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--- 224
Query: 656 APASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAI 715
P+ E + + + + V +
Sbjct: 225 ----------------------TPYCGMTCAE--LYEKLPQGYRLEKPLNCDDEVYDLMR 260
Query: 716 WCIQDNEEMRPTMGTVVKMLEGVLEVTAPPPPRLIQALVSGESYHGVRKDSS 767
C ++ RP+ ++ L +LE + L +Y G+ D S
Sbjct: 261 QCWREKPYERPSFAQILVSLNRMLE---ERKTYVNTTLYEKFTYAGI--DCS 307
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-51
Identities = 68/310 (21%), Positives = 115/310 (37%), Gaps = 56/310 (18%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRL--ERPGSGEREFRAEVCTIGNI-QH 508
F + LG G FG V + + VAVK L + +E+ + + H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK-----------------DGLNLNWDV 551
+N+V L G C+ L++ +Y G L +LR+ D L L+ +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 552 RFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611
+ A+G+A+L + IH D+ NILL K+ DFGLA+ I D + V+
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 612 ATM-RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE 670
R ++APE I T ++DV+SYG+ L EL
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS------------------ 245
Query: 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730
++ ++ + + + C + RPT
Sbjct: 246 --------SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 731 VVKMLEGVLE 740
+V+++E +
Sbjct: 298 IVQLIEKQIS 307
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 41/285 (14%)
Query: 458 FSEKLGHGGFGAVFQGELSDST-LVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVR 513
F ++G G F V++G +++T VA L+ S + F+ E + +QH N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 514 LRGFC----SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+LV + M +G L YL++ + + V +G+ +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTR 131
Query: 570 CRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
IIH D+K +NI + + K+ D GLA L F++ + GT ++APE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 187
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
DVY++GM +LE+ P++ Q
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSE--------------------------YPYSECQNAAQ 220
Query: 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
V ++ V + CI+ N++ R ++ ++
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 429 RKDVDEEDVFPVLNLKVFSYKELHTVTRGFSEKLGHGGFGAVFQGE-LSDSTLVAVKRLE 487
+D++ ED + ++ +LG G FG V++ + S L A K ++
Sbjct: 5 TRDLNPEDFWEII------------------GELGDGAFGKVYKAQNKETSVLAAAKVID 46
Query: 488 RPGSGERE-FRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN 546
E E + E+ + + H N+V+L ++ ++ ++ GA+ + +
Sbjct: 47 TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 106
Query: 547 LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606
L + T + YLH+ IIH D+K NIL D K++DFG++ R
Sbjct: 107 LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
Query: 607 FSRVLATMRGTWGYVAPEWI-----SGLAITTKADVYSYGMTLLELIGGRR 652
R + GT ++APE + KADV+S G+TL+E+
Sbjct: 164 IQR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 65/284 (22%), Positives = 113/284 (39%), Gaps = 40/284 (14%)
Query: 461 KLGHGGFGAVFQGELSDS---TLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRL 514
+LG G FG V +G VAVK L+ + E AE + + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G C E +LV + G L+ YL+++ ++ + + G+ YL E
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT--MRGTWGYVAPEWISGLAIT 632
+H D+ N+LL + + AK+SDFGL+K + D + A + + APE I+ +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 633 TKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692
+K+DV+S+G+ + E + P+ + E V A
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ-------------------------KPYRGMKGSE--VTA 221
Query: 693 VVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
+++ + + C + E RP V L
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 11/247 (4%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRL--ERPGSGEREFRAEVCTIGNIQHVNLVRLRG 516
+ LG G +G V VAVK + +R + E+C + H N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
E + + L +Y G L + D + R G+ YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG---ITH 126
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAI-TTK 634
DIKPEN+LLD K+SDFGLA + + R+L M GT YVAPE +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 635 ADVYSYGMTLLELIGGRRNVEAPASGRN--ANIGGGGEHGDKWFFPPWAARQIIEGNVAA 692
DV+S G+ L ++ G + P+ ++ + + W A ++ +
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246
Query: 693 VVDDRLG 699
R+
Sbjct: 247 NPSARIT 253
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 40/285 (14%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE---FRAEVCTIGNIQHVNLVRLR 515
+G G +G + SD ++ K L+ E E +EV + ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 516 GFCSENSHRLL--VYDYMRNGALSLYLRKDGLN---LNWDVRFRIAVGTARGIAYLHE-- 568
+ ++ L V +Y G L+ + K L+ + R+ + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 569 ECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
+ ++H D+KP N+ LD K+ DFGLA+++ D + GT Y++PE ++
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
++ K+D++S G L EL P + + A +I EG
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMP----PFTAFS---------------QKELAGKIREG 229
Query: 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
+ +E + + + RP++ +++
Sbjct: 230 KFRRIPYRY------SDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 70/311 (22%), Positives = 114/311 (36%), Gaps = 61/311 (19%)
Query: 458 FSEKLGHGGFGAVFQGELSDS------TLVAVKRL-ERPGSGERE-FRAEVCTIGNI-QH 508
F + LG G FG V VAVK L E+ S ERE +E+ + + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK----------------------DGLN 546
N+V L G C+ + L+++Y G L YLR D
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 547 LNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606
L ++ A A+G+ +L + +H D+ N+L+ K+ DFGLA+ I D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 607 FSRVL-ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI 665
+ V+ R ++APE + T K+DV+SYG+ L E+
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------------- 264
Query: 666 GGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMR 725
P+ + N ++ + E + ++ C + R
Sbjct: 265 ------------NPYPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
Query: 726 PTMGTVVKMLE 736
P+ + L
Sbjct: 312 PSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-49
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 458 FSEKLGHGGFGAVFQGELSDS-TLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLV 512
LG G FG V+ S ++A+K L + E + R EV +++H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
RL G+ + + L+ +Y G + L+K + A ++Y H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR-- 126
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAIT 632
+IH DIKPEN+LL S K++DFG + T+ GT Y+ PE I G
Sbjct: 127 -VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHD 182
Query: 633 TKADVYSYGMTLLELIGGRR 652
K D++S G+ E + G+
Sbjct: 183 EKVDLWSLGVLCYEFLVGKP 202
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 9e-49
Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 40/287 (13%)
Query: 460 EKLGHGGFGAVFQGELSDST----LVAVKRLERPGSGE----REFRAEVCTIGNIQHVNL 511
EKLG G FG V +GE + VAVK L+ + +F EV + ++ H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+RL G ++ V + G+L LRK + R AV A G+ YL +
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR- 131
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLI--GRDFSRVLATMRGTWGYVAPEWISGL 629
IH D+ N+LL + K+ DFGL + + D + + + + APE +
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 630 AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689
+ +D + +G+TL E+ + PW +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ-------------------------EPWIGLNGSQ-I 223
Query: 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
+ + + + + + V + C E RPT + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 62/285 (21%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 460 EKLGHGGFGAVFQGELSDS-----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLV 512
+ LG G FG V++G VA+K L S +E E + ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
RL G C ++ +L + M G L Y+R+ N+ V A+G+ YL +
Sbjct: 75 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-- 131
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT-MRGTWGYVAPEWISGLAI 631
++H D+ N+L+ + K++DFGLAKL+G + A + ++A E I
Sbjct: 132 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691
T ++DV+SYG+T+ EL+ P+ E ++
Sbjct: 191 THQSDVWSYGVTVWELMTFGS-------------------------KPYDGIPASE--IS 223
Query: 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
++++ V ++ + C + + RP ++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 39/290 (13%)
Query: 458 FSEKLGHGGFGAVFQGELSDS----TLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNL 511
+G G FG V QG VA+K + S +F E T+ H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
V+L G +EN ++ + G L +L+ +L+ A + +AYL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
+H DI N+L+ S+ K+ DFGL++ + + + ++APE I+
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRN-ANIGGGGEHGDKWFFPPWAARQIIEGNV 690
T+ +DV+ +G+ + E++ P G ++ G E+G++ PP +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS--- 240
Query: 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
+ C + RP + L +LE
Sbjct: 241 ----------------------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-47
Identities = 49/195 (25%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGF 517
EK+G G G V+ +++ VA++++ ++E E+ + ++ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
+V +Y+ G+L+ + + ++ + + + +LH +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 578 DIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADV 637
DIK +NILL D + K++DFG I + S+ +TM GT ++APE ++ A K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 638 YSYGMTLLELIGGRR 652
+S G+ +E+I G
Sbjct: 200 WSLGIMAIEMIEGEP 214
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 48/301 (15%)
Query: 458 FSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHV 509
S +LG G FG V++G T VA+K + S EF E +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTA 560
++VRL G S+ L++ + M G L YLR + ++A A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 561 RGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR-DFSRVLATMRGTWG 619
G+AYL+ +H D+ N ++ D+T K+ DFG+ + I D+ R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 620 YVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPP 679
+++PE + TT +DV+S+G+ L E+ P G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---QPYQGLS---------------NE 242
Query: 680 WAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739
R ++EG + D+ + + + C Q N +MRP+ ++ ++ +
Sbjct: 243 QVLRFVMEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
Query: 740 E 740
E
Sbjct: 294 E 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 5e-46
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGF 517
E+LG G FG V + E + A K + P ++E R E+ T+ ++H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
+++ +++Y++M G L + + ++ D +G+ ++HE +H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 148
Query: 578 DIKPENILLDSDY--TAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
D+KPENI+ + K+ DFGL + S GT + APE G +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEGKPVGYYT 206
Query: 636 DVYSYGMTLLELIGGRR 652
D++S G+ L+ G
Sbjct: 207 DMWSVGVLSYILLSGLS 223
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 9e-45
Identities = 65/313 (20%), Positives = 118/313 (37%), Gaps = 57/313 (18%)
Query: 458 FSEKLGHGGFGAVFQGEL--------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI- 506
+ LG G FG V E + T VAVK L+ + + +E+ + I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 507 QHVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLN---------------LNWDV 551
+H N++ L G C+++ ++ +Y G L YL+ L+
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 552 RFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS-RV 610
A ARG+ YL + IH D+ N+L+ D K++DFGLA+ I +
Sbjct: 137 LVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGE 670
R ++APE + T ++DV+S+G+ L E+
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------------------ 235
Query: 671 HGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGT 730
P+ + E + ++ + + ++ C RPT
Sbjct: 236 -------SPYPGVPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 731 VVKMLEGVLEVTA 743
+V+ L+ ++ +T+
Sbjct: 287 LVEDLDRIVALTS 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 42/196 (21%), Positives = 78/196 (39%), Gaps = 8/196 (4%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
E LG G FG V + E S K ++ G+ + + E+ + +H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
+++++++ + + LN + +LH I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 579 IKPENILLDSD--YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
I+PENI+ + T K+ +FG A+ + + Y APE ++T D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 637 VYSYGMTLLELIGGRR 652
++S G + L+ G
Sbjct: 186 MWSLGTLVYVLLSGIN 201
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 5e-44
Identities = 44/197 (22%), Positives = 86/197 (43%), Gaps = 9/197 (4%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGERE-FRAEVCTIGNIQHVNLVRLRGF 517
E+LG G FG V + E + + K + P ++ + E+ + + H L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
+ +L+ +++ G L + + ++ G+ ++HE I+H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 578 DIKPENILLDS--DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
DIKPENI+ ++ + K+ DFGLA + D ++ T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 636 DVYSYGMTLLELIGGRR 652
D+++ G+ L+ G
Sbjct: 210 DMWAIGVLGYVLLSGLS 226
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 77/312 (24%), Positives = 120/312 (38%), Gaps = 55/312 (17%)
Query: 458 FSEKLGHGGFGAVFQG------ELSDSTLVAVKRLERPG--SGEREFRAEVCTIGNIQH- 508
+ LG G FG V + + + VAVK L+ S R +E+ + +I H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 509 VNLVRLRGFCSENSHRL-LVYDYMRNGALSLYLRKDGLN---------------LNWDVR 552
+N+V L G C++ L ++ ++ + G LS YLR L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 553 FRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL- 611
+ A+G+ +L IH D+ NILL K+ DFGLA+ I +D V
Sbjct: 137 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEH 671
R ++APE I T ++DV+S+G+ L E+ + P G
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVK--------- 241
Query: 672 GDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTV 731
R++ EG D Y E + L C RPT +
Sbjct: 242 -----IDEEFCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSEL 287
Query: 732 VKMLEGVLEVTA 743
V+ L +L+ A
Sbjct: 288 VEHLGNLLQANA 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 458 FSEKLGHGGFGAVFQG-ELSDSTLVAVKRLERPG----SGEREFRAEVCTIGNIQHVNLV 512
F + LG G F V EL+ S A+K LE+ + E + + H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+L ++ Y +NG L Y+RK G RF A ++ L
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----EIVSALEYLHGK 127
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA-TMRGTWGYVAPEWISGLAI 631
IIH D+KPENILL+ D +++DFG AK++ + + A + GT YV+PE ++ +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 632 TTKADVYSYGMTLLELIGGRR 652
+D+++ G + +L+ G
Sbjct: 188 CKSSDLWALGCIIYQLVAGLP 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 1e-40
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 18/253 (7%)
Query: 458 FSEKLGHGGFGAVFQGELSDS-TLVAVKRLER----PGSGEREFRAEVCTI---GNIQHV 509
+G GGFG V+ +D+ + A+K L++ GE E +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+V + + D M G L +L + G+ D+RF A G+ ++H
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHNR 126
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI-SG 628
+++ D+KP NILLD ++SD GLA + GT GY+APE + G
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKG 180
Query: 629 LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW--AARQII 686
+A + AD +S G L +L+ G + I + R ++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240
Query: 687 EGNVAAVVDDRLG 699
EG + V+ RLG
Sbjct: 241 EGLLQRDVNRRLG 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 7e-40
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE--FRAEVCTIGNIQHVNLVRL 514
F + LG G F V E LVA+K + + +E E+ + I+H N+V L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
H L+ + G L + + G R+ + YLH+ I
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHD---LGI 128
Query: 575 IHCDIKPENILL---DSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
+H D+KPEN+L D D +SDFGL+K+ D VL+T GT GYVAPE ++
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 632 TTKADVYSYGMTLLELIGGRR 652
+ D +S G+ L+ G
Sbjct: 187 SKAVDCWSIGVIAYILLCGYP 207
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (372), Expect = 8e-40
Identities = 62/248 (25%), Positives = 98/248 (39%), Gaps = 20/248 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRL 514
LG G FG V + A+K L++ E + + H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
G + ++ DY+ G L LRK N +F A L I
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVCLALEYLHSKDI 125
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
I+ D+KPENILLD + K++DFG AK + T+ GT Y+APE +S
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGTPDYIAPEVVSTKPYNKS 181
Query: 635 ADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW---AARQIIEGNVA 691
D +S+G+ + E++ G P N + FPP+ + ++ +
Sbjct: 182 IDWWSFGILIYEMLAGYT----PFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237
Query: 692 AVVDDRLG 699
+ RLG
Sbjct: 238 RDLSQRLG 245
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 60/251 (23%), Positives = 102/251 (40%), Gaps = 18/251 (7%)
Query: 458 FSEKLGHGGFGAVFQGE-LSDSTLVAVKRLER-----PGSGEREFRAEVCTIGNIQHVNL 511
+ LG G FG VF E + A+K L++ E + +H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ + V +Y+ G L +++ + A G+ +LH +
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAI 631
I++ D+K +NILLD D K++DFG+ K ++ T GT Y+APE + G
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQKY 180
Query: 632 TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW---AARQIIEG 688
D +S+G+ L E++ G+ P G++ D F+P W A+ ++
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQS----PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236
Query: 689 NVAAVVDDRLG 699
+ RLG
Sbjct: 237 LFVREPEKRLG 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 3e-39
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE----------REFRAEVCTIGNIQ- 507
E LG G V + AVK ++ G G EV + +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 508 HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
H N+++L+ N+ LV+D M+ G L YL + L+ +I I LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH 127
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
+ I+H D+KPENILLD D K++DFG + + D L + GT Y+APE I
Sbjct: 128 KLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIE 182
Query: 628 G------LAITTKADVYSYGMTLLELIGGR 651
+ D++S G+ + L+ G
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 46/278 (16%), Positives = 102/278 (36%), Gaps = 17/278 (6%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
EK+G G +G V++ +VA+K++ E E+ + + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ LV++++ + + +G+A+ H ++
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 124
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+KP+N+L++++ K++DFGLA+ G + W + +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPWAARQIIEGNV 690
D++S G E++ R G + I D+ +P + + +
Sbjct: 185 DIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728
+ + +L++ + + R +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLS-QMLHYDPNKRISA 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 460 EKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGE------REFRAEVCTIGNIQHVNLV 512
+ LG G F V++ ++ +VA+K+++ E R E+ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 513 RLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
L S+ LV+D+M + ++ + L L + T +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-AI 631
I+H D+KP N+LLD + K++DFGLAK G + T Y APE + G
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMY 178
Query: 632 TTKADVYSYGMTLLELIGGR 651
D+++ G L EL+
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 460 EKLGHGGFGAVFQGE--LSDSTLVAVKRLERPGSGEREFR------AEVCTIGNIQHVNL 511
++G G +G VF+ + VA+KR+ E A + + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 512 VRLRGFCS-----ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYL 566
VRL C+ + LV++++ + + + + + RG+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 567 HEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWI 626
H ++H D+KP+NIL+ S K++DFGLA++ + ++ T Y APE +
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 627 SGLAITTKADVYSYGMTLLELIGGRR 652
+ T D++S G E+ +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (352), Expect = 2e-37
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE----REFRAEVCTIGNIQHVNLVRL 514
E LG GG V L VAVK L + + FR E + H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 515 RGFCSENSHRL----LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC 570
+ +V +Y+ L + +G + + + + + H+
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG 131
Query: 571 RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV--LATMRGTWGYVAPEWISG 628
IIH D+KP NI++ + KV DFG+A+ I + V A + GT Y++PE G
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 629 LAITTKADVYSYGMTLLELIGGRR 652
++ ++DVYS G L E++ G
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (351), Expect = 2e-37
Identities = 52/277 (18%), Positives = 105/277 (37%), Gaps = 17/277 (6%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRG 516
EK+G G +G V++ + + A+K++ E E+ + ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 517 FCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIH 576
+LV++++ L +G L + GIAY H+ ++H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRR---VLH 123
Query: 577 CDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKAD 636
D+KP+N+L++ + K++DFGLA+ G + + W + +T D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 637 VYSYGMTLLELIGGRRNVEAPASGRN-----ANIGGGGEHGDKWFFPPWAARQIIEGNVA 691
++S G E++ G G + I + +P + N
Sbjct: 184 IWSVGCIFAEMVNGTP----LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728
K + + L++ ++ + R T
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLS-KMLKLDPNQRITA 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-37
Identities = 53/203 (26%), Positives = 76/203 (37%), Gaps = 17/203 (8%)
Query: 459 SEKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGF 517
S+ LG G G V Q A+K L+ RE Q ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH---WRASQCPHIVRIVDV 73
Query: 518 C----SENSHRLLVYDYMRNGALSLYLRKDGLN-LNWDVRFRIAVGTARGIAYLHEECRD 572
+ L+V + + G L ++ G I I YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 573 CIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
I H D+KPEN+L S + K++DFG AK S T T YVAPE +
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVAPEVLGPE 188
Query: 630 AITTKADVYSYGMTLLELIGGRR 652
D++S G+ + L+ G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 446 FSYKELHTVTRGFSEKLGHGGFGAVFQGELSDS-TLVAVKRLERPGSGEREFRAEVCTIG 504
SY + + +G+G FG V+Q +L DS LVA+K++ + +R E+ +
Sbjct: 20 VSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMR 68
Query: 505 NIQHVNLVRLRGFCSE------NSHRLLVYDYMRNGALSLYLR--KDGLNLNWDVRFRIA 556
+ H N+VRLR F + LV DY+ + + L
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 557 VGTARGIAYLHEECRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLATMR 615
R +AY+H I H DIKP+N+LLD D K+ DFG AK + R V +
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYI 183
Query: 616 GTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRR 652
+ Y APE I G T+ DV+S G L EL+ G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 3e-36
Identities = 55/294 (18%), Positives = 99/294 (33%), Gaps = 39/294 (13%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVN-LVRLRGF 517
++G G FG +F+G L ++ VA+K R S + R E T + + + F
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHC 577
E H +LV D + L L G + A + +HE+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYR 125
Query: 578 DIKPENILLDSDYT-----AKVSDFGLAKLIGRDFSRV------LATMRGTWGYVAPEWI 626
DIKP+N L+ + V DFG+ K ++ + GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 627 SGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686
G + + D+ + G + + G + G K +I
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQ----------------GLKAATNKQKYERIG 229
Query: 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740
E + + + G E + + P + + VLE
Sbjct: 230 EKKQSTPLRELCAGF-----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRL-------ERPGSGEREFRAEVCTIGNIQHVNL 511
E+LG G F V + E S A K + R G + EV + IQH N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 512 VRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ L + +L+ + + G L +L + +L + G ++
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNG---VYYLHS 131
Query: 572 DCIIHCDIKPENILLDSD----YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWIS 627
I H D+KPENI+L K+ DFGLA I DF + GT +VAPE ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVN 189
Query: 628 GLAITTKADVYSYGMTLLELIGGR 651
+ +AD++S G+ L+ G
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGA 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-35
Identities = 45/287 (15%), Positives = 85/287 (29%), Gaps = 35/287 (12%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
K+G G FG ++ G ++ VA+K + + E +Q + +C
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 519 SENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCD 578
++ + +L + +A I Y+H + IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRD 128
Query: 579 IKPENIL---LDSDYTAKVSDFGLAKLIG------RDFSRVLATMRGTWGYVAPEWISGL 629
+KP+N L + DFGLAK R + GT Y + G+
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 630 AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689
+ + D+ S G L+ G + + K P +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMSTPIEVLCKGYPSE 247
Query: 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLE 736
A ++ +C + +P + ++
Sbjct: 248 FATYLN--------------------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 59/289 (20%), Positives = 96/289 (33%), Gaps = 59/289 (20%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE-------REFRAEVCTIGNIQ--HV 509
LG GGFG+V+ G +SD+ VA+K +E+ + EV + +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
++RL + +L+ + + L ++ + + H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 570 CRDCIIHCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG 628
++H DIK ENIL+D + K+ DFG L+ GT Y PEWI
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWIRY 183
Query: 629 -LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW---AARQ 684
A V+S G+ L +++ G P I G + FF +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI----PFEHDEEIIRG------QVFFRQRVSSECQH 233
Query: 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733
+I WC+ RPT +
Sbjct: 234 LIR----------------------------WCLALRPSDRPTFEEIQN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 15/202 (7%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE--REFRAEVCTIGNIQHVNLVRLRG 516
+G G +G V + + VA+K++ + E+ + +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 517 FCSENSHRLLVYDYMRNGALSL----YLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRD 572
+ + Y+ + L+ L+ D RG+ Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS--NDHICYFLYQILRGLKYIHSAN-- 129
Query: 573 CIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR--VLATMRGTWGYVAPEWI-SGL 629
++H D+KP N+LL++ K+ DFGLA++ D L T Y APE + +
Sbjct: 130 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 630 AITTKADVYSYGMTLLELIGGR 651
T D++S G L E++ R
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 10/198 (5%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRL 514
+ LG G FG V + A+K L + ++ E + N +H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+ + V +Y G L +L ++ + RF A ++ L +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSALEYLHSRDV 126
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
++ DIK EN++LD D K++DFGL K D + + T GT Y+APE +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 635 ADVYSYGMTLLELIGGRR 652
D + G+ + E++ GR
Sbjct: 186 VDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 1e-33
Identities = 56/251 (22%), Positives = 95/251 (37%), Gaps = 20/251 (7%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGERE----FRAEVCTIGNIQHVNLVRL 514
+ LG G FG V + A+K L++ + + E + + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 515 RGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCI 574
+NS+ +V +Y+ G + +LR+ G + A YLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 575 IHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTK 634
I+ D+KPEN+L+D +V+DFG AK + T+ GT +APE I
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKA 218
Query: 635 ADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPW---AARQIIEGNVA 691
D ++ G+ + E+ G P K FP + ++ +
Sbjct: 219 VDWWALGVLIYEMAAGYP----PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 692 AVVDDRLGGAY 702
+ R G
Sbjct: 275 VDLTKRFGNLK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 52/275 (18%), Positives = 99/275 (36%), Gaps = 11/275 (4%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
EK+G G +G VF+ + +VA+KR+ E E+C + ++H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 516 GFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ LV+++ + +G V+ + + + L ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLLKGLGFCHSRNVL 123
Query: 576 HCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKA 635
H D+KP+N+L++ + K+++FGLA+ G A + W +T
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 636 DVYSYGMTLLELIGGRRNVEAPASGRN--ANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693
D++S G EL R + + I + +P +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTM 728
L A L+ ++ N R +
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQ-NLLKCNPVQRISA 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 46/209 (22%), Positives = 75/209 (35%), Gaps = 20/209 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
K+G G FG VF+ VA+K++ E E+ + ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 516 GFCSENSHR--------LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLH 567
C + LV+D+ + L R+ G L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNG---LY 131
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR---DFSRVLATMRGTWGYVAPE 624
R+ I+H D+K N+L+ D K++DFGLA+ T Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 625 WISG-LAITTKADVYSYGMTLLELIGGRR 652
+ G D++ G + E+
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-32
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 27/223 (12%)
Query: 446 FSYKELHTVTRGFS------EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE---RE 495
F +E+ + +G G +GAV + VA+K+L RP E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 496 FRAEVCTIGNIQHVNLVRLRGFCSENSHR------LLVYDYMRNGALSLYLRKDGLNLNW 549
E+ + +++H N++ L + + LV +M G L K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGE 120
Query: 550 DVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609
D + +G+ Y+H IH D+KP N+ ++ D K+ DFGLA+ + +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMT- 176
Query: 610 VLATMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGR 651
T Y APE I T D++S G + E+I G+
Sbjct: 177 ---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 460 EKLGHGGFGAVFQGEL----SDSTLVAVKRLERPGSGERE-----FRAEVCTIGNIQHV- 509
+ LG G +G VF L A+K L++ ++ R E + +I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 510 NLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
LV L + L+ DY+ G L +L + +V+ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIVLALEHL 145
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
+ II+ DIK ENILLDS+ ++DFGL+K D + GT Y+AP+ + G
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 630 --AITTKADVYSYGMTLLELIGGRR 652
D +S G+ + EL+ G
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-29
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 460 EKLGHGGFGAVFQG-ELSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
+ +G G G V + VA+K+L RP + + E+ + + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 516 GFCS------ENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE 569
+ E LV + M + + + + + GI +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH-- 136
Query: 570 CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL 629
IIH D+KP NI++ SD T K+ DFGLA+ G F ++ T Y APE I G+
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGM 193
Query: 630 AITTKADVYSYGMTLLELIGGR 651
D++S G + E++ +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 5e-28
Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 20/210 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFC 518
KLG G F V+ + + ++T VA+K + E+ + + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 519 SENSHRLLVY---------------DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGI 563
+ + +LL + + + L+L + + + +I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 564 AYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLIG-RDFSRVLATMRGTWGYV 621
Y+H C IIH DIKPEN+L++ D + +A L + T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 622 APEWISGLAITTKADVYSYGMTLLELIGGR 651
+PE + G AD++S + ELI G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (281), Expect = 9e-28
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 26/284 (9%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGF 517
KLG G + VF+ ++++ V VK L+ +++ + E+ + N++ N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADI 98
Query: 518 CSENSHRL--LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCII 575
+ R LV++++ N + L + + Y H I+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG---IM 151
Query: 576 HCDIKPENILLDSD-YTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGL-AITT 633
H D+KP N+++D + ++ D+GLA+ + + PE +
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLVDYQMYDY 209
Query: 634 KADVYSYGMTLLELIGGRR-----NVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688
D++S G L +I + + R A + G + D
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 689 NVAAVVDDRLGGAYKVEEAERVALVAI----WCIQDNEEMRPTM 728
+ R E V+ A+ ++ + + R T
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-25
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 460 EKLGHGGFGAVFQGE-LSDSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLR 515
+G G +G+V VAVK+L RP + E+ + +++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 516 GFCSENSHRLLVYDYM----RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECR 571
+ D GA + K + V+F + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSADI 142
Query: 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISG-LA 630
H D+KP N+ ++ D K+ DFGLA+ + + T Y APE + +
Sbjct: 143 I---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----GYVATRWYRAPEIMLNWMH 195
Query: 631 ITTKADVYSYGMTLLELIGGR 651
D++S G + EL+ GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 7e-21
Identities = 32/208 (15%), Positives = 60/208 (28%), Gaps = 43/208 (20%)
Query: 460 EKLGHGGFGAVFQGELSDSTLVAVKRLERPGS-----------GEREFRAEVCTIGNIQH 508
+ +G G AVF VK + + G+ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFR-IAVGTARGIAYLH 567
L +L+G VY + N L + L + +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 568 EECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG---------RDFSRVLATMRGTW 618
I+H D+ N+L+ + + DF + +G RD ++ T+
Sbjct: 121 ---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176
Query: 619 GYVAPEWISGLAITTKADVYSYGMTLLE 646
+ D+ S +L+
Sbjct: 177 RT-------------EKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 63.0 bits (153), Expect = 1e-12
Identities = 22/140 (15%), Positives = 41/140 (29%), Gaps = 32/140 (22%)
Query: 35 IWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQST-NTEKATDM 93
I Y++ + + +S+ ++ L + L + D + + +T
Sbjct: 12 ILYSTQGNDNHPQTLHATQSL-QLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRA 70
Query: 94 YLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLS 153
L G + +L++ VW S + S G Y L
Sbjct: 71 VLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAGRYVFVLQ 105
Query: 154 PTGYNQIELVYNGTIVYWST 173
P L G W+T
Sbjct: 106 PDR----NLAIYGG-ALWTT 120
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 61.5 bits (149), Expect = 3e-12
Identities = 17/108 (15%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 12 ISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKL 71
+ Q+ + + + L ++ S VW +N ++ G
Sbjct: 10 LYAGQSLDVEPYHFIMQEDCNLVLYDHSTS----VWASNTGILG--KKGCKAVLQSDGNF 63
Query: 72 AIKDSQNSIIWQSTNTEKATD--MYLLETGNLVLLSSAGSLVWQSFDH 117
+ D++ +W S + + + L E GN+V+ S +W + +
Sbjct: 64 VVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.9 bits (124), Expect = 9e-09
Identities = 22/141 (15%), Positives = 40/141 (28%), Gaps = 31/141 (21%)
Query: 35 IWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTNTEKATDMY 94
I + ++ + +S+ + + L + DS + +T
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLEL-SSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAV 61
Query: 95 LLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSP 154
L G LV+L++ ++ W S S G Y L L P
Sbjct: 62 LQSDGLLVILTAQNTIRWSSGTK-------------------------GSIGNYVLVLQP 96
Query: 155 TGYNQIELVYNGTIVYWSTGN 175
+ G W +G
Sbjct: 97 DR----TVTIYGP-GLWDSGT 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 51.7 bits (123), Expect = 1e-08
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 13/107 (12%)
Query: 15 NQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIK 74
+ + Y VW + + L + G L I
Sbjct: 18 EGGYLFIIQ-NDCNLVLY--------DNNRAVWASGTNGKASG---CVLKMQNDGNLVIY 65
Query: 75 DSQNSIIWQSTNTEKATDMY-LLETGNLVLLSSAGSLVWQSFDHPTD 120
+I +TN + L N+V+ ++ + +W + + +
Sbjct: 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.5 bits (102), Expect = 8e-06
Identities = 15/73 (20%), Positives = 26/73 (35%), Gaps = 8/73 (10%)
Query: 44 TYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTNTEKATDMY--LLETGNL 101
+W N ++ G L + ++N +WQS KA L N+
Sbjct: 49 NPIWATNTGGLGNG---CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 102 VLLSSAGSLVWQS 114
V+ A +W +
Sbjct: 106 VIYGDA---LWAT 115
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 43.1 bits (101), Expect = 9e-06
Identities = 21/115 (18%), Positives = 36/115 (31%), Gaps = 18/115 (15%)
Query: 11 IISQNQTFRLGFFATNGESSWY------LGIWYASIPTPTYVWVANREKSVADVTQSTLL 64
I+ +T G F G + L ++ P W N L
Sbjct: 3 ILYSGETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPI----WATNTGGLSRS---CFLS 55
Query: 65 ITEKGKLAIKDSQNSIIWQSTNTEKATD--MYLLETGNLVLLSSAGSLVWQSFDH 117
+ G L + + N IW S + + L + N+V+ + W + H
Sbjct: 56 MQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGTH 107
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 804 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.72 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.72 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.54 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.53 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.24 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.93 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.91 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.85 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.65 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.04 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.96 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 83.28 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.04 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=427.72 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=204.3
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.+.++||+|+||+||+|.+.+++.||||+++......++|.+|+.++++++|||||+++|+|...+..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 46789999999999999998888999999988777888999999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
.+++......+++..++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++..............|
T Consensus 88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~g 164 (263)
T d1sm2a_ 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164 (263)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecceec
Confidence 9999887778999999999999999999999988 9999999999999999999999999998775544444445678
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceeccc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDD 696 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 696 (804)
|+.|+|||++.+..++.++|||||||++|||+|+..|+..... .......+..+..
T Consensus 165 t~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------------------~~~~~~~i~~~~~------ 220 (263)
T d1sm2a_ 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------------------NSEVVEDISTGFR------ 220 (263)
T ss_dssp CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------------------HHHHHHHHHHTCC------
T ss_pred CcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------------------HHHHHHHHHhcCC------
Confidence 9999999999999999999999999999999996544432111 0112222222211
Q ss_pred cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 697 RLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 697 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
...+....+++.+++.+||+.||++||||++|+++|+++.+
T Consensus 221 ---~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 ---LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11222345678999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=412.68 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=217.1
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCCh
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGAL 536 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 536 (804)
.|.++||+|+||+||+|++++++.||||+++......++|++|+.++++++||||++++|+|.+.+..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 46789999999999999998888999999998777889999999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccccc
Q 044374 537 SLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATMRG 616 (804)
Q Consensus 537 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 616 (804)
..++......+++..+++++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++..............+
T Consensus 87 ~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 163 (258)
T d1k2pa_ 87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163 (258)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCC
T ss_pred HHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCC
Confidence 9998877778999999999999999999999988 9999999999999999999999999998765554444445679
Q ss_pred ccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccceecc
Q 044374 617 TWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVD 695 (804)
Q Consensus 617 t~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 695 (804)
|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+..+..
T Consensus 164 t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------------------~~~~~~i~~~~~----- 219 (258)
T d1k2pa_ 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------------------SETAEHIAQGLR----- 219 (258)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------------------HHHHHHHHTTCC-----
T ss_pred CCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------------------HHHHHHHHhCCC-----
Confidence 999999999999999999999999999999998 8989875321 112223333221
Q ss_pred ccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 696 DRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 696 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
...+...++.+.+++..||+.||++|||+.+|++.|.++
T Consensus 220 ----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 ----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112233446789999999999999999999999999763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-50 Score=424.87 Aligned_cols=264 Identities=26% Similarity=0.463 Sum_probs=205.0
Q ss_pred cChHHHHHhhccc-----------ccccccccceeEEEEEeCC-C---cEEEEEEecCCCC--CHHHHHHHHHHHcCCCC
Q 044374 446 FSYKELHTVTRGF-----------SEKLGHGGFGAVFQGELSD-S---TLVAVKRLERPGS--GEREFRAEVCTIGNIQH 508 (804)
Q Consensus 446 ~~~~el~~~t~~~-----------~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H 508 (804)
++|+++.+++.+| .++||+|+||+||+|.+.. + ..||||++..... ..++|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555666655544 3579999999999998752 2 3689999865433 34579999999999999
Q ss_pred CCceeeeeEEecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC
Q 044374 509 VNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS 588 (804)
Q Consensus 509 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~ 588 (804)
||||+++|+|...+..++||||+++|+|.+++......+++.+++.++.|||+||+|||+.+ |+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECC
Confidence 99999999999999999999999999999999887778999999999999999999999988 999999999999999
Q ss_pred CCceEEeecCCccccCCCccc----cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCC
Q 044374 589 DYTAKVSDFGLAKLIGRDFSR----VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNA 663 (804)
Q Consensus 589 ~~~~kl~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 663 (804)
++.+||+|||+++........ ......+|+.|||||.+.+..++.++|||||||+||||+| |+.||.....
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---- 239 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---- 239 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999876543221 1222457899999999999999999999999999999998 8999874321
Q ss_pred cCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 664 NIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.-....+..+. ....+.+.+..+.+++.+||+.||++||||.||++.|+.+++
T Consensus 240 ---------------~~~~~~i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 ---------------QDVINAIEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---------------HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11112222221 112233456778999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=420.05 Aligned_cols=254 Identities=29% Similarity=0.427 Sum_probs=211.7
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.++||+|+||.||+|.+++++.||||+++......++|.+|+.++++++|||||+++|++.+ +..++||||+++|
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 345678999999999999999888899999998877788899999999999999999999998865 5679999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|.+++.... ..+++..+++|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++............
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9999876543 36899999999999999999999988 9999999999999999999999999999876554444556
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|||||++.+..++.++|||||||++|||+||..|+..... .......+..+..
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------------------~~~~~~~i~~~~~--- 228 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------------NPEVIQNLERGYR--- 228 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------------------HHHHHHHHHTTCC---
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------------------HHHHHHHHHhcCC---
Confidence 6799999999999999999999999999999999997666542211 1112222322211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
...+...++.+.+|+.+||+.||++||||.+|+++|++..
T Consensus 229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1122234467889999999999999999999999998743
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-50 Score=420.77 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=216.8
Q ss_pred HhhcccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.....+.++||+|+||+||+|.+. .++.||||+++......++|++|+.++++++|||||+++|+|.+.+..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 334556789999999999999875 5788999999887777889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKD-GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
++|+|.+++... ...+++..++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++....+....
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999764 457899999999999999999999988 9999999999999999999999999999876554444
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....|++.|+|||++.+..++.++|||||||++|||++|..|+..... .....+.+..+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------------------~~~~~~~i~~~-- 232 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------LSQVYELLEKD-- 232 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------------------HHHHHHHHHTT--
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------------------HHHHHHHHhcC--
Confidence 4556789999999999999999999999999999999998777643211 01111222222
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.....+...++.+.+|+..||+.||++||||.+|++.|+.+..
T Consensus 233 -------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233445678999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=414.70 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=202.6
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||+||+|++.. .||||+++.. ....+.|++|+.++++++|||||++++++.+ +..++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 466899999999999998753 5999999643 3345689999999999999999999999865 568999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~ 612 (804)
|+|.+++......+++..++.++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ......
T Consensus 88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~ 164 (276)
T d1uwha_ 88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164 (276)
T ss_dssp EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence 9999999877778999999999999999999999987 999999999999999999999999999876543 222345
Q ss_pred ccccccccccchhccCC---CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 613 TMRGTWGYVAPEWISGL---AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~---~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
...||+.|||||++.+. .++.++|||||||+||||+||+.||...... ......+..+.
T Consensus 165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------------------~~~~~~~~~~~ 226 (276)
T d1uwha_ 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------------DQIIFMVGRGY 226 (276)
T ss_dssp -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------------HHHHHHHHHTS
T ss_pred ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------------------HHHHHHHhcCC
Confidence 56799999999998653 5889999999999999999999999753221 11222222222
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+ ...+...++.+.+++.+||+.||++||||.+|+++|+.+.+
T Consensus 227 ~~p~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 LSPDL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCCG-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcc-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111 11223345678999999999999999999999999998654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=413.61 Aligned_cols=259 Identities=28% Similarity=0.372 Sum_probs=208.1
Q ss_pred hcccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
...+.++||+|+||+||+|.+.+++.||||+++......+.|.+|+.++++++|||||+++|+|.+ +..++||||+++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 355778999999999999999888889999998877788899999999999999999999999865 5678999999999
Q ss_pred ChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 535 ALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 535 sL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+|..++.... ..+++.+++.++.|||+||+|||+.+ |+||||||+||||+.++++||+|||+++............
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 9999887543 46899999999999999999999988 9999999999999999999999999998765444444455
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++....++.++|||||||++|||++|..|+...... ......+..+.
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------------------~~~~~~i~~~~---- 231 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------------REVLDQVERGY---- 231 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------HHHHHHHHTTC----
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHhcC----
Confidence 67999999999999999999999999999999999977666532111 11112222221
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccCCCC
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEVTAP 744 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~p 744 (804)
....+...++++.+++.+||+.||++||+|.+|+++|+.......|
T Consensus 232 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 232 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 1122334456789999999999999999999999999987655443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=412.63 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=202.3
Q ss_pred ccccccccccceeEEEEEeCCC-----cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSDS-----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
.+.+.||+|+||.||+|.+... ..||||+++.... ...+|.+|+.++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 4567899999999999987532 4799999975432 23568999999999999999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc-
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS- 608 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~- 608 (804)
|+.++++.+++......+++.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999999887778999999999999999999999988 99999999999999999999999999987644322
Q ss_pred -ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 -RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 -~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......||+.|||||++.+..++.++|||||||++|||+++..|+..... .....+.+.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~------------------~~~~~~~i~~ 228 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------------NHEVMKAIND 228 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------------------HHHHHHHHHT
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC------------------HHHHHHHHhc
Confidence 223345689999999999999999999999999999999997666543211 1112222232
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+ .....+.+.+..+.+|+.+||+.||++||+|.||+++|+.+++
T Consensus 229 ~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 G---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp T---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred c---------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2 1222333455778999999999999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=407.79 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=206.2
Q ss_pred ccc-ccccccceeEEEEEeC---CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 458 FSE-KLGHGGFGAVFQGELS---DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 458 ~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
+.+ +||+|+||+||+|.+. ++..||||+++.... ..++|.+|+.++++++|||||+++|+|.. +..+|||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 5999999999999764 345799999975432 34679999999999999999999999875 4689999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--c
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS--R 609 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~ 609 (804)
++|+|.+++......+++..++.++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999999999877778999999999999999999999988 99999999999999999999999999987654322 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcC
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEG 688 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 688 (804)
......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .-....+..+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------------------~~~~~~i~~~ 228 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------------------PEVMAFIEQG 228 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------------------HHHHHHHHTT
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------------------HHHHHHHHcC
Confidence 2334568999999999999999999999999999999998 8999975321 1122333333
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
... ..+...+..+.+|+.+||+.||++||+|.+|++.|+.+
T Consensus 229 ~~~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 KRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222 22334456788999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=405.98 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=199.5
Q ss_pred cccccccceeEEEEEeCC---CcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGELSD---STLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
++||+|+||+||+|.+.+ ++.||||+++.... ..++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997643 46799999965322 24579999999999999999999999965 457899999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc--ccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS--RVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~ 611 (804)
|+|.+++.... .+++..++.++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+++....... ...
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999998654 6999999999999999999999988 99999999999999999999999999987654322 223
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ......+..+..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------------------~~~~~~i~~~~~ 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------------SEVTAMLEKGER 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------------HHHHHHHHTTCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------------------HHHHHHHHcCCC
Confidence 34578999999999999999999999999999999998 8999974321 112223333322
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGV 738 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~ 738 (804)
. ..+...+..+.+|+.+||+.||++||||++|+++|+..
T Consensus 229 ~---------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1 22333456788999999999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=400.98 Aligned_cols=247 Identities=27% Similarity=0.351 Sum_probs=200.0
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||+||+|+.. +++.||||+++... ...+.+++|+.++++++|||||++++++.+.+..+|||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 45689999999999999764 68999999996542 3345789999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC-cccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD-FSRVLA 612 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~ 612 (804)
|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++..... ......
T Consensus 88 g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 88 GELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp EEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 99999997644 7999999999999999999999988 999999999999999999999999999876433 223345
Q ss_pred ccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 613 TMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
..+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ............
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------------------~~~~~~~~~~~~ 225 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKTY 225 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------------------HHHHHHHTTCTT
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------------------HHHHHHhcCCCC
Confidence 6789999999999988876 578999999999999999999997533210 011111111110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..........+.+++.+||+.||++|||+.||++
T Consensus 226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111223456788999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=392.44 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=204.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||+||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 346789999999999999775 688999999853 234567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|.+++...+ .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 88 APLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred cCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 99999999998654 6999999999999999999999988 9999999999999999999999999998654332
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+..+..
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------------------~~~~~~i~~~~~ 221 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------------------QETYKRISRVEF 221 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------------HHHHHHHHTTCC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------------------HHHHHHHHcCCC
Confidence 3456799999999999999999999999999999999999999974321 111222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
..+...++.+.+++.+||+.||++|||+.||++
T Consensus 222 ----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112233467889999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=411.85 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=204.7
Q ss_pred hcccccccccccceeEEEEEeCC------CcEEEEEEecCC--CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD------STLVAVKRLERP--GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 525 (804)
...+.++||+|+||+||+|+... ...||||++... ......+.+|+.++.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 34577899999999999997642 236999999643 33456789999999988 8999999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 044374 526 LVYDYMRNGALSLYLRKDG----------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPEN 583 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~N 583 (804)
+||||+++|+|.++|+... ..+++..++.++.||++||+|||+.+ |+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhc
Confidence 9999999999999997643 24789999999999999999999988 9999999999
Q ss_pred EEecCCCceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCC
Q 044374 584 ILLDSDYTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGR 661 (804)
Q Consensus 584 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~ 661 (804)
||++.++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~- 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD- 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987544322 22345678999999999999999999999999999999998 89999753221
Q ss_pred CCcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 662 NANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
....+.+..+ .....+...++.+.+|+.+||+.||++||||+||+++|..
T Consensus 274 -----------------~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 -----------------ANFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -----------------HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----------------HHHHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1111222222 1112233445678999999999999999999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=396.03 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=204.7
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 34567899999999999976 46899999999743 44567899999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|+|.+++.+. .+++.++..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+.... .....
T Consensus 102 g~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~ 175 (293)
T d1yhwa1 102 GSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST 175 (293)
T ss_dssp CBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred CcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence 9999988764 5899999999999999999999988 9999999999999999999999999998764432 22345
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+ ...
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------------------~~~~~~~~~~-~~~- 235 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------------------RALYLIATNG-TPE- 235 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------------HHHHHHHHHC-SCC-
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------------------HHHHHHHhCC-CCC-
Confidence 67999999999999999999999999999999999999999743211 1111111111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 236 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123345678899999999999999999998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=396.42 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=191.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEec--CCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSE--NSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E 529 (804)
+.+.+.||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.++++++|||||++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 346789999999999999764 6889999999765433 3468899999999999999999999865 456899999
Q ss_pred EcCCCChhHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 530 YMRNGALSLYLRK---DGLNLNWDVRFRIAVGTARGIAYLHEEC--RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 530 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
|+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999864 2357999999999999999999999865 2359999999999999999999999999998765
Q ss_pred CCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.... ......||+.|||||++.+..++.++|||||||++|||+||+.||..... ......
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------------------~~~~~~ 225 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------------KELAGK 225 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHHH
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------------------HHHHHH
Confidence 4322 23456799999999999999999999999999999999999999974321 112233
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
+..+.... .+...++.+.+++.+||+.||++|||+.||++
T Consensus 226 i~~~~~~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGKFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 33333222 12233457889999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=392.19 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=196.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEec----CCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSE----NSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 528 (804)
.|.++||+|+||+||+|... +++.||||++..... ..+.|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999765 578999999975432 23568999999999999999999999864 34679999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec-CCCceEEeecCCccccCCCc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD-SDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~ 607 (804)
||+++|+|.+++.... .+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999997654 7899999999999999999999865 4499999999999996 5789999999999865433
Q ss_pred cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 608 SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
......||+.|||||++.+ .++.++|||||||++|||++|+.||...... ....+.+..
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------------------~~~~~~i~~ 227 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------------------AQIYRRVTS 227 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------------HHHHHHHTT
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------------------HHHHHHHHc
Confidence 2345679999999999876 5999999999999999999999999642211 112222222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
+.... ..+....+.+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc--------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 21111 111122356889999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=396.04 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=203.9
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC-CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP-GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNG 534 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 534 (804)
.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 45688999999999999764 6889999999754 344567999999999999999999999999999999999999999
Q ss_pred ChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 535 ALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 535 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
+|.+++.+....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ......
T Consensus 95 ~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~ 170 (288)
T d2jfla1 95 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 170 (288)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence 999998876668999999999999999999999988 9999999999999999999999999997653321 123456
Q ss_pred ccccccccchhcc-----CCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 615 RGTWGYVAPEWIS-----GLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 615 ~gt~~y~aPE~l~-----~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.||+.|||||++. +..++.++|||||||++|||++|+.||...... .....+..+.
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-------------------~~~~~i~~~~ 231 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-------------------RVLLKIAKSE 231 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------------------GHHHHHHHSC
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-------------------HHHHHHHcCC
Confidence 7999999999984 456889999999999999999999999753221 0112222222
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 PPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 1122345678899999999999999999998763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=393.44 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=197.6
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC-CeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN-SHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~~~gs 535 (804)
.|.++||+|+||.||+|++. ++.||||+++.. ...++|++|+.++++++||||++++|+|.+. +..++||||+++|+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 46789999999999999984 678999999754 3457899999999999999999999999654 56899999999999
Q ss_pred hhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccccc
Q 044374 536 LSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLATM 614 (804)
Q Consensus 536 L~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 614 (804)
|.++|.... ..+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTG 160 (262)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----Cccc
Confidence 999997643 35899999999999999999999987 999999999999999999999999999865432 3345
Q ss_pred ccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 615 RGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 615 ~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
.+|..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+..+..
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------------------~~~~~i~~~~~--- 218 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------------------DVVPRVEKGYK--- 218 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------------------GHHHHHTTTCC---
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------------------HHHHHHHcCCC---
Confidence 67899999999999999999999999999999998 67776643221 11222222221
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.+.+.....++.+++.+||+.||++||||.+|+++|+.+..
T Consensus 219 ------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 ------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 22233445678899999999999999999999999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=395.89 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=198.3
Q ss_pred hcccccccccccceeEEEEEeCC----CcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSD----STLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
...+.+.||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 34567899999999999997643 35689999865433 23569999999999999999999999964 6789999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|.+++......+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999998877778999999999999999999999988 99999999999999999999999999987655444
Q ss_pred ccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------------------~~~~~i~~ 224 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------------------DVIGRIEN 224 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------------GHHHHHHT
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------------------HHHHHHHc
Confidence 44455678999999999999999999999999999999998 88888753221 12223333
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+... ..+...++.+.+|+..||+.||++|||+.||++.|+.+++
T Consensus 225 ~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 225 GERL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3221 1233445678999999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=397.74 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=207.7
Q ss_pred hcccccccccccceeEEEEEeCCC----cEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEec-CCeEEEE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELSDS----TLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSE-NSHRLLV 527 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 527 (804)
+.+|.++||+|+||+||+|.+.+. ..||||+++.... ..++|.+|+.++++++||||++++|++.+ ....++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 345678999999999999987542 3689999975332 33679999999999999999999999875 4688999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++|+|.+++......+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999999988778899999999999999999999988 9999999999999999999999999998764332
Q ss_pred c---ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 608 S---RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 608 ~---~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
. .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .. ....
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--------------~~----~~~~ 246 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FD----ITVY 246 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------------------CHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--------------HH----HHHH
Confidence 1 2233457899999999999999999999999999999999988887642211 00 1122
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
+..+... ..+....+.+.+++.+||+.||++||+|.||+++|+.++.
T Consensus 247 i~~g~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 247 LLQGRRL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222211 1122334678899999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=392.14 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=202.0
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
+.+.+.||+|+||+||+|+.. +++.||||+++. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999764 688999999963 244567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc-cc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-SR 609 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 609 (804)
+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.+.... ..
T Consensus 90 ~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999988654 7999999999999999999999988 9999999999999999999999999998765432 22
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------------~~~~~~i~~~~ 226 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------------------YLIFQKIIKLE 226 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHTTC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------------------HHHHHHHHcCC
Confidence 33456799999999999999999999999999999999999999974321 11122222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
. .++....+.+.+++.+||+.||++|||+.|+++
T Consensus 227 ~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 Y----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 112233466889999999999999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=402.12 Aligned_cols=196 Identities=24% Similarity=0.414 Sum_probs=173.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.++||+|+||+||+|... +++.||||+++... .....+.+|+.+|++++|||||++++++.+.++.++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 345689999999999999764 68999999997542 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEE-CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
+|+|.+++.+.+ .+++..+..++.|++.||.|||++ + |+||||||+||||+.++.+||+|||+|+..... ..
T Consensus 88 gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~ 160 (322)
T d1s9ja_ 88 GGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 160 (322)
T ss_dssp TEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC
T ss_pred CCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---cc
Confidence 999999998654 689999999999999999999974 7 999999999999999999999999999865432 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPA 658 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~ 658 (804)
...+||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 45689999999999999999999999999999999999999997643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=397.22 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=206.8
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||+||+|+.. +++.||||+++.... ..++|.+|+.++++++||||++++++|......++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 346789999999999999763 357899999975433 245799999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcE
Q 044374 528 YDYMRNGALSLYLRKDG-----------------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENI 584 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NI 584 (804)
|||+++|+|.++++... ..+++..++.|+.|+|.||+|||+.+ |+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccce
Confidence 99999999999997432 24789999999999999999999988 99999999999
Q ss_pred EecCCCceEEeecCCccccCCC-ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCC-CCCCCCcCCCC
Q 044374 585 LLDSDYTAKVSDFGLAKLIGRD-FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR-RNVEAPASGRN 662 (804)
Q Consensus 585 Ll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~ 662 (804)
||+.++.+||+|||+++..... .........+|+.|+|||.+.+..++.++|||||||++|||++|. .||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH---
Confidence 9999999999999999866433 222334567899999999999999999999999999999999996 45653211
Q ss_pred CcCCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 663 ANIGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.-....+.++.... .+...+..+.+|+.+||+.+|++||||.||+++|+.+.
T Consensus 249 ----------------~e~~~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ----------------EEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----------------HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----------------HHHHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11223344443322 22234467899999999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=397.85 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=203.0
Q ss_pred cccccccccccceeEEEEEeC-CCc----EEEEEEecCC--CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DST----LVAVKRLERP--GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
..+.++||+|+||+||+|.+. +++ +||||+++.. ....++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 346689999999999999764 333 6899998643 44567899999999999999999999999875 567889
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+.+|+|.+++......+++..+++++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999999888778999999999999999999999988 99999999999999999999999999997654432
Q ss_pred c-cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh
Q 044374 609 R-VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII 686 (804)
Q Consensus 609 ~-~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 686 (804)
. ......||+.|||||++.+..++.++|||||||+||||+| |+.||...... .....+.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------------------~~~~~i~ 227 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------------EISSILE 227 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------------------GHHHHHH
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------------------HHHHHHH
Confidence 2 2334568999999999999999999999999999999998 78888643221 0122222
Q ss_pred cCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 687 EGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 687 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
.+.. ...+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 228 ~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 228 KGER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 2221 1223344567899999999999999999999999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=388.40 Aligned_cols=273 Identities=23% Similarity=0.271 Sum_probs=203.1
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E~~~ 532 (804)
-+.++||+|+||.||+|++ +++.||||+++........++.|+..+.+++|||||+++++|.+.+ ..++||||++
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 3567899999999999987 5788999999754333333455666677889999999999997653 6799999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEEC-----RDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+|+|.++|+.. .+++..+++++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 85 HGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 99999999875 5899999999999999999999742 2459999999999999999999999999998764432
Q ss_pred c---ccccccccccccccchhccCCC------CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 608 S---RVLATMRGTWGYVAPEWISGLA------ITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 608 ~---~~~~~~~gt~~y~aPE~l~~~~------~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
. .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........... ....... ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~---~~~~~~~-~~ 238 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY---DLVPSDP-SV 238 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT---TTSCSSC-CH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh---hcccccc-hH
Confidence 1 2234567999999999987653 67799999999999999999988765433221111 0000111 11
Q ss_pred HHHHHHhhcCccceeccccccCCC-CHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAY-KVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.........+.. ++.+.... +.+....+.+++.+||+.||++||||.||+++|+.+.+
T Consensus 239 ~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112222222211 22221111 23456779999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=392.76 Aligned_cols=242 Identities=28% Similarity=0.354 Sum_probs=198.8
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
....++||+|+||+||+|+. .+++.||||+++..... .+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 34567899999999999975 46889999999765432 24688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 97 ~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999998776554 47999999999999999999999988 999999999999999999999999999865432
Q ss_pred ccccccccccccchhccC---CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 611 LATMRGTWGYVAPEWISG---LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~---~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------------------~~~~~~i~~ 228 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------------MSALYHIAQ 228 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------------HHHHHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------------------HHHHHHHHh
Confidence 34579999999999864 4689999999999999999999999974211 111122222
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
+...... +...++.+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2221111 1123467889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-45 Score=388.43 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=190.6
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC--CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG--SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
+.+.+.||+|+||+||+|+.. +++.||||++.... .....+.+|+.++++++|||||++++++.+.+..+|||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 456789999999999999765 68899999997542 334568899999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec---CCCceEEeecCCccccCCCccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD---SDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~~~~~~~ 609 (804)
+|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..... .
T Consensus 91 gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~ 164 (307)
T d1a06a_ 91 GGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--S 164 (307)
T ss_dssp SCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC--C
Confidence 999999997654 7999999999999999999999988 99999999999994 5789999999999865432 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------------~~~~~~i~~~~ 225 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------------------AKLFEQILKAE 225 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------------HHHHHHHHTTC
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------------------HHHHHHHhccC
Confidence 23456799999999999999999999999999999999999999974321 11112222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhc
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEG 737 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~ 737 (804)
.. .........++.+.+++.+||+.||++|||+.|+++. +.+
T Consensus 226 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 226 YE------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CC------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11 1111122344678899999999999999999999884 544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=388.41 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=194.9
Q ss_pred cccccccccccceeEEEEEeCC--C--cEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD--S--TLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||.||+|++.. + ..||||+++.. ....++|.+|+.++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3567899999999999997632 2 47899998643 2223579999999999999999999999976 467899
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
|||+++|++.+++..+...+++..+++++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999998877778999999999999999999999988 9999999999999999999999999999765442
Q ss_pred cc--cccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 608 SR--VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 608 ~~--~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... . ....
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------------------~-~~~~ 226 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------------------Q-ILHK 226 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------------H-HHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------------------H-HHHH
Confidence 22 2334568889999999999999999999999999999998 89998743211 1 1111
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEG 737 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~ 737 (804)
+.... .....+...+..+.+++.+||+.||++||||.+|++.|++
T Consensus 227 i~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 227 IDKEG--------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHTSC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCC--------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 21111 1111222334678899999999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-44 Score=391.41 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=208.6
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|.. .+++.||||+++.... ..+.+++|+.++++++|||||++++++.+.+..+|||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 45678999999999999976 4689999999976432 345688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--CCCceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--SDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
|+|.+++...+..+++.++..|+.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++...... ..
T Consensus 111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~ 185 (352)
T d1koba_ 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 185 (352)
T ss_dssp CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CE
T ss_pred ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--ce
Confidence 9999988877768999999999999999999999988 99999999999998 67899999999998765432 24
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------------------~~~~~i~~~~~~ 246 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------------------ETLQNVKRCDWE 246 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------------HHHHHHHHCCCC
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCCCC
Confidence 4567999999999999999999999999999999999999999753211 111222222111
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhc
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEG 737 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~ 737 (804)
............+.+|+.+||+.||++|||+.|++++ +++
T Consensus 247 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 247 ------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp ------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred ------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1111122334678899999999999999999999875 554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-44 Score=390.90 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=205.7
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCC-CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGS-GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|+.. +++.||||++..... ..+.+++|+.++++++|||||++++++.+.+..+|||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456789999999999999764 689999999975432 345688999999999999999999999999999999999999
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEec--CCCceEEeecCCccccCCCccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLD--SDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++...... ..
T Consensus 108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~ 182 (350)
T d1koaa2 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SV 182 (350)
T ss_dssp CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--CE
T ss_pred CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc--cc
Confidence 9999999776667999999999999999999999988 99999999999995 46789999999998765432 23
Q ss_pred cccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCccc
Q 044374 612 ATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVA 691 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (804)
....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+..+...
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------------------~~~~~~i~~~~~~ 243 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------------------DETLRNVKSCDWN 243 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHTCCC
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhCCCC
Confidence 456799999999999999999999999999999999999999974321 1111222222110
Q ss_pred eeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 692 AVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 692 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..........+.+.+++.+||+.||++|||+.|++++
T Consensus 244 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112234678899999999999999999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=390.60 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=196.3
Q ss_pred hcccccccccccceeEEEEEeC------CCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecC-CeE
Q 044374 455 TRGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSEN-SHR 524 (804)
Q Consensus 455 t~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~~ 524 (804)
...+.++||+|+||.||+|... .++.||||+++.... ..+.+.+|+..+.++ +|+||+++++++... ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3456789999999999999753 246899999975432 345677788777766 789999999998764 568
Q ss_pred EEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 525 LLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
++||||+++|+|.++|+... ..+++..++.++.||++||+|||+.+ |+||||||+||||+.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCC
Confidence 99999999999999997542 24889999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCccccCCCcc-ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCC-CCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDFS-RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR-RNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+||. .||.....
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-------- 242 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------- 242 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--------
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--------
Confidence 9999999999987644322 2334567999999999999999999999999999999999975 46653221
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
.......+.++.... .+...++.+.+++.+||+.||++||||.||+++|+++++
T Consensus 243 ----------~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 ----------DEEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----------SHHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------HHHHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122233333333222 122334678899999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=391.02 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=208.0
Q ss_pred HhhcccccccccccceeEEEEEe------CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCe
Q 044374 453 TVTRGFSEKLGHGGFGAVFQGEL------SDSTLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSH 523 (804)
Q Consensus 453 ~~t~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 523 (804)
.....+.++||+|+||.||+|++ ..++.||||+++.... ...+|.+|+.+++++ +|||||+++|+|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 34456788999999999999975 2457899999975433 334689999999998 69999999999999999
Q ss_pred EEEEEEEcCCCChhHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEe
Q 044374 524 RLLVYDYMRNGALSLYLRKDG-----------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILL 586 (804)
Q Consensus 524 ~~lV~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl 586 (804)
.++||||+++|+|.++++... ..+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 25889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCC-CCCCcCCCCCc
Q 044374 587 DSDYTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRN-VEAPASGRNAN 664 (804)
Q Consensus 587 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p-~~~~~~~~~~~ 664 (804)
+.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+|+..| +......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence 999999999999998765432 2333456789999999999999999999999999999999995544 4332111
Q ss_pred CCCCCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 665 IGGGGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
....+.+..+ .....+...+..+.+|+.+||+.||++||||.+|+++|++.+
T Consensus 255 --------------~~~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 --------------SKFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp --------------HHHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------HHHHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1111222222 122223334567899999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=388.50 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=203.2
Q ss_pred cccccccccccceeEEEEEeCC--------CcEEEEEEecCCCC--CHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeE
Q 044374 456 RGFSEKLGHGGFGAVFQGELSD--------STLVAVKRLERPGS--GEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHR 524 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 524 (804)
..+.++||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.+....
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 4467899999999999997532 24799999976443 346788898888888 899999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC
Q 044374 525 LLVYDYMRNGALSLYLRKDG---------------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD 589 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~ 589 (804)
++||||+++|+|.++|.... ..+++.+++.++.|||.||+|||+.+ |+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCC
Confidence 99999999999999997543 35899999999999999999999988 9999999999999999
Q ss_pred CceEEeecCCccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhh-CCCCCCCCcCCCCCcCCC
Q 044374 590 YTAKVSDFGLAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIG-GRRNVEAPASGRNANIGG 667 (804)
Q Consensus 590 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 667 (804)
+.+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------- 243 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------- 243 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--------
Confidence 999999999998765432 223445678999999999999999999999999999999998 6777763211
Q ss_pred CCCCCCccCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 668 GGEHGDKWFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
....+.+..+... ..+...++.+.+++.+||+.||++|||+.||+++|+.++.
T Consensus 244 -----------~~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -----------EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------HHHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1222333333222 2222345678999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=388.38 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=202.4
Q ss_pred ccccccccccceeEEEEEeCC-Cc--EEEEEEecCC--CCCHHHHHHHHHHHcCC-CCCCceeeeeEEecCCeEEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELSD-ST--LVAVKRLERP--GSGEREFRAEVCTIGNI-QHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
.+.++||+|+||.||+|.+.+ +. .||||+++.. ....++|.+|+.+|.++ +|||||+++|+|.+.+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 356899999999999998754 33 5788988643 33456799999999998 799999999999999999999999
Q ss_pred cCCCChhHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEe
Q 044374 531 MRNGALSLYLRKD---------------GLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVS 595 (804)
Q Consensus 531 ~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 595 (804)
+++|+|.++|+.. ...+++..+++++.|||+||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEc
Confidence 9999999999753 256899999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCC-CCCCCcCCCCCcCCCCCCCCCc
Q 044374 596 DFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRR-NVEAPASGRNANIGGGGEHGDK 674 (804)
Q Consensus 596 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~ 674 (804)
|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.....
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------------- 232 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------------- 232 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---------------
Confidence 999998654322 2234568999999999999999999999999999999999765 5543211
Q ss_pred cCchHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccccC
Q 044374 675 WFFPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLEV 741 (804)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 741 (804)
......+.++.. ...+...++.+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 233 ----~~~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 233 ----AELYEKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----HHHHHHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 112222322211 122334456799999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=382.43 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=203.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCC-------CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPG-------SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
+.+.++||+|+||+||+|+.. +++.||||+++... ...+.+++|+.++++++|||||++++++.+.+..+||
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456789999999999999864 68999999996421 2357899999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC----ceEEeecCCcccc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY----TAKVSDFGLAKLI 603 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~ 603 (804)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 92 ~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999998754 7999999999999999999999988 99999999999998876 5999999999876
Q ss_pred CCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 168 ~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------------------~~~~ 226 (293)
T d1jksa_ 168 DFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------------------ETLA 226 (293)
T ss_dssp TTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------HHHH
T ss_pred CCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------------------HHHH
Confidence 433 2234567899999999999999999999999999999999999999753211 1112
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..+... .........+..+.+++.+||+.||++|||+.||++.
T Consensus 227 ~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 227 NVSAVNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTTCCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222110 0000111234568899999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=388.91 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=206.7
Q ss_pred cccccccccccceeEEEEEeC------CCcEEEEEEecCCCCC--HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS------DSTLVAVKRLERPGSG--EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 527 (804)
..+.++||+|+||+||+|.+. .++.||||+++..... ...|.+|+.++++++||||++++|+|......++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 346789999999999999763 2578999999754332 24589999999999999999999999999999999
Q ss_pred EEEcCCCChhHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecC
Q 044374 528 YDYMRNGALSLYLRKDG---------LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFG 598 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 598 (804)
|||+++|+|.+++.... ..+++..+.+++.|+|+||.|||+.+ |+||||||+||||+.++++||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecc
Confidence 99999999999986432 34688999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCc-cccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCC-CCCCCCcCCCCCcCCCCCCCCCccC
Q 044374 599 LAKLIGRDF-SRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGR-RNVEAPASGRNANIGGGGEHGDKWF 676 (804)
Q Consensus 599 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 676 (804)
+++...... ........+|+.|+|||.+.+..++.++||||||+++|||+||. .||.....
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----------------- 241 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------------- 241 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------------
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----------------
Confidence 998764432 22334457899999999999999999999999999999999985 55543211
Q ss_pred chHHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 677 FPPWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
......+.++.... .+...+..+.+++.+||+.+|++||||.+|+++|++.++
T Consensus 242 --~~~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 242 --EQVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11222333332222 122334679999999999999999999999999988544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-43 Score=378.73 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=203.5
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.++||+|+||+||+|+.. +++.||||+++. .....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 346789999999999999864 689999999963 234567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred cCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 99999999888755 6788888999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+..+..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------------------~~~~~~i~~~~~ 218 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------------------MKTYEKILNAEL 218 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------------HHHHHHHHHCCC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------------------HHHHHHHHcCCC
Confidence 3456899999999999999999999999999999999999999975321 111222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~~ 734 (804)
..+....+.+.+++.+||+.||++|| ++++++++
T Consensus 219 ----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11223345688999999999999996 89999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=379.09 Aligned_cols=245 Identities=21% Similarity=0.261 Sum_probs=204.8
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCC----CCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP----GSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 34678999999999999976 46899999999642 34567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...... ..
T Consensus 87 ~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~ 161 (337)
T d1o6la_ 87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred cCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence 99999999998765 6889999999999999999999988 9999999999999999999999999998654332 22
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+..+..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------------------~~~~~i~~~~~ 222 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------------RLFELILMEEI 222 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------HHHHHHHHCCC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------------------HHHHHHhcCCC
Confidence 44578999999999999999999999999999999999999999753211 11222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
.++......+.+++..||+.||++||+ +.||+++
T Consensus 223 ----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 122233456889999999999999995 7777763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=377.65 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=205.2
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCCCC
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRNGA 535 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 535 (804)
.+.++||+|+||+||+|... +++.||||+++........+.+|+.+|++++|||||++++++.+.+..+|||||+++|+
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 46689999999999999765 68899999998766556678999999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCC--CceEEeecCCccccCCCccccccc
Q 044374 536 LSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSD--YTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 536 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
|.+++...+..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++..... .....
T Consensus 88 L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~~ 162 (321)
T d1tkia_ 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRL 162 (321)
T ss_dssp HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEE
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--Ccccc
Confidence 99999877667999999999999999999999988 9999999999999854 58999999999875433 22345
Q ss_pred cccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcccee
Q 044374 614 MRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNVAAV 693 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (804)
..+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..+...
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------------------~~~~~~i~~~~~~-- 221 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------------------QQIIENIMNAEYT-- 221 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------------------HHHHHHHHHTCCC--
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHhCCCC--
Confidence 6789999999999999999999999999999999999999975321 1112222222110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 694 VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 694 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
++... .......+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 01124568899999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-43 Score=371.50 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC----HHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG----EREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLL 526 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l 526 (804)
+.+.+.||+|+||.||+|+. .+++.||||+++..... ...|.+|+.++++++||||+++++++.... ..+|
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 34678999999999999975 47899999999754322 346899999999999999999999987543 4789
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+++++|.+++...+ .+++.++..++.||+.||+|||+.+ |+||||||+||||+.++..+|+|||.+......
T Consensus 89 vmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 999999999999887654 7899999999999999999999988 999999999999999999999999998765332
Q ss_pred --ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 607 --FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 607 --~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.........||+.|||||++.+..++.++|||||||++|||+||+.||...... ....+.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------------~~~~~~ 226 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------------SVAYQH 226 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------------HHHHHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------------------HHHHHH
Confidence 222344567999999999999999999999999999999999999999743211 111222
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-TMGTVVKMLEGVL 739 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVl~~L~~~~ 739 (804)
+..+... ........++.+.+++.+||+.||++|| |++++++.|..+.
T Consensus 227 ~~~~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 VREDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHCCCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhcCCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 2221111 0011122346788999999999999999 8999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-43 Score=366.52 Aligned_cols=247 Identities=27% Similarity=0.334 Sum_probs=202.4
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC----------HHHHHHHHHHHcCCC-CCCceeeeeEEecCCeE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG----------EREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----------~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 524 (804)
.+.++||+|+||+||+|+. .+++.||||+++..... .+.+.+|+.++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 4568999999999999976 47899999999754321 135788999999997 99999999999999999
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
+|||||+++|+|.++|..++ .+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999998755 7899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccchhccC------CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCch
Q 044374 605 RDFSRVLATMRGTWGYVAPEWISG------LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFP 678 (804)
Q Consensus 605 ~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (804)
... ......||+.|+|||++.+ ..++.++||||+||+++||++|+.||.....
T Consensus 162 ~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------------------- 220 (277)
T d1phka_ 162 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------------- 220 (277)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------
T ss_pred CCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------------------
Confidence 432 2345679999999999853 3578899999999999999999999975321
Q ss_pred HHHHHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 679 PWAARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
......+..+... .........++.+.+++.+||+.||++|||+.||++.
T Consensus 221 ~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 MLMLRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122233333221 1111122345678899999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-43 Score=377.43 Aligned_cols=241 Identities=23% Similarity=0.253 Sum_probs=203.4
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecC----CCCCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLER----PGSGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 530 (804)
..+.++||+|+||.||+|+.. +++.||||+++. .....+.+.+|+.+|++++|||||++++++......++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 345689999999999999764 689999999963 234567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccc
Q 044374 531 MRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 531 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 610 (804)
+.+|+|..++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 123 ~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred ccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 99999999997654 6899999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 611 LATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ......+..+..
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------------------~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------------------IQIYEKIVSGKV 255 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCCC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------------------HHHHHHHhcCCC
Confidence 3356799999999999999999999999999999999999999974321 112222222211
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRP-----TMGTVVK 733 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVl~ 733 (804)
..+......+.+++.+||+.||.+|+ ++.++++
T Consensus 256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223346688999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=373.78 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=200.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHHHHHHHc-CCCCCCceeeeeEEecCCeEEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRAEVCTIG-NIQHVNLVRLRGFCSENSHRLLVYD 529 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV~E 529 (804)
+.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|+.++. .++|||||++++++.+.+..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346789999999999999765 6899999999642 344556677777654 6899999999999999999999999
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccc
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 y~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred ecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999999998654 6889999999999999999999988 9999999999999999999999999998654332 2
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------------------~~~~~~i~~~~ 219 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------------------EELFHSIRMDN 219 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------------HHHHHHHHHCC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------------------HHHHHHHHcCC
Confidence 23456799999999999999999999999999999999999999975321 11222222221
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMG-TVVK 733 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVl~ 733 (804)
. ..+......+.+|+.+||+.||++||++. ++++
T Consensus 220 ~----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 P----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 11223346688999999999999999995 6764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=375.09 Aligned_cols=245 Identities=24% Similarity=0.235 Sum_probs=193.7
Q ss_pred cccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcC-CCCCCceeeeeEEec----CCeEEEEEEEcCC
Q 044374 460 EKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGN-IQHVNLVRLRGFCSE----NSHRLLVYDYMRN 533 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~lV~E~~~~ 533 (804)
+.||+|+||.||+|+. .+++.||||+++. ...+++|+.++.+ .+|||||++++++.+ ....++|||||++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 4699999999999976 5689999999974 3567889988654 589999999999865 4678999999999
Q ss_pred CChhHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCccc
Q 044374 534 GALSLYLRKDG-LNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFSR 609 (804)
Q Consensus 534 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 609 (804)
|+|.++|...+ ..+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-- 168 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 168 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC--
Confidence 99999998654 46999999999999999999999988 999999999999985 5679999999998765432
Q ss_pred cccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 610 VLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 610 ~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
......||+.|||||++.+..++.++|||||||+||||+||+.||.......... .....+..+.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---------------~~~~~i~~~~ 233 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------------GMKTRIRMGQ 233 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------------CCCSCS
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---------------HHHHHHhcCC
Confidence 2345679999999999999999999999999999999999999997543221000 0000000000
Q ss_pred cceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 690 VAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 690 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
..+.........+.+.+++.+||+.||++|||+.|++++
T Consensus 234 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000001112335678999999999999999999999884
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-42 Score=378.33 Aligned_cols=245 Identities=22% Similarity=0.265 Sum_probs=196.1
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCC----CCCHHHHHH---HHHHHcCCCCCCceeeeeEEecCCeEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERP----GSGEREFRA---EVCTIGNIQHVNLVRLRGFCSENSHRLLVY 528 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 528 (804)
.+.+.||+|+||.||+|+.. +++.||||++... ......+.+ |+.+++.++|||||++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 45689999999999999765 6899999998532 223333444 477888899999999999999999999999
Q ss_pred EEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcc
Q 044374 529 DYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 529 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 608 (804)
||+++|+|.++|.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 87 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp CCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999998754 6889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhc
Q 044374 609 RVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIE 687 (804)
Q Consensus 609 ~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (804)
.....||+.|+|||++.. ..++.++|||||||+||||+||+.||....... .....+....
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~~~~~~~ 223 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----------------KHEIDRMTLT 223 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----------------HHHHHHHSSS
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHhccc
Confidence 345679999999999865 568999999999999999999999997533211 0001111000
Q ss_pred CccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 044374 688 GNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVKM 734 (804)
Q Consensus 688 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~~ 734 (804)
. ....+....+.+.+++.+||+.||++||+ +.|++++
T Consensus 224 ~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 M----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp C----------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 01112223456889999999999999999 5788753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=368.44 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=193.3
Q ss_pred ccccccccceeEEEEEeC-CCcEEEEEEecCCCCC------HHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEc
Q 044374 459 SEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSG------EREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYM 531 (804)
Q Consensus 459 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 531 (804)
.++||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.++++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999864 6899999999643221 246889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVL 611 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 611 (804)
.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred cchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 99877766543 447899999999999999999999988 99999999999999999999999999987654322 23
Q ss_pred cccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhh---c
Q 044374 612 ATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQII---E 687 (804)
Q Consensus 612 ~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 687 (804)
....||+.|+|||++... .++.++|||||||++|||++|+.||........ .....+... .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---------------l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---------------LTRIFETLGTPTE 222 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HHHHHHHHCCCCT
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---------------HHHHHHhcCCCCh
Confidence 446799999999988654 679999999999999999999999975322100 000000000 0
Q ss_pred Ccc---ceecccc---ccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 688 GNV---AAVVDDR---LGGAYK-----VEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 688 ~~~---~~~~d~~---l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
... ....... .....+ ....+.+.+++.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 0000000 000001 1223568899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=361.64 Aligned_cols=277 Identities=18% Similarity=0.257 Sum_probs=199.2
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||+||+|+. .+++.||||+++... .....+.+|+.++++++|||||++++++.+....++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 3467999999999999976 568999999996432 235678999999999999999999999999999999999998
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
++.+..........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 85 ~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~ 160 (298)
T d1gz8a_ 85 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 160 (298)
T ss_dssp EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTT
T ss_pred CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-ccce
Confidence 76565555555567999999999999999999999988 9999999999999999999999999998765432 2344
Q ss_pred ccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc-CCCCCCCCCccCchHHHHHHhhcCcc
Q 044374 613 TMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN-IGGGGEHGDKWFFPPWAARQIIEGNV 690 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (804)
...||+.|+|||.+.... ++.++|||||||++|||++|+.||.......... +.........................
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 567999999999887765 5789999999999999999999997532110000 00000000000000000000000000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
......... .......+.+.+++.+||+.||++|||+.|+++. ++++
T Consensus 241 ~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 241 PKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000000 0001223567889999999999999999999986 6543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=366.07 Aligned_cols=270 Identities=19% Similarity=0.220 Sum_probs=195.8
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCC---CCHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcCC
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPG---SGEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
.+.++||+|+||+||+|+..+++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++++||+.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 3567899999999999999889999999996532 2357899999999999999999999999999999999999998
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCccccccc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLAT 613 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 613 (804)
+.+..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........ ....
T Consensus 85 ~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 159 (286)
T d1ob3a_ 85 DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH 159 (286)
T ss_dssp EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-ccce
Confidence 7777666544 47999999999999999999999988 99999999999999999999999999987654322 2334
Q ss_pred cccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH-Hhh-cCcc
Q 044374 614 MRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR-QII-EGNV 690 (804)
Q Consensus 614 ~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~ 690 (804)
..+++.|+|||.+.+. .++.++|||||||+++||++|+.||................ .......|... ... ....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL--GTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CCCCTTTSTTGGGSTTCCTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhh--CCCChhhccchhhhhhcccc
Confidence 5689999999998764 57899999999999999999999997532210000000000 00000000000 000 0000
Q ss_pred ceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 691 AAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 691 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.................+.+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001111223457889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=361.13 Aligned_cols=237 Identities=26% Similarity=0.410 Sum_probs=192.8
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCC-------CCHHHHHHHHHHHcCCC--CCCceeeeeEEecCCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPG-------SGEREFRAEVCTIGNIQ--HVNLVRLRGFCSENSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~ 525 (804)
+.+.++||+|+||+||+|+. .+++.||||+++... .....+.+|+.++++++ |||||++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 34678999999999999976 468999999996421 11234678999999886 899999999999999999
Q ss_pred EEEEEcCC-CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-CCceEEeecCCcccc
Q 044374 526 LVYDYMRN-GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-DYTAKVSDFGLAKLI 603 (804)
Q Consensus 526 lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~ 603 (804)
+||||+.+ +++.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 86 lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence 99999976 57777776544 7899999999999999999999988 999999999999985 479999999999865
Q ss_pred CCCccccccccccccccccchhccCCCC-CccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 604 GRDFSRVLATMRGTWGYVAPEWISGLAI-TTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 604 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------------------ 214 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------------ 214 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------------------
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------------------
Confidence 433 2345679999999999987765 577899999999999999999996421
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.+..+.. .+ +...+..+.+++.+||+.||++|||+.|+++.
T Consensus 215 -~i~~~~~------~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -EIIRGQV------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -HHHHCCC------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHhhccc------CC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111111 01 11223568899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=358.70 Aligned_cols=270 Identities=20% Similarity=0.263 Sum_probs=194.2
Q ss_pred cccccccccccceeEEEEEeC-C-CcEEEEEEecCC---CCCHHHHHHHHHHHcCC---CCCCceeeeeEEec-----CC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-D-STLVAVKRLERP---GSGEREFRAEVCTIGNI---QHVNLVRLRGFCSE-----NS 522 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 522 (804)
+.+.++||+|+||+||+|+.. . ++.||||+++.. ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 345689999999999999763 3 677999998632 22233466677666554 89999999999853 34
Q ss_pred eEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 523 HRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 523 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
..+++|||+.++++..........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 679999999998887776666668999999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCC-CCCCCCCccCchHHH
Q 044374 603 IGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIG-GGGEHGDKWFFPPWA 681 (804)
Q Consensus 603 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 681 (804)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ ......... .|.
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---~~~ 240 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE---DWP 240 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG---GSC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh---ccc
Confidence 5332 2345678999999999999999999999999999999999999999754221000000 000000000 000
Q ss_pred HHHh-hcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQI-IEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.... ........ .............+.+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCC-CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccc-cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000000 0000011122234567889999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-39 Score=345.25 Aligned_cols=258 Identities=19% Similarity=0.220 Sum_probs=196.1
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceee-eeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRL-RGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||.||+|+. .+++.||||++.... ...++..|++++++++|+|++.. .++..+....++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 34678999999999999976 468899999987543 23457889999999987765555 55567788899999998 4
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC---CCceEEeecCCccccCCCcc--
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS---DYTAKVSDFGLAKLIGRDFS-- 608 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~~~~~~~-- 608 (804)
++|...+......+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||+++.......
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 5666666666668999999999999999999999988 999999999999854 55799999999987643321
Q ss_pred ----ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 609 ----RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 609 ----~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.......||+.|||||.+.+..++.++|||||||++|||++|+.||......... .....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~----------------~~~~~ 227 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------------QKYER 227 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------------------HHH
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH----------------HHHHH
Confidence 2234567999999999999999999999999999999999999999754322100 00000
Q ss_pred hhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 044374 685 IIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVL 739 (804)
Q Consensus 685 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~ 739 (804)
....... ...+.+.. ..++++.+++..|++.+|++||++.++.+.|+.+.
T Consensus 228 ~~~~~~~-~~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 228 ISEKKMS-TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHHHHH-SCHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hhcccCC-CChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0000000 00011111 22356889999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-40 Score=348.64 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=203.9
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC-CCceeeeeEEecCCeEEEEEEEcCC
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-VNLVRLRGFCSENSHRLLVYDYMRN 533 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~ 533 (804)
+.+.++||+|+||+||+|+.. +++.||||++.... ....+++|++.++.++| +|++.+++++......++||||+ +
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 346789999999999999764 68899999986532 33457788888888865 89999999999999999999998 6
Q ss_pred CChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecC-----CCceEEeecCCccccCCCcc
Q 044374 534 GALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDS-----DYTAKVSDFGLAKLIGRDFS 608 (804)
Q Consensus 534 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~~~~~~~ 608 (804)
++|.+++...+..++..++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 8999999887778999999999999999999999988 999999999999974 57899999999987643211
Q ss_pred ------ccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHH
Q 044374 609 ------RVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAA 682 (804)
Q Consensus 609 ------~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (804)
.......||+.|||||.+.+..++.++|||||||++|||++|+.||....... .....
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~----------------~~~~~ 225 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----------------NKQKY 225 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC----------------HHHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh----------------HHHHH
Confidence 12345679999999999999999999999999999999999999997532210 01111
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccc
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKMLEGVLE 740 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~L~~~~~ 740 (804)
..+.+..... .-..+... .++++.+++..|++.+|++||++..+.+.|+++++
T Consensus 226 ~~i~~~~~~~-~~~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 226 ERIGEKKQST-PLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHHHS-CHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhccCCC-ChHHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111111000 00111111 23568889999999999999999999998887653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=360.80 Aligned_cols=271 Identities=24% Similarity=0.245 Sum_probs=193.1
Q ss_pred cccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCceeeeeEEecC------CeEEEEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGEREFRAEVCTIGNIQHVNLVRLRGFCSEN------SHRLLVY 528 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~lV~ 528 (804)
++..++||+|+||+||+|+.. .++.||||+++.... .+.+|+.+|++++||||+++++++... .+.+|||
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 345578999999999999875 689999999975432 234799999999999999999998543 3578999
Q ss_pred EEcCCCChhHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCC
Q 044374 529 DYMRNGALSLYLR--KDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGR 605 (804)
Q Consensus 529 E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~ 605 (804)
||++++.+..+.. .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9998775554433 23457999999999999999999999988 99999999999999775 899999999987644
Q ss_pred CccccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHH
Q 044374 606 DFSRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQ 684 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 684 (804)
.. ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||............. . ............
T Consensus 176 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~---~-~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 176 GE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII---K-VLGTPTREQIRE 249 (350)
T ss_dssp TS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH---H-HHCCCCHHHHHH
T ss_pred Cc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH---H-HhCCChHHhhhh
Confidence 32 2345679999999998765 578999999999999999999999997532110000000 0 000000000011
Q ss_pred hhcC----ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 685 IIEG----NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 685 ~~~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
.... ...................+.+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 0000000000111122334568899999999999999999999974 5554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=346.92 Aligned_cols=197 Identities=23% Similarity=0.320 Sum_probs=163.9
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCC---CCCHHHHHHHHHHHcCCCCCCceeeeeEEec--------CCeE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERP---GSGEREFRAEVCTIGNIQHVNLVRLRGFCSE--------NSHR 524 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~~~~ 524 (804)
.+.++||+|+||+||+|+. .+++.||||++... ....+.+.+|+.+|++++|||++++++++.. ....
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 4568999999999999976 47899999998543 3345678999999999999999999998855 3467
Q ss_pred EEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccC
Q 044374 525 LLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIG 604 (804)
Q Consensus 525 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 604 (804)
++||||++++.+..+... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp EEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecc
Confidence 999999998877655443 447888999999999999999999988 9999999999999999999999999998665
Q ss_pred CCc---cccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCC
Q 044374 605 RDF---SRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAP 657 (804)
Q Consensus 605 ~~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~ 657 (804)
... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 332 1223345799999999998765 6899999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=350.59 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=191.1
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecCC------eEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSENS------HRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 526 (804)
.+.++||+|+||+||+|.. .+++.||||+++..... .+.+.+|+.+|++++|||||++++++...+ +.++
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 3567899999999999976 46899999999765433 346889999999999999999999997654 5699
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+ +.+|..+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 101 v~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp EEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc
Confidence 99999 55777776654 6999999999999999999999988 999999999999999999999999999876443
Q ss_pred ccccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH--
Q 044374 607 FSRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR-- 683 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 683 (804)
.....||+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. .....+.....
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK----VTGTPPAEFVQRL 246 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCCCCHHHHHTC
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh----ccCCCcHHHHhhh
Confidence 3456799999999998764 578999999999999999999999975321100000000 00000000000
Q ss_pred ------HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhccc
Q 044374 684 ------QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGVL 739 (804)
Q Consensus 684 ------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~~ 739 (804)
.... ...+.....+. .........+.+|+.+||+.||++|||+.|++++ ++.+.
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMK-GLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHH-HSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhc-cCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00000000010 1111233567889999999999999999999986 66543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=344.92 Aligned_cols=271 Identities=18% Similarity=0.246 Sum_probs=198.7
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCC---CHHHHHHHHHHHcCCCCCCceeeeeEEecCCeEEEEEEEcC
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS---GEREFRAEVCTIGNIQHVNLVRLRGFCSENSHRLLVYDYMR 532 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 532 (804)
.+.++||+|+||+||+|+. .+++.||||+++.... ....+++|+.++++++||||+++++++......++|+|++.
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~ 84 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence 4568999999999999976 4788999999965432 34678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCcccccc
Q 044374 533 NGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDFSRVLA 612 (804)
Q Consensus 533 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 612 (804)
+++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++....... ...
T Consensus 85 ~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~ 159 (292)
T d1unla_ 85 QDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred ccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence 99998877654 47889999999999999999999988 99999999999999999999999999987654322 233
Q ss_pred ccccccccccchhccCCC-CCccceEEeehhhHHHhhhCCCCCCCCcCCCCCc--CCCCCCCCCccCchHHHHHHhhc-C
Q 044374 613 TMRGTWGYVAPEWISGLA-ITTKADVYSYGMTLLELIGGRRNVEAPASGRNAN--IGGGGEHGDKWFFPPWAARQIIE-G 688 (804)
Q Consensus 613 ~~~gt~~y~aPE~l~~~~-~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~ 688 (804)
...++..|+|||.+.... ++.++|||||||+++||++|+.||.......... +............+.. ....+ .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 237 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TKLPDYK 237 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG--GGSTTCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh--hhccccc
Confidence 456788999999987665 6899999999999999999999975322110000 0000000000000000 00000 0
Q ss_pred ccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 689 NVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 689 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...................+.+.+|+.+||+.||.+|||++||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000111122334568889999999999999999998763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=348.06 Aligned_cols=270 Identities=19% Similarity=0.236 Sum_probs=190.9
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCC--CHHHHHHHHHHHcCCCCCCceeeeeEEecCC----eEEEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGS--GEREFRAEVCTIGNIQHVNLVRLRGFCSENS----HRLLVYD 529 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 529 (804)
.+.++||+|+||+||+|.. .+++.||||+++.... ..+.+++|+.+|++++||||+++++++.... ..+++++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~ 90 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 90 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence 3568999999999999965 5789999999975432 2357889999999999999999999997543 3355667
Q ss_pred EcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc--
Q 044374 530 YMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF-- 607 (804)
Q Consensus 530 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-- 607 (804)
|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 91 ~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 91 HLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp ECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred eecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 78899999999765 5899999999999999999999988 9999999999999999999999999998654332
Q ss_pred cccccccccccccccchhccC-CCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcC----CCCCCCCC-ccCchHHH
Q 044374 608 SRVLATMRGTWGYVAPEWISG-LAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANI----GGGGEHGD-KWFFPPWA 681 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~-~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~ 681 (804)
........||+.|+|||++.. ..++.++||||+||+++||++|+.||........... ........ ........
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 222455679999999999854 5678999999999999999999999975321100000 00000000 00000000
Q ss_pred HHHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 682 ARQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 682 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
...... .......... ........++..++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~--~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 246 RNYLLS--LPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHT--SCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccccc--CCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000000000 0001122468899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=346.45 Aligned_cols=249 Identities=24% Similarity=0.278 Sum_probs=200.1
Q ss_pred cccccccccccceeEEEEEeC----CCcEEEEEEecCC-----CCCHHHHHHHHHHHcCCCC-CCceeeeeEEecCCeEE
Q 044374 456 RGFSEKLGHGGFGAVFQGELS----DSTLVAVKRLERP-----GSGEREFRAEVCTIGNIQH-VNLVRLRGFCSENSHRL 525 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~ 525 (804)
+.+.++||+|+||+||+|+.. .++.||||+++.. ....+.+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456789999999999999642 4789999998532 2345678899999999966 89999999999999999
Q ss_pred EEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCC
Q 044374 526 LVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGR 605 (804)
Q Consensus 526 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 605 (804)
+||||+.+|+|.+++...+ .+.+.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999998765 5678888999999999999999988 99999999999999999999999999987655
Q ss_pred CccccccccccccccccchhccCC--CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHH
Q 044374 606 DFSRVLATMRGTWGYVAPEWISGL--AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAAR 683 (804)
Q Consensus 606 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 683 (804)
..........|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ......+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---------------~~~~i~~ 246 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---------------SQAEISR 246 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---------------CHHHHHH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHH
Confidence 544445567899999999998764 46789999999999999999999997543221 1111111
Q ss_pred HhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 044374 684 QIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPT-----MGTVVK 733 (804)
Q Consensus 684 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVl~ 733 (804)
...... ...+.....++.+++.+||+.||++||+ +.|+++
T Consensus 247 ~~~~~~----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 247 RILKSE----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred hcccCC----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111 1122344577889999999999999995 788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-38 Score=339.81 Aligned_cols=262 Identities=16% Similarity=0.195 Sum_probs=193.7
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-CCCceeeeeEEec--CCeEEEEEEEc
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSE--NSHRLLVYDYM 531 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~E~~ 531 (804)
+.+.++||+|+||+||+|+. .+++.||||+++.. ..+.+++|+.+|.+++ ||||+++++++.. ....++||||+
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 44668999999999999976 46899999999743 4678899999999995 9999999999874 45689999999
Q ss_pred CCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCC-ceEEeecCCccccCCCcccc
Q 044374 532 RNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDY-TAKVSDFGLAKLIGRDFSRV 610 (804)
Q Consensus 532 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 610 (804)
.+++|..+.+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+++...... .
T Consensus 115 ~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~ 185 (328)
T d3bqca1 115 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--E 185 (328)
T ss_dssp CSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--C
T ss_pred CCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC--c
Confidence 9999977643 5899999999999999999999988 99999999999998655 69999999998765432 2
Q ss_pred ccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCCCccCchHHHHHHhhcCc
Q 044374 611 LATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHGDKWFFPPWAARQIIEGN 689 (804)
Q Consensus 611 ~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 689 (804)
.....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............. ....-.+..........
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i-----~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI-----AKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH-----HHHHCHHHHHHHHHHTT
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH-----HHHHCCchhhhhhhhcc
Confidence 3456789999999998765 47999999999999999999999997532210000000 00000000000000000
Q ss_pred cc------ee--------ccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 044374 690 VA------AV--------VDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVK 733 (804)
Q Consensus 690 ~~------~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~ 733 (804)
.. .. ................+.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 0000111112233456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=338.60 Aligned_cols=268 Identities=22% Similarity=0.262 Sum_probs=185.7
Q ss_pred ccccccccccceeEEEEEeC-CCcEEEEEEecCCCCCH---HHHHHHHHHHcCCCCCCceeeeeEEec------CCeEEE
Q 044374 457 GFSEKLGHGGFGAVFQGELS-DSTLVAVKRLERPGSGE---REFRAEVCTIGNIQHVNLVRLRGFCSE------NSHRLL 526 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~~l 526 (804)
.+.++||+|+||+||+|... +++.||||++....... ..+.+|+.++++++||||+++++++.. ..+.++
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 34579999999999999765 68999999997654333 458899999999999999999999963 368899
Q ss_pred EEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCC
Q 044374 527 VYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRD 606 (804)
Q Consensus 527 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 606 (804)
||||+.++.+.. +. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++.....
T Consensus 100 v~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 100 VMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence 999997765543 33 25889999999999999999999988 999999999999999999999999999865433
Q ss_pred ccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCC---CCCCCCcc-CchHHHH
Q 044374 607 FSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGG---GGEHGDKW-FFPPWAA 682 (804)
Q Consensus 607 ~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~ 682 (804)
.......+|+.|+|||++.+..++.++||||+||+++||++|+.||............. .....+.+ ......
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~- 249 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV- 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH-
T ss_pred --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH-
Confidence 22345678999999999999999999999999999999999999997532110000000 00000000 000000
Q ss_pred HHhhcCc--c-----ceecccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 044374 683 RQIIEGN--V-----AAVVDDRLG---GAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM 734 (804)
Q Consensus 683 ~~~~~~~--~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~ 734 (804)
.....+. . ......... ..........+.+|+.+||+.||++|||++||+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000110 0 000000010 11123345678899999999999999999999866
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=336.22 Aligned_cols=271 Identities=20% Similarity=0.247 Sum_probs=191.9
Q ss_pred ccccccccccceeEEEEEe-CCCcEEEEEEecCCCCC---HHHHHHHHHHHcCCCCCCceeeeeEEecC-----CeEEEE
Q 044374 457 GFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSG---EREFRAEVCTIGNIQHVNLVRLRGFCSEN-----SHRLLV 527 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV 527 (804)
.+.++||+|+||+||+|+. .+++.||||+++..... .+.+.+|+.++++++|||+|++++++... ...+++
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 4567999999999999975 57899999999765433 34678999999999999999999998643 345677
Q ss_pred EEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeecCCccccCCCc
Q 044374 528 YDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDFGLAKLIGRDF 607 (804)
Q Consensus 528 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 607 (804)
+||+.+|+|.+++..+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.....
T Consensus 101 ~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 101 VTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp EEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc--
Confidence 8888999999999654 6999999999999999999999988 99999999999999999999999999976432
Q ss_pred cccccccccccccccchhccCC-CCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCC--CCCC--CccCchHHHH
Q 044374 608 SRVLATMRGTWGYVAPEWISGL-AITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGG--GEHG--DKWFFPPWAA 682 (804)
Q Consensus 608 ~~~~~~~~gt~~y~aPE~l~~~-~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~ 682 (804)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.............. .... ..........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 23456789999999987665 468899999999999999999999975321100000000 0000 0000000000
Q ss_pred HHhhcCccceeccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 044374 683 RQIIEGNVAAVVDDRLGGAYKVEEAERVALVAIWCIQDNEEMRPTMGTVVKM--LEGV 738 (804)
Q Consensus 683 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVl~~--L~~~ 738 (804)
..... .........+.. ........+.+|+.+||+.||++|||+.|++++ +.+.
T Consensus 252 ~~~~~-~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 252 RNYIQ-SLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHT-TSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhh-hcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000 000000000000 001123567889999999999999999999974 5543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-35 Score=316.93 Aligned_cols=269 Identities=22% Similarity=0.246 Sum_probs=191.9
Q ss_pred cccccccccccceeEEEEEe-CCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----------CCCceeeeeEEec--C
Q 044374 456 RGFSEKLGHGGFGAVFQGEL-SDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----------HVNLVRLRGFCSE--N 521 (804)
Q Consensus 456 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~--~ 521 (804)
+.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 45678999999999999976 47899999999865544567888998888775 5789999988754 3
Q ss_pred CeEEEEEEEcCCCChhHHH--hhCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCcEEecCCC------ce
Q 044374 522 SHRLLVYDYMRNGALSLYL--RKDGLNLNWDVRFRIAVGTARGIAYLHE-ECRDCIIHCDIKPENILLDSDY------TA 592 (804)
Q Consensus 522 ~~~~lV~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dlkp~NILl~~~~------~~ 592 (804)
...+++++++..+...... ......+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++ .+
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccccee
Confidence 5667777777665433322 2334578889999999999999999997 66 99999999999998665 39
Q ss_pred EEeecCCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhHHHhhhCCCCCCCCcCCCCCcCCCCCCCC
Q 044374 593 KVSDFGLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTLLELIGGRRNVEAPASGRNANIGGGGEHG 672 (804)
Q Consensus 593 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 672 (804)
||+|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||......... .
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~--------~ 239 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT--------K 239 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------------C
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc--------c
Confidence 99999999865432 34567999999999999999999999999999999999999999753221000 0
Q ss_pred CccCc----------hHHHHHH-------hhcC-ccceecccc---------ccCCCCHHHHHHHHHHHhhccccCCCCC
Q 044374 673 DKWFF----------PPWAARQ-------IIEG-NVAAVVDDR---------LGGAYKVEEAERVALVAIWCIQDNEEMR 725 (804)
Q Consensus 673 ~~~~~----------~~~~~~~-------~~~~-~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 725 (804)
....+ +...... .... ....+.... ............+.+|+.+||+.||++|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 00000 0000000 0000 000000000 0122345667889999999999999999
Q ss_pred CCHHHHHHH--Hhccc
Q 044374 726 PTMGTVVKM--LEGVL 739 (804)
Q Consensus 726 Ps~~eVl~~--L~~~~ 739 (804)
||++|++++ +++..
T Consensus 320 pta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred cCHHHHhcCcccCCCC
Confidence 999999875 65443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.2e-22 Score=197.43 Aligned_cols=168 Identities=15% Similarity=0.140 Sum_probs=120.4
Q ss_pred ccccccccccceeEEEEEeCCCcEEEEEEecCCCC------C-------------HHHHHHHHHHHcCCCCCCceeeeeE
Q 044374 457 GFSEKLGHGGFGAVFQGELSDSTLVAVKRLERPGS------G-------------EREFRAEVCTIGNIQHVNLVRLRGF 517 (804)
Q Consensus 457 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~-------------~~~~~~Ei~~l~~l~H~niv~l~g~ 517 (804)
.+.++||+|+||+||+|...+++.||||+++.... . ...+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999988899999998753211 0 1234568888999999999988765
Q ss_pred EecCCeEEEEEEEcCCCChhHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcEEecCCCceEEeec
Q 044374 518 CSENSHRLLVYDYMRNGALSLYLRKDGLNLNWDVRFRIAVGTARGIAYLHEECRDCIIHCDIKPENILLDSDYTAKVSDF 597 (804)
Q Consensus 518 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 597 (804)
.. .+++|||+++..+. .++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+||
T Consensus 83 ~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred cC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 32 37999999986654 2445566789999999999999988 9999999999999865 5899999
Q ss_pred CCccccCCCccccccccccccccccchhccCCCCCccceEEeehhhH
Q 044374 598 GLAKLIGRDFSRVLATMRGTWGYVAPEWISGLAITTKADVYSYGMTL 644 (804)
Q Consensus 598 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ksDV~S~Gvvl 644 (804)
|+|.....+.....-. ..... -.|.+ .+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 9997654321110000 00000 01122 35678899999965443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.76 E-value=2.1e-18 Score=152.27 Aligned_cols=103 Identities=15% Similarity=0.312 Sum_probs=86.3
Q ss_pred eeecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEE
Q 044374 3 VIIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIW 82 (804)
Q Consensus 3 ~~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w 82 (804)
..|..|++|+| |.|+|+|+.+|+ |.|++. .++||.||++.|..+ +.|.|+.||+|+|+|. +.++|
T Consensus 8 q~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~~---~~l~l~~dGnLvl~~~-~~~~w 72 (112)
T d1xd5a_ 8 HQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKASG---CVLKMQNDGNLVIYSG-SRAIW 72 (112)
T ss_dssp EEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCSS---EEEEECTTSCEEEEET-TEEEE
T ss_pred CEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCCCC---cEEEEeccccEEEEec-CCeEE
Confidence 46889999985 999999999987 888764 589999999988543 5899999999999997 45677
Q ss_pred Eec-c-CCceeEEEEccCCcEEEecCCCCeeecccCCCcc
Q 044374 83 QST-N-TEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTD 120 (804)
Q Consensus 83 ~~~-~-~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTD 120 (804)
+++ . ..+..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus 73 ~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 73 ASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp ECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 665 2 2345689999999999999999999999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.72 E-value=1.3e-17 Score=145.66 Aligned_cols=97 Identities=16% Similarity=0.264 Sum_probs=81.8
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|.+|++|. +|.|+|.|+.+|+ |.||.. .++||.||++.|-. +..|.++.+|+|+|.|++|.+||+
T Consensus 9 ~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~---~~~l~l~~~Gnlvl~~~~g~~vWs 74 (108)
T d1jpca_ 9 TLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGLSR---SCFLSMQTDGNLVVYNPSNKPIWA 74 (108)
T ss_dssp EECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS---SCEEEECTTSCEEEECTTCCEEEE
T ss_pred EecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCCCC---ccEEEEeccceEEEECCCccceEE
Confidence 578889885 6999999999987 888864 47899999998843 347999999999999999999999
Q ss_pred ecc--CCceeEEEEccCCcEEEecCCCCeeecccCC
Q 044374 84 STN--TEKATDMYLLETGNLVLLSSAGSLVWQSFDH 117 (804)
Q Consensus 84 ~~~--~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~ 117 (804)
|+. .....+|+|+|+|||||++. .+||||+|
T Consensus 75 S~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 75 SNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 973 23345789999999999964 59999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.72 E-value=2.4e-17 Score=144.03 Aligned_cols=98 Identities=16% Similarity=0.300 Sum_probs=81.2
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
.|.+|++|+ +|.|.|+|+.+|+ |.++.. .++||+||++.|... +..|.|++||+|+|+|++|.+||+
T Consensus 9 ~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~~----~~~vW~ant~~~~~~--~~~l~l~~dGnLvl~~~~g~~vW~ 75 (109)
T d1kj1a_ 9 GLYAGQSLD--VEPYHFIMQEDCN-----LVLYDH----STSVWASNTGILGKK--GCKAVLQSDGNFVVYDAEGRSLWA 75 (109)
T ss_dssp EEETTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCCCTTCC--CCEEEECTTSCEEEECSSSCEEEE
T ss_pred EEeCCCEEE--eCCEEEEecCCCe-----EEEEeC----CEEEEEeCCCCCCce--eEEEEEcCCceEEEEeCCCcEEEE
Confidence 456777776 4889999999876 777653 588999999999775 468999999999999999999999
Q ss_pred eccC--CceeEEEEccCCcEEEecCCCCeeecccCC
Q 044374 84 STNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDH 117 (804)
Q Consensus 84 ~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~ 117 (804)
|+.. .+...|+|+|+|||||++. .+|||+-|
T Consensus 76 s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 76 SHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp CCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred EeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9733 3456799999999999964 69999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=6.9e-17 Score=143.39 Aligned_cols=98 Identities=18% Similarity=0.278 Sum_probs=82.2
Q ss_pred EEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCee
Q 044374 34 GIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLV 111 (804)
Q Consensus 34 ~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~ 111 (804)
-|||.++++++.+|++|++.|+... .-.|.|+.||||+|++. +.++|+++.. .....|.|+++|||||++.++.+|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g-~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~l 88 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLS-PYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV 88 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCS-SCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcC-CEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEE
Confidence 4899999999999999999999864 35899999999999986 6789998733 235689999999999999999999
Q ss_pred ecccCCCcccccCCCccccceeeeeccCCCCCCCcceeeeeCCCCCc
Q 044374 112 WQSFDHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYN 158 (804)
Q Consensus 112 WqSFd~PTDTlLpg~~l~~~~~L~Sw~s~~dps~G~ys~~~~~~g~~ 158 (804)
||||. +.++|.|.+.+++||..
T Consensus 89 W~S~t-------------------------~~~~~~~~l~Lq~DGnl 110 (120)
T d1dlpa2 89 WTSGN-------------------------SRSAGRYVFVLQPDRNL 110 (120)
T ss_dssp EECCC-------------------------CCSSSCCEEEECSSSCE
T ss_pred EEeCC-------------------------CCCCCcEEEEECCCCcE
Confidence 99983 34678999999999753
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=1.8e-15 Score=132.73 Aligned_cols=109 Identities=20% Similarity=0.318 Sum_probs=90.1
Q ss_pred EEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEEec-cCCceeEEEEccCCcEEEecCCCCeeec
Q 044374 35 IWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQST-NTEKATDMYLLETGNLVLLSSAGSLVWQ 113 (804)
Q Consensus 35 iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~-~~~~~~~~~l~~~gnlv~~~~~~~~~Wq 113 (804)
|||.-.+..+..|..+.++++.+. ...|.|+.||||||++ .+.++|+++ ....+..+.|+++|||||++.++.+|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g-~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELS-SFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECST-TEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred EEEecCCCCCCcceecCCCcEEcC-CEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEE
Confidence 678777778888999999999864 4589999999999998 467899997 3445678999999999999999999999
Q ss_pred ccCCCcccccCCCccccceeeeeccCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 114 SFDHPTDTWLPGMNISVGGSITSWKSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 114 SFd~PTDTlLpg~~l~~~~~L~Sw~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
|+. +.++|.|.+.|++||.. + +|. .+||.+|.
T Consensus 81 S~t-------------------------~~~~g~y~l~Lq~DGNl--v-lY~--~~~Wssgt 112 (115)
T d1dlpa1 81 SGT-------------------------KGSIGNYVLVLQPDRTV--T-IYG--PGLWDSGT 112 (115)
T ss_dssp CCC-------------------------CCCSSCCEEEECSSSCE--E-EEC--SEEEECSC
T ss_pred cCC-------------------------CCCCCCEEEEECCCCcE--E-EeC--CCeecCCC
Confidence 873 34689999999999753 2 453 37998885
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=4.2e-14 Score=124.75 Aligned_cols=99 Identities=15% Similarity=0.328 Sum_probs=81.1
Q ss_pred eeecCCCEE--EeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcE
Q 044374 3 VIIKGNSTI--ISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSI 80 (804)
Q Consensus 3 ~~~~~~~~~--~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~ 80 (804)
.+|.++|+| ++..|.|.|.|+.+|+ |-++ . ..++||.||+..|..+ ..|.|+.||+|+|.|++|.+
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~~~---~~l~l~~dGnLvL~d~~g~~ 82 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLGNG---CRAVLQPDGVLVVITNENVT 82 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSCSS---CEEEECTTSCEEEECTTCCE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCCcc---eEEEEEeCCCEEEECCCCcE
Confidence 467888877 5568999999999987 7664 3 3588999999877443 58999999999999999999
Q ss_pred EEEeccC--CceeEEEEccCCcEEEecCCCCeeecccC
Q 044374 81 IWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFD 116 (804)
Q Consensus 81 ~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd 116 (804)
||++++. ....+++|+|+|||||++ .++|||-.
T Consensus 83 vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 83 VWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred EEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9998743 234578999999999985 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.24 E-value=3.3e-12 Score=111.59 Aligned_cols=95 Identities=19% Similarity=0.345 Sum_probs=77.5
Q ss_pred eecCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEE
Q 044374 4 IIKGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQ 83 (804)
Q Consensus 4 ~~~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 83 (804)
+|.+++.| .+|.|+|.|..+|+ |.|+.. .++||.+|...+ .+.++.|+.+|||||.|.++.+||+
T Consensus 16 tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~~----~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 16 TLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA----TGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC----SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred eecCCCcE--EcCCEEEEECCCCe-----EEEEcC----CeeEEEcccCCC----CceEEEEeccCCEEEEccCCCEEEE
Confidence 57788988 57899999999987 888753 478999997543 3468999999999999999999999
Q ss_pred ecc--CCceeEEEEccCCcEEEecCCCCeeecccC
Q 044374 84 STN--TEKATDMYLLETGNLVLLSSAGSLVWQSFD 116 (804)
Q Consensus 84 ~~~--~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd 116 (804)
+.. ..+...++|+++|||||++ ..+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 973 3344579999999999995 47999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.93 E-value=1e-09 Score=96.42 Aligned_cols=92 Identities=20% Similarity=0.389 Sum_probs=69.8
Q ss_pred cCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEecCCCCCCCCCCCcEEEEeccccEEEecCCCcEEEEec
Q 044374 6 KGNSTIISQNQTFRLGFFATNGESSWYLGIWYASIPTPTYVWVANREKSVADVTQSTLLITEKGKLAIKDSQNSIIWQST 85 (804)
Q Consensus 6 ~~~~~~~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~~~vW~anr~~p~~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~ 85 (804)
..++.| ..|.|.|.|...|+ |.|+.. ..+||.+|-.. .+ ....+.|..+|||||.|.++.++|+|.
T Consensus 27 ~~~q~l--~~g~y~L~~q~DGN-----LvL~~~----~~~vW~s~t~~--~~-~~~~~~l~~~GnLvl~d~~~~~lW~S~ 92 (120)
T d1dlpa2 27 HATQSL--QLSPYRLSMETDCN-----LVLFDR----DDRVWSTNTAG--KG-TGCRAVLQPNGRMDVLTNQNIAVWTSG 92 (120)
T ss_dssp CSSCCC--BCSSCEEEEETTTE-----EEEEBT----TBCCSCCCCCS--SC-SSCEEEEETTTEEEEEETTTEEEEECC
T ss_pred cCCCee--EcCCEEEEEcCCCc-----EEEecC----CcEEEEEcccc--CC-CcEEEEEeCCeeEEEEcCCCCEEEEeC
Confidence 334444 36889999998876 878653 46789998543 22 235799999999999999999999997
Q ss_pred c--CCceeEEEEccCCcEEEecCCCCeeecc
Q 044374 86 N--TEKATDMYLLETGNLVLLSSAGSLVWQS 114 (804)
Q Consensus 86 ~--~~~~~~~~l~~~gnlv~~~~~~~~~WqS 114 (804)
. ..+...+.|+++|||||++ ..+|.|
T Consensus 93 t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 93 NSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp CCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred CCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 3 2344578999999999995 468875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.91 E-value=3e-09 Score=93.05 Aligned_cols=83 Identities=25% Similarity=0.462 Sum_probs=64.5
Q ss_pred EEEEeccccEEEecCCCcEEEEeccC--CceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeeccC
Q 044374 62 TLLITEKGKLAIKDSQNSIIWQSTNT--EKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWKS 139 (804)
Q Consensus 62 ~l~~~~~g~l~l~~~~~~~~w~~~~~--~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~s 139 (804)
.|.++.||||||+++ +.++|+++.. ...+.+.|+++|||||++..+.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 588999999999975 5689999833 23578999999999999999999997631
Q ss_pred CCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 140 LFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 140 ~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
.-+.|.|.+.++++|.. + +|. .+.|.++.
T Consensus 89 --~~~~~~~~l~Lq~DGNl--v-lYg--~~~W~S~T 117 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNV--V-IYG--DALWATQT 117 (119)
T ss_dssp --CCCSSCEEEEECTTSCE--E-EEE--SEEEECCC
T ss_pred --cCCCCceEEEEcCCCCE--E-EEC--CCEeccCC
Confidence 11457899999999753 2 343 36898874
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.85 E-value=7.2e-09 Score=89.32 Aligned_cols=85 Identities=27% Similarity=0.517 Sum_probs=65.0
Q ss_pred cEEEEeccccEEEecCCCcEEEEecc---CCceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeec
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTN---TEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSW 137 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~---~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw 137 (804)
-.|.|..||||||+. .+.+||+++. ......+.|+++|||||++.++.++|+|-
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~---------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH---------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC----------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe----------------------
Confidence 468899999999986 5679999973 23356799999999999999999999871
Q ss_pred cCCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCCC
Q 044374 138 KSLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGNW 176 (804)
Q Consensus 138 ~s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~w 176 (804)
+..+.|.|.+.++++|.. + +++ .+.|.|+.+
T Consensus 78 ---t~~~~~~~~l~L~ddGNl--v-ly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ---SVRGNGNYVLVLQEDGNV--V-IYG--SDIWSTGTY 108 (109)
T ss_dssp ---CCCCSSCCEEEECTTSCE--E-EEC--CEEEECCCC
T ss_pred ---eECCCCCEEEEEeCCCcE--E-EEC--CCEecCCCc
Confidence 112457899999999753 3 444 358887753
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.84 E-value=4e-09 Score=90.97 Aligned_cols=83 Identities=22% Similarity=0.403 Sum_probs=62.7
Q ss_pred cEEEEeccccEEEecCCCcEEEEeccCC--ceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTNTE--KATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~--~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
-+|.++.||||||++ .+.+||+++... ....+.|+++|||||++.++.+||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 478999999999997 467899997332 34689999999999999999999986
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTG 174 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg 174 (804)
.+..+.+.|.+.++++|.. + ++.. +.|.|+
T Consensus 76 -~t~~~~~~~~l~L~ddGNl--V-ly~~--~~W~S~ 105 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNV--V-IYGT--DRWATG 105 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCE--E-EEEC--CCCCCC
T ss_pred -cccCCCCcEEEEEcCCCCE--E-EeCC--CcccCC
Confidence 1122457889999999753 3 3432 456655
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.56 E-value=1.4e-07 Score=81.69 Aligned_cols=86 Identities=23% Similarity=0.407 Sum_probs=62.9
Q ss_pred cEEEEeccccEEEecCCCcEEEEecc--CCceeEEEEccCCcEEEecCCCCeeecccCCCcccccCCCccccceeeeecc
Q 044374 61 STLLITEKGKLAIKDSQNSIIWQSTN--TEKATDMYLLETGNLVLLSSAGSLVWQSFDHPTDTWLPGMNISVGGSITSWK 138 (804)
Q Consensus 61 ~~l~~~~~g~l~l~~~~~~~~w~~~~--~~~~~~~~l~~~gnlv~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~L~Sw~ 138 (804)
-.|.|+.||||||++ .+.+||+++. ....+.+.|+.+|||||++. +..+|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s------------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWAS------------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEEC------------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEE------------------------
Confidence 579999999999987 5679999973 23457899999999999986 4566744
Q ss_pred CCCCCCCcceeeeeCCCCCceEEEEEeCcEEEEecCC
Q 044374 139 SLFDPSPGFYSLRLSPTGYNQIELVYNGTIVYWSTGN 175 (804)
Q Consensus 139 s~~dps~G~ys~~~~~~g~~~~~~~~~~~~~yw~sg~ 175 (804)
.+.-..|.|.+.++.+|. +++.-....+.|.|+.
T Consensus 75 -~t~~~~~~~~l~L~ddGN--lvly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -NTNRQNGNYYLILQRDRN--VVIYDNSNNAIWATHT 108 (112)
T ss_dssp -CCCCSCCCCEEEECTTSC--EEEECTTSCEEEECCC
T ss_pred -eeccCCCceEEEEcCCCC--EEEECCCCcEEecCCC
Confidence 111235778999999974 3333333568898875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.88 E-value=4.5e-05 Score=75.92 Aligned_cols=131 Identities=12% Similarity=0.040 Sum_probs=87.9
Q ss_pred ccceeEEEEEeCCCcEEEEEEecCC-CCCHHHHHHHHHHHcCCC-CCCceeeeeEEecCCeEEEEEEEcCCCChhHHHhh
Q 044374 465 GGFGAVFQGELSDSTLVAVKRLERP-GSGEREFRAEVCTIGNIQ-HVNLVRLRGFCSENSHRLLVYDYMRNGALSLYLRK 542 (804)
Q Consensus 465 G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 542 (804)
++...||+.... ++.+.||+.... ......+.+|...+..+. +--+-+++.+....+..++|||++++..+.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 334689998764 445778887543 223345677777766553 33355677888888899999999999887654322
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------------
Q 044374 543 DGLNLNWDVRFRIAVGTARGIAYLHEEC---------------------------------------------------- 570 (804)
Q Consensus 543 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------------- 570 (804)
. .....++.++++.++.||+..
T Consensus 104 ~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 E------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp C------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred c------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 1 122334555555666666421
Q ss_pred ----CCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 571 ----RDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 571 ----~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.56 E-value=0.00018 Score=70.96 Aligned_cols=130 Identities=17% Similarity=0.099 Sum_probs=82.9
Q ss_pred cccccc-eeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC--CCCceeeeeEEecCCeEEEEEEEcCCCChhH
Q 044374 462 LGHGGF-GAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ--HVNLVRLRGFCSENSHRLLVYDYMRNGALSL 538 (804)
Q Consensus 462 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 538 (804)
+..|.. ..||+....++..+.+|....... ..+..|...++.+. .-.+-+++.+..+.+..++|||++++.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444443 679999888888888898754322 23566666665553 3345667888888888999999998876532
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHH---------------------------------------------------HHHHh
Q 044374 539 YLRKDGLNLNWDVRFRIAVGTARG---------------------------------------------------IAYLH 567 (804)
Q Consensus 539 ~l~~~~~~l~~~~~~~i~~~ia~g---------------------------------------------------L~yLH 567 (804)
.. .. ....+.++++. +..+.
T Consensus 96 ~~------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 96 SH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp SC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cc------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 10 00 00111122222 22222
Q ss_pred hc----CCCCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 568 EE----CRDCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 568 ~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
.. .+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122389999999999999887788999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.21 E-value=0.00062 Score=71.85 Aligned_cols=74 Identities=14% Similarity=0.093 Sum_probs=45.8
Q ss_pred cccccccceeEEEEEeCC-CcEEEEEEecC----C----CCCHHHHHHHHHHHcCCC-C--CCceeeeeEEecCCeEEEE
Q 044374 460 EKLGHGGFGAVFQGELSD-STLVAVKRLER----P----GSGEREFRAEVCTIGNIQ-H--VNLVRLRGFCSENSHRLLV 527 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~----~----~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 527 (804)
+.||.|....||+....+ ++.++||.-.. . .........|...++.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 478999999999997754 57899997532 1 112234456776666542 2 334455544 34456899
Q ss_pred EEEcCCCC
Q 044374 528 YDYMRNGA 535 (804)
Q Consensus 528 ~E~~~~gs 535 (804)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0013 Score=67.33 Aligned_cols=133 Identities=14% Similarity=0.100 Sum_probs=79.5
Q ss_pred eeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCCC-----CCceeee--eEEecCCeEEEEEEEcCCCChh---
Q 044374 468 GAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQH-----VNLVRLR--GFCSENSHRLLVYDYMRNGALS--- 537 (804)
Q Consensus 468 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H-----~niv~l~--g~~~~~~~~~lV~E~~~~gsL~--- 537 (804)
-.||+....+|+.+++|+.+......+++..|+..+..|.. +..+..- .........+.+++++++..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 57999999999999999987655677888889888766642 2112211 1223456778999998865431
Q ss_pred --HH---------Hhh----C----CCCCCHH-------------------HHHHHHHHHHHHHHHHhh----cCCCCeE
Q 044374 538 --LY---------LRK----D----GLNLNWD-------------------VRFRIAVGTARGIAYLHE----ECRDCII 575 (804)
Q Consensus 538 --~~---------l~~----~----~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~ii 575 (804)
.+ ++. . ...+++. .+..+...+.+.++.+.. ..+..+|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 10 110 0 0111111 111122222233333332 2245689
Q ss_pred ecCCCCCcEEecCCCceEEeecCCccc
Q 044374 576 HCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 576 H~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
|+|+.+.|||++.+ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.22 E-value=0.0048 Score=64.83 Aligned_cols=72 Identities=19% Similarity=0.212 Sum_probs=48.8
Q ss_pred cccccccceeEEEEEeCCC--------cEEEEEEecCCCCCHHHHHHHHHHHcCCCCCCc-eeeeeEEecCCeEEEEEEE
Q 044374 460 EKLGHGGFGAVFQGELSDS--------TLVAVKRLERPGSGEREFRAEVCTIGNIQHVNL-VRLRGFCSENSHRLLVYDY 530 (804)
Q Consensus 460 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 530 (804)
+.|+.|-.-.+|+....++ +.|.+++... ....-...+|..+++.+.-.++ .++++++.. .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4688888889999986542 4566666653 3344556778888887753344 367777653 689999
Q ss_pred cCCCCh
Q 044374 531 MRNGAL 536 (804)
Q Consensus 531 ~~~gsL 536 (804)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.65 E-value=0.047 Score=54.78 Aligned_cols=140 Identities=10% Similarity=0.020 Sum_probs=72.3
Q ss_pred ccccccceeEEEEEeCCCcEEEEEEecCCCCCHHHHHHHHHHHcCCC-----CCCceeee---eEEecCCeEEEEEEEcC
Q 044374 461 KLGHGGFGAVFQGELSDSTLVAVKRLERPGSGEREFRAEVCTIGNIQ-----HVNLVRLR---GFCSENSHRLLVYDYMR 532 (804)
Q Consensus 461 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~---g~~~~~~~~~lV~E~~~ 532 (804)
.|..|---+.|+.+..+++ +++|+.+... ...++..|+.++..+. -|..+... .+.........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3556666888999887766 8999886532 2234444555555442 22222211 01222345666777766
Q ss_pred CCChhH--------------HHhh--CC------C------------------CCCHHHHHHHHHHHHHHHHHHhhc-CC
Q 044374 533 NGALSL--------------YLRK--DG------L------------------NLNWDVRFRIAVGTARGIAYLHEE-CR 571 (804)
Q Consensus 533 ~gsL~~--------------~l~~--~~------~------------------~l~~~~~~~i~~~ia~gL~yLH~~-~~ 571 (804)
+..... .++. .. . ..........+..+...+.-.+.. -+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543311 0000 00 0 000011122222223333333221 24
Q ss_pred CCeEecCCCCCcEEecCCCceEEeecCCccc
Q 044374 572 DCIIHCDIKPENILLDSDYTAKVSDFGLAKL 602 (804)
Q Consensus 572 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 602 (804)
.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4699999999999999988788999998863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.04 E-value=0.0073 Score=37.80 Aligned_cols=33 Identities=39% Similarity=0.743 Sum_probs=26.9
Q ss_pred CCCcccccCCCCCccccCC-CCCCCCCCCCCcccC
Q 044374 253 EDICRVHGLCGNFGFCKSS-LLRPCMCFDGFRPVD 286 (804)
Q Consensus 253 ~~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 286 (804)
.|.|.+-..|| ||.|+.- ..-.|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 37899999999 6888654 467799999999853
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.96 E-value=0.098 Score=34.97 Aligned_cols=30 Identities=27% Similarity=0.703 Sum_probs=24.4
Q ss_pred CCccc-ccCCCCCccccCC-CCCCCCCCCCCc
Q 044374 254 DICRV-HGLCGNFGFCKSS-LLRPCMCFDGFR 283 (804)
Q Consensus 254 ~~C~~-~g~CG~~g~C~~~-~~~~C~C~~Gf~ 283 (804)
|+|.. ...|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56765 4679999999765 467899999997
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.28 E-value=0.25 Score=32.26 Aligned_cols=31 Identities=35% Similarity=0.774 Sum_probs=23.8
Q ss_pred CCcccccCCCCCccccCC-CCCCCCCCCCCccc
Q 044374 254 DICRVHGLCGNFGFCKSS-LLRPCMCFDGFRPV 285 (804)
Q Consensus 254 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 285 (804)
|.|. ..-|...|.|... ..-.|.|++||+=.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4679999999765 47889999999743
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.04 E-value=0.5 Score=31.49 Aligned_cols=31 Identities=23% Similarity=0.348 Sum_probs=24.3
Q ss_pred CCCcccccCCCCCccccCC-CCCCCCCCCCCcc
Q 044374 253 EDICRVHGLCGNFGFCKSS-LLRPCMCFDGFRP 284 (804)
Q Consensus 253 ~~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~ 284 (804)
.|+|... .|+.++.|... ++-.|.|++||+.
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 4789765 45578999876 5788999999985
|